<?xml version="1.0"?>
<!DOCTYPE FILE SYSTEM "cfc-2.dtd">
<FILE>


<RECORD>
<PAPERNUM>PN79001</PAPERNUM>
<RECORDNUM>00981 </RECORDNUM>
<MEDLINENUM>79120857</MEDLINENUM>
<AUTHORS><AUTHOR>Jensen-O</AUTHOR></AUTHORS>
<TITLE>'Rusters'.  The corrosive action of palmar sweat: I. Sodium chloride
in sweat.</TITLE>
<SOURCE>Acta-Derm-Venereol (Stockh). 1979. 59(2). P 135-8.</SOURCE>
<MAJORSUBJ><TOPIC>CORROSION</TOPIC><TOPIC>HYPERHIDROSIS</TOPIC><TOPIC>METALLURGY</TOPIC><TOPIC>OCCUPATIONAL-MEDICINE</TOPIC><TOPIC>SODIUM-CHLORIDE</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADMINISTRATION-TOPICAL</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ALUMINUM: tu</TOPIC><TOPIC>CHLORIDES: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DERMATOLOGIC-AGENTS: tu</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HAND</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERHIDROSIS: dt</TOPIC><TOPIC>IONTOPHORESIS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PILOCARPINE</TOPIC><TOPIC>SODIUM-CHLORIDE: an</TOPIC></MINORSUBJ>
<ABSTRACT>Sweat from 8 'rusters' and 8 control persons was examined for its
sodium concentration. Sweating was induced by iontophoresis of
pilocarpine on the distal forearm. In no case did the concentrations
exceed the normal upper limit for this procedure, and no difference
was found between the two groups. In this way the study failed to
confirm earlier reports of elevated sodium chloride concentrations in
sweat from 'rusters'. Proposals of a relationship between 'rusters'
and patients with pancreatic cystic fibrosis were not substantiated.
Hyperhidrosis of the palms and volar surfaces of the fingers was
present in all 'rusters'. This seemed to be the main cause of the
corrosive tendency, and patients referred for palmar hyperhidrosis
were found to produce corrosion similar to the 'rusters'. Topical
application of aluminium chloride hexahydrate in a 25% solution in
absolute ethyl alcohol proved effective against both hyperhidrosis
and the corrosive tendency.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLEN JA" publication="BR J DERMATOL" d1="90" d2="277" d3="974"/>
<CITE num="002" author="BANG PEDERSEN N" publication="BR J DERMATOL" d1="96" d2="332" d3="977"/>
<CITE num="003" author="BUCKLEY WR" publication="J OCCUP MED" d1="2" d2="23" d3="960"/>
<CITE num="004" author="BURTON JL" publication="BR J DERMATOL" d1="95" d2="417" d3="976"/>
<CITE num="005" author="DARLING RC" publication="ARCH PHYS MED" d1="29" d2="150" d3="948"/>
<CITE num="006" author="EISLER SJ" publication="CORROSION" d1="10" d2="237" d3="954"/>
<CITE num="007" author="EVANS UR" publication="INTRODUCTION TO METAL CORR" d1="" d2="28" d3="963"/>
<CITE num="008" author="FISHER AA" publication="CONTACT DERMATITIS" d1="" d2="94" d3="973"/>
<CITE num="009" author="FLENSBORG EW" publication="IONTROPHORESIS APPARATUS" d1="" d2="" d3="971"/>
<CITE num="010" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="011" author="HUFF WJ" publication="CHEM MET ENG" d1="25" d2="865" d3="921"/>
<CITE num="012" author="JOHNSON BB" publication="J INVEST DERMATOL" d1="53" d2="116" d3="969"/>
<CITE num="013" author="LOBITZ WC" publication="ARCH DERMATOL SYPHIL" d1="56" d2="462" d3="947"/>
<CITE num="014" author="ROBINSON S" publication="PHYSIOL REV" d1="34" d2="202" d3="954"/>
<CITE num="015" author="SATO K" publication="J INVEST DERMATOL" d1="55" d2="433" d3="970"/>
<CITE num="016" author="SHELLY WB" publication="ACTA DERM VENEREOL (STOCKH)" d1="55" d2="241" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79002</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSEN O              AC" publication="TA DERM VENEREOL (STOCKH)" d1="59" d2="39 9" d3="9"/>
<CITE num="2" author="TAYLOR JS" publication="J AM ACAD DERMATOL" d1="11" d2="1007" d3="984"/>
</CITATIONS>
<RECORDNUM>00982 </RECORDNUM>
<MEDLINENUM>79205962</MEDLINENUM>
<AUTHORS><AUTHOR>Bak-Pedersen-K</AUTHOR><AUTHOR>Larsen-P-K</AUTHOR></AUTHORS>
<TITLE>Inflammatory middle ear diseases in patients with cystic fibrosis.</TITLE>
<SOURCE>Acta-Otolaryngol [Suppl] (Stockh). 1979. (360). P 138-40.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>OTITIS-MEDIA: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACOUSTIC-IMPEDANCE-TESTS</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AUDIOMETRY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEARING-LOSS-PARTIAL: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NASAL-POLYPS: et</TOPIC><TOPIC>OTITIS-MEDIA: co, pp</TOPIC><TOPIC>PROSPECTIVE-STUDIES</TOPIC></MINORSUBJ>
<ABSTRACT>111 patients with cystic fibrosis (CF), aged 7 months to 29 years,
were examined to detect inflammatory middle ear diseases. 35% had a
history of one or more attacks of acute otitis media, an incidence at
the same level as in non-CF patients. None had chronic suppurative
otitis. Only 4 out of the 88 patients able to cooperate in audiometry
had a hearing impairment. In 2, the hearing loss was perceptive, in 3
very mild, and in the fourth case, moderately severe. The middle ear
pressure was measured in 108 patients, in 86 of whom it proved
normal. In 15 patients the middle ear pressure was lower than--100
mmH2O, indicating tubal occlusion, and in 7 patients the impedance
minimum was lacking, indicating an accumulation of mucus. These 7
patients (6%) had secretory otitis media. Nasal polyps were or had
been present in 32%. There was no correlation between nasal polyps
and tubal occlusion or secretory otitis. The incidence of
inflammatory middle ear diseases in CF patients was in the same range
as in non-CF patients, a finding at variance with some previous
investigations showing middle ear pathology in 25--48%.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAK-PEDERSEN K" publication="THESIS" d1="" d2="" d3="977"/>
<CITE num="002" author="FORCUCCI RA" publication="ARCH OTOLARYNGOL" d1="96" d2="361" d3="972"/>
<CITE num="003" author="FRITZE W" publication="Z KINDERHEILK" d1="114" d2="111" d3="973"/>
<CITE num="004" author="JERGER J" publication="ARCH OTOLARYNGOL" d1="93" d2="111" d3="971"/>
<CITE num="005" author="JOHANSEN PG" publication="LANCET" d1="1" d2="455" d3="968"/>
<CITE num="006" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="9" d2="390" d3="970"/>
<CITE num="007" author="NEELY JG" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="76" d2="313" d3="972"/>
<CITE num="008" author="PENNINGTON CL" publication="ARCH OTOLARYNGOL" d1="63" d2="576" d3="956"/>
<CITE num="009" author="SIEGEL J" publication="ARCH OTOLARYNGOL" d1="92" d2="523" d3="970"/>
<CITE num="010" author="TAYLOR BW" publication="ARCH DIS CHILD" d1="49" d2="133" d3="974"/>
<CITE num="011" author="TYGSTRUP I" publication="UGESKR LAEG TRANS DAN MED" d1="1" d2="6" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79003</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DERSEN M            CL" publication="IN OTOLARYNGOL" d1="7" d2="73 9" d3="2"/>
<CITE num="2" author="VANCAUWENBERGE PB" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="414" d2="147" d3="984"/>
<CITE num="3" author="DAVID TJ" publication="J ROY SOC MED" d1="79" d2="23" d3="986"/>
</CITATIONS>
<RECORDNUM>00983 </RECORDNUM>
<MEDLINENUM>79228230</MEDLINENUM>
<AUTHORS><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Hertz-J-B</AUTHOR></AUTHORS>
<TITLE>Precipitating antibodies against Escherichia coli, Bacteroides
fragilis ss.  thetaiotaomicron and Pseudomonas aeruginosa in serum
from normal persons and cystic fibrosis patients, determined by
means of crossed immunoelectrophoresis.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1979 Jul. 68(4). P 495-500.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-BACTERIAL</TOPIC><TOPIC>BACTEROIDES-FRAGILIS: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>ESCHERICHIA-COLI: im</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Serum from normal persons and from 133 cystic fibrosis patients was
examined for precipitins against faecal bacteria (E. coli and B.
fragilis) and against P. aeruginosa by means of crossed
immunoelectrophoresis.  27% of the normal sera contained 1-2
precipitins against E. coli, 16% contained one precipitin against B.
fragilis and 6% contained one precipitin against P. aeruginosa.  In
sera from cystic fibrosis patients, there was a significantly
increased prevalence of precipitins against E. coli (76%), B.
fragilis (38%) and P. aeruginosa (63%), and the mean number of
precipitins against each of these bacteria was 3 (range: 1-12), 1.4
(range: 1-4), and 16 (range: 1-60), respectively.  Increased numbers
of precipitins against P. aeruginosa were correlated with chronic
lung infection caused by this species and with poor prognosis,
whereas such associations were not revealed as regards precipitins
against the two other bacterial species.  Increased numbers of
precipitins against E. coli and B. fragilis were significantly
associated with increased numbers of precipitins against P.
aeruginosa.  It is suggested that this association is due to immune
reactions in the intestinal mucosa, resulting in increased
absorption of antigens from the gut.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BJORNEBOE M" publication="LANCET" d1="1" d2="58" d3="972"/>
<CITE num="002" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="003" author="FINEGOLD SM" publication="ANAEROBIC BACTERIA HUMAN DIS" d1="" d2="" d3="977"/>
<CITE num="004" author="GIBBONS A" publication="BR MED J" d1="1" d2="120" d3="976"/>
<CITE num="005" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="006" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="007" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="008" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="009" author="HOIBY N" publication="SCAND J IMMUNOL SUPPL 2" d1="4" d2="187" d3="975"/>
<CITE num="010" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="142" d3="977"/>
<CITE num="011" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="012" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="013" author="SASAKI M" publication="JAPAN J EXP MED" d1="45" d2="335" d3="975"/>
<CITE num="014" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="015" author="SCHWAB JH" publication="BACT REV" d1="39" d2="121" d3="975"/>
<CITE num="016" author="SKIDMORE BJ" publication="J IMMUNOL" d1="114" d2="770" d3="975"/>
<CITE num="017" author="THERKELSEN AJ" publication="MEDICINSK STATISTIK AKADEMISK" d1="" d2="" d3="968"/>
<CITE num="018" author="TOLO K" publication="IMMUNOLOGY" d1="33" d2="733" d3="977"/>
<CITE num="019" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="020" author="WALLWORK JC" publication="CLIN ALLERGY" d1="6" d2="349" d3="976"/>
<CITE num="021" author="WEEKE B" publication="SCAND J IMMUNOL SUPPL 1" d1="2" d2="15" d3="973"/>
<CITE num="022" author="WEEKE B" publication="SCAND J IMMUNOL SUPPL 1" d1="2" d2="47" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79004</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            AC" publication="TA PATH MICROBIOL SCAND (C) S2" d1="76" d2="1 9" d3="1"/>
<CITE num="2" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="89" d2="185" d3="981"/>
<CITE num="3" author="KOCH C" publication="ALLERGY" d1="37" d2="191" d3="982"/>
<CITE num="4" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="5" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="6" author="BERG RD" publication="EOS RIV IMMUNOL IMMUNOFARMACO" d1="5" d2="161" d3="985"/>
<CITE num="7" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
</CITATIONS>
<RECORDNUM>00984 </RECORDNUM>
<MEDLINENUM>79121155</MEDLINENUM>
<AUTHORS><AUTHOR>Berg-N-O</AUTHOR><AUTHOR>Dahlqvist-A</AUTHOR><AUTHOR>Lindberg-T</AUTHOR></AUTHORS>
<TITLE>Exocrine pancreatic insufficiency, small intestinal dysfunction and
protein intolerance.  A chance occurrence or a connection?.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1979 Mar. 68(2). P 275-6.</SOURCE>
<MAJORSUBJ><TOPIC>CELIAC-DISEASE: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DIPEPTIDASES: me</TOPIC><TOPIC>DISACCHARIDASES: me</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GLUTEN: du</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-MUCOSA: en, pa</TOPIC><TOPIC>INTESTINE-SMALL: en, pa</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>The coexistence of cystic fibrosis (CF) and coeliac disease (CD) is
reported in eight children, the odds against this occurring in the
same child being 1:2 million to 1:5.9 million.  In Sweden, it would
be around 1:3 million (incidence of CF 1:3000 and of CD 1:1000).
The coexistence of these two diseases is thought to be chance,
although CF might predispose to the development of CD.  In a 10-year
period (with 33405 live births), we observed three children with
exocrine pancreatic insufficiency and small intestine dysfunction.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="PEDIATRICS" d1="42" d2="492" d3="968"/>
<CITE num="003" author="DAHLQVIST A" publication="ACTA PAEDIATR SCAND" d1="59" d2="621" d3="970"/>
<CITE num="004" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="48" d2="684" d3="973"/>
<CITE num="005" author="KATZ AJ" publication="PEDIATRICS" d1="57" d2="715" d3="976"/>
<CITE num="006" author="KOLLBERG H" publication="ACTA UNIV UPSALIENSIS" d1="192" d2="" d3="974"/>
<CITE num="007" author="LEBENTHAL E" publication="GASTROENTEROLOGY" d1="70" d2="508" d3="976"/>
<CITE num="008" author="MORIN CL" publication="J PEDIATR" d1="88" d2="213" d3="976"/>
<CITE num="009" author="SHMERLING DH" publication="HELV PAEDIATR ACTA" d1="24" d2="547" d3="969"/>
<CITE num="010" author="SHWACHMAN H" publication="J PEDIATR" d1="65" d2="645" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79005</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OSTROM H            J" publication="BIOL CHEM                    2" d1="55" d2="32 9" d3="0"/>
</CITATIONS>
<RECORDNUM>00985 </RECORDNUM>
<MEDLINENUM>79228250</MEDLINENUM>
<AUTHORS><AUTHOR>Taussig-L-M</AUTHOR></AUTHORS>
<TITLE>Increased intracranial pressure in infants with cystic fibrosis
[letter].</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1979 Jul. 68(4). P 615-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>INTRACRANIAL-PRESSURE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<EXTRACT>Although the mechanism proposed by Dr Katznelson for the increased
intracranial pressure observed in three infants with cystic fibrosis
cannot be discounted, another explanation is possible.  It has been
reported previously that a deficiency of vitamin A may predispose to
development of increased intracranial pressure and bulging
fontanelles in cystic fibrosis.  Finally, it is somewhat difficult to
understand how such marked airway obstruction which produced
increased intracranial pressure could occur with preservation of
arterial blood gases. - Vitamin A and carotene blood levels were not
determined in our cases and therefore obviously this possibility
cannot be excluded, at least in two of the cases.  Dr Taussig's
suggestion that the improvement in the intracranial pressure in our
cases was really the result of the "unknowing" associated
administration of vitamin A and not to the improvements in the
pulmonary status, as I proposed, fails to note the clinical
observation that there had been a "rise and fall" in the bulge of the
fontanel concomitantly with the increase and decrease of respiratory
obstruction signs.  As to the question of the severity of airway
obstruction, the clinical reversible picture of severe tachypnea with
poor air entry, clear lung fields on X-ray with overdistended lungs
and small heart appear most suggestive of airway obstruction in C.F.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79006</PAPERNUM>
<REFERENCES>
<CITE num="001" author="KATZNELSON D" publication="ACTA PAEDIATR SCAND" d1="67" d2="607" d3="978"/>
<CITE num="002" author="KEATING JP" publication="PEDIATRICS" d1="46" d2="41" d3="970"/>
</REFERENCES>
<RECORDNUM>00986 </RECORDNUM>
<MEDLINENUM>80150170</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Hoiby-N</AUTHOR></AUTHORS>
<TITLE>Precipitating antibodies against Haemophilus influenzae and
Staphylococcus aureus in sputum and serum from patients with cystic
fibrosis.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [B]. 1979 Dec. 87(6). P 345-51.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-BACTERIAL: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>HAEMOPHILUS-INFLUENZAE: im</TOPIC><TOPIC>PRECIPITINS: an</TOPIC><TOPIC>SPUTUM: mi</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CROSS-REACTIONS</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Serum and sputum sol phase from 23 patients with cystic fibrosis (CF)
were examined for occurrence and titres of precipitins against
Haemophilus influenzae and Staphylococcus aureus by means of crossed
immunoelectrophoresis with intermediate gel. The patients had from
four to nine H. influenzae precipitins in serum and in most cases
fewer precipitins in sputum, but, on an average, there was no
difference between the titres of the antibodies in serum and sputum.
Most of the antibodies were cross-reactive with other species,
notably those of the Haemophilus genus. S. aureus precipitins were
generally found in higher numbers in serum than in sputum, but, on an
average, the titre of the precipitins in sputum was higher than in
serum. Three of the precipitins were detectable only in sputum and
not in serum, and one of these is a S. aureus-specific precipitin.
Most of the antibodies were cross-reactive with other species, and
these antibodies were often present in sputum in much higher titres
than in the corresponding sera. Antibodies against teichoic acid of
the S. aureus cell wall could not be demonstrated in sputum, while
they were present in 22 sera. The possible role of the local
pulmonary humoral immune response in protective immunity and in the
pathology of the lung disease in CF is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="002" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="003" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="004" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="005" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="006" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="007" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="008" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="009" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="010" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="011" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="012" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (B)" d1="87" d2="337" d3="979"/>
<CITE num="013" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (B)" d1="87" d2="329" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79007</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PERSEN F            AC" publication="TA PATH MICROBIOL SCAND (B)" d1="88" d2="37 9" d3="0"/>
<CITE num="2" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="88" d2="275" d3="980"/>
<CITE num="3" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="5" author="PRESSLER T" publication="ACTA PAEDIATR SCAND" d1="73" d2="541" d3="984"/>
</CITATIONS>
<RECORDNUM>00987 </RECORDNUM>
<MEDLINENUM>80016770</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Permin-H</AUTHOR><AUTHOR>Wiik-A</AUTHOR></AUTHORS>
<TITLE>IgA and IgG antibodies against surface antigens of Pseudomonas
aeruginosa in sputum and serum from patients with cystic fibrosis.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [C]. 1979 Jun. 87C(3). P 229-33.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>IGA</TOPIC><TOPIC>IGG</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC><TOPIC>SPUTUM: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBODIES-BACTERIAL</TOPIC><TOPIC>ANTIGENS-BACTERIAL</TOPIC><TOPIC>ANTIGENS-SURFACE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FLUORESCENT-ANTIBODY-TECHNIC</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Eleven cystic fibrosis (CF) patients chronically infected in the
lungs with mucoid Pseudomonas aeruginosa and presenting multiple
precipitins in serum against this bacterium (CF + P) and 10 CF
patients without P. aeruginosa infection (CF-P) had their serum and
sputum sol phase specimens examined for antibodies of the IgA and IgG
classes against surface antigens of P. aeruginosa by means of an
indirect immunofluorescence technique. Both the IgA and IgG antibody
titres demonstrated in serum and sputum of the CF + P patients were
significantly higher than in those of the CF-P patients (p less than
0.01). The titre of IgA antibodies in the sputum was higher than in
serum in 3 cases indicating local pulmonary production of specific
IgA antibodies. The role of the demonstrated antibodies in the local
pulmonary immune defense mechanisms and the possible patogenesis of
the pulmonary tissue damage in CF patients is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERGAN T" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="553" d3="975"/>
<CITE num="002" author="BIGGAR WD" publication="PROC NAT ACAD SCI USA" d1="68" d2="1716" d3="971"/>
<CITE num="003" author="BJORNSON AB" publication="J INFECT DIS SUPPL" d1="130" d2="119" d3="974"/>
<CITE num="004" author="BJORNSON AB" publication="J INFECT DIS SUPPL" d1="130" d2="127" d3="974"/>
<CITE num="005" author="BOXERBAUM B" publication="AM REV RESPIR DIS" d1="108" d2="777" d3="973"/>
<CITE num="006" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="007" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="008" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="009" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="010" author="GOVAN JRW" publication="J MED MICROBIOL" d1="8" d2="513" d3="975"/>
<CITE num="011" author="HANN S" publication="INFECT IMMUN" d1="14" d2="114" d3="976"/>
<CITE num="012" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="013" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="014" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="015" author="HOIBY N" publication="SCAND J IMMUNOL SUPPL 2" d1="4" d2="187" d3="975"/>
<CITE num="016" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="017" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="107" d3="977"/>
<CITE num="018" author="KOCH C" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="144" d3="975"/>
<CITE num="019" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="020" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="021" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="022" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="023" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="87" d2="1" d3="979"/>
<CITE num="024" author="WIIK A" publication="IMMUNOLOGY" d1="23" d2="53" d3="972"/>
<CITE num="025" author="YOUNG LS" publication="J INFECT DIS SUPPL" d1="130" d2="111" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79008</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            AC" publication="TA PATH MICROBIOL SCAND (C)" d1="88" d2="75 9" d3="0"/>
<CITE num="2" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="89" d2="185" d3="981"/>
<CITE num="3" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="4" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="5" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="6" author="SCHILLER NL" publication="PEDIATR RES" d1="17" d2="747" d3="983"/>
<CITE num="7" author="DORING G" publication="J INFECT DIS" d1="147" d2="744" d3="983"/>
<CITE num="8" author="KOHLER B" publication="Z KLIN MED" d1="40" d2="1773" d3="985"/>
<CITE num="9" author="BALTIMORE RS" publication="PEDIATR RES" d1="20" d2="1085" d3="986"/>
</CITATIONS>
<RECORDNUM>00988 </RECORDNUM>
<MEDLINENUM>79162009</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Sorensen-H</AUTHOR><AUTHOR>Hoiby-M</AUTHOR></AUTHORS>
<TITLE>Activated complement in the sputum from patients with cystic
fibrosis.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [C]. 1979 Feb. 87C(1). P 1-5.</SOURCE>
<MAJORSUBJ><TOPIC>COMPLEMENT-ACTIVATION</TOPIC><TOPIC>COMPLEMENT</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>SPUTUM: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ALBUMINS: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>COMPLEMENT-3: an</TOPIC><TOPIC>COMPLEMENT-4: an</TOPIC><TOPIC>COMPLEMENT-5: an</TOPIC><TOPIC>COMPLEMENT: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PNEUMONIA: et, im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: et, im</TOPIC><TOPIC>SERUM-ALBUMIN: an</TOPIC></MINORSUBJ>
<ABSTRACT>14 cystic fibrosis (CF) patients chronically infected with mucoid P.
aeruginosa and presenting multiple precipitins in serum against this
bacterium (CF + P) and 13 CF patients without P. aeruginosa infection
(CF-P) had their plasma and sputum sol phase examined for albumin,
Clq. C3/C3c, C4 and C5 by means of electroimmunoassays. Their sputum
sol phase was examined also for factor B by
rocketimmunoelectrophoresis. C3c was demonstrated in the sputum sol
phase but significantly more frequent (p less than 0.01) among the CF
+ P patients than among the CF-P patients. Factor B was also
demonstrated in the sputum sol phase, but no significant difference
in frequency could be demonstrated between the CF + P and the CF-P
patients. None of the results indicated that a local pulmonary
production of complement factors took place. Complement activation
was significantly (p less than 0.01) associated with inflammation
expressed as increased (formula: see text). The results show the
importance of complement mediated inflammation in the pathogenesis of
pulmonary tissue damage in patients with CF and support the concept
of chronic P. aeruginosa lung infection as an immune complex disease
in CF patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="002" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="003" author="GEWURTZ H" publication="J EXP MED" d1="128" d2="1049" d3="968"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="GREENBLATT J" publication="INFECT IMMUN" d1="19" d2="296" d3="978"/>
<CITE num="006" author="HOFF GE" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="219" d3="975"/>
<CITE num="007" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="008" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="009" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="010" author="LAURELL CB" publication="SCAND J CLIN LAB INVEST SUPPL" d1="124" d2="21" d3="972"/>
<CITE num="011" author="NELSON RA JR" publication="IN: ZWEIFACH BW" d1="3" d2="37" d3="974"/>
<CITE num="012" author="REYNOLDS HY" publication="J LAB CLIN MED" d1="84" d2="559" d3="974"/>
<CITE num="013" author="ROBERTSON J" publication="J IMMUNOL" d1="117" d2="900" d3="976"/>
<CITE num="014" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="015" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="016" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="017" author="STALENHEIM G" publication="IMMUNOCHEMISTRY" d1="10" d2="501" d3="973"/>
<CITE num="018" author="TEISBERG P" publication="CLIN CHIM ACTA" d1="62" d2="35" d3="975"/>
<CITE num="019" author="THUESEN-PEDERSEN J" publication="DAN MED BULL" d1="21" d2="12" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79009</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            AC" publication="TA PATH MICROBIOL SCAND (C)" d1="87" d2="29 9" d3="9"/>
<CITE num="2" author="ETIEVANT M" publication="ANN IMMUNOL (PARIS)" d1="D131" d2="13" d3="980"/>
<CITE num="3" author="SKOV PS" publication="ALLERGY" d1="35" d2="23" d3="980"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="88" d2="275" d3="980"/>
<CITE num="5" author="SMITH TF" publication="INFECT IMMUN" d1="33" d2="43" d3="981"/>
<CITE num="6" author="MOSS RB" publication="CLIN EXP IMMUNOL" d1="47" d2="301" d3="982"/>
<CITE num="7" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="8" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="9" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="10" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND" d1="72" d2="283" d3="983"/>
<CITE num="11" author="PIER GB" publication="J INFECT DIS" d1="150" d2="223" d3="984"/>
<CITE num="12" author="SORDELLI DO" publication="EUR J RESPIR DIS" d1="67" d2="118" d3="985"/>
<CITE num="13" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
<CITE num="14" author="KHARAZMI A" publication="EUR J CLIN INVEST" d1="16" d2="143" d3="986"/>
<CITE num="15" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
<CITE num="16" author="EDWARDS KM" publication="ARCH VIROL" d1="88" d2="49" d3="986"/>
<CITE num="17" author="MOSS RB" publication="AM REV RESPIR DIS" d1="133" d2="648" d3="986"/>
</CITATIONS>
<RECORDNUM>00989 </RECORDNUM>
<MEDLINENUM>80084554</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Egeskjold-E-M</AUTHOR><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Permin-H</AUTHOR></AUTHORS>
<TITLE>Autoantibodies in serum and sputum from patients with cystic
fibrosis.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [C]. 1979 Oct. 87(5). P 319-24.</SOURCE>
<MAJORSUBJ><TOPIC>AUTOANTIBODIES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>SPUTUM: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTINUCLEAR-FACTORS: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DNA: im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FLUORESCENT-ANTIBODY-TECHNIC</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGA: an</TOPIC><TOPIC>IGG: an</TOPIC><TOPIC>IGM: an</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>LATEX-FIXATION-TESTS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co, im</TOPIC><TOPIC>RHEUMATOID-FACTOR: an</TOPIC></MINORSUBJ>
<ABSTRACT>Sera from 89 patients with cystic fibrosis (CF) and 88 control
persons were examined for the occurrence of rheumatoid factors (RF)
of the IgG, IgA and IgM classes by an indirect immunofluorescence
method and by the latex fixation slide test. The prevalence of RF-IgG
was significantly higher (88%) (p less than 0.0005) among the CF
patients than among the control persons (7%), while no difference was
found between the two groups with regard to RF of the IgA or IgM
classes. Fifty-five of the CF patients had chronic Pseudomonas
aeruginosa infection in their lungs and two or more precipitins
against these bacteria in their sera determined by crossed
immunoelectrophoresis. These CF patients did not differ from the 34
CF patients without chronic P. aeruginosa infection, neither with
regard to prevalence nor titer of RFs, but there was a positive
correlation between the number of P. aeruginosa precipitins in the 55
chronically infected CF patients and their titers of IgG-RF. Nineteen
CF patients were examined also for RFs, antinuclear antibodies (ANA)
and anti-DNA antibodies in their sputum sol phase and corresponding
sera. RFs were demonstrated in the sputum sol phase from 6 of the
patients by the latex fixation test, whereas their sera were negative
in this test, possibly indicating a local production of RF. Positive
reactions for ANA and anti-DNA antibodies were found in 7 and 10 of
the sputa respectively, and in higher titers than in the
corresponding sera, also suggesting a local production. Titers of
autoantibodies in sputum were low and no difference was found between
patients with chronic P. aeruginosa infection and patients without P.
aeruginosa infection. The possible role of autoantibodies in the
patogenesis of pulmonary tissue damage in CF patients is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARTFELD H" publication="ANN NY ACAD SCI" d1="168" d2="30" d3="969"/>
<CITE num="002" author="BONOMO L" publication="AM J CLIN PATHOL" d1="45" d2="313" d3="966"/>
<CITE num="003" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="004" author="CARSON DA" publication="CLIN EXP IMMUNOL" d1="31" d2="100" d3="978"/>
<CITE num="005" author="DEHORATIUS RJ" publication="ARCH INTERN MED" d1="129" d2="441" d3="972"/>
<CITE num="006" author="DEHORATIUS RJ" publication="ARTHRITIS RHEUM" d1="15" d2="293" d3="972"/>
<CITE num="007" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="008" author="ESTES D" publication="ARTHRITIS RHEUM" d1="16" d2="59" d3="973"/>
<CITE num="009" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="010" author="HODSON ME" publication="BR J DIS CHEST" d1="70" d2="83" d3="976"/>
<CITE num="011" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="012" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="013" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="014" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="015" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="107" d3="977"/>
<CITE num="016" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="017" author="KALLERUP HE" publication="SCAND J RHEUMATOL" d1="8" d2="1" d3="979"/>
<CITE num="018" author="KOFFLER D" publication="J EXP MED" d1="126" d2="607" d3="967"/>
<CITE num="019" author="KOFFLER D" publication="J EXP MED" d1="134" d2="169" d3="971"/>
<CITE num="020" author="LIEBERMAN J" publication="LAB INVEST" d1="14" d2="249" d3="965"/>
<CITE num="021" author="LIND I" publication="SCAND J IMMUNOL" d1="3" d2="689" d3="974"/>
<CITE num="022" author="MCCORMICK JN" publication="IN: DUMONDE D" d1="" d2="68" d3="976"/>
<CITE num="023" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="024" author="MUNTHE E" publication="CLIN EXP IMMUNOL" d1="8" d2="249" d3="971"/>
<CITE num="025" author="PERMIN H" publication="ACTA MED SCAND" d1="203" d2="61" d3="978"/>
<CITE num="026" author="RHEINS MS" publication="J LAB CLIN MED" d1="50" d2="113" d3="957"/>
<CITE num="027" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="028" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="029" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="030" author="TAN EM" publication="J CLIN INVEST" d1="45" d2="1732" d3="966"/>
<CITE num="032" author="THUESEN-PEDERSEN J" publication="DAN MED BULL" d1="21" d2="12" d3="974"/>
<CITE num="033" author="TURNER-WARWICK M" publication="BR MED J" d1="3" d2="492" d3="970"/>
<CITE num="034" author="WALLER M" publication="J INFECT DIS" d1="125" d2="45" d3="972"/>
<CITE num="035" author="WIIK A" publication="IMMUNOLOGY" d1="23" d2="53" d3="972"/>
<CITE num="036" author="WIIK A" publication="ANN RHEUM DIS" d1="33" d2="515" d3="974"/>
<CITE num="037" author="WINCHESTER RJ" publication="CLIN EXP IMMUNOL" d1="6" d2="689" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79010</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ESKJOLD EM          AL" publication="LERGY" d1="36" d2="73 9" d3="1"/>
<CITE num="2" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="89" d2="185" d3="981"/>
<CITE num="3" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="4" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="5" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="6" author="EGESKJOLD EM" publication="SCAND J RHEUMATOL" d1="14" d2="51" d3="985"/>
<CITE num="7" author="DISIS ML" publication="PEDIATR RES" d1="20" d2="385" d3="986"/>
<CITE num="8" author="LIMSCHOU EME" publication="DAN MED BULL" d1="33" d2="249" d3="986"/>
<CITE num="9" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
</CITATIONS>
<RECORDNUM>00990 </RECORDNUM>
<MEDLINENUM>80172132</MEDLINENUM>
<AUTHORS><AUTHOR>Taussig-L-M</AUTHOR><AUTHOR>Lemen-R-J</AUTHOR></AUTHORS>
<TITLE>Chronic obstructive lung disease.</TITLE>
<SOURCE>Adv-Pediatr. 1979. 26. P 343-416. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>LUNG-DISEASES-OBSTRUCTIVE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AIRWAY-OBSTRUCTION: di</TOPIC><TOPIC>ASTHMA: di</TOPIC><TOPIC>ATELECTASIS: di</TOPIC><TOPIC>BRONCHIAL-DISEASES: di</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPOVENTILATION: et</TOPIC><TOPIC>IMMUNOLOGIC-DEFICIENCY-SYNDROMES: di</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: di, et, th</TOPIC><TOPIC>MEDICAL-HISTORY-TAKING</TOPIC><TOPIC>PHYSICAL-EXAMINATION</TOPIC><TOPIC>PNEUMONIA-ASPIRATION: di</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>TRACHEAL-DISEASES: di</TOPIC></MINORSUBJ>
<EXTRACT>This chapter deals with the problems of chronic obstructive lung
disease in children by first considering an approach to the
evaluation, diagnosis and management of various forms of chronic
obstructive lung disease with emphasis on history, physical and
laboratory data.  A brief overview of therapeutic principles that can
be applied to most forms of chronic obstructive lung disease are
included.  The second part of this chapter consists of reviews of
some of the more common diseases producing chronic airway obstruction
in infancy and childhood.  Patient evaluation topics discussed
include history and physical examination and laboratory studies.
Therapeutic principles in the management of chronic obstructive lung
disease, pediatric precursors of chronic obstructive lung disease,
and chronic obstructive lung disorders (asthma, cystic fibrosis,
bronchopulmonary dysplasia, aspiration pneumonitis, atelectasis,
bronchomalacia and tracheomalacia, immunodeficiency, bronchiectasis,
chronic bronchitis, and chronic upper airway obstruction with
hypoventilation) are examined.</EXTRACT>
<REFERENCES>
<CITE num="001" author="TAUSSIG LM" publication="ARIZ MED" d1="33" d2="205" d3="976"/>
<CITE num="002" author="HOLSCLAW DS" publication="PEDIATR ANN" d1="6" d2="438" d3="977"/>
<CITE num="003" author="ANON" publication="US NATL HEALTH SURVEY" d1="" d2="" d3="975"/>
<CITE num="004" author="WARING WW" publication="RESPIR CARE" d1="20" d2="1138" d3="975"/>
<CITE num="005" author="HOGG JC" publication="IN: KENDIG EL JR" d1="" d2="" d3="977"/>
<CITE num="006" author="DUNNILL MS" publication="THORAX" d1="17" d2="329" d3="962"/>
<CITE num="007" author="WILLIAMS HE" publication="RESPIRATORY ILLNESS IN CHILDR" d1="" d2="" d3="975"/>
<CITE num="008" author="TAUSSIG LM" publication="AM REV RESPIR DIS" d1="116" d2="233" d3="977"/>
<CITE num="009" author="WARING WW" publication="IN: KENDIG EL JR" d1="" d2="105" d3="977"/>
<CITE num="010" author="SMITH CB" publication="RADIOL CLIN NORTH AM" d1="11" d2="261" d3="973"/>
<CITE num="011" author="FLETCHER BD" publication="IN: KENDIG EL JR" d1="" d2="" d3="977"/>
<CITE num="012" author="LEMEN RG" publication="IN: KENDIG EL JR" d1="" d2="166" d3="977"/>
<CITE num="013" author="POLGAR G" publication="PULMONARY FUNCTION TESTING IN" d1="" d2="" d3="971"/>
<CITE num="014" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="015" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="016" author="GODFREY S" publication="EXERCISE TESTING IN CHILDREN" d1="" d2="" d3="974"/>
<CITE num="017" author="WARING WW" publication="DIAGNOSTIC PROCEDURES PRACTIC" d1="" d2="" d3="975"/>
<CITE num="018" author="EULER AR" publication="PEDIATRICS" d1="60" d2="65" d3="977"/>
<CITE num="019" author="CHRISTIE DL" publication="J PEDIATR" d1="93" d2="23" d3="978"/>
<CITE num="020" author="JONES FL JR" publication="IN: JOHNSTON RF" d1="" d2="" d3="973"/>
<CITE num="021" author="RICKARD K" publication="PEDIATR CLIN NORTH AM" d1="24" d2="157" d3="977"/>
<CITE num="022" author="SUSKIND RM" publication="MALNUTRITION AND THE IMMUNE R" d1="7" d2="" d3="977"/>
<CITE num="023" author="HAMBRAEUS L" publication="PEDIATR CLIN NORTH AM" d1="24" d2="17" d3="977"/>
<CITE num="024" author="FELDMAN J" publication="AM REV RESPIR DIS" d1="119" d2="239" d3="979"/>
<CITE num="025" author="HARTSELL M" publication="AM REV RESPIR DIS" d1="117" d2="204" d3="978"/>
<CITE num="026" author="WARING WW" publication="IN: KENDIG EL JR" d1="" d2="77" d3="977"/>
<CITE num="027" author="TAUSSIG LM" publication="J PEDIATR" d1="84" d2="619" d3="974"/>
<CITE num="028" author="KEENS TG" publication="AM REV RESPIR DIS" d1="116" d2="853" d3="977"/>
<CITE num="029" author="MACKOWIAK PA" publication="N ENGL J MED" d1="298" d2="21" d3="978"/>
<CITE num="030" author="AMMANN AJ" publication="N ENGL J MED" d1="297" d2="897" d3="977"/>
<CITE num="031" author="AUSTRIAN R" publication="N ENGL J MED" d1="297" d2="938" d3="977"/>
<CITE num="032" author="MONSET-COUCHARD M" publication="CURR PROB PEDIATR NO 4" d1="5" d2="" d3="975"/>
<CITE num="033" author="LUCAS RV" publication="MINN MED" d1="52" d2="1537" d3="969"/>
<CITE num="034" author="HEINEMANN H" publication="AM J MED" d1="64" d2="367" d3="978"/>
<CITE num="035" author="BERGLUND E" publication="AM J CARDIOL" d1="11" d2="477" d3="963"/>
<CITE num="036" author="BLAND R" publication="J CLIN INVEST" d1="62" d2="601" d3="978"/>
<CITE num="037" author="TAUSSIG LM" publication="PEDIATR RES" d1="11" d2="216" d3="977"/>
<CITE num="038" author="KERREBIJN KF" publication="ACTA PAEDIATR SCAND SUPPL" d1="261" d2="3" d3="977"/>
<CITE num="039" author="LANG WR" publication="BR MED J" d1="1" d2="73" d3="969"/>
<CITE num="040" author="GOLD R" publication="J CAN ASSOC RADIOL" d1="20" d2="218" d3="969"/>
<CITE num="041" author="BECROFT DMO" publication="J CLIN PATHOL" d1="24" d2="72" d3="971"/>
<CITE num="042" author="COLLEY JRT" publication="BR MED J" d1="2" d2="213" d3="970"/>
<CITE num="043" author="COLLEY JRT" publication="BR MED BULL" d1="27" d2="9" d3="971"/>
<CITE num="044" author="HOLLAND WW" publication="BR MED J" d1="2" d2="205" d3="969"/>
<CITE num="045" author="DOUGLAS JWB" publication="BR J PREV SOC MED" d1="20" d2="1" d3="966"/>
<CITE num="046" author="ZAPLETAL A" publication="AM REV RESPIR DIS" d1="107" d2="400" d3="973"/>
<CITE num="047" author="HARLAP S" publication="LANCET" d1="1" d2="529" d3="974"/>
<CITE num="048" author="COLLEY JRT" publication="LANCET" d1="2" d2="1031" d3="974"/>
<CITE num="049" author="COLLEY JRT" publication="BR MED J" d1="2" d2="201" d3="974"/>
<CITE num="050" author="BLAND M" publication="ARCH DIS CHILD" d1="53" d2="100" d3="978"/>
<CITE num="051" author="LEBOWITZ MD" publication="CHEST" d1="69" d2="48" d3="976"/>
<CITE num="052" author="SCHILLING RSF" publication="AM J EPIDEMIOL" d1="106" d2="274" d3="977"/>
<CITE num="053" author="SEELY JE" publication="SCIENCE" d1="172" d2="741" d3="971"/>
<CITE num="054" author="HAYNES WF JR" publication="AM REV RESPIR DIS SUPPL" d1="93" d2="730" d3="966"/>
<CITE num="055" author="COLLEY JRT" publication="BR MED J" d1="3" d2="195" d3="973"/>
<CITE num="056" author="KIERNAN KE" publication="RESPIRATION" d1="33" d2="236" d3="976"/>
<CITE num="057" author="BURROWS B" publication="AM REV RESPIR DIS" d1="115" d2="751" d3="977"/>
<CITE num="058" author="LOUGHLIN GM" publication="J PEDIATR" d1="94" d2="365" d3="979"/>
<CITE num="059" author="BECKERMAN RC" publication="PEDIATR RES" d1="12" d2="559" d3="978"/>
<CITE num="060" author="KATTAN M" publication="PEDIATRICS" d1="59" d2="683" d3="977"/>
<CITE num="061" author="SIMS DG" publication="BR MED J" d1="1" d2="11" d3="978"/>
<CITE num="062" author="KONIG P" publication="ARCH DIS CHILD" d1="47" d2="578" d3="972"/>
<CITE num="063" author="ROONEY JC" publication="J PEDIATR" d1="79" d2="744" d3="971"/>
<CITE num="064" author="ZWEIMAN B" publication="J ALLERGY" d1="37" d2="48" d3="966"/>
<CITE num="065" author="HILL DJ" publication="AM REV RESPIR DIS" d1="106" d2="873" d3="972"/>
<CITE num="066" author="MCFADDEN ER JR" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="18" d3="975"/>
<CITE num="067" author="PALMER KNV" publication="BR MED J" d1="1" d2="485" d3="975"/>
<CITE num="068" author="BLAIR H" publication="ARCH DIS CHILD" d1="52" d2="613" d3="977"/>
<CITE num="069" author="BURANAKUL B" publication="AM J DIS CHILD" d1="128" d2="343" d3="974"/>
<CITE num="070" author="DEES SC" publication="ADV ASTHMA ALLERGY" d1="1" d2="12" d3="974"/>
<CITE num="071" author="LEVISON H" publication="PEDIATR CLIN NORTH AM" d1="21" d2="951" d3="974"/>
<CITE num="072" author="GOLD WM" publication="J APPL PHYSIOL" d1="33" d2="496" d3="972"/>
<CITE num="073" author="OLIVE JT" publication="AM REV RESPIR DIS" d1="106" d2="366" d3="972"/>
<CITE num="074" author="TSUCHIYA Y" publication="J ALLERGY" d1="36" d2="514" d3="965"/>
<CITE num="075" author="TURIAF J" publication="REV TUBERC" d1="26" d2="238" d3="962"/>
<CITE num="076" author="INNES IR" publication="IN: GOODMAN LS" d1="" d2="447" d3="975"/>
<CITE num="077" author="SCHAER H" publication="PFLUEGERS ARCH" d1="347" d2="297" d3="974"/>
<CITE num="078" author="STALCUP SA" publication="N ENGL J MED" d1="297" d2="592" d3="977"/>
<CITE num="079" author="GALANT SP" publication="PEDIATRICS" d1="61" d2="46" d3="978"/>
<CITE num="080" author="MCFADDEN ER JR" publication="N ENGL J MED" d1="288" d2="221" d3="973"/>
<CITE num="081" author="EGGLESTON PA" publication="PEDIATRICS" d1="54" d2="442" d3="974"/>
<CITE num="082" author="WEISS EB" publication="CIBA FOUND SYMP" d1="27" d2="71" d3="975"/>
<CITE num="083" author="WEINBERGER M" publication="POSTGRAD MED J" d1="61" d2="85" d3="977"/>
<CITE num="084" author="CHAI H" publication="ADV ASTHMA ALLERGY" d1="2" d2="1" d3="975"/>
<CITE num="085" author="BIERMAN CW" publication="PEDIATRICS" d1="54" d2="245" d3="974"/>
<CITE num="086" author="WALSON PD" publication="J PEDIATR" d1="91" d2="321" d3="977"/>
<CITE num="087" author="KOCH-WEBER J" publication="N ENGL J MED" d1="297" d2="476" d3="977"/>
<CITE num="088" author="INGRAM RH JR" publication="AM REV RESPIR DIS" d1="101" d2="364" d3="970"/>
<CITE num="089" author="WOOD DW" publication="ANN ALLERGY" d1="31" d2="607" d3="973"/>
<CITE num="090" author="PIERSON WE" publication="PEDIATRICS" d1="54" d2="282" d3="974"/>
<CITE num="091" author="BERMAN SZ" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="206" d3="975"/>
<CITE num="092" author="MCINTOSH K" publication="J PEDIATR" d1="82" d2="578" d3="973"/>
<CITE num="093" author="SHAPIRO GG" publication="PEDIATRICS" d1="53" d2="867" d3="974"/>
<CITE num="094" author="MINOR TE" publication="JAMA" d1="227" d2="292" d3="974"/>
<CITE num="095" author="TAUSSIG LM" publication="IN: KELLEY VC" d1="4" d2="1" d3="976"/>
<CITE num="096" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="097" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="098" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="099" author="ZUELZER WW" publication="PEDIATRICS" d1="4" d2="53" d3="949"/>
<CITE num="100" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="101" author="BEDROSSIAN CWM" publication="HUM PATHOL" d1="7" d2="195" d3="976"/>
<CITE num="102" author="LAMARRE A" publication="PEDIATRICS" d1="50" d2="291" d3="972"/>
<CITE num="103" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="104" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
<CITE num="105" author="FOX WW" publication="PEDIATRICS" d1="54" d2="293" d3="974"/>
<CITE num="106" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="111" d2="725" d3="975"/>
<CITE num="107" author="TAUSSIG LM" publication="J PEDIATR" d1="84" d2="724" d3="974"/>
<CITE num="108" author="LLOYD-STILL JD" publication="PEDIATRICS" d1="53" d2="678" d3="974"/>
<CITE num="109" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="110" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="111" author="STRUNK RC" publication="ARCH DIS CHILD" d1="52" d2="687" d3="977"/>
<CITE num="112" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="113" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="114" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="120" d2="432" d3="970"/>
<CITE num="115" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="116" author="BARDANA EJ JR" publication="AM J DIS CHILD" d1="129" d2="1164" d3="975"/>
<CITE num="117" author="GALANT SP" publication="AM REV RESPIR DIS" d1="114" d2="325" d3="976"/>
<CITE num="118" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="119" author="SHAPIRO GG" publication="PEDIATRICS" d1="58" d2="740" d3="976"/>
<CITE num="120" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="121" author="TALAMO RC" publication="IN: MANGOS JA" d1="" d2="195" d3="976"/>
<CITE num="122" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="111" d2="408" d3="966"/>
<CITE num="123" author="MARTINEZ-TELLO FJ" publication="J IMMUNOL" d1="101" d2="989" d3="968"/>
<CITE num="124" author="PENNINGTON JE" publication="AM J MED" d1="58" d2="629" d3="975"/>
<CITE num="125" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="559" d3="974"/>
<CITE num="126" author="BIGGAR WD" publication="PROC NAT ACAD SCI USA" d1="68" d2="1716" d3="971"/>
<CITE num="127" author="BOXERBAUM B" publication="AM REV RESPIR DIS" d1="108" d2="777" d3="973"/>
<CITE num="128" author="STEIN AA" publication="J PEDIATR" d1="65" d2="495" d3="964"/>
<CITE num="129" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="130" author="HODSON ME" publication="BR J DIS CHEST" d1="70" d2="83" d3="976"/>
<CITE num="131" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="132" author="WARWICK WJ" publication="J CHRON DIS" d1="28" d2="609" d3="975"/>
<CITE num="133" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="976"/>
<CITE num="134" author="THOMPSON T" publication="J PERINATAL MED" d1="5" d2="149" d3="977"/>
<CITE num="135" author="NORTHWAY WH JR" publication="N ENGL J MED" d1="276" d2="357" d3="967"/>
<CITE num="136" author="BENOIST MR" publication="BULL EUR PHYSIOPATH RESP" d1="12" d2="703" d3="976"/>
<CITE num="137" author="JOHNSON JD" publication="J PEDIATR" d1="84" d2="272" d3="974"/>
<CITE num="138" author="RHODES PG" publication="PEDIATRICS" d1="55" d2="788" d3="975"/>
<CITE num="139" author="HARROD JR" publication="J PEDIATR" d1="84" d2="277" d3="974"/>
<CITE num="140" author="SPOELSTRA AJG" publication="BIOL NEONATE" d1="17" d2="321" d3="971"/>
<CITE num="141" author="SHEPARD FM" publication="N ENGL J MED" d1="279" d2="1063" d3="968"/>
<CITE num="142" author="BOSS JA" publication="PEDIATRICS" d1="29" d2="890" d3="962"/>
<CITE num="143" author="TAGHIZADEH A" publication="AM J PATHOL" d1="82" d2="241" d3="976"/>
<CITE num="144" author="ANDERSON WR" publication="ARCH PATHOL" d1="91" d2="506" d3="971"/>
<CITE num="145" author="LALANDE J" publication="ANN RADIOL (PARIS)" d1="15" d2="R74" d3="973"/>
<CITE num="146" author="STAHLMAN M" publication="PEDIATR CLIN NORTH AM" d1="20" d2="433" d3="973"/>
<CITE num="147" author="BRYAN MH" publication="PEDIATRICS" d1="52" d2="169" d3="973"/>
<CITE num="148" author="OUTERBRIDGE EW" publication="AM J DIS CHILD" d1="123" d2="99" d3="972"/>
<CITE num="149" author="LAMARRE A" publication="AM REV RESPIR DIS" d1="108" d2="56" d3="973"/>
<CITE num="150" author="WESTGATE HD" publication="DIS CHEST" d1="55" d2="465" d3="969"/>
<CITE num="151" author="WATTS JL" publication="PEDIATRICS" d1="60" d2="273" d3="977"/>
<CITE num="152" author="STOCKS J" publication="PEDIATRICS" d1="57" d2="352" d3="976"/>
<CITE num="153" author="BARNES ND" publication="LANCET" d1="2" d2="1096" d3="969"/>
<CITE num="154" author="COATES AL" publication="J PEDIATR" d1="90" d2="611" d3="977"/>
<CITE num="155" author="EDWARDS DK" publication="PEDIATRICS" d1="59" d2="839" d3="977"/>
<CITE num="156" author="DELEMOS R" publication="ANESTHESIOLOGY" d1="30" d2="609" d3="969"/>
<CITE num="157" author="LEE CJ" publication="J THORAC CARDIOVASC SURG" d1="53" d2="759" d3="967"/>
<CITE num="158" author="NASH G" publication="ARCH PATHOL" d1="21" d2="234" d3="971"/>
<CITE num="159" author="BERG TJ" publication="PEDIATRICS" d1="55" d2="51" d3="975"/>
<CITE num="160" author="FLETCHER BD" publication="ANN RADIOL (PARIS)" d1="16" d2="R78" d3="973"/>
<CITE num="161" author="PHILIP AGS" publication="PEDIATRICS" d1="55" d2="44" d3="975"/>
<CITE num="162" author="REYNOLDS EOR" publication="ARCH DIS CHILD" d1="49" d2="50" d3="974"/>
<CITE num="163" author="LILAND AE" publication="J SURG RES" d1="20" d2="85" d3="976"/>
<CITE num="164" author="RASCHE RFH" publication="PEDIATRICS" d1="50" d2="632" d3="972"/>
<CITE num="165" author="SAHEBJAMI H" publication="AM REV RESPIR DIS" d1="110" d2="566" d3="974"/>
<CITE num="166" author="BADEN M" publication="PEDIATRICS" d1="50" d2="526" d3="972"/>
<CITE num="167" author="PINNEY MA" publication="PEDIATRICS" d1="58" d2="856" d3="976"/>
<CITE num="168" author="MCNAMARA JJ" publication="PEDIATRICS" d1="43" d2="527" d3="969"/>
<CITE num="169" author="DAVIS MV" publication="ANN THORAC SURG" d1="3" d2="99" d3="967"/>
<CITE num="170" author="HERBST JJ" publication="J PEDIATR" d1="92" d2="73" d3="978"/>
<CITE num="171" author="LEAPE LL" publication="PEDIATRICS" d1="60" d2="924" d3="977"/>
<CITE num="172" author="WILLIAMS HE" publication="RESPIRATORY ILLNESS IN CHILDR" d1="" d2="" d3="975"/>
<CITE num="173" author="JOHNSON DG" publication="PEDIATRICS" d1="59" d2="62" d3="977"/>
<CITE num="174" author="JAMES V" publication="Q J MED" d1="25" d2="121" d3="956"/>
<CITE num="175" author="WARING WW" publication="PEDIATRICS" d1="39" d2="166" d3="967"/>
<CITE num="176" author="NEMIR RL" publication="IN: KENDIG EL JR" d1="" d2="553" d3="977"/>
<CITE num="177" author="STANGER P" publication="PEDIATRICS" d1="43" d2="760" d3="969"/>
<CITE num="178" author="WILLIAMS H" publication="ARCH DIS CHILD" d1="35" d2="182" d3="960"/>
<CITE num="179" author="WILLIAMS HE" publication="ARCH DIS CHILD" d1="47" d2="423" d3="972"/>
<CITE num="180" author="GUPTA TCM" publication="AM J DIS CHILD" d1="115" d2="88" d3="968"/>
<CITE num="182" author="AGOSTI E" publication="ACTA PAEDIATR SCAND" d1="63" d2="616" d3="974"/>
<CITE num="183" author="WAYNE KS" publication="AM REV RESPIR DIS" d1="114" d2="15" d3="976"/>
<CITE num="184" author="LANDING BH" publication="PERSPECT PEDIATR PATHOL" d1="1" d2="" d3="973"/>
<CITE num="185" author="EIGEN H" publication="AM REV RESPIR DIS" d1="113" d2="823" d3="976"/>
<CITE num="186" author="JONES JF" publication="ARIZ MED" d1="33" d2="359" d3="976"/>
<CITE num="187" author="POLMAR SH" publication="IN: KIRKPATRICK CH" d1="" d2="191" d3="976"/>
<CITE num="188" author="STIEHM ER" publication="IMMUNOL DISORD INFANT CHILD" d1="" d2="145" d3="973"/>
<CITE num="189" author="AMMANN AJ" publication="CURR PROB PEDIATR" d1="5" d2="" d3="975"/>
<CITE num="190" author="BACHMANN R" publication="SCAND J CLIN LAB INVEST" d1="17" d2="316" d3="965"/>
<CITE num="191" author="HUGHES WT" publication="N ENGL J MED" d1="297" d2="1381" d3="977"/>
<CITE num="192" author="FIELD CE" publication="ARCH DIS CHILD" d1="44" d2="551" d3="969"/>
<CITE num="193" author="WIGLESWORTH FW" publication="MCGILL MED J" d1="24" d2="189" d3="955"/>
<CITE num="194" author="ELIASSON R" publication="N ENGL J MED" d1="297" d2="1" d3="977"/>
<CITE num="195" author="GLAUSER EM" publication="ACTA PAEDIATR SCAND SUPPL" d1="165" d2="" d3="966"/>
<CITE num="196" author="LANDAU LI" publication="THORAX" d1="29" d2="304" d3="974"/>
<CITE num="197" author="MOORE JR" publication="SURG GYNECOL OBSTET" d1="89" d2="146" d3="949"/>
<CITE num="198" author="STRANG LB" publication="ARCH DIS CHILD" d1="35" d2="224" d3="960"/>
<CITE num="199" author="AVERY ME" publication="BULL JOHNS HOPKINS HOSP" d1="109" d2="20" d3="961"/>
<CITE num="200" author="CHERNIACK RM" publication="RESPIRATION IN HEALTH AND DIS" d1="" d2="331" d3="972"/>
<CITE num="201" author="MCNAMARA MJ" publication="AM REV RESPIR DIS" d1="100" d2="19" d3="969"/>
<CITE num="202" author="GUMP DW" publication="AM REV RESPIR DIS" d1="113" d2="465" d3="976"/>
<CITE num="203" author="MCFADDEN ER JR" publication="N ENGL J MED" d1="292" d2="555" d3="975"/>
<CITE num="204" author="HIRSCH SR" publication="CHEST" d1="63" d2="9" d3="973"/>
<CITE num="205" author="BURROWS B" publication="ANN INTERN MED" d1="77" d2="993" d3="972"/>
<CITE num="206" author="NOONAN JA" publication="CIRCULATION SUPPL 2" d1="32" d2="164" d3="965"/>
<CITE num="207" author="MENASHE VD" publication="J PEDIATR" d1="67" d2="198" d3="965"/>
<CITE num="208" author="LUKE MJ" publication="PEDIATRICS" d1="37" d2="762" d3="966"/>
<CITE num="209" author="AINGER LE" publication="BR HEART J" d1="30" d2="356" d3="968"/>
<CITE num="210" author="DJALILIAN M" publication="MAYO CLIN PROC" d1="50" d2="11" d3="975"/>
<CITE num="211" author="GUILLEMINAULT C" publication="PEDIATRICS" d1="58" d2="23" d3="976"/>
<CITE num="212" author="PERLMAN M" publication="ARCH DIS CHILD" d1="50" d2="727" d3="975"/>
<CITE num="213" author="COGSWELL JJ" publication="ARCH DIS CHILD" d1="49" d2="520" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79011</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LGAR G              WI" publication="EN KLIN WOCHENSCHR" d1="95" d2="14 9" d3="3"/>
<CITE num="2" author="COLOMBO JL" publication="PEDIATR PULMONOL" d1="3" d2="86" d3="987"/>
</CITATIONS>
<RECORDNUM>00991 </RECORDNUM>
<MEDLINENUM>80172130</MEDLINENUM>
<AUTHORS><AUTHOR>Antonowicz-I</AUTHOR><AUTHOR>Shwachman-H</AUTHOR></AUTHORS>
<TITLE>Meconium in health and in disease.</TITLE>
<SOURCE>Adv-Pediatr. 1979. 26. P 275-310. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>INFANT-NEWBORN-DISEASES: pa</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: pa</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di, en, pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: di</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: di</TOPIC><TOPIC>MASS-SCREENING</TOPIC><TOPIC>MECONIUM: en</TOPIC><TOPIC>REVIEW</TOPIC></MINORSUBJ>
<EXTRACT>Meconium is the first gastrointestinal excretion normally expelled by
the neonate.  This review discusses the composition of meconium:
proteins, lipids, steroid and sterols, bile pigments and bile acids,
glycoproteins, mineral composition, and enzymes.  The major
complications relating to meconium are serious: they include
aspiration pneumonia, which may prove fatal and is not related to
cystic fibrosis, the "meconium plug syndrome" and meconium ileus.
Screening for cystic fibrosis is also examined.</EXTRACT>
<REFERENCES>
<CITE num="001" author="EMERY JL" publication="ARCH DIS CHILD" d1="32" d2="17" d3="957"/>
<CITE num="002" author="WINDLE WF" publication="PHYSIOLOGY OF THE FETUS" d1="" d2="" d3="940"/>
<CITE num="003" author="POLLIFRONI GC" publication="LATTANTE" d1="23" d2="331" d3="952"/>
<CITE num="004" author="JIRASEK JE" publication="ACTA HISTOCHEM" d1="22" d2="33" d3="965"/>
<CITE num="005" author="SCHAFFER AJ" publication="DISEASES OF THE NEWBORN" d1="" d2="267" d3="971"/>
<CITE num="006" author="SHERRY SN" publication="J PEDIATR" d1="46" d2="158" d3="955"/>
<CITE num="007" author="ZACHARY RB" publication="PROG PEDIATR SURG" d1="2" d2="57" d3="971"/>
<CITE num="008" author="GRULEE CG" publication="NEWBORN PHYSIOLOGY AND CA" d1="" d2="" d3="926"/>
<CITE num="009" author="DAVY J" publication="MEDICO CHIRURGICAL TRANS" d1="27" d2="189" d3="844"/>
<CITE num="010" author="RAPOPORT S" publication="SCIENCE" d1="112" d2="150" d3="950"/>
<CITE num="011" author="FELDMAN WM" publication="PRINCIPLES OF ANE NATAL" d1="" d2="191" d3="920"/>
<CITE num="013" author="YOSIDA KI" publication="Z GESAMTE EXP MED" d1="63" d2="331" d3="928"/>
<CITE num="014" author="OKAJIMA S" publication="JAPAN J MED SCI VII SOC MED H" d1="3" d2="54" d3="940"/>
<CITE num="015" author="BUCHANAN DJ" publication="PROC SOC EXP BIOL MED" d1="77" d2="114" d3="951"/>
<CITE num="016" author="BUCHANAN DJ" publication="J BIOL CHEM" d1="192" d2="251" d3="951"/>
<CITE num="017" author="PUTKONEN T" publication="ACTA MED FENN DUODENUM (A)" d1="" d2="" d3="930"/>
<CITE num="018" author="ODIN L" publication="ACTA CHEM SCAND" d1="9" d2="862" d3="955"/>
<CITE num="019" author="SCHACHTER H" publication="CAN J BIOCHEM" d1="43" d2="381" d3="965"/>
<CITE num="020" author="KIMURA A" publication="SEIKAGAKU" d1="36" d2="454" d3="964"/>
<CITE num="021" author="CURTAIN CC" publication="AUST J EXP BIOL MED SCI" d1="31" d2="349" d3="953"/>
<CITE num="022" author="BUCHANAN DJ" publication="PEDIATRICS" d1="9" d2="304" d3="952"/>
<CITE num="023" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="024" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="025" author="KNAUFF RE" publication="PROC SOC EXP BIOL MED" d1="127" d2="801" d3="968"/>
<CITE num="026" author="BERNHARD K" publication="HELV CHIM ACTA" d1="39" d2="1443" d3="956"/>
<CITE num="027" author="KINSELLA RA JR" publication="J CLIN ENDOCRINOL METAB" d1="32" d2="801" d3="971"/>
<CITE num="028" author="ENEROTH P" publication="FEBS" d1="3-4" d2="129" d3="969"/>
<CITE num="029" author="GUSTAFSSON JA" publication="PROC R SOC LOND BIOL" d1="180" d2="179" d3="972"/>
<CITE num="030" author="BACK P" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="354" d2="83" d3="973"/>
<CITE num="031" author="LAVY U" publication="J LIPID RES" d1="18" d2="232" d3="977"/>
<CITE num="032" author="BROWN AK" publication="IN: SMITH CA" d1="" d2="323" d3="976"/>
<CITE num="033" author="WATKINS JB" publication="IN: PAUMGARTNER G" d1="" d2="3582" d3="976"/>
<CITE num="034" author="DELEZE G" publication="EXP J CLIN INVEST" d1="8" d2="41" d3="978"/>
<CITE num="035" author="SHARP HL" publication="PEDIATR RES" d1="5" d2="274" d3="971"/>
<CITE num="036" author="FRASER D" publication="CLIN CHIM ACTA" d1="59" d2="301" d3="975"/>
<CITE num="037" author="SCHRAGER J" publication="ARCH ORAL BIOL" d1="16" d2="287" d3="971"/>
<CITE num="038" author="BOUCHIER IAD" publication="CLIN CHIM ACTA" d1="35" d2="219" d3="971"/>
<CITE num="039" author="BROGAN TD" publication="BIOCHEM J" d1="71" d2="125" d3="959"/>
<CITE num="040" author="BROGAN TD" publication="BR J EXP PATHOL" d1="41" d2="288" d3="960"/>
<CITE num="041" author="OATES MDG" publication="BIOCHEM J" d1="97" d2="697" d3="965"/>
<CITE num="042" author="HOUGH L" publication="CARBOHYD RES" d1="23" d2="1" d3="972"/>
<CITE num="043" author="DISCHE Z" publication="ARCH BIOCHEM BIOPHYS" d1="135" d2="1" d3="969"/>
<CITE num="044" author="LIEBERMAN J" publication="GASTROENTEROLOGY" d1="50" d2="183" d3="966"/>
<CITE num="046" author="EMERY JL" publication="ARCH DIS CHILD" d1="27" d2="257" d3="952"/>
<CITE num="047" author="SHIVELY JA" publication="AM J CLIN PATHOL" d1="22" d2="1220" d3="952"/>
<CITE num="048" author="DE FILIPPI F" publication="PEDIATRICS" d1="15" d2="114" d3="954"/>
<CITE num="049" author="MACCHIA A" publication="RIV PEDIAT SICILIANA" d1="12" d2="285" d3="967"/>
<CITE num="050" author="EGGERMONT E" publication="BIOL NEONATE" d1="10" d2="266" d3="966"/>
<CITE num="051" author="ANTONOWICZ I" publication="GASTROENTEROLOGY" d1="72" d2="1299" d3="977"/>
<CITE num="052" author="EGGERMONT E" publication="ACTA GASTROENTEROL BELG" d1="34" d2="655" d3="971"/>
<CITE num="053" author="FOMINA LS" publication="VOPR MED KHIM" d1="2" d2="" d3="956"/>
<CITE num="054" author="ZWEIFEL" publication="ARCH J GYNAEK" d1="7" d2="474" d3="875"/>
<CITE num="055" author="MULLER F" publication="Z BIOL" d1="20" d2="327" d3="884"/>
<CITE num="056" author="WIDDOWSON EM" publication="LANCET" d1="2" d2="373" d3="962"/>
<CITE num="057" author="KOPITO L" publication="J PEDIATR" d1="68" d2="313" d3="966"/>
<CITE num="058" author="DESROCHES A" publication="J GYN OBSTET BIOL REPR" d1="3" d2="321" d3="974"/>
<CITE num="059" author="SCHWARZ E" publication="ANN PAEDIATR" d1="181" d2="306" d3="953"/>
<CITE num="060" author="LINDBERG T" publication="CLIN SCI" d1="30" d2="505" d3="966"/>
<CITE num="061" author="GRUNDIG CA" publication="ACTA BIOL MED GER" d1="19" d2="193" d3="967"/>
<CITE num="062" author="POTTEVIN MH" publication="C R SOC BIOL (PARIS)" d1="11" d2="589" d3="900"/>
<CITE num="063" author="GALERNE D" publication="J GYN OBSTET BIOL REPR" d1="2" d2="969" d3="973"/>
<CITE num="064" author="GEYER VH" publication="Z KLIN CHEM KLIN BIOCHEM" d1="8" d2="145" d3="970"/>
<CITE num="065" author="DAHLQVIST A" publication="CLIN SCI" d1="30" d2="517" d3="966"/>
<CITE num="066" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
<CITE num="067" author="AURICCHIO S" publication="PEDIATRICS" d1="35" d2="944" d3="965"/>
<CITE num="068" author="SHEEHY TW" publication="AM J DIS CHILD" d1="121" d2="464" d3="971"/>
<CITE num="069" author="ANTONOWICZ I" publication="GASTROENTEROLOGY" d1="67" d2="51" d3="974"/>
<CITE num="070" author="ANTONOWICZ I" publication="BIOL NEONATE" d1="32" d2="280" d3="977"/>
<CITE num="071" author="ANDERSEN H" publication="ACTA PATH MICROBIOL SCAND" d1="61" d2="377" d3="964"/>
<CITE num="072" author="WATZKA M" publication="VERH ANAT GES" d1="66" d2="" d3="971"/>
<CITE num="073" author="BIERRING F" publication="ACTA PATH MICROBIOL SCAND" d1="61" d2="365" d3="964"/>
<CITE num="074" author="LEV R" publication="HISTOCHEMIE" d1="29" d2="103" d3="972"/>
<CITE num="076" author="TAKIMOTO M" publication="BIOL NEONATE" d1="18" d2="66" d3="971"/>
<CITE num="077" author="ELIAKIS E" publication="MED LEG DOMM CORP" d1="4" d2="163" d3="971"/>
<CITE num="078" author="ASENSIO C" publication="MEDICAMENTA MARK" d1="15" d2="51" d3="956"/>
<CITE num="079" author="HERNANDEZ-JODRA M" publication="ENZYME" d1="12" d2="682" d3="971"/>
<CITE num="081" author="CLATWORTHY HW" publication="SURGERY" d1="39" d2="131" d3="956"/>
<CITE num="082" author="ROSENSTEIN BJ" publication="AM J DIS CHILD" d1="132" d2="167" d3="978"/>
<CITE num="083" author="EMERY JL" publication="ARCH DIS CHILD" d1="29" d2="34" d3="954"/>
<CITE num="084" author="GRIFFITHS AD" publication="BIORHEOLOGY" d1="13" d2="225" d3="976"/>
<CITE num="085" author="YOUNG DM" publication="PROC SOC EXP BIOL MED" d1="99" d2="673" d3="958"/>
<CITE num="086" author="FARBER S" publication="J PEDIATR" d1="24" d2="387" d3="944"/>
<CITE num="087" author="NOBLETT HR" publication="J PEDIATR SURG" d1="4" d2="190" d3="969"/>
<CITE num="088" author="GLANZMANN E" publication="ANN PAEDIATR" d1="175" d2="33" d3="950"/>
<CITE num="089" author="LANDSTEINER K" publication="ZENTRALBL ALLG PATHOL" d1="16" d2="903" d3="905"/>
<CITE num="090" author="NEUHAUSER EBD" publication="RADIOLOGY" d1="46" d2="319" d3="946"/>
<CITE num="091" author="DONNISON AB" publication="PEDIATRICS" d1="37" d2="833" d3="966"/>
<CITE num="092" author="HOLSCLAW DS" publication="AM J DIS CHILD" d1="109" d2="101" d3="965"/>
<CITE num="093" author="ANON" publication="CF FND 1976 REP SURVI STUD PA" d1="" d2="3" d3="973"/>
<CITE num="094" author="BERNSTEIN JG" publication="AM J DIS CHILD" d1="99" d2="804" d3="960"/>
<CITE num="095" author="GROSS RE" publication="SURGERY OF INFANCY AND CHILDH" d1="" d2="" d3="953"/>
<CITE num="096" author="SANTULLI TV" publication="IN: BENSON CD" d1="" d2="" d3="953"/>
<CITE num="097" author="BISHOP HC" publication="ANN SURG" d1="145" d2="410" d3="957"/>
<CITE num="098" author="SHWACHMAN H" publication="IN: KENDIG EL JR" d1="1" d2="524" d3="972"/>
<CITE num="099" author="ELIAN E" publication="N ENGL J MED" d1="264" d2="13" d3="961"/>
<CITE num="100" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="101" author="WISER WC" publication="PEDIATRICS" d1="33" d2="115" d3="964"/>
<CITE num="102" author="CHODOS DD" publication="PROC SOC EXP BIOL MED" d1="99" d2="775" d3="958"/>
<CITE num="103" author="RULE AH" publication="PEDIATRICS" d1="45" d2="847" d3="970"/>
<CITE num="104" author="RULE AH" publication="PEDIATRICS" d1="48" d2="601" d3="971"/>
<CITE num="105" author="RYLEY HC" publication="ARCH DIS CHILD" d1="49" d2="901" d3="974"/>
<CITE num="106" author="PECAU Y" publication="BIOL GASTROENTEROL" d1="8" d2="193" d3="975"/>
<CITE num="107" author="ZUELZER WW" publication="PEDIATRICS" d1="4" d2="53" d3="949"/>
<CITE num="108" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
<CITE num="109" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="110" author="HINDEN E" publication="ARCH DIS CHILD" d1="25" d2="99" d3="950"/>
<CITE num="111" author="STEPHAN U" publication="IN: MANGOS JA" d1="" d2="281" d3="973"/>
<CITE num="112" author="GOTTSCHALK B" publication="DTSCH GESUNDHEITSW" d1="32" d2="2439" d3="977"/>
<CITE num="113" author="HOLSCLAW DS" publication="PEDIATR ANN" d1="7" d2="29" d3="968"/>
<CITE num="114" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="116" author="ALPERS DH" publication="BIOCHIM BIOPHYS ACTA" d1="401" d2="28" d3="975"/>
<CITE num="117" author="SEETHARAM B" publication="LIFE SCI" d1="18" d2="89" d3="976"/>
<CITE num="118" author="ANTONOWICZ I" publication="LANCET" d1="1" d2="746" d3="976"/>
<CITE num="119" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="132" d2="112" d3="978"/>
<CITE num="120" author="SHWACHMAN H" publication="IN: MANGOS JA" d1="" d2="277" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79012</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RK RW               GA" publication="STROENTEROLOGY" d1="81" d2="43 9" d3="1"/>
<CITE num="2" author="KNIGHT PJ" publication="SURGERY" d1="89" d2="332" d3="981"/>
<CITE num="3" author="SHWACHMAN H" publication="J PEDIATR SURG" d1="18" d2="570" d3="983"/>
<CITE num="4" author="KOPELMAN H" publication="N ENGL J MED" d1="312" d2="329" d3="985"/>
<CITE num="5" author="EGGERMONT E" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="16" d3="985"/>
<CITE num="6" author="DEHNER LP" publication="HUM PATHOL" d1="17" d2="807" d3="986"/>
<CITE num="7" author="KING A" publication="PEDIATR RES" d1="20" d2="536" d3="986"/>
<CITE num="8" author="HUNSINGER RN" publication="CLIN CHIM ACTA" d1="156" d2="165" d3="986"/>
</CITATIONS>
<RECORDNUM>00992 </RECORDNUM>
<MEDLINENUM>79184947</MEDLINENUM>
<AUTHORS><AUTHOR>Palin-D</AUTHOR><AUTHOR>Underwood-B-A</AUTHOR><AUTHOR>Denning-C-R</AUTHOR></AUTHORS>
<TITLE>The effect of oral zinc supplementation on plasma levels of vitamin
A and retinol-binding protein in cystic fibrosis.</TITLE>
<SOURCE>Am-J-Clin-Nutr. 1979 Jun. 32(6). P 1253-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>RETINOL-BINDING-PROTEINS: me</TOPIC><TOPIC>VITAMIN-A: bl</TOPIC><TOPIC>ZINC: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>DIET</TOPIC><TOPIC>GROWTH: de</TOPIC><TOPIC>HAIR: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PLACEBOS</TOPIC><TOPIC>TASTE: de</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>ZINC: bl, tu</TOPIC></MINORSUBJ>
<ABSTRACT>Oral zinc supplementation with 100 mg zinc sulfate over an 8-week
period in 36 patients with cystic fibrosis and 17 siblings did not
affect the vitamin A transport system, as evidenced by an absence of
consistent and significant quantitative changes in plasma levels of
vitamin A, retinol-binding protein, and zinc, nor did the exogenous
zinc appear to stimulate growth or exert any clinical benefit to the
cystic fibrosis patients. The lack of response to zinc
supplementation might be explained by the fact that the group of
cystic fibrosis subjects studied was fairly healthy in regard to
clinical status and certain blood parameters, including zinc.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="MAY CD" publication="J CLIN INVEST" d1="27" d2="226" d3="948"/>
<CITE num="002" author="BENNETT MJ" publication="AM J CLIN NUTR" d1="20" d2="415" d3="967"/>
<CITE num="003" author="UNDERWOOD BA" publication="BULL NY ACAD MED" d1="47" d2="34" d3="971"/>
<CITE num="004" author="ANDERSEN DH" publication="J PEDIATR" d1="15" d2="763" d3="939"/>
<CITE num="005" author="SMITH FR" publication="J LAB CLIN MED" d1="80" d2="423" d3="972"/>
<CITE num="006" author="NAVAB M" publication="J BIOL CHEM" d1="252" d2="5107" d3="977"/>
<CITE num="007" author="STEVENSON J" publication="J ANIMAL SCI" d1="15" d2="1036" d3="956"/>
<CITE num="008" author="SMITH JC JR" publication="SCIENCE" d1="181" d2="954" d3="973"/>
<CITE num="009" author="SMITH JC JR" publication="J NUTR" d1="106" d2="569" d3="976"/>
<CITE num="010" author="CARNEY SM" publication="J NUTR" d1="106" d2="1773" d3="976"/>
<CITE num="011" author="HALSTED JA" publication="LANCET" d1="1" d2="322" d3="970"/>
<CITE num="012" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="013" author="CAGGIANO V" publication="AM J MED SCI" d1="257" d2="305" d3="969"/>
<CITE num="014" author="UNDERWOOD BA" publication="PEDIATR RES" d1="6" d2="26" d3="972"/>
<CITE num="015" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
<CITE num="016" author="ANON" publication="NUTRITIVE VALUE OF FOODS HOME" d1="" d2="" d3="971"/>
<CITE num="017" author="PRASAD AS" publication="ZINC METABOLISM" d1="" d2="" d3="966"/>
<CITE num="018" author="LARKIN D" publication="FOOD RES" d1="19" d2="211" d3="954"/>
<CITE num="019" author="SCHROEDER HA" publication="J CHRON DIS" d1="20" d2="179" d3="967"/>
<CITE num="020" author="GORMICAN A" publication="J AM DIET ASSOC" d1="56" d2="397" d3="970"/>
<CITE num="021" author="MURPHY EW" publication="J AM DIET ASSOC" d1="66" d2="345" d3="975"/>
<CITE num="022" author="HENKIN RI" publication="J CLIN INVEST" d1="42" d2="727" d3="963"/>
<CITE num="023" author="NEELD JB" publication="J NUTR" d1="79" d2="454" d3="963"/>
<CITE num="024" author="MANCINI G" publication="IMMUNOCHEMISTRY" d1="2" d2="235" d3="965"/>
<CITE num="025" author="HACKLEY B" publication="CLIN CHEM" d1="14" d2="1" d3="968"/>
<CITE num="026" author="ANON" publication="MANUAL FOR NUTRITION SURVEYS" d1="" d2="133" d3="963"/>
<CITE num="027" author="HENRY R" publication="AM J CLIN PATHOL" d1="34" d2="381" d3="960"/>
<CITE num="028" author="KALOW W" publication="CAN J BIOCHEM PHYSIOL" d1="33" d2="568" d3="955"/>
<CITE num="029" author="RICHTERICH R" publication="CLINICAL CHEMISTRY THEORY AND" d1="" d2="" d3="969"/>
<CITE num="030" author="DIXON R" publication="J CLIN PATHOL" d1="27" d2="341" d3="974"/>
<CITE num="031" author="KLEVAY LM" publication="AM J CLIN NUTR" d1="23" d2="284" d3="970"/>
<CITE num="032" author="STEEL RGD" publication="PRIN PROC OF STATISTICS" d1="" d2="" d3="960"/>
<CITE num="033" author="NIE NH" publication="STAT PACKAGE FOR THE SOCIAL S" d1="" d2="" d3="975"/>
<CITE num="034" author="BAKER H" publication="AM J CLIN NUTR" d1="20" d2="850" d3="967"/>
<CITE num="035" author="SMITH FR" publication="J CLIN INVEST" d1="50" d2="2426" d3="971"/>
<CITE num="036" author="HARPER HA" publication="REVIEW PHYSIOLOGICAL CHEMI" d1="" d2="201" d3="969"/>
<CITE num="037" author="ANON" publication="RECOMMENDED DIETARY ALLOWANCE" d1="" d2="" d3="974"/>
<CITE num="038" author="JACOB RA" publication="AM J CLIN NUTR" d1="31" d2="638" d3="978"/>
<CITE num="039" author="PETERSEN RA" publication="AM J DIS CHILD" d1="116" d2="662" d3="968"/>
<CITE num="040" author="BLACKFAN KD" publication="J PEDIATR" d1="13" d2="627" d3="938"/>
<CITE num="041" author="UNDERWOOD BA" publication="WORLD REV NUTR DIET" d1="19" d2="123" d3="974"/>
<CITE num="042" author="KOPITO L" publication="NATURE" d1="202" d2="501" d3="964"/>
<CITE num="043" author="KOPITO L" publication="AM J CLIN NUTR" d1="21" d2="533" d3="968"/>
<CITE num="044" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="045" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79013</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VARRO J             AM" publication="J CLIN NUTR" d1="34" d2="39 9" d3="1"/>
<CITE num="2" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="3" author="GORDON EF" publication="J PEDIATR" d1="99" d2="341" d3="981"/>
<CITE num="4" author="JOHNSON MA" publication="AM J CLIN NUTR" d1="35" d2="1332" d3="982"/>
<CITE num="5" author="SOLOMONS NW" publication="NUTR REV" d1="41" d2="33" d3="983"/>
<CITE num="6" author="RUSSELL RM" publication="ANN INTERN MED" d1="99" d2="227" d3="983"/>
<CITE num="7" author="GAETANI S" publication="NUTR REP INT" d1="30" d2="111" d3="984"/>
<CITE num="8" author="BALY DL" publication="AM J CLIN NUTR" d1="40" d2="199" d3="984"/>
<CITE num="9" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="10" author="BAER MT" publication="AM J CLIN NUTR" d1="41" d2="1220" d3="985"/>
<CITE num="11" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
</CITATIONS>
<RECORDNUM>00993 </RECORDNUM>
<MEDLINENUM>80062331</MEDLINENUM>
<AUTHORS><AUTHOR>Roy-C-C</AUTHOR><AUTHOR>Delage-G</AUTHOR><AUTHOR>Fontaine-A</AUTHOR><AUTHOR>Robitaille-L</AUTHOR><AUTHOR>Chartrand-L</AUTHOR><AUTHOR>Weber-A</AUTHOR><AUTHOR>Morin-C-L</AUTHOR></AUTHORS>
<TITLE>The fecal microflora and bile acids in children with cystic fibrosis.</TITLE>
<SOURCE>Am-J-Clin-Nutr. 1979 Dec. 32(12). P 2404-9.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>BILE-ACIDS-AND-SALTS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me, mi</TOPIC><TOPIC>FECES: an, mi</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBENICILLIN: tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CLOXACILLIN: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>GENTAMICINS: tu</TOPIC><TOPIC>GRAM-NEGATIVE-AEROBIC-BACTERIA</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<ABSTRACT>Fecal fat, bile acids, and the rectal microflora were studied in
seven control children and in three groups of patients with cystic
fibrosis (CF).  Seven were off antibiotics, ten on oral cloxacillin,
and six on i.v. triple therapy (cloxacillin, gentamycin, and
carbenicillin) for at least 2 weeks.  Controls had lower
concentrations (milligrams per gram dry stool) of both fat (P &lt;
0.005) and vile acids (P &lt; 0.025) than CF children off antibiotics.
Antibiotics had little or no effect on fat but led to a striking
decrease (P &lt; 0.01) of bile acids in the triple therapy group.
Concomitantly, there was reduced deconjugation of bile acids (P &lt;
0.01) and formation of secondary bile acids (P &lt; 0.005).  This was
associated with a 5-fold increase in the percentage of bile acids
found in the aqueous phase of stools and with a marked reduction (P
&lt; 0.001) of the anaerobic flora (log counts per gram wet stool) in
children on triple therapy (4.3 plus or minus 1.9) when compared to
controls (9.8 plus or minus 0.1), CF off antibiotics (9.1 plus or
minus 0.1) and CF on cloxacillin (9.6 plus or minus 0.2).  The close
relationship between the anaerobic flora, the extent of bile acid
microbial transformation, and fecal bile acid concentrations suggest
that reduction of the anaerobic flora decreases adsorption of bile
acids to dietary residues and microbes, favors bile acid absorption,
and leads to a decreased fecal loss of bile acids in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ROY CC" publication="CLIN GASTROENTEROL" d1="6" d2="377" d3="977"/>
<CITE num="002" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="003" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="004" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="005" author="LEFEBVRE D" publication="EXPERIENTIA" d1="33" d2="616" d3="977"/>
<CITE num="006" author="HOLDEMAN LV" publication="ANAEROBE LABORATORY MANUAL" d1="" d2="" d3="975"/>
<CITE num="007" author="BEST WR" publication="AM J CLIN NUTR" d1="23" d2="1609" d3="970"/>
<CITE num="008" author="JEEJEEBHOY KN" publication="CLIN BIOCHEM" d1="3" d2="157" d3="970"/>
<CITE num="009" author="LEVIN SJ" publication="ANAL CHEM" d1="33" d2="1407" d3="961"/>
<CITE num="010" author="WEBER AM" publication="CLIN CHIM ACTA" d1="39" d2="524" d3="972"/>
<CITE num="011" author="BANCROFT TA" publication="TOPICS IN INTERMED STAT METH" d1="1" d2="100" d3="968"/>
<CITE num="012" author="HOLDEMAN LV" publication="APPL ENVIRON MICROBIOL" d1="31" d2="539" d3="976"/>
<CITE num="013" author="MOORE WEC" publication="APPL MICROBIOL" d1="27" d2="961" d3="974"/>
<CITE num="014" author="ATTEBERY HR" publication="AM J CLIN NUTR" d1="25" d2="1931" d3="972"/>
<CITE num="015" author="MATA LJ" publication="AM J CLIN NUTR" d1="25" d2="1380" d3="972"/>
<CITE num="016" author="FLOCH MH" publication="AM J CLIN NUTR" d1="25" d2="1418" d3="972"/>
<CITE num="017" author="SUTTER VL" publication="J INFECT DIS" d1="131" d2="417" d3="975"/>
<CITE num="018" author="SUTTER VL" publication="ANTIMICROB AGENTS CHEMOTHER" d1="10" d2="736" d3="976"/>
<CITE num="019" author="MIDTVEDT T" publication="AM J CLIN NUTR" d1="27" d2="1341" d3="974"/>
<CITE num="020" author="GARBUTT JT" publication="GASTROENTEROLOGY" d1="56" d2="711" d3="969"/>
<CITE num="021" author="KRAG E" publication="J CLIN INVEST" d1="53" d2="1686" d3="974"/>
<CITE num="022" author="GUSTAFSSON BE" publication="ACTA PATH MICROBIOL SCAND" d1="72" d2="433" d3="968"/>
<CITE num="023" author="EASTWOOD MA" publication="BIOCHIM BIOPHYS ACTA" d1="152" d2="165" d3="968"/>
<CITE num="024" author="GUSTAFSSON BE" publication="SCAND J GASTROENTEROL" d1="3" d2="125" d3="968"/>
<CITE num="025" author="SCHIFF ER" publication="J CLIN INVEST" d1="51" d2="1351" d3="972"/>
<CITE num="026" author="EASTWOOD M" publication="AM J CLIN NUTR" d1="29" d2="1461" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79014</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IBY N               AC" publication="TA PAEDIATR SCAND SUPPL 301 19" d1="82" d2="33 9" d3="2"/>
<CITE num="2" author="BALISTRERI WF" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="105" d3="983"/>
<CITE num="3" author="ISENBERG JN" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="447" d3="983"/>
<CITE num="4" author="WESLEY A" publication="PEDIATR RES" d1="17" d2="65" d3="983"/>
<CITE num="5" author="COLOMBO C" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="556" d3="984"/>
<CITE num="6" author="TAZAWA Y" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="378" d3="984"/>
<CITE num="7" author="GRYBOSKI JD" publication="AM J GASTROENTEROL" d1="80" d2="871" d3="985"/>
<CITE num="8" author="WEBER AM" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="9" d3="985"/>
<CITE num="9" author="LEROY C" publication="DIG DIS SCI" d1="31" d2="911" d3="986"/>
<CITE num="10" author="LONNQVIST B" publication="J INFECT DIS" d1="153" d2="175" d3="986"/>
</CITATIONS>
<RECORDNUM>00994 </RECORDNUM>
<MEDLINENUM>79184974</MEDLINENUM>
<AUTHORS><AUTHOR>Lloyd-Still-J-D</AUTHOR><AUTHOR>Demers-L-M</AUTHOR></AUTHORS>
<TITLE>Serum glycine-conjugated bile acids in pediatric hepatobiliary
disorders.</TITLE>
<SOURCE>Am-J-Clin-Pathol. 1979 Apr. 71(4). P 444-51.</SOURCE>
<MAJORSUBJ><TOPIC>BILE-ACIDS-AND-SALTS: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: bl</TOPIC><TOPIC>INTESTINAL-DISEASES: bl</TOPIC><TOPIC>LIVER-DISEASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHOLESTASIS: bl</TOPIC><TOPIC>DIARRHEA-INFANTILE: bl</TOPIC><TOPIC>GLYCOCHENODEOXYCHOLIC-ACID: bl</TOPIC><TOPIC>GLYCOCHOLIC-ACID: bl</TOPIC><TOPIC>GLYCODEOXYCHOLIC-ACID: bl</TOPIC><TOPIC>HEPATITIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>REYES-SYNDROME: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Measurements of serum bile acids (glycine conjugates of cholic,
chenodeoxycholic, deoxycholic, and lithocholic acids) by
radioimmunoassay in a variety of pediatric hepatobiliary disorders
showed elevations in neonatal hepatitis syndromes, cholestasis, and
hepatitis of extrahepatic or intrahepatic origin. Measurements of
individual serum bile acids failed to differentiate between the
various neonatal hepatitis syndromes. In one patient with
cholestasis, the increased levels of bile acids observed returned to
normal following therapy with cholestyramine and phenobarbital. In
chronic active hepatitis the serum bile acid values correlated well
with the bilirubin and SGOT in response to therapy with
corticosteroids. These data confirm suggestions that serum
cholylglycine and chenodeoxycholylglycine levels are a sensitive
indicator of disturbed hepatic function and can be used in monitoring
the course, activity, and therapeutic response in various hepatitis
syndromes. In Reye's syndrome and protracted diarrhea of infancy,
elevations in serum bile acids were detected without associated
hyperbilirubinemia and provided additional evidence of disturbed
hepatic function.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BALISTRERI WF" publication="IN: POLLACK JD" d1="" d2="269" d3="975"/>
<CITE num="002" author="BALISTRERI WF" publication="PEDIATR RES" d1="8" d2="378" d3="974"/>
<CITE num="003" author="BOVE KE" publication="GASTROENTEROLOGY" d1="69" d2="685" d3="975"/>
<CITE num="004" author="BURKE V" publication="AUST PAEDIATR J" d1="2" d2="219" d3="966"/>
<CITE num="005" author="DASHER CA" publication="CLIN RES" d1="24" d2="11A" d3="976"/>
<CITE num="006" author="DEMERS LM" publication="CLIN CHEM" d1="22" d2="602" d3="976"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="GASTROENTEROLOGY" d1="40" d2="64" d3="961"/>
<CITE num="008" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="009" author="GRACEY M" publication="GUT" d1="12" d2="683" d3="971"/>
<CITE num="010" author="JAVITT NB" publication="POSTGRAD MED J" d1="50" d2="354" d3="974"/>
<CITE num="011" author="JAVITT NB" publication="GASTROENTEROLOGY" d1="70" d2="1172" d3="976"/>
<CITE num="012" author="JAVITT NB" publication="J CLIN INVEST" d1="47" d2="1002" d3="968"/>
<CITE num="013" author="JAVITT NB" publication="J PEDIATR" d1="90" d2="786" d3="977"/>
<CITE num="014" author="KAPLOWITZ N" publication="JAMA" d1="225" d2="292" d3="973"/>
<CITE num="015" author="KORMAN MG" publication="N ENGL J MED" d1="290" d2="1399" d3="974"/>
<CITE num="016" author="LANDING BH" publication="PROG PEDIATR SURG" d1="6" d2="113" d3="974"/>
<CITE num="017" author="LLOYD-STILL JD" publication="PEDIATRICS" d1="59" d2="626" d3="977"/>
<CITE num="018" author="LLOYD-STILL JD" publication="AM J DIS CHILD" d1="125" d2="358" d3="973"/>
<CITE num="019" author="MURPHY GM" publication="GUT" d1="15" d2="151" d3="974"/>
<CITE num="020" author="NORMAN A" publication="ACTA PAEDIATR SCAND" d1="62" d2="253" d3="973"/>
<CITE num="021" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="022" author="POLEY JR" publication="J LAB CLIN MED" d1="63" d2="838" d3="964"/>
<CITE num="023" author="SANDBERG DH" publication="PEDIATR RES" d1="4" d2="262" d3="970"/>
<CITE num="024" author="SCHEUER P" publication="LIVER BIOPSY INTERPRETATION" d1="" d2="22" d3="973"/>
<CITE num="025" author="TOULOUKIAN RJ" publication="ARCH SURG" d1="106" d2="58" d3="973"/>
<CITE num="026" author="UTILI R" publication="GASTROENTEROLOGY" d1="70" d2="248" d3="976"/>
<CITE num="027" author="WATKINS JB" publication="PEDIATR CLIN NORTH AM" d1="21" d2="501" d3="974"/>
<CITE num="028" author="WATKINS JB" publication="PEDIATR RES" d1="7" d2="341" d3="973"/>
<CITE num="029" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="67" d2="835" d3="974"/>
<CITE num="030" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="031" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79015</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNI K               AN" publication="N CLIN RES" d1="12" d2="68 9" d3="0"/>
<CITE num="2" author="MATSUI A" publication="J CLIN PATHOL" d1="35" d2="1011" d3="982"/>
<CITE num="3" author="FINNI K" publication="EUR J PEDIATR" d1="138" d2="53" d3="982"/>
<CITE num="4" author="STREET JM" publication="J LIPID RES" d1="24" d2="491" d3="983"/>
<CITE num="5" author="STRANDVIK B" publication="SCAND J GASTROENTEROL" d1="20" d2="381" d3="985"/>
</CITATIONS>
<RECORDNUM>00995 </RECORDNUM>
<MEDLINENUM>79252922</MEDLINENUM>
<AUTHORS><AUTHOR>Warwick-W-J</AUTHOR><AUTHOR>Hansen-L</AUTHOR><AUTHOR>Viela-I</AUTHOR><AUTHOR>Matheson-J</AUTHOR></AUTHORS>
<TITLE>Comparison of the chloride electrode and gravimetric chloride
titration sweat tests.</TITLE>
<SOURCE>Am-J-Clin-Pathol. 1979 Aug. 72(2). P 142-5.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEATING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>COMPUTERS</TOPIC><TOPIC>ELECTRODES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MODELS-BIOLOGICAL</TOPIC><TOPIC>PROBABILITY</TOPIC></MINORSUBJ>
<ABSTRACT>The chloride electrode sweat test and gravimetric chloride titration
technic are compared. The two technics gave comparable mean values,
ogives, equivalent points, and overlap for patients with cystic
fibrosis and healthy subjects. As a single test with either technic
has an unacceptable risk for false-positive or false-negative
results, tests should always be done in pairs. A statistical
interpretation technic based on prevalence and technical variability
of the two tests will decrease the number of undiagnosed subjects and
will define probability of cystic fibrosis in the undiagnosed group.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="CLIN PEDIATR" d1="12" d2="450" d3="973"/>
<CITE num="002" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="003" author="HANSEN L" publication="MINN MED" d1="50" d2="1191" d3="967"/>
<CITE num="004" author="HANSEN L" publication="AM J CLIN PATHOL" d1="49" d2="834" d3="968"/>
<CITE num="005" author="KOPITO L" publication="PEDIATRICS" d1="43" d2="794" d3="969"/>
<CITE num="006" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="007" author="WARWICK WJ" publication="CF CLUB ABST" d1="" d2="5" d3="975"/>
<CITE num="008" author="WARWICK WJ" publication="PEDIATRICS" d1="36" d2="261" d3="965"/>
<CITE num="009" author="WARWICK WJ" publication="CLIN CHEM" d1="24" d2="381" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79016</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BSTER HL            CR" publication="C CRIT REV CLIN LAB SCI" d1="18" d2="13 9" d3="3"/>
</CITATIONS>
<RECORDNUM>00996 </RECORDNUM>
<MEDLINENUM>79252934</MEDLINENUM>
<AUTHORS><AUTHOR>Warwick-W-J</AUTHOR><AUTHOR>Viela-I</AUTHOR><AUTHOR>Hansen-L-G</AUTHOR></AUTHORS>
<TITLE>Comparison of the errors due to the use of gauze and the use of
filter paper in the gravimetric chloride titration sweat test.</TITLE>
<SOURCE>Am-J-Clin-Pathol. 1979 Aug. 72(2). P 211-5.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEATING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MATHEMATICS</TOPIC></MINORSUBJ>
<ABSTRACT>Potential sources of error in the Gibson and Cooke method of sweat
testing using gauze and filter paper as collection media as
described. The absolute chloride content of gauze was higher than
that of filter paper; however, the variability of chloride contents
between the two was insignificant. Complete chloride elution from
filter paper requires more time than elution from gauze. A method of
determining probability of a clinically acceptable measurement based
on sweat sample size, chloride determination, and variability of
chloride in collection media is also described.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="002" author="HANSEN L" publication="MINN MED" d1="50" d2="1191" d3="967"/>
<CITE num="003" author="SCHALES O" publication="J BIOL CHEM" d1="140" d2="879" d3="941"/>
<CITE num="004" author="SHWACHMAN H" publication="MOD PROBL PEDIATR" d1="10" d2="158" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79017</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HWACHMAN H          J" publication="PEDIATR" d1="98" d2="76 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00997 </RECORDNUM>
<MEDLINENUM>79253016</MEDLINENUM>
<AUTHORS><AUTHOR>Nussbaum-E</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Wood-R-E</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis with acute hypoelectrolytemia and metabolic
alkalosis in infancy.</TITLE>
<SOURCE>Am-J-Dis-Child. 1979 Sep. 133(9). P 965-6.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALOSIS: et</TOPIC><TOPIC>WATER-ELECTROLYTE-IMBALANCE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALKALOSIS: th</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>COLD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FLUID-THERAPY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SEASONS</TOPIC><TOPIC>SWEATING</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>WATER-ELECTROLYTE-IMBALANCE: th</TOPIC></MINORSUBJ>
<EXTRACT>We describe two infants with previously undiagnosed cystic fibrosis
who had electrolyte depletion, metabolic alkalosis, and dehydration
in the winter and three infants known to have CF in whom similar
manifestations developed.  We confirm previous reports that salt
depletion and metabolic alkalosis do occur throughout the year in the
northern United States and England.  When metabolic alkalosis and
hypoelectrolytemia in infancy are not explained on the basis of other
clinical conditions, CF should be suspected.  Pediatricians should
measure serum electrolyte values promptly and consider early
parenteral fluid and electrolyte therapy as a preventive measure for
infants with CF with persistent vomiting and/or diarrhea.</EXTRACT>
<REFERENCES>
<CITE num="001" author="KESSLER WR" publication="PEDIATRICS" d1="8" d2="648" d3="951"/>
<CITE num="002" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="003" author="RENDLE-SHORT J" publication="ARCH DIS CHILD" d1="31" d2="28" d3="956"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2014" d3="960"/>
<CITE num="005" author="GOTTLIEB RP" publication="J PEDIATR" d1="79" d2="930" d3="971"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="007" author="STOLL E" publication="HELV PAEDIATR ACTA" d1="25" d2="234" d3="970"/>
<CITE num="008" author="BECKERMAN RC" publication="PEDIATRICS" d1="63" d2="580" d3="979"/>
<CITE num="009" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="82" d2="535" d3="973"/>
<CITE num="010" author="HOCHMAN HI" publication="ARCH DIS CHILD" d1="51" d2="390" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79018</PAPERNUM>
<CITATIONS>
<CITE num="1" author="UGHLIN JJ           PE" publication="DIATRICS" d1="68" d2="03 9" d3="1"/>
<CITE num="2" author="RAPAPORT R" publication="J PEDIATR" d1="98" d2="768" d3="981"/>
<CITE num="3" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="4" author="ZAMMARCHI E" publication="RIV ITAL PEDIATR" d1="9" d2="505" d3="983"/>
<CITE num="5" author="ORENSTEIN DM" publication="PEDIATR RES" d1="17" d2="267" d3="983"/>
<CITE num="6" author="ORENSTEIN DM" publication="J APPL PHYSIOL" d1="57" d2="408" d3="984"/>
</CITATIONS>
<RECORDNUM>00998 </RECORDNUM>
<MEDLINENUM>79185026</MEDLINENUM>
<AUTHORS><AUTHOR>Mischler-E-H</AUTHOR><AUTHOR>Chesney-P-J</AUTHOR><AUTHOR>Chesney-R-W</AUTHOR><AUTHOR>Mazess-R-B</AUTHOR></AUTHORS>
<TITLE>Demineralization in cystic fibrosis detected by direct photon
absorptiometry.</TITLE>
<SOURCE>Am-J-Dis-Child. 1979 Jun. 133(6). P 632-5.</SOURCE>
<MAJORSUBJ><TOPIC>BONE-AND-BONES: me</TOPIC><TOPIC>BONE-DISEASES: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>GROWTH-DISORDERS: et</TOPIC><TOPIC>MINERALS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ALKALINE-PHOSPHATASE: bl</TOPIC><TOPIC>BONE-DEVELOPMENT</TOPIC><TOPIC>BONE-DISEASES: di, me</TOPIC><TOPIC>CALCIUM: bl, me</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>DENSITOMETRY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GROWTH-DISORDERS: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>PHOSPHORUS: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Bone mineral content, bone width, and their ratio were measured in
patients with cystic fibrosis (CF) using monoenergetic photon
absorptiometry. Serial measurements of the radius and ulna were made
in 27 patients with CF and were compared with 968 age-matched
controls. Demineralization was found in 37% of the boys and 63% of
the girls. Patients under age 10 years had normal bone mineral
content and nine of 15 patients aged 13 or older were demineralized
(P less than .01). Demineralization correlated with the extent of
weight reduction in patients (P less than .001). Patients most likely
to be demineralized were adolescent girls. To our knowledge, this is
the first report of bone mineral status of children with CF, and the
results indicate that a sizable proportion of these patients may be
demineralized without overt rickets.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="002" author="SCOTT J" publication="AM J MED" d1="63" d2="488" d3="977"/>
<CITE num="003" author="AVIOLI LV" publication="METABOLISM" d1="22" d2="507" d3="973"/>
<CITE num="004" author="CHESNEY RW" publication="PEDIATRICS" d1="60" d2="864" d3="977"/>
<CITE num="005" author="CHESNEY RW" publication="AM J DIS CHILD" d1="132" d2="768" d3="978"/>
<CITE num="006" author="LEVIN ME" publication="N ENGL J MED" d1="294" d2="241" d3="976"/>
<CITE num="007" author="CHRISTIANSEN C" publication="AM J ROENTGENOL" d1="126" d2="1302" d3="976"/>
<CITE num="008" author="CAMERON JR" publication="INVEST RADIOL" d1="3" d2="141" d3="968"/>
<CITE num="009" author="MAZESS RB" publication="INVEST RADIOL" d1="6" d2="52" d3="971"/>
<CITE num="010" author="CHRISTIANSEN C" publication="SCAND J CLIN LAB INVEST" d1="35" d2="425" d3="975"/>
<CITE num="011" author="MAZESS RB" publication="GROWTH" d1="36" d2="77" d3="972"/>
<CITE num="012" author="MAZESS RB" publication="AM J ANTHROPOL" d1="35" d2="399" d3="971"/>
<CITE num="013" author="MAZESS RB" publication="IN: MAZESS RB" d1="" d2="228" d3="974"/>
<CITE num="014" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="015" author="SPROUL A" publication="J PEDIATR" d1="65" d2="664" d3="964"/>
<CITE num="016" author="ANON" publication="MONTHLY VITAL STAT REPORT USD" d1="25" d2="76" d3="976"/>
<CITE num="017" author="LACHMAN E" publication="AM J ROENTG RAD THER NUCL MED" d1="74" d2="712" d3="955"/>
<CITE num="018" author="SIWE SA" publication="DTSCH ARCH KLIN MED" d1="173" d2="339" d3="932"/>
<CITE num="019" author="OPPENHEIMER EH" publication="BULL JOHNS HOPKINS HOSP" d1="98" d2="353" d3="956"/>
<CITE num="020" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="021" author="PARK EA" publication="ARCH DIS CHILD" d1="29" d2="269" d3="954"/>
<CITE num="022" author="BYERS PD" publication="IN: AVIOLI LV" d1="" d2="184" d3="977"/>
<CITE num="023" author="COOKE RE" publication="J PEDIATR" d1="57" d2="326" d3="960"/>
<CITE num="024" author="SIMOPOULOS AP" publication="PEDIATR RES" d1="6" d2="95" d3="972"/>
<CITE num="025" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="026" author="FARRELL PM" publication="PEDIATR RES" d1="11" d2="113" d3="977"/>
<CITE num="027" author="GALLAGHER JC" publication="N ENGL J MED" d1="298" d2="193" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79019</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TT MJ               RA" publication="DIOL CLIN NORTH AM" d1="19" d2="81 9" d3="1"/>
<CITE num="2" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="3" author="CHESNEY RW" publication="AM J DIS CHILD" d1="136" d2="578" d3="982"/>
<CITE num="4" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="5" author="FARRELL PM" publication="J DENT CHILD" d1="50" d2="385" d3="983"/>
<CITE num="6" author="LANDIN LA" publication="ACTA ORTHOP SCAND" d1="54" d2="1" d3="983"/>
<CITE num="7" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="8" author="HELIN I" publication="ACTA PAEDIATR SCAND" d1="74" d2="264" d3="985"/>
<CITE num="9" author="REITER EO" publication="J PEDIATR" d1="106" d2="21" d3="985"/>
<CITE num="10" author="STEAD RJ" publication="CLIN ENDOCRINOL" d1="26" d2="187" d3="987"/>
</CITATIONS>
<RECORDNUM>00999 </RECORDNUM>
<MEDLINENUM>79142382</MEDLINENUM>
<AUTHORS><AUTHOR>Strauss-G-D</AUTHOR><AUTHOR>Pedersen-S</AUTHOR><AUTHOR>Dudovitz-D</AUTHOR></AUTHORS>
<TITLE>Psychosocial support for adults with cystic fibrosis: a group
approach.</TITLE>
<SOURCE>Am-J-Dis-Child. 1979 Mar. 133(3). P 301-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: px</TOPIC><TOPIC>SELF-HELP-GROUPS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADAPTATION-PSYCHOLOGICAL</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ATTITUDE-TO-HEALTH</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NURSING-STAFF-HOSPITAL</TOPIC><TOPIC>PSYCHIATRY</TOPIC><TOPIC>ROLE</TOPIC><TOPIC>SOCIAL-WORK</TOPIC></MINORSUBJ>
<ABSTRACT>This article describes the first time-limited psychosocial support
group for adults with cystic fibrosis (CF).The chronology of the
group is traced, focusing on issues of importance for health
professionals who work with patients with CF. Some of the issues
raised by patient members include doubts about the competence of
nonpediatricians to adequately treat CF; resentment towards "normals"
(those without CF), including health professionals; and the desire to
control as many areas of their lives as possible. Covert (ie,
unrecognized) issues, the role of staff, risks, and outcome are
detailed as a guide for others who may wish to conduct such groups.
The literature on groups for medical patients and a rationale for the
beneficial effects on the group are given.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOWMAN BH" publication="N ENGL J MED" d1="294" d2="937" d3="976"/>
<CITE num="002" author="WARWICK WJ" publication="JAMA" d1="238" d2="2159" d3="977"/>
<CITE num="003" author="ROSENLUND ML" publication="ANN INTERN MED" d1="78" d2="959" d3="973"/>
<CITE num="004" author="PATTERSON PR" publication="PSYCHOSOCIAL ASPECTS OF CF" d1="" d2="" d3="973"/>
<CITE num="005" author="BOYLE IR" publication="J PEDIATR" d1="88" d2="318" d3="976"/>
<CITE num="006" author="DENNING CR" publication="IN: MANGOS JA" d1="" d2="127" d3="976"/>
<CITE num="007" author="PRATT JH" publication="JAMA" d1="49" d2="755" d3="907"/>
<CITE num="008" author="CUNNINGHAM J" publication="COMPR PSYCHIATRY" d1="19" d2="135" d3="978"/>
<CITE num="009" author="REID J" publication="GERIATRICS" d1="17" d2="823" d3="962"/>
<CITE num="010" author="DUDLEY DL" publication="AM REV RESPIR DIS" d1="100" d2="575" d3="969"/>
<CITE num="011" author="FORTIN JN" publication="INT J GROUP PSYCHOTHER" d1="6" d2="838" d3="956"/>
<CITE num="012" author="GUY W" publication="ARCH DERMATOL SYPHIL" d1="70" d2="767" d3="954"/>
<CITE num="013" author="ADSETT CA" publication="CAN MED ASSOC J" d1="99" d2="577" d3="968"/>
<CITE num="014" author="LONG RT" publication="J NERV MENT DIS" d1="119" d2="366" d3="954"/>
<CITE num="015" author="TEITELBAUM SH" publication="GROUP PSYCHOTHER" d1="17" d2="49" d3="964"/>
<CITE num="016" author="PARSELL S" publication="AM J NURS" d1="74" d2="650" d3="974"/>
<CITE num="017" author="SCHOENBERG B" publication="J CHRON DIS" d1="19" d2="649" d3="966"/>
<CITE num="018" author="COOKE M" publication="CF SOCIALWORK HIGHLIGHTS" d1="1" d2="5" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79020</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RAUSS GD            J" publication="CHRON DIS" d1="34" d2="41 9" d3="1"/>
</CITATIONS>
<RECORDNUM>01000 </RECORDNUM>
<MEDLINENUM>79121969</MEDLINENUM>
<AUTHORS><AUTHOR>di-Santagnese-P-A</AUTHOR><AUTHOR>Davis-P-B</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in adults.  75 cases and a review of 232 cases in
the literature.</TITLE>
<SOURCE>Am-J-Med. 1979 Jan. 66(1). P 121-32.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi, ra</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: di</TOPIC><TOPIC>LUNG: ra</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis is now the most common cause of chronic obstructive
pulmonary disease (COPD) and of pancreatic insufficiency in the
first three decades of life in the United States.  In this report we
describe 75 patients with cystic fibrosis aged 18 to 47 years and
review another 232 cases reported in the literature.  All of these
307 patients had elevated sweat chloride and sodium levels, which
proved excellent discriminants for cystic fibrosis even in patients
in the older age group.  COPD, present in 97 per cent, was the major
cause of morbidity and mortality, and differed from COPD of other
etiologies.  The progressive downhill course in these patients was
punctuated by recurrent symptomatic exacerbations of chronic
bacterial bronchitis caused by Pseudomonas aeruginosa and
Staphyloccocus aureus, and terminated in pulmonary insufficiency,
cor pulmonale and death.  COPD was complicated by minor hemoptysis
in 60 per cent, massive hemoptysis in 7 per cent and pneumothorax in
16 per cent, problems rare in children.  Sinusitis was present in
all those examined roentgenographically, and 48 per cent had nasal
polyposis.  Pancreatic insufficiency was present in 95 per cent of
the patients, but in contrast to younger patients it was seldom
symptomatic although steatorrhea and azotorrhea were still massive.
Intussusception and meconium ileus equivalent (fecal accumulation)
are frequent in adults (21 per cent) but rare in children, and they
require immediate diagnostic and therapeutic intervention with
enemas of diatrizoate sodium.  Glycosuria, biliary cirrhosis,
cholelithiasis and aspermia were among other complications.  Height
and weight were usually within the lower limits of normal, but 17
per cent of the men were above 180 cm in height and 7 per cent were
overweight.  Therefore, a high index of suspicion is needed to make
the diagnosis, because older patients with cystic fibrosis may look
quite well.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="MANGOS JA" publication="TEX REP BIOL MED" d1="31" d2="651" d3="973"/>
<CITE num="003" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
<CITE num="004" author="SCHULZ IJ" publication="J CLIN INVEST" d1="48" d2="1470" d3="969"/>
<CITE num="005" author="ANON" publication="CF FND 1974 REP SURVI STUD PA" d1="" d2="" d3="976"/>
<CITE num="006" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="007" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="008" author="GRACEY M" publication="AUSTRALAS ANN MED" d1="18" d2="91" d3="969"/>
<CITE num="009" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="010" author="SCHWARTZ EE" publication="AM J ROENTG RAD THER NUCL MED" d1="122" d2="708" d3="974"/>
<CITE num="011" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
<CITE num="012" author="FRIEDMAN PJ" publication="AM REV RESPIR DIS" d1="113" d2="159" d3="976"/>
<CITE num="013" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="014" author="SCHWERT GW" publication="BIOCHIM BIOPHYS ACTA" d1="16" d2="570" d3="955"/>
<CITE num="015" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="63" d2="643" d3="942"/>
<CITE num="016" author="FOLK JE" publication="J BIOL CHEM" d1="235" d2="2272" d3="960"/>
<CITE num="017" author="VAN LOON EJ" publication="AM J CLIN PATHOL" d1="22" d2="1134" d3="952"/>
<CITE num="018" author="SUN DCH" publication="GASTROENTEROLOGY" d1="44" d2="602" d3="963"/>
<CITE num="019" author="TAUSSIG LM" publication="PEDIATRICS" d1="54" d2="229" d3="974"/>
<CITE num="020" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="021" author="WOLLAEGER EE" publication="GASTROENTEROLOGY" d1="9" d2="272" d3="947"/>
<CITE num="022" author="TANNER JM" publication="ARCH DIS CHILD" d1="41" d2="454" d3="966"/>
<CITE num="023" author="NICKLAUS TM" publication="AM REV RESPIR DIS" d1="93" d2="889" d3="966"/>
<CITE num="024" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="025" author="JENSEN KG" publication="ACTA PAEDIATR SCAND" d1="51" d2="344" d3="962"/>
<CITE num="026" author="DI SANTAGNESE PA" publication="IN: DOWNEY JA" d1="" d2="25" d3="974"/>
<CITE num="027" author="WARWICK WJ" publication="J CHRON DIS" d1="28" d2="609" d3="975"/>
<CITE num="028" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="029" author="KRAEMER R" publication="ACTA PAEDIATR SCAND" d1="67" d2="33" d3="978"/>
<CITE num="030" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="031" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="032" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="033" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="178" d3="953"/>
<CITE num="034" author="ELIASSON R" publication="N ENGL J MED" d1="297" d2="1" d3="977"/>
<CITE num="035" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="036" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="037" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
<CITE num="038" author="FOX WW" publication="PEDIATRICS" d1="54" d2="293" d3="974"/>
<CITE num="039" author="COOPER DM" publication="AM REV RESPIR DIS" d1="109" d2="519" d3="974"/>
<CITE num="040" author="REYNOLDS HY" publication="JAMA" d1="236" d2="2190" d3="976"/>
<CITE num="041" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="042" author="BEDROSSIAN CWM" publication="HUM PATHOL" d1="7" d2="195" d3="976"/>
<CITE num="043" author="MILLIS RM" publication="CHEST" d1="71" d2="508" d3="977"/>
<CITE num="044" author="DAVIS PB" publication="JAMA" d1="239" d2="1851" d3="978"/>
<CITE num="045" author="BOAT TF" publication="AM REV RESPIR DIS" d1="116" d2="1" d3="977"/>
<CITE num="046" author="TAGER I" publication="N ENGL J MED" d1="292" d2="563" d3="975"/>
<CITE num="047" author="ROSENTHAL A" publication="PEDIATRICS" d1="59" d2="588" d3="977"/>
<CITE num="048" author="SIASSI B" publication="J PEDIATR" d1="78" d2="794" d3="971"/>
<CITE num="049" author="ROSENTHAL A" publication="PEDIATRICS" d1="59" d2="588" d3="977"/>
<CITE num="050" author="RYSSING E" publication="ACTA PAEDIATR SCAND" d1="66" d2="753" d3="977"/>
<CITE num="051" author="LEVITSKY S" publication="JAMA" d1="213" d2="125" d3="970"/>
<CITE num="052" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="053" author="SCHUSTER SR" publication="J PEDIATR SURG" d1="12" d2="889" d3="977"/>
<CITE num="054" author="LUCK SR" publication="J THORAC CARDIOVASC SURG" d1="74" d2="834" d3="977"/>
<CITE num="055" author="KATTWINKEL J" publication="JAMA" d1="226" d2="557" d3="973"/>
<CITE num="056" author="TAUSSIG LM" publication="J PEDIATR" d1="90" d2="574" d3="977"/>
<CITE num="057" author="COHEN LF" publication="J PEDIATR" d1="90" d2="574" d3="977"/>
<CITE num="058" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="389" d3="962"/>
<CITE num="059" author="CAPLIN I" publication="ANN ALLERGY" d1="29" d2="631" d3="971"/>
<CITE num="060" author="KULCZYCKI LL" publication="JAMA" d1="175" d2="358" d3="961"/>
<CITE num="061" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="062" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="063" author="KOPITO LE" publication="PEDIATR RES" d1="10" d2="742" d3="976"/>
<CITE num="064" author="DI SANTAGNESE PA" publication="IN: YOUNG DS" d1="" d2="" d3="976"/>
<CITE num="065" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="066" author="LAPEY A" publication="J PEDIATR" d1="84" d2="328" d3="974"/>
<CITE num="067" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="068" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="90" d2="302" d3="977"/>
<CITE num="069" author="UNDERWOOD BA" publication="PEDIATR RES" d1="6" d2="26" d3="972"/>
<CITE num="070" author="SCOTT J" publication="AM J MED" d1="63" d2="488" d3="977"/>
<CITE num="071" author="HUBBARD VS" publication="LANCET" d1="2" d2="1302" d3="977"/>
<CITE num="072" author="MULLINS F" publication="JAMA" d1="192" d2="741" d3="965"/>
<CITE num="073" author="MATSESHE JW" publication="GASTROENTEROLOGY" d1="72" d2="732" d3="977"/>
<CITE num="074" author="MCPARTLIN JF" publication="BR J SURG" d1="60" d2="707" d3="973"/>
<CITE num="075" author="KATTWINKEL J" publication="J PEDIATR" d1="82" d2="234" d3="973"/>
<CITE num="076" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="077" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="078" author="STERN RC" publication="GASTROENTEROLOGY" d1="70" d2="645" d3="976"/>
<CITE num="079" author="HUBBARD VS" publication="PEDIATR RES" d1="12" d2="437" d3="978"/>
<CITE num="080" author="ISENBERG JN" publication="AM J GASTROENTEROL" d1="65" d2="134" d3="976"/>
<CITE num="081" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="082" author="HANDWERGER S" publication="N ENGL J MED" d1="281" d2="451" d3="969"/>
<CITE num="083" author="LIPPE BM" publication="J PEDIATR" d1="90" d2="751" d3="977"/>
<CITE num="084" author="STAHL M" publication="J PEDIATR" d1="84" d2="821" d3="974"/>
<CITE num="085" author="MULLER WA" publication="AM J MED" d1="54" d2="52" d3="973"/>
<CITE num="086" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="087" author="TAUSSIG LM" publication="N ENGL J MED" d1="287" d2="586" d3="972"/>
<CITE num="088" author="HOLSCLAW DS" publication="J UROL" d1="106" d2="568" d3="971"/>
<CITE num="089" author="KAPLAN E" publication="N ENGL J MED" d1="279" d2="65" d3="968"/>
<CITE num="090" author="OPPENHEIMER EH" publication="J PEDIATR" d1="75" d2="806" d3="969"/>
<CITE num="091" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="092" author="HERROD HG" publication="J PEDIATR" d1="91" d2="276" d3="977"/>
<CITE num="093" author="DI SANTAGNESE PA" publication="IN: VAUGHAN VC III" d1="" d2="903" d3="975"/>
<CITE num="094" author="KOPITO LE" publication="FERTIL STERIL" d1="24" d2="512" d3="973"/>
<CITE num="095" author="OPPENHEIMER EH" publication="J PEDIATR" d1="77" d2="991" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79021</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  BR" publication="MED J" d1="2" d2="26 9" d3="9"/>
<CITE num="2" author="GURWITZ D" publication="PEDIATR CLIN NORTH AM" d1="26" d2="603" d3="979"/>
<CITE num="3" author="HOLSCLAW DS" publication="CLIN CHEST MED" d1="1" d2="407" d3="980"/>
<CITE num="4" author="COHEN LF" publication="LANCET" d1="2" d2="842" d3="980"/>
<CITE num="5" author="LELANNOU D" publication="ANN UROLOGIE" d1="14" d2="94" d3="980"/>
<CITE num="6" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="7" author="MATTHAY RA" publication="BR HEART J" d1="43" d2="474" d3="980"/>
<CITE num="8" author="DAVIS PB" publication="AM J MED" d1="69" d2="643" d3="980"/>
<CITE num="9" author="FAIRFAX AJ" publication="BR J DIS CHEST" d1="74" d2="345" d3="980"/>
<CITE num="10" author="SANDERS JS" publication="CHEST" d1="77" d2="226" d3="980"/>
<CITE num="11" author="HUBBARD VS" publication="AM J DIS CHILD" d1="134" d2="317" d3="980"/>
<CITE num="12" author="WILLI UV" publication="AM J ROENTGENOL" d1="134" d2="1005" d3="980"/>
<CITE num="13" author="HODSON ME" publication="PRACTITIONER" d1="224" d2="301" d3="980"/>
<CITE num="14" author="PASSERO MA" publication="CLIN PEDIATR" d1="20" d2="264" d3="981"/>
<CITE num="15" author="BLACKWOOD LL" publication="INFECT IMMUN" d1="32" d2="443" d3="981"/>
<CITE num="16" author="EVANS RT" publication="J CLIN PATHOL" d1="34" d2="911" d3="981"/>
<CITE num="17" author="RUTLAND J" publication="THORAX" d1="36" d2="654" d3="981"/>
<CITE num="18" author="LELANNOU D" publication="SEM HOP PARIS" d1="57" d2="608" d3="981"/>
<CITE num="19" author="MATTHAY RA" publication="MED CLIN NORTH AM" d1="65" d2="489" d3="981"/>
<CITE num="20" author="WELCH MJ" publication="PEDIATRICS" d1="67" d2="664" d3="981"/>
<CITE num="21" author="PENNINGTON JE" publication="J CLIN INVEST" d1="68" d2="1140" d3="981"/>
<CITE num="22" author="JACOBS WH" publication="AM J GASTROENTEROL" d1="76" d2="342" d3="981"/>
<CITE num="23" author="LAMBERT JR" publication="GASTROENTEROLOGY" d1="80" d2="169" d3="981"/>
<CITE num="24" author="FRIEDMAN PJ" publication="AM J ROENTGENOL" d1="136" d2="1131" d3="981"/>
<CITE num="25" author="HODSON ME" publication="EUR J PEDIATR" d1="137" d2="117" d3="981"/>
<CITE num="26" author="CORKEY CWB" publication="AM J OBSTET GYNECOL" d1="140" d2="737" d3="981"/>
<CITE num="27" author="OBOYLE CP" publication="IR J MED SCI" d1="150" d2="286" d3="981"/>
<CITE num="28" author="OGRADY JG" publication="IR J MED SCI" d1="150" d2="220" d3="981"/>
<CITE num="29" author="TABACHNIK NF" publication="SURG GYNECOL OBSTET" d1="152" d2="837" d3="981"/>
<CITE num="30" author="MACONE AB" publication="N ENGL J MED" d1="304" d2="1445" d3="981"/>
<CITE num="31" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="32" author="HOOGENRAAD TU" publication="NEUROOPHTHALMOL" d1="2" d2="267" d3="982"/>
<CITE num="33" author="JAGGER KS" publication="J CLIN MICROBIOL" d1="15" d2="1054" d3="982"/>
<CITE num="34" author="MCKIERNAN J" publication="PEDIATR RES" d1="16" d2="60" d3="982"/>
<CITE num="35" author="PUGASHETTI BK" publication="J CLIN MICROBIOL" d1="16" d2="686" d3="982"/>
<CITE num="36" author="HARVEY J" publication="BR J HOSP MED" d1="27" d2="278" d3="982"/>
<CITE num="37" author="KISTLER I" publication="HELV PAEDIATR ACTA" d1="36" d2="495" d3="982"/>
<CITE num="38" author="OHMAN DE" publication="INFECT IMMUN" d1="37" d2="662" d3="982"/>
<CITE num="39" author="PENKETH ARL" publication="THORAX" d1="37" d2="850" d3="982"/>
<CITE num="40" author="HUBBARD VS" publication="J AM DIET ASSOC" d1="80" d2="127" d3="982"/>
<CITE num="41" author="NOLAN G" publication="J PEDIATR" d1="101" d2="626" d3="982"/>
<CITE num="42" author="RIVERA M" publication="AM REV RESPIR DIS" d1="126" d2="833" d3="982"/>
<CITE num="43" author="STERN RC" publication="AM J DIS CHILD" d1="136" d2="1067" d3="982"/>
<CITE num="44" author="TSCHOLAKOFF D" publication="FORTSCHR GEB RONTG NUKL" d1="137" d2="18" d3="982"/>
<CITE num="45" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="46" author="GUIDOTTI TL" publication="AM J MED SCI" d1="283" d2="157" d3="982"/>
<CITE num="47" author="BONFORTE RJ" publication="LANCET" d1="1" d2="71" d3="983"/>
<CITE num="48" author="SHAWKER TH" publication="J ULTRASOUND MED" d1="2" d2="439" d3="983"/>
<CITE num="49" author="WAGENER JS" publication="AM J PEDIATR HEMATOL ONCOL" d1="5" d2="153" d3="983"/>
<CITE num="50" author="WEBSTER HL" publication="CRC CRIT REV CLIN LAB SCI" d1="18" d2="313" d3="983"/>
<CITE num="51" author="BRECHER DB" publication="AM FAM PHYSICIAN" d1="28" d2="187" d3="983"/>
<CITE num="52" author="KRAMER NR" publication="J CAN ASSOC RADIOL" d1="34" d2="271" d3="983"/>
<CITE num="53" author="DAVIS PB" publication="J CHRON DIS" d1="36" d2="269" d3="983"/>
<CITE num="54" author="JEFFREY I" publication="J CLIN PATHOL" d1="36" d2="1292" d3="983"/>
<CITE num="55" author="DORING G" publication="INFECT IMMUN" d1="42" d2="197" d3="983"/>
<CITE num="56" author="GUIDOTTI TL" publication="RESPIRATION" d1="44" d2="351" d3="983"/>
<CITE num="57" author="JACOBS RL" publication="ANN ALLERGY" d1="51" d2="500" d3="983"/>
<CITE num="58" author="GEMBITSKAYA TE" publication="KLIN MED" d1="61" d2="9" d3="983"/>
<CITE num="59" author="JOHNSON SR" publication="OBSTET GYNECOL" d1="61" d2="S  2" d3="983"/>
<CITE num="60" author="DOHERTY DE" publication="SOUTH MED J" d1="76" d2="1580" d3="983"/>
<CITE num="61" author="ALLEN JM" publication="GASTROENTEROLOGY" d1="85" d2="1379" d3="983"/>
<CITE num="62" author="PORTER DK" publication="J THORAC CARDIOVASC SURG" d1="86" d2="409" d3="983"/>
<CITE num="63" author="ANON" publication="ANN INTERN MED" d1="98" d2="1033" d3="983"/>
<CITE num="64" author="DAVIS PB" publication="AM REV RESPIR DIS" d1="128" d2="34" d3="983"/>
<CITE num="65" author="PORTER DK" publication="ARCH INTERN MED" d1="143" d2="287" d3="983"/>
<CITE num="66" author="BOUCHER RC" publication="LUNG" d1="161" d2="1" d3="983"/>
<CITE num="67" author="ROSENBERG E" publication="KLIN PAEDIATR" d1="195" d2="323" d3="983"/>
<CITE num="68" author="HANLY JG" publication="BR MED J" d1="286" d2="1411" d3="983"/>
<CITE num="69" author="HODSON ME" publication="BR MED J" d1="286" d2="1381" d3="983"/>
<CITE num="70" author="ZENTLERMUNRO PL" publication="GUT" d1="25" d2="500" d3="984"/>
<CITE num="71" author="MCCLURE HM" publication="ADV VET SCI COMP MED" d1="28" d2="267" d3="984"/>
<CITE num="72" author="MATTHEWS LW" publication="PEDIATR CLIN NORTH AM" d1="31" d2="133" d3="984"/>
<CITE num="73" author="PENKETH A" publication="THORAX" d1="39" d2="299" d3="984"/>
<CITE num="74" author="COWEN L" publication="PSYCHOSOM MED" d1="46" d2="363" d3="984"/>
<CITE num="75" author="WILSONSHARP RC" publication="ARCH DIS CHILD" d1="59" d2="923" d3="984"/>
<CITE num="76" author="LEWIS MI" publication="S AFR MED J" d1="65" d2="641" d3="984"/>
<CITE num="77" author="ABRAMS CK" publication="J CLIN INVEST" d1="73" d2="374" d3="984"/>
<CITE num="78" author="SLAVIN RG" publication="J ALLERGY CLIN IMMUNOL" d1="73" d2="712" d3="984"/>
<CITE num="79" author="JACOBS RL" publication="J ALLERGY CLIN IMMUNOL" d1="74" d2="61" d3="984"/>
<CITE num="80" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="81" author="DAVIS PB" publication="CHEST" d1="85" d2="802" d3="984"/>
<CITE num="82" author="MCCARTHY VP" publication="GASTROENTEROLOGY" d1="86" d2="564" d3="984"/>
<CITE num="83" author="SPINO M" publication="J PEDIATR" d1="105" d2="829" d3="984"/>
<CITE num="84" author="GUGGER M" publication="SCHWEIZ MED WOCHENSCHR" d1="114" d2="620" d3="984"/>
<CITE num="85" author="SIGG C" publication="SCHWEIZ MED WOCHENSCHR" d1="114" d2="1942" d3="984"/>
<CITE num="86" author="GEFFNER ME" publication="AM J DIS CHILD" d1="138" d2="677" d3="984"/>
<CITE num="87" author="HANDELSMAN DJ" publication="N ENGL J MED" d1="310" d2="1670" d3="984"/>
<CITE num="88" author="SPRINCE  NL" publication="N ENGL J MED" d1="310" d2="375" d3="984"/>
<CITE num="89" author="PINKERTON P" publication="LANCET" d1="2" d2="761" d3="985"/>
<CITE num="90" author="CRAWFORD AM" publication="RHEUMATOL INT" d1="5" d2="283" d3="985"/>
<CITE num="91" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="92" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="314" d3="985"/>
<CITE num="93" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="319" d3="985"/>
<CITE num="94" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="299" d3="985"/>
<CITE num="95" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="96" author="SHAW LMA" publication="J OBSTET GYNAECOL BR COMMONW" d1="6" d2="1" d3="985"/>
<CITE num="97" author="SWOBODNIK W" publication="J CLIN ULTRASOUND" d1="13" d2="469" d3="985"/>
<CITE num="98" author="REINIG JW" publication="PEDIATR RADIOL" d1="15" d2="222" d3="985"/>
<CITE num="99" author="SEAMAN WB" publication="HOSP PRACT" d1="20" d2="123" d3="985"/>
<CITE num="100" author="KAHAN A" publication="PHARMACOL THER" d1="28" d2="163" d3="985"/>
<CITE num="101" author="GRAHAM N" publication="CLIN RADIOL" d1="36" d2="199" d3="985"/>
<CITE num="102" author="TRENTO A" publication="ANN THORAC SURG" d1="39" d2="254" d3="985"/>
<CITE num="103" author="DAVIS PB" publication="THORAX" d1="40" d2="376" d3="985"/>
<CITE num="104" author="HUNT B" publication="THORAX" d1="40" d2="23" d3="985"/>
<CITE num="105" author="AMES P" publication="INFECT IMMUN" d1="49" d2="281" d3="985"/>
<CITE num="106" author="HANLY JG" publication="Q J MED" d1="56" d2="377" d3="985"/>
<CITE num="107" author="MEARNS MB" publication="ARCH DIS CHILD" d1="60" d2="272" d3="985"/>
<CITE num="108" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="109" author="ROTH RM" publication="SOUTH MED J" d1="78" d2="573" d3="985"/>
<CITE num="110" author="ISPIZUA AU" publication="MED CLIN" d1="85" d2="628" d3="985"/>
<CITE num="111" author="REITER EO" publication="J PEDIATR" d1="106" d2="21" d3="985"/>
<CITE num="112" author="MELLIS CM" publication="MED J AUST" d1="143" d2="227" d3="985"/>
<CITE num="113" author="OCONNOR KW" publication="ARCH INTERN MED" d1="145" d2="153" d3="985"/>
<CITE num="114" author="OHMAN DE" publication="J BACTERIOL" d1="162" d2="1068" d3="985"/>
<CITE num="115" author="ISPIZUA AU" publication="REV CLIN ESP" d1="176" d2="417" d3="985"/>
<CITE num="116" author="KNOPFLE G" publication="KLIN PAEDIATR" d1="197" d2="481" d3="985"/>
<CITE num="117" author="HUGHES RL" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="42" d3="985"/>
<CITE num="118" author="OHMAN DE" publication="EUR J CLIN MICROBIOL" d1="5" d2="6" d3="986"/>
<CITE num="119" author="PENNINGTON JE" publication="REV INFECT DIS" d1="8" d2="S426" d3="986"/>
<CITE num="120" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="121" author="KRIEG DP" publication="J CLIN MICROBIOL" d1="24" d2="986" d3="986"/>
<CITE num="122" author="PIER GB" publication="J CLIN MICROBIOL" d1="24" d2="189" d3="986"/>
<CITE num="123" author="OJEDA VJ" publication="DIS COLON RECTUM" d1="29" d2="567" d3="986"/>
<CITE num="124" author="ROBERTS JA" publication="SCOTT MED J" d1="31" d2="109" d3="986"/>
<CITE num="125" author="RODMAN HM" publication="MEDICINE" d1="65" d2="389" d3="986"/>
<CITE num="126" author="PIER GB" publication="J CLIN INVEST" d1="77" d2="491" d3="986"/>
<CITE num="127" author="DINWIDDIE R" publication="J ROY SOC MED" d1="79" d2="6" d3="986"/>
<CITE num="128" author="ROSENSTEIN BJ" publication="SOUTH MED J" d1="79" d2="319" d3="986"/>
<CITE num="129" author="WELLER PH" publication="J ROY SOC MED" d1="79" d2="36" d3="986"/>
<CITE num="130" author="TRAVIS WD" publication="AM J CLIN PATHOL" d1="85" d2="419" d3="986"/>
<CITE num="131" author="ABDULKARIM FW" publication="ARCH PATHOL LAB MED" d1="110" d2="602" d3="986"/>
<CITE num="132" author="MCGLENNEN RC" publication="ARCH PATHOL LAB MED" d1="110" d2="879" d3="986"/>
<CITE num="133" author="COHEN AM" publication="AM J DIS CHILD" d1="140" d2="74" d3="986"/>
<CITE num="134" author="ROSENSTEIN BJ" publication="AM J DIS CHILD" d1="140" d2="966" d3="986"/>
<CITE num="135" author="KRUHLAK RT" publication="WEST J MED" d1="145" d2="196" d3="986"/>
<CITE num="136" author="STEINKAMP G" publication="EUR J PEDIATR" d1="145" d2="526" d3="986"/>
<CITE num="137" author="KUMARISUBAIYA S" publication="J PEDIATR GASTROENTEROL NUTR" d1="6" d2="71" d3="987"/>
<CITE num="138" author="STEAD RJ" publication="CLIN ENDOCRINOL" d1="26" d2="187" d3="987"/>
<CITE num="139" author="STEAD RJ" publication="THORAX" d1="42" d2="59" d3="987"/>
<CITE num="140" author="MCHUGO JM" publication="BR J RADIOL" d1="60" d2="137" d3="987"/>
<CITE num="141" author="DAVIS PB" publication="J DENT RES" d1="66" d2="667" d3="987"/>
<CITE num="142" author="BAILEY DJ" publication="PEDIATRICS" d1="79" d2="281" d3="987"/>
</CITATIONS>
<RECORDNUM>01001 </RECORDNUM>
<MEDLINENUM>80062584</MEDLINENUM>
<AUTHORS><AUTHOR>Fisher-N-L</AUTHOR></AUTHORS>
<TITLE>Genetic counseling and prenatal diagnosis of cystic fibrosis
[letter].</TITLE>
<SOURCE>Am-J-Obstet-Gynecol. 1979 Nov 1. 135(5). P 699.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC><TOPIC>PRENATAL-DIAGNOSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<EXTRACT>Turner and associates cited cystic fibrosis as an example of the
application of the judicious use of genetic counseling and prenatal
diagnosis.  The reader who is unfamiliar with genetic disorders,
prenatal diagnosis, and genetic counseling may have taken the "cystic
fibrosis example" as fact rather than a model, as intended.  Cystic
fibrosis is a recessive disorder for which prenatal diagnosis and
heterozygote detection are not yet possible.  Currently, because of
the present inability to detect the heterozygous state, genetic
counseling of individuals with a family history of cystic fibrosis
frequently means a statistical prediction is given, rather than a
precise recurrence risk.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79022</PAPERNUM>
<REFERENCES>
<CITE num="000" author="TURNER JH" publication="AM J OBSTET GYNECOL" d1="134" d2="83" d3="979"/>
</REFERENCES>
<RECORDNUM>01002 </RECORDNUM>
<MEDLINENUM>79206917</MEDLINENUM>
<AUTHORS><AUTHOR>Imrie-J-R</AUTHOR><AUTHOR>Fagan-D-G</AUTHOR><AUTHOR>Sturgess-J-M</AUTHOR></AUTHORS>
<TITLE>Quantitative evaluation of the development of the exocrine pancreas
in cystic fibrosis and control infants.</TITLE>
<SOURCE>Am-J-Pathol. 1979 Jun. 95(3). P 697-707.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>PANCREAS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CONNECTIVE-TISSUE: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GESTATIONAL-AGE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MECONIUM</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<ABSTRACT>The development of the exocrine pancreas has been determined
quantitatively in 31 infants with cystic fibrosis (CF) both  with and
without meconium ileus and in 29 control infants. In the normal
pancreas, the ratio of acinar to connective tissue volume is 0.5 at
32 weeks postconceptional age (PCA) and increases linearly to 2.0 at
52 weeks PGA. In cystic fibrosis infants, with or without meconium
ileus, the ration is 0.5 at 35 weeks PCA  anddecreases linearly to
0.3 at 52 weeks PCA. The volume of acinar and duct lumens is greater
in CF than control infants but is independent of age or acinar
volume. The development of the exocrine pancreas in infants with CF
with and without meconium ileus diverges from the normal pattern:
There is consistent lack of exocrine tissue before or a full-term
birth, which persists throghout the age range of this study. CF
infants above 42 weeks PCA can be discriminated from controls on the
basis of the quantitative assessment of acinar volume.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="FARBER S" publication="J PEDIATR" d1="24" d2="387" d3="944"/>
<CITE num="002" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="003" author="KORNBLITH BA" publication="AM J PATHOL" d1="5" d2="249" d3="929"/>
<CITE num="004" author="HURWITT ES" publication="AM J DIS CHILD" d1="64" d2="443" d3="942"/>
<CITE num="005" author="GLANZMANN E" publication="ANN PAEDIATR" d1="166" d2="289" d3="946"/>
<CITE num="006" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="007" author="WEIBEL ER" publication="MORPHOMETRY OF THE HUMAN LUNG" d1="" d2="" d3="963"/>
<CITE num="008" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
<CITE num="009" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="010" author="DONNISON AB" publication="PEDIATRICS" d1="37" d2="833" d3="966"/>
<CITE num="011" author="KOPITO LE" publication="PEDIATR RES" d1="10" d2="742" d3="976"/>
<CITE num="012" author="RICKHAM PP" publication="PROG PEDIATR SURG" d1="2" d2="73" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79023</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLARD BK            PE" publication="DIATR RES" d1="14" d2="68 9" d3="0"/>
<CITE num="2" author="CARREL O" publication="HELV PAEDIATR ACTA" d1="36" d2="405" d3="981"/>
<CITE num="3" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="4" author="STURGESS J" publication="AM J PATHOL" d1="106" d2="303" d3="982"/>
<CITE num="5" author="REID L" publication="INT REV EXP PATHOL" d1="24" d2="335" d3="983"/>
<CITE num="6" author="MASOERO G" publication="AM J DIS CHILD" d1="137" d2="167" d3="983"/>
<CITE num="7" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="8" author="GOTZ M" publication="ATEMWEGS LUNGENKRANKH" d1="10" d2="594" d3="984"/>
<CITE num="9" author="LANGLEY FA" publication="CLIN OBSTET GYNAECOL" d1="11" d2="79" d3="984"/>
<CITE num="10" author="MULLER F" publication="PRENAT DIAGN" d1="5" d2="109" d3="985"/>
<CITE num="11" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="299" d3="985"/>
<CITE num="12" author="GOTZ M" publication="MED KLIN" d1="80" d2="657" d3="985"/>
<CITE num="13" author="FRIEND PA" publication="J INFECT" d1="13" d2="55" d3="986"/>
<CITE num="14" author="DODGE JA" publication="J ROY SOC MED" d1="79" d2="27" d3="986"/>
<CITE num="15" author="HUNSINGER RN" publication="CLIN CHIM ACTA" d1="156" d2="165" d3="986"/>
</CITATIONS>
<RECORDNUM>01003 </RECORDNUM>
<MEDLINENUM>79185761</MEDLINENUM>
<AUTHORS><AUTHOR>Larsen-G-L</AUTHOR><AUTHOR>Barron-R-J</AUTHOR><AUTHOR>Cotton-E-K</AUTHOR><AUTHOR>Brooks-J-G</AUTHOR></AUTHORS>
<TITLE>A comparative study of inhaled atropine sulfate and isoproterenol
hydrochloride in cystic fibrosis.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1979 Mar. 119(3). P 399-407.</SOURCE>
<MAJORSUBJ><TOPIC>ATROPINE: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>ISOPROTERENOL: du</TOPIC><TOPIC>RESPIRATION: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AEROSOLS</TOPIC><TOPIC>AIRWAY-RESISTANCE: de</TOPIC><TOPIC>ATROPINE: ad, pd</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>DOSE-RESPONSE-RELATIONSHIP-DRUG</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOPROTERENOL: ad, pd</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MAXIMAL-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>MAXIMAL-EXPIRATORY-FLOW-VOLUME-CURVES</TOPIC><TOPIC>RESIDUAL-VOLUME</TOPIC><TOPIC>TOTAL-LUNG-CAPACITY</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>To investigate the contribution of vagal tone to the obstructive
airway disease in cystic fibrosis, we evaluated the pulmonary
function response to administration of 0.1 mg of atropine sulfate
per kg of body weight, 0.05 mg of isoproterenol hydrochloride per kg
of body weight, or isotonic saline (control solution) administered
by nebulization on 3 different days to each of 10 patients with
cystic fibrosis in a single blind study.  The doses of atropine
sulfate and isoproterenol hydrochloride were based on published
dose-response characteristics of the drugs.  Each day, thoracic gas
volume and airway resistance were measured in a volume displacement
body plethysmograph, and maximal expiratory flow-volume curves were
performed before and at 15, 30, and 60 min after the inhalation.
After inhalation of saline, group mean values for all pulmonary
functions indicated greater airway obstruction at 15, 30, and 60 min
when compared to pretreatment values.  After inhalation of
isoproterenol and atropine, significant improvement (P &lt; 0.05) was
noted in maximal expiratory flows at 60 per cent of total lung
capacity, specific airway conductance, thoracic gas volume, and
residual volume.  Inhalation of atropine also significantly improved
maximal expiratory flow at 25 per cent of vital capacity.
Isoproterenol increased the mean flows by 8 to 46 per cent above
baseline, and decreased thoracic gas volume and residual volume by
11 to 16 per cent with the maximal response at 15 or 30 min.
Atropine increased mean flows by 15 to 77 per cent and decreased
thoracic gas volume and residual volume by 16 to 25 per cent with
the maximal effect at 30 to 60 min.  The mean response to atropine,
expressed as a percentage of baseline, was always greater than or
equal to that for isoproterenol.  We conclude that vagal tone, which
may reflect increased irritant receptor activity, contributes to the
obstructive pulmonary function in cystic fibrosis.  Inhalation of
atropine sulfate will decrease the pulmonary function abnormality,
but side effects prohibit its clinical usefulness.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WEST JR" publication="PEDIATRICS" d1="13" d2="155" d3="954"/>
<CITE num="002" author="COOK CD" publication="PEDIATRICS" d1="24" d2="181" d3="959"/>
<CITE num="003" author="BEIER FR" publication="AM REV RESPIR DIS" d1="94" d2="430" d3="966"/>
<CITE num="004" author="GANDEVIA B" publication="ARCH DIS CHILD" d1="34" d2="511" d3="959"/>
<CITE num="005" author="POLGAR G" publication="AM J DIS CHILD" d1="100" d2="733" d3="960"/>
<CITE num="006" author="MELLINS RB" publication="PEDIATRICS" d1="41" d2="560" d3="968"/>
<CITE num="007" author="MEARNS MB" publication="ARCH DIS CHILD" d1="43" d2="528" d3="968"/>
<CITE num="008" author="LIFSCHITZ MI" publication="AM REV RESPIR DIS" d1="99" d2="399" d3="969"/>
<CITE num="009" author="PHELAN PD" publication="ARCH DIS CHILD" d1="44" d2="393" d3="969"/>
<CITE num="010" author="FEATHERBY EA" publication="CAN MED ASSOC J" d1="102" d2="835" d3="970"/>
<CITE num="011" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
<CITE num="012" author="CHANG N" publication="AM REV RESPIR DIS" d1="106" d2="867" d3="972"/>
<CITE num="013" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="014" author="SHAPIRO GG" publication="PEDIATRICS" d1="58" d2="740" d3="976"/>
<CITE num="015" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="016" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="017" author="EMPEY DW" publication="AM REV RESPIR DIS" d1="113" d2="131" d3="976"/>
<CITE num="018" author="KLOCK LE" publication="AM REV RESPIR DIS" d1="112" d2="371" d3="975"/>
<CITE num="019" author="CROPP GJA" publication="AM REV RESPIR DIS" d1="112" d2="599" d3="975"/>
<CITE num="020" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="021" author="BARRON R" publication="AM REV RESPIR DIS SUPPL" d1="115" d2="275" d3="977"/>
<CITE num="022" author="CAVANAUGH MJ" publication="AM REV RESPIR DIS" d1="114" d2="517" d3="976"/>
<CITE num="023" author="TINKELMAN D" publication="ANN ALLERGY" d1="38" d2="298" d3="977"/>
<CITE num="024" author="MERCER TT" publication="ANN ALLERGY" d1="23" d2="314" d3="965"/>
<CITE num="025" author="MEAD J" publication="J APPL PHYSIOL" d1="15" d2="736" d3="960"/>
<CITE num="026" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="027" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="028" author="POLGAR G" publication="PULMONARY FUNCTION TESTING IN" d1="" d2="" d3="971"/>
<CITE num="029" author="WENG TR" publication="AM REV RESPIR DIS" d1="99" d2="879" d3="969"/>
<CITE num="030" author="DEMUTH GR" publication="PEDIATRICS" d1="35" d2="200" d3="965"/>
<CITE num="031" author="MATTHYS H" publication="RESPIRATION" d1="27" d2="447" d3="970"/>
<CITE num="032" author="ZAPLETAL A" publication="J APPL PHYSIOL" d1="26" d2="308" d3="969"/>
<CITE num="033" author="STEEL RGD" publication="PRIN PROC OF STATISTICS" d1="" d2="" d3="960"/>
<CITE num="034" author="HAHN GJ" publication="BIOMETRIKA" d1="58" d2="323" d3="971"/>
<CITE num="035" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="036" author="MANSELL A" publication="AM REV RESPIR DIS" d1="109" d2="190" d3="974"/>
<CITE num="037" author="COOPER DM" publication="AM REV RESPIR DIS" d1="109" d2="519" d3="974"/>
<CITE num="038" author="INGRAM RH" publication="J CLIN INVEST" d1="59" d2="696" d3="977"/>
<CITE num="039" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="040" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="041" author="MELLIS CM" publication="PEDIATRICS" d1="61" d2="446" d3="978"/>
<CITE num="042" author="WANNER A" publication="AM REV RESPIR DIS" d1="116" d2="73" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79024</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HADANA AB           CL" publication="IN RESP PHYSIOL" d1="16" d2="69 9" d3="0"/>
<CITE num="2" author="KATTAN M" publication="THORAX" d1="35" d2="531" d3="980"/>
<CITE num="3" author="BERGMAN KR" publication="CHEST" d1="78" d2="891" d3="980"/>
<CITE num="4" author="BOUSHEY HA" publication="AM REV RESPIR DIS" d1="121" d2="389" d3="980"/>
<CITE num="5" author="LARSEN GL" publication="AM J DIS CHILD" d1="134" d2="1143" d3="980"/>
<CITE num="6" author="KRAEMER R" publication="PEDIATR RES" d1="15" d2="1433" d3="981"/>
<CITE num="7" author="KRADJAN WA" publication="AM REV RESPIR DIS" d1="123" d2="471" d3="981"/>
<CITE num="8" author="VANASPEREN P" publication="AM J DIS CHILD" d1="135" d2="815" d3="981"/>
<CITE num="9" author="GRIFFIN MP" publication="J APPL PHYSIOL" d1="53" d2="1576" d3="982"/>
<CITE num="10" author="PAK CCF" publication="AM REV RESPIR DIS" d1="125" d2="331" d3="982"/>
<CITE num="11" author="DAVIS PB" publication="J CHRON DIS" d1="36" d2="269" d3="983"/>
<CITE num="12" author="FRANCIS PB" publication="MED CLIN NORTH AM" d1="67" d2="657" d3="983"/>
<CITE num="13" author="DAVIS PB" publication="CHEST" d1="85" d2="802" d3="984"/>
<CITE num="14" author="HEIDEPRIEM CC" publication="DRUG INTEL CLIN PHARM" d1="19" d2="732" d3="985"/>
<CITE num="15" author="SCHONI MH" publication="PEDIATR RES" d1="19" d2="47" d3="985"/>
<CITE num="16" author="KONIG P" publication="ANN ALLERGY" d1="55" d2="95" d3="985"/>
<CITE num="17" author="HORDVIK NL" publication="AM REV RESPIR DIS" d1="131" d2="889" d3="985"/>
<CITE num="18" author="DARGA LL" publication="PEDIATR PULMONOL" d1="2" d2="82" d3="986"/>
<CITE num="19" author="KNOWLES MR" publication="CLIN CHEST MED" d1="7" d2="285" d3="986"/>
<CITE num="20" author="BROWN SE" publication="CHEST" d1="89" d2="7" d3="986"/>
<CITE num="21" author="BOUCHER RC" publication="TOXICOL APPL PHARMACOL" d1="87" d2="264" d3="987"/>
</CITATIONS>
<RECORDNUM>01004 </RECORDNUM>
<MEDLINENUM>79185775</MEDLINENUM>
<AUTHORS><AUTHOR>Reid-L-M</AUTHOR></AUTHORS>
<TITLE>The pulmonary circulation: remodeling in growth and disease.  The
1978 J. Burns Amberson lecture.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1979 Apr. 119(4). P 531-46.</SOURCE>
<MAJORSUBJ><TOPIC>PULMONARY-ARTERY: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>ANOXIA: pa</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>HEART-DEFECTS-CONGENITAL: pa</TOPIC><TOPIC>HEART-SEPTAL-DEFECTS-VENTRICULAR: pa</TOPIC><TOPIC>HEART-VENTRICLE: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERTENSION-PULMONARY: et, pa</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>LUNG: bs, em, gd</TOPIC><TOPIC>PULMONARY-ARTERY: ah, gd</TOPIC><TOPIC>PULMONARY-HEART-DISEASE: pa</TOPIC><TOPIC>RATS</TOPIC><TOPIC>SWINE</TOPIC></MINORSUBJ>
<EXTRACT>This account draws on studies of young and mature lung, on normal and
morbid anatomic features, on normal adaptations as in growth, and
remodeling by disease.  Qualitative analysis of the vascular bed,
development of the pulmonary circulation, right ventricular
hypertrophy or cor pulmonale, remodeling in disease, and experimental
studies are discussed.  Pulmonary hypertension offers us a complex
pattern of structural and functional interaction; we are just
beginning to realize how complex it is.  Information on normal
structure, its modification and remodeling by growth and disease, and
appropriate techniques are available that will enable us to formulate
our questions with due regard for anatomic precision and functional
implication.  And so research will lead to understanding and, it can
be expected, to control of the undesirable aspects of pulmonary
hypertension.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT FM" publication="THESIS" d1="" d2="" d3="964"/>
<CITE num="002" author="ONEAL RM" publication="ARCH PATHOL" d1="60" d2="267" d3="955"/>
<CITE num="003" author="WEIBEL ER" publication="J APPL PHYSIOL" d1="17" d2="343" d3="962"/>
<CITE num="004" author="DUNNILL MS" publication="THORAX" d1="17" d2="329" d3="962"/>
<CITE num="005" author="HAYWARD J" publication="THORAX" d1="7" d2="89" d3="952"/>
<CITE num="006" author="BUCHER U" publication="THORAX" d1="16" d2="207" d3="961"/>
<CITE num="007" author="BRIGHT R" publication="GUYS HOSP REP" d1="1" d2="338" d3="836"/>
<CITE num="008" author="SHORT DS" publication="J FACULTY RADIOL" d1="8" d2="118" d3="956"/>
<CITE num="009" author="HISLOP A" publication="THORAX" d1="25" d2="682" d3="970"/>
<CITE num="010" author="ELLIOTT FJ" publication="CLIN RADIOL" d1="16" d2="193" d3="965"/>
<CITE num="011" author="REID L" publication="IN: SCIENTIFIC BASIS OF M" d1="" d2="289" d3="968"/>
<CITE num="012" author="HISLOP A" publication="J ANAT" d1="113" d2="35" d3="972"/>
<CITE num="013" author="HISLOP A" publication="THORAX" d1="28" d2="313" d3="973"/>
<CITE num="014" author="HISLOP A" publication="THORAX" d1="28" d2="129" d3="973"/>
<CITE num="015" author="HISLOP A" publication="IN: DAVIS JA" d1="" d2="214" d3="974"/>
<CITE num="016" author="REID L" publication="AM J ROENTGENOL" d1="129" d2="777" d3="977"/>
<CITE num="017" author="HISLOP A" publication="IN: HODSON WA" d1="6" d2="37" d3="977"/>
<CITE num="018" author="BOYDEN EA" publication="AM J ANAT" d1="121" d2="749" d3="967"/>
<CITE num="019" author="DAVIES G" publication="THORAX" d1="25" d2="669" d3="970"/>
<CITE num="020" author="ANON" publication="WHO TECH REP SER NO 213" d1="" d2="" d3="961"/>
<CITE num="021" author="FULTON RM" publication="BR HEART J" d1="14" d2="413" d3="952"/>
<CITE num="022" author="HISLOP A" publication="J CLIN PATHOL" d1="25" d2="534" d3="972"/>
<CITE num="023" author="WEEKS JR" publication="PROC SOC EXP BIOL MED" d1="104" d2="646" d3="960"/>
<CITE num="024" author="HERGET J" publication="ARCH INT PHARMACODYN THER" d1="198" d2="107" d3="972"/>
<CITE num="025" author="RABINOVITCH M" publication="CIRCULATION SUPPL 2" d1="56" d2="275" d3="977"/>
<CITE num="026" author="RENDAS A" publication="J APPL PHYSIOL" d1="45" d2="806" d3="978"/>
<CITE num="027" author="DAVIES GM" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="350" d3="969"/>
<CITE num="028" author="RYLAND D" publication="THORAX" d1="30" d2="285" d3="975"/>
<CITE num="029" author="ANDERSON EG" publication="J PATHOL" d1="110" d2="273" d3="973"/>
<CITE num="030" author="MEYRICK B" publication="BR J DIS CHEST" d1="68" d2="11" d3="974"/>
<CITE num="031" author="HISLOP A" publication="BR HEART J" d1="35" d2="1178" d3="973"/>
<CITE num="032" author="HISLOP A" publication="BR HEART J" d1="37" d2="1014" d3="975"/>
<CITE num="033" author="HAWORTH SG" publication="AM J CARDIOL" d1="40" d2="781" d3="977"/>
<CITE num="034" author="HAWORTH SG" publication="THORAX" d1="32" d2="129" d3="977"/>
<CITE num="035" author="HAWORTH SG" publication="THORAX" d1="32" d2="121" d3="977"/>
<CITE num="036" author="HAWORTH SG" publication="BR HEART J" d1="39" d2="80" d3="977"/>
<CITE num="037" author="GROVER RF" publication="AM HEART J" d1="66" d2="1" d3="963"/>
<CITE num="038" author="ANDERSON G" publication="CLIN RADIOL" d1="24" d2="113" d3="973"/>
<CITE num="039" author="HAWORTH SG" publication="BR HEART J" d1="40" d2="826" d3="978"/>
<CITE num="040" author="RABINOVITCH M" publication="CIRCULATION SUPPL 2" d1="56" d2="193" d3="977"/>
<CITE num="041" author="RABINOVITCH M" publication="CIRCULATION" d1="58" d2="1107" d3="978"/>
<CITE num="042" author="HEATH D" publication="CIRCULATION" d1="18" d2="533" d3="958"/>
<CITE num="043" author="MEYRICK B" publication="COLLOQ INSERM ECHANG GAZ PUL" d1="51" d2="145" d3="975"/>
<CITE num="044" author="HISLOP A" publication="BR J EXP PATHOL" d1="57" d2="542" d3="976"/>
<CITE num="045" author="MEYRICK B" publication="ANAT REC" d1="193" d2="71" d3="979"/>
<CITE num="046" author="MEYRICK B" publication="J ANAT" d1="125" d2="209" d3="978"/>
<CITE num="047" author="MEYRICK B" publication="LAB INVEST" d1="38" d2="188" d3="978"/>
<CITE num="048" author="HISLOP A" publication="BR J EXP PATHOL" d1="58" d2="653" d3="977"/>
<CITE num="050" author="HISLOP A" publication="BR J EXP PATHOL" d1="55" d2="153" d3="974"/>
<CITE num="051" author="MEYRICK B" publication="AM J PATHOL" d1="94" d2="37" d3="979"/>
<CITE num="052" author="RENDAS A" publication="J THORAC CARDIOVASC SURG" d1="77" d2="109" d3="979"/>
<CITE num="053" author="CHEUNG DLC" publication="THESIS" d1="" d2="" d3="977"/>
<CITE num="054" author="UNGER M" publication="J APPL PHYSIOL" d1="43" d2="662" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79025</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ID L                J" publication="PEDIATR" d1="95" d2="36 9" d3="9"/>
<CITE num="2" author="RENDAS A" publication="AM REV RESPIR DIS" d1="121" d2="873" d3="980"/>
<CITE num="3" author="SCHNEEBERGER EE" publication="CIRC RES" d1="49" d2="1102" d3="981"/>
<CITE num="4" author="JANNEY CG" publication="AM J CLIN PATHOL" d1="76" d2="722" d3="981"/>
<CITE num="5" author="INSELMAN LS" publication="J PEDIATR" d1="98" d2="1" d3="981"/>
<CITE num="6" author="GEWITZ MH" publication="PEDIATR PHARMACOL" d1="2" d2="57" d3="982"/>
<CITE num="7" author="DAVIES P" publication="HUM PATHOL" d1="13" d2="911" d3="982"/>
<CITE num="8" author="BERGOFSKY EH" publication="BULL EUR PHYSIOPATH RESP" d1="18" d2="63" d3="982"/>
<CITE num="9" author="DAVIES P" publication="J APPL PHYSIOL" d1="53" d2="859" d3="982"/>
<CITE num="10" author="VANDEVENNE A" publication="SEM HOP PARIS" d1="58" d2="397" d3="982"/>
<CITE num="11" author="REID L" publication="ANN NY ACAD SCI" d1="384" d2="3" d3="982"/>
<CITE num="12" author="MEYRICK B" publication="CLIN CHEST MED" d1="4" d2="199" d3="983"/>
<CITE num="13" author="SOIFER SJ" publication="J DEV PHYSIOL" d1="5" d2="237" d3="983"/>
<CITE num="14" author="GAULIN P" publication="CAN J SURG" d1="26" d2="250" d3="983"/>
<CITE num="15" author="ZHU YJ" publication="J APPL PHYSIOL" d1="54" d2="680" d3="983"/>
<CITE num="16" author="PITT BR" publication="J APPL PHYSIOL" d1="55" d2="383" d3="983"/>
<CITE num="17" author="SOBIN SS" publication="J APPL PHYSIOL" d1="55" d2="1445" d3="983"/>
<CITE num="18" author="WILCKEN B" publication="J PEDIATR" d1="102" d2="383" d3="983"/>
<CITE num="19" author="GAULTIER C" publication="AM REV RESPIR DIS" d1="127" d2="527" d3="983"/>
<CITE num="20" author="HALES CA" publication="AM REV RESPIR DIS" d1="128" d2="747" d3="983"/>
<CITE num="21" author="KAY JM" publication="AM REV RESPIR DIS" d1="128" d2="S 53" d3="983"/>
<CITE num="22" author="LISTER G" publication="PEDIATR PHARMACOL" d1="4" d2="85" d3="984"/>
<CITE num="23" author="SCHALL SA" publication="INT J CARDIOL" d1="5" d2="103" d3="984"/>
<CITE num="24" author="HEYMANN MA" publication="J DEV PHYSIOL" d1="6" d2="281" d3="984"/>
<CITE num="25" author="LUCAS CL" publication="CRC CRIT REV BIOMED ENG" d1="10" d2="317" d3="984"/>
<CITE num="26" author="LYRENE RK" publication="CLIN PERINATOL" d1="11" d2="551" d3="984"/>
<CITE num="27" author="SOIFER SJ" publication="CLIN PERINATOL" d1="11" d2="745" d3="984"/>
<CITE num="28" author="BRIGHAM KL" publication="CIRC RES" d1="54" d2="623" d3="984"/>
<CITE num="29" author="PITT BR" publication="J APPL PHYSIOL" d1="57" d2="1158" d3="984"/>
<CITE num="30" author="CASSIO A" publication="ACTA PAEDIATR SCAND" d1="73" d2="554" d3="984"/>
<CITE num="31" author="REID LM" publication="BR J DIS CHEST" d1="78" d2="113" d3="984"/>
<CITE num="32" author="PERKIN RM" publication="J PEDIATR" d1="105" d2="511" d3="984"/>
<CITE num="33" author="HALES CA" publication="SEM RESPIR MED" d1="7" d2="136" d3="985"/>
<CITE num="34" author="KINSELLA JP" publication="PEDIATR RADIOL" d1="15" d2="340" d3="985"/>
<CITE num="35" author="GAULTIER C" publication="BULL EUR PHYSIOPATH RESP" d1="21" d2="55" d3="985"/>
<CITE num="36" author="BURROWS FA" publication="CAN ANAESTH SOC J" d1="32" d2="364" d3="985"/>
<CITE num="37" author="MEYRICK B" publication="J APPL PHYSIOL" d1="59" d2="443" d3="985"/>
<CITE num="38" author="ABMAN SH" publication="PEDIATRICS" d1="75" d2="80" d3="985"/>
<CITE num="39" author="COTTON DJ" publication="CHEST" d1="87" d2="217" d3="985"/>
<CITE num="40" author="MICHAEL JR" publication="LUNG" d1="163" d2="65" d3="985"/>
<CITE num="41" author="HUREWITZ AN" publication="HEART LUNG" d1="15" d2="327" d3="986"/>
<CITE num="42" author="THOMPSON BT" publication="HEART LUNG" d1="15" d2="457" d3="986"/>
<CITE num="43" author="BENITZ WE" publication="PEDIATR RES" d1="20" d2="966" d3="986"/>
<CITE num="44" author="HEYMANN MA" publication="DRUGS" d1="32" d2="164" d3="986"/>
<CITE num="45" author="CUSTER JR" publication="J APPL PHYSIOL" d1="60" d2="32" d3="986"/>
<CITE num="46" author="OU LC" publication="RESPIR PHYSIOL" d1="64" d2="81" d3="986"/>
<CITE num="47" author="REID LM" publication="CHEST" d1="89" d2="279" d3="986"/>
</CITATIONS>
<RECORDNUM>01005 </RECORDNUM>
<MEDLINENUM>80063276</MEDLINENUM>
<AUTHORS><AUTHOR>Nelson-L-A</AUTHOR><AUTHOR>Callerame-M-L</AUTHOR><AUTHOR>Schwartz-R-H</AUTHOR></AUTHORS>
<TITLE>Aspergillosis and atopy in cystic fibrosis.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1979 Oct. 120(4). P 863-73.</SOURCE>
<MAJORSUBJ><TOPIC>ASPERGILLOSIS-ALLERGIC-BRONCHOPULMONARY: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ASPERGILLOSIS-ALLERGIC-BRONCHOPULMONARY: di, im</TOPIC><TOPIC>ASPERGILLUS: ip</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: im, mi</TOPIC><TOPIC>EOSINOPHILS</TOPIC><TOPIC>FOLLOW-UP-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGE: an</TOPIC><TOPIC>PRECIPITINS: an</TOPIC><TOPIC>SKIN-TESTS</TOPIC><TOPIC>SPUTUM: cy, mi</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Forty-six patients with cystic fibrosis (CF) were studied for
colonization and sensitization by Aspergillus organisms. The fungus
was cultured from 21 of 37 (57%) patients who produced sputum. The
non-CF sputum isolation rate was 6.5%. Sputum hyphae were seen in 95%
of patients with positive cultures. Sputum eosinophilia accompanied
colonization by Aspergillus. Aspergillus precipitins were found in
37% of CF patients; positive immediate skin tests were found in 39%.
"Atopy" defined by skin test criteria was found in 46%. All of these
findings were more common in patients with more severe disease (p
less than 0.05). CF patients had predominant mold sensitivity in
contrast to predominant pollen sensitivity in a control group of
asthmatic subjects. Serum IgE concentrations were increased in 22% of
CF patients. CF patients who had increased serum concentrations of
IgE were more likely to have a family history of atopy. Wheezing was
more common in those who were atopic, especially the group with
predominant mold sensitivity who had more severe disease. Four
patients fulfilled the diagnostic criteria for allergic
bronchopulmonary aspergillosis (ABPA) during the time of study and
follow-up. A fifth patient had ABPA diagnosed before the study. The
incidence of ABPA during a 2-yr period in our CF population was 11%.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="MEARNS MB" publication="LANCET" d1="1" d2="538" d3="967"/>
<CITE num="002" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="120" d2="432" d3="970"/>
<CITE num="003" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="004" author="BARDANA EJ JR" publication="AM J DIS CHILD" d1="129" d2="1164" d3="975"/>
<CITE num="005" author="GALANT SP" publication="AM REV RESPIR DIS" d1="114" d2="325" d3="976"/>
<CITE num="006" author="WELLS ID" publication="J ALLERGY CLIN IMMUNOL" d1="57" d2="234" d3="976"/>
<CITE num="007" author="YOUNG RC" publication="MEDICINE (BALTIMORE)" d1="49" d2="147" d3="970"/>
<CITE num="008" author="MEARNS MB" publication="THORAX" d1="20" d2="385" d3="965"/>
<CITE num="009" author="BATTEN JC" publication="MOD PROBL PEDIATR" d1="10" d2="227" d3="967"/>
<CITE num="010" author="ORES CN" publication="CF CLUB ABST" d1="16" d2="48" d3="975"/>
<CITE num="011" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="012" author="SLAVIN RG" publication="J ALLERGY" d1="46" d2="150" d3="970"/>
<CITE num="013" author="SAFIRSTEIN BH" publication="AM REV RESPIR DIS" d1="108" d2="450" d3="973"/>
<CITE num="014" author="ROSENBERG M" publication="ANN INTERN MED" d1="86" d2="405" d3="977"/>
<CITE num="015" author="SLAVIN RG" publication="IN: MIDDLETON E" d1="" d2="843" d3="978"/>
<CITE num="016" author="ESTERLY JR" publication="JOHNS HOPKINS MED J" d1="122" d2="94" d3="968"/>
<CITE num="017" author="NEMIR RL" publication="IN: KENDIG EL JR" d1="" d2="446" d3="977"/>
<CITE num="018" author="FRASER RG" publication="DIAGNOSIS OF DISEASES OF CHES" d1="" d2="" d3="970"/>
<CITE num="019" author="COMSTOCK GW" publication="MYCOPATHOL MYCOL APPL" d1="54" d2="55" d3="974"/>
<CITE num="020" author="AUSTWICK PKC" publication="IN: LENNETTE EH" d1="" d2="" d3="974"/>
<CITE num="021" author="SCHNEIERSON SS" publication="ATLAS OF DIAGNOSTIC MICROBIOL" d1="" d2="" d3="974"/>
<CITE num="022" author="KJELLMAN NIM" publication="THESIS" d1="" d2="" d3="976"/>
<CITE num="023" author="BLYTH W" publication="SABOURAUDIA" d1="9" d2="273" d3="971"/>
<CITE num="024" author="BLYTH W" publication="SABOURAUDIA" d1="9" d2="283" d3="971"/>
<CITE num="025" author="SLAVIN RG" publication="J ALLERGY CLIN IMMUNOL" d1="62" d2="7" d3="978"/>
<CITE num="026" author="HENDERSON AH" publication="THORAX" d1="23" d2="501" d3="968"/>
<CITE num="027" author="IRANI FA" publication="AM REV RESPIR DIS" d1="103" d2="552" d3="971"/>
<CITE num="028" author="ROSENBERG M" publication="J PEDIATR" d1="91" d2="194" d3="977"/>
<CITE num="029" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="030" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="031" author="BARRON R" publication="CF CLUB ABST" d1="" d2="23" d3="977"/>
<CITE num="032" author="BUCKLEY RH" publication="N ENGL J MED" d1="281" d2="465" d3="969"/>
<CITE num="033" author="TOWNSEND RW" publication="IN: FEINGOLD BF" d1="" d2="" d3="973"/>
<CITE num="034" author="MORROW MB" publication="ANN ALLERGY" d1="22" d2="575" d3="964"/>
<CITE num="035" author="CAMPBELL MJ" publication="AM REV RESPIR DIS" d1="89" d2="186" d3="964"/>
<CITE num="036" author="SCHWARTZ HJ" publication="J ALLERGY CLIN IMMUNOL" d1="62" d2="9" d3="978"/>
<CITE num="037" author="PEPYS J" publication="CLIN ALLERGY SUPPL" d1="3" d2="491" d3="973"/>
<CITE num="038" author="NOVEY HS" publication="WEST J MED" d1="180" d2="1" d3="979"/>
<CITE num="039" author="MELLIS CM" publication="PEDIATRICS" d1="61" d2="446" d3="978"/>
<CITE num="040" author="SMITH JM" publication="IN: MIDDLETON E" d1="" d2="633" d3="978"/>
<CITE num="041" author="PATTERSON R" publication="INT ARCH ALLERGY" d1="46" d2="150" d3="974"/>
<CITE num="042" author="MARX JJ" publication="J ALLERGY CLIN IMMUNOL" d1="57" d2="328" d3="976"/>
<CITE num="043" author="GEHA RS" publication="J ALLERGY CLIN IMMUNOL" d1="60" d2="357" d3="977"/>
<CITE num="044" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="045" author="LEWISTON NJ" publication="CF CLUB ABST" d1="" d2="47" d3="973"/>
<CITE num="046" author="IMBEAU SA" publication="J ALLERGY CLIN IMMUNOL" d1="52" d2="91" d3="978"/>
<CITE num="047" author="SHADOMY S" publication="IN: LENNETTE EH" d1="" d2="569" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79026</PAPERNUM>
<CITATIONS>
<CITE num="1" author="Y PD                AU" publication="ST PAEDIATR J" d1="16" d2="05 9" d3="0"/>
<CITE num="2" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="3" author="LARSEN GL" publication="AM J DIS CHILD" d1="134" d2="1143" d3="980"/>
<CITE num="4" author="SCHWARTZ RH" publication="J ALLERGY CLIN IMMUNOL" d1="68" d2="290" d3="981"/>
<CITE num="5" author="CLARKE CW" publication="BR J DIS CHEST" d1="75" d2="15" d3="981"/>
<CITE num="6" author="GLIMP RA" publication="CHEST" d1="80" d2="85" d3="981"/>
<CITE num="7" author="LEWISTON NJ" publication="CHEST" d1="80" d2="389" d3="981"/>
<CITE num="8" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="9" author="HENRY RL" publication="AUST PAEDIATR J" d1="18" d2="110" d3="982"/>
<CITE num="10" author="PITCHERWILMOTT RW" publication="ARCH DIS CHILD" d1="57" d2="582" d3="982"/>
<CITE num="11" author="VOSS MJ" publication="J ALLERGY CLIN IMMUNOL" d1="69" d2="536" d3="982"/>
<CITE num="12" author="MANTHEI U" publication="AM REV RESPIR DIS" d1="126" d2="253" d3="982"/>
<CITE num="13" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="14" author="KATZ SM" publication="JAMA" d1="248" d2="2284" d3="982"/>
<CITE num="15" author="GUIDOTTI TL" publication="AM J MED SCI" d1="283" d2="157" d3="982"/>
<CITE num="16" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="17" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="18" author="SCHOLER HJ" publication="MYKOSEN" d1="26" d2="173" d3="983"/>
<CITE num="19" author="LAUFER P" publication="CUTIS" d1="31" d2="665" d3="983"/>
<CITE num="20" author="BACULARD A" publication="ARCH FR PEDIATR" d1="40" d2="109" d3="983"/>
<CITE num="21" author="EFTHIMIOU J" publication="THORAX" d1="39" d2="150" d3="984"/>
<CITE num="22" author="SMITH MJ" publication="THORAX" d1="39" d2="369" d3="984"/>
<CITE num="23" author="BIRX DL" publication="ANN ALLERGY" d1="53" d2="124" d3="984"/>
<CITE num="24" author="LAUFER P" publication="J ALLERGY CLIN IMMUNOL" d1="73" d2="44" d3="984"/>
<CITE num="25" author="ROHATGI PK" publication="SOUTH MED J" d1="77" d2="1291" d3="984"/>
<CITE num="26" author="SLAVIN RG" publication="CLIN REV ALLERGY" d1="3" d2="167" d3="985"/>
<CITE num="27" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="28" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="29" author="LAUFER P" publication="J ASTHMA" d1="22" d2="253" d3="985"/>
<CITE num="30" author="LAUFER P" publication="CUTIS" d1="35" d2="557" d3="985"/>
<CITE num="31" author="LAUFER P" publication="CUTIS" d1="36" d2="245" d3="985"/>
<CITE num="32" author="DUPONT B" publication="ARCH FR PEDIATR" d1="42" d2="943" d3="985"/>
<CITE num="33" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="34" author="ISPIZUA AU" publication="MED CLIN" d1="85" d2="628" d3="985"/>
<CITE num="35" author="FINK JN" publication="CHEST" d1="87" d2="S 81" d3="985"/>
<CITE num="36" author="SCHONHEYDER H" publication="ACTA PATH MICROB IMMU SCA (B)" d1="93" d2="105" d3="985"/>
<CITE num="37" author="WILMOTT RW" publication="AM J DIS CHILD" d1="139" d2="669" d3="985"/>
<CITE num="38" author="GORDON IJ" publication="J ROY COLL PHYSICIANS LOND" d1="20" d2="206" d3="986"/>
<CITE num="39" author="PATY E" publication="ARCH FR PEDIATR" d1="43" d2="243" d3="986"/>
<CITE num="40" author="SLAVIN RG" publication="ARCH INTERN MED" d1="146" d2="1799" d3="986"/>
</CITATIONS>
<RECORDNUM>01006 </RECORDNUM>
<MEDLINENUM>79163856</MEDLINENUM>
<AUTHORS><AUTHOR>Feldman-J</AUTHOR><AUTHOR>Traver-G-A</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR></AUTHORS>
<TITLE>Maximal expiratory flows after postural drainage.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1979 Feb. 119(2). P 239-45.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHITIS: th</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>RESPIRATION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGED</TOPIC><TOPIC>BRONCHITIS: pp</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MAXIMAL-EXPIRATORY-FLOW-VOLUME-CURVES</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PEAK-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC><TOPIC>POSTURE</TOPIC><TOPIC>TOTAL-LUNG-CAPACITY</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>Flows measured from maximal expiratory flow-volume (MEFV) curves were
used to evaluate the efficacy of postural drainage in improving
ventilatory function acutely. Maximal expiratory flow-volume curves
were obtained for 9 cystic fibrosis subjects and 10 subjects with
chronic bronchitis before and 5, 15, and 45 min after a 30-min
session of postural drainage with percussion, vibration, and
coughing. Forced vital capacity (FVC) was significantly increased 45
min after drainage for the combining group. Flows at high lung
volumes were different for the 2 subgroups. Subjects with cystic
fibrosis demonstrated a significant increase in peak expiratory flow
rates 45 min after drainage and an increase in forced expiratory
volume in one sec at all time intervals. The subjects with chronic
bronchitis had a decreased peak expiratory flow rate 5 min after
drainage, but by 45 min, it had returned to baseline. There was no
significant change in one-sec forced expiratory volume at any time
interval for the chronic bronchitis subgroup. Changes in flows at low
lung volumes were similar for the 2 subgroups. Forty-five min after
drainage there was an increase in flow rates near 50 per cent of FVC.
Flows near 25 per cent of FVC were increased 15 and 45 min after
drainage. This study demonstrated that postural drainage with
coughing resulted in significant improvement in flows at low lung
volumes. Changes in flows at high lung volumes were less consistent.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="THACKER EW" publication="POSTURAL DRAINAGE AND RESPIRA" d1="" d2="" d3="971"/>
<CITE num="002" author="PETTY TL" publication="INTENSIVE AND REHABILITATIVE" d1="" d2="" d3="974"/>
<CITE num="003" author="GASKELL DV" publication="BROMPTON HOSP GUIDE TO CHEST" d1="" d2="" d3="973"/>
<CITE num="004" author="JONES NL" publication="AM REV RESPIR DIS" d1="110" d2="132" d3="974"/>
<CITE num="005" author="HUBER AL" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="109" d3="974"/>
<CITE num="006" author="KANG B" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="109" d3="974"/>
<CITE num="007" author="MARCH H" publication="ARCH PHYS MED REHABIL" d1="52" d2="528" d3="971"/>
<CITE num="008" author="PETERSEN SE" publication="ACTA MED SCAND" d1="182" d2="293" d3="967"/>
<CITE num="009" author="TECKLIN JS" publication="PHYS THER" d1="55" d2="1081" d3="975"/>
<CITE num="010" author="MOTOYAMA EK" publication="IN: MANGOS JA" d1="" d2="335" d3="973"/>
<CITE num="011" author="HYATT RE" publication="AM REV RESPIR DIS" d1="107" d2="191" d3="973"/>
<CITE num="012" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="013" author="GELB AF" publication="N ENGL J MED" d1="288" d2="395" d3="973"/>
<CITE num="014" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="015" author="WALKER HM" publication="STATISTICAL INFERENCE" d1="" d2="" d3="953"/>
<CITE num="016" author="DUNN OJ" publication="APPLIED STATISTICS ANALYSIS O" d1="" d2="" d3="974"/>
<CITE num="017" author="POLGAR G" publication="PULMONARY FUNCTION TESTING IN" d1="" d2="" d3="971"/>
<CITE num="018" author="BATES DV" publication="RESPIRATORY FUNCTION IN DISEA" d1="" d2="" d3="971"/>
<CITE num="019" author="ANTHONISEN P" publication="ACTA MED SCAND" d1="175" d2="715" d3="964"/>
<CITE num="020" author="MEAD J" publication="J APPL PHYSIOL" d1="22" d2="95" d3="967"/>
<CITE num="021" author="MEAD J" publication="J APPL PHYSIOL" d1="44" d2="156" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79027</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WTH CJL             PE" publication="DIATR CLIN NORTH AM" d1="26" d2="17 9" d3="9"/>
<CITE num="2" author="CONNORS AF" publication="CHEST" d1="78" d2="559" d3="980"/>
<CITE num="3" author="DARROW G" publication="AM REV RESPIR DIS" d1="122" d2="155" d3="980"/>
<CITE num="4" author="ROCHESTER DF" publication="AM REV RESPIR DIS" d1="122" d2="133" d3="980"/>
<CITE num="5" author="PASSERO MA" publication="CLIN PEDIATR" d1="20" d2="264" d3="981"/>
<CITE num="6" author="HUDSON LD" publication="MED CLIN NORTH AM" d1="65" d2="629" d3="981"/>
<CITE num="7" author="PETTY TL" publication="SEM RESPIR MED" d1="3" d2="263" d3="982"/>
<CITE num="8" author="KERREBIJN KF" publication="EUR J RESPIR DIS" d1="63" d2="35" d3="982"/>
<CITE num="9" author="MALONEY FP" publication="ARCH PHYS MED REHABIL" d1="63" d2="423" d3="982"/>
<CITE num="10" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="63" d2="188" d3="982"/>
<CITE num="11" author="REDDING GJ" publication="AM REV RESPIR DIS" d1="126" d2="31" d3="982"/>
<CITE num="12" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="64" d2="62" d3="983"/>
<CITE num="13" author="ZAPLETAL A" publication="EUR J RESPIR DIS" d1="64" d2="426" d3="983"/>
<CITE num="14" author="DESMOND KJ" publication="J PEDIATR" d1="103" d2="538" d3="983"/>
<CITE num="15" author="DEBOECK C" publication="AM REV RESPIR DIS" d1="129" d2="182" d3="984"/>
<CITE num="16" author="WOLLMER P" publication="EUR J RESPIR DIS" d1="66" d2="233" d3="985"/>
<CITE num="17" author="KIRILOFF LH" publication="CHEST" d1="88" d2="436" d3="985"/>
<CITE num="18" author="FALING LJ" publication="CLIN CHEST MED" d1="7" d2="599" d3="986"/>
<CITE num="19" author="VANDERSCHANS CP" publication="THORAX" d1="41" d2="448" d3="986"/>
<CITE num="20" author="VERBOON JML" publication="EUR J RESPIR DIS" d1="69" d2="169" d3="986"/>
<CITE num="21" author="WEBBER BA" publication="BR J DIS CHEST" d1="80" d2="353" d3="986"/>
</CITATIONS>
<RECORDNUM>01007 </RECORDNUM>
<MEDLINENUM>79207490</MEDLINENUM>
<AUTHORS><AUTHOR>Zambie-M-F</AUTHOR><AUTHOR>Gupta-S</AUTHOR><AUTHOR>Lemen-R-J</AUTHOR><AUTHOR>Hilman-B</AUTHOR><AUTHOR>Waring-W-W</AUTHOR><AUTHOR>Sly-R-M</AUTHOR></AUTHORS>
<TITLE>Relationship between response to exercise and allergy in patients
with cystic fibrosis.</TITLE>
<SOURCE>Ann-Allergy. 1979 May. 42(5). P 290-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>EXERTION</TOPIC><TOPIC>HYPERSENSITIVITY: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BODY-HEIGHT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PEAK-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>Responses to treadmill exercise of 36 patients with cystic fibrosis
were studied to evaluate their usefulness in identifying those with
atopy. Ten of 36 patients with cystic fibrosis (28%) had an abnormal
response to exercise but had no more frequent atopic characteristics
than those who had normal exercise responses. Response to treadmill
exercise alone cannot identify patients with atopic disease among
those with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="002" author="VAN METRE TE JR" publication="J ALLERGY CLIN IMMUNOL" d1="31" d2="141" d3="960"/>
<CITE num="003" author="KULCZYCKI LL" publication="JAMA" d1="175" d2="358" d3="961"/>
<CITE num="004" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="005" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="006" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="007" author="FEATHERBY EA" publication="CAN MED ASSOC J" d1="102" d2="835" d3="970"/>
<CITE num="008" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="009" author="MCFARLANE H" publication="CLIN ALLERGY" d1="7" d2="279" d3="977"/>
<CITE num="010" author="SPITZ E" publication="J ALLERGY CLIN IMMUNOL" d1="49" d2="337" d3="972"/>
<CITE num="011" author="GODFREY S" publication="EXERCISE TESTING IN CHILDREN" d1="" d2="" d3="974"/>
<CITE num="012" author="CROPP GJA" publication="PEDIATR CLIN NORTH AM" d1="22" d2="63" d3="975"/>
<CITE num="013" author="SLY RM" publication="IN: WEISS EB" d1="" d2="" d3="976"/>
<CITE num="014" author="BIERMAN CW" publication="PEDIATRICS" d1="56" d2="847" d3="975"/>
<CITE num="015" author="HANSEL FK" publication="CLIN ALLERGY" d1="" d2="" d3="953"/>
<CITE num="016" author="KJELLMAN NIM" publication="CLIN ALLERGY" d1="6" d2="51" d3="976"/>
<CITE num="017" author="DERBES VJ" publication="J ALLERGY" d1="28" d2="287" d3="957"/>
<CITE num="018" author="MELLIS CM" publication="PEDIATRICS" d1="61" d2="446" d3="978"/>
<CITE num="019" author="ROTHSTEIN RJ" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="100" d3="974"/>
<CITE num="020" author="HEIMLICH EM" publication="J ALLERGY CLIN IMMUNOL" d1="37" d2="103" d3="966"/>
<CITE num="021" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="022" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="023" author="GIMENO F" publication="THORAX" d1="29" d2="16" d3="974"/>
<CITE num="024" author="BARBEE RA" publication="ANN INTERN MED" d1="84" d2="129" d3="976"/>
<CITE num="025" author="SLY RM" publication="ANN ALLERGY" d1="28" d2="1" d3="970"/>
<CITE num="026" author="CROPP GJA" publication="PEDIATRICS SUPPL" d1="56" d2="868" d3="975"/>
<CITE num="027" author="KATTAN M" publication="J PEDIATR" d1="92" d2="718" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79028</PAPERNUM>
<CITATIONS>
<CITE num="1" author="Y PD                AU" publication="ST PAEDIATR J" d1="16" d2="05 9" d3="0"/>
</CITATIONS>
<RECORDNUM>01008 </RECORDNUM>
<MEDLINENUM>80086311</MEDLINENUM>
<AUTHORS><AUTHOR>Stagg-B-H</AUTHOR><AUTHOR>Wood-T-P</AUTHOR></AUTHORS>
<TITLE>Radioimmunoassay of trypsin.  A new aid in the assessment of
pancreatic function.</TITLE>
<SOURCE>Ann-Clin-Biochem. 1979 May. 16(3). P 147-51.</SOURCE>
<MAJORSUBJ><TOPIC>PANCREAS: en</TOPIC><TOPIC>PANCREATIC-DISEASES: di</TOPIC><TOPIC>TRYPSIN: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DIABETES-MELLITUS-INSULIN-DEPENDENT: di</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREATIC-DISEASES: en</TOPIC><TOPIC>PANCREATIC-NEOPLASMS: di</TOPIC><TOPIC>PANCREATITIS: di</TOPIC><TOPIC>RADIOIMMUNOASSAY: mt</TOPIC></MINORSUBJ>
<ABSTRACT>This review describes the development and application of a novel test
to determine levels of human immunoreactive trypsin, an enzyme
produced solely by the pancreas, in biological fluids. Being organ-
specific, the assay of immunoreactive trypsin should be an ideal
marker of pancreatic function, and this is supported by the results
of a number of clinical and research investigations. Use of this
assay in studies of chronic pancreatitis, juvenile-onset diabetes,
and cystic fibrosis has yielded much valuable data, and it is
expected that further research will lead to an improved understanding
of these and other conditions associated with the pancreas in health
and disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ADRIAN TE" publication="GUT" d1="19" d2="A960" d3="978"/>
<CITE num="002" author="ADRIAN TE" publication="CLIN SCI MOL MED" d1="54" d2="13P" d3="978"/>
<CITE num="004" author="BAMBULE-DICK J" publication="IR J MED SCI SUPPL 1" d1="146" d2="3" d3="978"/>
<CITE num="005" author="BRAY PT" publication="CLIN CHIM ACTA" d1="80" d2="333" d3="977"/>
<CITE num="006" author="CROSSLEY JR" publication="LANCET" d1="2" d2="1093" d3="977"/>
<CITE num="007" author="CROSSLEY JR" publication="LANCET" d1="1" d2="472" d3="979"/>
<CITE num="008" author="DANDONA P" publication="BR MED J" d1="2" d2="1125" d3="978"/>
<CITE num="009" author="DOMSCHKE S" publication="AM J DIG DIS" d1="20" d2="309" d3="975"/>
<CITE num="010" author="ELIAS E" publication="LANCET" d1="2" d2="66" d3="977"/>
<CITE num="011" author="FEDAIL SS" publication="GUT" d1="19" d2="A445" d3="978"/>
<CITE num="012" author="FRIER BM" publication="GUT" d1="17" d2="685" d3="976"/>
<CITE num="013" author="GOWENLOCK AH" publication="ANN CLIN BIOCHEM" d1="14" d2="61" d3="977"/>
<CITE num="014" author="GREENE LJ" publication="IN: FRITZ H" d1="" d2="188" d3="974"/>
<CITE num="016" author="KOOP H" publication="PROC EUROP PANCREAS 11TH SYM" d1="" d2="" d3="978"/>
<CITE num="017" author="LAKE-BAKAAR G" publication="GUT" d1="19" d2="A446" d3="978"/>
<CITE num="018" author="LAKE-BAKAAR G" publication="GUT"  d1="19" d2="A960" d3="978"/>
<CITE num="019" author="LAKE-BAKAAR G" publication="GUT" d1="19" d2="A445" d3="978"/>
<CITE num="020" author="LAKE-BAKAAR G" publication="GUT"  d1="19" d2="A960" d3="978"/>
<CITE num="021" author="LIEBOW C" publication="SCIENCE" d1="189" d2="472" d3="975"/>
<CITE num="023" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="024" author="SMALLEY CA" publication="LANCET" d1="2" d2="415" d3="978"/>
<CITE num="025" author="TEMLER RS" publication="BIOCHIM BIOPHYS ACTA" d1="236" d2="72" d3="971"/>
<CITE num="026" author="TEMLER RS" publication="BIOCHIM BIOPHYS ACTA" d1="445" d2="720" d3="976"/>
<CITE num="027" author="TEMLER RS" publication="ENZYME" d1="22" d2="249" d3="977"/>
<CITE num="028" author="WOOD TP" publication="LANCET" d1="1" d2="781" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79029</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RLINA A             SC" publication="AND J GASTROENTEROL" d1="15" d2="35 9" d3="0"/>
<CITE num="2" author="FAHRENKRUG J" publication="CLIN CHEM" d1="26" d2="1573" d3="980"/>
<CITE num="3" author="ODONNELL MD" publication="CLIN CHIM ACTA" d1="104" d2="265" d3="980"/>
<CITE num="4" author="BUTTERWORTH J" publication="ANAL BIOCHEM" d1="106" d2="156" d3="980"/>
<CITE num="5" author="FIEDLER F" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="361" d2="1661" d3="980"/>
<CITE num="6" author="FAHRENKRUG J" publication="CLIN CHEM" d1="27" d2="1655" d3="981"/>
<CITE num="7" author="KOEHN HD" publication="CLIN CHEM" d1="27" d2="502" d3="981"/>
<CITE num="8" author="OCONNOR CM" publication="CLIN CHIM ACTA" d1="114" d2="29" d3="981"/>
<CITE num="9" author="LAWRENCE CH" publication="BIOCHIM BIOPHYS ACTA" d1="657" d2="13" d3="981"/>
<CITE num="10" author="BECKER H" publication="LANGENBECKS ARCH CHIR" d1="S" d2="47" d3="983"/>
<CITE num="11" author="HAFKENSCHEID JCM" publication="J CLIN CHEM CLIN BIOCHEM" d1="21" d2="167" d3="983"/>
<CITE num="12" author="BOHNER J" publication="J CLIN CHEM CLIN BIOCHEM" d1="22" d2="943" d3="984"/>
<CITE num="13" author="LEUNG FY" publication="CLIN CHEM" d1="30" d2="1361" d3="984"/>
<CITE num="14" author="ASH KO" publication="J MED TECHNOL" d1="2" d2="427" d3="985"/>
<CITE num="15" author="LESI C" publication="CLIN BIOCHEM" d1="18" d2="317" d3="985"/>
<CITE num="16" author="LESI C" publication="DIG DIS SCI" d1="30" d2="552" d3="985"/>
</CITATIONS>
<RECORDNUM>01009 </RECORDNUM>
<MEDLINENUM>79208273</MEDLINENUM>
<AUTHORS><AUTHOR>Swersky-R-B</AUTHOR><AUTHOR>Chang-J-B</AUTHOR><AUTHOR>Wisoff-B-G</AUTHOR><AUTHOR>Gorvoy-J</AUTHOR></AUTHORS>
<TITLE>Endobronchial balloon tamponade of hemoptysis in patients with
cystic fibrosis.</TITLE>
<SOURCE>Ann-Thorac-Surg. 1979 Mar. 27(3). P 262-4.</SOURCE>
<MAJORSUBJ><TOPIC>CATHETERIZATION: mt</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEMOPTYSIS: th</TOPIC><TOPIC>HEMOSTATIC-TECHNICS</TOPIC><TOPIC>TAMPONS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BRONCHOSCOPY: is</TOPIC><TOPIC>CATHETERIZATION: is</TOPIC><TOPIC>CYSTIC-FIBROSIS: ra</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FIBER-OPTICS</TOPIC><TOPIC>HEMOPTYSIS: et, ra</TOPIC><TOPIC>HEMOSTATIC-TECHNICS: is</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>RECURRENCE</TOPIC></MINORSUBJ>
<ABSTRACT>The flexible bronchoscope with Fogarty balloon and irrigating
catheters is used effectively to manage and treat hemoptysis in a
series of patients with cystic fibrosis.  This procedure is well
suited to such patients, who are prone to recurrent hemoptysis, and
may also be indicated in any inoperable patient with poor
cardiopulmonary reserve.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CROCCO JA" publication="ARCH INTERN MED" d1="121" d2="495" d3="968"/>
<CITE num="002" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="003" author="FOGARTY T" publication="SURG GYNECOL OBSTET" d1="116" d2="241" d3="963"/>
<CITE num="004" author="GOTTLIEB LS" publication="CHEST" d1="67" d2="482" d3="975"/>
<CITE num="005" author="GOURIN A" publication="CHEST" d1="68" d2="120" d3="975"/>
<CITE num="006" author="HIEBERT CA" publication="CHEST" d1="66" d2="397" d3="974"/>
<CITE num="007" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="008" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="499" d3="972"/>
<CITE num="009" author="ORES CN" publication="AM REV RESPIR DIS" d1="99" d2="790" d3="969"/>
<CITE num="010" author="REMY J" publication="RADIOLOGY" d1="122" d2="33" d3="977"/>
<CITE num="011" author="SAW EC" publication="CHEST" d1="70" d2="589" d3="976"/>
<CITE num="012" author="SCHUSTER SR" publication="J THORAC CARDIOVASC SURG" d1="48" d2="750" d3="964"/>
<CITE num="013" author="SMIDDY JF" publication="CHEST" d1="64" d2="158" d3="973"/>
<CITE num="014" author="WHOLEY MH" publication="JAMA" d1="236" d2="2501" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79030</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ROSA JFT            AN" publication="N THORAC SURG" d1="30" d2="09 9" d3="0"/>
<CITE num="2" author="FERMON C" publication="NY STATE J MED" d1="81" d2="1223" d3="981"/>
<CITE num="3" author="TABACHNIK NF" publication="SURG GYNECOL OBSTET" d1="152" d2="837" d3="981"/>
<CITE num="4" author="MARMON L" publication="J PEDIATR SURG" d1="18" d2="811" d3="983"/>
<CITE num="5" author="PORTER DK" publication="ARCH INTERN MED" d1="143" d2="287" d3="983"/>
<CITE num="6" author="HOWARD WJ" publication="POSTGRAD MED" d1="77" d2="53" d3="985"/>
</CITATIONS>
<RECORDNUM>01010 </RECORDNUM>
<MEDLINENUM>79230232</MEDLINENUM>
<AUTHORS><AUTHOR>Maybury-B-A</AUTHOR><AUTHOR>Blessing-Moore-J</AUTHOR><AUTHOR>deWit-S-A</AUTHOR><AUTHOR>Lewiston-N-J</AUTHOR><AUTHOR>Yeager-A-S</AUTHOR></AUTHORS>
<TITLE>Antimicrobial susceptibilities of rough, smooth, and mucoid colony
types of Pseudomonas isolated from cystic fibrosis patients.</TITLE>
<SOURCE>Antimicrob-Agents-Chemother. 1979 Mar. 15(3). P 494-6.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: pd</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>PSEUDOMONAS: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>PSEUDOMONAS: cy</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MINORSUBJ>
<ABSTRACT>Minimal inhibitory concentrations of carbenicillin, chloramphenicol,
tetracycline, gentamicin, tobramycin, and trimethoprim-
sulfamethoxazole were determined for rough, smooth, and mucoid
Pseudomonas sp. isolates from sputa collected from 40 cystic
fibrosis patients.  Ninety-four percent of the minimal inhibitory
concentrations obtained by using mixed inocula of colonies of
different morphological types fell within one serial dilution of the
most resistant minimal inhibitory concentration obtained when each
colony type was tested separately.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARRY AL" publication="ANTIMICROBIC SUSCEPTIBILI" d1="" d2="" d3="976"/>
<CITE num="002" author="BARRY AL" publication="ANTIMICROB AGENTS CHEMOTHER" d1="13" d2="61" d3="978"/>
<CITE num="003" author="BERGAN T" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="553" d3="975"/>
<CITE num="004" author="DOGGETT RG" publication="INFECT IMMUN" d1="6" d2="628" d3="972"/>
<CITE num="005" author="GAVAN TL" publication="IN: BALOWS A" d1="" d2="88" d3="974"/>
<CITE num="006" author="GAVAN TL" publication="AM J CLIN PATHOL" d1="53" d2="880" d3="970"/>
<CITE num="007" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="008" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="009" author="WASHINGTON JA II" publication="IN: LENNETTE EH" d1="" d2="410" d3="974"/>
<CITE num="010" author="ZIERDT CH" publication="J BACTERIOL" d1="87" d2="1003" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79031</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLY HW              DR" publication="UG INTEL CLIN PHARM" d1="18" d2="72 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01011 </RECORDNUM>
<MEDLINENUM>80264180</MEDLINENUM>
<AUTHORS><AUTHOR>Greven-Brauns-G</AUTHOR><AUTHOR>Mulkens-E</AUTHOR></AUTHORS>
<TITLE>Results of 10 years of screening of newborn infants for inherited
metabolic diseases in the province of Limburg (Belgium).</TITLE>
<SOURCE>Arch-Belg-Med-Soc. 1979 Oct. 37(8). P 516-9.</SOURCE>
<MAJORSUBJ><TOPIC>METABOLISM-INBORN-ERRORS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMINO-ACID-METABOLISM-INBORN-ERRORS: oc</TOPIC><TOPIC>BELGIUM</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>GALACTOSEMIA: oc</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PHENYLKETONURIA: oc</TOPIC></MINORSUBJ>
<ABSTRACT>In the province of Limburg, all newborn babies are screened for
metabolic anomalies: for amino acidopathies since 1968, for
galactosemia since 1974 and for mucoviscidosis since 1978.  On
127,676 newborns, there were 12 cases of phenylketonuria and 3 other
inherited anomalies.  A meaningful policy of the government on
neonatal screening necessarily requires a good organization, to put
together the screening data, diagnosis, treatment and follow-up.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79032</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BEUTLER E" publication="J LAB CLIN MED" d1="68" d2="137" d3="966"/>
<CITE num="002" author="CLOW C" publication="AM J DIS CHILD" d1="117" d2="48" d3="969"/>
<CITE num="003" author="EFRON ML" publication="N ENGL J MED" d1="270" d2="1378" d3="964"/>
<CITE num="004" author="GREVEN-BRAUNS G" publication="BELG ARCH SOC GENEESK HYG ARB" d1="28" d2="538" d3="970"/>
<CITE num="005" author="GREVEN-BRAUNS G" publication="BELG ARCH SOC GENEESK HYG ARB" d1="33" d2="253" d3="975"/>
<CITE num="006" author="GUTHRIE R" publication="PEDIATRICS" d1="32" d2="338" d3="963"/>
<CITE num="007" author="LEVY HL" publication="CLIN BIOCHEM" d1="1" d2="200" d3="968"/>
<CITE num="008" author="SCRIVER CR" publication="LANCET" d1="2" d2="230" d3="964"/>
</REFERENCES>
<RECORDNUM>01012 </RECORDNUM>
<MEDLINENUM>80018835</MEDLINENUM>
<AUTHORS><AUTHOR>Maxwell-M</AUTHOR><AUTHOR>Redmond-A</AUTHOR></AUTHORS>
<TITLE>Comparative trial of manual and mechanical percussion technique with
gravity-assisted bronchial drainage in patients with cystic fibrosis.</TITLE>
<SOURCE>Arch-Dis-Child. 1979 Jul. 54(7). P 542-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>DRAINAGE</TOPIC><TOPIC>PHYSICAL-THERAPY: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>GRAVITATION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PHYSICAL-THERAPY: is</TOPIC><TOPIC>RANDOM-ALLOCATION</TOPIC><TOPIC>SPUTUM</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC></MINORSUBJ>
<ABSTRACT>Chest physiotherapy still remains one of the most important aspects
in the treatment of chest complications of cystic fibrosis. A
mechanical device that allows the patient with cystic fibrosis to do
his own chest physiotherapy will be of great benefit if it is as
effective as manual percussion. 14 patients with cystic fibrosis
using mechanical and manual percussion physiotherapy were studied by
measuring sputum volumes, and FEV and FVC. Results with mechanical
percussor were as good as with the manual percussor and, therefore,
it would be reasonable for the older patient to use the former on his
own.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="002" author="DENTON R" publication="AM REV RESPIR DIS" d1="86" d2="41" d3="962"/>
<CITE num="003" author="KENDIG EL JR" publication="IN: WARING W" d1="" d2="114" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79033</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="2" d2="29 9" d3="9"/>
<CITE num="2" author="DARROW G" publication="AM REV RESPIR DIS" d1="122" d2="155" d3="980"/>
<CITE num="3" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="63" d2="188" d3="982"/>
<CITE num="4" author="SUTTON PP" publication="SEM RESPIR MED" d1="5" d2="353" d3="984"/>
<CITE num="5" author="WANNER A" publication="AM REV RESPIR DIS" d1="130" d2="701" d3="984"/>
<CITE num="6" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="66" d2="147" d3="985"/>
</CITATIONS>
<RECORDNUM>01013 </RECORDNUM>
<MEDLINENUM>79164522</MEDLINENUM>
<TITLE>Paediatric Research Society.  Plymouth, 15 and 16 September 1978:
Abstracts.</TITLE>
<SOURCE>Arch-Dis-Child. 1979 Feb. 54(2). P 160-5.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: th</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>PEDIATRICS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CONGRESSES</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GREAT-BRITAIN</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>RESEARCH</TOPIC><TOPIC>SOCIETIES-MEDICAL</TOPIC></MINORSUBJ>
<EXTRACT>Abstracts are given for articles on abnormalities of the complement
system in children with liver disease, hepatic collagen synthesis and
its modification by colchicine is a rat model of cirrhosis of the
liver, postprandal total serum bile acid concentrations in cystic
fibrosis, release of endogenous secretin in children with cystic
fibrosis, bronchial allergy in children with cystic fibrosis, and
other topics.</EXTRACT>
<REFERENCES>
<CITE num="001" author="MCNEISH AS" publication="LANCET" d1="2" d2="946" d3="975"/>
<CITE num="001" author="POPA VT" publication="J ALLERGY CLIN IMMUNOL" d1="59" d2="54" d3="977"/>
<CITE num="001" author="CHARLESWORTH JA" publication="CLIN EXP IMMUNOL" d1="28" d2="496" d3="977"/>
<CITE num="001" author="HOLMES H" publication="LANCET" d1="1" d2="755" d3="977"/>
<CITE num="001" author="MASHIGE F" publication="CLIN CHIM ACTA" d1="70" d2="79" d3="976"/>
<CITE num="002" author="OFEK I" publication="NATURE" d1="265" d2="623" d3="977"/>
<CITE num="002" author="SOOTHILL JF" publication="CLIN EXP IMMUNOL" d1="27" d2="30" d3="977"/>
<CITE num="003" author="WURTMAN RJ" publication="N ENGL J MED" d1="296" d2="1383" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79034</PAPERNUM>
<CITATIONS>
<CITE num="1" author="KIERNAN J           IR" publication="MED J" d1="74" d2="89 9" d3="1"/>
<CITE num="2" author="MCKIERNAN J" publication="IR J MED SCI" d1="150" d2="66" d3="981"/>
</CITATIONS>
<RECORDNUM>01014 </RECORDNUM>
<MEDLINENUM>79164528</MEDLINENUM>
<AUTHORS><AUTHOR>Ryley-H-C</AUTHOR><AUTHOR>Neale-L-M</AUTHOR><AUTHOR>Brogan-T-D</AUTHOR><AUTHOR>Bray-P-T</AUTHOR></AUTHORS>
<TITLE>Screening for cystic fibrosis in the newborn by meconium analysis.</TITLE>
<SOURCE>Arch-Dis-Child. 1979 Feb. 54(2). P 92-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pc</TOPIC><TOPIC>MASS-SCREENING: mt</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALBUMINS: an</TOPIC><TOPIC>ALPHA-1-ANTITRYPSIN: an</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>FECES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PROTEASE-INHIBITORS: an</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>During a 4-year routine screening programme for cystic fibrosis (CF)
15 464 specimens were examined for raised meconium albumin levels by
a test strip method and by electroimmunoassay. The incidence of false-
positive results was about 5 per 1000 specimens in either test. This
could be reduced by 90% by determining the ratio of albumin : alpha-1-
trypsin inhibitor (a ratio below 2.0 being considered as a negative
result), and it could be reduced to zero by determining the ratio in
subsequent faecal specimens. Three of 12 meconium specimens from
infants with proved CF gave false-negative results in all 3 tests.
The other 9 specimens had greater than 100 mg albumin/g dry weight
and albumin: alpha-1-trypsin inhibitor ratios of greater than 3.0; in
subsequent faecal specimens the ratios were over 4.0. 176 meconium
specimens from elsewhere in the UK were examined and these included
23 from infants who were subsequently proved to have CF. Six of these
23 CF specimens gave false-negative results, the other 17 being
strongly positive. The origins of meconium serum protein suggest that
infants with CF in whom meconium gives false-negative results have
normal pancreatic functions at birth. The specificity of current
meconium tests therefore cannot be improved as they depend on
pancreatic dysfunction.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="002" author="GITLIN D" publication="AM J OBSTET GYNECOL" d1="113" d2="632" d3="972"/>
<CITE num="003" author="GRIFFITHS AD" publication="ARCH DIS CHILD" d1="51" d2="321" d3="976"/>
<CITE num="004" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="005" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="64" d2="477" d3="975"/>
<CITE num="006" author="MAKAREM A" publication="IN: HENRY RJ" d1="" d2="1123" d3="974"/>
<CITE num="007" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="008" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="009" author="RULE AH" publication="PEDIATRICS" d1="45" d2="847" d3="970"/>
<CITE num="010" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="64" d2="117" d3="975"/>
<CITE num="011" author="RYLEY HC" publication="ARCH DIS CHILD" d1="51" d2="641" d3="976"/>
<CITE num="012" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="013" author="SCHUTTRINGER G" publication="CLIN CHIM ACTA" d1="83" d2="109" d3="978"/>
<CITE num="014" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="015" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="016" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="017" author="WARWICK WJ" publication="MINN MED" d1="52" d2="1567" d3="969"/>
<CITE num="018" author="WISER WC" publication="PEDIATRICS" d1="33" d2="115" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79035</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RNOKY AL            J" publication="ROY SOC MED" d1="73" d2="73 9" d3="0"/>
<CITE num="2" author="LITTLEWOOD JM" publication="PRACTITIONER" d1="224" d2="305" d3="980"/>
<CITE num="3" author="MASTELLA G" publication="RIV ITAL PEDIATR" d1="7" d2="581" d3="981"/>
<CITE num="4" author="LAMBOTTE C" publication="J GENET HUM" d1="29" d2="85" d3="981"/>
<CITE num="5" author="EVANS RT" publication="J CLIN PATHOL" d1="34" d2="911" d3="981"/>
<CITE num="6" author="RYLEY HC" publication="J CLIN PATHOL" d1="34" d2="906" d3="981"/>
<CITE num="7" author="RYLEY HC" publication="J CLIN PATHOL" d1="34" d2="179" d3="981"/>
<CITE num="8" author="PEDERZINI F" publication="RIV ITAL PEDIATR" d1="9" d2="445" d3="983"/>
<CITE num="9" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="10" author="CASSIO A" publication="ACTA PAEDIATR SCAND" d1="73" d2="554" d3="984"/>
<CITE num="11" author="ORENSTEIN DM" publication="SEM RESPIR MED" d1="6" d2="252" d3="985"/>
</CITATIONS>
<RECORDNUM>01015 </RECORDNUM>
<MEDLINENUM>80018840</MEDLINENUM>
<AUTHORS><AUTHOR>Jenner-B-M</AUTHOR><AUTHOR>Landau-L-I</AUTHOR><AUTHOR>Phelan-P-D</AUTHOR></AUTHORS>
<TITLE>Pulmonary candidiasis in cystic fibrosis.</TITLE>
<SOURCE>Arch-Dis-Child. 1979 Jul. 54(7). P 555-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>LUNG-DISEASES-FUNGAL: et</TOPIC><TOPIC>CANDIDIASIS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ASTHMA: co</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>A child with cystic fibrosis and asthma developed pulmonary
candidiasis. Predisposing factors in this patient were prolonged
antibiotic therapy, high-dose corticosteroids, and intravenous
catherisation. A diagnosis was made by lung puncture and confirmed by
rapid response to 5-fluorocytosine.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BANDT PD" publication="JAMA" d1="220" d2="1578" d3="972"/>
<CITE num="002" author="GOLDSTEIN E" publication="J INFECT DIS" d1="125" d2="190" d3="972"/>
<CITE num="003" author="HURLEY DL" publication="J INFECT DIS" d1="132" d2="393" d3="975"/>
<CITE num="004" author="KLEIN JO" publication="PEDIATRICS" d1="44" d2="486" d3="969"/>
<CITE num="005" author="KOHLSCHUTTER A" publication="ARCH DIS CHILD" d1="49" d2="154" d3="974"/>
<CITE num="006" author="MIRSKY HS" publication="CANCER" d1="30" d2="348" d3="972"/>
<CITE num="007" author="MONTGOMERIE JZ" publication="J INFECT DIS" d1="132" d2="82" d3="975"/>
<CITE num="008" author="WINNER HI" publication="PROC SYMP ON CANDIDA INFECTIO" d1="" d2="87" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79036</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IBY N               AC" publication="TA PAEDIATR SCAND SUPPL 301 19" d1="82" d2="33 9" d3="2"/>
<CITE num="2" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="3" author="MALFROOT A" publication="PEDIATR INFECT DIS" d1="5" d2="376" d3="986"/>
<CITE num="4" author="RUBIO TT" publication="AM J MED" d1="81" d2="73" d3="986"/>
</CITATIONS>
<RECORDNUM>01016 </RECORDNUM>
<MEDLINENUM>79122941</MEDLINENUM>
<AUTHORS><AUTHOR>Harries-J-T</AUTHOR><AUTHOR>Muller-D-P</AUTHOR><AUTHOR>McCollum-J-P</AUTHOR><AUTHOR>Lipson-A</AUTHOR><AUTHOR>Roma-E</AUTHOR><AUTHOR>Norman-A-P</AUTHOR></AUTHORS>
<TITLE>Intestinal bile salts in cystic fibrosis: studies in the patient and
experimental animal.</TITLE>
<SOURCE>Arch-Dis-Child. 1979 Jan. 54(1). P 19-24.</SOURCE>
<MAJORSUBJ><TOPIC>BILE-ACIDS-AND-SALTS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>DUODENUM: me</TOPIC><TOPIC>INTESTINAL-SECRETIONS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>ENTEROHEPATIC-CIRCULATION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ILEUM: me</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INTESTINAL-ABSORPTION: de</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RATS</TOPIC><TOPIC>RICINOLEIC-ACIDS: pd</TOPIC><TOPIC>SERUM-ALBUMIN-BOVINE: pd</TOPIC><TOPIC>TAUROCHOLIC-ACID: me</TOPIC><TOPIC>TRIOLEIN: pd</TOPIC></MINORSUBJ>
<ABSTRACT>The quantitative and qualitative distribution of bile salts in the
duodenal juice of 13 patients with cystic fibrosis (CF) was studied
after a test meal. The effects of triolein (TO), bovine serum albumin
(BSA), and ricinoleic acid (RA) on the absorption of taurocholate
(TCA) in the distal ileum of the rat in vivo was also studied. The
mean (and ranges) of total bile salt concentrations, glycine: taurine
conjugate ratios, and percentage of dihydroxy bile salts in the
patients with CF and pancreatic insufficiency were 3.5 (1.3--6.6)
mmol/l, 8.6 (greater than 10-3.1), and 37 (10--60) compared with
control values of 7.4 (3.0--16.0) mmol/l, 3.0 (1.3--4.5), and 61 (52--
70) respectively. The differences between the control and CF values
were statistically significant (P less than 0.01--P less than 0.001).
Three of the 13 CF patients had total bile salt concentrations less
than 2 mmol/l, 8 had much higher glycine: taurine ratios, and 8 had a
reduced percentage of dihydroxy bile salts. In 2 patients with normal
pancreatic enzyme activities, duodenal bile salts were both
quantitatively and qualitatively normal. TO (10 and 30 mmol/l), BSA
(3%), and RA (5 mmol/l) had no inhibitory effect on the ileal
absorption of TCA. These results show pronounced abnormalities of
duodenal juice bile salts in CF with pancreatic insufficiency
consistent with a broken enterohepatic circulation (EHC); such
abnormalities may contribute to defective lipid absorption in CF. The
data in the experimental animal do not support the suggestion that
unhydrolysed dietary substrates play a role in the pathophysiology of
the broken EHC.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="PEDIATRICS" d1="42" d2="492" d3="968"/>
<CITE num="002" author="DAWSON AM" publication="PROC SOC EXP BIOL MED" d1="142" d2="906" d3="973"/>
<CITE num="003" author="DEREN JJ" publication="N ENGL J MED" d1="288" d2="949" d3="973"/>
<CITE num="004" author="DOWLING RH" publication="GASTROENTEROLOGY" d1="62" d2="122" d3="972"/>
<CITE num="005" author="FREYE HB" publication="J PEDIATR" d1="64" d2="575" d3="964"/>
<CITE num="006" author="GIBBONS ISE" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="279" d3="969"/>
<CITE num="007" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="008" author="HARRIES JT" publication="GUT" d1="13" d2="596" d3="972"/>
<CITE num="009" author="HEATON KW" publication="BILE SALTS IN HEALTH AND DISE" d1="" d2="" d3="972"/>
<CITE num="010" author="HOFMANN AF" publication="IN: JAMES AT" d1="" d2="362" d3="964"/>
<CITE num="011" author="IWATA T" publication="J BIOCHEM (TOKYO)" d1="56" d2="424" d3="964"/>
<CITE num="012" author="MCCOLLUM JPK" publication="ARCH DIS CHILD" d1="52" d2="887" d3="977"/>
<CITE num="013" author="MAKINO I" publication="ANAL LETT" d1="5" d2="341" d3="972"/>
<CITE num="014" author="MATTHEWS DM" publication="GUT" d1="6" d2="411" d3="965"/>
<CITE num="015" author="MORIN CL" publication="J PEDIATR" d1="88" d2="213" d3="976"/>
<CITE num="016" author="POLEY JR" publication="J LAB CLIN MED" d1="63" d2="838" d3="964"/>
<CITE num="017" author="ROLLER RJ" publication="GASTROENTEROLOGY" d1="72" d2="661" d3="977"/>
<CITE num="018" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="019" author="SLADEN GE" publication="BIOCHIM BIOPHYS ACTA" d1="288" d2="443" d3="972"/>
<CITE num="020" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="021" author="TOSKES PP" publication="J CLIN INVEST" d1="52" d2="1660" d3="973"/>
<CITE num="022" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="67" d2="835" d3="974"/>
<CITE num="023" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="73" d2="1023" d3="977"/>
<CITE num="024" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="025" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79037</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EDRIKZON B          PE" publication="DIATR RES" d1="14" d2="87 9" d3="0"/>
<CITE num="2" author="GORIUP U" publication="HELV PAEDIATR ACTA" d1="35" d2="177" d3="980"/>
<CITE num="3" author="BALISTRERI WF" publication="J PEDIATR" d1="96" d2="582" d3="980"/>
<CITE num="4" author="ELIAS E" publication="LANCET" d1="2" d2="1319" d3="981"/>
<CITE num="5" author="FONDACARO JD" publication="PROC SOC EXP BIOL MED" d1="168" d2="276" d3="981"/>
<CITE num="6" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="7" author="MULLER DPR" publication="CLIN GASTROENTEROL" d1="11" d2="119" d3="982"/>
<CITE num="8" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="9" author="HEUBI JE" publication="GASTROENTEROLOGY" d1="83" d2="804" d3="982"/>
<CITE num="10" author="FREDRIKZON B" publication="ACTA PAEDIATR SCAND SUPPL 296" d1="1982" d2="75" d3="982"/>
<CITE num="11" author="BALISTRERI WF" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="105" d3="983"/>
<CITE num="12" author="ISENBERG JN" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="447" d3="983"/>
<CITE num="13" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="152" d3="983"/>
<CITE num="14" author="FONDACARO JD" publication="PROC SOC EXP BIOL MED" d1="173" d2="118" d3="983"/>
<CITE num="15" author="COLOMBO C" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="556" d3="984"/>
<CITE num="16" author="TAZAWA Y" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="378" d3="984"/>
<CITE num="17" author="ZENTLERMUNRO PL" publication="GUT" d1="25" d2="500" d3="984"/>
<CITE num="18" author="ABRAMS CK" publication="J CLIN INVEST" d1="73" d2="374" d3="984"/>
<CITE num="19" author="MCKENNA MC" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="45" d3="985"/>
<CITE num="20" author="DARLING PB" publication="PEDIATR RES" d1="19" d2="578" d3="985"/>
<CITE num="21" author="ROBB TA" publication="GUT" d1="26" d2="1246" d3="985"/>
<CITE num="22" author="SETCHELL KDR" publication="CLIN CHIM ACTA" d1="151" d2="101" d3="985"/>
<CITE num="23" author="WEBER AM" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="9" d3="985"/>
<CITE num="24" author="WEIZMAN Z" publication="GUT" d1="27" d2="1043" d3="986"/>
<CITE num="25" author="LEROY C" publication="DIG DIS SCI" d1="31" d2="911" d3="986"/>
<CITE num="26" author="DUTTA SK" publication="GASTROENTEROLOGY" d1="91" d2="1243" d3="986"/>
</CITATIONS>
<RECORDNUM>01017 </RECORDNUM>
<MEDLINENUM>79254866</MEDLINENUM>
<AUTHORS><AUTHOR>Hubbard-V-S</AUTHOR><AUTHOR>Davis-P-B</AUTHOR><AUTHOR>di-SantAgnese-P-A</AUTHOR></AUTHORS>
<TITLE>Possible hazard of timed-release aspirin in a patient with
pancreatic insufficiency.</TITLE>
<SOURCE>Arch-Intern-Med. 1979 Sep. 139(9). P 1054-5.</SOURCE>
<MAJORSUBJ><TOPIC>ASPIRIN: ae</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEMORRHAGE-GASTROINTESTINAL: ci</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ASPIRIN: ad</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>DELAYED-ACTION-PREPARATIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINE-SMALL: de</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: dt, et</TOPIC></MINORSUBJ>
<ABSTRACT>An episode of severe small intestinal hemorrhage occurred in a cystic
fibrosis patient having pancreatic insufficiency and receiving timed-
release aspirin therapy for disabling hypertrophic pulmonary
osteoarthropathy. The increased acidity of small intestinal contents
due to decreased bicarbonate secretion observed in patients with
pancreatic insufficiency may alter the luminal environment and result
in mucosal erosions and/or ulcerations in association with the
presence of aspirin. Thus, physicians should be aware of the
possibility that timed-release aspirin causes small intestinal
hemorrhage in such patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LANGMAN MJS" publication="GUT" d1="11" d2="627" d3="970"/>
<CITE num="002" author="LOEBL DH" publication="JAMA" d1="237" d2="976" d3="977"/>
<CITE num="003" author="GARTNER AH" publication="JADA" d1="93" d2="111" d3="976"/>
<CITE num="004" author="TREADWELL BLJ" publication="NZ MED J" d1="78" d2="435" d3="973"/>
<CITE num="005" author="ROSSOUW JE" publication="RHEUMATOL REHAB" d1="15" d2="31" d3="976"/>
<CITE num="006" author="HOON JR" publication="JAMA" d1="229" d2="841" d3="974"/>
<CITE num="007" author="TAUSSIG LM" publication="RADIOLOGY" d1="106" d2="369" d3="973"/>
<CITE num="008" author="HADORN B" publication="J PEDIATR" d1="73" d2="39" d3="968"/>
<CITE num="009" author="THJODLEIFSSON B" publication="SCAND J GASTROENTEROL" d1="11" d2="273" d3="976"/>
<CITE num="010" author="THJODLEIFSSON B" publication="SCAND J GASTROENTEROL" d1="11" d2="505" d3="976"/>
<CITE num="011" author="IVEY KJ" publication="GASTROENTEROLOGY" d1="76" d2="50" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79038</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RIENTE EA           GA" publication="STROENTEROL CLIN BIOL" d1="6" d2="16 9" d3="2"/>
<CITE num="2" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="299" d3="985"/>
<CITE num="3" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
</CITATIONS>
<RECORDNUM>01018 </RECORDNUM>
<MEDLINENUM>79123379</MEDLINENUM>
<AUTHORS><AUTHOR>Duffner-P-K</AUTHOR><AUTHOR>Cohen-M-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis with brain abscess.</TITLE>
<SOURCE>Arch-Neurol. 1979 Jan. 36(1). P 27-8.</SOURCE>
<MAJORSUBJ><TOPIC>BRAIN-ABSCESS: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>STREPTOCOCCAL-INFECTIONS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>BRAIN-ABSCESS: ra</TOPIC><TOPIC>BRAIN: ra</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>STREPTOCOCCAL-INFECTIONS: ra</TOPIC><TOPIC>TOMOGRAPHY-X-RAY-COMPUTED</TOPIC></MINORSUBJ>
<ABSTRACT>A 21-year-old patient with cystic fibrosis developed bilateral brain
abscesses due to anaerobic Streptococcus. This rare association
presents an interesting etiologic study.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GATES EM" publication="MEDICINE" d1="29" d2="71" d3="950"/>
<CITE num="002" author="BREWER NS" publication="ANN INTERN MED" d1="82" d2="571" d3="975"/>
<CITE num="003" author="MARTINEZ-TELLO FJ" publication="J IMMUNOL" d1="101" d2="989" d3="968"/>
<CITE num="004" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="111" d2="408" d3="966"/>
<CITE num="005" author="NETER E" publication="J INFECT DIS SUPPL" d1="130" d2="132" d3="974"/>
<CITE num="006" author="DIAZ F" publication="J INFECT DIS" d1="121" d2="269" d3="970"/>
<CITE num="007" author="HALBERT SP" publication="PEDIATRICS" d1="26" d2="792" d3="960"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79039</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SCHER EG            J" publication="PEDIATR" d1="95" d2="85 9" d3="9"/>
<CITE num="2" author="MCCARTHY MM" publication="CLIN PEDIATR" d1="19" d2="746" d3="980"/>
<CITE num="3" author="AYRES J" publication="BR J DIS CHEST" d1="76" d2="99" d3="982"/>
<CITE num="4" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="5" author="RABKIN CS" publication="ANN NEUROL" d1="15" d2="608" d3="984"/>
<CITE num="6" author="KLINE MW" publication="PEDIATR INFECT DIS" d1="4" d2="72" d3="985"/>
<CITE num="7" author="CANNY GJ" publication="THORAX" d1="41" d2="221" d3="986"/>
<CITE num="8" author="KURLAND G" publication="PEDIATRICS" d1="78" d2="1097" d3="986"/>
</CITATIONS>
<RECORDNUM>01019 </RECORDNUM>
<MEDLINENUM>79208794</MEDLINENUM>
<AUTHORS><AUTHOR>Forman-Franco-B</AUTHOR><AUTHOR>Abramson-A-L</AUTHOR><AUTHOR>Gorvoy-J-D</AUTHOR><AUTHOR>Stein-T</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis and hearing loss.</TITLE>
<SOURCE>Arch-Otolaryngol. 1979 Jun. 105(6). P 338-42.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEARING-LOSS-CONDUCTIVE: et</TOPIC><TOPIC>HEARING-LOSS-PARTIAL: et</TOPIC><TOPIC>HEARING-LOSS-SENSORINEURAL: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACOUSTIC-IMPEDANCE-TESTS</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AUDIOMETRY</TOPIC><TOPIC>AUDITORY-THRESHOLD</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>EAR-OSSICLES: pp</TOPIC><TOPIC>EAR-MIDDLE: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENTAMICINS: ae</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PRESSURE</TOPIC><TOPIC>STAPES: pp</TOPIC><TOPIC>TOBRAMYCIN: ae</TOPIC><TOPIC>TYMPANIC-MEMBRANE: pp</TOPIC></MINORSUBJ>
<ABSTRACT>The mucosal epithelium of the middle ear and Eustachian tube is in
direct continuity with the upper respiratory tract. Since the
otolaryngological aspects of cystic fibrosis (CF) are dominated by
involvement of the paranasal sinuses, it might be assumed that
children with CF would be expected to have a higher than usual
incidence of middle ear disease. Eighty patients who were afflicted
with CF had audiological evaluations, which consisted of hearing
threshold levels (250 to 8,000 Hz) and speech and impedance
audiometry. We found no greater incidence of a conductive or
sensorineural hearing loss in patients with CF when compared with a
normal age-adjusted population.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="9" d2="390" d3="970"/>
<CITE num="002" author="ANON" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="63" d2="236" d3="959"/>
<CITE num="003" author="JERGER J" publication="ARCH OTOLARYNGOL" d1="93" d2="111" d3="971"/>
<CITE num="004" author="TAYLOR BW" publication="ARCH DIS CHILD" d1="49" d2="133" d3="974"/>
<CITE num="005" author="GOODMAN A" publication="ASHA" d1="7" d2="262" d3="965"/>
<CITE num="006" author="RULON JT" publication="ARCH OTOLARYNGOL" d1="78" d2="192" d3="963"/>
<CITE num="007" author="CRIFO S" publication="PRACT OTORHINOLARYNGOL" d1="33" d2="394" d3="971"/>
<CITE num="008" author="KULCZYCKI LL" publication="ARCH OTOLARYNGOL" d1="92" d2="54" d3="970"/>
<CITE num="009" author="ROBINSON CG" publication="CAN MED ASSOC J" d1="97" d2="1199" d3="967"/>
<CITE num="010" author="EAGLES E" publication="LARYNGOSCOPE" d1="73" d2="12" d3="963"/>
<CITE num="011" author="SIEGEL J" publication="ARCH OTOLARYNGOL" d1="92" d2="523" d3="970"/>
<CITE num="012" author="FORCUCCI RA" publication="ARCH OTOLARYNGOL" d1="96" d2="361" d3="972"/>
<CITE num="013" author="FRITZE W" publication="Z KINDERHEILK" d1="114" d2="111" d3="973"/>
<CITE num="014" author="WATSON TJ" publication="PROC R SOC MED" d1="62" d2="455" d3="969"/>
<CITE num="015" author="BROOKS DN" publication="INT AUDIOL" d1="8" d2="563" d3="969"/>
<CITE num="016" author="NEELY JG" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="76" d2="313" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79040</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IFO S               IN" publication="T J PEDIATR OTORHINOLARYNGO" d1="2" d2="51 9" d3="0"/>
<CITE num="2" author="FRASER GL" publication="DRUG INTEL CLIN PHARM" d1="19" d2="757" d3="985"/>
<CITE num="3" author="DAVID TJ" publication="J ROY SOC MED" d1="79" d2="23" d3="986"/>
</CITATIONS>
<RECORDNUM>01020 </RECORDNUM>
<MEDLINENUM>79230729</MEDLINENUM>
<AUTHORS><AUTHOR>Goldberg-R-T</AUTHOR><AUTHOR>Isralsky-M</AUTHOR><AUTHOR>Shwachman-H</AUTHOR></AUTHORS>
<TITLE>Vocational development and adjustment of adolescents with cystic
fibrosis.</TITLE>
<SOURCE>Arch-Phys-Med-Rehabil. 1979 Aug. 60(8). P 369-74.</SOURCE>
<MAJORSUBJ><TOPIC>ATTITUDE</TOPIC><TOPIC>CAREER-CHOICE</TOPIC><TOPIC>CYSTIC-FIBROSIS: rh</TOPIC><TOPIC>DECISION-MAKING</TOPIC><TOPIC>GOALS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD-DEVELOPMENT</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: px</TOPIC><TOPIC>EDUCATION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SOCIAL-VALUES</TOPIC><TOPIC>VOCATIONAL-GUIDANCE</TOPIC></MINORSUBJ>
<ABSTRACT>Adolescents with cystic fibrosis were compared with normal
adolescents of the same age and educational grade on several measures
of vocational development and adjustment. The cystic fibrosis group
in ages 12--16 and in grades 7, 8, and 9 scored lower than their
normal counterparts in measures of vocational and educational plans,
and were less realistic than normals in considering their limitations
and financial constraints. In contrast, the cystic fibrosis group at
nearly all age and grade levels scored significantly higher on
strength of commitment to vocational choice, work values, and
awareness of occupational information. Compared to 4 additional
handicapped groups already studied, adolescents with cystic fibrosis
scored favorably. They not only plan to work but also hold strong
work values compared to normals. Rehabilitation programs should
emphasize preparation for a career and the development of educational
and vocational plans while the adolescent is still in high school.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOYLE IR" publication="J PEDIATR" d1="88" d2="318" d3="976"/>
<CITE num="002" author="TROPAUER A" publication="AM J DIS CHILD" d1="119" d2="424" d3="970"/>
<CITE num="003" author="CYTRYN L" publication="IN: ANTHONY EJ" d1="" d2="37" d3="973"/>
<CITE num="004" author="GAYTON WF" publication="AM J DIS CHILD" d1="126" d2="856" d3="973"/>
<CITE num="005" author="ROSENLUND ML" publication="ANN INTERN MED" d1="78" d2="959" d3="973"/>
<CITE num="006" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="007" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="008" author="SHWACHMAN H" publication="N ENGL J MED" d1="296" d2="1519" d3="977"/>
<CITE num="009" author="TURK J" publication="PEDIATRICS" d1="34" d2="67" d3="964"/>
<CITE num="010" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
<CITE num="011" author="MCCRAE WM" publication="PHYSIOTHERAPY" d1="61" d2="252" d3="975"/>
<CITE num="012" author="MATTHEWS LW" publication="VOCATIONAL AND LIFE ADJUSTMEN" d1="" d2="" d3="969"/>
<CITE num="013" author="GOLDBERG RT" publication="SCAND J REHAB MED" d1="9" d2="85" d3="977"/>
<CITE num="014" author="GOLDBERG RT" publication="J COUNSELING PSYCH" d1="21" d2="428" d3="974"/>
<CITE num="015" author="GOLDBERG RT" publication="REHAB COUNS BULL" d1="19" d2="140" d3="975"/>
<CITE num="016" author="GOLDBERG RT" publication="SCAND J REHAB MED" d1="10" d2="215" d3="978"/>
<CITE num="017" author="GOLDBERG RT" publication="VOCATIONAL AND SOCIAL REHABIL" d1="" d2="" d3="972"/>
<CITE num="018" author="KULCZYCKI LL" publication="IN: PATTERSON PR" d1="" d2="117" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79041</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NKERTON P           LA" publication="NCET" d1="2" d2="61 9" d3="5"/>
<CITE num="2" author="SIMMONS RJ" publication="PSYCHOSOM MED" d1="47" d2="111" d3="985"/>
<CITE num="3" author="GOLDBERG RT" publication="ARCH PHYS MED REHABIL" d1="66" d2="492" d3="985"/>
</CITATIONS>
<RECORDNUM>01021 </RECORDNUM>
<MEDLINENUM>80175020</MEDLINENUM>
<AUTHORS><AUTHOR>Bergan-T</AUTHOR><AUTHOR>Michalsen-H</AUTHOR></AUTHORS>
<TITLE>Pharmacokinetics of azlocillin in children with cystic fibrosis.</TITLE>
<SOURCE>Arzneimittelforschung. 1979. 29(12a). P 1955-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>PENICILLINS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>DOSE-RESPONSE-RELATIONSHIP-DRUG</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HALF-LIFE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PENICILLINS: bl, ur</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>6-E1(R)-2-(oxo-imidazolidine-1-carboxamido)-2-phenyl-acetamido]-
penicillanic acid sodium salt (azlocillin, Securopen) was given in
doses of 100 and 200 mg/kg body weight to children with cystic
fibrosis. After intravenous bolus infections, the serum half-life was
0.82 +/- 0.12 h after the lower dose and 0.98 +/- 0.18 h after the
higher dose. This was consequent to a dose limited elimination
kinetics due to limitation in both renal and non-renal processes of
elimination. Upon doubling of the dose from 100 to 200 mg/kg, the
total body clearance dropped from 13.93 to 5.10 1/h. Evaluation of
data presented in other publications indicate that a dose limited
elimination kinetics is the normal situation for azlocillin. Besides,
the serum concentrations of patients with cystic fibrosis were
considerably lower than seen in the healthy state. The reason is
faster elimination by the renal route in cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERGAN T" publication="ANTIMICROB AGENTS CHEMOTHER" d1="13" d2="801" d3="978"/>
<CITE num="002" author="BERGAN T" publication="ACTA PATH MICROBIOL SCAND (B)" d1="80" d2="101" d3="972"/>
<CITE num="003" author="EVANS MAL" publication="J ANTIMICROB CHEMOTHER" d1="4" d2="255" d3="978"/>
<CITE num="004" author="GIAMARELLOU H" publication="INT SYMPOS ACYLUREIDOPENICILL" d1="" d2="68" d3="978"/>
<CITE num="005" author="JUSKO WJ" publication="PEDIATRICS" d1="56" d2="1038" d3="975"/>
<CITE num="006" author="KONIG HB" publication="INFECTION" d1="5" d2="170" d3="977"/>
<CITE num="007" author="KRASEMANN C" publication="INT SYMPOS ACYLUREIDOPENICILL" d1="" d2="84" d3="978"/>
<CITE num="008" author="LODE H" publication="INFECTION" d1="5" d2="163" d3="977"/>
<CITE num="009" author="REEVES DS" publication="INT SYMPOS ACYLUREIDOPENICILL" d1="" d2="18" d3="978"/>
<CITE num="010" author="WAGNER JG" publication="FUND CLIN PHARMACOKINETICS" d1="" d2="" d3="975"/>
<CITE num="011" author="WIRTH K" publication="INFECTION" d1="4" d2="25" d3="976"/>
<CITE num="012" author="YAFFE SJ" publication="J INFECT DIS" d1="135" d2="828" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79042</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHALSEN H           AN" publication="TIMICROB AGENTS CHEMOTHER" d1="19" d2="29 9" d3="1"/>
<CITE num="2" author="BERGAN T" publication="SCAND J INFECT DIS" d1="1981" d2="33" d3="981"/>
<CITE num="3" author="MALMBORG AS" publication="SCAND J INFECT DIS" d1="1981" d2="64" d3="981"/>
<CITE num="4" author="MICHALSEN H" publication="SCAND J INFECT DIS" d1="1981" d2="92" d3="981"/>
<CITE num="5" author="LEVY J" publication="J ANTIMICROB CHEMOTHER" d1="10" d2="235" d3="982"/>
<CITE num="6" author="ELIOPOULOS GM" publication="ANN INTERN MED" d1="97" d2="755" d3="982"/>
<CITE num="7" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="8" author="MICHALSEN H" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="101" d3="982"/>
<CITE num="9" author="AGOSTINI M" publication="DRUGS UNDER EXP CLIN RES" d1="9" d2="671" d3="983"/>
<CITE num="10" author="BERGAN T" publication="J ANTIMICROB CHEMOTHER" d1="11" d2="101" d3="983"/>
<CITE num="11" author="MASTELLA G" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="297" d3="983"/>
<CITE num="12" author="ISLES A" publication="AM REV RESPIR DIS" d1="127" d2="417" d3="983"/>
<CITE num="13" author="MARTINI N" publication="J CLIN HOSP PHARM" d1="9" d2="303" d3="984"/>
<CITE num="14" author="SINGLAS E" publication="PRESSE MED" d1="13" d2="788" d3="984"/>
<CITE num="15" author="LEEDER JS" publication="CLIN PHARMACOL THER" d1="36" d2="355" d3="984"/>
<CITE num="16" author="PENKETH A" publication="THORAX" d1="39" d2="299" d3="984"/>
<CITE num="17" author="MICHALSEN H" publication="PATHOL RES PRACT" d1="178" d2="261" d3="984"/>
<CITE num="18" author="ANON" publication="LANCET" d1="1" d2="1020" d3="985"/>
<CITE num="19" author="WOOLF RA" publication="CLIN PHARMACY" d1="4" d2="664" d3="985"/>
<CITE num="20" author="PRANDOTA J" publication="DEVELOP PHARM THER" d1="8" d2="311" d3="985"/>
<CITE num="21" author="HORREVORTS AM" publication="CHEST" d1="88" d2="260" d3="985"/>
<CITE num="22" author="JACOBS RF" publication="J PEDIATR" d1="106" d2="1001" d3="985"/>
<CITE num="23" author="WILSON CB" publication="J PEDIATR" d1="106" d2="1049" d3="985"/>
<CITE num="24" author="SORGEL F" publication="EUR J PEDIATR" d1="143" d2="249" d3="985"/>
<CITE num="25" author="MICHALSEN H" publication="METH FIND EXP CLIN PHARMACOL" d1="8" d2="727" d3="986"/>
<CITE num="26" author="BENDER SW" publication="INFECTION" d1="14" d2="17" d3="986"/>
<CITE num="27" author="SCHAAD UB" publication="ACTA PAEDIATR SCAND" d1="75" d2="128" d3="986"/>
</CITATIONS>
<RECORDNUM>01022 </RECORDNUM>
<MEDLINENUM>80129795</MEDLINENUM>
<AUTHORS><AUTHOR>Chapman-J-A</AUTHOR><AUTHOR>Goodall-J</AUTHOR></AUTHORS>
<TITLE>Dying children need help too.</TITLE>
<SOURCE>Aust-Fam-Physician. 1979 Dec. 8(12). P 1236-7.</SOURCE>
<MAJORSUBJ><TOPIC>CHILD-HOSPITALIZED</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>TERMINAL-CARE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ATTITUDE-TO-DEATH</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FAMILY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GRIEF</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PAIN</TOPIC></MINORSUBJ>
<EXTRACT>The control of symptoms in dying children is often sadly neglected.
This neglect is reflected in a review of the case notes of two
children who died of cystic fibrosis within three years of each
other.  The girls were under the care of the same consultant, who in
the interval between the two cases was introduced to the concern of
proper terminal care for children.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79043</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BRETT EM" publication="DEVELOP MED CHILD NEUROL" d1="12" d2="655" d3="970"/>
<CITE num="002" author="SHAFFER D" publication="IN: RUTTER M" d1="" d2="" d3="977"/>
<CITE num="003" author="TWYCROSS RG" publication="IN: SAUNDERS CM" d1="" d2="" d3="978"/>
</REFERENCES>
<RECORDNUM>01023 </RECORDNUM>
<MEDLINENUM>80129794</MEDLINENUM>
<AUTHORS><AUTHOR>Phelan-P-D</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: is it relevant to family practitioners?.</TITLE>
<SOURCE>Aust-Fam-Physician. 1979 Dec. 8(12). P 1232-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FAMILY-PRACTICE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AUSTRALIA</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc, th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PATIENT-CARE-TEAM</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79044</PAPERNUM>
<ABSTRACT>There has been a major change in the outlook for children with cystic
fibrosis during the last 20 years. Provided the diagnosis is made
before serious irreversible lung disease has occurred, most patients
can expect to reach adult life without very serious disability.</ABSTRACT>
<RECORDNUM>01024 </RECORDNUM>
<MEDLINENUM>80019967</MEDLINENUM>
<AUTHORS><AUTHOR>Carey-W-F</AUTHOR><AUTHOR>Hosli-P</AUTHOR></AUTHORS>
<TITLE>Inhibition of Tamm-Horsfall glycoprotein induction of alkaline
phosphatase in cystic fibrosis fibroblasts by medium conditioned by
normal cells.</TITLE>
<SOURCE>Aust-J-Exp-Biol-Med-Sci. 1979 Apr. 57(2). P 225-30.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: me</TOPIC><TOPIC>CELLS-CULTURED: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>GLYCOPROTEINS: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CULTURE-MEDIA</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>It is confirmed that the level of alkaline phosphatase in fibroblasts
derived from cystic fibrosis patients can be induced many-fold by
growing the cells in the presence of Tamm-Horsfall glycoprotein. It
is further shown that normal fibroblasts produce a "CF corrective
factor" which markedly inhibits this phenomenon. These observations
support a previous hypothesis on the nature of the metabolic defect
in cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BACH G" publication="PROC NAT ACAD SCI USA" d1="69" d2="2048" d3="972"/>
<CITE num="002" author="FRATANTONI JC" publication="PROC NAT ACAD SCI USA" d1="64" d2="360" d3="969"/>
<CITE num="003" author="HOSLI P" publication="ADV EXP MED BIOL" d1="68" d2="1" d3="976"/>
<CITE num="004" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
<CITE num="005" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="006" author="HOSLI P" publication="HUM GENET" d1="41" d2="169" d3="978"/>
<CITE num="007" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="008" author="HOSLI P" publication="PROC INT CF CONG 7TH" d1="" d2="278" d3="976"/>
<CITE num="009" author="HOSLI P" publication="ACTA PAEDIATR SCAND" d1="67" d2="617" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79045</PAPERNUM>
<CITATIONS>
<CITE num="1" author="REY WF              ME" publication="D J AUST" d1="2" d2="04 9" d3="9"/>
<CITE num="2" author="LYNN KL" publication="BIOCHEM J" d1="194" d2="561" d3="981"/>
<CITE num="3" author="CEDER O" publication="ULTRASTRUCTURAL PATHOL" d1="4" d2="305" d3="983"/>
<CITE num="4" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="5" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
</CITATIONS>
<RECORDNUM>01025 </RECORDNUM>
<MEDLINENUM>80087357</MEDLINENUM>
<AUTHORS><AUTHOR>Feery-B-J</AUTHOR><AUTHOR>Phelan-P-D</AUTHOR><AUTHOR>Gallichio-H-A</AUTHOR><AUTHOR>Hampson-A-W</AUTHOR></AUTHORS>
<TITLE>Antibody responses to influenza virus vaccine in patients with
cystic fibrosis.</TITLE>
<SOURCE>Aust-Paediatr-J. 1979 Sep. 15(3). P 181-2.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-VIRAL: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>INFLUENZA-VACCINE: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HEMAGGLUTINATION-INHIBITION-TESTS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFLUENZA-VACCINE: ad</TOPIC><TOPIC>ORTHOMYXOVIRUSES-TYPE-A: im</TOPIC></MINORSUBJ>
<ABSTRACT>Patients with cystic fibrosis were immunized with subunit influenza
vaccine and their haemagglutination-inhibiting (HI) antibody
responses were compared with responses in young healthy adults.
There was no significant difference in the antibody levels reached
after immunization and no evidence of any impairment of responses in
the patient group.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79046</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DAVENPORT FM" publication="J EXP MED" d1="98" d2="641" d3="953"/>
<CITE num="002" author="ANON" publication="MED J AUST" d1="1" d2="1310" d3="970"/>
<CITE num="003" author="PALMER DF" publication="ADVANCED LABORATORY TECHNIQUE" d1="" d2="" d3="975"/>
</REFERENCES>
<RECORDNUM>01026 </RECORDNUM>
<MEDLINENUM>79255569</MEDLINENUM>
<AUTHORS><AUTHOR>Bogart-B-I</AUTHOR><AUTHOR>Conod-E-J</AUTHOR><AUTHOR>Gaerlan-P-F</AUTHOR><AUTHOR>Denning-C-R</AUTHOR><AUTHOR>Conover-J</AUTHOR></AUTHORS>
<TITLE>Biological activities of cystic fibrosis serum.  III.  CF serum
induced uptake of 45Ca++ by rabbit tracheal explants.</TITLE>
<SOURCE>Biochem-Biophys-Res-Commun. 1979 Jun 27. 88(4). P 1398-404.</SOURCE>
<MAJORSUBJ><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CELL-MEMBRANE-PERMEABILITY: de</TOPIC><TOPIC>CILIA: pp</TOPIC><TOPIC>CYSTIC-FIBROSIS: me, pp</TOPIC><TOPIC>GALLOPAMIL: pd</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGG: ph</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>TRACHEA: me</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic Fibrosis (CF) serum and its isolated component IgG fraction
produce an increased uptake of 45Ca++ in rabbit tracheal explants
when compared to control serum and its isolated IgG fraction.
Heterozygote serum also produced an increased uptake of 45Ca++ but
not to the same extent as CF serum.  The calcium channel blocker
D600 inhibited the CF serum induced uptake of 45Ca++ indicating that
CF serum may be acting on the plasma membrane to produce changes in
calcium permeability in rabbit tracheal explants.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="002" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="004" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="005" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="006" author="BOGART BI" publication="PEDIATR RES" d1="12" d2="15" d3="978"/>
<CITE num="007" author="PUTNEY JW" publication="J PHARMACOL EXP THER" d1="199" d2="526" d3="976"/>
<CITE num="008" author="CONOD EJ" publication="PEDIATR RES" d1="11" d2="45" d3="977"/>
<CITE num="009" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="010" author="CONOVER JH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="83" d2="1595" d3="978"/>
<CITE num="011" author="FLECKENSTEIN A" publication="IN: CARAFOLI E" d1="" d2="555" d3="975"/>
<CITE num="012" author="BANSCHBACH MW" publication="BIOCHEM BIOPHYS RES COMMUN" d1="84" d2="922" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79047</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WMAN BH             FE" publication="D PROC" d1="39" d2="95 9" d3="0"/>
<CITE num="2" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="3" author="WILSON GB" publication="MED HYPOTHESES" d1="8" d2="527" d3="982"/>
<CITE num="4" author="BOGART BI" publication="PEDIATR RES" d1="16" d2="223" d3="982"/>
<CITE num="5" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="6" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
</CITATIONS>
<RECORDNUM>01027 </RECORDNUM>
<MEDLINENUM>79144816</MEDLINENUM>
<AUTHORS><AUTHOR>Alhadeff-J-A</AUTHOR><AUTHOR>Watkins-P</AUTHOR></AUTHORS>
<TITLE>Differential concanavalin A binding of cystic fibrosis and normal
liver alpha-L-fucosidase.</TITLE>
<SOURCE>Biochem-Biophys-Res-Commun. 1979 Feb 14. 86(3). P 787-92.</SOURCE>
<MAJORSUBJ><TOPIC>CONCANAVALIN-A: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FUCOSIDASE: me</TOPIC><TOPIC>LIVER: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>PROTEIN-BINDING</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>A novel technique has been employed to demonstrate that alpha-L-
fucosidase purified from cystic fibrosis and control livers exhibits
differential binding to the lectin Concanavalin A.  The
concentration of alpha-CH3-mannoside necessary to prevent 50%
binding of alpha-L-fucosidase to Concanavalin A is considerably
lower for the cystic fibrosis enzyme (13.5 vs. 33.3 mM).  Comparable
results were found when binding studies were done on crude
supernatant alpha-L-fucosidase from 8 cystic fibrosis and 8 control
livers (5.6 plus or minus 0.4 mM and 13.2 plus or minus 3.4
respectively), without any overlap of values between the cystic
fibrosis and control livers.  These results suggest that comparative
lectin binding studies on cystic fibrosis and normal glycoproteins
from readily available tissues might result in an assay for
detecting the cystic fibrosis genotype.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="002" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="003" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="005" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="417" d3="978"/>
<CITE num="006" author="ALHADEFF JA" publication="J BIOL CHEM" d1="250" d2="7106" d3="975"/>
<CITE num="007" author="ALHADEFF JA" publication="MOL CELL BIOCHEM" d1="18" d2="33" d3="977"/>
<CITE num="008" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="009" author="ALHADEFF JA" publication="IN: GLEW RH" d1="" d2="247" d3="977"/>
<CITE num="010" author="BISHAYEE S" publication="BIOCHIM BIOPHYS ACTA" d1="334" d2="378" d3="974"/>
<CITE num="011" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="012" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="013" author="SCANLIN TF JR" publication="PEDIATR RES ABST 549" d1="11" d2="463" d3="977"/>
<CITE num="014" author="LIS H" publication="IN: SELA M" d1="4" d2="429" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79048</PAPERNUM>
<CITATIONS>
<CITE num="1" author="APIRA E             BI" publication="OCHEM BIOPHYS RES COMMUN" d1="93" d2="50 9" d3="0"/>
<CITE num="2" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="105" d2="131" d3="980"/>
<CITE num="3" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="4" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="117" d2="227" d3="981"/>
<CITE num="5" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="6" author="SCANLIN TF" publication="BIOCHEMISTRY" d1="21" d2="491" d3="982"/>
<CITE num="7" author="BOURASSA C" publication="CLIN CHIM ACTA" d1="129" d2="263" d3="983"/>
<CITE num="8" author="HERMELIN B" publication="CELL MOL BIOL" d1="33" d2="83" d3="987"/>
</CITATIONS>
<RECORDNUM>01028 </RECORDNUM>
<MEDLINENUM>80069763</MEDLINENUM>
<AUTHORS><AUTHOR>Adams-T-H</AUTHOR><AUTHOR>Ramsay-G-M</AUTHOR><AUTHOR>Wisdom-G-B</AUTHOR></AUTHORS>
<TITLE>Enzyme immunoassay of albumin as an aid to the diagnosis of cystic
fibrosis in the newborn human [proceedings].</TITLE>
<SOURCE>Biochem-Soc-Trans. 1979 Oct. 7(5). P 1018-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SERUM-ALBUMIN: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOENZYME-TECHNICS</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MECONIUM: an</TOPIC></MINORSUBJ>
<EXTRACT>One of the symptoms of cystic fibrosis (mucoviscidosis) is pancreatic
insufficiency.  The reduced proteolytic activity in the gut of
children with the disease results in an elevated concentration of
protein, especially serum albumin, in the meconium.  This feature is
used in the diagnosis of the disease in the newborn, and we decided
to examine the utility of enzyme immunoassay for the measurement of
albumin in meconium samples from normal and cystic fibrosis infants.
Normal samples were found to have apparent albumin concentrations in
the range 0.05-0.26 mg/g dry wt., whereas cystic fibrosis samples had
concentrations in the range 60-230 mg/g dry wt.  The assay provides a
cheap and relatively rapid method of differentiating cystic fibrosis
positive and negative meconium samples.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HELLSING K" publication="SCAND J CLIN LAB INVEST" d1="33" d2="333" d3="974"/>
<CITE num="002" author="MAIOLINI R" publication="J IMMUNOL METH" d1="8" d2="223" d3="975"/>
<CITE num="003" author="NAKANE PK" publication="J HISTOCHEM CYTOCHEM" d1="22" d2="1084" d3="974"/>
<CITE num="004" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="64" d2="117" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79049</PAPERNUM>
<CITATIONS>
<CITE num="1" author="YLOR EW             SE" publication="M PERINATOL" d1="9" d2="32 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01029 </RECORDNUM>
<MEDLINENUM>80021202</MEDLINENUM>
<AUTHORS><AUTHOR>Wijcik-L</AUTHOR><AUTHOR>Buchwald-M</AUTHOR><AUTHOR>Riordan-J-R</AUTHOR></AUTHORS>
<TITLE>Induction of alkaline phosphatase in cultured human fibroblasts.
Comparison of normal cells and those from patients with cystic
fibrosis.</TITLE>
<SOURCE>Biochim-Biophys-Acta. 1979 Jul 4. 585(3). P 374-82.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: bi</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-DIVISION</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>DNA: bi</TOPIC><TOPIC>ENZYME-INDUCTION: de</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>The membrane glycoprotein enzyme, alkaline phosphatase was induced in
cultured human fibroblasts by dibutyryl cyclic AMP, sodium butyrate,
the serum glycoprotein fetuin, the Tamm-Horsfall urinary
glycoprotein, and by a number of inhibitors of DNA synthesis. The
uninduced basal enzyme activity increased at later stages of growth
when the cells became confluent. Induction by dibutyryl cyclic AMP or
fetuin was most effective when the agents were added after the cells
had reached stationary phase and was maximal after at least two days
of exposure. The levels of induction resulting from the addition of
pairs of the agents, dibutyryl cyclic AMP, n-butyrate and fetuin were
additive indicating that these have different modes of action. The
inhibitors of DNA synthesis, cytosine arabinoside, hydroxyurea, and
methothrexate were less effective inducers. Bromodeoxyuridine which
also has non-DNA mediated effects induced to the same extent as
dibutyryl cyclic AMP. Similar experiments with sex- and age-matched
cell strains derived from patients with cystic fibrosis failed to
detect differences in the levels of induction from those observed in
normal cells. In addition, the combined inductive effects of Tamm-
Horsfall glycoprotein, isoproterenol and theophylline, were similar
with normal and cystic fibrosis cells.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="STEPAN J" publication="EXPERIENTIA" d1="29" d2="948" d3="973"/>
<CITE num="002" author="FISHMAN WH" publication="AM J MED" d1="56" d2="617" d3="974"/>
<CITE num="003" author="LIN CW" publication="J HISTOCHEM CYTOCHEM" d1="24" d2="659" d3="976"/>
<CITE num="004" author="RIORDAN JR" publication="IN: JULIONO RL" d1="2" d2="146" d3="978"/>
<CITE num="005" author="KOYAMA H" publication="BIOCHEM BIOPHYS RES COMMUN" d1="46" d2="305" d3="972"/>
<CITE num="006" author="MAZIERE JC" publication="BIOCHIMIE" d1="59" d2="221" d3="977"/>
<CITE num="007" author="NOSE K" publication="JAPAN J EXP MED" d1="46" d2="347" d3="976"/>
<CITE num="008" author="COX RJ" publication="BIOCHEM J" d1="105" d2="155" d3="967"/>
<CITE num="009" author="COX RP" publication="J MOL BIOL" d1="58" d2="197" d3="971"/>
<CITE num="010" author="GRIFFIN MJ" publication="ARCH BIOCHEM BIOPHYS" d1="164" d2="619" d3="974"/>
<CITE num="011" author="MIEDEMA E" publication="EXP CELL RES" d1="53" d2="488" d3="968"/>
<CITE num="012" author="VANNEUVILLE FJ" publication="BIOCHEM SOC TRANS" d1="5" d2="1117" d3="977"/>
<CITE num="013" author="LUNDGREN E" publication="EXP CELL RES" d1="110" d2="25" d3="977"/>
<CITE num="014" author="HOSLI P" publication="ADV EXP MED BIOL" d1="68" d2="1" d3="974"/>
<CITE num="015" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="016" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="017" author="RIORDAN JR" publication="J SUPRAMOL STRUCT SUPPL" d1="2" d2="126" d3="978"/>
<CITE num="018" author="TAMM I" publication="J EXP MED" d1="95" d2="71" d3="952"/>
<CITE num="019" author="BUCHWALD M" publication="MOD PROBL PEDIATR" d1="19" d2="165" d3="977"/>
<CITE num="020" author="STANNERS CP" publication="NATURE NEW BIOL" d1="230" d2="52" d3="971"/>
<CITE num="021" author="BOHLEN P" publication="ARCH BIOCHEM BIOPHYS" d1="155" d2="213" d3="973"/>
<CITE num="022" author="DEUTSCH SI" publication="BIOCHIM BIOPHYS ACTA" d1="499" d2="382" d3="977"/>
<CITE num="023" author="GHOSH NK" publication="NATURE" d1="267" d2="435" d3="977"/>
<CITE num="024" author="HENNEBERRY RC" publication="NATURE" d1="268" d2="252" d3="977"/>
<CITE num="025" author="TALLMAN JF" publication="PROC NAT ACAD SCI USA" d1="74" d2="873" d3="977"/>
<CITE num="026" author="MERIMEE TJ" publication="J CLIN ENDOCRINOL METAB" d1="43" d2="1190" d3="976"/>
<CITE num="027" author="FISHMAN PH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="59" d2="292" d3="974"/>
<CITE num="028" author="GHOSH NK" publication="NATURE" d1="267" d2="435" d3="977"/>
<CITE num="029" author="WRIGHT JA" publication="EXP CELL RES" d1="78" d2="456" d3="973"/>
<CITE num="030" author="GINSBURG E" publication="PROC NAT ACAD SCI USA" d1="70" d2="2457" d3="973"/>
<CITE num="031" author="HENNEBERRY RC" publication="CELL" d1="5" d2="1" d3="975"/>
<CITE num="032" author="VIDALI G" publication="PROC NAT ACAD SCI USA" d1="75" d2="2239" d3="978"/>
<CITE num="033" author="HORVAT A" publication="J CELL PHYSIOL" d1="83" d2="59" d3="974"/>
<CITE num="034" author="MAZIERE C" publication="BIOCHIMIE" d1="59" d2="225" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79050</PAPERNUM>
<CITATIONS>
<CITE num="1" author="REY WF              ME" publication="D J AUST" d1="2" d2="04 9" d3="9"/>
<CITE num="2" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="3" author="MALER T" publication="BIOCHIM BIOPHYS ACTA" d1="598" d2="1" d3="980"/>
<CITE num="4" author="CROFTON PM" publication="CRC CRIT REV CLIN LAB SCI" d1="16" d2="161" d3="982"/>
<CITE num="5" author="BUCHWALD M" publication="CLIN BIOCHEM" d1="17" d2="143" d3="984"/>
<CITE num="6" author="ZGURSKII AA" publication="BIOCHEMISTRY USSR" d1="49" d2="1380" d3="984"/>
<CITE num="7" author="ZGURSKY AA" publication="TSITOLOGIYA" d1="27" d2="775" d3="985"/>
<CITE num="8" author="YANG AH" publication="IN VITRO CELL DEVEL BIOL" d1="23" d2="34" d3="987"/>
<CITE num="9" author="WHYTE MP" publication="CALC TISS INT" d1="40" d2="244" d3="987"/>
</CITATIONS>
<RECORDNUM>01030 </RECORDNUM>
<MEDLINENUM>80000602</MEDLINENUM>
<AUTHORS><AUTHOR>Riordan-J-R</AUTHOR><AUTHOR>Alon-N</AUTHOR><AUTHOR>Buchwald-M</AUTHOR></AUTHORS>
<TITLE>Plasma membrane lipids of human diploid fibroblasts from normal
individuals and patients with cystic fibrosis.</TITLE>
<SOURCE>Biochim-Biophys-Acta. 1979 Jul 27. 574(1). P 39-47.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MEMBRANE-LIPIDS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHOLESTEROL: an</TOPIC><TOPIC>FATTY-ACIDS: an</TOPIC><TOPIC>FIBROBLASTS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MEMBRANE-FLUIDITY</TOPIC><TOPIC>PHOSPHOLIPIDS: an</TOPIC><TOPIC>SKIN: an</TOPIC></MINORSUBJ>
<ABSTRACT>The lipid composition of isolated plasma membranes of human skin
fibroblasts is described for the first time. Plasma membranes from a
number of strains of fibroblasts from patients with cystic fibrosis
and matched normals were isolated by a recently described procedure
and analysed for major phospholipid classes, cholesterol and fatty
acids. No differences in the quantities of these compounds were
detected between cells of the two different origins. The fetal calf
serum used to supplement the growth medium contained relatively more
palmitoleate and oleate but less stearate than the membranes. There
were also no consistent differences between cystic fibrosis and
normal membranes in terms of the fatty acid compositions of their
individual phospholipid classes. Consistent with this lack of
chemical change in the lipids of membranes of cystic fibrosis cells,
the degree of fluorescence polarization of diphenylhexatriene, an
index of fluidity, was also unchanged.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KARTNER N" publication="J MEMBR BIOL" d1="36" d2="191" d3="977"/>
<CITE num="002" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="003" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="004" author="SANJURJO P" publication="LANCET" d1="1" d2="752" d3="977"/>
<CITE num="005" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="006" author="RIVERS JPW" publication="LANCET" d1="2" d2="642" d3="975"/>
<CITE num="007" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="534" d3="976"/>
<CITE num="009" author="FARIAS RN" publication="BIOCHIM BIOPHYS ACTA" d1="415" d2="231" d3="975"/>
<CITE num="010" author="LUCY JA" publication="FEBS LETTERS SUPP 1" d1="40" d2="5105" d3="974"/>
<CITE num="011" author="CHRISTIAN ST" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="966" d3="977"/>
<CITE num="012" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="013" author="FOLCH J" publication="J BIOL CHEM" d1="226" d2="497" d3="957"/>
<CITE num="014" author="BARTLETT GR" publication="J BIOL CHEM" d1="234" d2="466" d3="959"/>
<CITE num="015" author="ROUSER G" publication="IN: MARINETTI GV" d1="1" d2="99" d3="967"/>
<CITE num="016" author="VAN HOEVEN RP" publication="J MEMBR BIOL" d1="9" d2="105" d3="972"/>
<CITE num="017" author="SHINITZKY M" publication="BIOCHIM BIOPHYS ACTA" d1="433" d2="133" d3="976"/>
<CITE num="018" author="MALKIEWICZ-WASOWICZ B" publication="BIOCHIM BIOPHYS ACTA" d1="482" d2="358" d3="977"/>
<CITE num="019" author="BENEDETTI EL" publication="IN: DALTON AJ" d1="" d2="33" d3="968"/>
<CITE num="020" author="PATTON S" publication="J THEOR BIOL" d1="29" d2="489" d3="970"/>
<CITE num="021" author="PFLEGER RC" publication="BIOCHEMISTRY" d1="7" d2="2826" d3="968"/>
<CITE num="022" author="WOOD RE" publication="ARCH BIOCHEM BIOPHYS" d1="141" d2="174" d3="970"/>
<CITE num="023" author="HENNING R" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="351" d2="1191" d3="970"/>
<CITE num="024" author="HOROWITZ AF" publication="PROC NAT ACAD SCI USA" d1="71" d2="3115" d3="974"/>
<CITE num="025" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="026" author="CHANGUS JE" publication="ARCH PATHOL LAB MED" d1="100" d2="7" d3="976"/>
<CITE num="027" author="SCHROEDER F" publication="J BIOL CHEM" d1="251" d2="5015" d3="976"/>
<CITE num="028" author="SAHU S" publication="AM REV RESPIR DIS" d1="115" d2="233" d3="977"/>
<CITE num="029" author="MCEVOY FA" publication="LANCET" d1="2" d2="236" d3="975"/>
<CITE num="030" author="DALE RE" publication="J BIOL CHEM" d1="252" d2="7500" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79051</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ELEY FW             CA" publication="N J BIOCHEM" d1="57" d2="73 9" d3="9"/>
<CITE num="2" author="PHILLIPS MC" publication="ATHEROSCLEROSIS" d1="36" d2="409" d3="980"/>
<CITE num="3" author="RIORDAN JR" publication="CAN J BIOCHEM" d1="58" d2="928" d3="980"/>
<CITE num="4" author="MALER T" publication="BIOCHIM BIOPHYS ACTA" d1="598" d2="1" d3="980"/>
<CITE num="5" author="KOIZUMI K" publication="BIOCHIM BIOPHYS ACTA" d1="619" d2="344" d3="980"/>
<CITE num="6" author="ROGIERS V" publication="PEDIATR RES" d1="16" d2="761" d3="982"/>
<CITE num="7" author="FIELDING CJ" publication="J BIOL CHEM" d1="257" d2="955" d3="982"/>
<CITE num="8" author="ROTHBLAT GH" publication="J BIOL CHEM" d1="257" d2="4775" d3="982"/>
<CITE num="9" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="10" author="HUBBARD VS" publication="EUR J PEDIATR" d1="141" d2="68" d3="983"/>
<CITE num="11" author="SLOTTE JP" publication="BIOCHEM J" d1="220" d2="605" d3="984"/>
<CITE num="12" author="SLOTTE JP" publication="BIOCHIM BIOPHYS ACTA" d1="793" d2="423" d3="984"/>
<CITE num="13" author="RIORDAN JR" publication="PHARMACOL THER" d1="28" d2="51" d3="985"/>
<CITE num="14" author="LUNDBERG B" publication="ATHEROSCLEROSIS" d1="56" d2="345" d3="985"/>
<CITE num="15" author="BRAUNAGEL SC" publication="BIOCHIM BIOPHYS ACTA" d1="813" d2="183" d3="985"/>
<CITE num="16" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="4" d2="305" d3="986"/>
<CITE num="17" author="LUNDBERG B" publication="ACTA CHEM SCAND (A)" d1="40" d2="315" d3="986"/>
</CITATIONS>
<RECORDNUM>01031 </RECORDNUM>
<MEDLINENUM>79232883</MEDLINENUM>
<AUTHORS><AUTHOR>Lappe-M</AUTHOR></AUTHORS>
<TITLE>2. Theories of genetic causation in human disease.</TITLE>
<SOURCE>Birth-Defects. 1979. 15(2). P 33-45.</SOURCE>
<MAJORSUBJ><TOPIC>GENETICS-MEDICAL</TOPIC><TOPIC>HEREDITARY-DISEASES</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALCOHOLISM: fg</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENETICS-BEHAVIORAL</TOPIC><TOPIC>GENOTYPE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LESCH-NYHAN-SYNDROME: fg</TOPIC><TOPIC>PHENOTYPE</TOPIC><TOPIC>PHENYLKETONURIA: fg</TOPIC><TOPIC>VARIATION-GENETICS</TOPIC><TOPIC>XYY-KARYOTYPE</TOPIC></MINORSUBJ>
<EXTRACT>The central problem of the mid-20th century genetic counselor has
been to determine the place of the genes in the origin of complex
human characteristics - such as neural tube defects, cleft palate,
diabetes, and congenital heart disease - in short, the major
malformation and polygenic syndromes which make up the bulk of what
we call birth defects.  Of comparable importance in terms of genetic
counseling is understanding the origin and incidence of the newly
recognized genetic heterogeneity lying behind what had previously
been regarded as simple, single-gene determined diseases.  Topics
include dealing with genetic heterogeneity, phenotypes and genotypes,
where genetic causation defies simple analysis, and sources of
variation.  Behavior disorders with presumptive single-gene causation
(Lesch-Nyhan disease), presumptive sex-linked causation
(aggressivity), and presumptive polygenic causation (alcoholism) are
also discussed.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79052</PAPERNUM>
<REFERENCES>
<CITE num="000" author="JOHANSSEN W" publication="IN: PETERS JA" d1="" d2="" d3="959"/>
<CITE num="001" author="KAUFMAN S" publication="N ENGL J MED" d1="293" d2="785" d3="975"/>
<CITE num="002" author="BLANCK RR" publication="JAMA" d1="235" d2="1364" d3="976"/>
<CITE num="003" author="DARLINGTON CD" publication="GENETICS AND MAN" d1="" d2="102" d3="969"/>
<CITE num="004" author="NEWMAN HH" publication="EVOLUTION GENETICS AND EUGENI" d1="" d2="485" d3="969"/>
<CITE num="005" author="WRIGHT S" publication="GENETICS" d1="19" d2="537" d3="934"/>
<CITE num="006" author="BECK F" publication="IN: ROBSON JM" d1="" d2="1" d3="965"/>
<CITE num="007" author="FRASER FC" publication="PROC INT CONF CONGENITA 1ST" d1="" d2="179" d3="961"/>
<CITE num="008" author="KALTER H" publication="TERATOLOGY" d1="13" d2="1" d3="976"/>
<CITE num="009" author="BARLOW SM" publication="TERATOLOGY" d1="12" d2="97" d3="975"/>
<CITE num="010" author="ERWAY L" publication="SCIENCE" d1="152" d2="1766" d3="966"/>
<CITE num="011" author="ANON" publication="COLUMBIA JOURNALISM REVIEW MA" d1="" d2="" d3="975"/>
<CITE num="012" author="LENZ W" publication="J MED GENET" d1="10" d2="34" d3="973"/>
<CITE num="013" author="DEGENHARDT KH" publication="IN: RASPE G" d1="6" d2="" d3="971"/>
<CITE num="014" author="ROSENTHAL MR" publication="LANCET" d1="2" d2="250" d3="976"/>
<CITE num="015" author="VAN DE PUTTE I" publication="LANCET" d1="2" d2="251" d3="976"/>
<CITE num="016" author="CAVALLI-SFORZA LL" publication="AM J HUM GENET" d1="25" d2="618" d3="973"/>
<CITE num="017" author="ANDERSON LT" publication="PSYCHOLOGICAL SPECTATOR" d1="10" d2="4" d3="975"/>
<CITE num="018" author="SELMANOFF MK" publication="NATURE" d1="253" d2="529" d3="975"/>
<CITE num="019" author="SELMANOFF MK" publication="BEHAV GENET" d1="6" d2="53" d3="976"/>
<CITE num="020" author="LAGERSPETZ KMJ" publication="IN: VAN ABEELEN" d1="" d2="321" d3="974"/>
<CITE num="021" author="RANDT CT" publication="DEVELOP PSYCHOBIOL" d1="8" d2="275" d3="975"/>
<CITE num="023" author="OMENN GS" publication="ANN NY ACAD SCI" d1="197" d2="16" d3="972"/>
<CITE num="024" author="FULLER JL" publication="COMPARATIVE PHYSIOL PSYCHOL" d1="57" d2="85" d3="965"/>
<CITE num="025" author="RANDALL CL" publication="SCIENCE" d1="189" d2="149" d3="975"/>
<CITE num="026" author="HIRSCH J" publication="IN: HIRSCH J" d1="" d2="416" d3="967"/>
</REFERENCES>
<RECORDNUM>01032 </RECORDNUM>
<MEDLINENUM>79233368</MEDLINENUM>
<AUTHORS><AUTHOR>MacErlean-D-P</AUTHOR><AUTHOR>Gray-B-J</AUTHOR><AUTHOR>FitzGerald-M-X</AUTHOR></AUTHORS>
<TITLE>Bronchial artery embolization in the control of massive haemoptysis.</TITLE>
<SOURCE>Br-J-Radiol. 1979 Jul. 52(619). P 558-61.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-ARTERIES</TOPIC><TOPIC>EMBOLIZATION-THERAPEUTIC</TOPIC><TOPIC>HEMOPTYSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ASPERGILLOSIS: co</TOPIC><TOPIC>BRONCHIAL-ARTERIES: ra</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEMOPTYSIS: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-FUNGAL: co</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Bronchial artery embolization is a useful palliative treatment for
life-threatening haemoptyses where surgery is contra-indicated.
Patients presenting with haemoptyses complicating cystic fibrosis and
aspergilloma have been embolized. Control of haemoptysis was achieved
in the former, but late recurrence of haemoptysis in the latter led
to asphyxiation.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOOKSTEIN JJ" publication="CHEST" d1="72" d2="658" d3="977"/>
<CITE num="002" author="BREDIN CP" publication="CHEST" d1="72" d2="258" d3="977"/>
<CITE num="003" author="KARDJIEV V" publication="RADIOLOGY" d1="112" d2="81" d3="974"/>
<CITE num="004" author="MACERLEAN DP" publication="BR J RADIOL" d1="51" d2="414" d3="978"/>
<CITE num="005" author="REMY J" publication="RADIOLOGY" d1="122" d2="33" d3="977"/>
<CITE num="006" author="SCHUSTER SR" publication="J PEDIATR SURG" d1="12" d2="889" d3="977"/>
<CITE num="007" author="STONE RM" publication="SURG FORUM" d1="17" d2="109" d3="966"/>
<CITE num="008" author="WHOLEY MH" publication="JAMA" d1="236" d2="2501" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79053</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLINS JV            BR" publication="J HOSP MED" d1="23" d2="79 9" d3="0"/>
<CITE num="2" author="FAIRFAX AJ" publication="BR J DIS CHEST" d1="74" d2="345" d3="980"/>
<CITE num="3" author="MAGILLIGAN DJ" publication="ANN THORAC SURG" d1="32" d2="392" d3="981"/>
<CITE num="4" author="FERRIS EJ" publication="CHEST" d1="80" d2="710" d3="981"/>
<CITE num="5" author="KUCERA V" publication="THORAC CARDIOVASC SURG" d1="30" d2="152" d3="982"/>
<CITE num="6" author="GRENIER P" publication="AM J ROENTGENOL" d1="140" d2="467" d3="983"/>
<CITE num="7" author="NAAR CA" publication="AM J ROENTGENOL" d1="140" d2="271" d3="983"/>
<CITE num="8" author="PORTER DK" publication="ARCH INTERN MED" d1="143" d2="287" d3="983"/>
<CITE num="9" author="UFLACKER R" publication="RADIOLOGY" d1="146" d2="627" d3="983"/>
<CITE num="10" author="TAFRESHI M" publication="NY STATE J MED" d1="85" d2="38" d3="985"/>
<CITE num="11" author="KLAMUT M" publication="FORTSCHR GEB RONTG NUKL" d1="143" d2="645" d3="985"/>
<CITE num="12" author="NOLAN MT" publication="IR J MED SCI" d1="154" d2="336" d3="985"/>
</CITATIONS>
<RECORDNUM>01033 </RECORDNUM>
<MEDLINENUM>80044035</MEDLINENUM>
<TITLE>Cystic fibrosis in adults [editorial].</TITLE>
<SOURCE>Br-Med-J. 1979 Sep 15. 2(6191). P 626.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BRONCHIAL-DISEASES: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREATIC-DISEASES: et</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is the commonest semilethal genetic disorder in
Caucasians.  The biochemical sequence that leads to widespread
dysfunction of exocrine glands has yet to be determined.  Cystic
fibrosis in adults has been the subject of extensive review.  We
still do not know the cause of the changes in the lungs.  Pancreatic
insufficiency was recorded in 95% of the patients, but the older ones
needed little dietary restriction and some seemed to thrive without
pancreatic replacement.  Ninety-five per cent of males have aspermia
due to failure of development of the vas deferens, epididymis, and
seminal vesicles.  Despite the obvious handicap and emotional and
social strains in all four series, adolescent and adult patients with
cystic fibrosis not only did well at school and at work but managed
to fit in well in their social framework.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79054</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="AM J MED" d1="66" d2="121" d3="979"/>
<CITE num="003" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="004" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="005" author="GRACEY M" publication="AUSTRALAS ANN MED" d1="18" d2="91" d3="969"/>
</REFERENCES>
<RECORDNUM>01034 </RECORDNUM>
<MEDLINENUM>80044037</MEDLINENUM>
<AUTHORS><AUTHOR>Flower-K-A</AUTHOR><AUTHOR>Eden-R-I</AUTHOR><AUTHOR>Lomax-L</AUTHOR><AUTHOR>Mann-N-M</AUTHOR><AUTHOR>Burgess-J</AUTHOR></AUTHORS>
<TITLE>New mechanical aid to physiotherapy in cystic fibrosis.</TITLE>
<SOURCE>Br-Med-J. 1979 Sep 15. 2(6191). P 630-1.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>PERCUSSION: is</TOPIC><TOPIC>PHYSICAL-THERAPY: is</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGED</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PRESSURE</TOPIC></MINORSUBJ>
<ABSTRACT>The force of impact and frequency of percussion by physiotherapists
and parents of children with cystic fibrosis were analysed on a
special test rig and incorporated in a prototype percussor. In adult
volunteers and cadavers a maximum intrathoracic pressure could be
achieved by a critical frequency of mechanical percussion which was
higher than that reached by physiotherapists and parents.
Consequently the percussor was redesigned to operate at this optimum
frequency. It was then discovered that if the percussor was pressed
firmly enough against the chest, this maximum intrathoracic pressure
could be indicated by quivering of the voice. In a continuing study
of intrathoracic pressures obtained mechanically and manually the
Salford percussor's produced higher pressures than the
physiotherapists' and maintained them constantly, while the
physiotherapists' efforts and results varied from one to another.
Hospital and domiciliary use of the percussor have shown it to help
in the first stage of the physiotherapy routine for patients with
cystic fibrosis. The percussor should enable adolescents and adults
to treat themselves and encourage twice-daily and more effective
chest treatments. It is easy to apply and its speed and efficiency
should enable parents to improve the quality of their chest therapy
for younger children at home. Its long-term benefits are difficult to
assess because of the nature of the disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="CF CLUB ABST" d1="13" d2="" d3="974"/>
<CITE num="002" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="003" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="004" author="HODSON ME" publication="BR MED J" d1="1" d2="971" d3="978"/>
<CITE num="005" author="LOUGH MD" publication="PEDIATRIC RESPIRATORY THERAPY" d1="" d2="" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79055</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="2" d2="29 9" d3="9"/>
<CITE num="2" author="FREEDMAN BJ" publication="EUR J RESPIR DIS" d1="61" d2="254" d3="980"/>
<CITE num="3" author="HOLODY B" publication="AM REV RESPIR DIS" d1="124" d2="372" d3="981"/>
<CITE num="4" author="KERREBIJN KF" publication="EUR J RESPIR DIS" d1="63" d2="35" d3="982"/>
<CITE num="5" author="BATTISTINI A" publication="RIV ITAL PEDIATR" d1="10" d2="220" d3="984"/>
</CITATIONS>
<RECORDNUM>01035 </RECORDNUM>
<MEDLINENUM>80021861</MEDLINENUM>
<AUTHORS><AUTHOR>Pryor-J-A</AUTHOR><AUTHOR>Webber-B-A</AUTHOR><AUTHOR>Hodson-M-E</AUTHOR><AUTHOR>Batten-J-C</AUTHOR></AUTHORS>
<TITLE>Evaluation of the forced expiration technique as an adjunct to
postural drainage in treatment of cystic fibrosis.</TITLE>
<SOURCE>Br-Med-J. 1979 Aug 18. 2(6187). P 417-8.</SOURCE>
<MAJORSUBJ><TOPIC>BREATHING-EXERCISES</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHYSICAL-THERAPY: mt</TOPIC><TOPIC>POSTURE</TOPIC><TOPIC>SPUTUM</TOPIC></MINORSUBJ>
<ABSTRACT>Sixteen patients with cystic fibrosis were treated with conventional
physiotherapy aided by an assistant. The results were compared with
those produced by physiotherapy using the forced expiration technique
cleared more sputum in less time than conventional physiotherapy. A
sputum in less time than conventional physiotherapy. A second study
showed that an assistant did not further improve the results obtained
by the patient performing the forced expiration technique himself.
These findings mean that patients with cystic fibrosis who have had
to rely on the help of others for their home treatment may now
perform more effective treatment without help. The forced expiration
technique might also be helpful for patients with chronic bronchitis,
asthma, or bronchiectasis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="COCHRANE GM" publication="BR MED J" d1="2" d2="1181" d3="977"/>
<CITE num="002" author="GASKELL DV" publication="BROMPTON HOSP GUIDE TO CHEST" d1="" d2="" d3="977"/>
<CITE num="003" author="THOMPSON BJ" publication="NZ J PHYSIOTHERAPY" d1="4" d2="4" d3="973"/>
<CITE num="004" author="MEAD J" publication="J APPL PHYSIOL" d1="22" d2="95" d3="967"/>
<CITE num="005" author="DAWSON SV" publication="J APPL PHYSIOL" d1="43" d2="498" d3="977"/>
<CITE num="006" author="DE KOCK MA" publication="DYNAMIC BRONCHOSCOPY" d1="" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79056</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKERSON BG          AM" publication="REV RESPIR DIS              1" d1="22" d2="59 9" d3="0"/>
<CITE num="2" author="HODSON ME" publication="PRACTITIONER" d1="224" d2="301" d3="980"/>
<CITE num="3" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="63" d2="188" d3="982"/>
<CITE num="4" author="HARRISON AC" publication="NZ MED J" d1="95" d2="270" d3="982"/>
<CITE num="5" author="ROSSMAN CM" publication="AM REV RESPIR DIS" d1="126" d2="131" d3="982"/>
<CITE num="6" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="64" d2="62" d3="983"/>
<CITE num="7" author="HODSON ME" publication="PRACTITIONER" d1="227" d2="1723" d3="983"/>
<CITE num="8" author="SUTTON PP" publication="SEM RESPIR MED" d1="5" d2="353" d3="984"/>
<CITE num="9" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="10" author="FALK M" publication="EUR J RESPIR DIS" d1="65" d2="423" d3="984"/>
<CITE num="11" author="DEBOECK C" publication="AM REV RESPIR DIS" d1="129" d2="182" d3="984"/>
<CITE num="12" author="MACKENZIE CF" publication="CRIT CARE MED" d1="13" d2="483" d3="985"/>
<CITE num="13" author="MEARNS MB" publication="ARCH DIS CHILD" d1="60" d2="272" d3="985"/>
<CITE num="14" author="SUTTON PP" publication="EUR J RESPIR DIS" d1="66" d2="147" d3="985"/>
<CITE num="15" author="KIRILOFF LH" publication="CHEST" d1="88" d2="436" d3="985"/>
<CITE num="16" author="MAZZOCCO MC" publication="CHEST" d1="88" d2="360" d3="985"/>
<CITE num="17" author="COCHRANE GM" publication="BR MED J" d1="290" d2="1026" d3="985"/>
<CITE num="18" author="OBERWALDNER B" publication="PEDIATR PULMONOL" d1="2" d2="358" d3="986"/>
<CITE num="19" author="FALING LJ" publication="CLIN CHEST MED" d1="7" d2="599" d3="986"/>
<CITE num="20" author="HOFMEYR JL" publication="THORAX" d1="41" d2="951" d3="986"/>
<CITE num="21" author="KIM CS" publication="J APPL PHYSIOL" d1="60" d2="908" d3="986"/>
<CITE num="22" author="BLOMQUIST M" publication="ARCH DIS CHILD" d1="61" d2="362" d3="986"/>
<CITE num="23" author="TYRRELL JC" publication="ARCH DIS CHILD" d1="61" d2="598" d3="986"/>
<CITE num="24" author="DINWIDDIE R" publication="J ROY SOC MED" d1="79" d2="6" d3="986"/>
<CITE num="25" author="CURRIE DC" publication="BR J DIS CHEST" d1="80" d2="249" d3="986"/>
<CITE num="26" author="WEBBER BA" publication="BR J DIS CHEST" d1="80" d2="353" d3="986"/>
<CITE num="27" author="SUTTON PP" publication="THORAX" d1="42" d2="159" d3="987"/>
<CITE num="28" author="KIM CS" publication="J APPL PHYSIOL" d1="62" d2="959" d3="987"/>
<CITE num="29" author="ANDREASSON B" publication="ACTA PAEDIATR SCAND" d1="76" d2="70" d3="987"/>
</CITATIONS>
<RECORDNUM>01036 </RECORDNUM>
<MEDLINENUM>79146187</MEDLINENUM>
<AUTHORS><AUTHOR>Chapman-J-A</AUTHOR><AUTHOR>Goodall-J</AUTHOR></AUTHORS>
<TITLE>Dying children need help too.</TITLE>
<SOURCE>Br-Med-J. 1979 Mar 3. 1(6163). P 593-4.</SOURCE>
<MAJORSUBJ><TOPIC>CHILD-CARE</TOPIC><TOPIC>TERMINAL-CARE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD-CARE: mt, st</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>TERMINAL-CARE: mt, st</TOPIC></MINORSUBJ>
<EXTRACT>The control of symptoms in dying children is often sadly neglected.
This neglect is reflected in a review of the case notes of two
children who died of cystic fibrosis within three years of each
other.  The girls were under the care of the same consultant, who in
the interval between the two cases was introduced to the concept of
proper terminal care for children.  These two cases show that illness
can cause physical, emotional, and spiritual pain to family and
staff.  In retrospect these areas of distress were not clearly
defined in either case and opportunities to alleviate suffering were
missed.  The principles of controlling symptoms need to be remembered
as much during distressing treatment as during the distress of dying.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79057</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BRETT EM" publication="DEVELOP MED CHILD NEUROL" d1="12" d2="655" d3="970"/>
<CITE num="002" author="SHAFFER D" publication="IN: RUTTER M" d1="" d2="" d3="977"/>
<CITE num="003" author="TWYCROSS RG" publication="IN: SAUNDERS CM" d1="" d2="" d3="978"/>
</REFERENCES>
<RECORDNUM>01037 </RECORDNUM>
<MEDLINENUM>79125271</MEDLINENUM>
<AUTHORS><AUTHOR>Bradley-J-A</AUTHOR><AUTHOR>Axon-A-T</AUTHOR><AUTHOR>Hill-G-L</AUTHOR></AUTHORS>
<TITLE>Nocturnal elemental diet for retarded growth in a patient with
cystic fibrosis.</TITLE>
<SOURCE>Br-Med-J. 1979 Jan 20. 1(6157). P 167.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FOOD-FORMULATED</TOPIC><TOPIC>NUTRITION-DISORDERS: dh</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BODY-WEIGHT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTUBATION-GASTROINTESTINAL</TOPIC><TOPIC>NUTRITION-DISORDERS: et</TOPIC><TOPIC>POTASSIUM: me</TOPIC></MINORSUBJ>
<EXTRACT>The combination of chronic pulmonary sepsis and pancreatic
insufficiency in children with cystic fibrosis may lead to
malnutrition.  We describe our experience of the long-term use of
continuous nocturnal infusion of elemental diet in a patient with
cystic fibrosis.  Our patient tolerated the long-term nocturnal
elemental diet well, and it enabled her to continue normal
everyday activity and eat normal meals.  The periods of nutritional
support coincided with periods of increased body weight and total
body potassium, indicating that the lean body mass was increased.
We think that these results show a need for further studies of home
treatment in children with cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WEIHOFEN DM" publication="J AM DIET ASSOC" d1="54" d2="206" d3="969"/>
<CITE num="002" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="003" author="COUCH R" publication="FED PROC" d1="19" d2="13" d3="960"/>
<CITE num="004" author="ANDRASSY RJ" publication="SURGERY" d1="82" d2="205" d3="977"/>
<CITE num="005" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79058</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ULIN E              CA" publication="N J SURG" d1="25" d2="84 9" d3="2"/>
<CITE num="2" author="WORTHEN DB" publication="DRUG INTEL CLIN PHARM" d1="18" d2="794" d3="984"/>
<CITE num="3" author="BERTRAND JM" publication="J PEDIATR" d1="104" d2="41" d3="984"/>
<CITE num="4" author="SOUTTER VL" publication="CLIN GASTROENTEROL" d1="15" d2="137" d3="986"/>
<CITE num="5" author="MOORE MC" publication="AM J CLIN NUTR" d1="44" d2="33" d3="986"/>
</CITATIONS>
<RECORDNUM>01038 </RECORDNUM>
<MEDLINENUM>80043560</MEDLINENUM>
<AUTHORS><AUTHOR>Zapletal-A</AUTHOR><AUTHOR>Houstek-J</AUTHOR><AUTHOR>Samanek-M</AUTHOR><AUTHOR>Vavrova-V</AUTHOR><AUTHOR>Srajer-J</AUTHOR></AUTHORS>
<TITLE>Lung function abnormalities in cystic fibrosis and changes during
growth.</TITLE>
<SOURCE>Bull-Eur-Physiopathol-Respir. 1979 Jul-Aug. 15(4). P 575-92.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AIRWAY-RESISTANCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FOLLOW-UP-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-COMPLIANCE</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC><TOPIC>LUNG: gd</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Static lung volumes (VC, TLC, FRC, RV), elastic recoil pressure of
the lungs (Pst(1) at 100, 90, and 60% of TLC), static lung compliance
[Cst(1)], specific airway conductance at FRC level (Gaw/TGVex),
forced expiratory volume in the first second (FEV1), maximal
expiratory flows (Vmax.) at 25 and 50% of VC and at 60% of TLC, and
"upstream" airway conductance (Gus) at 60% of TLC were studied in 28
patients with cystic fibrosis, 5 to 25 years old, over a period of 1
to 5 years. The data were compared individually with normal values,
related to body height in the form of regression equations and
expressed in percentage of predicted values. From the indices
assessing airway function, Vmax. at low lung volumes, Gus at 60% TLC,
RV and RV/TLC were the functional parameters most consistently
abnormal. Among the indices characterizing lung elasticity, Pst(1) at
60% TLC was the most abnormal. Generally, the values of the majority
of lung function indices [VC, TLC, FRC, Pst(1)] declined during
growth. Vmax. at all lung volumes and Gus at 60% TLC did not
deteriorate with growth probably due to the great abnormality of
these parameters already in young patients. It was also observed that
lung function did not change significantly over a period of 1 to 5
years corresponding to a 10 cm increase in body height. However, over
that period, lung function improved in some of the subjects, did not
change in over 50% of the cases and deteriorated in the others.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BEIER FR" publication="AM REV RESPIR DIS" d1="94" d2="430" d3="966"/>
<CITE num="002" author="COOK CD" publication="PEDIATRICS" d1="24" d2="181" d3="959"/>
<CITE num="003" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="004" author="DEMUTH GR" publication="AM J DIS CHILD" d1="103" d2="129" d3="962"/>
<CITE num="005" author="FEATHERBY EA" publication="AM REV RESPIR DIS" d1="102" d2="737" d3="970"/>
<CITE num="006" author="GOLDRING RM" publication="J PEDIATR" d1="65" d2="501" d3="964"/>
<CITE num="007" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="963"/>
<CITE num="008" author="HOUSTEK J" publication="PRAKT LEKAR" d1="49" d2="216" d3="969"/>
<CITE num="009" author="HOUSTEK J" publication="VNITR LEK" d1="16" d2="449" d3="970"/>
<CITE num="010" author="LOUGH MD" publication="PEDIATRIC RESPIRATORY THERAPY" d1="" d2="" d3="974"/>
<CITE num="011" author="MANSELL A" publication="AM REV RESPIR DIS" d1="109" d2="190" d3="974"/>
<CITE num="012" author="MEAD J" publication="J APPL PHYSIOL" d1="22" d2="95" d3="967"/>
<CITE num="013" author="MELLINS RB" publication="PEDIATRICS" d1="41" d2="560" d3="968"/>
<CITE num="014" author="NEUBURGER N" publication="AM REV RESPIR DIS" d1="114" d2="753" d3="976"/>
<CITE num="015" author="SAMANEK M" publication="ACTA PAEDIATR SCAND" d1="60" d2="149" d3="971"/>
<CITE num="016" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="017" author="VAVROVA V" publication="CESK PEDIATR" d1="28" d2="528" d3="973"/>
<CITE num="018" author="WILLIAMS HE" publication="RESPIRATORY ILLNESS IN CHILDR" d1="" d2="" d3="975"/>
<CITE num="019" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
<CITE num="020" author="ZAPLETAL A" publication="CESK PEDIATR" d1="31" d2="532" d3="976"/>
<CITE num="021" author="ZAPLETAL A" publication="J APPL PHYSIOL" d1="40" d2="953" d3="976"/>
<CITE num="022" author="ZAPLETAL A" publication="Z ERKR ATMUNGSORGANE" d1="149" d2="343" d3="977"/>
<CITE num="023" author="ZAPLETAL A" publication="CAS LEK CES" d1="113" d2="1225" d3="974"/>
<CITE num="024" author="ZAPLETAL A" publication="CESK PEDIATR" d1="32" d2="513" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79059</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TZ M                EU" publication="R J RESPIR DIS" d1="61" d2="22 9" d3="0"/>
<CITE num="2" author="SOLYMAR L" publication="EUR J RESPIR DIS" d1="61" d2="275" d3="980"/>
<CITE num="3" author="DESWINIARSKI R" publication="BULL EUR PHYSIOPATH RESP" d1="18" d2="39" d3="982"/>
<CITE num="4" author="ZAPLETAL A" publication="EUR J RESPIR DIS" d1="64" d2="426" d3="983"/>
<CITE num="5" author="LEUPOLD W" publication="Z KLIN MED" d1="40" d2="661" d3="985"/>
<CITE num="6" author="ZACH MS" publication="AM REV RESPIR DIS" d1="131" d2="537" d3="985"/>
<CITE num="7" author="WIESEMANN HG" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="726" d3="985"/>
<CITE num="8" author="OBERWALDNER B" publication="PEDIATR PULMONOL" d1="2" d2="358" d3="986"/>
<CITE num="9" author="ANDREASSON B" publication="ACTA PAEDIATR SCAND" d1="76" d2="70" d3="987"/>
</CITATIONS>
<RECORDNUM>01039 </RECORDNUM>
<MEDLINENUM>80021639</MEDLINENUM>
<AUTHORS><AUTHOR>Coates-A-L</AUTHOR><AUTHOR>Boyce-P</AUTHOR><AUTHOR>Muller-D</AUTHOR><AUTHOR>Mearns-M</AUTHOR><AUTHOR>Godfrey-S</AUTHOR></AUTHORS>
<TITLE>The role of nutritional status, airway obstruction, hypoxia and
abnormalities in serum lipid composition in limiting exercise
tolerance in children with cystic fibrosis.</TITLE>
<SOURCE>Bull-Eur-Physiopathol-Respir. 1979 Mar-Apr. 15(2). P 341-2.</SOURCE>
<MAJORSUBJ><TOPIC>AIRWAY-OBSTRUCTION: bl</TOPIC><TOPIC>ANOXIA: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>EXERTION</TOPIC><TOPIC>LIPIDS: bl</TOPIC><TOPIC>NUTRITION-DISORDERS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBON-DIOXIDE: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>HEART-RATE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC><TOPIC>OXYGEN: bl</TOPIC></MINORSUBJ>
<EXTRACT>This study investigated the roles of hypoxia, pulmonary mechanics,
nutritional status and serum fatty acid composition in limiting
exercise tolerance in cystic fibrosis.  Twenty children with CF of
carrying severity performed two progressive exercise tests on a cycle
ergometer, once while breathing air, once while breathing O2. The
children with the lower maximal mid-expiratory flow rates tended to
have very little respiratory reserve at the final work load.  We
conclude that nutritional status and airway obstruction are closely
correlated with exercise tolerance in CF and that, unlike the adult
with chronic obstructive pulmonary disease, exercise limiting
dyspnoea occurs in the presence of normal end-tidal CO2.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79060</PAPERNUM>
<CITATIONS>
<CITE num="1" author="UPOLD W             Z" publication="KLIN MED" d1="40" d2="61 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01040 </RECORDNUM>
<MEDLINENUM>79234522</MEDLINENUM>
<AUTHORS><AUTHOR>Sams-C-A</AUTHOR></AUTHORS>
<TITLE>One breath at a time: a family teaching program for children with
cystic fibrosis.</TITLE>
<SOURCE>Can-Nurse. 1979 Sep. 75(8). P 20-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: rh</TOPIC><TOPIC>PARENTS: ed</TOPIC><TOPIC>PATIENTS: ed</TOPIC><TOPIC>PATIENT-EDUCATION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BREATHING-EXERCISES</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FAMILY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-THERAPY</TOPIC></MINORSUBJ>
<EXTRACT>We have found patients who have cystic fibrosis to be very special
people; they have to overcome apparently insurmountable odds.  Our
teaching program comes from a basic belief that with support,
encouragement and affection, information and a focus on the positive
aspects of life, a person with CF can live well, even if only one
breath at a time.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79061</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="001" author="LEFEBVRE A" publication="DISSERTATION" d1="" d2="" d3="974"/>
<CITE num="002" author="BURNETTE BA" publication="AM J NURS" d1="75" d2="1986" d3="975"/>
<CITE num="002" author="STEINHAUER PD" publication="PEDIATR CLIN NORTH AM" d1="21" d2="825" d3="974"/>
<CITE num="003" author="MCCOLLUM AT" publication="COPING WITH PROLONG HLTH IMP" d1="" d2="" d3="975"/>
<CITE num="004" author="FAKKEM L" publication="AM J NURS" d1="59" d2="1269" d3="959"/>
<CITE num="005" author="LEONARD CO" publication="N ENGL J MED" d1="287" d2="433" d3="972"/>
</REFERENCES>
<RECORDNUM>01041 </RECORDNUM>
<MEDLINENUM>80022554</MEDLINENUM>
<AUTHORS><AUTHOR>Berger-H-J</AUTHOR><AUTHOR>Zaret-B-L</AUTHOR></AUTHORS>
<TITLE>Noninvasive radionuclide assessment of right ventricular performance
in man.</TITLE>
<SOURCE>Cardiovasc-Clin. 1979. 10(2). P 91-104.</SOURCE>
<MAJORSUBJ><TOPIC>HEART-VENTRICLE: ri</TOPIC><TOPIC>RADIONUCLIDE-IMAGING: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp, ri</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>HEART-VENTRICLE: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: pp, ri</TOPIC><TOPIC>MYOCARDIAL-INFARCTION: pp, ri</TOPIC><TOPIC>RESPIRATION</TOPIC><TOPIC>STROKE-VOLUME</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>This chapter focuses on the application of radionuclide
angiocardiography to assessment of right ventricular ejection
fraction and the relationship between right and left heart
performance demonstrated by this technique.  Prior to discussion of
the clinical applications, the functional geometry of the two
ventricles will be reviewed.  In addition, the first-pass radiotracer
techniques will be compared to other radionuclide imaging approaches
of the right heart.  First-pass radionuclide angiocardiographic
techniques are now suitable for clinical application.  They have been
validated and standardized and can be relied upon for accurate,
reproducible noninvasive assessment of right and left ventricular
performance.  They already have been applied to the study of patients
with cardiopulmonary disease; future directions will include earlier
evaluation of myocardial infarction, application to children and
adults with a variety of congenital cardiac abnormalities (primarily
those affecting the right heart), and assessment of the effects of
physiologic stress upon right ventricular function.  With this
background valuable clinical and investigative insights should become
available during the coming years.</EXTRACT>
<REFERENCES>
<CITE num="001" author="STARR I" publication="AM HEART J" d1="26" d2="291" d3="943"/>
<CITE num="002" author="BURROWS B" publication="N ENGL J MED" d1="286" d2="912" d3="972"/>
<CITE num="003" author="PONTOPPIDAN H" publication="N ENGL J MED" d1="287" d2="690" d3="972"/>
<CITE num="004" author="COHN J" publication="AM J CARDIOL" d1="33" d2="209" d3="974"/>
<CITE num="005" author="BERGER HJ" publication="AM J CARDIOL" d1="41" d2="897" d3="978"/>
<CITE num="006" author="ELLIS J" publication="CHEST SUPPL" d1="71" d2="281" d3="977"/>
<CITE num="007" author="FISHER EA" publication="AM J CARDIOL" d1="36" d2="67" d3="975"/>
<CITE num="008" author="ARCILLA R" publication="CHEST" d1="60" d2="446" d3="971"/>
<CITE num="009" author="GRAHAM TP JR" publication="CIRCULATION" d1="47" d2="144" d3="973"/>
<CITE num="010" author="GRAHAM TP JR" publication="CIRCULATION" d1="51" d2="881" d3="975"/>
<CITE num="011" author="GENTZLER R" publication="CIRCULATION" d1="50" d2="324" d3="974"/>
<CITE num="012" author="MARSHALL RC" publication="CIRCULATION" d1="56" d2="820" d3="977"/>
<CITE num="013" author="RUSHMER RF" publication="CARDIOVASCULAR DYNAMICS" d1="" d2="89" d3="976"/>
<CITE num="014" author="FERLINZ J" publication="CIRCULATION" d1="52" d2="608" d3="975"/>
<CITE num="015" author="JAFFE C" publication="CURR PROB RADIOL" d1="4" d2="1" d3="974"/>
<CITE num="016" author="BLUMGART HL" publication="J CLIN INVEST" d1="4" d2="399" d3="927"/>
<CITE num="017" author="PRINZMETAL M" publication="SCIENCE" d1="108" d2="340" d3="948"/>
<CITE num="018" author="VAN DYKE D" publication="J NUCL MED" d1="13" d2="585" d3="972"/>
<CITE num="019" author="WEBER P" publication="J NUCL MED" d1="13" d2="815" d3="972"/>
<CITE num="020" author="SHELBERT H" publication="CIRCULATION" d1="51" d2="902" d3="975"/>
<CITE num="021" author="STEELE P" publication="AM J CARDIOL" d1="34" d2="179" d3="974"/>
<CITE num="022" author="STEELE P" publication="AM J CARDIOL" d1="37" d2="388" d3="976"/>
<CITE num="023" author="ELLIS J" publication="CHEST" d1="69" d2="575" d3="976"/>
<CITE num="024" author="STEELE P" publication="CHEST" d1="70" d2="51" d3="976"/>
<CITE num="025" author="TOBINICK E" publication="CIRCULATION SUPPL" d1="56" d2="140" d3="977"/>
<CITE num="026" author="MARSHALL RC" publication="AM J CARDIOL" d1="41" d2="531" d3="978"/>
<CITE num="027" author="BERGER HJ" publication="CLIN RES" d1="25" d2="209A" d3="977"/>
<CITE num="028" author="BORKOWSKI H" publication="CIRCULATION SUPPL" d1="56" d2="198" d3="977"/>
<CITE num="029" author="STEELE P" publication="AM J MED" d1="59" d2="21" d3="975"/>
<CITE num="030" author="KLINE L" publication="CHEST" d1="72" d2="5" d3="977"/>
<CITE num="031" author="MATTHAY R" publication="AM HEART J" d1="92" d2="730" d3="976"/>
<CITE num="032" author="MATTHAY R" publication="CHEST" d1="72" d2="407" d3="977"/>
<CITE num="033" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="034" author="YATER WM" publication="AM HEART J" d1="36" d2="683" d3="948"/>
<CITE num="035" author="ERHARDT L" publication="ACTA MED SCAND SUPPL" d1="560" d2="1" d3="974"/>
<CITE num="036" author="SHARPE N" publication="CIRCULATION SUPPL 2" d1="54" d2="76" d3="976"/>
<CITE num="037" author="BUSEMAN SOKOLE E" publication="CIRCULATION SUPPL 3" d1="56" d2="62" d3="977"/>
<CITE num="038" author="REDUTO L" publication="ANN INTERN MED" d1="89" d2="441" d3="978"/>
<CITE num="039" author="RIGO P" publication="CIRCULATION" d1="52" d2="268" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79062</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VAN S               VA" publication="SC SURG" d1="18" d2="72 9" d3="4"/>
<CITE num="2" author="DETRANO R" publication="J AM COLL CARDIOL" d1="5" d2="1377" d3="985"/>
<CITE num="3" author="DEC GW" publication="N ENGL J MED" d1="312" d2="885" d3="985"/>
</CITATIONS>
<RECORDNUM>01042 </RECORDNUM>
<MEDLINENUM>79126800</MEDLINENUM>
<AUTHORS><AUTHOR>Hoogkamp-Korstanje-J-A</AUTHOR><AUTHOR>Westerdaal-N-A</AUTHOR></AUTHORS>
<TITLE>In vitro susceptibility of pseudomonas to four
beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin,
piperacillin), to four aminoglycosides (kanamycin, amikacin,
gentamicin, tobramycin) and to colimycin.</TITLE>
<SOURCE>Chemotherapy. 1979. 25(1). P 48-53.</SOURCE>
<MAJORSUBJ><TOPIC>AMINOGLYCOSIDES: pd</TOPIC><TOPIC>CEPHALOTHIN: pd</TOPIC><TOPIC>COLISTIN: pd</TOPIC><TOPIC>PENICILLINS: pd</TOPIC><TOPIC>PSEUDOMONAS: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMIKACIN: pd</TOPIC><TOPIC>AMPICILLIN: pd</TOPIC><TOPIC>CARBENICILLIN: pd</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>GENTAMICINS: pd</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KANAMYCIN: pd</TOPIC><TOPIC>MICROBIAL-SENSITIVITY-TESTS</TOPIC><TOPIC>SPUTUM: mi</TOPIC><TOPIC>TOBRAMYCIN: pd</TOPIC></MINORSUBJ>
<ABSTRACT>Of 97 well-defined strains of Pseudomonas, isolated from sputum of
patients with cystic fibrosis (CF), the minimum inhibitory
concentration (MIC) of several antibiotics was determined with a
broth dilution method. The majority of the strains were resistant to
ampicillin and cephalothin, moderately susceptible to carbenicillin
(70% to 100 microgram/ml) and highly susceptible to piperacillin
(100% to 25 microgram/ml, 88% to 6.25 microgram and 60% to 3.12
microgram/ml). If the pharmacological properties of piperacillin are
comparable with those of carbenicillin, it can be expected that the
sputum level of this drug will be adequate to treat Pseudomonas
pulmonary infections. At the lowest concentration tested (0.78
microgram/ml) 3% of the strains were susceptible to kanamycin, 85,5%
to amikacin, 95% to gentamicin, 98% of tobramycin, and 80% to
colimycin. With regard to clinically attainable concentrations, 98.9%
of the strains were susceptible to gentamicin and tobramycin 97.9% to
amikacin, 96.9% to colimycin, 88.6%  to piperacillin, 38% to
carbenicillin, 25.7% to kanamycin, 12.3% to ampicillin, and 1% to
cephalothin.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BLAIR JE" publication="MANUAL OF CLINICAL MICROBIOLO" d1="" d2="" d3="970"/>
<CITE num="002" author="BOXERBAUM B" publication="J INFECT DIS SUPPL" d1="122" d2="59" d3="970"/>
<CITE num="003" author="BOXERBAUM B" publication="J INFECT DIS SUPPL" d1="124" d2="293" d3="971"/>
<CITE num="004" author="COWAN ST" publication="MANUAL FOR THE IDENTIFICATION" d1="" d2="" d3="973"/>
<CITE num="005" author="ERICSSON HM" publication="ACTA PATH MICROBIOL SCAND" d1="S217" d2="" d3="971"/>
<CITE num="006" author="MARKS MI" publication="J PEDIATR" d1="79" d2="822" d3="971"/>
<CITE num="007" author="MONROE PW" publication="APPL MICROBIOL" d1="18" d2="214" d3="969"/>
<CITE num="008" author="PENNINGTON JE" publication="ANTIMICROB AGENTS CHEMOTHER" d1="4" d2="299" d3="973"/>
<CITE num="009" author="PHAIR JP" publication="AM J DIS CHILD" d1="120" d2="22" d3="970"/>
<CITE num="010" author="REYNOLDS AV" publication="BR MED J" d1="3" d2="778" d3="974"/>
<CITE num="011" author="SAGGERS BA" publication="ARCH DIS CHILD" d1="43" d2="404" d3="968"/>
<CITE num="012" author="WOOD RE" publication="PSEUDOMONAS INFECTION IN CF P" d1="" d2="" d3="975"/>
<CITE num="013" author="ZIERDT CH" publication="J CLIN MICROBIOL" d1="1" d2="521" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79063</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OGKAMPKORSTANJE JAA J" publication="ANTIMICROB CHEMOTHER" d1="8" d2="01 9" d3="1"/>
<CITE num="2" author="HOOGKAMPKORSTANJE JAA" publication="INFECTION" d1="10" d2="S257" d3="982"/>
<CITE num="3" author="HOOGKAMPKORSTANJE JAA" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="175" d3="983"/>
<CITE num="4" author="SEGNI G" publication="CURR THER RES CLIN EXP" d1="33" d2="265" d3="983"/>
</CITATIONS>
<RECORDNUM>01043 </RECORDNUM>
<MEDLINENUM>79190706</MEDLINENUM>
<AUTHORS><AUTHOR>Allen-H-D</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR><AUTHOR>Gaines-J-A</AUTHOR><AUTHOR>Sahn-D-J</AUTHOR><AUTHOR>Goldberg-S-J</AUTHOR></AUTHORS>
<TITLE>Echocardiographic profiles of the long-term cardiac changes in
cystic fibrosis.</TITLE>
<SOURCE>Chest. 1979 Apr. 75(4). P 428-33.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>ECHOCARDIOGRAPHY</TOPIC><TOPIC>HEART-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AORTIC-DISEASES: di, et</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEART-DISEASES: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>In this echocardiographic study, assessment of the heart in children
with cystic fibrosis has shown that changes occur in not only the
right ventricle but also in the left ventricle and aorta, as compared
with normal. Echocardiograms could be successfully performed in 34 of
37 patients. The thickness of the right ventricular anterior wall and
the dimension of the right ventricular cavity  were abnormal, even in
patients with mild disease (National Institutes of Health [NIH] score
for severity of disease of 85 or greater). Larger, older children
with lower NIH score had disproportionately larger right ventricular
anterior walls and cavities. The thickness of the septal wall, the
thickness of the left ventricular posterior wall, and the aortic
dimensions were increased in those with severe disease. The
dimensions of the left ventricular cavity for the population were
slightly but significantly smaller than normal in systole and in
diastole throughout the course of the disease. This study
demonstrates that echocardiography is an effective noninvasive means
of assessing the long-term changes in children with cystic fibrosis.
These changes occur in both sides of the heart and appear to worsen
as the disease progresses.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="CIRCULATION" d1="27" d2="594" d3="963"/>
<CITE num="002" author="LIEBMAN J" publication="CHEST" d1="63" d2="218" d3="973"/>
<CITE num="003" author="RYLAND D" publication="THORAX" d1="30" d2="285" d3="975"/>
<CITE num="004" author="SIASSI B" publication="J PEDIATR" d1="78" d2="794" d3="971"/>
<CITE num="005" author="MOSS AJ" publication="J PEDIATR" d1="67" d2="797" d3="965"/>
<CITE num="006" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="007" author="WARSHAWSKY JK" publication="IN: KULCZYCKI LL" d1="" d2="16" d3="974"/>
<CITE num="008" author="GEWITZ M" publication="AM J DIS CHILD" d1="131" d2="275" d3="977"/>
<CITE num="009" author="ROSENTHAL A" publication="PEDIATR CLIN NORTH AM" d1="23" d2="327" d3="976"/>
<CITE num="010" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="011" author="GOLDBERG SJ" publication="PEDIATRIC AND ADOLESCENT ECHO" d1="" d2="" d3="975"/>
<CITE num="012" author="ALLEN HD" publication="WORKBOOK IN PEDIATRIC ECHOCAR" d1="" d2="" d3="978"/>
<CITE num="013" author="EPSTEIN ML" publication="CIRCULATION" d1="51" d2="1124" d3="975"/>
<CITE num="014" author="GRIFFITH JM" publication="IEEE TRANS BIOMED ENG" d1="22" d2="337" d3="975"/>
<CITE num="015" author="ROYCE SW" publication="PEDIATRICS" d1="8" d2="255" d3="951"/>
<CITE num="016" author="LARTER WE" publication="CIRCULATION" d1="53" d2="19" d3="976"/>
<CITE num="017" author="WEYMAN AE" publication="CIRCULATION" d1="54" d2="179" d3="976"/>
<CITE num="018" author="STEELE P" publication="AM J MED" d1="59" d2="21" d3="975"/>
<CITE num="019" author="MITCHELL RS" publication="AM REV RESPIR DIS" d1="114" d2="147" d3="976"/>
<CITE num="020" author="WILLIAMS JF JR" publication="J CLIN INVEST" d1="47" d2="1143" d3="968"/>
<CITE num="021" author="KOUNTZ WB" publication="AM HEART J" d1="11" d2="163" d3="936"/>
<CITE num="022" author="SCOTT RW" publication="AM HEART J" d1="22" d2="56" d3="941"/>
<CITE num="023" author="MICHELSON N" publication="DIS CHEST" d1="38" d2="435" d3="960"/>
<CITE num="024" author="FLUCK DC" publication="BR HEART J" d1="28" d2="92" d3="966"/>
<CITE num="025" author="RAO BS" publication="AM J MED" d1="45" d2="229" d3="968"/>
<CITE num="026" author="BAUM GL" publication="N ENGL J MED" d1="285" d2="361" d3="971"/>
<CITE num="027" author="FULTON RM" publication="BR HEART J" d1="14" d2="413" d3="952"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79064</PAPERNUM>
<CITATIONS>
<CITE num="1" author="STER LA             J" publication="PEDIATR" d1="97" d2="42 9" d3="0"/>
<CITE num="2" author="FRANCIS PWJ" publication="AM J DIS CHILD" d1="134" d2="734" d3="980"/>
<CITE num="3" author="JACOBSTEIN MD" publication="CHEST" d1="80" d2="399" d3="981"/>
<CITE num="4" author="MOSS AJ" publication="PEDIATRICS" d1="70" d2="728" d3="982"/>
<CITE num="5" author="TEPPER RS" publication="CHEST" d1="84" d2="388" d3="983"/>
<CITE num="6" author="CHERON G" publication="ACTA PAEDIATR SCAND" d1="73" d2="697" d3="984"/>
<CITE num="7" author="MICHAEL JR" publication="AM REV RESPIR DIS" d1="130" d2="516" d3="984"/>
<CITE num="8" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
</CITATIONS>
<RECORDNUM>01044 </RECORDNUM>
<MEDLINENUM>79168494</MEDLINENUM>
<AUTHORS><AUTHOR>Lieberman-J</AUTHOR><AUTHOR>Kaneshiro-W</AUTHOR></AUTHORS>
<TITLE>Lymphocytic acid-hydrolases and response to mitogens in cystic
fibrosis.</TITLE>
<SOURCE>Chest. 1979 Feb. 75(2 Suppl). P 220-3.</SOURCE>
<MAJORSUBJ><TOPIC>ACID-PHOSPHATASE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLYCOSIDE-HYDROLASES: bl</TOPIC><TOPIC>LYMPHOCYTES: en</TOPIC><TOPIC>MITOGENS: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLGLUCOSAMINIDASE: bl</TOPIC><TOPIC>AMYLASES: bl</TOPIC><TOPIC>BETA-GALACTOSIDASES: bl</TOPIC><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CULTURE-MEDIA</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FUCOSIDASE: bl</TOPIC><TOPIC>GLUCOSIDASES: bl</TOPIC><TOPIC>GLUCURONIDASE: bl</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MANNOSIDASES: bl</TOPIC><TOPIC>STIMULATION-CHEMICAL</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>XYLOSIDASES: bl</TOPIC></MINORSUBJ>
<EXTRACT>In the present study, we compared the levels of a series of cultured
lymphocytic acid-hydrolase enzymes in cystic fibrosis homozygotes,
heterozygotes and controls; compared the effects of three different
mitogens on these levels; and studied the effect of CF vs control
serum in the culture medium.  Our observations provide an entirely
new interpretation for the apparent changes occurring in lymphocytic
enzymes during culture of lymphocytes with mitogens, and suggest that
a serum factor is present in cystic fibrosis serum that mimics
mitogens in this regard.  Lymphocytic acid-hydrolases and total
protein are present in higher concentrations in lymphocytes cultured
for 48 hours without mitogen when CF homozygous or heterozygous serum
is present in the culture media.  This appears to result from a CF
serum factor that has mitogen-like activity and prevents loss of cell
protein during culture.  Responsiveness of the cellular proteins to
mitogens is blunted when CF serum is present in the culture media,
either because the cell proteins are already maximally stimulated by
the CF serum factor, or the factor blocks or modifies the action of
mitogens on lymphocyte protein content.  This phenomenon is useful
for detection of CF heterozygosity, and appears to reflect the
genetic abnormality causing cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="002" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="116" d2="1047" d3="977"/>
<CITE num="003" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79065</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ALE TW              AN" publication="N CLIN LAB SCI" d1="12" d2="15 9" d3="2"/>
</CITATIONS>
<RECORDNUM>01045 </RECORDNUM>
<MEDLINENUM>79190766</MEDLINENUM>
<AUTHORS><AUTHOR>Weng-T-R</AUTHOR><AUTHOR>Spence-J-A</AUTHOR><AUTHOR>Polgar-G</AUTHOR><AUTHOR>Nyboer-J</AUTHOR></AUTHORS>
<TITLE>Measurement of regional lung function by tetrapolar electrical
impedance plethysmography.</TITLE>
<SOURCE>Chest. 1979 Jul. 76(1). P 64-9.</SOURCE>
<MAJORSUBJ><TOPIC>PLETHYSMOGRAPHY-IMPEDANCE: mt</TOPIC><TOPIC>PULMONARY-CIRCULATION</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>ELECTRODES</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEART-DEFECTS-CONGENITAL: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PLETHYSMOGRAPHY-IMPEDANCE: is</TOPIC><TOPIC>PULMONARY-VEINS: ab</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS: is</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: pp</TOPIC><TOPIC>VENTILATION-PERFUSION-RATIO</TOPIC></MINORSUBJ>
<ABSTRACT>This study demonstrates the clinical feasibility of atraumatically
measuring dynamic regional lung function with tetrapolar electrical
impedance plethysmography (EIP) in the pediatric age group. A
tetrapolar electrode system was used because of its ability to detect
local baseline and pulsatile impedance changes, minimal electrode-
tissue impedance interference, and uniform current distribution.
Studies performed on 4 children 4 to 15 years old with various
pulmonary diseases are presented. The information obtained on their
regional ventilation and pulsatile perfusion by EIP was found to
agree closely with pulmonary ventilation and perfusion scans. In one
case, EIP detected pulsatile perfusion abnormalities which were not
apparent in the non-pulsatile perfusion scan but were demonstrated by
cineangiography. It is concluded that tetrapolar EIP can provide
safe, reliable regional information about ventilation and perfusion
in diseased lungs, and because of its atraumatic approach, is
technically most suitable for use in children.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="OLSSON T" publication="ACTA PAEDIATR SCAND SUPPL 20" d1="" d2="390" d3="970"/>
<CITE num="002" author="VAN DE WATER JM" publication="CHEST" d1="64" d2="598" d3="973"/>
<CITE num="003" author="POMERANTZ M" publication="ANN SURG" d1="171" d2="686" d3="970"/>
<CITE num="004" author="LABABIDI Z" publication="PEDIATRICS" d1="47" d2="870" d3="971"/>
<CITE num="005" author="HOON RS" publication="BR HEART J" d1="39" d2="61" d3="977"/>
<CITE num="006" author="DENNISTON JC" publication="J APPL PHYSIOL" d1="19" d2="166" d3="964"/>
<CITE num="007" author="ALLISON RD" publication="J APPL PHYSIOL" d1="19" d2="166" d3="964"/>
<CITE num="008" author="NYBOER J" publication="PROC INT CONG OF BIOL 2ND" d1="" d2="216" d3="976"/>
<CITE num="009" author="SPENCE JA" publication="PEDIATR RES ABST" d1="11" d2="579" d3="977"/>
<CITE num="010" author="POLGAR G" publication="CF CLUB ABST" d1="" d2="4" d3="978"/>
<CITE num="011" author="NYBOER J" publication="PROC INT CONG OF BIOL 2ND" d1="" d2="5" d3="976"/>
<CITE num="012" author="NYBOER J" publication="ELECTRICAL IMPEDANCE PLETHYSM" d1="" d2="390" d3="970"/>
<CITE num="013" author="NYBOER J" publication="PROC J SOC CLIN INVEST" d1="19" d2="963" d3="940"/>
<CITE num="014" author="NYBOER J" publication="ANN NY ACAD SCI" d1="170" d2="421" d3="970"/>
<CITE num="015" author="KAUFMAN SS" publication="NAT RES COUNC COMM AVIAT" d1="" d2="1" d3="944"/>
<CITE num="016" author="GOLDENSOHN ES" publication="J APPL PHYSIOL" d1="14" d2="463" d3="959"/>
<CITE num="017" author="GEDDES LA" publication="PRINCIPLES OF APPL BIOMEDICAL" d1="" d2="616" d3="975"/>
<CITE num="018" author="KUBICEK WG" publication="AEROSP MED" d1="37" d2="1208" d3="966"/>
<CITE num="019" author="NYBOER J" publication="HARPER HOSP BULL" d1="22" d2="232" d3="964"/>
<CITE num="020" author="NYBOER J" publication="AM J ROENTG RAD THER NUCL MED" d1="98" d2="497" d3="966"/>
<CITE num="021" author="KIRA S" publication="JAPAN HEART J" d1="11" d2="149" d3="970"/>
<CITE num="022" author="KAWAKAMI K" publication="MED BIOL ENG" d1="11" d2="460" d3="973"/>
<CITE num="023" author="KAWAKAMI K" publication="J RADIOL ELECTROL MED NUCL" d1="54" d2="135" d3="973"/>
<CITE num="024" author="WELTMAN G" publication="ANN BIOMED ENG" d1="1" d2="69" d3="972"/>
<CITE num="025" author="SCHRAIBMAN IG" publication="BR J SURG" d1="63" d2="413" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79066</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNEY BC             CR" publication="C CRIT REV BIOMED ENG" d1="13" d2="27 9" d3="6"/>
<CITE num="2" author="WENG TR" publication="AVIAT SPACE ENVIRON MED" d1="57" d2="449" d3="986"/>
</CITATIONS>
<RECORDNUM>01046 </RECORDNUM>
<MEDLINENUM>79190761</MEDLINENUM>
<AUTHORS><AUTHOR>Keens-T-G</AUTHOR><AUTHOR>Mansell-A</AUTHOR><AUTHOR>Krastins-I-R</AUTHOR><AUTHOR>Levison-H</AUTHOR><AUTHOR>Bryan-A-C</AUTHOR><AUTHOR>Hyland-R-H</AUTHOR><AUTHOR>Zamel-N</AUTHOR></AUTHORS>
<TITLE>Evaluation of the single-breath diffusing capacity in asthma and
cystic fibrosis.</TITLE>
<SOURCE>Chest. 1979 Jul. 76(1). P 41-4.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: di</TOPIC><TOPIC>CARBON-MONOXIDE: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>PULMONARY-DIFFUSING-CAPACITY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AIRWAY-OBSTRUCTION: pp</TOPIC><TOPIC>ASTHMA: pp</TOPIC><TOPIC>BRONCHODILATOR-AGENTS: du</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MICROCIRCULATION</TOPIC><TOPIC>PULMONARY-CIRCULATION</TOPIC></MINORSUBJ>
<ABSTRACT>To explain why the single-breath carbon monoxide diffusing capacity
(Dsb) was, on the average, elevated in 163 asthmatic subjects and 175
patients with cystic fibrosis, we simulated this elevation in ten
normal subjects by having them perform the test for Dsb through an
inspiratory obstruction. This resulted in an 18 percent increase in
Dsb corrected for pulmonary volume. Inhalation of a bronchodilator
drug was associated with relief of obstruction and a fall in the
corrected Dsb in 31 asthmatic subjects but did not change either the
obstruction or the corrected Dsb in 17 patients with cystic fibrosis.
We suggest that elevated Dsb in asthma and cystic fibrosis is partly
due to maximal inspiration against obstructed airways. This requires
abnormally negative intrathoracic pressures, increasing the pulmonary
capillary blood volume, and, thereby, increasing the Dsb.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WENG TR" publication="AM REV RESPIR DIS" d1="99" d2="719" d3="969"/>
<CITE num="002" author="OGILVIE CM" publication="BR MED J" d1="1" d2="768" d3="968"/>
<CITE num="003" author="EVANS CC" publication="LANCET" d1="1" d2="891" d3="968"/>
<CITE num="004" author="COTES JE" publication="J APPL PHYSIOL" d1="15" d2="372" d3="960"/>
<CITE num="005" author="STEINER SH" publication="J CLIN INVEST" d1="44" d2="1623" d3="965"/>
<CITE num="006" author="SMITH TC" publication="J APPL PHYSIOL" d1="27" d2="826" d3="969"/>
<CITE num="007" author="OGILVIE CM" publication="J CLIN INVEST" d1="36" d2="1" d3="957"/>
<CITE num="008" author="ROUGHTON FJM" publication="J APPL PHYSIOL" d1="11" d2="290" d3="957"/>
<CITE num="009" author="CAREL RS" publication="ISR J MED SCI" d1="9" d2="1535" d3="973"/>
<CITE num="010" author="PECORA LJ" publication="J ALLERGY" d1="37" d2="204" d3="966"/>
<CITE num="011" author="WAGNER PD" publication="J APPL PHYSIOL" d1="31" d2="847" d3="971"/>
<CITE num="012" author="HYATT RE" publication="J APPL PHYSIOL" d1="21" d2="477" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79067</PAPERNUM>
<CITATIONS>
<CITE num="1" author="INBERGER SE         CH" publication="EST" d1="78" d2="83 9" d3="0"/>
<CITE num="2" author="DAVIES NJH" publication="BR J DIS CHEST" d1="76" d2="105" d3="982"/>
<CITE num="3" author="RUSSELL NJ" publication="BR J DIS CHEST" d1="76" d2="35" d3="982"/>
<CITE num="4" author="OBRODOVICH HM" publication="AM REV RESPIR DIS" d1="125" d2="670" d3="982"/>
<CITE num="5" author="OGILVIE C" publication="THORAX" d1="38" d2="5" d3="983"/>
<CITE num="6" author="COTTON DJ" publication="RESPIR PHYSIOL" d1="54" d2="19" d3="983"/>
<CITE num="7" author="GRAHAM BL" publication="AM REV RESPIR DIS" d1="129" d2="403" d3="984"/>
<CITE num="8" author="COTTON DJ" publication="CHEST" d1="87" d2="217" d3="985"/>
<CITE num="9" author="PAOLETTI P" publication="AM REV RESPIR DIS" d1="132" d2="806" d3="985"/>
<CITE num="10" author="LEBECQUE P" publication="CHEST" d1="91" d2="693" d3="987"/>
</CITATIONS>
<RECORDNUM>01047 </RECORDNUM>
<MEDLINENUM>79126767</MEDLINENUM>
<AUTHORS><AUTHOR>Hirschfeld-S-S</AUTHOR><AUTHOR>Fleming-D-G</AUTHOR><AUTHOR>Doershuk-C</AUTHOR><AUTHOR>Liebman-J</AUTHOR></AUTHORS>
<TITLE>Echocardiographic abnormalities in patients with cystic fibrosis.</TITLE>
<SOURCE>Chest. 1979 Mar. 75(3). P 351-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>ECHOCARDIOGRAPHY</TOPIC><TOPIC>HEART: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEART-FAILURE-CONGESTIVE: di, et, pp</TOPIC><TOPIC>HEART-VENTRICLE: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MYOCARDIAL-CONTRACTION</TOPIC><TOPIC>RESIDUAL-VOLUME</TOPIC><TOPIC>SYSTOLE</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>An echographic study was undertaken to evaluate left (LV) and right
ventricular (RV) function in 30 patients with cystic fibrosis.
Echographic recording of the pulmonary and aortic valve echogram
permitted measurement of the phases of right and left ventricular
systole. The ratio of the LV preejection period/LV ejection time
(LPEP/LVET) and shortening of the LV internal dimension %SID was
employed to reflect LV function, while RV preejection period/RV
ejection time (RPEP/RVET) has excellent correlation with pulmonary
artery diastolic pressure. RPEP/RVET and two other echographic
measurements, right ventricular wall (RVW) and internal dimension
(RVD) were compared with pulmonary function tests and clinical
scores. RPEP/RVET correlated well with percent vital capacity(%VC), r
= -0.73, percent residual volume (%RVol) r = +0.72, and clinical
score, r = -0.77. Multilinear regression of RPEP/RVET, RVD, and RVW
improved correlation for %VC (r = -0.80), %RVol, r = +0.82, and
clinical score, r = -0.84. Patients in overt right heart failure
exhibited elevated RPEP/RVET (mean = 0.48) when compared to patients
not in right heart failure (mean = .33). Marked diminution of LV
function was present in two patients. A variety of cardiovascular
abnormalities were demonstrated echographically and were valuable in
assessing the degree of cardiac involvement in patients with cystic
fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LIEBMAN J" publication="IN: MANGOS JA" d1="" d2="41" d3="976"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="SIASSI B" publication="J PEDIATR" d1="78" d2="794" d3="971"/>
<CITE num="004" author="GOLDRING RM" publication="J PEDIATR" d1="65" d2="501" d3="964"/>
<CITE num="005" author="THOMAS AJ" publication="BR HEART J" d1="34" d2="653" d3="972"/>
<CITE num="006" author="LIEBMAN J" publication="CIRCULATION" d1="35" d2="552" d3="967"/>
<CITE num="007" author="ROSENTHAL A" publication="PEDIATR CLIN NORTH AM" d1="23" d2="327" d3="976"/>
<CITE num="008" author="RYSSING E" publication="ACTA PAEDIATR SCAND" d1="66" d2="753" d3="977"/>
<CITE num="009" author="GEWITZ M" publication="AM J DIS CHILD" d1="131" d2="275" d3="977"/>
<CITE num="010" author="HIRSCHFELD S" publication="CIRCULATION" d1="51" d2="304" d3="975"/>
<CITE num="011" author="HIRSCHFELD S" publication="CIRCULATION" d1="52" d2="641" d3="975"/>
<CITE num="012" author="RIGGS T" publication="CIRCULATION" d1="57" d2="939" d3="978"/>
<CITE num="013" author="WEISSLER AM" publication="IN: YU PN" d1="1" d2="155" d3="972"/>
<CITE num="014" author="FORTUIN NJ" publication="CIRCULATION" d1="46" d2="26" d3="972"/>
<CITE num="015" author="HELLIESEN PJ" publication="PEDIATRICS" d1="22" d2="80" d3="958"/>
<CITE num="016" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="017" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="018" author="GALANT SP" publication="PEDIATRICS" d1="61" d2="46" d3="978"/>
<CITE num="019" author="MEYER RA" publication="ECHOCARDIOGRAPHY" d1="" d2="257" d3="977"/>
<CITE num="020" author="GUTGESELL HP" publication="CIRCULATION" d1="56" d2="457" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79068</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TTHAY RA            BR" publication="HEART J" d1="43" d2="74 9" d3="0"/>
<CITE num="2" author="LESTER LA" publication="J PEDIATR" d1="97" d2="742" d3="980"/>
<CITE num="3" author="FRANCIS PWJ" publication="AM J DIS CHILD" d1="134" d2="734" d3="980"/>
<CITE num="4" author="BERGER HJ" publication="AM J CARDIOL" d1="47" d2="950" d3="981"/>
<CITE num="5" author="JACOBSTEIN MD" publication="CHEST" d1="80" d2="399" d3="981"/>
<CITE num="6" author="NEWTH CJL" publication="AM REV RESPIR DIS" d1="124" d2="463" d3="981"/>
<CITE num="7" author="MOSS AJ" publication="PEDIATRICS" d1="70" d2="728" d3="982"/>
<CITE num="8" author="HIRSCHFELD SS" publication="CHEST" d1="82" d2="524" d3="982"/>
<CITE num="9" author="MATTHAY RA" publication="CLIN CHEST MED" d1="4" d2="269" d3="983"/>
<CITE num="10" author="MATTHAY RA" publication="CRIT CARE MED" d1="11" d2="329" d3="983"/>
<CITE num="11" author="MACDONALD NE" publication="J PEDIATR" d1="103" d2="985" d3="983"/>
<CITE num="12" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="13" author="BENSON LN" publication="AM REV RESPIR DIS" d1="130" d2="987" d3="984"/>
<CITE num="14" author="MOSKOWITZ WB" publication="PEDIATR PHARMACOL" d1="5" d2="139" d3="985"/>
<CITE num="15" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="16" author="PANIDIS IP" publication="J AM COLL CARDIOL" d1="6" d2="701" d3="985"/>
<CITE num="17" author="PIEPSZ A" publication="PEDIATR PULMONOL" d1="3" d2="24" d3="987"/>
</CITATIONS>
<RECORDNUM>01048 </RECORDNUM>
<MEDLINENUM>80090384</MEDLINENUM>
<AUTHORS><AUTHOR>Price-J-F</AUTHOR><AUTHOR>Weller-P-H</AUTHOR><AUTHOR>Harper-S-A</AUTHOR><AUTHOR>Matthew-D-J</AUTHOR></AUTHORS>
<TITLE>Response to bronchial provocation and exercise in children with
cystic fibrosis.</TITLE>
<SOURCE>Clin-Allergy. 1979 Nov. 9(6). P 563-70.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: et</TOPIC><TOPIC>BRONCHIAL-PROVOCATION-TESTS</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ASPERGILLUS-FUMIGATUS: im</TOPIC><TOPIC>ASTHMA: di</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>EXERTION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SKIN-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>Ten of fifteen cystic fibrosis children with positive skin prick
tests to common antigens gave an immediate bronchial reaction to the
antigen inhaled, five of them also gave a late reaction; however only
one gave a history of asthma. The antigen most commonly eliciting a
positive skin reaction in cystic fibrosis patients is Aspergillus
fumigatus. In six children tested to this antigen the bronchial
response varied, two were negative, one gave an immediate reaction
and three gave a dual (immediate and late) reaction. None of the
children showed the characteristic pattern of response to exercise
seen in asthmatic patients, an initial rise in Peak Expiratory Flow
Rate followed by a fall of greater than 14% below the resting level.
Two patients showed an abnormal rise in Peak Expiratory Flow Rate
during exercise, a pattern described previously in cystic fibrosis.
The results suggest that bronchial allergy, immediate or late does
completely explain susceptibility to asthma, and that other factors
including perhaps the type of bronchial reactivity shown by
bronchoconstriction after exercise may be required. However the
majority of the children tested had bronchial allergy and anti-
allergy therapy such as inhaled sodium cromoglycate may have a place
in the management of selected patients with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="002" author="ANDERSON SD" publication="THESIS" d1="" d2="" d3="972"/>
<CITE num="003" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="004" author="COGSWELL JJ" publication="BR J DIS CHEST" d1="69" d2="177" d3="975"/>
<CITE num="005" author="COGSWELL JJ" publication="BR J DIS CHEST" d1="69" d2="177" d3="975"/>
<CITE num="006" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="007" author="GODFREY RC" publication="CLIN ALLERGY" d1="6" d2="79" d3="976"/>
<CITE num="008" author="GODFREY S" publication="EXERCISE TESTING IN CHILDREN" d1="" d2="" d3="974"/>
<CITE num="009" author="KONIG P" publication="ARCH DIS CHILD" d1="48" d2="513" d3="973"/>
<CITE num="010" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="011" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="012" author="MEARNS MB" publication="LANCET" d1="1" d2="538" d3="967"/>
<CITE num="013" author="MEARNS MB" publication="THORAX" d1="20" d2="385" d3="965"/>
<CITE num="014" author="ORES CN" publication="CF CLUB ABST" d1="16" d2="48" d3="975"/>
<CITE num="015" author="PRICE JF" publication="PROC INT CF CONG 7TH" d1="" d2="253" d3="976"/>
<CITE num="016" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="017" author="SILVERMAN M" publication="ARCH DIS CHILD" d1="53" d2="873" d3="978"/>
<CITE num="018" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="019" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="020" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="021" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="022" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79069</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNE R               CL" publication="IN ALLERGY" d1="15" d2="55 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01049 </RECORDNUM>
<MEDLINENUM>79190129</MEDLINENUM>
<AUTHORS><AUTHOR>Ganier-M</AUTHOR><AUTHOR>Lieberman-P</AUTHOR></AUTHORS>
<TITLE>IgE mediated hypersensitivity to pancreatic extract (PE) in parents
of cystic fibrosis (CF) children.</TITLE>
<SOURCE>Clin-Allergy. 1979 Mar. 9(2). P 125-32.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DRUG-HYPERSENSITIVITY: im</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: ci</TOPIC><TOPIC>PANCREATIC-EXTRACTS: ae</TOPIC><TOPIC>PARENTS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ANTIGENIC-DETERMINANTS</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>DRUG-HYPERSENSITIVITY: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HISTAMINE-LIBERATION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: co</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>IMMUNIZATION-PASSIVE</TOPIC><TOPIC>RADIOALLERGOSORBENT-TEST</TOPIC><TOPIC>SKIN-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>On exposure to pancreatic extract (PE), four parents of cystic
fibrosis (CF) children developed immediate hypersensitivity-like
symptoms: i.e. rhinoconjunctivitis, asthma, and/or anaphylaxis. IgE
to PE was demonstrated in the subjects by skin testing, leucocyte
histamine release and radioallergosorbent test (RAST). No serum
precipitating antibodies were found. Bronchial challenge caused an
immediate asthmatic response. No delayed asthmatic response or
hypersensitivity pneumonitis-like reaction occurred. The responsible
antigen for PE induced asthma is unknown; trypsin failed to inhibit
PE-RAST and is therefore not responsible in these subjects. Caution
should be exercised in using PE for skin testing and bronchial
challenge in subjects with suspected hypersensitivity to PE. Certain
measures were found useful in preventing the occurrence of symptoms
in the four subjects.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ABERNATHY RS" publication="PEDIATRICS" d1="56" d2="141" d3="975"/>
<CITE num="002" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="003" author="BATES DV" publication="J CANADA" d1="18" d2="211" d3="962"/>
<CITE num="004" author="BERGNER A" publication="PEDIATRICS" d1="55" d2="814" d3="975"/>
<CITE num="005" author="BERNSTEIN IL" publication="J ALLERGY CLIN IMMUNOL" d1="57" d2="141" d3="976"/>
<CITE num="006" author="BOOTH BH III" publication="IN: PATTERSON R" d1="" d2="74" d3="972"/>
<CITE num="007" author="COLTEN HR" publication="N ENGL J MED" d1="292" d2="1050" d3="975"/>
<CITE num="008" author="DOLAN TF JR" publication="AM REV RESPIR DIS" d1="110" d2="812" d3="974"/>
<CITE num="009" author="HILL D" publication="MED J AUST" d1="2" d2="553" d3="975"/>
<CITE num="010" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="011" author="KULCZYCKI LL" publication="JAMA" d1="175" d2="358" d3="961"/>
<CITE num="012" author="MURPHY RLH JR" publication="IN: WEISS EB" d1="" d2="517" d3="976"/>
<CITE num="013" author="NAKAMURA S" publication="J ASTHMA RES" d1="10" d2="37" d3="972"/>
<CITE num="014" author="OUCHTERLONY O" publication="HANDBOOK OF IMMUNODIFFUSION A" d1="" d2="" d3="968"/>
<CITE num="015" author="PEPYS J" publication="CLIN ALLERGY" d1="2" d2="225" d3="972"/>
<CITE num="016" author="PRAUSNITZ C" publication="ZENTRALBL BAKTERIOL" d1="86" d2="160" d3="921"/>
<CITE num="017" author="PRUZANSKY JJ" publication="J ALLERGY" d1="38" d2="315" d3="966"/>
<CITE num="018" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="019" author="ROBERTSON DG" publication="J ALLERGY CLIN IMMUNOL" d1="54" d2="244" d3="974"/>
<CITE num="020" author="SAKALA A" publication="LANCET" d1="1" d2="193" d3="977"/>
<CITE num="021" author="SCHLEUTER D" publication="IN: STOLLERMAN G" d1="" d2="153" d3="972"/>
<CITE num="022" author="SHORE PA" publication="J PHARMACOL EXP THER" d1="127" d2="182" d3="959"/>
<CITE num="023" author="TWAROG FJ" publication="J ALLERGY CLIN IMMUNOL" d1="59" d2="35" d3="977"/>
<CITE num="024" author="WIDE L" publication="LANCET" d1="2" d2="1105" d3="967"/>
<CITE num="025" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79070</PAPERNUM>
<CITATIONS>
<CITE num="1" author="THEWS KP            AF" publication="R J CLIN EXP IMMUNOL" d1="3" d2="69 9" d3="2"/>
<CITE num="2" author="BAUR X" publication="DTSCH MED WSCHR" d1="109" d2="257" d3="984"/>
<CITE num="3" author="WIESSMANN KJ" publication="EUR J RESPIR DIS" d1="66" d2="13" d3="985"/>
<CITE num="4" author="WARREN CPW" publication="AM J MED" d1="81" d2="939" d3="986"/>
<CITE num="5" author="DAVIS PB" publication="THORAX" d1="42" d2="120" d3="987"/>
</CITATIONS>
<RECORDNUM>01050 </RECORDNUM>
<MEDLINENUM>79211680</MEDLINENUM>
<AUTHORS><AUTHOR>Kutty-K-M</AUTHOR><AUTHOR>Guha-A-K</AUTHOR><AUTHOR>Chandra-R-K</AUTHOR><AUTHOR>Vaze-D</AUTHOR></AUTHORS>
<TITLE>A study of erythrocyte fatty acids, adenosinetriphosphatase and
acetylcholinesterase in cystic fibrosis.</TITLE>
<SOURCE>Clin-Biochem. 1979 Jun. 12(3). P 98-9.</SOURCE>
<MAJORSUBJ><TOPIC>ACETYLCHOLINESTERASE: bl</TOPIC><TOPIC>ADENOSINE-TRIPHOSPHATASE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>ERYTHROCYTES: me</TOPIC><TOPIC>FATTY-ACIDS-UNSATURATED: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ARACHIDONIC-ACIDS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LINOLEIC-ACIDS: bl</TOPIC></MINORSUBJ>
<ABSTRACT>1. The proportions of both saturated and polyunsaturated fatty acids
were measured in the erythrocytes in Cystic Fibrosis (CF) patients
along with two membrane bound enzymes ATPase and
acetylcholinesterase. Linoleic acid was found to be significantly
decreased and arachidonic acid increased in CF patients. The
proportion of saturated fatty acids were not significantly different
from the controls. Only adenosinetriphosphatase activity was found to
be reduced and not acetylcholinesterase in CF patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LEHINGER AL" publication="MOLECULAR BASIS OF CELL" d1="" d2="660" d3="975"/>
<CITE num="002" author="ROTHFIELD LI" publication="STRUCTURE AND FUNCTION OF BIO" d1="" d2="196" d3="971"/>
<CITE num="003" author="LEE JB" publication="PERSPECTIVES ON THE PROSTAGLA" d1="" d2="8" d3="973"/>
<CITE num="004" author="BONELLI EJ" publication="LIPID ANALYSIS BY GAS CHROMAT" d1="" d2="" d3="968"/>
<CITE num="005" author="DUNHAM ET" publication="J PHYSIOL (LOND)" d1="156" d2="274" d3="961"/>
<CITE num="007" author="MCEVOY FA" publication="LANCET" d1="2" d2="236" d3="975"/>
<CITE num="008" author="BALFE JW" publication="SCIENCE" d1="162" d2="689" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79071</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BBARD VS            CL" publication="IN CHIM ACTA                 1" d1="02" d2="15 9" d3="0"/>
<CITE num="2" author="WARWICK WJ" publication="AM J MED TECHNOLOGY" d1="48" d2="539" d3="982"/>
</CITATIONS>
<RECORDNUM>01051 </RECORDNUM>
<MEDLINENUM>80002169</MEDLINENUM>
<AUTHORS><AUTHOR>Chalmers-R-A</AUTHOR><AUTHOR>Valman-H-B</AUTHOR><AUTHOR>Liberman-M-M</AUTHOR></AUTHORS>
<TITLE>Measurement of 4-hydroxyphenylacetic aciduria as a screening test
for small-bowel disease.</TITLE>
<SOURCE>Clin-Chem. 1979 Oct. 25(10). P 1791-4.</SOURCE>
<MAJORSUBJ><TOPIC>INTESTINAL-DISEASES: di</TOPIC><TOPIC>MANDELIC-ACIDS: ur</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: ur</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-DISEASES: ur</TOPIC><TOPIC>MASS-SCREENING</TOPIC><TOPIC>REFERENCE-VALUES</TOPIC></MINORSUBJ>
<ABSTRACT>We evaluted measurement of urinary 4-hydroxyphenyl acetic acid as a
potential screening method for small-bowel disease and bacterial
overgrowth syndromes in 360 unselected acutely ill infants and
children. Control data were obtained on 120 healthy children, ages
1.5 to 15 years, from a general medical practice, 48 healthy infants,
ages one to five years, from local day nurseries, and 150 healthy
babies, ages less than one to eight days. Comparative data were from
300 acutely ill hospitalized babies and children, ranging in age from
less than one day to 15 years and without clinical evidence for small-
bowel disease and bacterial overgrowth syndrome. No false-negative
results and only 2% false-positive results were observed. Among the
10 patients whose urinary excretion of the analyte was considered to
be abnormal were patients with Giardia lamblia infestation, ileal
resection with blind loop, and other diseases of the small intestine
associated with bacterial overgrowth. We conclude that measurement of
4-hydroxyphenylacetic acid excretion is useful in screening for such
diseases.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GARRETTSON LK" publication="AM J CLIN PATHOL" d1="55" d2="318" d3="971"/>
<CITE num="002" author="GIBBONS ISE" publication="LANCET" d1="1" d2="877" d3="967"/>
<CITE num="003" author="GJESSING LR" publication="LANCET" d1="2" d2="47" d3="967"/>
<CITE num="004" author="VAN DER HEIDEN C" publication="CLIN CHIM ACTA" d1="31" d2="133" d3="971"/>
<CITE num="005" author="VAN DER HEIDEN C" publication="CLIN CHIM ACTA" d1="34" d2="289" d3="971"/>
<CITE num="006" author="CHALMERS RA" publication="ANN CLIN BIOCHEM" d1="14" d2="149" d3="977"/>
<CITE num="007" author="CHALMERS RA" publication="CLIN CHEM" d1="22" d2="1292" d3="976"/>
<CITE num="008" author="CHALMERS RA" publication="ANALYST" d1="97" d2="958" d3="972"/>
<CITE num="009" author="HEALY MJR" publication="J CHROMATOGR" d1="87" d2="365" d3="973"/>
<CITE num="010" author="LAWSON AM" publication="CLIN CHEM" d1="22" d2="1283" d3="976"/>
<CITE num="011" author="FELLMAN JH" publication="CLIN BIOCHEM" d1="10" d2="171" d3="977"/>
<CITE num="012" author="BORUD O" publication="ACTA PHARMACOL TOXICOL" d1="30" d2="185" d3="971"/>
<CITE num="013" author="AMENT ME" publication="PEDIATR CLIN NORTH AM" d1="22" d2="807" d3="975"/>
<CITE num="014" author="BURKE JA" publication="AM J DIS CHILD" d1="129" d2="1304" d3="975"/>
<CITE num="015" author="CHALLACOMBE DN" publication="AM J DIS CHILD" d1="128" d2="719" d3="974"/>
<CITE num="016" author="GORBACH S" publication="IN: DIETSCHY JM" d1="" d2="137" d3="976"/>
<CITE num="017" author="AARBAKKE J" publication="SCAND J GASTROENTEROL" d1="11" d2="409" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79072</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TTS RWE             J" publication="MENT DEFIC RES" d1="24" d2="57 9" d3="0"/>
<CITE num="2" author="WILLIAMS DA" publication="J SMALL ANIMAL PRACT" d1="22" d2="263" d3="981"/>
<CITE num="3" author="GRACEY M" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="13" d3="982"/>
<CITE num="4" author="BURROWS CF" publication="J AM VET MED ASSOC" d1="183" d2="318" d3="983"/>
<CITE num="5" author="GRACEY M" publication="NAHRUNG" d1="28" d2="659" d3="984"/>
<CITE num="6" author="BYRD DJ" publication="KLIN PAEDIATR" d1="196" d2="298" d3="984"/>
<CITE num="7" author="HAAN E" publication="EUR J PEDIATR" d1="144" d2="63" d3="985"/>
</CITATIONS>
<RECORDNUM>01052 </RECORDNUM>
<MEDLINENUM>79105836</MEDLINENUM>
<AUTHORS><AUTHOR>Shwachman-H</AUTHOR><AUTHOR>Mohmoodian-A</AUTHOR></AUTHORS>
<TITLE>Quality of sweat test performance in the diagnosis of cystic
fibrosis.</TITLE>
<SOURCE>Clin-Chem. 1979 Jan. 25(1). P 158-61.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEATING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PILOCARPINE: du</TOPIC><TOPIC>SWEAT: ph</TOPIC></MINORSUBJ>
<ABSTRACT>The sweat test, correctly performed, appears to be reliable, but
results were found to be unreliable about half the time in 84 small
community hospitals assessed. The reasons are inexperienced and
untrained technicians, the infrequency of test performance, the use
of unstandardized equipment, and the lack of appropriate standards.
It behooves all clinical laboratory directors to re-examine and
standardize their procedures and use the recommendations of the
Cystic Fibrosis Foundation. Physicians should be made aware of the
current situation and send their patients only to laboratories that
perform the test reliably.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="002" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="963"/>
<CITE num="003" author="SCHALES O" publication="J BIOL CHEM" d1="140" d2="879" d3="941"/>
<CITE num="004" author="SHWACHMAN H" publication="N ENGL J MED" d1="255" d2="999" d3="956"/>
<CITE num="005" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="167" d3="962"/>
<CITE num="006" author="KOPITO L" publication="N ENGL J MED" d1="272" d2="504" d3="965"/>
<CITE num="007" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="008" author="WEBSTER L" publication="MED J AUST" d1="1" d2="923" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79073</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WACHMAN H           CL" publication="IN CHEM" d1="25" d2="08 9" d3="9"/>
<CITE num="2" author="SHWACHMAN H" publication="J PEDIATR" d1="95" d2="661" d3="979"/>
<CITE num="3" author="SEALE TW" publication="PEDIATR RES" d1="14" d2="1398" d3="980"/>
<CITE num="4" author="DENNING CR" publication="PEDIATRICS" d1="66" d2="752" d3="980"/>
<CITE num="5" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="6" author="BOWLING SA" publication="AM J MED TECHNOLOGY" d1="48" d2="25" d3="982"/>
<CITE num="7" author="RANDOLPH VS" publication="AM J MED TECHNOLOGY" d1="48" d2="15" d3="982"/>
<CITE num="8" author="KIRK JM" publication="ANN CLIN BIOCHEM" d1="20" d2="369" d3="983"/>
<CITE num="9" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="10" author="GREEN A" publication="ANN CLIN BIOCHEM" d1="22" d2="171" d3="985"/>
<CITE num="11" author="ITANO M" publication="RESPIRATION" d1="47" d2="220" d3="985"/>
<CITE num="12" author="WARWICK WJ" publication="CLIN CHEM" d1="32" d2="850" d3="986"/>
<CITE num="13" author="ROSENSTEIN BJ" publication="CLIN PEDIATR" d1="26" d2="78" d3="987"/>
</CITATIONS>
<RECORDNUM>01053 </RECORDNUM>
<MEDLINENUM>79105888</MEDLINENUM>
<AUTHORS><AUTHOR>Willcox-P</AUTHOR></AUTHORS>
<TITLE>Secretion of beta-N-acetylglucosaminidase isoenzymes by cultured
cystic fibrosis fibroblasts.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Jan 1. 91(1). P 81-9.</SOURCE>
<MAJORSUBJ><TOPIC>ACETYLGLUCOSAMINIDASE: se</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLUCOSAMINIDASE: se</TOPIC><TOPIC>ISOENZYMES: se</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>Secretion of the lysosomal enzyme beta-N-acetylglucosaminidase (EC
3.2.1.30) by normal and cystic fibrosis fibroblasts has been
compared. In contrast to an earlier report, no differences were found
in either the rate of secretion, or in the molecular forms of the
enzyme secreted by normal fibroblast cultures and cultures initiated
from patients with cystic fibrosis. The B isoenzyme of beta-N-
acetylglucosaminidase from cystic fibrosis fibroblasts was converted
to a more negatively charged form during preincubation for 3 h at pH
5.0 and 37 degrees C. The enzyme from normal fibroblasts was
unaffected by this treatment.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="002" author="WILLCOX P" publication="EUR J BIOCHEM" d1="73" d2="579" d3="977"/>
<CITE num="003" author="WILLCOX P" publication="BIOCHEM J" d1="173" d2="433" d3="978"/>
<CITE num="004" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
<CITE num="005" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="006" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="007" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="534" d3="976"/>
<CITE num="009" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79074</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLCOX P             BI" publication="OCHIM BIOPHYS ACTA           5" d1="86" d2="42 9" d3="9"/>
<CITE num="2" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="110" d2="319" d3="981"/>
<CITE num="3" author="FIGARELLA C" publication="EUR J CLIN INVEST" d1="12" d2="145" d3="982"/>
</CITATIONS>
<RECORDNUM>01054 </RECORDNUM>
<MEDLINENUM>79211819</MEDLINENUM>
<AUTHORS><AUTHOR>Casola-L</AUTHOR><AUTHOR>Di-Matteo-G</AUTHOR><AUTHOR>Romano-M</AUTHOR><AUTHOR>Rutigliano-B</AUTHOR><AUTHOR>Mastella-G</AUTHOR></AUTHORS>
<TITLE>Glycosidases in serum of cystic fibrosis patients.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 May 16. 94(1). P 83-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLYCOSIDE-HYDROLASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLGLUCOSAMINIDASE: bl</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ARYLSULFATASES: bl</TOPIC><TOPIC>BETA-GALACTOSIDASES: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FUCOSIDASE: bl</TOPIC><TOPIC>GLUCURONIDASE: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MANNOSIDASES: bl</TOPIC><TOPIC>REFERENCE-VALUES</TOPIC></MINORSUBJ>
<ABSTRACT>In a study of eight glycosidases in serum samples from 72 cystic
fibrosis patients, 85 cystic fibrosis parents and 34 healthy and
diseased controls, significant elevations of mean alpha-glucosidase
levels were found in cystic fibrosis patients. All other glycosidases
did not show any significant change. Mean alpha-glucosidase levels in
obligate heterozygotes were the same as in control individuals.
Moreover, alpha-glucosidase levels in cystic fibrosis patients
correlated with the degree of clinical impairment as measured by the
Schwachman score.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARTMAN J" publication="J PEDIATR" d1="76" d2="430" d3="970"/>
<CITE num="002" author="DANES BS" publication="LANCET" d1="1" d2="1061" d3="968"/>
<CITE num="003" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="004" author="MATALON R" publication="BIOCHEM BIOPHYS RES COMMUN" d1="33" d2="954" d3="968"/>
<CITE num="005" author="DANES BS" publication="BIOCHEM BIOPHYS RES COMMUN" d1="36" d2="919" d3="969"/>
<CITE num="006" author="KRAUS I" publication="PEDIATRICS" d1="47" d2="1010" d3="971"/>
<CITE num="007" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
<CITE num="008" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="41" d2="367" d3="972"/>
<CITE num="009" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="010" author="WILSON RG" publication="CLIN CHIM ACTA" d1="36" d2="189" d3="972"/>
<CITE num="011" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="012" author="GIBBS GE" publication="SCIENCE" d1="167" d2="993" d3="970"/>
<CITE num="013" author="GRIFFIN GD" publication="PROC SOC EXP BIOL MED" d1="137" d2="438" d3="971"/>
<CITE num="014" author="GIBBS GE" publication="J INVEST DERMATOL" d1="51" d2="200" d3="968"/>
<CITE num="015" author="EVANS BW" publication="AM J DIS CHILD" d1="127" d2="660" d3="974"/>
<CITE num="016" author="BENKE PJ" publication="N ENGL J MED" d1="284" d2="731" d3="971"/>
<CITE num="017" author="FILLIAT M" publication="PATHOL BIOL (PARIS)" d1="21" d2="13" d3="973"/>
<CITE num="018" author="RUSSELL SB" publication="J MED GENET" d1="8" d2="441" d3="971"/>
<CITE num="019" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="020" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="021" author="STAHL P" publication="ARCH BIOCHEM BIOPHYS" d1="170" d2="53" d3="975"/>
<CITE num="022" author="MORELL AG" publication="J BIOL CHEM" d1="246" d2="1461" d3="971"/>
<CITE num="023" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="024" author="DAHLQVIST A" publication="ANAL BIOCHEM" d1="7" d2="18" d3="964"/>
<CITE num="025" author="SMITH BW" publication="J BIOL CHEM" d1="227" d2="357" d3="957"/>
<CITE num="026" author="ANNUNZIATA P" publication="CLIN CHIM ACTA" d1="90" d2="101" d3="978"/>
<CITE num="027" author="JEFFREY PL" publication="BIOCHEMISTRY" d1="9" d2="1416" d3="970"/>
<CITE num="028" author="NIKOLAJEK WP" publication="EUR J PEDIATR" d1="122" d2="289" d3="976"/>
<CITE num="029" author="TOWNES PL" publication="AM J HUM GENET" d1="28" d2="378" d3="976"/>
<CITE num="030" author="STANBURY JB" publication="METABOLIC BASIS OF INHERITED" d1="" d2="" d3="972"/>
<CITE num="031" author="KAWASAKI T" publication="J BIOL CHEM" d1="251" d2="1296" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79075</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HADEFF JA           CL" publication="IN CHIM ACTA                 1" d1="05" d2="31 9" d3="0"/>
<CITE num="2" author="MALER T" publication="FEBS LETTERS" d1="121" d2="153" d3="980"/>
<CITE num="3" author="BARLOW JJ" publication="J NATL CANCER INST" d1="67" d2="1005" d3="981"/>
<CITE num="4" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="117" d2="227" d3="981"/>
<CITE num="5" author="CALVO P" publication="CLIN CHIM ACTA" d1="119" d2="15" d3="982"/>
<CITE num="6" author="CABRINI G" publication="RIV ITAL PEDIATR" d1="10" d2="405" d3="984"/>
<CITE num="7" author="ALHADEFF JA" publication="PEDIATR RES" d1="19" d2="171" d3="985"/>
<CITE num="8" author="PORTER WH" publication="CLIN CHEM" d1="32" d2="652" d3="986"/>
</CITATIONS>
<RECORDNUM>01055 </RECORDNUM>
<MEDLINENUM>80045420</MEDLINENUM>
<AUTHORS><AUTHOR>Butterworth-J</AUTHOR><AUTHOR>Duncan-J-J</AUTHOR></AUTHORS>
<TITLE>Carboxypeptidase B activity of cultured skin fibroblasts and
relationship to cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Sep 15. 97(1). P 39-43.</SOURCE>
<MAJORSUBJ><TOPIC>CARBOXYPEPTIDASES: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ARGININE: aa, me</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>DITHIOTHREITOL: pd</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HIPPURATES: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>SUBCELLULAR-FRACTIONS: en</TOPIC></MINORSUBJ>
<ABSTRACT>Enzyme activity against hippuryl-L-arginine was studied in cultured
skin fibroblasts from controls and cystic fibrosis patients. The
enzyme had a lysosomal distribution and an acid optimum of pH 4.5
with little or no activity present above pH 7.0. Dithiothreitol was
required for full activity and the kinetics of thiol activation were
different for the control and cystic fibrosis enzyme. The properties
and lysosomal distribution of the enzyme indicated that it was a
carboxypeptidase B. Substrate affinity, thermolability, pH stability,
the fall and rise in activity with subculture, the cyclical pattern
of activity through serial passage and the level of activity were
similar for the control and cystic fibrosis enzyme.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="002" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="44" d2="295" d3="973"/>
<CITE num="003" author="GUY GJ" publication="CLIN CHIM ACTA" d1="87" d2="63" d3="978"/>
<CITE num="004" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="005" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="006" author="DAWSON RMC" publication="DATA FOR BIOCHEMICAL RESEARCH" d1="" d2="" d3="972"/>
<CITE num="007" author="MARINKOVIC DV" publication="BIOCHEM J" d1="163" d2="265" d3="951"/>
<CITE num="008" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="11" d2="585" d3="962"/>
<CITE num="009" author="OSHIMA G" publication="BIOCHIM BIOPHYS ACTA" d1="365" d2="344" d3="974"/>
<CITE num="010" author="PLUMMER TH" publication="J BIOL CHEM" d1="253" d2="3907" d3="978"/>
<CITE num="011" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="111" d2="100" d3="975"/>
<CITE num="012" author="KOHEIL A" publication="BIOCHIM BIOPHYS ACTA" d1="524" d2="156" d3="978"/>
<CITE num="013" author="GREENBAUM LM" publication="J BIOL CHEM" d1="237" d2="1082" d3="962"/>
<CITE num="014" author="OTTO K" publication="BIOCHIM BIOPHYS ACTA" d1="379" d2="462" d3="975"/>
<CITE num="015" author="NINJOOR V" publication="BIOCHIM BIOPHYS ACTA" d1="370" d2="308" d3="974"/>
<CITE num="016" author="TAYLOR SL" publication="BIOCHIM BIOPHYS ACTA" d1="341" d2="99" d3="974"/>
<CITE num="017" author="MCDONALD JK" publication="IN: BARRETT AJ" d1="" d2="311" d3="977"/>
<CITE num="018" author="SHAPIRO BL" publication="PROC SOC EXP BIOL MED" d1="144" d2="181" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79076</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TTERWORTH J         AN" publication="AL BIOCHEM                   1" d1="06" d2="56 9" d3="0"/>
<CITE num="2" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="143" d3="980"/>
<CITE num="3" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="4" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="122" d2="51" d3="982"/>
<CITE num="5" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
</CITATIONS>
<RECORDNUM>01056 </RECORDNUM>
<MEDLINENUM>80045463</MEDLINENUM>
<AUTHORS><AUTHOR>Ben-Yoseph-Y</AUTHOR><AUTHOR>Defranco-C-L</AUTHOR><AUTHOR>Nadler-H-L</AUTHOR></AUTHORS>
<TITLE>Decreased sialic acid and altered binding to lectins of purified
alpha 2-macroglobulin from patients with cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Nov 15. 99(1). P 31-5.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-MACROGLOBULINS</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LECTINS</TOPIC><TOPIC>SIALIC-ACIDS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALPHA-MACROGLOBULINS: ip</TOPIC><TOPIC>CONCANAVALIN-A</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HEXOSES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Purified preparations of plasma alpha 2-macroglobulin from patients
with cystic fibrosis are shown to have normal amounts of total hexose
but as much as 40% decrease in their sialic acid content. The binding
of these preparations to concanavalin A and wheat-germ agglutinin was
markedly reduced as compared to normal values in controls.
Intermediate values were found in obligate heterozygotes. These
results suggest a possible alteration in the carbohydrate moiety of
alpha 2-macroglobulin in cystic fibrosis, presumably due to a
defective posttranslational process.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="CLIN GENET" d1="14" d2="189" d3="978"/>
<CITE num="002" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="003" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="004" author="HICKMAN S" publication="BIOCHEM BIOPHYS RES COMMUN" d1="57" d2="55" d3="974"/>
<CITE num="005" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="417" d3="978"/>
<CITE num="006" author="SCHULTZE HE" publication="MOLECULAR BIOL OF HUMAN PROTE" d1="1" d2="" d3="966"/>
<CITE num="007" author="DUNN JT" publication="J BIOL CHEM" d1="242" d2="5549" d3="967"/>
<CITE num="008" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="009" author="SHAPIRA E" publication="CLIN CHIM ACTA" d1="78" d2="359" d3="977"/>
<CITE num="010" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
<CITE num="011" author="PORATH J" publication="NATURE" d1="215" d2="1401" d3="967"/>
<CITE num="012" author="WEBER K" publication="J BIOL CHEM" d1="244" d2="4406" d3="969"/>
<CITE num="013" author="SPIRO RG" publication="IN: NEUFELD EF" d1="8" d2="3" d3="966"/>
<CITE num="014" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
<CITE num="015" author="GOLDSTEIN IJ" publication="ADV CARBOHYDR CHEM BIOCHEM" d1="35" d2="127" d3="978"/>
<CITE num="016" author="GREENAWAY PJ" publication="NATURE NEW BIOL" d1="241" d2="191" d3="973"/>
<CITE num="017" author="ROUSSON R" publication="BIOCHEM J" d1="180" d2="501" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79077</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MINGS DE            AM" publication="J HUM GENET" d1="32" d2="73 9" d3="0"/>
<CITE num="2" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="93" d2="50" d3="980"/>
<CITE num="3" author="BENYOSEPH Y" publication="BIOCHEM J" d1="189" d2="9" d3="980"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="5" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="6" author="BENYOSEPH Y" publication="PEDIATR RES" d1="15" d2="839" d3="981"/>
<CITE num="7" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="8" author="OWENSWILLIAMS L" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="567" d3="982"/>
<CITE num="9" author="BURY AF" publication="IRCS MED SCI BIOCHEM" d1="10" d2="255" d3="982"/>
<CITE num="10" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="11" author="ROBERTS RC" publication="PEDIATR RES" d1="16" d2="416" d3="982"/>
<CITE num="12" author="BRIDGES MA" publication="CLIN CHIM ACTA" d1="118" d2="33" d3="982"/>
<CITE num="13" author="BURY AF" publication="CLIN CHIM ACTA" d1="118" d2="45" d3="982"/>
<CITE num="14" author="TUMMLER B" publication="CLIN CHIM ACTA" d1="125" d2="219" d3="982"/>
<CITE num="15" author="MARGOLIES R" publication="PEDIATR RES" d1="17" d2="931" d3="983"/>
<CITE num="16" author="BACK SA" publication="BIOCHEM MED" d1="30" d2="34" d3="983"/>
<CITE num="17" author="SLOMIANY A" publication="J BIOL CHEM" d1="258" d2="8535" d3="983"/>
<CITE num="18" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="19" author="SHAPIRA E" publication="ANN NY ACAD SCI" d1="421" d2="352" d3="983"/>
<CITE num="20" author="ANDERSON CM" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="15" d3="984"/>
<CITE num="21" author="EAGER KB" publication="PEDIATR RES" d1="18" d2="999" d3="984"/>
<CITE num="22" author="KARLSSON S" publication="J MED GENET" d1="21" d2="441" d3="984"/>
<CITE num="23" author="GUEANT JL" publication="CLIN CHIM ACTA" d1="143" d2="217" d3="984"/>
<CITE num="24" author="PARK CM" publication="PEDIATR RES" d1="19" d2="344" d3="985"/>
</CITATIONS>
<RECORDNUM>01057 </RECORDNUM>
<MEDLINENUM>79084606</MEDLINENUM>
<AUTHORS><AUTHOR>Scanlin-T-F</AUTHOR><AUTHOR>Matacic-S-S</AUTHOR><AUTHOR>Glick-M-C</AUTHOR></AUTHORS>
<TITLE>Abnormal distribution of alpha-L-fucosidase in cystic fibrosis:
decreased activity in serum.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Jan 15. 91(2). P 197-202.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FUCOSIDASE: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLGLUCOSAMINIDASE: bl</TOPIC><TOPIC>ACID-PHOSPHATASE: bl</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>FUCOSIDASE: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>SKIN: en</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The activity of alpha-L-fucosidase is decreased in the serum of
cystic fibrosis patients when compared to age-matched controls. This
result, combined with the elevated activity in skin fibroblasts,
supports the concept of an abnormal intracellular and extracellular
distribution of alpha-L-fucosidase in cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="004" author="ZIELKE K" publication="J LAB CLIN MED" d1="79" d2="164" d3="972"/>
<CITE num="005" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="006" author="SCANLIN TF JR" publication="PROC INT CF CONG 7TH" d1="" d2="44" d3="976"/>
<CITE num="007" author="SCANLIN TF JR" publication="PEDIATR RES ABST 549" d1="11" d2="463" d3="977"/>
<CITE num="008" author="NG WG" publication="AM J HUM GENET" d1="28" d2="42" d3="976"/>
<CITE num="009" author="RAMAGE P" publication="BIOCHIM BIOPHYS ACTA" d1="403" d2="473" d3="975"/>
<CITE num="010" author="TURNER BM" publication="AM J HUM GENET" d1="27" d2="651" d3="975"/>
<CITE num="011" author="DI MATTEO G" publication="BIOCHIM BIOPHYS ACTA" d1="429" d2="538" d3="976"/>
<CITE num="012" author="CHESTER MA" publication="BIOCHIM BIOPHYS ACTA" d1="485" d2="147" d3="977"/>
<CITE num="013" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="014" author="SCANLIN TF JR" publication="PEDIATR RES" d1="12" d2="457" d3="978"/>
<CITE num="015" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="016" author="NEUFELD EF" publication="ANNU REV BIOCHEM" d1="44" d2="357" d3="975"/>
<CITE num="017" author="KAPLAN A" publication="PROC NAT ACAD SCI USA" d1="74" d2="2026" d3="977"/>
<CITE num="018" author="HIEBER V" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="710" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79078</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="3" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="105" d2="131" d3="980"/>
<CITE num="4" author="BARLOW JJ" publication="J NATL CANCER INST" d1="67" d2="1005" d3="981"/>
<CITE num="5" author="JAKEL HP" publication="BIOL ZENTRALBL" d1="100" d2="273" d3="981"/>
<CITE num="6" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="110" d2="319" d3="981"/>
<CITE num="7" author="SCANLIN TF" publication="CLIN CHIM ACTA" d1="114" d2="269" d3="981"/>
<CITE num="8" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="117" d2="227" d3="981"/>
<CITE num="9" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="10" author="SCANLIN TF" publication="BIOCHEMISTRY" d1="21" d2="491" d3="982"/>
<CITE num="11" author="SHEPHERD VL" publication="J RETICULOENDOTHEL SOC" d1="32" d2="423" d3="982"/>
<CITE num="12" author="BOURASSA C" publication="CLIN CHIM ACTA" d1="129" d2="263" d3="983"/>
<CITE num="13" author="SCANLIN TF" publication="PEDIATR RES" d1="19" d2="368" d3="985"/>
</CITATIONS>
<RECORDNUM>01058 </RECORDNUM>
<MEDLINENUM>80023017</MEDLINENUM>
<AUTHORS><AUTHOR>Lake-C-R</AUTHOR><AUTHOR>Davis-P-B</AUTHOR><AUTHOR>Ziegler-M</AUTHOR><AUTHOR>Kopin-I-J</AUTHOR></AUTHORS>
<TITLE>Electrolytes and norepinephrine levels in blood of patients with
cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Mar 1. 92(2). P 141-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>ELECTROLYTES: bl</TOPIC><TOPIC>NOREPINEPHRINE: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>BLOOD-PRESSURE</TOPIC><TOPIC>DOPAMINE-BETA-HYDROXYLASE: bl</TOPIC><TOPIC>EXERTION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>MALE</TOPIC><TOPIC>POSTURE</TOPIC><TOPIC>SEASONS</TOPIC></MINORSUBJ>
<ABSTRACT>Young adults with cystic fibrosis in good to excellent condition have
reduced plasma sodium and chloride and elevated plasma potassium
compared to a group of healthy young adult control subjects. Blood
pressure was also lower in the patients with cystic fibrosis.
However, plasma norepinephrine and dopamine-beta-hydroxylase and
their response to standing and isometric hand grip were normal in the
cystic fibrosis patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DAVIS PB" publication="PEDIATR RES" d1="12" d2="703" d3="978"/>
<CITE num="002" author="BARBERO GJ" publication="CF CLUB ABST" d1="" d2="4" d3="967"/>
<CITE num="003" author="BONGIOVANNI AM" publication="LAB INVEST" d1="10" d2="956" d3="961"/>
<CITE num="004" author="HENRY DP" publication="LIFE SCI" d1="16" d2="375" d3="975"/>
<CITE num="005" author="LAKE CR" publication="LIFE SCI" d1="18" d2="1315" d3="976"/>
<CITE num="006" author="WEINSHILBOUM RM" publication="SCIENCE" d1="174" d2="1349" d3="971"/>
<CITE num="007" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="008" author="WEINSHILBOUM RM" publication="CIRC RES" d1="28" d2="307" d3="971"/>
<CITE num="009" author="BOLANDE RP" publication="ARCH PATHOL" d1="95" d2="172" d3="973"/>
<CITE num="010" author="LAKE CR" publication="CIRCULATION" d1="57" d2="774" d3="978"/>
<CITE num="011" author="LAKE CR" publication="AM SOC NEPHROL ABST" d1="" d2="50A" d3="979"/>
<CITE num="012" author="OGIHARA T" publication="J LAB CLIN MED" d1="85" d2="566" d3="975"/>
<CITE num="013" author="LIEBERMAN J" publication="ANN INTERN MED" d1="82" d2="806" d3="975"/>
<CITE num="014" author="DI SANTAGNESE PA" publication="ANN NY ACAD SCI" d1="93" d2="555" d3="962"/>
<CITE num="015" author="QUINTERO-ATENCIO J" publication="N ENGL J MED" d1="274" d2="1224" d3="966"/>
<CITE num="016" author="LEVI J" publication="ISR J MED SCI" d1="6" d2="665" d3="970"/>
<CITE num="017" author="MCCANE RA" publication="LANCET" d1="1" d2="823" d3="936"/>
<CITE num="018" author="MCCANE RA" publication="PROC R SOC LOND BIOL" d1="119" d2="245" d3="936"/>
<CITE num="019" author="SIMOPOULOS AP" publication="PEDIATR RES" d1="5" d2="626" d3="971"/>
<CITE num="020" author="ROBSON AM" publication="J PEDIATR" d1="79" d2="42" d3="971"/>
<CITE num="021" author="GRAND RJ" publication="J PEDIATR" d1="70" d2="357" d3="967"/>
<CITE num="022" author="MONTALVO JM" publication="J CLIN ENDOCRINOL METAB" d1="28" d2="582" d3="968"/>
<CITE num="023" author="ROSENTHAL A" publication="PEDIATRICS" d1="59" d2="588" d3="977"/>
<CITE num="024" author="STROBER W" publication="PEDIATRICS" d1="43" d2="416" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79079</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              IR" publication="CS MED SCI BIOCHEM" d1="8" d2="13 9" d3="0"/>
<CITE num="2" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="3" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="4" author="ZAMMARCHI E" publication="RIV ITAL PEDIATR" d1="9" d2="505" d3="983"/>
<CITE num="5" author="DAVIS PB" publication="J CHRON DIS" d1="36" d2="269" d3="983"/>
<CITE num="6" author="DAVIS PB" publication="J CLIN INVEST" d1="71" d2="1787" d3="983"/>
<CITE num="7" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="319" d3="985"/>
<CITE num="8" author="SCHONI MH" publication="PEDIATR RES" d1="19" d2="47" d3="985"/>
<CITE num="9" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="21" d2="127" d3="985"/>
<CITE num="10" author="DAVIS PB" publication="HORM METAB RES" d1="18" d2="217" d3="986"/>
<CITE num="11" author="SCHONI MH" publication="EUR J PEDIATR" d1="145" d2="80" d3="986"/>
</CITATIONS>
<RECORDNUM>01059 </RECORDNUM>
<MEDLINENUM>80023013</MEDLINENUM>
<AUTHORS><AUTHOR>Butterworth-J</AUTHOR><AUTHOR>Guy-G-J</AUTHOR></AUTHORS>
<TITLE>Primary amniotic fluid cell, skin fibroblast and liver
alpha-L-fucosidase and its relation to cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1979 Mar 1. 92(2). P 109-16.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FUCOSIDASE: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMNIOTIC-FLUID: en</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHROMATOGRAPHY-DEAE-CELLULOSE</TOPIC><TOPIC>CHROMATOGRAPHY-GEL</TOPIC><TOPIC>FUCOSIDASE: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC><TOPIC>LIVER: en</TOPIC><TOPIC>SKIN: en</TOPIC></MINORSUBJ>
<ABSTRACT>Cultured skin fibroblast and primary amniotic fluid cell alpha-L-
fucosidase had a double optimum of pH 5.0 and 6.0. Alpha-L-fucosidase
was largely bound as a single peak to DEAE-cellulose at pH 6.6.
Sucrose density isoelectric focusing revealed up to seven components
with pI values of 4.9, 5.2, 5.4, 5.8, 6.1, 6.5 and 7.1 with their
apparent KM values (77--500 mumol/l) being higher than that (57
mumol/l) of the unfocused enzyme. Liver, skin fibroblast and amniotic
fluid cell alpha-L-fucosidase was separated into two peaks by gel
filtration. Peak one was more active and stable at low pH and more
thermostable at 50 degrees C than peak two, while both peaks had an
apparent KM of 52 mumol/l. Apart from the different proportions of
the peaks separated by gel filtration, the results for the three
tissues were similar. The properties of alpha-L-fucosidase studied
were similar for control and cystic fibrosis liver or skin
fibroblasts.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="VAN HOOF F" publication="LANCET" d1="1" d2="1198" d3="968"/>
<CITE num="002" author="ZIELKE K" publication="J EXP MED" d1="136" d2="197" d3="972"/>
<CITE num="003" author="POENARU L" publication="CLIN GENET" d1="10" d2="260" d3="976"/>
<CITE num="004" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="005" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="006" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="007" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="78" d2="335" d3="977"/>
<CITE num="008" author="DAWSON RMC" publication="DATA FOR BIOCHEMICAL RESEARCH" d1="" d2="" d3="972"/>
<CITE num="009" author="BUTTERWORTH J" publication="CLIN GENET" d1="12" d2="297" d3="977"/>
<CITE num="010" author="BUTTERWORTH J" publication="CLIN GENET" d1="9" d2="505" d3="976"/>
<CITE num="011" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="012" author="GODSON NG" publication="ANAL BIOCHEM" d1="35" d2="66" d3="970"/>
<CITE num="013" author="BERATIS NG" publication="PEDIATR RES" d1="11" d2="862" d3="977"/>
<CITE num="014" author="ROBINSON D" publication="CLIN CHIM ACTA" d1="55" d2="65" d3="974"/>
<CITE num="015" author="BERATIS NG" publication="J PEDIATR" d1="87" d2="1193" d3="975"/>
<CITE num="016" author="ELLIS RB" publication="CLIN SCI MOL MED" d1="49" d2="543" d3="973"/>
<CITE num="017" author="WILLCOX P" publication="EUR J BIOCHEM" d1="73" d2="579" d3="977"/>
<CITE num="018" author="ROBINSON D" publication="CLIN CHIM ACTA" d1="47" d2="403" d3="973"/>
<CITE num="019" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="57" d2="307" d3="974"/>
<CITE num="020" author="THORPE R" publication="FEBS LETTERS" d1="54" d2="89" d3="975"/>
<CITE num="021" author="DI MATTEO G" publication="BIOCHIM BIOPHYS ACTA" d1="429" d2="527" d3="976"/>
<CITE num="022" author="TURNER BM" publication="AM J HUM GENET" d1="27" d2="651" d3="975"/>
<CITE num="023" author="WIEDERSCHAIN GY" publication="CLIN CHIM ACTA" d1="46" d2="305" d3="973"/>
<CITE num="024" author="WOOD S" publication="J LAB CLIN MED" d1="88" d2="469" d3="976"/>
<CITE num="025" author="CHESTER MA" publication="BIOCHIM BIOPHYS ACTA" d1="485" d2="147" d3="977"/>
<CITE num="026" author="CARLSEN RB" publication="J BIOL CHEM" d1="247" d2="23" d3="972"/>
<CITE num="027" author="ALHADEFF JA" publication="J BIOL CHEM" d1="250" d2="7106" d3="975"/>
<CITE num="028" author="ANDREWS P" publication="BIOCHEM J" d1="96" d2="595" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79080</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HADEFF JA           CL" publication="IN CHIM ACTA                 1" d1="05" d2="31 9" d3="0"/>
<CITE num="2" author="BUTTERWORTH J" publication="ANAL BIOCHEM" d1="106" d2="156" d3="980"/>
<CITE num="3" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="4" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="143" d3="980"/>
<CITE num="5" author="MALER T" publication="FEBS LETTERS" d1="121" d2="153" d3="980"/>
<CITE num="6" author="JAKEL HP" publication="BIOL ZENTRALBL" d1="100" d2="273" d3="981"/>
<CITE num="7" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="110" d2="319" d3="981"/>
<CITE num="8" author="HARRIS A" publication="CLIN CHIM ACTA" d1="116" d2="171" d3="981"/>
<CITE num="9" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="10" author="COHENFORD MA" publication="COMP BIOCHEM PHYSIOL (B)" d1="72" d2="695" d3="982"/>
<CITE num="11" author="BURY AF" publication="CLIN CHIM ACTA" d1="118" d2="45" d3="982"/>
<CITE num="12" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="122" d2="51" d3="982"/>
<CITE num="13" author="BEYER EM" publication="CLIN CHIM ACTA" d1="123" d2="251" d3="982"/>
<CITE num="14" author="BOURASSA C" publication="CLIN CHIM ACTA" d1="129" d2="263" d3="983"/>
<CITE num="15" author="WAUTERS J" publication="ARCH INT PHYSIOL BIOCHIM" d1="92" d2="B115" d3="984"/>
<CITE num="16" author="HERMELIN B" publication="CELL MOL BIOL" d1="33" d2="83" d3="987"/>
</CITATIONS>
<RECORDNUM>01060 </RECORDNUM>
<MEDLINENUM>79147574</MEDLINENUM>
<AUTHORS><AUTHOR>Carswell-F</AUTHOR><AUTHOR>Oliver-J</AUTHOR><AUTHOR>Silverman-M</AUTHOR></AUTHORS>
<TITLE>Allergy in cystic fibrosis.</TITLE>
<SOURCE>Clin-Exp-Immunol. 1979 Jan. 35(1). P 141-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ANTIGENS: im</TOPIC><TOPIC>ASPERGILLUS-FUMIGATUS: im</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: fg, im</TOPIC><TOPIC>IGE: an</TOPIC><TOPIC>IGG: an</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SKIN-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>Forty-four patients with cystic fibrosis, sixty-seven parents, and
thirty-nine controls were compared with regard to their immediate
cutaneous hypersensitivity, total and specific serum IgE and serum
IgG4 concentrations. The patients had increased prick test reactions
and specific IgE to Aspergillus fumigatus. The development of
reactions to A. fumigatus correlated with the severity of the
disease. There were no other significant differences when serum total
IgE, specific IgE and IgG4 concentrations or skin test reactivity
were compared in the patients, parents and controls.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="002" author="BATTEN JC" publication="MOD PROBL PEDIATR" d1="10" d2="227" d3="967"/>
<CITE num="003" author="BUTLER U" publication="PROC BPA RESPIRATORY GROUP MT" d1="" d2="" d3="977"/>
<CITE num="004" author="COGSWELL JJ" publication="BR J DIS CHEST" d1="69" d2="177" d3="975"/>
<CITE num="005" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="006" author="DAVIS JB" publication="CLIN ALLERGY" d1="6" d2="329" d3="976"/>
<CITE num="007" author="GODFREY RC" publication="CLIN ALLERGY" d1="6" d2="79" d3="976"/>
<CITE num="008" author="GODFREY S" publication="BR J DIS CHEST" d1="64" d2="15" d3="970"/>
<CITE num="009" author="JOHANSSON SGO" publication="IN: VYAS GN" d1="" d2="225" d3="975"/>
<CITE num="010" author="KJELLMAN NIM" publication="ACTA PAEDIATR SCAND" d1="65" d2="465" d3="976"/>
<CITE num="011" author="KJELLMAN NIM" publication="CLIN ALLERGY" d1="6" d2="51" d3="976"/>
<CITE num="012" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="013" author="MCFARLANE H" publication="LANCET" d1="1" d2="1241" d3="976"/>
<CITE num="014" author="MCFARLANE H" publication="CLIN ALLERGY" d1="7" d2="279" d3="977"/>
<CITE num="015" author="MALO JL" publication="THORAX" d1="32" d2="269" d3="977"/>
<CITE num="016" author="SARSFIELD JK" publication="ARCH DIS CHILD" d1="49" d2="711" d3="974"/>
<CITE num="017" author="SHAKIB F" publication="J IMMUNOL METH" d1="8" d2="17" d3="975"/>
<CITE num="018" author="SHAKIB F" publication="CLIN ALLERGY" d1="6" d2="237" d3="976"/>
<CITE num="019" author="STANWORTH DR" publication="CLIN ALLERGY" d1="3" d2="37" d3="973"/>
<CITE num="020" author="VIJAY HM" publication="INT ARCH ALLERGY APPL IMMUNOL" d1="53" d2="78" d3="977"/>
<CITE num="021" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="022" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="023" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="024" author="WARNOCK DW" publication="J CLIN PATHOL" d1="30" d2="388" d3="977"/>
<CITE num="025" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79081</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EN DJ               CL" publication="IN ALLERGY" d1="11" d2="71 9" d3="1"/>
<CITE num="2" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="3" author="WONNE R" publication="CLIN ALLERGY" d1="15" d2="455" d3="985"/>
<CITE num="4" author="MOSS RB" publication="MONOGR ALLERGY" d1="19" d2="202" d3="986"/>
<CITE num="5" author="MOSS RB" publication="CHEST" d1="91" d2="522" d3="987"/>
</CITATIONS>
<RECORDNUM>01061 </RECORDNUM>
<MEDLINENUM>80002327</MEDLINENUM>
<AUTHORS><AUTHOR>Super-M</AUTHOR><AUTHOR>van-Schalkwyk-D-J</AUTHOR></AUTHORS>
<TITLE>Heterozygote advantage in cystic fibrosis: mosquito tests.</TITLE>
<SOURCE>Clin-Genet. 1979 Aug. 16(2). P 65-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>INSECT-BITES-AND-STINGS</TOPIC><TOPIC>MOSQUITOES</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALARIA: mo, oc</TOPIC></MINORSUBJ>
<ABSTRACT>Tests to demonstrate a preference by mosquitoes for stinging controls
as opposed to obligate heterozygotes for Cystic Fibrosis proved
negative. If a heterozygote advantage caused a lower malarial
incidence in carriers in South West Africa, it must have worked
through the malarial parasite being adversely affected by a serum
factor. This remains to be tested.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79082</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="MOD PROBL PEDIATR" d1="10" d2="381" d3="967"/>
<CITE num="003" author="COHEN FL" publication="J MED GENET" d1="11" d2="253" d3="974"/>
<CITE num="004" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="005" author="CRAWFURD MDA" publication="HEREDITY" d1="29" d2="126" d3="972"/>
<CITE num="006" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="007" author="EDWARDS JH" publication="ARCH DIS CHILD" d1="52" d2="343" d3="977"/>
<CITE num="009" author="GAIRDNER D" publication="LANCET" d1="1" d2="279" d3="975"/>
<CITE num="010" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="012" author="KNUDSON AG JR" publication="AM J HUM GENET" d1="19" d2="388" d3="967"/>
<CITE num="013" author="MASTERSON J" publication="PROC EWGCF 6TH ANNU MTG" d1="" d2="" d3="975"/>
<CITE num="014" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
<CITE num="015" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="016" author="STUART AB" publication="LANCET" d1="2" d2="1521" d3="974"/>
<CITE num="017" author="SUPER M" publication="S AFR MED J" d1="49" d2="818" d3="975"/>
<CITE num="018" author="SUPER M" publication="THESIS" d1="" d2="" d3="978"/>
</REFERENCES>
<RECORDNUM>01062 </RECORDNUM>
<MEDLINENUM>80090635</MEDLINENUM>
<AUTHORS><AUTHOR>Koheil-A</AUTHOR><AUTHOR>Corey-M</AUTHOR><AUTHOR>Forstner-G</AUTHOR></AUTHORS>
<TITLE>Deficiency of serum carboxypeptidase B-like (anaphylatoxin
inactivator, carboxypeptidase N) activity in sera from patients with
cystic fibrosis.</TITLE>
<SOURCE>Clin-Invest-Med. 1979. 2(2-3). P 99-103.</SOURCE>
<MAJORSUBJ><TOPIC>CARBOXYPEPTIDASES: df</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>ARGININE-CARBOXYPEPTIDASE: df</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ARGININE-CARBOXYPEPTIDASE: bl</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Serum from 95 patients with cystic fibrosis and 47 control subjects
without cystic fibrosis was analyzed for carboxypeptidase B-like
activity in the presence of optimal concentrations of Co2+ ion,
hippuryl-L-lysine and serum.  Fourteen of the cystic fibrosis
patients had no steatorrhea and therefore minimal pancreatic
dysfunction.  Patients with cystic fibrosis and controls were of
comparable age.  Serum carboxypeptidase B-like activity was
significantly decreased in cystic fibrosis patients including cystic
fibrosis patients without steatorrhea.  Significantly low values
were found in both male and female cystic fibrosis patients when
compared with controls of similar sex.  Although values were
unaffected by age in the control population, values in older
patients with cystic fibrosis were significantly lower than values
in younger patients.  No correlation was obtained between serum
carboxypeptidase B-like activity and pulmonary or hepatic function.
Serum carboxypeptidase B-like activity therefore falls with
progression of the disease and may limit the ability to degrade
circulating peptides in older patients with cystic fibrosis.
Deficient serum carboxypeptidase B-like activity is less likely,
however, to be a factor in the development of the early
manifestations of the disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="OSHIMA G" publication="BIOCHIM BIOPHYS ACTA" d1="365" d2="344" d3="974"/>
<CITE num="002" author="BOKISCH VA" publication="J CLIN INVEST" d1="49" d2="2427" d3="970"/>
<CITE num="003" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="13" d2="893" d3="964"/>
<CITE num="004" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="11" d2="585" d3="962"/>
<CITE num="005" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="8" d2="112" d3="961"/>
<CITE num="006" author="CORBIN NC" publication="ANAL BIOCHEM" d1="73" d2="41" d3="976"/>
<CITE num="007" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="16" d2="1287" d3="967"/>
<CITE num="008" author="ERDOS EG" publication="CLIN CHIM ACTA" d1="11" d2="39" d3="965"/>
<CITE num="009" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="010" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="011" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="111" d2="100" d3="975"/>
<CITE num="012" author="CUSHMAN DW" publication="BIOCHEM PHARMACOL" d1="20" d2="1637" d3="971"/>
<CITE num="013" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="014" author="NIE NH" publication="STAT PACKAGE FOR THE SOCIAL S" d1="" d2="" d3="975"/>
<CITE num="015" author="KOHEIL A" publication="BIOCHIM BIOPHYS ACTA" d1="524" d2="156" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79083</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HWEISFURTH H        DT" publication="SCH MED WSCHR                1" d1="09" d2="66 9" d3="4"/>
<CITE num="2" author="SCHWEISFURTH H" publication="DTSCH MED WSCHR" d1="109" d2="1254" d3="984"/>
<CITE num="3" author="SCHWEISFURTH H" publication="CLIN BIOCHEM" d1="18" d2="242" d3="985"/>
<CITE num="4" author="SCHWEISFURTH H" publication="CLIN BIOCHEM" d1="20" d2="43" d3="987"/>
</CITATIONS>
<RECORDNUM>01063 </RECORDNUM>
<MEDLINENUM>79235200</MEDLINENUM>
<AUTHORS><AUTHOR>Crass-J-R</AUTHOR><AUTHOR>LHeureux-P</AUTHOR><AUTHOR>Loken-M</AUTHOR></AUTHORS>
<TITLE>False-positive 111In-labeled leukocyte scan in cystic fibrosis.</TITLE>
<SOURCE>Clin-Nucl-Med. 1979 Jul. 4(7). P 291-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: ri</TOPIC><TOPIC>INDIUM: du</TOPIC><TOPIC>RADIOISOTOPES: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ABDOMEN: ri</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFLAMMATION: ri</TOPIC><TOPIC>ISOTOPE-LABELING</TOPIC><TOPIC>LEUKOCYTES</TOPIC><TOPIC>LUNG-DISEASES: ri</TOPIC><TOPIC>PELVIS: ri</TOPIC></MINORSUBJ>
<ABSTRACT>A false-positive 111In-labeled leukocyte scan was obtained in a girl
with cystic fibrosis and infection. There was focal accumulation of
111In activity in the abdomen and marked pulmonary uptake. Surgical
exploration and postmortem examination revealed no abdominal
abnormality. The abnormal activity was apparently due to swallowed
sputum which contained labeled leukocytes. Broader clinical
implications are discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="THAKUR ML" publication="J NUCL MED" d1="18" d2="1014" d3="977"/>
<CITE num="002" author="THAKUR ML" publication="J LAB CLIN MED" d1="89" d2="217" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79084</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ODWIN DA            CL" publication="IN NUCL MED" d1="8" d2="36 9" d3="3"/>
<CITE num="2" author="KIPPER MS" publication="CLIN NUCL MED" d1="8" d2="449" d3="983"/>
<CITE num="3" author="KRIEVES DA" publication="CLIN NUCL MED" d1="8" d2="243" d3="983"/>
<CITE num="4" author="GAINEY MA" publication="CLIN NUCL MED" d1="9" d2="71" d3="984"/>
<CITE num="5" author="LOKEN MK" publication="CLIN NUCL MED" d1="10" d2="902" d3="985"/>
<CITE num="6" author="LOMENA F" publication="MED CLIN" d1="84" d2="58" d3="985"/>
<CITE num="7" author="MCAFEE JG" publication="RADIOLOGY" d1="155" d2="221" d3="985"/>
<CITE num="8" author="FLOYD JL" publication="J NUCL MED" d1="27" d2="495" d3="986"/>
<CITE num="9" author="DATZ FL" publication="RADIOLOGY" d1="160" d2="635" d3="986"/>
<CITE num="10" author="WILLIAMSON SL" publication="CLIN NUCL MED" d1="12" d2="27" d3="987"/>
</CITATIONS>
<RECORDNUM>01064 </RECORDNUM>
<MEDLINENUM>80090738</MEDLINENUM>
<AUTHORS><AUTHOR>Clamp-J-R</AUTHOR><AUTHOR>Gough-M</AUTHOR></AUTHORS>
<TITLE>Study of the oligosaccharide units from mucus glycoproteins of
meconium from normal infants and from cases of cystic fibrosis with
meconium ileus.</TITLE>
<SOURCE>Clin-Sci. 1979 Nov. 57(5). P 445-51.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MECONIUM: an</TOPIC><TOPIC>MUCOPROTEINS</TOPIC><TOPIC>OLIGOSACCHARIDES: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBOHYDRATES: me</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FUCOSE: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: me</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: me</TOPIC><TOPIC>MECONIUM: me</TOPIC><TOPIC>MONOSACCHARIDES: an</TOPIC></MINORSUBJ>
<ABSTRACT>1. The mucus glycoproteins in meconium from normal infants and from
infants having cystic fibrosis with meconium ileus have been studied.
2. Whereas normal meconium contained about 50% protein-bound
carbohydrate, the meconium from cystic fibrosis contained only about
10%. 3. Glycopolypeptides were prepared from the mucus of
glycoproteins. The oligosaccharide units from this material were
released and fractionated. The fractions ranged widely in size and
composition. 4. The fractions from cystic fibrosis specimens had a
significantly higher content of fucose than those from normal
specimens.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="BIOCHEM BIOPHYS RES COMMUN" d1="86" d2="787" d3="979"/>
<CITE num="002" author="ALLEN A" publication="BR MED BULL" d1="34" d2="28" d3="978"/>
<CITE num="003" author="BOORMAN KE" publication="INTRO BLOOD GROUP SEROL" d1="" d2="72" d3="970"/>
<CITE num="004" author="BUCHANAN DJ" publication="PROC SOC EXP BIOL MED" d1="77" d2="114" d3="951"/>
<CITE num="005" author="CARLSON DM" publication="J BIOL CHEM" d1="243" d2="616" d3="968"/>
<CITE num="006" author="CLAMP JR" publication="BIOCHEM SOC TRANS" d1="5" d2="1693" d3="977"/>
<CITE num="007" author="DISCHE Z" publication="ANN NY ACAD SCI" d1="106" d2="259" d3="963"/>
<CITE num="008" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="009" author="DUBOIS M" publication="ANAL CHEM" d1="28" d2="350" d3="956"/>
<CITE num="010" author="DURAND P" publication="J PEDIATR" d1="75" d2="665" d3="969"/>
<CITE num="011" author="FRASER D" publication="THESIS" d1="" d2="122" d3="974"/>
<CITE num="012" author="FRASER D" publication="CLIN CHIM ACTA" d1="59" d2="301" d3="975"/>
<CITE num="013" author="GIBBONS RA" publication="BR MED BULL" d1="34" d2="34" d3="978"/>
<CITE num="014" author="HARRIES JT" publication="BR MED BULL" d1="34" d2="75" d3="978"/>
<CITE num="015" author="LIST SJ" publication="BIOCHEM J" d1="175" d2="565" d3="978"/>
<CITE num="016" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="017" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="018" author="SCANLIN TF JR" publication="CLIN CHIM ACTA" d1="91" d2="197" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79085</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LER T               J" publication="BIOL CHEM                    2" d1="56" d2="20 9" d3="1"/>
<CITE num="2" author="SCANLIN TF" publication="BIOCHEMISTRY" d1="21" d2="491" d3="982"/>
<CITE num="3" author="WESLEY AW" publication="ADV EXP MED BIOL" d1="144" d2="145" d3="982"/>
<CITE num="4" author="WESLEY A" publication="PEDIATR RES" d1="17" d2="65" d3="983"/>
<CITE num="5" author="JACOBS LR" publication="DIG DIS SCI" d1="28" d2="422" d3="983"/>
<CITE num="6" author="RUDICK VL" publication="J CELL PHYSIOL" d1="115" d2="143" d3="983"/>
<CITE num="7" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="8" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="134" d2="1" d3="983"/>
<CITE num="9" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="135" d2="49" d3="983"/>
<CITE num="10" author="SLOMIANY A" publication="BIOCHIM BIOPHYS ACTA" d1="750" d2="253" d3="983"/>
<CITE num="11" author="CROWTHER RS" publication="J PHARMACY PHARMACOL" d1="36" d2="21" d3="984"/>
<CITE num="12" author="ALBAZZAZ FJ" publication="RESPIRATION" d1="46" d2="88" d3="984"/>
<CITE num="13" author="SCANLIN TF" publication="PEDIATR RES" d1="19" d2="368" d3="985"/>
<CITE num="14" author="EGGERMONT E" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="16" d3="985"/>
<CITE num="15" author="SMITH AC" publication="CLIN GASTROENTEROL" d1="15" d2="815" d3="986"/>
<CITE num="16" author="SCHACHTER M" publication="J HISTOCHEM CYTOCHEM" d1="34" d2="927" d3="986"/>
</CITATIONS>
<RECORDNUM>01065 </RECORDNUM>
<MEDLINENUM>79212183</MEDLINENUM>
<AUTHORS><AUTHOR>Pennington-J-E</AUTHOR></AUTHORS>
<TITLE>Pseudomonas aeruginosa infection: pathogenesis and therapy.</TITLE>
<SOURCE>Compr-Ther. 1979 May. 5(5). P 14-22.</SOURCE>
<MAJORSUBJ><TOPIC>PSEUDOMONAS-INFECTIONS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BACTERIAL-VACCINES: tu</TOPIC><TOPIC>BURNS: co</TOPIC><TOPIC>CARBENICILLIN: tu</TOPIC><TOPIC>CROSS-INFECTION: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>GENTAMICINS: tu</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOSUPPRESSION: ae</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: di, et</TOPIC><TOPIC>TICARCILLIN: tu</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC><TOPIC>WOUND-INFECTION: et</TOPIC></MINORSUBJ>
<EXTRACT>Infection with the gram-negative bacillus, Pseudomonas aeruginosa, is
less common than infections with Escherichia coli, Klebsiella
pneumoniae, and Proteus sp; however, the mortality associated with
pseudomonas sepsis exceeds that found with the more commonly isolated
gram-negative bacilli by a considerable margin.  While explanations
exist for this increased virulence of pseudomonas, including
secretions of toxic exoproducts and a high degree of antibiotic
resistance, the precise reasons for such unfavorable clinical
experience with this organism are uncertain.  The current interest in
pseudomonas infection is partly due to the ever-increasing numbers of
immunosuppressed and granulocytopenic patients seen in clinical
practice.  The organism, pathogenesis, clinical presentations (burn
patients, nosocomial infections, immunosuppressed patients, cystic
fibrosis), and therapy are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="REYNOLDS HY" publication="ANN INTERN MED" d1="82" d2="819" d3="975"/>
<CITE num="002" author="LIU PV" publication="J INFECT DIS SUPPL" d1="130" d2="94" d3="974"/>
<CITE num="003" author="YOUNG LS" publication="J INFECT DIS SUPPL" d1="130" d2="111" d3="974"/>
<CITE num="004" author="TAPPER ML" publication="J INFECT DIS SUPPL" d1="130" d2="14" d3="974"/>
<CITE num="005" author="STEVENS RM" publication="ARCH INTERN MED" d1="134" d2="106" d3="974"/>
<CITE num="006" author="IANNINI PB" publication="JAMA" d1="230" d2="558" d3="974"/>
<CITE num="007" author="PENNINGTON JE" publication="AM J MED" d1="55" d2="155" d3="973"/>
<CITE num="008" author="SCHIMPFF SC" publication="ANN INTERN MED" d1="77" d2="707" d3="972"/>
<CITE num="009" author="PENNINGTON JE" publication="J INFECT DIS" d1="131" d2="158" d3="975"/>
<CITE num="010" author="NOONE P" publication="BR MED J" d1="1" d2="477" d3="974"/>
<CITE num="011" author="ANDRIOLE VT" publication="J INFECT DIS" d1="129" d2="124" d3="974"/>
<CITE num="012" author="PARRY MF" publication="AM J MED" d1="64" d2="961" d3="978"/>
<CITE num="013" author="KLASTERSKY J" publication="CHEST" d1="61" d2="117" d3="972"/>
<CITE num="014" author="FEELEY TW" publication="N ENGL J MED" d1="293" d2="471" d3="975"/>
<CITE num="015" author="PENNINGTON JE" publication="J INFECT DIS SUPPL" d1="130" d2="159" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79086</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IMBACH DM           RE" publication="V INFECT DIS" d1="6" d2="44 9" d3="4"/>
<CITE num="2" author="KNOLLE P" publication="BURNS" d1="11" d2="54" d3="984"/>
<CITE num="3" author="HOLDER IA" publication="CAN J MICROBIOL" d1="31" d2="393" d3="985"/>
<CITE num="4" author="SCHENTAG JJ" publication="AM J MED" d1="78" d2="34" d3="985"/>
</CITATIONS>
<RECORDNUM>01066 </RECORDNUM>
<MEDLINENUM>80112075</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenlund-M-L</AUTHOR><AUTHOR>Walsh-E-P</AUTHOR><AUTHOR>Scott-D-A</AUTHOR><AUTHOR>Kritchevsky-D</AUTHOR></AUTHORS>
<TITLE>Lipids in cystic fibrosis.</TITLE>
<SOURCE>Curr-Concepts-Nutr. 1979. 8. P 219-27. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC><TOPIC>DIETARY-FATS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, me</TOPIC><TOPIC>FATTY-ACIDS: bl, me</TOPIC><TOPIC>FATTY-ACIDS-ESSENTIAL: df</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OILS</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>There are certain aspects of the symptomatology of cystic fibrosis
that bear a resemblance to those of essential fatty acid deficiency.
We fed a group of patients essential fatty acids orally since
intravenous administration is not a practical method for long term
treatment.  Results of the study were varied.  Although some response
was noted in all patients, there were no consistent clinical changes
seen in every patient.  The oral EFA therapy effected no change in
sputum cultures.  After one year of EFA, the sweat sodium
concentration was lower in all but one patient.  The clinical aspect
of our study is small, but promising.  The results suggest a role for
EFAs in the care of CF.  Whether EFA is a factor in the etiology of
CF or merely a manifestation of malabsorption requires further
investigation.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WARWICK WJ" publication="JAMA" d1="238" d2="2159" d3="977"/>
<CITE num="002" author="BURR GO" publication="J BIOL CHEM" d1="86" d2="587" d3="930"/>
<CITE num="003" author="KRAMAR J" publication="J NUTR" d1="50" d2="149" d3="953"/>
<CITE num="004" author="HANSEN AE" publication="TEX REP BIOL MED" d1="9" d2="491" d3="951"/>
<CITE num="005" author="HANSEN AE" publication="PEDIATRICS" d1="31" d2="171" d3="963"/>
<CITE num="006" author="ELLIOTT RB" publication="PEDIATR RES" d1="7" d2="427" d3="973"/>
<CITE num="007" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="008" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="009" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="010" author="KUO PT" publication="J CLIN INVEST" d1="44" d2="1924" d3="965"/>
<CITE num="011" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="012" author="WIESE HF" publication="AM J CLIN NUTR" d1="18" d2="155" d3="966"/>
<CITE num="013" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="014" author="BENNETT MJ" publication="AM J CLIN NUTR" d1="20" d2="415" d3="967"/>
<CITE num="015" author="ROSENLUND ML" publication="NATURE" d1="251" d2="719" d3="974"/>
<CITE num="016" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="017" author="MOHRHAUER H" publication="J LIPID RES" d1="4" d2="151" d3="963"/>
<CITE num="018" author="PELUFFO RO" publication="BIOCHIM BIOPHYS ACTA" d1="441" d2="25" d3="976"/>
<CITE num="019" author="SPRECHER H" publication="IN: KUNAU WH" d1="" d2="1" d3="977"/>
<CITE num="020" author="HOWARD BV" publication="BIOCHIM BIOPHYS ACTA" d1="187" d2="293" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79087</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RNHAM MJ            AG" publication="ENTS ACTIONS" d1="14" d2="23 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01067 </RECORDNUM>
<MEDLINENUM>80112266</MEDLINENUM>
<AUTHORS><AUTHOR>Houstek-J</AUTHOR><AUTHOR>Zapletal-A</AUTHOR><AUTHOR>Samanek-M</AUTHOR><AUTHOR>Vavrova-V</AUTHOR></AUTHORS>
<TITLE>Obstruction of the respiratory pathways, its evaluation by methods
of functional examination of the lungs and development in patients
with cystic fibrosis.</TITLE>
<SOURCE>Czech-Med. 1979. 2(1-2). P 1-10.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AIRWAY-OBSTRUCTION: et</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FORCED-EXPIRATORY-FLOW-RATES</TOPIC><TOPIC>FUNCTIONAL-RESIDUAL-CAPACITY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESIDUAL-VOLUME</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>TOTAL-LUNG-CAPACITY</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>In 28 patients with cystic fibrosis aged 5--24 years the values of
maximum expiratory flow rates (Vmax) at lower volume levels were
assessed, as well as the "specific" conductance of the respiratory
pathways (Gaw/TGV), the vital capacity (VC), total lung capacity
(TLC), residual volume (RV), functional residual capacity (FRC),
RV/TLC and FRC/TLC ratios and the one-second forced expiration of the
vital capacity (FEV1) to evaluate obstruction of the respiratory
pathways. Most markedly and most frequently abnormal were the values
of Vmax, RV and of the RV/TLC ratio. These findings revealed that in
almost all patients with CF there was already during the initial
examination an obstruction of the peripheral respiratory pathways and
hyperinflation of the lungs. During repeated measurement of the above
values of lung function in 15 patients with cystic fibrosis during a
period of 1--5 years when the patients increased in height by 10 cm
on average, the above values did not deteriorate on average. There
was, however, an individual variability of the investigated values
during this period. The comprehensive treatment provided in our
country prevented in patients with CF a deterioration of obstruction
of the respiratory pathways during the period of investigation.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79088</PAPERNUM>
<REFERENCES>
<CITE num="001" author="COOK CD" publication="PEDIATRICS" d1="24" d2="181" d3="959"/>
<CITE num="002" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="003" author="HOUSTEK J" publication="Z ERKR ATMUNGSORGANE" d1="139" d2="7" d3="974"/>
<CITE num="004" author="HOUSTEK J" publication="PRAKT LEKAR" d1="49" d2="216" d3="969"/>
<CITE num="005" author="VAVROVA V" publication="CESK PEDIATR" d1="28" d2="528" d3="973"/>
<CITE num="006" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
<CITE num="007" author="ZAPLETAL A" publication="CESK PEDIATR" d1="31" d2="532" d3="976"/>
<CITE num="008" author="ZAPLETAL A" publication="CESK PEDIATR" d1="32" d2="513" d3="977"/>
<CITE num="009" author="ZAPLETAL A" publication="Z ERKR ATMUNGSORGANE" d1="149" d2="343" d3="977"/>
</REFERENCES>
<RECORDNUM>01068 </RECORDNUM>
<MEDLINENUM>80070028</MEDLINENUM>
<AUTHORS><AUTHOR>Harris-A</AUTHOR></AUTHORS>
<TITLE>Prenatal diagnosis of cystic fibrosis [letter].</TITLE>
<SOURCE>Dev-Med-Child-Neurol. 1979 Oct. 21(5). P 675-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>PRENATAL-DIAGNOSIS: mt</TOPIC></MINORSUBJ>
<EXTRACT>As far as I know, no test for the prenatal diagnosis of cystic
fibrosis has yet been shown to be reliable, but several experimental
studies on prenatal diagnosis of cystic fibrosis are being carried
out.  Deficient protease activity, assayed by 4-methylumbelliferyl
guanidinobenzoate, an active site titrant of serine proteases, has
been reported in plasma and cultivated skin fibroblasts from patients
with cystic fibrosis.  Another prenatal diagnostic test for cystic
fibrosis involves the observed resistance of patients' skin
fibroblasts to dexamethasone (a synthetic glucocorticoid) toxicity,
in comparison to normal fibroblasts.  Specific induction of alkaline
phosphatase with Tamm Horsfall glycoprotein, isoproterenol and
theophylline has been recorded in skin-derived fibroblasts from
affected patients.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79089</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WALSH-PLATT M" publication="AM J HUM GENET" d1="29" d2="111A" d3="977"/>
<CITE num="002" author="RAO GJS" publication="ENZYME" d1="23" d2="314" d3="978"/>
<CITE num="003" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="874" d3="978"/>
<CITE num="004" author="WALSH-PLATT M" publication="LANCET" d1="1" d2="622" d3="979"/>
<CITE num="005" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="006" author="BRESLOW JL" publication="CELL" d1="13" d2="663" d3="978"/>
<CITE num="007" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="008" author="HOSLI P" publication="HUM GENET" d1="41" d2="169" d3="978"/>
</REFERENCES>
<RECORDNUM>01069 </RECORDNUM>
<MEDLINENUM>79192319</MEDLINENUM>
<AUTHORS><AUTHOR>MacLeod-S-M</AUTHOR></AUTHORS>
<TITLE>Clinical pharmacology in a paediatric hospital.</TITLE>
<SOURCE>Dimens-Health-Serv. 1979 May. 56(5). P 33-4.</SOURCE>
<MAJORSUBJ><TOPIC>DRUG-THERAPY: st</TOPIC><TOPIC>HOSPITALS-PEDIATRIC</TOPIC><TOPIC>HOSPITALS-SPECIAL</TOPIC><TOPIC>PEDIATRICS</TOPIC><TOPIC>PHARMACOLOGY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CANADA</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMMUNICABLE-DISEASES: dt</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>SUBSTANCE-ABUSE</TOPIC><TOPIC>DRUG-EVALUATION</TOPIC><TOPIC>DRUG-INFORMATION-SERVICES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>NERVOUS-SYSTEM-DISEASES: dt</TOPIC><TOPIC>PHARMACOLOGY: ed, td</TOPIC><TOPIC>PHARMACY-SERVICE-HOSPITAL</TOPIC><TOPIC>RESEARCH</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79090</PAPERNUM>
<EXTRACT>Despite the critical role played by a clinical pharmacologist, there
are only three in Canada who specialize in paediatrics.  The role of
paediatric clinical pharmacologists in the promotion of safer and
more effective drug use, in research, in teaching, and in service are
discussed, as well as contributions from clinical pharmacology.</EXTRACT>
<RECORDNUM>01070 </RECORDNUM>
<MEDLINENUM>80024183</MEDLINENUM>
<AUTHORS><AUTHOR>Walsh-Platt-M</AUTHOR><AUTHOR>Rao-G-J</AUTHOR><AUTHOR>Nadler-H-L</AUTHOR></AUTHORS>
<TITLE>Protease deficiency in plasma of patients with cystic fibrosis.
Reduced reaction of 4-methylumbelliferylguanidinobenzoate with
plasma of patients with cystic fibrosis.</TITLE>
<SOURCE>Enzyme. 1979. 24(4). P 224-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HYMECROMONE: bl</TOPIC><TOPIC>PEPTIDE-HYDROLASES: df</TOPIC><TOPIC>UMBELLIFERONES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BENZAMIDINES: pd</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>GUANIDINES: bl, me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYMECROMONE: aa, me</TOPIC><TOPIC>PEPTIDE-HYDROLASES: bl</TOPIC><TOPIC>TRYPSIN-INHIBITORS: me</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Protease activity in plasma is assayed using 4-
methylumbelliferylguanidinobenzoate. The assay is modified by
carrying out the reaction in the presence and absence of benzamidine,
a competitive inhibitor of trypsin-like proteases. The parameters of
the assay are described in detail. Using this assay, our earlier
demonstration of a deficiency of protease activity in plasma of
patients with cystic fibrosis is confirmed. The activity, corrected
for the nonspecific hydrolysis of 4-
methylumbelliferylguanidinobenzoate by benzamidine, is expressed as
nanomoles of 4-methylumbelliferone released per milliliter plasma.
Under standard conditions, the activity in plasma activated with
chloroform-ellagic acid was 127.2 +/- 23.1 in 7 controls, 70.4 +/-
11.7 in 11 obligate heterozygotes, and 48.7 +/- 16.6 in 12 patients
with cystic fibrosis. Identical results were obtained when
unactivated plasma was used. These data demonstrate that the
judicious use of specific inhibitors such as benzamidine might be
useful in assaying low levels of protease activity in crude systems.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARMITAGE P" publication="STATISTICAL METHODS IN MEDICA" d1="" d2="" d3="971"/>
<CITE num="002" author="BENDER ML" publication="J AM CHEM SOC" d1="88" d2="5890" d3="966"/>
<CITE num="003" author="CHASE T JR" publication="BIOCHEMISTRY" d1="8" d2="2212" d3="969"/>
<CITE num="004" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="005" author="RAO GJS" publication="J PEDIATR" d1="80" d2="573" d3="972"/>
<CITE num="006" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="007" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="008" author="RAO GJS" publication="SCIENCE" d1="177" d2="610" d3="972"/>
<CITE num="009" author="RAO GJS" publication="ENZYME" d1="23" d2="314" d3="978"/>
<CITE num="010" author="WALSH-PLATT M" publication="AM J HUM GENET" d1="29" d2="111A" d3="977"/>
<CITE num="011" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="874" d3="978"/>
<CITE num="012" author="WALSH-PLATT M" publication="LANCET" d1="1" d2="622" d3="979"/>
<CITE num="013" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="874" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79091</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DLER HL             LA" publication="NCET" d1="2" d2="96 9" d3="0"/>
<CITE num="2" author="NADLER HL" publication="PEDIATRICS" d1="66" d2="690" d3="980"/>
<CITE num="3" author="WALSH MMJ" publication="AM J OBSTET GYNECOL" d1="137" d2="978" d3="980"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="5" author="SCHWARTZ M" publication="LANCET" d1="2" d2="1226" d3="981"/>
<CITE num="6" author="BRANCHINI BR" publication="LANCET" d1="1" d2="618" d3="982"/>
<CITE num="7" author="CAREY WF" publication="MED J AUST" d1="2" d2="314" d3="982"/>
<CITE num="8" author="BURY AF" publication="PEDIATR RES" d1="16" d2="613" d3="982"/>
<CITE num="9" author="SCHWARTZ M" publication="CLIN CHIM ACTA" d1="124" d2="213" d3="982"/>
<CITE num="10" author="TUMMLER B" publication="CLIN CHIM ACTA" d1="125" d2="219" d3="982"/>
<CITE num="11" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="12" author="CAREY WF" publication="MED J AUST" d1="2" d2="528" d3="983"/>
<CITE num="13" author="BROCK DJH" publication="PRENAT DIAGN" d1="3" d2="1" d3="983"/>
<CITE num="14" author="POENARU L" publication="PRENAT DIAGN" d1="3" d2="169" d3="983"/>
<CITE num="15" author="BRANCHINI BR" publication="PEDIATR RES" d1="17" d2="850" d3="983"/>
<CITE num="16" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="17" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="18" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="19" author="ANON" publication="LANCET" d1="2" d2="249" d3="985"/>
<CITE num="20" author="QURESHI AR" publication="J PEDIATR" d1="106" d2="913" d3="985"/>
</CITATIONS>
<RECORDNUM>01071 </RECORDNUM>
<MEDLINENUM>79169319</MEDLINENUM>
<AUTHORS><AUTHOR>Paporisz-U</AUTHOR><AUTHOR>Posselt-H-G</AUTHOR><AUTHOR>Wonne-R</AUTHOR><AUTHOR>Ristow-W</AUTHOR><AUTHOR>Roser-D</AUTHOR><AUTHOR>Knothe-H</AUTHOR><AUTHOR>Bender-S-W</AUTHOR></AUTHORS>
<TITLE>Evaluation of long term tobramycin therapy in patients with cystic
fibrosis and advanced pulmonary disease.</TITLE>
<SOURCE>Eur-J-Pediatr. 1979 Apr 3. 130(4). P 259-69.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>LUNG-DISEASES: dt</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: ra</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: ra</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>TOBRAMYCIN: ad, ae</TOPIC></MINORSUBJ>
<ABSTRACT>To nine cystic fibrosis patients with chronic bronchopulmonary
infection of severely damaged lungs invaded by Pseudomonas
aeruginosa, eleven courses of prolonged tobramycin treatment (5
mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms
improved and a better quality of life was achieved in all but one
patient. Objective parameters (chest X-ray, pulmonary function tests)
changed to a lesser extent. In only one patient was Pseudomonas
eradicated from the sputum but reappeared after discontinuation of
therapy. In the rest of the patients Pseudomonas was significantly
suppressed or replaced by other pathogens. Four patients showed rises
of antibody titres to Candida and two to Aspergillus fumigatus. No
nephrotoxic side effects were observed, but vestibular function was
reversibly impaired in one patient without corresponding clinical
symptoms. No bacterial resistance to tobramycin was observed during
therapy.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79092</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BOXERBAUM B" publication="J INFECT DIS SUPPL" d1="124" d2="293" d3="971"/>
<CITE num="002" author="DOGGETT RG" publication="SOUTH MED J" d1="61" d2="1347" d3="968"/>
<CITE num="003" author="DOGGETT RG" publication="J BACTERIOL" d1="87" d2="427" d3="964"/>
<CITE num="004" author="DOGGETT RG" publication="SOUTH MED J" d1="57" d2="1476" d3="964"/>
<CITE num="005" author="DOGGETT RG" publication="SOUTH MED J" d1="57" d2="1470" d3="964"/>
<CITE num="006" author="DOGGETT RG" publication="SOUTH MED J" d1="61" d2="1346" d3="968"/>
<CITE num="007" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="008" author="DOGGETT RG" publication="BACT PROC" d1="69" d2="87" d3="969"/>
<CITE num="009" author="DOGGETT RG" publication="INFECT IMMUN" d1="6" d2="628" d3="972"/>
<CITE num="010" author="HAWLEY HB" publication="CURR THER RES" d1="16" d2="414" d3="974"/>
<CITE num="011" author="HARRISON GM" publication="PAEDIATRICIAN" d1="1" d2="180" d3="972"/>
<CITE num="012" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="013" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="014" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="015" author="HUMPHREY JH" publication="ADV IMMUNOL" d1="11" d2="75" d3="969"/>
<CITE num="016" author="MAY JR" publication="CHEMOTHERAPY OF CHRONIC BRONC" d1="" d2="" d3="968"/>
<CITE num="017" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="018" author="WAITZ JA" publication="ANTIMICROB AGENTS CHEMOTHER" d1="2" d2="431" d3="972"/>
</REFERENCES>
<RECORDNUM>01072 </RECORDNUM>
<MEDLINENUM>80004150</MEDLINENUM>
<AUTHORS><AUTHOR>Hosli-P</AUTHOR><AUTHOR>Vogt-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: decreased thermostability of alpha-mannosidase in
crude extracellular fluids of patients and carriers.</TITLE>
<SOURCE>FEBS-Lett. 1979 Aug 15. 104(2). P 271-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>EXTRACELLULAR-SPACE: en</TOPIC><TOPIC>MANNOSIDASES: me</TOPIC><TOPIC>SKIN: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>DRUG-STABILITY</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HEAT</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC></MINORSUBJ>
<EXTRACT>We wish to demonstrate that an abnormal thermostability has been
found in crude extracellular fluids for alpha-mannosidase.  More
extensive studies involving several of the 'leaky' hydrolases are
under way and they indicate that the observed thermolabilities can
be exploited to develop the urgently needed simple diagnostic tools
for cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="004" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="43" d2="695" d3="968"/>
<CITE num="005" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="006" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="007" author="PAPP Z" publication="CLIN GENET" d1="11" d2="431" d3="977"/>
<CITE num="008" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="009" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="010" author="HOSLI P" publication="PROC INT CF CONG 7TH" d1="" d2="278" d3="976"/>
<CITE num="011" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="979"/>
<CITE num="012" author="NEUFELD EF" publication="J SUPRAMOL STRUCT" d1="6" d2="95" d3="977"/>
<CITE num="013" author="KAPLAN A" publication="PROC NAT ACAD SCI USA" d1="74" d2="2026" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79093</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RANI S              LA" publication="NCET" d1="2" d2="06 9" d3="9"/>
<CITE num="2" author="HOSLI P" publication="FEBS LETTERS" d1="106" d2="U421" d3="979"/>
<CITE num="3" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="4" author="CAREY WF" publication="MED J AUST" d1="2" d2="314" d3="982"/>
<CITE num="5" author="CRISTOL P" publication="SEM HOP PARIS" d1="58" d2="449" d3="982"/>
<CITE num="6" author="CEDER O" publication="CLIN GENET" d1="23" d2="298" d3="983"/>
<CITE num="7" author="CEDER O" publication="ACTA PAEDIATR SCAND" d1="72" d2="291" d3="983"/>
<CITE num="8" author="KOHLSCHUTTER A" publication="FEBS LETTERS" d1="155" d2="223" d3="983"/>
<CITE num="9" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="10" author="BOZON D" publication="ARCH BIOCHEM BIOPHYS" d1="249" d2="546" d3="986"/>
</CITATIONS>
<RECORDNUM>01073 </RECORDNUM>
<MEDLINENUM>80114944</MEDLINENUM>
<AUTHORS><AUTHOR>Kraemer-R</AUTHOR><AUTHOR>Rudeberg-A</AUTHOR><AUTHOR>Klay-M</AUTHOR><AUTHOR>Rossi-E</AUTHOR></AUTHORS>
<TITLE>Relationship between clinical conditions, radiographic findings and
pulmonary functions in patients with cystic fibrosis.</TITLE>
<SOURCE>Helv-Paediatr-Acta. 1979. 34(5). P 417-28.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BLOOD-GAS-ANALYSIS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, ra</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>FUNCTIONAL-RESIDUAL-CAPACITY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PARTIAL-PRESSURE</TOPIC><TOPIC>TOTAL-LUNG-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>Clinical and radiological findings, quantified by special scores, in
36 patients with cystic fibrosis are compared with lung function
measurements, including the ratio of RV/TLC and FEV/VC and the
arterial blood gases at rest and during exercise. Although
respiratory function tests were found to correlate well with both the
pulmonary finding score and the chest radiographic score, distinction
of three severity groups was possible only by a vector calculation of
the blood gases in PaO2-PaCO2-diagram, at rest and during exercise.
Thus, measurements of pO2 and pCO2 at rest and on exercise appear to
be a helpful adjuvant to routine spirometry for the individual
appraisal of the degree of lung involvement, performance and care
level.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BACHOFEN H" publication="SCHWEIZ MED WOCHENSCHR" d1="102" d2="1061" d3="972"/>
<CITE num="002" author="BACHOFEN H" publication="J APPL PHYSIOL" d1="34" d2="137" d3="973"/>
<CITE num="003" author="BACHOFEN H" publication="PNEUMONOLOGY" d1="153" d2="160" d3="976"/>
<CITE num="004" author="BATSCHELET E" publication="STATISTICAL METHODS FOR THE A" d1="" d2="" d3="965"/>
<CITE num="005" author="BEIER FR" publication="AM REV RESPIR DIS" d1="94" d2="430" d3="966"/>
<CITE num="006" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="007" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="008" author="DEMUTH GR" publication="AM J DIS CHILD" d1="103" d2="129" d3="962"/>
<CITE num="009" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="010" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="011" author="FEATHERBY EA" publication="AM REV RESPIR DIS" d1="102" d2="737" d3="970"/>
<CITE num="012" author="GODFREY S" publication="ARCH DIS CHILD" d1="45" d2="534" d3="970"/>
<CITE num="013" author="GODFREY S" publication="ARCH DIS CHILD" d1="46" d2="144" d3="971"/>
<CITE num="014" author="GODFREY S" publication="ARCH DIS CHILD" d1="53" d2="83" d3="978"/>
<CITE num="015" author="GREENWOOD JA" publication="ANN MATH STAT" d1="26" d2="233" d3="955"/>
<CITE num="016" author="JOHNSON RL JR" publication="J APPL PHYSIOL" d1="25" d2="1" d3="968"/>
<CITE num="017" author="KNOKE JD" publication="PEDIATR RES" d1="12" d2="676" d3="978"/>
<CITE num="018" author="KRAEMER R" publication="MONOGR PAEDIATR" d1="10" d2="61" d3="979"/>
<CITE num="019" author="KRAEMER R" publication="PADIAT FORTBILDK PRAXIS" d1="48" d2="7" d3="979"/>
<CITE num="020" author="LAMARRE A" publication="PEDIATRICS" d1="50" d2="291" d3="972"/>
<CITE num="021" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="022" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="111" d2="725" d3="975"/>
<CITE num="023" author="MARDIA KV" publication="STATISTICS OF DIRECTION DATA" d1="" d2="" d3="972"/>
<CITE num="024" author="MATTHEW DJ" publication="PEDIATR RADIOL" d1="5" d2="198" d3="977"/>
<CITE num="025" author="MEARNS MB" publication="ARCH DIS CHILD" d1="43" d2="528" d3="968"/>
<CITE num="026" author="MELLINS RB" publication="PEDIATRICS" d1="44" d2="315" d3="969"/>
<CITE num="027" author="PHELAN PD" publication="ARCH DIS CHILD" d1="44" d2="393" d3="969"/>
<CITE num="028" author="STRUTT JW" publication="NATURE" d1="72" d2="318" d3="905"/>
<CITE num="029" author="SCHERRER M" publication="SCHWEIZ MED WOCHENSCHR" d1="107" d2="1072" d3="977"/>
<CITE num="030" author="SPEARMAN C" publication="AM J PSYCHOL" d1="15" d2="72" d3="904"/>
<CITE num="031" author="WATSON GS" publication="BIOMETRIKA" d1="43" d2="344" d3="956"/>
<CITE num="032" author="WEST JB" publication="N ENGL J MED" d1="284" d2="1232" d3="971"/>
<CITE num="033" author="WEST JB" publication="J APPL PHYSIOL" d1="30" d2="479" d3="971"/>
<CITE num="034" author="WHEELER S" publication="BIOMETRIKA" d1="51" d2="256" d3="964"/>
<CITE num="035" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79094</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AEMER R             ME" publication="TH INF MED" d1="19" d2="50 9" d3="0"/>
<CITE num="2" author="KRAEMER R" publication="EUR J RESPIR DIS" d1="61" d2="118" d3="980"/>
<CITE num="3" author="KRAEMER R" publication="EUR J PEDIATR" d1="138" d2="172" d3="982"/>
<CITE num="4" author="HARMS HK" publication="KLIN PAEDIATR" d1="195" d2="24" d3="983"/>
<CITE num="5" author="SUTER S" publication="J INFECT DIS" d1="149" d2="523" d3="984"/>
<CITE num="6" author="SUTER S" publication="PEDIATR RES" d1="19" d2="346" d3="985"/>
<CITE num="7" author="SCHAAD UB" publication="ACTA PAEDIATR SCAND" d1="75" d2="128" d3="986"/>
</CITATIONS>
<RECORDNUM>01074 </RECORDNUM>
<MEDLINENUM>80114945</MEDLINENUM>
<AUTHORS><AUTHOR>Strauss-R-G</AUTHOR></AUTHORS>
<TITLE>Complement in cystic fibrosis.</TITLE>
<SOURCE>Helv-Paediatr-Acta. 1979. 34(5). P 429-35.</SOURCE>
<MAJORSUBJ><TOPIC>COMPLEMENT-3: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPLEMENT-PATHWAY-ALTERNATIVE</TOPIC><TOPIC>COMPLEMENT-PATHWAY-CLASSICAL</TOPIC><TOPIC>COMPLEMENT-3B-INACTIVATORS: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INULIN: du</TOPIC></MINORSUBJ>
<ABSTRACT>Quantitative and functional assessments were made of both the
classical and alternative pathways of complement activation in sera
from 23 patients with cystic fibrosis. The classical pathway
functioned similarly in patients and controls as measured by CH50
titre. Alternative pathway function, initiated in patient sera by
incubation with inulin, was equal to that of controls as determined
by cleavage of Factor B and C3, and by the consumption of terminal
components. Factor B, however, was more readily activated in patient
than in control sera. This rapid alteration of Factor B did not lead
to accelerated or more extensive activation of the terminal
complement components via the alternative pathway when assessed by C3
cleavage and the consumption of terminal components. Thus, a
complement deficiency was not found. The importance of the easily
activated Factor B is undefined.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="002" author="BUESCHER ES" publication="J PEDIATR" d1="93" d2="530" d3="978"/>
<CITE num="003" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="004" author="CONOVER JH" publication="TEX REP BIOL MED" d1="34" d2="45" d3="976"/>
<CITE num="005" author="FORRISTAL J" publication="CLIN EXP IMMUNOL" d1="23" d2="61" d3="977"/>
<CITE num="006" author="GOTZ M" publication="EUR J PEDIATR" d1="127" d2="133" d3="978"/>
<CITE num="007" author="GOTZE O" publication="J EXP MED" d1="134" d2="90S" d3="971"/>
<CITE num="008" author="HOLZHAUER RJ" publication="PEDIATR RES" d1="10" d2="365" d3="976"/>
<CITE num="009" author="HANN S" publication="LANCET" d1="2" d2="520" d3="974"/>
<CITE num="010" author="KABAT EA" publication="EXPERIMENTAL IMMUNOCHEMISTRY" d1="" d2="" d3="961"/>
<CITE num="011" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="111" d2="100" d3="975"/>
<CITE num="012" author="LYRENE RK" publication="J PEDIATR" d1="91" d2="681" d3="977"/>
<CITE num="013" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="014" author="SCANLIN TF JR" publication="LANCET" d1="1" d2="1382" d3="974"/>
<CITE num="015" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="016" author="STRAUSS RG" publication="PEDIATR RES" d1="11" d2="285" d3="977"/>
<CITE num="017" author="STRUNK RC" publication="ARCH DIS CHILD" d1="52" d2="687" d3="977"/>
<CITE num="018" author="WEST CD" publication="J IMMUNOL" d1="96" d2="650" d3="966"/>
<CITE num="019" author="WILSON GB" publication="J LAB CLIN MED" d1="92" d2="463" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79095</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EERT DP             SU" publication="RV SYNTH PATHOL RES" d1="4" d2="14 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01075 </RECORDNUM>
<MEDLINENUM>80005196</MEDLINENUM>
<AUTHORS><AUTHOR>Cusack-D</AUTHOR><AUTHOR>Cannon-D</AUTHOR><AUTHOR>Skrabanek-P</AUTHOR><AUTHOR>Powell-D</AUTHOR></AUTHORS>
<TITLE>Substance P plasma levels in pregnancy and in various clinical
disorders.</TITLE>
<SOURCE>Horm-Metab-Res. 1979 Jul. 11(7). P 448-51.</SOURCE>
<MAJORSUBJ><TOPIC>PREGNANCY</TOPIC><TOPIC>SUBSTANCE-P: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-DISEASES: bl</TOPIC><TOPIC>NEOPLASMS: bl</TOPIC><TOPIC>RADIOIMMUNOASSAY</TOPIC><TOPIC>THYROID-DISEASES: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Using radioimmunoassay, immunoreactive SP (iSP) has been measured in
the plasma of 162 hospital patients with various disorders and in the
plasma of 67 pregnant women. In pregnancy, iSP was undetectable in
40% women as compared to 12% in other hospital patients. The mean iSP
plasma level in pregnancy was 37.8 +/- 4.6 (SEM) as compared to 77.1
+/- 4.9 (SEM) pg/ml in other hospital patients. The results support
earlier observations based on bioassay, suggesting that the blood of
pregnant women contains higher concentrations of a SP-inactivating
factor. Of the hospital patients, elevated levels of iSP were found
in patients with chronic leukaemia, in one patient with a basaloid
carcinoma of the anus, and in one patient with toxic liver damage and
pancreatic insufficiency. No correlation was found between thyroid
function and iSP plasma levels. ISP plasma levels in various
gastrointestinal disorders were similar to those found in normal
subjects.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALUMETS J" publication="HISTOCHEMISTRY" d1="52" d2="217" d3="977"/>
<CITE num="002" author="CANNON D" publication="BIOCHEM SOC TRANS" d1="5" d2="1776" d3="977"/>
<CITE num="003" author="EHRENPREIS T" publication="ACTA PHYSIOL SCAND" d1="27" d2="380" d3="953"/>
<CITE num="004" author="HARKINS J" publication="BRAIN RES" d1="147" d2="405" d3="978"/>
<CITE num="005" author="KOCIC-METROVIC D" publication="PROC SCI SOC BOSNIA HERZEGOVI" d1="1" d2="113" d3="961"/>
<CITE num="006" author="NAKANO T" publication="JAPAN J PHARMACOL" d1="25" d2="43P" d3="975"/>
<CITE num="007" author="OCONNELL R" publication="IR J MED SCI" d1="145" d2="392" d3="976"/>
<CITE num="008" author="PARTINGTON MW" publication="ARCH DIS CHILD" d1="52" d2="386" d3="977"/>
<CITE num="009" author="PEARSE AGE" publication="HISTOCHEMISTRY" d1="41" d2="373" d3="975"/>
<CITE num="010" author="PERNOW B" publication="PROC SCI SOC BOSNIA HERZEGOVI" d1="1" d2="57" d3="961"/>
<CITE num="011" author="POLAK JM" publication="IN: FUJITA T" d1="" d2="103" d3="976"/>
<CITE num="013" author="SKRABANEK PD" publication="IR J MED SCI" d1="145" d2="399" d3="976"/>
<CITE num="014" author="SKRABANEK PD" publication="IR J MED SCI" d1="147" d2="47" d3="978"/>
<CITE num="015" author="SKRABANEK PD" publication="SUBSTANCE P" d1="" d2="" d3="978"/>
<CITE num="016" author="STERN PI" publication="PROC SCI SOC BOSNIA HERZEGOVI" d1="1" d2="139" d3="961"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79096</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RABANEK P           EU" publication="R J OBSTE GYNECOL REPR BIOL" d1="11" d2="57 9" d3="0"/>
<CITE num="2" author="KAIYA  H" publication="PSYCHIATRY RES" d1="5" d2="11" d3="981"/>
<CITE num="3" author="POLLOCK M" publication="NEUROLOGY" d1="32" d2="1311" d3="982"/>
<CITE num="4" author="VERMA PS" publication="EUR J PHARMACOL" d1="86" d2="275" d3="982"/>
<CITE num="5" author="SKRABANEK P" publication="OBSTET GYNECOL" d1="61" d2="641" d3="983"/>
<CITE num="6" author="SKRABANEK P" publication="IR J MED SCI" d1="153" d2="47" d3="984"/>
<CITE num="7" author="ZHANG CL" publication="ACTA ZOOL SINICA" d1="31" d2="106" d3="985"/>
</CITATIONS>
<RECORDNUM>01076 </RECORDNUM>
<MEDLINENUM>80070842</MEDLINENUM>
<AUTHORS><AUTHOR>Tucker-R-D</AUTHOR><AUTHOR>Hudrlik-T-R</AUTHOR><AUTHOR>Gibbs-G-E</AUTHOR><AUTHOR>Christensen-M-B</AUTHOR></AUTHORS>
<TITLE>The effect of serum from patients with pancreatic disease on the
short circuit current of rat jejunum.</TITLE>
<SOURCE>IEEE-Trans-Biomed-Eng. 1979 Nov. 26(11). P 607-13.</SOURCE>
<MAJORSUBJ><TOPIC>BIOLOGICAL-ASSAY: mt</TOPIC><TOPIC>JEJUNUM: ph</TOPIC><TOPIC>PANCREATIC-DISEASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>BIOLOGICAL-ASSAY: is</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>DIABETES-MELLITUS: bl</TOPIC><TOPIC>ELECTRIC-CONDUCTIVITY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MEMBRANE-POTENTIALS</TOPIC><TOPIC>PANCREATITIS: bl</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<ABSTRACT>The short circuit current rat jejunum bioassay, first employed in an
attempt to discern the cystic fibrosis (CF) serum "factor," was
evaluated using sera from patients with pancreatic disease.  The
data suggest other pancreatic diseases, specifically genetic
diabetes and alcoholic pancreatitis, also present with a serum
"factor" (or "factors") which reduce the short circuit current of
rat jejunum, an effect very similar to that of the CF serum
"factor."  A large number of sera from presumed normal subjects also
exhibited a significant reduction in short circuit current; these
(false positives) represent a yet to be defined mechanism, however,
they do decrease the likelihood that the observed effect is merely
due to pancreatic destruction.  Detailed procedure and equipment
specifications for the bioassay system are included.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="004" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="007" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="008" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="009" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="010" author="CHERRY JD" publication="J PEDIATR" d1="79" d2="937" d3="971"/>
<CITE num="011" author="POSSELT HG" publication="Z KINDERHEILK" d1="110" d2="93" d3="971"/>
<CITE num="012" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="013" author="ARAKI H" publication="PROC INT CF CONG 7TH" d1="" d2="28" d3="976"/>
<CITE num="014" author="GILMORE JP" publication="PROC SOC EXP BIOL MED" d1="157" d2="70" d3="978"/>
<CITE num="016" author="CONOVER JH" publication="LANCET" d1="1" d2="1194" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79097</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKER RD             CO" publication="MPUT BIOL MED" d1="11" d2="53 9" d3="1"/>
</CITATIONS>
<RECORDNUM>01077 </RECORDNUM>
<MEDLINENUM>79129529</MEDLINENUM>
<AUTHORS><AUTHOR>Sorensen-R-U</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Chase-P</AUTHOR><AUTHOR>Polmar-S-H</AUTHOR></AUTHORS>
<TITLE>Defective cellular immunity to gram-negative bacteria in cystic
fibrosis patients.</TITLE>
<SOURCE>Infect-Immun. 1979 Feb. 23(2). P 398-402.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIGENS-BACTERIAL: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>ENTEROBACTERIACEAE: im</TOPIC><TOPIC>LYMPHOCYTE-TRANSFORMATION</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>KLEBSIELLA-PNEUMONIAE: im</TOPIC><TOPIC>PROTEUS-MIRABILIS: im</TOPIC><TOPIC>SERRATIA-MARCESCENS: im</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>In vitro lymphocyte responses to Pseudomonas aeruginosa have been
found to be impaired in cystic fibrosis patients with advanced
clinical disease. The responses to Klebsiella pneumoniae, Serratia
marcescens, and Proteus mirabilis were studied in a similar group of
cystic fibrosis patients and normal individuals. Cystic fibrosis
patients found to be unresponsive to pseudomonas were also
unresponsive to klebsiella, serratia, and proteus. Responsiveness to
Staphylococcus aureus was not impaired in cystic fibrosis patients.
We postulate that in vitro lymphocyte responses to several gram-
negative bacteria require the function of a lymphocyte subpopulation
which may be impaired in some cystic fibrosis patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CHANDRA RK" publication="PEDIATRICS" d1="59" d2="423" d3="977"/>
<CITE num="002" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="003" author="FERGUSON AC" publication="J PEDIATR" d1="85" d2="717" d3="974"/>
<CITE num="004" author="GREEN GM" publication="AM REV RESPIR DIS" d1="102" d2="691" d3="970"/>
<CITE num="005" author="GREEN GM" publication="J EXP MED" d1="119" d2="167" d3="964"/>
<CITE num="006" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="559" d3="974"/>
<CITE num="007" author="KALTREIDER HB" publication="AM REV RESPIR DIS" d1="113" d2="347" d3="976"/>
<CITE num="008" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="116" d2="1047" d3="977"/>
<CITE num="009" author="MOORE VL" publication="RES J RETICULOENDOTHEL SOC" d1="21" d2="131" d3="977"/>
<CITE num="010" author="NEUMANN CG" publication="AM J CLIN NUTR" d1="28" d2="89" d3="975"/>
<CITE num="011" author="PRESSMAN D" publication="IN: SAUNTER M" d1="" d2="11" d3="971"/>
<CITE num="012" author="SELLMEYER E" publication="ARCH DIS CHILD" d1="47" d2="429" d3="972"/>
<CITE num="013" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="014" author="SORENSEN RU" publication="INFECT IMMUN" d1="18" d2="735" d3="977"/>
<CITE num="015" author="SORENSEN RU" publication="J PEDIATR" d1="93" d2="201" d3="978"/>
<CITE num="016" author="THORSBY E" publication="HISTOCOMPATIBILITY TESTING" d1="" d2="655" d3="970"/>
<CITE num="017" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="018" author="WARR GA" publication="AM REV RESPIR DIS" d1="108" d2="371" d3="973"/>
<CITE num="019" author="WEIGLE WO" publication="IMMUNOLOGY" d1="7" d2="239" d3="964"/>
<CITE num="020" author="WEIGLE WO" publication="J EXP MED" d1="121" d2="289" d3="965"/>
<CITE num="021" author="WEIGLE WO" publication="J IMMUNOL" d1="94" d2="117" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79098</PAPERNUM>
<CITATIONS>
<CITE num="1" author="USKANEN O           J" publication="CLIN LAB IMMUNOL" d1="4" d2="11 9" d3="0"/>
<CITE num="2" author="RUUSKANEN O" publication="J IMMUNOL" d1="125" d2="411" d3="980"/>
<CITE num="3" author="MATTHEWS WJ" publication="N ENGL J MED" d1="302" d2="245" d3="980"/>
<CITE num="4" author="SORENSEN RU" publication="PEDIATR RES" d1="15" d2="14" d3="981"/>
<CITE num="5" author="JOHNSON DL" publication="RES COMMUN CHEM PATH PHARM" d1="32" d2="377" d3="981"/>
<CITE num="6" author="RUBIN HR" publication="CELL IMMUNOL" d1="57" d2="307" d3="981"/>
<CITE num="7" author="SORENSEN RU" publication="AM REV RESPIR DIS" d1="123" d2="37" d3="981"/>
<CITE num="8" author="VANGEFFEL R" publication="ANN IMMUNOL (PARIS)" d1="D133" d2="293" d3="982"/>
<CITE num="9" author="WILSON GB" publication="MED HYPOTHESES" d1="8" d2="527" d3="982"/>
<CITE num="10" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="11" author="LILLIE MA" publication="J CLIN MICROBIOL" d1="16" d2="111" d3="982"/>
<CITE num="12" author="WOLFE JHN" publication="ARCH SURG" d1="117" d2="1266" d3="982"/>
<CITE num="13" author="MCIRVINE AJ" publication="ANN SURG" d1="196" d2="297" d3="982"/>
<CITE num="14" author="GUIDOTTI TL" publication="AM J MED SCI" d1="283" d2="157" d3="982"/>
<CITE num="15" author="RUBIN HR" publication="INFECT IMMUN" d1="39" d2="630" d3="983"/>
<CITE num="16" author="PORWOLL JM" publication="INFECT IMMUN" d1="40" d2="670" d3="983"/>
<CITE num="17" author="SORENSEN RU" publication="INFECT IMMUN" d1="41" d2="321" d3="983"/>
<CITE num="18" author="MCIRVINE AJ" publication="SURG CLIN NORTH AM" d1="63" d2="245" d3="983"/>
<CITE num="19" author="SORENSEN RU" publication="EUR J RESPIR DIS" d1="64" d2="524" d3="983"/>
<CITE num="20" author="MILLER KM" publication="CLIN EXP IMMUNOL" d1="56" d2="415" d3="984"/>
<CITE num="21" author="AUERBACH HS" publication="LANCET" d1="2" d2="686" d3="985"/>
<CITE num="22" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="23" author="ZAPATASIRVENT RI" publication="SURGERY" d1="97" d2="721" d3="985"/>
<CITE num="24" author="ZAPATASIRVENT RL" publication="SURGERY" d1="99" d2="53" d3="986"/>
<CITE num="25" author="HANSBROUGH JF" publication="AM J SURG" d1="151" d2="249" d3="986"/>
<CITE num="26" author="KEANE RM" publication="IR J MED SCI" d1="155" d2="143" d3="986"/>
</CITATIONS>
<RECORDNUM>01078 </RECORDNUM>
<MEDLINENUM>81093097</MEDLINENUM>
<AUTHORS><AUTHOR>Thomsen-J</AUTHOR><AUTHOR>Friis-B</AUTHOR></AUTHORS>
<TITLE>High dosage tobramycin treatment of children with cystic fibrosis.
Bacteriological effect and clinical ototoxicity.</TITLE>
<SOURCE>Int-J-Pediatr-Otorhinolaryngol. 1979 Jul. 1(1). P 33-40.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: ad</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC><TOPIC>TOBRAMYCIN: ad</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBENICILLIN: ad</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co, mi</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: co, mi</TOPIC><TOPIC>TOBRAMYCIN: ae</TOPIC></MINORSUBJ>
<ABSTRACT>The bacteriological effect of chemotherapy against mucoid strains of
Pseudominas aeruginosa in the lower respiratory tract of patients
with cystic fibrosis is reported. A comparison of the effect of high
doses of tobramycin (10 mg/kg/24 h) given alone or in combination
with carbenicillin showed a significant difference in favour of the
combination therapy. In 74.5% of the initially successful courses the
patients were recolonized within one month. Fifty-three patients were
examined by audiometric and vestibular tests. Only in one patient was
it possible to register a transient, high tone hearing impairment at
8000 Hz bilaterally, that might be attributed to the tobramycin
treatment. It is concluded that high dose tobramycin treatment in
children and adolescents with normal kidney function implies only a
minimal clinical risk of adverse ototoxic effects, even after
repeated courses of treatment. No nephrotoxic side-effects were found
in this material.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRUMMET RE" publication="ARCH OTOLARYNGOL" d1="101" d2="540" d3="975"/>
<CITE num="002" author="BRUMMET RE" publication="ARCH OTOLARYNGOL" d1="96" d2="505" d3="972"/>
<CITE num="004" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="005" author="LOGAN TB" publication="ARCH OTOLARYNGOL" d1="99" d2="190" d3="974"/>
<CITE num="006" author="MCCRAE WM" publication="SCOTT MED J" d1="21" d2="68" d3="976"/>
<CITE num="007" author="NEU HC" publication="J INFECT DIS SUPPL" d1="134" d2="206" d3="976"/>
<CITE num="008" author="STUPP HF" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="262" d2="1" d3="970"/>
<CITE num="009" author="WILSON P" publication="BR MED J" d1="1" d2="259" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79099</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CK B                AC" publication="TA PAEDIATR SCAND SUPPL 301 19" d1="82" d2="25 9" d3="2"/>
<CITE num="2" author="SCHOFIELD DH" publication="DRUG INTEL CLIN PHARM" d1="18" d2="153" d3="984"/>
<CITE num="3" author="MILLER JJ" publication="LANCET" d1="2" d2="272" d3="985"/>
<CITE num="4" author="CHRYSTYN H" publication="J CLIN HOSP PHARM" d1="10" d2="219" d3="985"/>
<CITE num="5" author="FRASER GL" publication="DRUG INTEL CLIN PHARM" d1="19" d2="757" d3="985"/>
</CITATIONS>
<RECORDNUM>01079 </RECORDNUM>
<MEDLINENUM>79215540</MEDLINENUM>
<AUTHORS><AUTHOR>Afzelius-B-A</AUTHOR></AUTHORS>
<TITLE>The immotile-cilia syndrome and other ciliary diseases.</TITLE>
<SOURCE>Int-Rev-Exp-Pathol. 1979. 19. P 1-43. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CILIA: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>BRAIN: pp</TOPIC><TOPIC>CILIA: ph, ul</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>DOGS</TOPIC><TOPIC>DYNEIN: ph</TOPIC><TOPIC>EAR: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KARTAGENER-TRIAD: pp</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MOVEMENT</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: pp</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SPERM-MOTILITY</TOPIC><TOPIC>SYNDROME</TOPIC><TOPIC>TUBULIN: ph</TOPIC><TOPIC>UROGENITAL-SYSTEM: pp</TOPIC></MINORSUBJ>
<EXTRACT>It is the purpose of this review to present evidence for a disorder
which is believed to be caused by defective cilia and to review some
data on the occurrence of abnormal cilia, evidently formed in
response to environmental insults.  The cilium, human ciliated
structures, the immotile-cilia syndrome and other inborn ciliary
diseases, cystic fibrosis, and acquired disorders of ciliated
structures are discussed.  Ciliary activity is not vital, but its
loss will cause a great deal of discomfort.  The greatest problems
relate to the lower respiratory tract, which is also a site of most
of the cilia in the body.  It is striking that a certain degree of
clearance can be maintained in the lungs in the absence of motile
cilia by coughing, hawking, and other mechanisms.</EXTRACT>
<REFERENCES>
<CITE num="001" author="AARONS GH" publication="POSTGRAD MED J" d1="45" d2="736" d3="959"/>
<CITE num="002" author="ADAMS R" publication="J THORAC SURG" d1="7" d2="206" d3="937"/>
<CITE num="003" author="AFZELIUS BA" publication="J BIOPHYS BIOCHEM CYTOL" d1="5" d2="269" d3="959"/>
<CITE num="004" author="AFZELIUS BA" publication="IN: BACCETTI B" d1="" d2="565" d3="970"/>
<CITE num="005" author="AFZELIUS BA" publication="SCIENCE" d1="193" d2="317" d3="976"/>
<CITE num="006" author="AFZELIUS BA" publication="J CELL BIOL" d1="66" d2="225" d3="975"/>
<CITE num="007" author="AFZELIUS BA" publication="FERTIL STERIL" d1="29" d2="72" d3="978"/>
<CITE num="008" author="AILSBY RL" publication="J PATHOL" d1="109" d2="75" d3="973"/>
<CITE num="009" author="ALLEN RA" publication="J ULTRASTRUCT RES" d1="12" d2="730" d3="965"/>
<CITE num="010" author="AMJAD H" publication="JAMA" d1="227" d2="1420" d3="974"/>
<CITE num="011" author="ANDERSEN I" publication="ARCH ENVIRON HEALTH" d1="29" d2="290" d3="974"/>
<CITE num="012" author="ANDERSON H" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="247" d2="1" d3="969"/>
<CITE num="013" author="ARGE E" publication="LANCET" d1="1" d2="412" d3="960"/>
<CITE num="014" author="AUERBACH O" publication="N ENGL J MED" d1="256" d2="97" d3="957"/>
<CITE num="015" author="BACCETTI B" publication="J SUBMICROSC CYTOL" d1="7" d2="349" d3="975"/>
<CITE num="016" author="BALDETORP L" publication="CELL TISSUE RES" d1="180" d2="421" d3="977"/>
<CITE num="017" author="BARNES BG" publication="J ULTRASTRUCT RES" d1="5" d2="453" d3="961"/>
<CITE num="018" author="BERGSTROM WH" publication="PEDIATRICS" d1="6" d2="573" d3="950"/>
<CITE num="019" author="BISSON JP" publication="J GYN OBSTET BIOL REPR SUPP 1" d1="4" d2="37" d3="975"/>
<CITE num="020" author="BLAKE J" publication="J BIOMECH" d1="8" d2="179" d3="975"/>
<CITE num="021" author="BLOM E" publication="NATURE" d1="209" d2="739" d3="966"/>
<CITE num="022" author="BOQUIST L" publication="Z ZELLFORSCH MIKROSK ANAT" d1="89" d2="519" d3="968"/>
<CITE num="023" author="BORELL U" publication="ACTA OBSTET GYNECOL SCAND" d1="36" d2="22" d3="957"/>
<CITE num="024" author="BOWMAN BH" publication="LIFE SCI" d1="19" d2="1289" d3="976"/>
<CITE num="025" author="BREDBERG G" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="" d2="301" d3="972"/>
<CITE num="026" author="BROKAW CJ" publication="IN: INOUE S" d1="" d2="165" d3="975"/>
<CITE num="027" author="BRUSIS T" publication="Z LARYNGOL RHINOL OTOL" d1="52" d2="883" d3="973"/>
<CITE num="028" author="BRYAN JHD" publication="CELL TISSUE RES" d1="180" d2="187" d3="977"/>
<CITE num="029" author="BURIAN K" publication="ACTA OTOLARYNGOL STOCKH" d1="56" d2="376" d3="963"/>
<CITE num="030" author="CAMNER P" publication="ENVIRON PHYSIOL" d1="1" d2="137" d3="971"/>
<CITE num="031" author="CAMNER P" publication="AM REV RESPIR DIS" d1="112" d2="807" d3="975"/>
<CITE num="032" author="CARRIG GB" publication="J AM VETER MED" d1="164" d2="1127" d3="974"/>
<CITE num="033" author="CATHCART RC" publication="J NEUROPATH EXP NEUROL" d1="23" d2="60" d3="964"/>
<CITE num="034" author="CHANG KH" publication="J THORAC CARDIOVASC SURG" d1="43" d2="27" d3="962"/>
<CITE num="035" author="CHATTERJEE K" publication="J INDIAN MED ASSOC" d1="52" d2="389" d3="969"/>
<CITE num="036" author="CHERNIAK NS" publication="AM J MED" d1="41" d2="562" d3="966"/>
<CITE num="037" author="CHEVANCE LG" publication="ACTA OTOLARYNGOL STOCKH" d1="72" d2="121" d3="971"/>
<CITE num="038" author="CHUNG JW" publication="CELL TISSUE RES" d1="175" d2="421" d3="976"/>
<CITE num="039" author="CHURCHILL ED" publication="J THORAC SURG" d1="18" d2="279" d3="949"/>
<CITE num="040" author="CLYMAN MJ" publication="FERTIL STERIL" d1="17" d2="281" d3="966"/>
<CITE num="041" author="COCKAYNE EA" publication="Q J MED" d1="7" d2="479" d3="938"/>
<CITE num="042" author="COHEN S" publication="J MED SOC NJ" d1="47" d2="557" d3="950"/>
<CITE num="043" author="COLE DB" publication="J THORAC SURG" d1="9" d2="689" d3="940"/>
<CITE num="044" author="COLLIER AM" publication="INFECT IMMUN" d1="3" d2="694" d3="971"/>
<CITE num="045" author="CONOVER JH" publication="LANCET" d1="1" d2="1194" d3="973"/>
<CITE num="046" author="COOK CD" publication="AM J HUM GENET" d1="14" d2="290" d3="962"/>
<CITE num="047" author="DAHLGREN SE" publication="VIRCHOWS ARCH CELL PATHOL" d1="11" d2="211" d3="972"/>
<CITE num="048" author="DAROCZY J" publication="ZENTRALBL ALLG PATHOL" d1="118" d2="314" d3="974"/>
<CITE num="049" author="DAVID G" publication="J GYN OBSTET BIOL REPR SUPP 1" d1="4" d2="17" d3="975"/>
<CITE num="050" author="DE DUVE C" publication="SCIENCE" d1="189" d2="186" d3="975"/>
<CITE num="051" author="DELP MH" publication="J KANSAS MED SOC" d1="47" d2="93" d3="946"/>
<CITE num="052" author="DEMPSEY LC" publication="J NEUROSURG" d1="45" d2="53" d3="976"/>
<CITE num="053" author="DI MAURO S" publication="J NEUROL SCI" d1="27" d2="217" d3="976"/>
<CITE num="054" author="DOCHEZ C" publication="TIJDSCHR GASTROENTEROL" d1="18" d2="263" d3="975"/>
<CITE num="055" author="DOUEK E" publication="PROC R SOC MED" d1="69" d2="467" d3="975"/>
<CITE num="056" author="DOURMASHKIN RR" publication="J GEN VIROL" d1="9" d2="77" d3="970"/>
<CITE num="057" author="ELIASSON R" publication="N ENGL J MED" d1="297" d2="1" d3="977"/>
<CITE num="058" author="ENGSTROM H" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="301" d2="75" d3="972"/>
<CITE num="059" author="ERNSTSON S" publication="ACTA OTOLARYNGOL STOCKH" d1="67" d2="521" d3="969"/>
<CITE num="060" author="EWERT G" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="200" d2="1" d3="965"/>
<CITE num="061" author="FADEL HE" publication="FERTIL STERIL" d1="27" d2="1176" d3="976"/>
<CITE num="062" author="FAWCETT DW" publication="J MORPHOL" d1="94" d2="221" d3="954"/>
<CITE num="063" author="FINKLER E" publication="SCHWEIZ MED WOCHENSCHR" d1="86" d2="631" d3="956"/>
<CITE num="064" author="FLOCK A" publication="J CELL BIOL" d1="25" d2="1" d3="965"/>
<CITE num="065" author="FLOCK A" publication="ACTA OTOLARYNGOL STOCKH" d1="83" d2="85" d3="977"/>
<CITE num="066" author="FLOOD PR" publication="CELL TISSUE RES" d1="183" d2="281" d3="977"/>
<CITE num="067" author="FONTE VG" publication="J CELL BIOL" d1="49" d2="226" d3="971"/>
<CITE num="068" author="FORNATTO EJ" publication="LARYNGOSCOPE" d1="66" d2="1202" d3="956"/>
<CITE num="069" author="FOX MH" publication="ANAT REC" d1="124" d2="189" d3="956"/>
<CITE num="070" author="FRASCA JM" publication="EXP MOL PATH" d1="9" d2="380" d3="968"/>
<CITE num="071" author="FREDRICSSON B" publication="Z ZELLFORSCH MIKROSK ANAT" d1="58" d2="387" d3="962"/>
<CITE num="072" author="FRIEDMANN I" publication="LARYNGOSCOPE" d1="81" d2="1852" d3="971"/>
<CITE num="073" author="GADDUM-ROSSE P" publication="BIOL REPROD" d1="14" d2="605" d3="976"/>
<CITE num="074" author="GADDUM-ROSSE P" publication="AM J ANAT" d1="138" d2="26" d3="973"/>
<CITE num="075" author="GIBBONS IR" publication="NATURE" d1="190" d2="1128" d3="961"/>
<CITE num="076" author="GIBBONS IR" publication="J BIOPHYS BIOCHEM CYTOL" d1="11" d2="179" d3="961"/>
<CITE num="077" author="GIBBONS IR" publication="IN: INOUE S" d1="" d2="207" d3="975"/>
<CITE num="078" author="GLAUM K" publication="MEITR KLIN TUBERK" d1="91" d2="421" d3="938"/>
<CITE num="079" author="GOODENOUGH UW" publication="J CELL BIOL" d1="66" d2="480" d3="975"/>
<CITE num="080" author="GUDE HE" publication="JAMA" d1="171" d2="1825" d3="959"/>
<CITE num="081" author="GUILLON G" publication="COLLOQ NATL SOC FERTIL STERIL" d1="" d2="391" d3="972"/>
<CITE num="082" author="HALBERT SP" publication="GYNECOL INVEST" d1="7" d2="306" d3="976"/>
<CITE num="083" author="HANCOCK JL" publication="VET REC" d1="67" d2="825" d3="955"/>
<CITE num="084" author="HARADA Y" publication="ACTA OTOLARYNGOL STOCKH" d1="83" d2="284" d3="977"/>
<CITE num="085" author="HERS HG" publication="BIOCHEM J" d1="86" d2="11" d3="963"/>
<CITE num="086" author="HERS HG" publication="LYSOSOMES AND STORAGE DISEASE" d1="" d2="" d3="973"/>
<CITE num="087" author="HILDING AC" publication="ANN INTERN MED" d1="6" d2="227" d3="932"/>
<CITE num="088" author="HILDING AC" publication="ANN OTOL RHINOL LARYNGOL" d1="52" d2="5" d3="943"/>
<CITE num="089" author="HILDING AC" publication="N ENGL J MED" d1="256" d2="634" d3="957"/>
<CITE num="090" author="HILDING AC" publication="ANN OTOL RHINOL LARYNGOL" d1="80" d2="306" d3="971"/>
<CITE num="091" author="HILDING AC" publication="ANN OTOL RHINOL LARYNGOL" d1="75" d2="281" d3="966"/>
<CITE num="092" author="HOLMES LB" publication="AM J MED SCI" d1="255" d2="13" d3="968"/>
<CITE num="093" author="HOLSTEIN AF" publication="ZWANGLOSE ABH GEB NORM PATHOL" d1="20" d2="1" d3="969"/>
<CITE num="094" author="HOLSTEIN AF" publication="VIRCHOWS ARCH PATHOL ANAT" d1="367" d2="93" d3="975"/>
<CITE num="095" author="HOORN B" publication="PROG MED VIROL" d1="11" d2="408" d3="969"/>
<CITE num="096" author="HUBERMAN D" publication="ACTA PHYSIOL SCAND" d1="99" d2="42" d3="977"/>
<CITE num="097" author="HUMMEL KP" publication="J HERED" d1="50" d2="9" d3="959"/>
<CITE num="098" author="JAHNKE V" publication="Z LARYNGOL RHINOL OTOL" d1="51" d2="30" d3="972"/>
<CITE num="099" author="JAHNKE V" publication="Z LARYNGOL RHINOL OTOL" d1="55" d2="637" d3="976"/>
<CITE num="100" author="JEFFERY PK" publication="IN: BRAIN JD" d1="5" d2="193" d3="977"/>
<CITE num="101" author="JEFFERY PK" publication="IN: AHARONSON EF" d1="" d2="253" d3="976"/>
<CITE num="102" author="JONES R" publication="BR MED J" d1="2" d2="142" d3="972"/>
<CITE num="103" author="KAPA E" publication="ACTA ANAT (BASEL)" d1="95" d2="444" d3="976"/>
<CITE num="104" author="KARANI S" publication="BR MED J" d1="2" d2="74" d3="952"/>
<CITE num="105" author="KARTAGENER M" publication="BEITR KLIN TUBERK" d1="83" d2="489" d3="933"/>
<CITE num="106" author="KARTAGENER M" publication="BEITR KLIN TUBERK" d1="87" d2="331" d3="935"/>
<CITE num="107" author="KATSUHARA K" publication="CHEST" d1="61" d2="56" d3="972"/>
<CITE num="108" author="KATZ M" publication="N ENGL J MED" d1="248" d2="730" d3="953"/>
<CITE num="109" author="KAWABATA I" publication="ACTA OTOLARYNGOL STOCKH" d1="67" d2="511" d3="969"/>
<CITE num="110" author="KENNEDY JR" publication="J CELL BIOL" d1="70" d2="80A" d3="976"/>
<CITE num="111" author="KIEFER BI" publication="IN: RUDDLE FH" d1="" d2="47" d3="973"/>
<CITE num="112" author="KILKUCHI K" publication="J FRANC OTORHINOLARYNGOL" d1="23" d2="697" d3="974"/>
<CITE num="113" author="KILBURN KH" publication="J ULTRASTRUCT RES" d1="60" d2="34" d3="977"/>
<CITE num="114" author="KONRADOVA V" publication="FOLIA MORPHOL (PRAGUE)" d1="16" d2="398" d3="968"/>
<CITE num="115" author="KONRADOVA V" publication="FOLIA MORPHOL (PRAGUE)" d1="23" d2="293" d3="975"/>
<CITE num="116" author="KUBOTA K" publication="AM J ANAT" d1="144" d2="119" d3="975"/>
<CITE num="117" author="LATTA H" publication="J BIOPHYS BIOCHEM CYTOL" d1="11" d2="248" d3="961"/>
<CITE num="118" author="LAYTON WM" publication="J HERED" d1="67" d2="336" d3="976"/>
<CITE num="119" author="LEONARD SL" publication="ANAT REC" d1="104" d2="89" d3="949"/>
<CITE num="120" author="LINDBERG LA" publication="CELL TISSUE RES" d1="179" d2="121" d3="977"/>
<CITE num="121" author="LINDGREN E" publication="ACTA RADIOL" d1="35" d2="277" d3="951"/>
<CITE num="122" author="LOFBERG J" publication="ZOON" d1="2" d2="3" d3="974"/>
<CITE num="123" author="LOGAN WD" publication="DIS CHEST" d1="48" d2="613" d3="965"/>
<CITE num="124" author="LUDWIG H" publication="ARCH CYNAEKOL" d1="212" d2="380" d3="972"/>
<CITE num="125" author="LUFT R" publication="J CLIN INVEST" d1="41" d2="1776" d3="962"/>
<CITE num="126" author="MANN T" publication="PROC SOC STUDY FERT" d1="9" d2="3" d3="958"/>
<CITE num="127" author="MATULIONIS DH" publication="AM J ANAT" d1="145" d2="79" d3="976"/>
<CITE num="128" author="MCDOWELL EM" publication="ARCH PATHOL LAB MED" d1="100" d2="429" d3="976"/>
<CITE num="129" author="MENCO BPM" publication="MEDEDEL LANDBOUWHOGESCH WAGEN" d1="1" d2="77" d3="977"/>
<CITE num="130" author="MEYER CH" publication="FRANKF Z PATHOL" d1="76" d2="21" d3="966"/>
<CITE num="131" author="MOHRI H" publication="IN: PERRY SV" d1="" d2="336" d3="976"/>
<CITE num="132" author="MORE IAR" publication="J REPROD FERTIL" d1="47" d2="19" d3="976"/>
<CITE num="133" author="MORITA I" publication="ARCH HISTOL JAP" d1="26" d2="341" d3="966"/>
<CITE num="134" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="59" d2="55" d3="978"/>
<CITE num="135" author="MYGIND N" publication="ACTA ALLERGOL" d1="28" d2="9" d3="973"/>
<CITE num="136" author="MYKLEBUST R" publication="ANAT EMBRYOL" d1="151" d2="127" d3="977"/>
<CITE num="137" author="NAGY L" publication="BEITR KLIN TUBERK" d1="95" d2="26" d3="940"/>
<CITE num="138" author="NAKAYAMA Y" publication="J NEUROCYTOL" d1="3" d2="449" d3="974"/>
<CITE num="139" author="NIELSEN SL" publication="LAB INVEST" d1="30" d2="618" d3="974"/>
<CITE num="140" author="NICHAMIN SJ" publication="JAMA" d1="161" d2="966" d3="956"/>
<CITE num="141" author="NILSSON O" publication="UPSALA J MED SCI" d1="77" d2="3" d3="972"/>
<CITE num="142" author="NUNN JF" publication="J CELL SCI" d1="15" d2="537" d3="974"/>
<CITE num="143" author="OKUDA M" publication="ACTA OTOLARYNGOL STOCKH" d1="76" d2="283" d3="973"/>
<CITE num="144" author="OLSEN AM" publication="AM REV TUBERC" d1="47" d2="435" d3="943"/>
<CITE num="145" author="PAVELKA M" publication="ACTA ANAT (BASEL)" d1="94" d2="262" d3="976"/>
<CITE num="146" author="PEDERSEN H" publication="Z ZELLFORSCH MIKROSK ANAT" d1="123" d2="305" d3="972"/>
<CITE num="147" author="PEDERSEN H" publication="NATURE" d1="262" d2="494" d3="976"/>
<CITE num="148" author="PEDERSEN H" publication="BIOL REPROD" d1="12" d2="541" d3="975"/>
<CITE num="149" author="PEDERSEN H" publication="FERTIL STERIL" d1="22" d2="156" d3="971"/>
<CITE num="150" author="PFALLER W" publication="CELL TISSUE RES" d1="166" d2="91" d3="976"/>
<CITE num="151" author="PROCTOR DF" publication="IN: FENN WO" d1="1" d2="309" d3="964"/>
<CITE num="152" author="PROCTOR DF" publication="AM REV RESPIR DIS" d1="115" d2="97" d3="977"/>
<CITE num="153" author="RANDALL JT" publication="J PROTOZOOL SUPPL" d1="6" d2="30" d3="959"/>
<CITE num="154" author="RANDALL J" publication="IN: BEATTY RA" d1="" d2="13" d3="972"/>
<CITE num="155" author="RASH JE" publication="J ULTRASTRUCT RES" d1="29" d2="470" d3="969"/>
<CITE num="156" author="REED SE" publication="INFECT IMMUN" d1="6" d2="68" d3="972"/>
<CITE num="157" author="REESE TS" publication="J CELL BIOL" d1="25" d2="209" d3="965"/>
<CITE num="158" author="RHODIN JAG" publication="AM REV RESPIR DIS SUPPL 3" d1="93" d2="1" d3="966"/>
<CITE num="159" author="ROGERS L" publication="LARYNGOSCOPE" d1="72" d2="456" d3="962"/>
<CITE num="160" author="ROMRELL LJ" publication="J ULTRASTRUCT RES" d1="38" d2="578" d3="972"/>
<CITE num="161" author="ROSS SM" publication="THESIS" d1="" d2="" d3="971"/>
<CITE num="162" author="ROSSMAN CM" publication="J PEDIATR" d1="90" d2="579" d3="977"/>
<CITE num="163" author="RUNGGER-BRANDLE E" publication="EXP CELL RES" d1="107" d2="313" d3="977"/>
<CITE num="164" author="RUSSAKOFF AH" publication="N ENGL J MED" d1="235" d2="253" d3="946"/>
<CITE num="165" author="SADE J" publication="ARCH OTOLARYNGOL" d1="86" d2="128" d3="967"/>
<CITE num="166" author="SAFIAN LS" publication="J FL MED ASSOC" d1="45" d2="1143" d3="959"/>
<CITE num="167" author="SANCHIS J" publication="N ENGL J MED" d1="288" d2="651" d3="973"/>
<CITE num="168" author="SANDOZ D" publication="J CELL BIOL" d1="71" d2="449" d3="976"/>
<CITE num="169" author="SANTA CRUZ R" publication="AM REV RESPIR DIS" d1="109" d2="458" d3="974"/>
<CITE num="170" author="SATIR P" publication="J CELL BIOL" d1="26" d2="805" d3="965"/>
<CITE num="171" author="SCHERFT JP" publication="J ULTRASTRUCT RES" d1="19" d2="546" d3="967"/>
<CITE num="172" author="SCHOEMPERLEN CB" publication="AM REV RESPIR DIS" d1="88" d2="698" d3="968"/>
<CITE num="173" author="SEINSCH W" publication="ACTA ANAT (BASEL)" d1="95" d2="537" d3="976"/>
<CITE num="174" author="SETHI BR" publication="J LARYNGOL OTOL" d1="89" d2="183" d3="975"/>
<CITE num="175" author="SEVTENKO G" publication="FOLIA MORPHOL (PRAGUE)" d1="21" d2="261" d3="973"/>
<CITE num="176" author="SHACK W" publication="BULL MATH BIOPHYS" d1="34" d2="342" d3="972"/>
<CITE num="177" author="SHENEFELT RE" publication="TERATOLOGY" d1="5" d2="103" d3="972"/>
<CITE num="178" author="SIELICKA-ZUBER L" publication="PRZEGL DERMATOL" d1="61" d2="171" d3="974"/>
<CITE num="179" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="180" author="STEPHENS RE" publication="BIOL BULL" d1="139" d2="438" d3="970"/>
<CITE num="181" author="STOWATER JL" publication="J AM VET RADIOL SOC" d1="17" d2="174" d3="976"/>
<CITE num="182" author="SUMMERS K" publication="BIOCHIM BIOPHYS ACTA" d1="416" d2="153" d3="975"/>
<CITE num="183" author="TAIANA JA" publication="J THORAC SURG" d1="30" d2="34" d3="955"/>
<CITE num="184" author="TAMM SL" publication="PROC R SOC LOND BIOL" d1="175" d2="219" d3="970"/>
<CITE num="185" author="TENDLER H" publication="Z ERKR ATMUNGSORGANE" d1="137" d2="161" d3="972"/>
<CITE num="186" author="THOMSON ML" publication="N ENGL J MED" d1="289" d2="749" d3="973"/>
<CITE num="187" author="TIHEN JA" publication="J HERED" d1="39" d2="29" d3="948"/>
<CITE num="188" author="TOREMALM NG" publication="RHINOLOGY" d1="13" d2="113" d3="975"/>
<CITE num="189" author="TORGERSEN J" publication="ACTA RADIOL" d1="28" d2="17" d3="947"/>
<CITE num="190" author="TORGERSEN J" publication="SCHWEIZ MED WOCHENSCHR" d1="82" d2="770" d3="952"/>
<CITE num="191" author="TORIKATA C" publication="VIRCHOWS ARCH PATHOL NAT HIS" d1="371" d2="121" d3="976"/>
<CITE num="192" author="VARANO NR" publication="INT COLL SURG" d1="33" d2="131" d3="960"/>
<CITE num="193" author="VICKERS TH" publication="ARCH ENTWICKLUNGSMECH ORGAN" d1="153" d2="255" d3="961"/>
<CITE num="194" author="WALKER TR" publication="SCIENCE" d1="153" d2="1248" d3="966"/>
<CITE num="195" author="WARNER FD" publication="J CELL BIOL" d1="63" d2="35" d3="974"/>
<CITE num="196" author="WENT HA" publication="EXP CELL RES" d1="108" d2="63" d3="977"/>
<CITE num="197" author="WENT HA" publication="J THEOR BIOL" d1="68" d2="95" d3="977"/>
<CITE num="198" author="WHEATLEY DN" publication="J ANAT" d1="101" d2="223" d3="967"/>
<CITE num="199" author="WHEATLEY DN" publication="EXPERIENTIA" d1="24" d2="1157" d3="968"/>
<CITE num="200" author="WILHELM DL" publication="J PATHOL BACTERIOL" d1="67" d2="361" d3="954"/>
<CITE num="201" author="WILKINSON RF" publication="J ULTRASTRUCT RES" d1="48" d2="242" d3="974"/>
<CITE num="202" author="WILSON GB" publication="NATURE" d1="266" d2="463" d3="977"/>
<CITE num="203" author="WILSON JG" publication="AM J ANAT" d1="85" d2="113" d3="949"/>
<CITE num="204" author="WILSON JG" publication="AM J ANAT" d1="92" d2="153" d3="953"/>
<CITE num="205" author="WITMAN GB" publication="COLD SPRING HARBOR SYMP" d1="41" d2="969" d3="977"/>
<CITE num="206" author="WOLINSKY JS" publication="LAB INVEST" d1="37" d2="229" d3="977"/>
<CITE num="207" author="WONG YC" publication="LAB INVEST" d1="24" d2="55" d3="971"/>
<CITE num="208" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="209" author="WOODRUFF KH" publication="AM J PATHOL" d1="72" d2="91" d3="973"/>
<CITE num="210" author="WORTHINGTON RC" publication="SCIENCE" d1="139" d2="221" d3="963"/>
<CITE num="211" author="YEATES DB" publication="ARCH DIS CHILD" d1="51" d2="28" d3="976"/>
<CITE num="212" author="YONEDA K" publication="AM REV RESPIR DIS" d1="114" d2="837" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79100</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ZELIUS B            BR" publication="MED J" d1="2" d2="74 9" d3="9"/>
<CITE num="2" author="AFZELIUS BA" publication="J ULTRASTRUCT RES" d1="69" d2="43" d3="979"/>
<CITE num="3" author="BACCETTI B" publication="ANDROLOGIA" d1="12" d2="525" d3="980"/>
<CITE num="4" author="NORWOOD JT" publication="BIOL REPROD" d1="23" d2="788" d3="980"/>
<CITE num="5" author="AFZELIUS BA" publication="THORAX" d1="35" d2="401" d3="980"/>
<CITE num="6" author="ROSSMAN CM" publication="CHEST" d1="78" d2="580" d3="980"/>
<CITE num="7" author="AFZELIUS BA" publication="ACTA MED SCAND" d1="208" d2="145" d3="980"/>
<CITE num="8" author="DIRKSEN ER" publication="CELL MOTIL" d1="1" d2="247" d3="981"/>
<CITE num="9" author="VANDEDONK HJM" publication="PHARM INT" d1="2" d2="157" d3="981"/>
<CITE num="10" author="FRIDAY GA" publication="PEDIATR CLIN NORTH AM" d1="28" d2="807" d3="981"/>
<CITE num="11" author="AFZELIUS BA" publication="AM J HUM GENET" d1="33" d2="852" d3="981"/>
<CITE num="12" author="ANTONELLI M" publication="ACTA PAEDIATR SCAND" d1="70" d2="571" d3="981"/>
<CITE num="13" author="TEGNER H" publication="ACTA PAEDIATR SCAND" d1="70" d2="629" d3="981"/>
<CITE num="14" author="ROSSMAN CM" publication="CHEST" d1="80" d2="860" d3="981"/>
<CITE num="15" author="KAPELLEROVA A" publication="SB LEK" d1="83" d2="316" d3="981"/>
<CITE num="16" author="PABST HF" publication="J PEDIATR" d1="98" d2="223" d3="981"/>
<CITE num="17" author="AFZELIUS BA" publication="AM REV RESPIR DIS" d1="124" d2="107" d3="981"/>
<CITE num="18" author="SVEDBERGH B" publication="ALB V GRAEF ARCH KLIN EX OPHT" d1="215" d2="265" d3="981"/>
<CITE num="19" author="DALEN H" publication="CELL TISSUE RES" d1="220" d2="685" d3="981"/>
<CITE num="20" author="HAKANSSON CH" publication="SCANN ELECTRON MICROSC" d1="1981" d2="93" d3="981"/>
<CITE num="21" author="JOHANNESSEN JV" publication="DIAGN HISTOPATHOL" d1="5" d2="113" d3="982"/>
<CITE num="22" author="VANDEDONK HJM" publication="INT J PHARMACEUT" d1="12" d2="57" d3="982"/>
<CITE num="23" author="AUGUST JR" publication="J AM ANIM HOSP ASSOC" d1="18" d2="822" d3="982"/>
<CITE num="24" author="FINKELSTEIN D" publication="BIRTH DEF ORIG ART SER" d1="18" d2="197" d3="982"/>
<CITE num="25" author="KONRADOVA V" publication="EUR J RESPIR DIS" d1="63" d2="516" d3="982"/>
<CITE num="26" author="DUDLEY JP" publication="LARYNGOSCOPE" d1="92" d2="297" d3="982"/>
<CITE num="27" author="HYBBINETTE JC" publication="ACTA OTOLARYNGOL STOCKH" d1="93" d2="151" d3="982"/>
<CITE num="28" author="HYBBINETTE JC" publication="ACTA OTOLARYNGOL STOCKH" d1="94" d2="121" d3="982"/>
<CITE num="29" author="DORUP J" publication="ANAT EMBRYOL" d1="164" d2="19" d3="982"/>
<CITE num="30" author="WILSMAN NJ" publication="AM J ANAT" d1="164" d2="343" d3="982"/>
<CITE num="31" author="WEN GY" publication="ANAT EMBRYOL" d1="165" d2="315" d3="982"/>
<CITE num="32" author="JONSSON MS" publication="N ENGL J MED" d1="307" d2="1131" d3="982"/>
<CITE num="33" author="AFZELIUS BA" publication="J SUBMICROSC CYTOL" d1="15" d2="111" d3="983"/>
<CITE num="34" author="HARD R" publication="TISSUE CELL" d1="15" d2="217" d3="983"/>
<CITE num="35" author="HARD R" publication="TISSUE CELL" d1="15" d2="227" d3="983"/>
<CITE num="36" author="MELTZER EO" publication="PEDIATR CLIN NORTH AM" d1="30" d2="847" d3="983"/>
<CITE num="37" author="NEVILLE E" publication="THORAX" d1="38" d2="929" d3="983"/>
<CITE num="38" author="AFZELIUS BA" publication="EUR J RESPIR DIS" d1="64" d2="280" d3="983"/>
<CITE num="39" author="NIELSEN MH" publication="EUR J RESPIR DIS" d1="64" d2="19" d3="983"/>
<CITE num="40" author="PEDERSEN M" publication="EUR J RESPIR DIS" d1="64" d2="78" d3="983"/>
<CITE num="41" author="ROOMANS GM" publication="EUR J RESPIR DIS" d1="64" d2="416" d3="983"/>
<CITE num="42" author="SLEIGH MA" publication="EUR J RESPIR DIS" d1="64" d2="157" d3="983"/>
<CITE num="43" author="MURPHY S" publication="PEDIATRICS" d1="72" d2="1" d3="983"/>
<CITE num="44" author="KENNEDY HG" publication="J ROY SOC MED" d1="76" d2="1065" d3="983"/>
<CITE num="45" author="LEWIS FH" publication="CHEST" d1="83" d2="487" d3="983"/>
<CITE num="46" author="MYGIND N" publication="ACTA OTOLARYNGOL STOCKH" d1="95" d2="688" d3="983"/>
<CITE num="47" author="RUNGGERBRANDLE E" publication="AM J PATHOL" d1="110" d2="361" d3="983"/>
<CITE num="48" author="EDWARDS DF" publication="J AM VET MED ASSOC" d1="183" d2="667" d3="983"/>
<CITE num="49" author="BRYAN JHD" publication="VIRCHOWS ARCH PATHOL ANAT HIS" d1="399" d2="265" d3="983"/>
<CITE num="50" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="51" author="NEWHOUSE MT" publication="SEM RESPIR MED" d1="5" d2="341" d3="984"/>
<CITE num="52" author="KATZ SM" publication="ULTRASTRUCTURAL PATHOL" d1="6" d2="285" d3="984"/>
<CITE num="53" author="LUNGARELLA G" publication="ULTRASTRUCTURAL PATHOL" d1="6" d2="1" d3="984"/>
<CITE num="54" author="CANET E" publication="PRESSE MED" d1="13" d2="1607" d3="984"/>
<CITE num="55" author="HOLLEY MC" publication="TISSUE CELL" d1="16" d2="287" d3="984"/>
<CITE num="56" author="ISAWA T" publication="J NUCL MED" d1="25" d2="447" d3="984"/>
<CITE num="57" author="RANDOLPH JF" publication="J SMALL ANIMAL PRACT" d1="25" d2="679" d3="984"/>
<CITE num="58" author="BECKER B" publication="RESPIRATION" d1="46" d2="180" d3="984"/>
<CITE num="59" author="WELCH MJ" publication="ANN ALLERGY" d1="52" d2="32" d3="984"/>
<CITE num="60" author="GREENSTONE M" publication="ARCH DIS CHILD" d1="59" d2="704" d3="984"/>
<CITE num="61" author="GREENSTONE MA" publication="ARCH DIS CHILD" d1="59" d2="481" d3="984"/>
<CITE num="62" author="WASSERMAN SJ" publication="J ALLERGY CLIN IMMUNOL" d1="73" d2="17" d3="984"/>
<CITE num="63" author="HANDEL MA" publication="J HERED" d1="75" d2="498" d3="984"/>
<CITE num="64" author="LIDOW MS" publication="J ULTRASTRUCT RES" d1="86" d2="18" d3="984"/>
<CITE num="65" author="ELOFSSON R" publication="J ULTRASTRUCT RES" d1="87" d2="212" d3="984"/>
<CITE num="66" author="ERNSTSON S" publication="ACTA OTOLARYNGOL STOCKH" d1="97" d2="83" d3="984"/>
<CITE num="67" author="FISCHER L" publication="SCHWEIZ MED WOCHENSCHR" d1="114" d2="610" d3="984"/>
<CITE num="68" author="ROSSMAN CM" publication="AM REV RESPIR DIS" d1="129" d2="161" d3="984"/>
<CITE num="69" author="WELCH MJ" publication="WEST J MED" d1="141" d2="509" d3="984"/>
<CITE num="70" author="CORNILLIE FJ" publication="PATHOL RES PRACT" d1="178" d2="595" d3="984"/>
<CITE num="71" author="AFZELIUS BA" publication="J AM VET MED ASSOC" d1="184" d2="560" d3="984"/>
<CITE num="72" author="HANDELSMAN DJ" publication="N ENGL J MED" d1="310" d2="3" d3="984"/>
<CITE num="73" author="CHARPIN D" publication="REV MALAD RESPIR" d1="2" d2="151" d3="985"/>
<CITE num="74" author="GONZALEZ S" publication="ULTRASTRUCTURAL PATHOL" d1="8" d2="345" d3="985"/>
<CITE num="75" author="AFZELIUS BA" publication="CRC CRIT REV BIOCHEM" d1="19" d2="63" d3="985"/>
<CITE num="76" author="SATO T" publication="EXP MOL PATH" d1="43" d2="13" d3="985"/>
<CITE num="77" author="AFZELIUS BA" publication="EUR J RESPIR DIS" d1="66" d2="173" d3="985"/>
<CITE num="78" author="LUNGARELLA G" publication="EUR J RESPIR DIS" d1="66" d2="165" d3="985"/>
<CITE num="79" author="BABIN RW" publication="SOUTH MED J" d1="78" d2="737" d3="985"/>
<CITE num="80" author="GREENSTONE M" publication="BR J DIS CHEST" d1="79" d2="9" d3="985"/>
<CITE num="81" author="GREENSTONE M" publication="J LARYNGOL OTOL" d1="99" d2="985" d3="985"/>
<CITE num="82" author="WU R" publication="J CELL PHYSIOL" d1="125" d2="167" d3="985"/>
<CITE num="83" author="ODOR DL" publication="AM J ANAT" d1="174" d2="437" d3="985"/>
<CITE num="84" author="GONZALEZ S" publication="PATHOL RES PRACT" d1="180" d2="511" d3="985"/>
<CITE num="85" author="CARSON JL" publication="N ENGL J MED" d1="312" d2="463" d3="985"/>
<CITE num="86" author="WANNER A" publication="CLIN CHEST MED" d1="7" d2="247" d3="986"/>
<CITE num="87" author="HOLLEY MC" publication="TISSUE CELL" d1="18" d2="521" d3="986"/>
<CITE num="88" author="AFZELIUS BA" publication="HOSP PRACT" d1="21" d2="73" d3="986"/>
<CITE num="89" author="TEICHTAHL H" publication="MED BIOL ENG COMPUT" d1="24" d2="193" d3="986"/>
<CITE num="90" author="WOODS RP" publication="ARCH NEUROL" d1="43" d2="1083" d3="986"/>
<CITE num="91" author="HO KL" publication="ACTA NEUROPATH (BERL)" d1="70" d2="30" d3="986"/>
<CITE num="92" author="RAMET J" publication="CHEST" d1="90" d2="138" d3="986"/>
<CITE num="93" author="EAVEY RD" publication="ARCH OTOLARYNG HEAD NECK SURG" d1="112" d2="646" d3="986"/>
<CITE num="94" author="SOIFER D" publication="ANN NY ACAD SCI" d1="466" d2="1" d3="986"/>
<CITE num="95" author="KAISER D" publication="ATEMWEGS LUNGENKRANKH" d1="13" d2="101" d3="987"/>
<CITE num="96" author="DELAROCHA SR" publication="PEDIATR RADIOL" d1="17" d2="97" d3="987"/>
</CITATIONS>
<RECORDNUM>01080 </RECORDNUM>
<MEDLINENUM>80007295</MEDLINENUM>
<AUTHORS><AUTHOR>Barry-M-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis.</TITLE>
<SOURCE>J-Am-Diet-Assoc. 1979 Oct. 75(4). P 446-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, dh, di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GROWTH-DISORDERS: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: co</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MECONIUM</TOPIC><TOPIC>PANCREATIC-DISEASES: co</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: co</TOPIC><TOPIC>SWEATING</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is an hereditary disorder that affects infants,
children, adolescents, and young adults.  Its genetic influence,
signs and symptoms, diagnostic tests, nutritional management and diet
therapy, respiratory infection, and growth retardation are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="002" author="FRANCIS DEM" publication="DIETS FOR SICK CHILDREN" d1="" d2="" d3="974"/>
<CITE num="003" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
<CITE num="004" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="005" author="GAYTON WF" publication="PEDIATRICS" d1="59" d2="888" d3="977"/>
<CITE num="006" author="MEARNS MB" publication="BR J HOSP MED" d1="12" d2="497" d3="974"/>
<CITE num="007" author="MORRIS W" publication="AMERICAN HERITAGE DICTIONARY" d1="" d2="" d3="973"/>
<CITE num="008" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
<CITE num="009" author="PIKE R" publication="DIGESTION AND ABSORPTION-" d1="" d2="" d3="975"/>
<CITE num="010" author="ROLLER RJ" publication="GASTROENTEROLOGY" d1="72" d2="661" d3="977"/>
<CITE num="011" author="BARBERO GJ" publication="IN: MANGOS JA" d1="" d2="83" d3="976"/>
<CITE num="012" author="ANON" publication="CYSTIC FIBROSIS" d1="" d2="" d3="975"/>
<CITE num="013" author="ANON" publication="TEACHERS' GUIDE TO CF" d1="" d2="" d3=""/>
<CITE num="014" author="BRUNS WT" publication="AM J DIS CHILD" d1="131" d2="71" d3="977"/>
<CITE num="015" author="DESAI N" publication="J PEDIATR" d1="91" d2="447" d3="977"/>
<CITE num="016" author="KASTRUP E" publication="GASTROINTESTINAL DRUGS FACTS" d1="" d2="308B" d3="979"/>
<CITE num="017" author="MITCHELL H" publication="COOPERS NUTRITION IN HEALTH" d1="" d2="380" d3="968"/>
<CITE num="018" author="GOODHART RS" publication="MODERN NUTRITION IN HEALTH AN" d1="" d2="826" d3="974"/>
<CITE num="019" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
<CITE num="020" author="HUANG NN" publication="GUIDE TO DRUG THERAPY IN PATI" d1="" d2="" d3="979"/>
<CITE num="021" author="FOMON SJ" publication="IN: FOMON SJ" d1="" d2="472" d3="974"/>
<CITE num="022" author="WEIHOFEN DM" publication="J AM DIET ASSOC" d1="54" d2="206" d3="969"/>
<CITE num="023" author="KEATING JP" publication="PEDIATRICS" d1="46" d2="41" d3="970"/>
<CITE num="024" author="FILER LJ JR" publication="PEDIATRICS" d1="48" d2="483" d3="971"/>
<CITE num="025" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="026" author="WILMSHURST EG" publication="PEDIATRICS" d1="55" d2="75" d3="975"/>
<CITE num="027" author="RUDOLPH AM" publication="IN: RUDOLPH AM" d1="" d2="1563" d3="977"/>
<CITE num="028" author="ANON" publication="GENETICS OF CF" d1="" d2="" d3=""/>
<CITE num="029" author="LIEBERMAN J" publication="ANN INTERN MED" d1="82" d2="806" d3="975"/>
<CITE num="030" author="NEWBURGER EH" publication="CLIN PEDIATR" d1="12" d2="456" d3="973"/>
<CITE num="031" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="73" d2="1023" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79101</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LL L                J" publication="CAN DIET ASSOC" d1="42" d2="62 9" d3="1"/>
<CITE num="2" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
</CITATIONS>
<RECORDNUM>01081 </RECORDNUM>
<MEDLINENUM>80006346</MEDLINENUM>
<AUTHORS><AUTHOR>Thomsen-J</AUTHOR><AUTHOR>Friis-B</AUTHOR><AUTHOR>Jensen-K</AUTHOR><AUTHOR>Bak-Pedersen-K</AUTHOR><AUTHOR>Larsen-P-K</AUTHOR></AUTHORS>
<TITLE>Tobramycin ototoxicity.  Repeated courses of high dosage treatment
in children with cystic fibrosis.</TITLE>
<SOURCE>J-Antimicrob-Chemother. 1979 May. 5(3). P 257-60.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: ae</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>EAR-DISEASES: ci</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC><TOPIC>TOBRAMYCIN: ae</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>DRUG-ADMINISTRATION-SCHEDULE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEARING-DISORDERS: ci</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: co</TOPIC><TOPIC>TOBRAMYCIN: ad, tu</TOPIC></MINORSUBJ>
<ABSTRACT>Fifty-three patients with cystic fibrosis were treated with large
doses of tobramycin sulphate, 10 mg/kg/24 h.  Patients received an
average of 3.2 courses, each lasting 10 to 14 days.  The patients
were examined with audiometric and vestibular tests, and in one
patient, a 10-year-old girl, we found a transient high tone loss at
8000 Hz bilaterally that might be attributed to the tobramycin
treatment.  All patients had normal kidney function.  High dose
tobramycin treatment in children with normal kidney function gives
minimal clinical risks of adverse ototoxic effects, even after
repeated courses of treatment.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BODEY GP" publication="ANTIMICROB AGENTS CHEMOTHER" d1="2" d2="109" d3="972"/>
<CITE num="002" author="BREZEZINSKA M" publication="BIOCHEMISTRY NY" d1="2" d2="671" d3="972"/>
<CITE num="003" author="BRUMMET RE" publication="ARCH OTOLARYNGOL" d1="94" d2="59" d3="971"/>
<CITE num="004" author="BRUMMET RE" publication="ARCH OTOLARYNGOL" d1="96" d2="505" d3="972"/>
<CITE num="005" author="BRUMMET RE" publication="ARCH OTOLARYNGOL" d1="101" d2="540" d3="975"/>
<CITE num="006" author="DRASAR FA" publication="BR MED J" d1="2" d2="1284" d3="976"/>
<CITE num="007" author="FEDERSPIL P" publication="PROC TOBRAMYCIN SEL 8TH INT C" d1="" d2="38" d3="973"/>
<CITE num="009" author="HIGGINS CE" publication="ANTIMICROB AGENTS CHEMOTHER" d1="7" d2="332" d3="967"/>
<CITE num="010" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="011" author="LOGAN TB" publication="ARCH OTOLARYNGOL" d1="99" d2="190" d3="974"/>
<CITE num="012" author="MCCRAE WM" publication="SCOTT MED J" d1="21" d2="68" d3="976"/>
<CITE num="013" author="NEU HC" publication="J INFECT DIS SUPPL" d1="134" d2="206" d3="976"/>
<CITE num="014" author="PRAZMA J" publication="LARYNGOSCOPE" d1="86" d2="259" d3="976"/>
<CITE num="015" author="STUPP HF" publication="ACTA OTOLARYNGOL STOCKH SUPPL" d1="262" d2="1" d3="970"/>
<CITE num="016" author="WILSON P" publication="BR MED J" d1="1" d2="259" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79102</PAPERNUM>
<CITATIONS>
<CITE num="1" author="FF L                SE" publication="M PERINATOL" d1="6" d2="55 9" d3="2"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="3" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="4" author="BEREZHINSKAYA VV" publication="ANTIBIOTIKI" d1="28" d2="218" d3="983"/>
<CITE num="5" author="RYBAK LP" publication="AM J OTOL" d1="6" d2="482" d3="985"/>
<CITE num="6" author="FRASER GL" publication="DRUG INTEL CLIN PHARM" d1="19" d2="757" d3="985"/>
<CITE num="7" author="HUY PTB" publication="J CLIN INVEST" d1="77" d2="1492" d3="986"/>
<CITE num="8" author="PEDERSEN SS" publication="ANTIMICROB AGENTS CHEMOTHER" d1="31" d2="594" d3="987"/>
</CITATIONS>
<RECORDNUM>01082 </RECORDNUM>
<MEDLINENUM>80137261</MEDLINENUM>
<AUTHORS><AUTHOR>Hughes-D-T</AUTHOR><AUTHOR>Pines-A</AUTHOR><AUTHOR>Percival-A</AUTHOR><AUTHOR>Stille-W</AUTHOR></AUTHORS>
<TITLE>Round table discussion--treatment of lower respiratory tract
infections with co-trimoxazole.</TITLE>
<SOURCE>J-Antimicrob-Chemother. 1979 Nov. 5(B). P 207-19.</SOURCE>
<MAJORSUBJ><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC><TOPIC>SULFAMETHOXAZOLE: tu</TOPIC><TOPIC>TRIMETHOPRIM: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHIECTASIS: dt</TOPIC><TOPIC>BRONCHITIS: co, pc</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>DRUG-COMBINATIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-ABSCESS: dt</TOPIC><TOPIC>PNEUMONIA: co</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: co</TOPIC></MINORSUBJ>
<ABSTRACT>Over one thousand patients with acute and chronic chest infections
have been treated with a combination of trimethoprim and
sulphamethoxazole.  The patients may be divided into four groups and
the results are summarised in this presentation.  Much of the work
is published elsewhere.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79103</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HUGHES DTD" publication="BR MED J" d1="4" d2="470" d3="969"/>
<CITE num="002" author="HUGHES DTD" publication="ADV IN ANTIMICROBIAL ANTINEO" d1="1" d2="1105" d3="972"/>
<CITE num="003" author="HUGHES DTD" publication="J ANTIMICROB CHEMOTHER" d1="2" d2="320" d3="976"/>
<CITE num="004" author="HUGHES DTD" publication="J ANTIMICROB CHEMOTHER" d1="1" d2="55" d3="975"/>
<CITE num="005" author="PERCIVAL A" publication="IN: BAKER FJ" d1="" d2="154" d3="972"/>
<CITE num="006" author="BUSHBY SRM" publication="BR MED J" d1="3" d2="50" d3="973"/>
<CITE num="007" author="HOWARD AJ" publication="BR MED J" d1="1" d2="1657" d3="978"/>
<CITE num="008" author="LAMBERT HP" publication="SCAND J INFECT DIS SUPPL" d1="14" d2="262" d3="978"/>
<CITE num="009" author="MAY JR" publication="BR MED J" d1="3" d2="376" d3="972"/>
<CITE num="010" author="PERCIVAL A" publication="IN: BAKER FJ" d1="" d2="154" d3="972"/>
<CITE num="011" author="WONG GA" publication="AM J MED" d1="59" d2="219" d3="975"/>
<CITE num="012" author="BAGG R" publication="J ANTIMICROB CHEMOTHER" d1="4" d2="297" d3="978"/>
<CITE num="013" author="PHILLIPS I" publication="IN: PHILLIPS I" d1="" d2="37" d3="974"/>
<CITE num="014" author="THORNSBERRY C" publication="CURRENT MICROBIOL" d1="1" d2="51" d3="978"/>
</REFERENCES>
<RECORDNUM>01083 </RECORDNUM>
<MEDLINENUM>79151301</MEDLINENUM>
<AUTHORS><AUTHOR>Frydman-M-I</AUTHOR></AUTHORS>
<TITLE>Epidemiology of cystic fibrosis: a review.</TITLE>
<SOURCE>J-Chronic-Dis. 1979. 32(3). P 211-9. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>AUSTRALIA</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, pp</TOPIC><TOPIC>EUROPE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FERTILITY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>UNITED-STATES</TOPIC></MINORSUBJ>
<ABSTRACT>Three main reasons have been advanced for the degree of ignorance
and confusion surrounding epidemiologic measures of the incidence
and prevalence of Cystic Fibrosis. (CF)  Relatively recent
recognition of CF as a specific disease entity.  Wide range of
clinical manifestations, presentation as a multisystem disease, and
great natural variation in the severity of involvement of various
organs.  Past difficulty in establishing a diagnosis based on sound
laboratory evidence, this being largely due to the lack of a
screening test that had gained wide acceptance among diagnosticians,
and inaccuracies in the performance and interpretation of the sweat
test.  In addition to these factors, there are a number of
methodological deficiencies and questionable assumptions in several
of the papers that have here been reviewed.  It may be noteworthy
that the two sets of authors whose research design most closely
matched being aimed at providing multiple ascertainment of cases and
cross-checks of validity, have arrived at nearly the same estimated
incidence of this particular disorder (1/3700 and 1/3800
respectively).  The issue of selection and diagnostic criteria is
one that has important implications for epidemiologic studies of
cystic fibrosis.  Particularly in a disease like CF, where the
spectrum of clinical manifestations and severity of involvement is
so broad, estimates of incidence will vary according to the criteria
by which cases are ascertained and included.  A greater degree of
uniformity in standards than has been employed in previous studies
is necessary before comparisons can meaningfully be made.  There are
good grounds for regarding most estimates of CF incidence to be
minimum confirmed figures, and this is particularly so where the
research design ensures that multiple ascertainments of the same
case will be identifiable.  Higher estimates are made where several
sources of error (respondent bias, generalization of hospital data
to the wider population, multiple ascertainments of the same
patient) are not recognised.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="CF GUIDELINES FOR HEALTH PERS" d1="" d2="" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="IN: DOWNEY JA" d1="" d2="25" d3="974"/>
<CITE num="003" author="FANCONI G" publication="WIEN MED WOCHENSCHR" d1="86" d2="753" d3="936"/>
<CITE num="004" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="005" author="BLACKFAN KD" publication="J PEDIATR" d1="13" d2="627" d3="938"/>
<CITE num="006" author="ANDERSEN DH" publication="CHILDREN" d1="7" d2="11" d3="960"/>
<CITE num="007" author="WARWICK WJ" publication="MINN MED" d1="52" d2="1567" d3="969"/>
<CITE num="008" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="009" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="010" author="LIFSCHITZ M" publication="ARCH FOUND THANATOLOGY" d1="1" d2="23" d3="969"/>
<CITE num="011" author="POGUE RE" publication="MINN MED" d1="52" d2="1551" d3="969"/>
<CITE num="012" author="BURTON L" publication="HEALTH VISITOR" d1="456" d2="186" d3="973"/>
<CITE num="013" author="LAWLER RH" publication="CAN MED ASSOC J" d1="94" d2="1043" d3="966"/>
<CITE num="014" author="SHWACHMAN H" publication="IN: GELLIS SS" d1="" d2="237" d3="970"/>
<CITE num="015" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="92" d2="347" d3="956"/>
<CITE num="016" author="LAPEY A" publication="IN: GELLIS SS" d1="" d2="221" d3="976"/>
<CITE num="017" author="MAY CD" publication="J PEDIATR" d1="34" d2="663" d3="949"/>
<CITE num="018" author="MATTHEWS LW" publication="MINN MED" d1="52" d2="1506" d3="969"/>
<CITE num="019" author="CHILDRESS J" publication="IN: PATTERSON PR" d1="" d2="" d3="973"/>
<CITE num="020" author="ANON" publication="GAP CONF REP CHRON BRONC CF" d1="" d2="1" d3="977"/>
<CITE num="021" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="022" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="023" author="ANDERSEN DH" publication="J CHRON DIS" d1="7" d2="58" d3="958"/>
<CITE num="024" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2065" d3="960"/>
<CITE num="025" author="MCPARTLIN JF" publication="ARCH DIS CHILD" d1="47" d2="207" d3="972"/>
<CITE num="026" author="HIATT RB" publication="SURG GYNECOL OBSTET" d1="87" d2="317" d3="948"/>
<CITE num="027" author="KULCZYCKI LL" publication="N ENGL J MED" d1="257" d2="203" d3="957"/>
<CITE num="028" author="DI SANTAGNESE PA" publication="AM J MED" d1="21" d2="406" d3="956"/>
<CITE num="029" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="24" d2="313" d3="959"/>
<CITE num="030" author="ROSENLUND ML" publication="ANN INTERN MED" d1="78" d2="959" d3="973"/>
<CITE num="031" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="032" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="033" author="TECKLIN JS" publication="PHYS THER" d1="55" d2="1081" d3="975"/>
<CITE num="034" author="HOLSCLAW DS" publication="GAP CONF REP CHRON BRONC CF" d1="" d2="13" d3="977"/>
<CITE num="035" author="DENNING CR" publication="PEDIATRICS" d1="41" d2="7" d3="968"/>
<CITE num="036" author="KAPLAN E" publication="N ENGL J MED" d1="279" d2="65" d3="968"/>
<CITE num="037" author="HOLSCLAW DS" publication="J UROL" d1="106" d2="568" d3="971"/>
<CITE num="038" author="ANON" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="9" d3="975"/>
<CITE num="039" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="279" d2="103" d3="968"/>
<CITE num="040" author="KOCH E" publication="INTERNIST (BERL)" d1="1" d2="35" d3="960"/>
<CITE num="041" author="FEIGELSON J" publication="ARCH FR PEDIATR" d1="26" d2="937" d3="969"/>
<CITE num="042" author="TAUSSIG LM" publication="N ENGL J MED" d1="287" d2="586" d3="972"/>
<CITE num="043" author="MEYEROWITZ JH" publication="IN: PATTERSON PR" d1="" d2="40" d3="973"/>
<CITE num="044" author="HOLSCLAW DS" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="1" d3="975"/>
<CITE num="045" author="DENNING CR" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="2" d3="975"/>
<CITE num="046" author="GRAND RJ" publication="JAMA" d1="195" d2="993" d3="966"/>
<CITE num="047" author="NOVY MJ" publication="OBSTET GYNECOL" d1="30" d2="530" d3="967"/>
<CITE num="048" author="SIEGEL B" publication="OBSTET GYNECOL" d1="16" d2="438" d3="960"/>
<CITE num="049" author="POLGAR G" publication="AM REV RESPIR DIS" d1="85" d2="319" d3="962"/>
<CITE num="050" author="BALL RE" publication="N ENGL J MED" d1="265" d2="31" d3="961"/>
<CITE num="051" author="ROSENOW EC 3RD" publication="JAMA" d1="203" d2="227" d3="968"/>
<CITE num="052" author="SALHANICK H" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="4" d3="975"/>
<CITE num="053" author="VANDE WIELE R" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="5" d3="975"/>
<CITE num="054" author="LOWE CU" publication="AM J DIS CHILD" d1="78" d2="349" d3="949"/>
<CITE num="055" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="056" author="GOODMAN HO" publication="AM J HUM GENET" d1="4" d2="59" d3="952"/>
<CITE num="057" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="058" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="059" author="SELANDER P" publication="ACTA PAEDIATR SCAND" d1="51" d2="65" d3="962"/>
<CITE num="060" author="BAUMANN T" publication="HELV PAEDIATR ACTA SUPPL 8" d1="13" d2="1" d3="958"/>
<CITE num="061" author="ROBERTS GBS" publication="ANN HUM GENET" d1="24" d2="127" d3="960"/>
<CITE num="062" author="FANCONI G" publication="SCHWEIZ MED WOCHENSCHR" d1="74" d2="85" d3="944"/>
<CITE num="063" author="BRODY H" publication="NY STATE J MED" d1="41" d2="1256" d3="941"/>
<CITE num="065" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="3" d2="692" d3="964"/>
<CITE num="066" author="KULCZYCKI LL" publication="IN: PATTERSON PR" d1="" d2="117" d3="973"/>
<CITE num="067" author="WANG CI" publication="N ENGL J MED" d1="279" d2="1216" d3="968"/>
<CITE num="068" author="HARRIS RL" publication="PEDIATRICS" d1="41" d2="733" d3="968"/>
<CITE num="069" author="HAMAMOTO E" publication="NIPON SHONIKAGAKKAI ZASSHI" d1="65" d2="502" d3="961"/>
<CITE num="070" author="YAMAMOTO T" publication="SHONIKA RINSHO" d1="10" d2="1003" d3="957"/>
<CITE num="071" author="LEVIN S" publication="IN: GOLDSCHMIDT E" d1="" d2="294" d3="963"/>
<CITE num="072" author="KANDAR HR" publication="ANTISEPTIC" d1="58" d2="863" d3="961"/>
<CITE num="073" author="SALAM M" publication="LEB MED J" d1="15" d2="61" d3="962"/>
<CITE num="074" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="075" author="MACMAHON B" publication="EPIDEMIOLOGY PRINCIPLES AND M" d1="" d2="" d3="970"/>
<CITE num="076" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="72" d2="62" d3="946"/>
<CITE num="077" author="HARPER MH" publication="MED J AUST" d1="1" d2="137" d3="949"/>
<CITE num="078" author="SUDNOW D" publication="PASSING ON THE SOCIAL ORGANIS" d1="" d2="76" d3="967"/>
<CITE num="079" author="EVANS AE" publication="N ENGL J MED" d1="278" d2="138" d3="968"/>
<CITE num="080" author="MERRITT AD" publication="J LAB CLIN MED" d1="60" d2="998" d3="962"/>
<CITE num="081" author="KRAMM ER" publication="AM J PUBLIC HEALTH" d1="52" d2="2041" d3="962"/>
<CITE num="082" author="KRAMM ER" publication="PEDIATRICS" d1="28" d2="128" d3="961"/>
<CITE num="083" author="GREGG RH" publication="PEDIATRICS" d1="36" d2="700" d3="965"/>
<CITE num="084" author="GIBSON LE" publication="CLIN PEDIATR" d1="12" d2="450" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79104</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NG CF               AM" publication="J MED GENET" d1="13" d2="79 9" d3="2"/>
<CITE num="2" author="LONGNECKER DS" publication="AM J PATHOL" d1="107" d2="103" d3="982"/>
<CITE num="3" author="KUMMER F" publication="ATEMWEGS LUNGENKRANKH" d1="10" d2="567" d3="984"/>
<CITE num="4" author="GORTMAKER SL" publication="PEDIATR CLIN NORTH AM" d1="31" d2="3" d3="984"/>
</CITATIONS>
<RECORDNUM>01084 </RECORDNUM>
<MEDLINENUM>79151302</MEDLINENUM>
<AUTHORS><AUTHOR>Kerner-J</AUTHOR><AUTHOR>Harvey-B</AUTHOR><AUTHOR>Lewiston-N</AUTHOR></AUTHORS>
<TITLE>The impact of grief: a retrospective study of family function
following loss of a child with cystic fibrosis.</TITLE>
<SOURCE>J-Chronic-Dis. 1979. 32(3). P 221-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: px</TOPIC><TOPIC>DEATH</TOPIC><TOPIC>FAMILY</TOPIC><TOPIC>GRIEF</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LIFE-CHANGE-EVENTS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PARENTS</TOPIC><TOPIC>RELIGION</TOPIC><TOPIC>RETROSPECTIVE-STUDIES</TOPIC></MINORSUBJ>
<ABSTRACT>The impact of the death of a cystic fibrosis child on subsequent
family function was evaluated in a retrospective study of 16
families.  In findings similar to that reported for another model of
fatal childhood illness, leukemia, there was a high incidence of
emotional and medical problems in the parents.  There was an
unexpectedly high incidence (7/16) of incomplete mourning, i.e.,
maintenance of the child's room as a shrine or weekly grave visit
for more than six months.  Siblings had less difficulty in adjusting
to the loss than that reported for the siblings of leukemic
children.  It is suggested that the prolonged course of a disease
with a hopeless prognosis prepares the family for the child's death
but also retards the mourning process.  The family may need
counseling to ensure that mourning is completed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GOLDBERG IK" publication="IN: PATTERSON PR" d1="" d2="168" d3="973"/>
<CITE num="002" author="TURK J" publication="PEDIATRICS" d1="34" d2="67" d3="964"/>
<CITE num="003" author="LAWLER RH" publication="CAN MED ASSOC J" d1="94" d2="1043" d3="966"/>
<CITE num="004" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
<CITE num="005" author="TROPAUER A" publication="AM J DIS CHILD" d1="119" d2="424" d3="970"/>
<CITE num="006" author="GAYTON WF" publication="AM J DIS CHILD" d1="126" d2="856" d3="973"/>
<CITE num="007" author="FARKAS A" publication="IN: PATTERSON PR" d1="" d2="202" d3="973"/>
<CITE num="008" author="BINGER CM" publication="N ENGL J MED" d1="280" d2="414" d3="969"/>
<CITE num="009" author="MEYEROWITZ JH" publication="SOC SCI MED" d1="1" d2="249" d3="967"/>
<CITE num="010" author="HILGARD JR" publication="INTERN PSYCHIATRY CLIN" d1="6" d2="197" d3="969"/>
<CITE num="011" author="KOLB LC" publication="MODERN CLINICAL PSYCHIATRY" d1="" d2="56" d3="973"/>
<CITE num="012" author="FISCHHOFF J" publication="J PEDIATR" d1="88" d2="140" d3="976"/>
<CITE num="013" author="MCCRAE WM" publication="LANCET" d1="2" d2="141" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79105</PAPERNUM>
<CITATIONS>
<CITE num="1" author="INETTA JJ           CA" publication="NCER" d1="53" d2="30 9" d3="4"/>
<CITE num="2" author="DEWET B" publication="S AFR MED J" d1="65" d2="526" d3="984"/>
<CITE num="3" author="LEWISTON NJ" publication="SEM RESPIR MED" d1="6" d2="321" d3="985"/>
<CITE num="4" author="MILES MS" publication="NURS RES" d1="34" d2="76" d3="985"/>
<CITE num="5" author="WILSON AL" publication="AM J DIS CHILD" d1="139" d2="1235" d3="985"/>
</CITATIONS>
<RECORDNUM>01085 </RECORDNUM>
<MEDLINENUM>79194554</MEDLINENUM>
<AUTHORS><AUTHOR>Spicer-K-M</AUTHOR><AUTHOR>Allen-R-C</AUTHOR><AUTHOR>Hallett-D</AUTHOR><AUTHOR>Buse-M-G</AUTHOR></AUTHORS>
<TITLE>Synthesis of hemoglobin Aic and related minor hemoglobin by
erythrocytes.  In vitro study of regulation.</TITLE>
<SOURCE>J-Clin-Invest. 1979 Jul. 64(1). P 40-8.</SOURCE>
<MAJORSUBJ><TOPIC>ERYTHROCYTES: me</TOPIC><TOPIC>HEMOGLOBIN-A: bi</TOPIC><TOPIC>HEMOGLOBINS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>DIABETES-MELLITUS: bl</TOPIC><TOPIC>FETAL-HEMOGLOBIN: me</TOPIC><TOPIC>GLUCOSE: pd</TOPIC><TOPIC>HEMODIALYSIS</TOPIC><TOPIC>HEMOGLOBIN-C: me</TOPIC><TOPIC>HEMOGLOBIN-SICKLE: me</TOPIC><TOPIC>HEXOSES: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>INSULIN: pd</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHOSPHORYLATION</TOPIC><TOPIC>TEMPERATURE</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Factors that influence hemoglobin (Hb)Aic synthesis by intact
erythrocytes were studied in vitro.  After incubation cells were
lysed, and hemoglobins were separated by isoelectric focusing on
polyacrylamide slab gels and quantitated by microdensitometry.
HbAic increased with time, glucose concentrations (5-500 mM) and
incubation temperature (4 degrees-37 degrees C).  Low temperatures
allowed prolonged incubations with minimal hemolysis.  At 4 degrees
C HbAic increased linearly with time for 6 wk; after incubation at
the highest glucose concentration, HbAic comprised 50% of total
hemoglobin.  Insulin (1 and 0.1 mU/ml) did not affect HbAic
synthesis in vitro.  In addition to glucose, galactose and mannose,
but not fructose, served as precursors to HbAic.  A good substrate
for hexokinase (2-deoxy-glucose) and a poor hexokinase substrate
(3-O-methyl-glucose), were better precursors for HbAic synthesis
than glucose, suggesting that enzymatic phosphorylation of glucose
is not required for HbAic synthesis.  Autoradiography after
erythrocyte incubation with 32P-phosphate showed incorporation of
radioactivity into HbAia1 and HbAia2, but not HbAib, Aic, or A.
Acetylated HbA, generated during incubation with acetylsalicylate,
migrated anodal to HbAic and clearly separated from it.
Erythrocytes from patients with insulinopenic diabetes mellitus
synthesized HbAic at the same rate as controls when incubated with
identical glucose concentrations.  Likewise, the rate of HbAic
synthesis by erythrocytes from patients with cystic fibrosis and
congenital spherocytosis paralleled controls.  When erythrocytes
from cord blood and from HbC and sickle cell anemia patients were
incubated with elevated concentrations of glucose, fetal Hb, HbC,
and sickle Hb decreased whereas hemoglobins focusing at isoelectric
points near those expected for the corresponding glycosylated
derivatives appeared in proportionately increased amounts.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BUNN HF" publication="J CLIN INVEST" d1="57" d2="1652" d3="976"/>
<CITE num="002" author="KOENIG RJ" publication="DIABETES" d1="25" d2="230" d3="976"/>
<CITE num="003" author="KOENIG RJ" publication="N ENGL J MED" d1="295" d2="417" d3="976"/>
<CITE num="004" author="GABBAY KH" publication="J CLIN ENDOCRINOL METAB" d1="44" d2="859" d3="977"/>
<CITE num="005" author="GONEN BA" publication="LANCET" d1="1" d2="734" d3="977"/>
<CITE num="006" author="STEVENS VJ" publication="J BIOL CHEM" d1="252" d2="2998" d3="977"/>
<CITE num="007" author="HANEY DN" publication="PROC NAT ACAD SCI USA" d1="73" d2="3534" d3="976"/>
<CITE num="008" author="BUNN HF" publication="SCIENCE" d1="200" d2="21" d3="978"/>
<CITE num="009" author="DIXON HBF" publication="BIOCHEM J" d1="129" d2="203" d3="972"/>
<CITE num="010" author="BUNN HF" publication="BIOCHEM BIOPHYS RES COMMUN" d1="67" d2="103" d3="975"/>
<CITE num="011" author="KOENIG RJ" publication="J BIOL CHEM" d1="252" d2="2992" d3="977"/>
<CITE num="012" author="SPICER KM" publication="DIABETES" d1="27" d2="384" d3="978"/>
<CITE num="013" author="BEUTLER E" publication="IN: GREENWALT TJ" d1="" d2="189" d3="974"/>
<CITE num="014" author="BEUTLER E" publication="J LAB CLIN MED" d1="80" d2="723" d3="972"/>
<CITE num="015" author="BRIDGES KR" publication="J CLIN INVEST" d1="56" d2="201" d3="975"/>
<CITE num="016" author="TRIVELLI LA" publication="N ENGL J MED" d1="284" d2="353" d3="971"/>
<CITE num="017" author="SCHNEK AG" publication="J AM CHEM SOC" d1="83" d2="1472" d3="961"/>
<CITE num="018" author="DRABKIN DL" publication="J BIOL CHEM" d1="164" d2="703" d3="946"/>
<CITE num="019" author="STEVENS VJ" publication="PROC NAT ACAD SCI USA" d1="75" d2="2918" d3="978"/>
<CITE num="020" author="PAULSEN EP" publication="DIABETES" d1="25" d2="890" d3="976"/>
<CITE num="021" author="MORGAN HE" publication="CURR TOP MEMBRANES TRANSP" d1="4" d2="255" d3="973"/>
<CITE num="022" author="MCDONALD MJ" publication="J BIOL CHEM" d1="253" d2="2327" d3="978"/>
<CITE num="023" author="BUNN HF" publication="HUMAN HEMOGLOBIN" d1="" d2="8" d3="977"/>
<CITE num="024" author="BASSETT PY" publication="BLOOD" d1="51" d2="971" d3="978"/>
<CITE num="025" author="ROSE IA" publication="J BIOL CHEM" d1="239" d2="12" d3="964"/>
<CITE num="026" author="BEUTLER E" publication="RED CELL METABOLISM" d1="" d2="123" d3="975"/>
<CITE num="027" author="KRISHNAMOORTHY R" publication="FEBS LETTERS" d1="77" d2="99" d3="977"/>
<CITE num="028" author="DOLHOFER R" publication="FEBS LETTERS" d1="85" d2="86" d3="978"/>
<CITE num="029" author="LEFEVRE PG" publication="PHARMACOL REV" d1="13" d2="39" d3="961"/>
<CITE num="030" author="CANTOR SM" publication="J AM CHEM SOC" d1="62" d2="2113" d3="940"/>
<CITE num="031" author="LOS JM" publication="J AM CHEM SOC" d1="78" d2="1564" d3="956"/>
<CITE num="032" author="FLUCKIGER R" publication="FEBS LETTERS" d1="71" d2="356" d3="976"/>
<CITE num="033" author="ZIPPER H" publication="BIOCHIM BIOPHYS ACTA" d1="282" d2="311" d3="972"/>
<CITE num="034" author="GAMBHIR KK" publication="DIABETES" d1="27" d2="701" d3="978"/>
<CITE num="035" author="GRAF R" publication="DIABETES SUPPL" d1="26" d2="368" d3="977"/>
<CITE num="036" author="ABDELLA PM" publication="BIOCHIM BIOPHYS ACTA" d1="490" d2="462" d3="977"/>
<CITE num="037" author="BUNN HF" publication="J CLIN INVEST" d1="49" d2="1088" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79106</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TZGERALD MD         AM" publication="J HEMATOL" d1="9" d2="11 9" d3="0"/>
<CITE num="2" author="SVENDSEN PA" publication="DIABETOLOGIA" d1="19" d2="130" d3="980"/>
<CITE num="3" author="BERNSTEIN RE" publication="CLIN CHEM" d1="26" d2="174" d3="980"/>
<CITE num="4" author="MENARD L" publication="CLIN CHEM" d1="26" d2="1598" d3="980"/>
<CITE num="5" author="ROMEN W" publication="KLIN WSCHR" d1="58" d2="1013" d3="980"/>
<CITE num="6" author="BERGER W" publication="SCHWEIZ MED WOCHENSCHR" d1="110" d2="485" d3="980"/>
<CITE num="7" author="BARTOSZ G" publication="MECH AGEING DEV" d1="17" d2="237" d3="981"/>
<CITE num="8" author="MONNIER LH" publication="DIABETOLOGIA" d1="20" d2="12" d3="981"/>
<CITE num="9" author="BOUCHER BJ" publication="DIABETOLOGIA" d1="21" d2="34" d3="981"/>
<CITE num="10" author="DEAN PDG" publication="DIABETOLOGIA" d1="21" d2="579" d3="981"/>
<CITE num="11" author="MORTENSEN HB" publication="SCAND J CLIN LAB INVEST" d1="41" d2="451" d3="981"/>
<CITE num="12" author="FADEL HE" publication="AM J OBSTET GYNECOL" d1="139" d2="397" d3="981"/>
<CITE num="13" author="FADEL HE" publication="AM J OBSTET GYNECOL" d1="141" d2="704" d3="981"/>
<CITE num="14" author="GOEBEL FD" publication="RES EXP MED" d1="179" d2="133" d3="981"/>
<CITE num="15" author="PEREJDA AJ" publication="COLLAGEN RELAT RES" d1="2" d2="83" d3="982"/>
<CITE num="16" author="ESCHWEGE E" publication="DIABETE METAB" d1="8" d2="137" d3="982"/>
<CITE num="17" author="LEUTENEGGER M" publication="DIABETE METAB" d1="8" d2="249" d3="982"/>
<CITE num="18" author="UITTO J" publication="CONNECT TISS RES" d1="10" d2="287" d3="982"/>
<CITE num="19" author="POWELL HC" publication="CLIN BIOCHEM" d1="15" d2="133" d3="982"/>
<CITE num="20" author="PEER G" publication="ISR J MED SCI" d1="18" d2="960" d3="982"/>
<CITE num="21" author="BARTOSZ G" publication="MECH AGEING DEV" d1="20" d2="223" d3="982"/>
<CITE num="22" author="VIALETTES B" publication="DIABETOLOGIA" d1="22" d2="264" d3="982"/>
<CITE num="23" author="HOWARD CF" publication="DIABETES" d1="31" d2="1105" d3="982"/>
<CITE num="24" author="ARNQVIST H" publication="SCAND J CLIN LAB INVEST" d1="42" d2="265" d3="982"/>
<CITE num="25" author="PANZER S" publication="BLOOD" d1="59" d2="1348" d3="982"/>
<CITE num="26" author="BACHEM MG" publication="KLIN WSCHR" d1="60" d2="497" d3="982"/>
<CITE num="27" author="SMITH RJ" publication="J CLIN INVEST" d1="69" d2="1164" d3="982"/>
<CITE num="28" author="BASSET P" publication="J CHROMATOGR" d1="227" d2="267" d3="982"/>
<CITE num="29" author="MORTENSEN HB" publication="BIOCHIM BIOPHYS ACTA" d1="707" d2="154" d3="982"/>
<CITE num="30" author="MEHL TD" publication="DIABETES CARE" d1="6" d2="34" d3="983"/>
<CITE num="31" author="ZELLER WP" publication="PEDIATR RES" d1="17" d2="200" d3="983"/>
<CITE num="32" author="COHEN MP" publication="EXP GERONTOL" d1="18" d2="461" d3="983"/>
<CITE num="33" author="WETTRE S" publication="DIABETOLOGIA" d1="24" d2="148" d3="983"/>
<CITE num="34" author="CZECH A" publication="J CHRON DIS" d1="36" d2="803" d3="983"/>
<CITE num="35" author="SANDHU RS" publication="CLIN BIOCHEM CONTEM THEO TECH" d1="3" d2="215" d3="984"/>
<CITE num="36" author="MIEDEMA K" publication="ANN CLIN BIOCHEM" d1="21" d2="2" d3="984"/>
<CITE num="37" author="OLESEN HA" publication="SCAND J CLIN LAB INVEST" d1="44" d2="329" d3="984"/>
<CITE num="38" author="DAVIDOFF P" publication="REV MED CHIL" d1="112" d2="3" d3="984"/>
<CITE num="39" author="COSSU G" publication="J CHROMATOGR" d1="307" d2="103" d3="984"/>
<CITE num="40" author="KUMAR A" publication="BIOCHEM MED" d1="34" d2="112" d3="985"/>
<CITE num="41" author="ABRAHAM EC" publication="HEMOGLOBIN" d1="10" d2="173" d3="986"/>
</CITATIONS>
<RECORDNUM>01086 </RECORDNUM>
<MEDLINENUM>79151454</MEDLINENUM>
<AUTHORS><AUTHOR>Seale-T-W</AUTHOR><AUTHOR>Thirkill-H</AUTHOR><AUTHOR>Tarpay-M</AUTHOR><AUTHOR>Flux-M</AUTHOR><AUTHOR>Rennert-O-M</AUTHOR></AUTHORS>
<TITLE>Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa
isolates from single sputa of cystic fibrosis patients.</TITLE>
<SOURCE>J-Clin-Microbiol. 1979 Jan. 9(1). P 72-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: cl</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBIOTICS: pd</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>HAEMOPHILUS-INFLUENZAE: ip</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: de</TOPIC><TOPIC>SEROTYPING</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS: ip</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>A phenotypic characterization of Pseudomonas aeruginosa from single
sputum samples of 21 typical cystic fibrosis patients indicated a
high frequency of heterogeneity among isolates on the basis of
differences in antibiotic resistance, colony morphology,
pigmentation, and serotype.  Two or more isolates with different but
stable susceptibilities to carnecillin, gentamycin, streptomycin,
tetracycline, chloramphenicol, and sulfamethoxazole plus
trimethoprim were detected in 38% of the sputa.  Differences
generally were independent of the mucoid state of the strain.  O-
antigen group determination with the Difco typing set showed that
two or more serologically distinct strains were present in 10/21
sputum specimens.  Nonmucoid derivatives of mucoid isolates almost
always retained both the antibiotic susceptibilities and serotype of
their parent strain.  These data suggest that cystic fibrosis
patients may be cocolonized/coinfected by difference strains of P.
aeruginosa more frequently than generally believed.  Alternatively,
phenotypically distinct strains from a single patient might arise as
phenotypic dissociants from a single infecting strain.  Because of
the frequency and multiplicity of phenotypically distinct P.
aeruginosa isolates which we obtained from our cystic fibrosis
patients, it is important to select multiple isolates from sputum
cultures for antimicrobial susceptibility testing so as to assess
adequately the susceptibility of this organism to antibiotic therapy
in cystic fibrosis.  We recommend that several colonies of each
distinguishable colony type of P. aeruginosa be pooled for the
antibiogram.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAUER AW" publication="AM J CLIN PATHOL" d1="45" d2="493" d3="966"/>
<CITE num="002" author="BERGAN T" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="553" d3="975"/>
<CITE num="003" author="BOWMAN BH" publication="IN: MANGOS JA" d1="" d2="277" d3="976"/>
<CITE num="004" author="BOXERBAUM B" publication="AM REV RESPIR DIS" d1="108" d2="777" d3="973"/>
<CITE num="005" author="DIAZ F" publication="J INFECT DIS" d1="121" d2="269" d3="970"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="007" author="DOGGETT RG" publication="J PEDIATR" d1="68" d2="215" d3="966"/>
<CITE num="008" author="GRIEBLE HG" publication="N ENGL J MED" d1="282" d2="531" d3="970"/>
<CITE num="009" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="010" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="011" author="LEVISON H" publication="IN: MANGOS JA" d1="" d2="3" d3="976"/>
<CITE num="012" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="013" author="SCHWARZMANN S" publication="INFECT IMMUN" d1="3" d2="762" d3="971"/>
<CITE num="014" author="TALAMO RC" publication="IN: MANGOS JA" d1="" d2="195" d3="976"/>
<CITE num="015" author="WILLIAMS RJ" publication="J MED MICROBIOL" d1="6" d2="409" d3="973"/>
<CITE num="016" author="ZIERDT CH" publication="J BACTERIOL" d1="87" d2="1003" d3="964"/>
<CITE num="017" author="ZIERDT CH" publication="J CLIN MICROBIOL" d1="1" d2="521" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79107</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MKO CA              CU" publication="RRENT MICROBIOL" d1="4" d2="69 9" d3="0"/>
<CITE num="2" author="MARKOWITZ SM" publication="J ANTIMICROB CHEMOTHER" d1="6" d2="251" d3="980"/>
<CITE num="3" author="GODFREY AJ" publication="ANTIMICROB AGENTS CHEMOTHER" d1="19" d2="705" d3="981"/>
<CITE num="4" author="IRVIN RT" publication="ANTIMICROB AGENTS CHEMOTHER" d1="19" d2="1056" d3="981"/>
<CITE num="5" author="WILSON LA" publication="AM J OPHTHALMOL" d1="92" d2="546" d3="981"/>
<CITE num="6" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="7" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="8" author="JANDA JM" publication="J CLIN MICROBIOL" d1="15" d2="178" d3="982"/>
<CITE num="9" author="SHEEHAN DJ" publication="J CLIN MICROBIOL" d1="15" d2="926" d3="982"/>
<CITE num="10" author="PUGASHETTI BK" publication="J CLIN MICROBIOL" d1="16" d2="686" d3="982"/>
<CITE num="11" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="12" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="13" author="ANON" publication="LANCET" d1="2" d2="257" d3="983"/>
<CITE num="14" author="GOVAN JRW" publication="REV INFECT DIS" d1="5" d2="S874" d3="983"/>
<CITE num="15" author="JAGGER KN" publication="J CLIN MICROBIOL" d1="17" d2="55" d3="983"/>
<CITE num="16" author="FLOURNOY DJ" publication="METH FIND EXP CLIN PHARMACOL" d1="6" d2="487" d3="984"/>
<CITE num="17" author="CHAN R" publication="J CLIN MICROBIOL" d1="19" d2="8" d3="984"/>
<CITE num="18" author="MCNEILL WF" publication="AM J CLIN PATHOL" d1="81" d2="742" d3="984"/>
<CITE num="19" author="GOLD R" publication="PEDIATR INFECT DIS" d1="4" d2="172" d3="985"/>
<CITE num="20" author="LUZAR MA" publication="INFECT IMMUN" d1="50" d2="577" d3="985"/>
<CITE num="21" author="KOMIYAMA K" publication="ORAL SURG" d1="59" d2="590" d3="985"/>
<CITE num="22" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="23" author="PIER GB" publication="J INFECT DIS" d1="151" d2="575" d3="985"/>
<CITE num="24" author="PACIFICO L" publication="J INFECT DIS" d1="152" d2="852" d3="985"/>
<CITE num="25" author="MAYO MS" publication="J CLIN MICROBIOL" d1="24" d2="372" d3="986"/>
<CITE num="26" author="PIER GB" publication="J CLIN MICROBIOL" d1="24" d2="189" d3="986"/>
<CITE num="27" author="KOMIYAMA K" publication="CAN J MICROBIOL" d1="33" d2="221" d3="987"/>
<CITE num="28" author="OGLE JW" publication="J INFECT DIS" d1="155" d2="119" d3="987"/>
</CITATIONS>
<RECORDNUM>01087 </RECORDNUM>
<MEDLINENUM>79174043</MEDLINENUM>
<AUTHORS><AUTHOR>Lloyd-J-K</AUTHOR></AUTHORS>
<TITLE>Dietary problems associated with the care of chronically sick
children.</TITLE>
<SOURCE>J-Hum-Nutr. 1979 Apr. 33(2). P 135-9.</SOURCE>
<MAJORSUBJ><TOPIC>CHRONIC-DISEASE: dh</TOPIC><TOPIC>DIET</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELIAC-DISEASE: dh</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC><TOPIC>DIABETES-MELLITUS-INSULIN-DEPENDENT: dh</TOPIC><TOPIC>DIABETIC-DIET</TOPIC><TOPIC>HEART-DEFECTS-CONGENITAL: dh</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KIDNEY-FAILURE-CHRONIC: dh</TOPIC><TOPIC>MENINGOMYELOCELE: dh</TOPIC><TOPIC>MENTAL-RETARDATION: dh</TOPIC><TOPIC>PHENYLKETONURIA: dh</TOPIC></MINORSUBJ>
<ABSTRACT>The dietary problems associated with the care of chronically sick
children can be considered under two broad headings.  First, there
are the problems in those children for whom diet is an essential
part of the treatment of their chronic disorder; and second there
are nutritional complications which may occur in children with
chronic diseases in which diet does not have a specific role in
treatment, and is thus often neglected or considered only at a later
stage of management.  Many of the problems are of course common to
both situations.  This paper will review briefly some of the
difficulties, illustrating these with specific examples; no attempt
will be made to describe or discuss the treatment of any particular
disorder.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLAN JD" publication="AM J DIS CHILD" d1="126" d2="22" d3="973"/>
<CITE num="002" author="BIRBECK JA" publication="ARCH DIS CHILD" d1="51" d2="467" d3="976"/>
<CITE num="003" author="COURT JM" publication="J HUM NUTR" d1="32" d2="285" d3="978"/>
<CITE num="004" author="HAYES-ALLEN MC" publication="BR J PREV SOC MED" d1="27" d2="192" d3="973"/>
<CITE num="005" author="LINDE LM" publication="J PEDIATR" d1="70" d2="413" d3="967"/>
<CITE num="006" author="PACKER SM" publication="ARCH DIS CHILD" d1="53" d2="449" d3="978"/>
<CITE num="007" author="RICKARD K" publication="PEDIATR CLIN NORTH AM" d1="24" d2="157" d3="977"/>
<CITE num="008" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="009" author="SMITH I" publication="IN: MCLAREN DS" d1="" d2="263" d3="976"/>
<CITE num="010" author="SMITH I" publication="BR MED J" d1="2" d2="723" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79108</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SCHER M             J" publication="MENT DEFIC RES" d1="29" d2="73 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01088 </RECORDNUM>
<MEDLINENUM>79174045</MEDLINENUM>
<AUTHORS><AUTHOR>Francis-D-E</AUTHOR></AUTHORS>
<TITLE>Inborn errors of metabolism: the need for sugar.</TITLE>
<SOURCE>J-Hum-Nutr. 1979 Apr. 33(2). P 146-54.</SOURCE>
<MAJORSUBJ><TOPIC>DIETARY-CARBOHYDRATES</TOPIC><TOPIC>METABOLISM-INBORN-ERRORS: dh</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AMINO-ACID-METABOLISM-INBORN-ERRORS: dh</TOPIC><TOPIC>CARBOHYDRATE-METABOLISM-INBORN-ERRORS: dh</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC><TOPIC>DENTAL-CARIES: et</TOPIC><TOPIC>DIETARY-FATS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIPID-METABOLISM-INBORN-ERRORS: dh</TOPIC><TOPIC>MAPLE-SYRUP-URINE-DISEASE: dh</TOPIC><TOPIC>METABOLISM-INBORN-ERRORS: co</TOPIC><TOPIC>PHENYLKETONURIA: dh</TOPIC></MINORSUBJ>
<EXTRACT>Inborn errors of metabolism are conditions in which the body fails to
metabolise certain chemicals due to an inherited enzyme deficiency.
The inborn errors of metabolism considered in this paper are those
which affect the metabolism of dietary nutrients and which require
manipulation of the carbohydrate intake.  In these cases the need for
sugar - either as a source of energy when other energy-supplying
nutrients have to be suppressed, or for the control of hypoglycaemia
- is vitally important.  Inborn errors of protein metabolism include
phenylketonuria, maple-syrup urine disease, organic acidaemias, and
hyperammonaemia.  Inborn errors of fat metabolism  include
abetalipoprotinaemia, type I lipoprotein-lipase deficiency, and
lymphangiectasia.  Inborn errors of carbohydrate metabolism include
diabetes, galactosaemia, fructosaemia, and glucose-6-phosphate
deficiency (type I glycogen storage disease).  Inborn errors of
multiple nutrients include cystic fibrosis.  Dietary carbohydrate,
psychological considerations, and dental caries are examined.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79109</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="002" author="CLAYTON BE" publication="IN: DICKERSON JWT" d1="" d2="29" d3="978"/>
<CITE num="003" author="COURT JM" publication="YOUR CHILD HAS DIABETES" d1="" d2="" d3="972"/>
<CITE num="004" author="CORNBLATH M" publication="DISORDERS CARBOHYD METAB INFA" d1="" d2="115" d3="966"/>
<CITE num="005" author="CRAIG O" publication="CHILDHOOD DIABETES AND ITS MA" d1="" d2="" d3="977"/>
<CITE num="006" author="CRIGLER JF" publication="CIBA FOUND SYMP 55" d1="" d2="331" d3="978"/>
<CITE num="007" author="FRANCIS DEM" publication="DIETS FOR SICK CHILDREN" d1="" d2="" d3="974"/>
<CITE num="008" author="GREENE HL" publication="N ENGL J MED" d1="294" d2="1125" d3="976"/>
<CITE num="009" author="HENNON DK" publication="JADA" d1="95" d2="965" d3="977"/>
<CITE num="010" author="LEVINE RS" publication="BR DENT J" d1="137" d2="429" d3="974"/>
<CITE num="011" author="LLOYD JK" publication="IN: MCLAREN DS" d1="" d2="254" d3="976"/>
<CITE num="012" author="LLOYD JK" publication="IN: PEETERS H" d1="" d2="331" d3="972"/>
<CITE num="013" author="PARTIN JC" publication="PEDIATR RES" d1="8" d2="384" d3="974"/>
<CITE num="014" author="SMALLEY CA" publication="ARCH DIS CHILD" d1="53" d2="477" d3="978"/>
<CITE num="015" author="SMITH I" publication="BR MED J" d1="2" d2="723" d3="978"/>
<CITE num="016" author="SMITH I" publication="IN: MCLAREN DS" d1="" d2="263" d3="976"/>
<CITE num="017" author="STEPHEN KW" publication="BR DENT J" d1="144" d2="202" d3="978"/>
<CITE num="018" author="WINTER GB" publication="CARIES RES" d1="8" d2="256" d3="974"/>
<CITE num="019" author="YASSA JG" publication="ARCH DIS CHILD" d1="53" d2="777" d3="978"/>
</REFERENCES>
<RECORDNUM>01089 </RECORDNUM>
<MEDLINENUM>80095419</MEDLINENUM>
<AUTHORS><AUTHOR>Vymola-F</AUTHOR><AUTHOR>Trojanova-M</AUTHOR><AUTHOR>Pillich-J</AUTHOR><AUTHOR>Lochmann-O</AUTHOR></AUTHORS>
<TITLE>Therapeutic possibilities in Pseudomonas infections.</TITLE>
<SOURCE>J-Hyg-Epidemiol-Microbiol-Immunol (Praha). 1979. 23(1). P 114-7.</SOURCE>
<MAJORSUBJ><TOPIC>PSEUDOMONAS-INFECTIONS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACUTE-DISEASE</TOPIC><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>BACTERIOPHAGES</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>GAMMA-GLOBULINS: ad, tu</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNIZATION-PASSIVE</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>TOXOIDS: ad, tu</TOPIC><TOPIC>IMMUNOTHERAPY</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79110</PAPERNUM>
<ABSTRACT>Acute pseudomonas infections require treatment with antibiotics
producing a bactericidal effect. The most useful are gentamicin,
tobramycin, sisomicin and polymyxin B. In resistant strains, amikacin
is indicated in addition. Carbenicillin, ticarcillin, carfenicillin
or azocillin should never be given alone but in combination with some
of the above preparations. Other drugs, such as chloramphenicol,
tetracycline or streptomycin, though effective in vitro, should be
avoided. Chemotherapy may be complemented by passive immunization
either with hyperimmune specific gama globulin or hyperimmune plasma.
A programmatic item of combined treatment is active immunization,
especially with toxoid vaccine. Chronic processes are not, perhaps
with the exception of urinary infections, suitable for antibiotic
therapy. For this reason effective polyvalent vaccines should be
developed from appropriate strains. It is now certain that in
infections caused by mucous strains (most frequently encountered in
cystic fibrosis) the vaccine should be prepared from these strains,
since they have distinct functional and antigenic characteristics.</ABSTRACT>
<RECORDNUM>01090 </RECORDNUM>
<MEDLINENUM>80161290</MEDLINENUM>
<AUTHORS><AUTHOR>Thomassen-M-J</AUTHOR><AUTHOR>Demko-C-A</AUTHOR><AUTHOR>Boxerbaum-B</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Kuchenbrod-P-J</AUTHOR></AUTHORS>
<TITLE>Multiple of isolates of Pseudomonas aeruginosa with differing
antimicrobial susceptibility patterns from patients with cystic
fibrosis.</TITLE>
<SOURCE>J-Infect-Dis. 1979 Dec. 140(6). P 873-80.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: ip</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CARBENICILLIN: tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>GENTAMICINS: tu</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>KANAMYCIN: tu</TOPIC><TOPIC>MICROBIAL-SENSITIVITY-TESTS</TOPIC><TOPIC>TETRACYCLINE: tu</TOPIC><TOPIC>TICARCILLIN: tu</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Clinical isolates of Pseudomonas aeruginosa from patients with cystic
fibrosis were studied in an effort to determine the unique
characteristics of the infecting strains and to elucidate the pattern
of colonization. Of 413 patients studied, 81% were chronically
infected with P. aeruginosa. Patients from whom P. aeruginosa was
never or only occasionally isolated were in better clinical condition
than the chronically infected patients. Isolates were classified into
six morphologic varieties: classic, rough, mucoid, gelatinous, dwarf,
and enterobacter. Most patients had two or more of these varieties.
Such multiple varieties from the same individual were of the same
serotype but often differed in antibiotic susceptibility as
determined by both the disk and the minimal inhibitory concentration
methods. These differences were apparent when mucoid strains were
compared with nonmucoid strains and when nonmucoid strains were
compared with one another. Studies of antibiotic susceptibility
should be performed on each morphologically different type of P.
aeruginosa obtained from patients with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DOERSHUK CF" publication="IN: GREEN M" d1="" d2="707" d3="968"/>
<CITE num="002" author="DOGGETT RG" publication="APPL MICROBIOL" d1="18" d2="936" d3="969"/>
<CITE num="003" author="MARTIN DR" publication="J MED MICROBIOL" d1="6" d2="111" d3="973"/>
<CITE num="004" author="ZIERDT CH" publication="J BACTERIOL" d1="87" d2="1003" d3="964"/>
<CITE num="005" author="GOVAN JRW" publication="J MED MICROBIOL" d1="8" d2="513" d3="975"/>
<CITE num="006" author="DIAZ F" publication="J INFECT DIS" d1="121" d2="269" d3="970"/>
<CITE num="007" author="WILLIAMS RJ" publication="J MED MICROBIOL" d1="6" d2="409" d3="973"/>
<CITE num="008" author="BERGAN T" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="553" d3="975"/>
<CITE num="009" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="010" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="011" author="WAHBA AH" publication="J GEN MICROBIOL" d1="38" d2="329" d3="965"/>
<CITE num="012" author="BAUER AW" publication="AM J CLIN PATHOL" d1="45" d2="493" d3="966"/>
<CITE num="013" author="BAILEY WR" publication="DIAGNOSTIC MICROBIOLOGY" d1="" d2="313" d3="974"/>
<CITE num="014" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="015" author="REYNOLDS HY" publication="ANN INTERN MED" d1="82" d2="819" d3="975"/>
<CITE num="016" author="GOVAN JRW" publication="J ANTIMICROB CHEMOTHER" d1="4" d2="233" d3="978"/>
<CITE num="017" author="ZIERDT CH" publication="J CLIN MICROBIOL" d1="1" d2="521" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79111</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MKO CA              CU" publication="RRENT MICROBIOL" d1="4" d2="69 9" d3="0"/>
<CITE num="2" author="JANDA JM" publication="J CLIN MICROBIOL" d1="12" d2="626" d3="980"/>
<CITE num="3" author="IRVIN RT" publication="ANTIMICROB AGENTS CHEMOTHER" d1="19" d2="1056" d3="981"/>
<CITE num="4" author="BLACKWOOD LL" publication="INFECT IMMUN" d1="32" d2="443" d3="981"/>
<CITE num="5" author="THOMASSEN MJ" publication="INFECT IMMUN" d1="33" d2="512" d3="981"/>
<CITE num="6" author="PENNINGTON JE" publication="J CLIN INVEST" d1="68" d2="1140" d3="981"/>
<CITE num="7" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="8" author="MACONE AB" publication="N ENGL J MED" d1="304" d2="1445" d3="981"/>
<CITE num="9" author="JANDA JM" publication="J CLIN MICROBIOL" d1="15" d2="178" d3="982"/>
<CITE num="10" author="SHEEHAN DJ" publication="J CLIN MICROBIOL" d1="15" d2="926" d3="982"/>
<CITE num="11" author="PUGASHETTI BK" publication="J CLIN MICROBIOL" d1="16" d2="686" d3="982"/>
<CITE num="12" author="OHMAN DE" publication="INFECT IMMUN" d1="37" d2="662" d3="982"/>
<CITE num="13" author="THOMASSEN MJ" publication="INFECT IMMUN" d1="38" d2="802" d3="982"/>
<CITE num="14" author="WINNIE GB" publication="INFECT IMMUN" d1="38" d2="1088" d3="982"/>
<CITE num="15" author="SPEERT DP" publication="J PEDIATR" d1="101" d2="227" d3="982"/>
<CITE num="16" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="17" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="18" author="COSTERTON JW" publication="REV INFECT DIS" d1="5" d2="S867" d3="983"/>
<CITE num="19" author="GOVAN JRW" publication="REV INFECT DIS" d1="5" d2="S874" d3="983"/>
<CITE num="20" author="BOROWSKI RS" publication="CURRENT MICROBIOL" d1="9" d2="25" d3="983"/>
<CITE num="21" author="NINANE G" publication="INFECTION" d1="11" d2="S 16" d3="983"/>
<CITE num="22" author="JAGGER KN" publication="J CLIN MICROBIOL" d1="17" d2="55" d3="983"/>
<CITE num="23" author="BASSETTI  D" publication="CURR THER RES CLIN EXP" d1="33" d2="874" d3="983"/>
<CITE num="24" author="JOHNSON SR" publication="OBSTET GYNECOL" d1="61" d2="S  2" d3="983"/>
<CITE num="25" author="FLOURNOY DJ" publication="METH FIND EXP CLIN PHARMACOL" d1="6" d2="487" d3="984"/>
<CITE num="26" author="CHAN R" publication="J CLIN MICROBIOL" d1="19" d2="8" d3="984"/>
<CITE num="27" author="MCNEILL WF" publication="AM J CLIN PATHOL" d1="81" d2="742" d3="984"/>
<CITE num="28" author="THOMASSEN MJ" publication="J PEDIATR" d1="104" d2="352" d3="984"/>
<CITE num="29" author="GOLD R" publication="PEDIATR INFECT DIS" d1="4" d2="172" d3="985"/>
<CITE num="30" author="KOMIYAMA K" publication="ORAL SURG" d1="59" d2="590" d3="985"/>
<CITE num="31" author="THOMASSEN MJ" publication="AM REV RESPIR DIS" d1="131" d2="791" d3="985"/>
<CITE num="32" author="PACIFICO L" publication="J INFECT DIS" d1="152" d2="852" d3="985"/>
<CITE num="33" author="MCCARTHY VP" publication="PEDIATR INFECT DIS" d1="5" d2="256" d3="986"/>
<CITE num="34" author="GILLJAM H" publication="THORAX" d1="41" d2="641" d3="986"/>
<CITE num="35" author="PITT TL" publication="J ROY SOC MED" d1="79" d2="13" d3="986"/>
<CITE num="36" author="LEVY J" publication="J PEDIATR" d1="108" d2="841" d3="986"/>
<CITE num="37" author="REED MD" publication="PEDIATR PULMONOL" d1="3" d2="101" d3="987"/>
<CITE num="38" author="DUNNE WM" publication="DIAGN MICROBIOL INFECT DIS" d1="6" d2="165" d3="987"/>
<CITE num="39" author="SPEERT DP" publication="J HOSP INFECT" d1="9" d2="11" d3="987"/>
<CITE num="40" author="KOMIYAMA K" publication="CAN J MICROBIOL" d1="33" d2="221" d3="987"/>
<CITE num="41" author="OGLE JW" publication="J INFECT DIS" d1="155" d2="119" d3="987"/>
</CITATIONS>
<RECORDNUM>01091 </RECORDNUM>
<MEDLINENUM>80007721</MEDLINENUM>
<AUTHORS><AUTHOR>Pennington-J-E</AUTHOR><AUTHOR>Wolff-S-M</AUTHOR><AUTHOR>Puziss-M</AUTHOR></AUTHORS>
<TITLE>Summary of a workshop on infections in patients with cystic fibrosis.</TITLE>
<SOURCE>J-Infect-Dis. 1979 Aug. 140(2). P 252-6.</SOURCE>
<MAJORSUBJ><TOPIC>BACTERIAL-INFECTIONS: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANTIBODIES-BACTERIAL: an</TOPIC><TOPIC>CONGRESSES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im, ip</TOPIC><TOPIC>SPUTUM: mi</TOPIC><TOPIC>NATIONAL-INSTITUTES-OF-HEALTH-U-S</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is currently the most common fatal hereditary disease
of the Caucasian race.  The lack of effective oral antibiotics
against Pseudomonas aeruginosa precludes either systemic treatment or
suppression, in an outpatient setting, of the chronic pseudomonas
bronchitis typically seen in CF patients.  Because of the central
role of infection, and particularly pseudomonas infection, in the
sequence of events that leads to respiratory failure and death in CF,
currently available information regarding the pathogenesis of
infections caused by P. aeruginosa was emphasized and discussed at a
workshop on infections in patients with CF, sponsored by the National
Institute of Allergy and Infectious Diseases in Bethesda, Md., on
January 9 and 10, 1979.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79112</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SSINO RJJ           PE" publication="DIATR RES" d1="14" d2="12 9" d3="0"/>
<CITE num="2" author="FICK RB" publication="J IMMUNOL METH" d1="38" d2="103" d3="980"/>
<CITE num="3" author="BANNATYNE RM" publication="ANTIMICROB AGENTS CHEMOTHER" d1="20" d2="493" d3="981"/>
<CITE num="4" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="5" author="OBOYLE CP" publication="IR J MED SCI" d1="150" d2="286" d3="981"/>
<CITE num="6" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="7" author="SCHOFIELD DH" publication="DRUG INTEL CLIN PHARM" d1="18" d2="153" d3="984"/>
<CITE num="8" author="SUTER S" publication="J INFECT DIS" d1="149" d2="523" d3="984"/>
<CITE num="9" author="JEWETT CV" publication="J PEDIATR" d1="106" d2="669" d3="985"/>
<CITE num="10" author="SUTER S" publication="J INFECT DIS" d1="153" d2="902" d3="986"/>
</CITATIONS>
<RECORDNUM>01092 </RECORDNUM>
<MEDLINENUM>79152690</MEDLINENUM>
<AUTHORS><AUTHOR>Dreisin-R-B</AUTHOR><AUTHOR>Mostow-S-R</AUTHOR></AUTHORS>
<TITLE>Sulfhydryl-mediated depression of ciliary activity: an adverse
effect of acetylcysteine.</TITLE>
<SOURCE>J-Lab-Clin-Med. 1979 Apr. 93(4). P 674-8.</SOURCE>
<MAJORSUBJ><TOPIC>ACETYLCYSTEINE: ae</TOPIC><TOPIC>CILIA: de</TOPIC><TOPIC>SULFHYDRYL-COMPOUNDS: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>DEPRESSION-CHEMICAL</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Although N-acetyl-L-cysteine (Mucomyst) is an effective mycolytic,
numerous investigations have failed to demonstrate a consistent
improvement in pulmonary mechanics following its use. In order to
determine whether its beneficial mucolytic activity might be
counterbalanced by a deleterious direct effect on cilia, we studied
its effect on the activity of ciliated epithelium in the ferret
tracheal organ culture system. N-acetyl-L-cysteine consistently
caused progressive time-dependent ciliostasis at concentrations
clinically employed, with complete ciliary paralysis within 8 hr. The
effect was only partially reversed by the removal of the drug.
Control preparations retained full ciliary activity for 3 to 12
weeks. In order to determine the active site on the N-acetyl-L-
cysteine molecule, we investigated the ciliostatic effects of five of
its chemical analogs. Isomolar N-acetyl-L-alanine was not
ciliostatic, indicating the necessity of a sulfhydryl group for
activity. Ciliostasis was independent of isomeric structure,
acetylation, and chain length, as evidenced by the similar
ciliostatic effects of L-cysteine, D-cysteine, 2-mercaptoethylamine,
and N-acetyl-L-homocysteine. We conclude that N-acetyl-L-cysteine
induces partially reversible ciliostasis of tracheal epithelium via
its sulfhydryl group; prolonged use of this drug may impair
mucociliary clearance.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HURST GA" publication="AM REV RESPIR DIS" d1="96" d2="962" d3="967"/>
<CITE num="002" author="HIRSCH SR" publication="J LAB CLIN MED" d1="74" d2="346" d3="969"/>
<CITE num="003" author="SHEFFNER AL" publication="TUBERCULOLOGY" d1="23" d2="31" d3="966"/>
<CITE num="004" author="CARSON S" publication="AM REV RESPIR DIS SUPPL" d1="93" d2="86" d3="966"/>
<CITE num="005" author="STAMM SJ" publication="DIS CHEST" d1="47" d2="414" d3="965"/>
<CITE num="006" author="MOSER KM" publication="DIS CHEST" d1="49" d2="370" d3="966"/>
<CITE num="007" author="PULLE DF" publication="CURR THER RES" d1="12" d2="485" d3="970"/>
<CITE num="008" author="HIRSCH SJ" publication="J ALLERGY" d1="39" d2="265" d3="967"/>
<CITE num="009" author="WALTEMATH CL" publication="AM REV RESPIR DIS" d1="108" d2="520" d3="973"/>
<CITE num="010" author="TECKLIN JS" publication="PHYS THER" d1="56" d2="999" d3="976"/>
<CITE num="011" author="SILVERS GW" publication="AM REV RESPIR DIS" d1="110" d2="170" d3="974"/>
<CITE num="012" author="MOSTOW SR" publication="ARCH GESAMTE VIRUSFORSCH" d1="43" d2="385" d3="973"/>
<CITE num="013" author="WILCOXON F" publication="SOME RAPID APPROXIMATE STATIS" d1="" d2="" d3="964"/>
<CITE num="014" author="WANNER A" publication="AM REV RESPIR DIS" d1="116" d2="73" d3="977"/>
<CITE num="015" author="SHEFFNER AL" publication="ANN NY ACAD SCI" d1="106" d2="298" d3="963"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79113</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NAURA S             JA" publication="P J PHARMACOL" d1="31" d2="57 9" d3="1"/>
<CITE num="2" author="ROOMANS GM" publication="EUR J RESPIR DIS" d1="64" d2="416" d3="983"/>
<CITE num="3" author="NIEDERMAN MS" publication="AM REV RESPIR DIS" d1="127" d2="85" d3="983"/>
<CITE num="4" author="VENTURELLI J" publication="CRIT CARE MED" d1="12" d2="926" d3="984"/>
<CITE num="5" author="FREDERICK KA" publication="LAB ANIM SCI" d1="35" d2="298" d3="985"/>
<CITE num="6" author="LOW PMP" publication="ANN ALLERGY" d1="54" d2="273" d3="985"/>
<CITE num="7" author="STAFANGER G" publication="EUR J RESPIR DIS" d1="70" d2="157" d3="987"/>
</CITATIONS>
<RECORDNUM>01093 </RECORDNUM>
<MEDLINENUM>80050997</MEDLINENUM>
<AUTHORS><AUTHOR>Bria-W-F</AUTHOR><AUTHOR>Kenny-W-R</AUTHOR></AUTHORS>
<TITLE>Adult cystic fibrosis: a new therapeutic challenge for the primary
care physician.</TITLE>
<SOURCE>J-Med-Assoc-Ga. 1979 Oct. 68(10). P 912-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANTIBIOTICS</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, pp</TOPIC><TOPIC>DIET-THERAPY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG: pp</TOPIC><TOPIC>POSTURE</TOPIC></MINORSUBJ>
<EXTRACT>In this article, we will examine the reasons for the prolonged
survival of individuals with cystic fibrosis as well as discuss the
pathogenesis, diagnosis and treatment of this multisystemic disease.
The reasons for the improved prognosis in CF are multiple: improved
antibiotic therapy, early diagnosis, specialized care centers, and
aggressive treatment regimens.  This presents the primary care
physician with a new and challenging patient population, requiring
the coordinated effort of the health care team, including
specialists, nurses, therapists, etc., to achieve effective therapy
for this truly multisystemic disease.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79114</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ROSENLUND ML" publication="ANN INTERN MED" d1="78" d2="959" d3="973"/>
<CITE num="002" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="003" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="AM FAM PHYSICIAN" d1="7" d2="102" d3="973"/>
<CITE num="005" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="006" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="007" author="HANDWERGER S" publication="N ENGL J MED" d1="281" d2="451" d3="969"/>
<CITE num="008" author="STERN RC" publication="GASTROENTEROLOGY" d1="70" d2="645" d3="976"/>
<CITE num="009" author="LOBER CW" publication="CHEST" d1="66" d2="332" d3="974"/>
<CITE num="010" author="KULCZYCKI LL" publication="JAMA" d1="240" d2="30" d3="978"/>
<CITE num="011" author="EWING C" publication="CHEST" d1="73" d2="750" d3="978"/>
<CITE num="012" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
</REFERENCES>
<RECORDNUM>01094 </RECORDNUM>
<MEDLINENUM>79218787</MEDLINENUM>
<AUTHORS><AUTHOR>Nevin-G-B</AUTHOR><AUTHOR>Nevin-N-C</AUTHOR><AUTHOR>Redmond-A-O</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in Northern Ireland.</TITLE>
<SOURCE>J-Med-Genet. 1979 Apr. 16(2). P 122-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>NORTHERN-IRELAND</TOPIC><TOPIC>RETROSPECTIVE-STUDIES</TOPIC></MINORSUBJ>
<ABSTRACT>In a retrospective study of cystic fibrosis in Northern Ireland for
1961 to 1971, the incidence was 1 in 1857 livebirths, which is
comparable to figures from Great Britain and the Republic of Ireland.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CARTER CO" publication="J MED GENET" d1="14" d2="316" d3="977"/>
<CITE num="002" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="003" author="GOODMAN HO" publication="AM J HUM GENET" d1="4" d2="59" d3="952"/>
<CITE num="004" author="HALL BD" publication="J MED GENET" d1="5" d2="262" d3="968"/>
<CITE num="005" author="HONEYMAN MS" publication="AM J HUM GENET" d1="17" d2="461" d3="965"/>
<CITE num="006" author="KRAMM ER" publication="AM J PUBLIC HEALTH" d1="52" d2="2041" d3="962"/>
<CITE num="007" author="NEVIN NC" publication="INT J EPIDEMIOL" d1="7" d2="319" d3="978"/>
<CITE num="008" author="OREILLY D" publication="INT J EPIDEMIOL" d1="3" d2="247" d3="974"/>
<CITE num="009" author="PUGH RJ" publication="ARCH DIS CHILD" d1="42" d2="544" d3="967"/>
<CITE num="010" author="SELANDER P" publication="ACTA PAEDIATR SCAND" d1="51" d2="65" d3="962"/>
<CITE num="011" author="STEVENSON AC" publication="RADIAT RES SUPPL" d1="1" d2="306" d3="959"/>
<CITE num="012" author="TEN KATE LP" publication="INT J EPIDEMIOL" d1="6" d2="23" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79115</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIN GB              HU" publication="M GENET" d1="56" d2="87 9" d3="1"/>
<CITE num="2" author="GRATAROLI R" publication="PEDIATR RES" d1="18" d2="130" d3="984"/>
<CITE num="3" author="STURGESS JM" publication="AM J MED GENET" d1="22" d2="383" d3="985"/>
<CITE num="4" author="JAMIESON A" publication="HUM GENET" d1="70" d2="168" d3="985"/>
</CITATIONS>
<RECORDNUM>01095 </RECORDNUM>
<MEDLINENUM>79196306</MEDLINENUM>
<AUTHORS><AUTHOR>Soter-N-A</AUTHOR><AUTHOR>Mihm-M-C-Jr</AUTHOR><AUTHOR>Colten-H-R</AUTHOR></AUTHORS>
<TITLE>Cutaneous necrotizing venulitis in patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Aug. 95(2). P 197-201.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PHLEBITIS: pa</TOPIC><TOPIC>PURPURA: pa</TOPIC><TOPIC>SKIN: bs</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BIOPSY</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHLEBITIS: et</TOPIC><TOPIC>PURPURA: et</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>VENULES: pa</TOPIC></MINORSUBJ>
<ABSTRACT>Palpable purpura was noted to occur late in the course of some
patients with cystic fibrosis. Skin biopsy specimens showed
necrotizing venulitis characterized by a perivenular infiltrate
composed of neutrophilic leukocytes, fibrin, hypogranulated mast
cells, and endothelial cell necrosis. Circulating immune complexes
were detected. Recurrent pulmonary infections and the chronic
administration of therapeutic agents provide sources of potential
antigens.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SOTER NA" publication="IN: SAMTER M" d1="" d2="993" d3="978"/>
<CITE num="002" author="PARISH WE" publication="IN: BEUTNER EH" d1="" d2="153" d3="974"/>
<CITE num="003" author="MOSCHELLA SL" publication="ARCH DERMATOL" d1="95" d2="565" d3="967"/>
<CITE num="004" author="QUISMORIO FP JR" publication="CLIN IMMUNOL IMMUNOPATHOL" d1="9" d2="184" d3="978"/>
<CITE num="005" author="LEVO Y" publication="TRANS ASSOC AM PHYSICIANS" d1="90" d2="167" d3="977"/>
<CITE num="006" author="DIENSTAG JL" publication="ANN INTERN MED" d1="89" d2="34" d3="978"/>
<CITE num="007" author="SOTER NA" publication="J INVEST DERMATOL" d1="63" d2="219" d3="974"/>
<CITE num="008" author="SAMS WM JR" publication="BR J DERMATOL" d1="80" d2="555" d3="968"/>
<CITE num="009" author="THEOFILOPOULOS AN" publication="J CLIN INVEST" d1="57" d2="169" d3="976"/>
<CITE num="010" author="KAMMER GM" publication="CLIN RES" d1="25" d2="361A" d3="977"/>
<CITE num="011" author="REYNOLDS HY" publication="ANN INTERN MED" d1="82" d2="819" d3="975"/>
<CITE num="012" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="013" author="DVORAK HF" publication="J EXP MED" d1="135" d2="235" d3="972"/>
<CITE num="014" author="MIHM MC JR" publication="J INVEST DERMATOL" d1="67" d2="305" d3="976"/>
<CITE num="015" author="NYDEGGER UE" publication="J CLIN INVEST" d1="54" d2="297" d3="974"/>
<CITE num="016" author="SOTER NA" publication="J ALLERGY CLIN IMMUNOL" d1="59" d2="294" d3="977"/>
<CITE num="017" author="BEAVEN MA" publication="CLIN CHIM ACTA" d1="37" d2="91" d3="972"/>
<CITE num="018" author="NIELSEN HE" publication="ACTA PAEDIATR SCAND" d1="67" d2="443" d3="978"/>
<CITE num="019" author="SCHROETER AL" publication="ARCH DERMATOL" d1="104" d2="254" d3="971"/>
<CITE num="020" author="BRAVERMAN IM" publication="J INVEST DERMATOL" d1="64" d2="105" d3="975"/>
<CITE num="021" author="FEIG PU" publication="JAMA" d1="236" d2="2065" d3="976"/>
<CITE num="022" author="KAMMER GM" publication="CLIN IMMUNOL IMMUNOPATHOL" d1="10" d2="202" d3="978"/>
<CITE num="023" author="MARTINEZ-TELLO FJ" publication="J IMMUNOL" d1="101" d2="989" d3="968"/>
<CITE num="024" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79116</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HN EG               J" publication="PEDIATR" d1="97" d2="05 9" d3="0"/>
<CITE num="2" author="MATTHEWS WJ" publication="N ENGL J MED" d1="302" d2="245" d3="980"/>
<CITE num="3" author="SORENSEN RU" publication="PEDIATR RES" d1="15" d2="14" d3="981"/>
<CITE num="4" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="5" author="SAVEL P" publication="ANN DERMATOL VENEREOL" d1="109" d2="503" d3="982"/>
<CITE num="6" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="7" author="GIGLI I" publication="J AM ACAD DERMATOL" d1="11" d2="948" d3="984"/>
<CITE num="8" author="SCHIDLOW DV" publication="ARCH DIS CHILD" d1="59" d2="377" d3="984"/>
<CITE num="9" author="AUERBACH HS" publication="LANCET" d1="2" d2="686" d3="985"/>
<CITE num="10" author="RESNICK AH" publication="INT J DERMATOL" d1="24" d2="139" d3="985"/>
<CITE num="11" author="SANCHEZ NP" publication="ARCH DERMATOL" d1="121" d2="220" d3="985"/>
<CITE num="12" author="WISNIESKI JJ" publication="AM REV RESPIR DIS" d1="132" d2="770" d3="985"/>
<CITE num="13" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="14" author="SUMMERS GD" publication="BR J RHEUMATOL" d1="25" d2="393" d3="986"/>
<CITE num="15" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
<CITE num="16" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
<CITE num="17" author="MOSS RB" publication="AM REV RESPIR DIS" d1="133" d2="648" d3="986"/>
</CITATIONS>
<RECORDNUM>01096 </RECORDNUM>
<MEDLINENUM>79153525</MEDLINENUM>
<AUTHORS><AUTHOR>Herrod-H-G</AUTHOR><AUTHOR>Amos-D-B</AUTHOR><AUTHOR>Spock-A</AUTHOR></AUTHORS>
<TITLE>HLA determinants in families with more than one member with cystic
fibrosis [letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Apr. 94(4). P 676.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIGENIC-DETERMINANTS</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HLA-ANTIGENS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Attempts to identify the carrier state for cystic fibrosis (CF) or to
make a prenatal diagnosis of CF have been unsuccessful.  One approach
to this problem is to look for associations between known genetic
markers and the locus for CF.  In general these studies have looked
at the frequency of HLA types in patients with CF and have failed to
demonstrate a strong association.  We attempted to look for linkage
between HLA haplotypes and CF in families with more than one affected
member.  The segregation of HLA in these affected sibpairs vary
little from the expected.  Although the sample size is small, it is
unlikely that a close linkage exists between the HLA loci and the CF
locus.</EXTRACT>
<REFERENCES>
<CITE num="001" author="LAMM LU" publication="ANN HUM GENET" d1="38" d2="383" d3="975"/>
<CITE num="002" author="GOODCHILD MC" publication="J MED GENET" d1="13" d2="417" d3="976"/>
<CITE num="003" author="AMOS DB" publication="IN: ROSE NR" d1="" d2="797" d3="976"/>
<CITE num="004" author="HERROD HG" publication="J PEDIATR" d1="91" d2="276" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79117</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="2" d2="49 9" d3="5"/>
<CITE num="2" author="MOSS RB" publication="MONOGR ALLERGY" d1="19" d2="202" d3="986"/>
</CITATIONS>
<RECORDNUM>01097 </RECORDNUM>
<MEDLINENUM>79153494</MEDLINENUM>
<AUTHORS><AUTHOR>Newman-A-J</AUTHOR><AUTHOR>Ansell-B-M</AUTHOR></AUTHORS>
<TITLE>Episodic arthritis in children with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Apr. 94(4). P 594-6.</SOURCE>
<MAJORSUBJ><TOPIC>ARTHRITIS: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>Five children 2 to 10 years of age with cystic fibrosis developed
transient episodic arthritis.  Although polyarticular in
distribution, only one joint might be involved during each attack.
No laboratory or radiologic evidence of juvenile chronic arthritis
was present and no permanent joint limitation was noted.</EXTRACT>
<REFERENCES>
<CITE num="001" author="LINDSLEY CB" publication="J PEDIATR" d1="84" d2="16" d3="974"/>
<CITE num="002" author="PETTY RE" publication="ARTHRITIS RHEUM" d1="19" d2="902" d3="976"/>
<CITE num="003" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="004" author="GIBSON TJ" publication="J RHEUMATOL" d1="2" d2="7" d3="975"/>
<CITE num="005" author="MULLIN GT" publication="ANN INTERN MED" d1="68" d2="75" d3="968"/>
<CITE num="006" author="LUCAS PF" publication="GUT" d1="3" d2="146" d3="962"/>
<CITE num="007" author="TANNENBAUM H" publication="J RHEUMATOL" d1="2" d2="14" d3="975"/>
<CITE num="008" author="SMITH BS" publication="BR MED J" d1="1" d2="1403" d3="966"/>
<CITE num="009" author="HASLOCK I" publication="RHEUMATOL REHAB" d1="13" d2="51" d3="974"/>
<CITE num="010" author="STAPLETON FB" publication="N ENGL J MED" d1="295" d2="246" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79118</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ZE D                J" publication="PEDIATR" d1="96" d2="46 9" d3="0"/>
<CITE num="2" author="SAGRANSKY DM" publication="AM J DIS CHILD" d1="134" d2="319" d3="980"/>
<CITE num="3" author="BYWATERS EGL" publication="N ENGL J MED" d1="302" d2="1467" d3="980"/>
<CITE num="4" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="5" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="6" author="DELUMLEY L" publication="ARCH FR PEDIATR" d1="40" d2="723" d3="983"/>
<CITE num="7" author="SCHIDLOW DV" publication="ARCH DIS CHILD" d1="59" d2="377" d3="984"/>
<CITE num="8" author="BRAUDE S" publication="BR MED J" d1="288" d2="822" d3="984"/>
<CITE num="9" author="CRAWFORD AM" publication="RHEUMATOL INT" d1="5" d2="283" d3="985"/>
<CITE num="10" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="11" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="12" author="SUMMERS GD" publication="BR J RHEUMATOL" d1="25" d2="393" d3="986"/>
<CITE num="13" author="CASSIDY JT" publication="PEDIATR CLIN NORTH AM" d1="33" d2="1033" d3="986"/>
<CITE num="14" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
<CITE num="15" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
<CITE num="16" author="COHEN AM" publication="AM J DIS CHILD" d1="140" d2="74" d3="986"/>
</CITATIONS>
<RECORDNUM>01098 </RECORDNUM>
<MEDLINENUM>79196242</MEDLINENUM>
<AUTHORS><AUTHOR>Worley-L</AUTHOR><AUTHOR>Poole-C</AUTHOR><AUTHOR>Valdes-Depena-M</AUTHOR></AUTHORS>
<TITLE>Failure to thrive, anemia, and anasarca.</TITLE>
<SOURCE>J-Pediatr. 1979 Jun. 94(6). P 1005-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FOOD-HYPERSENSITIVITY: co</TOPIC><TOPIC>MILK: ae</TOPIC><TOPIC>PROTEIN-LOSING-ENTEROPATHIES: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANEMIA: et</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<EXTRACT>A 5-month-old white girl was admitted to an Infant Intensive Care
Unit of Jackson Memorial Hospital.  According to her mother, the baby
had been in "her usual state of health" until one week before
admission, when she began to "spit up" after feedings and her lower
extremities became puffy.  Vomiting increased in frequency until it
occurred after every meal; eventually the baby refused all feedings;
there was no diarrhea.  Ultimately, the family's physician, when
consulted, recommended that she be admitted to the hospital.  On the
fourth day she developed renal failure with anuria and rising
creatinine concentration despite adequate fluid intake; peritoneal
dialysis was begun.  However, she soon became hypothermic and
developed pulmonary edema, and she died a few hours later.  A
discussion of the case is presented.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79119</PAPERNUM>
<REFERENCES>
<CITE num="001" author="MACLEAN WC JR" publication="J PEDIATR" d1="83" d2="86" d3="973"/>
<CITE num="002" author="LEE PA" publication="JAMA" d1="228" d2="585" d3="974"/>
<CITE num="003" author="COLON AR" publication="SOUTH MED J" d1="66" d2="641" d3="973"/>
<CITE num="004" author="SWISCHUK LE" publication="J PEDIATR" d1="88" d2="452" d3="976"/>
<CITE num="005" author="GRISCOM NT" publication="RADIOLOGY" d1="117" d2="385" d3="975"/>
<CITE num="006" author="MELHEM RE" publication="PEDIATR RADIOL" d1="4" d2="153" d3="976"/>
</REFERENCES>
<RECORDNUM>01099 </RECORDNUM>
<MEDLINENUM>79196248</MEDLINENUM>
<AUTHORS><AUTHOR>Mihalas-L-S</AUTHOR><AUTHOR>Mitchell-I</AUTHOR></AUTHORS>
<TITLE>Bronchial hyperreactivity in cystic fibrosis [letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Jun. 94(6). P 1013-4.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-SPASM: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Mitchell and co-workers conclude that bronchial hyperreactivity is
common in cystic fibrosis (CF) but is different from that in asthma.
Their data were interesting, but I do not agree with their
conclusion.  One can interpret these data as suggesting a common
reversible component in both patient groups, and perhaps a common
denominator in mechanism.  Because of certain problems with baseline
measurements and withholding of medication, it seems that the
conclusion of Mitchell et al may not be well supported. - We felt
justified in studying those patients with a low baseline FEV (forced
expiratory volume in one second), since a subject's bronchial
response to methacholine remains stable even if these is moderate
fluctuation both in initial specific airway conductance and in the
severity of the disease.  We feel that withholding the drug for a
longer period would not have affected the comparisons.  Although
there might be a common underlying mechanism in bronchial
hyperreactivity in asthma and cystic fibrosis, our data showed a
number of differences between the two groups of patients.  Although
these differences would not exclude a common mechanism in bronchial
hyperreactivity in the two diseases, the existence of the differences
should lead to caution in concluding that there is a common
underlying mechanism in the bronchial hyperreactivity in the two
diseases.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79120</PAPERNUM>
<REFERENCES>
<CITE num="001" author="MITCHELL I" publication="J PEDIATR" d1="93" d2="744" d3="978"/>
<CITE num="002" author="SPECTOR SL" publication="MED CLIN NORTH AM" d1="58" d2="71" d3="974"/>
<CITE num="003" author="CHAI H" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="323" d3="975"/>
<CITE num="004" author="RUBINFELD AR" publication="AM REV RESPIR DIS" d1="115" d2="381" d3="977"/>
</REFERENCES>
<RECORDNUM>01100 </RECORDNUM>
<MEDLINENUM>79196281</MEDLINENUM>
<AUTHORS><AUTHOR>Malis-F</AUTHOR><AUTHOR>Fric-P</AUTHOR><AUTHOR>Kasafirek-E</AUTHOR><AUTHOR>Jodl-J</AUTHOR><AUTHOR>Vavrova-V</AUTHOR><AUTHOR>Slaby-J</AUTHOR></AUTHORS>
<TITLE>A peroral test of pancreatic insufficiency with
4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic
fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Jun. 94(6). P 942-4.</SOURCE>
<MAJORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: du</TOPIC><TOPIC>AMINOBENZOIC-ACIDS: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: aa</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>TYROSINE: aa, du</TOPIC></MINORSUBJ>
<EXTRACT>We report on the examination of stimulated pancreatic secretion using
4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic
fibrosis.  In controls the urinary excretion of 4-aminobenzoic acid
amounted to 54.8 +/- 11.7% with 19.6% as the lower limit of normal
during six hours, and 74.7 +/- 10.8% and 40.5% during eight hours.
In children with cystic fibrosis the mean values were 5.6% in the
six-hour test and 13.7% in the eight-hour test.  Both values are
significantly different in comparison with controls.  It may be
assumed that both 4-(N-acetyl-L-tyrosyl)aminobenzoic acid and
4-(N-benzoyl-L-tyrosyl)aminobenzoic acid are suitable for indirect
determination of exocrine pancreatic secretion in children.</EXTRACT>
<REFERENCES>
<CITE num="001" author="IMONDI AR" publication="GUT" d1="13" d2="726" d3="972"/>
<CITE num="002" author="GYR K" publication="GUT" d1="17" d2="27" d3="976"/>
<CITE num="003" author="ARVANITAKIS C" publication="LANCET" d1="1" d2="663" d3="976"/>
<CITE num="004" author="BORNSCHEIN W" publication="CLIN CHIM ACTA" d1="67" d2="21" d3="976"/>
<CITE num="005" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="92" d2="734" d3="978"/>
<CITE num="006" author="MALIS F" publication="J CLIN CHEM CLIN BIOCHEM" d1="14" d2="499" d3="976"/>
<CITE num="007" author="MALIS F" publication="ACTA HEPATOGASTROENTEROL" d1="25" d2="233" d3="978"/>
<CITE num="008" author="SMITH HW" publication="J CLIN INVEST" d1="24" d2="388" d3="945"/>
<CITE num="009" author="ZASSENHAUS PH" publication="ANAL BIOCHEM" d1="76" d2="321" d3="976"/>
<CITE num="010" author="WOLGEMUTH RL" publication="AM J DIG DIS" d1="21" d2="821" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79121</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IC P                HE" publication="PATOGASTROENTEROLOGY" d1="27" d2="20 9" d3="0"/>
<CITE num="2" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="746" d3="980"/>
<CITE num="3" author="SCHONBERGER W" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="195" d3="980"/>
<CITE num="4" author="LANKISCH PG" publication="HEPATOGASTROENTEROLOGY" d1="28" d2="333" d3="981"/>
<CITE num="5" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="6" author="NEIS P" publication="MONATSSCHR KINDERHEILKD" d1="129" d2="347" d3="981"/>
<CITE num="7" author="LANKISCH PG" publication="GUT" d1="23" d2="777" d3="982"/>
<CITE num="8" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="15" d3="982"/>
<CITE num="9" author="LANKISCH PG" publication="CLIN GASTROENTEROL" d1="13" d2="717" d3="984"/>
<CITE num="10" author="SCOTTA MS" publication="CLIN BIOCHEM" d1="18" d2="233" d3="985"/>
<CITE num="11" author="RIEU D" publication="ANN PEDIATR (PARIS)" d1="32" d2="205" d3="985"/>
<CITE num="12" author="CUMMING JGR" publication="ARCH DIS CHILD" d1="61" d2="573" d3="986"/>
</CITATIONS>
<RECORDNUM>01101 </RECORDNUM>
<MEDLINENUM>79131916</MEDLINENUM>
<AUTHORS><AUTHOR>Cox-K-L</AUTHOR><AUTHOR>Isenberg-J-N</AUTHOR><AUTHOR>Osher-A-B</AUTHOR><AUTHOR>Dooley-R-R</AUTHOR></AUTHORS>
<TITLE>The effect of cimetidine on maldigestion in cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Mar. 94(3). P 488-92.</SOURCE>
<MAJORSUBJ><TOPIC>CIMETIDINE: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>GUANIDINES: tu</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: dt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CIMETIDINE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: bl, et</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREATIC-EXTRACTS: tu</TOPIC><TOPIC>PANCREATIN: tu</TOPIC><TOPIC>CELIAC-DISEASE: dt, et</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Ten patients (6 to 27 years of age) who had severe pancreatic
exocrine insufficiency due to cystic fibrosis were studied to
determine whether cimetidine would improve dietary fat and nitrogen
absorption. When a constant diet was consumed and oral pancreatic
enzymes were administered, the addition of cimetidine (150 or 200 mg
taken orally one-half hour before meals) signficantly reduced fecal
fat excretion from 25.3 +/- 2.9 to 17.3 +/- 2.1 gm/24 hours and fecal
nitrogen excretion from 4.5 +/- 0.6 to 3.4 +/- 0.5 gm/24 hours (P
less than 0.05). Lower doses of cimetidine resulted in less
significant reductions of steatorrhea and azotorrhea. Cimetidine may
be a useful adjunct to oral pancreatic enzyme therapy in patients
with cystic fibrosis who continue to have steatorrhea and azotorrhea
with enzyme therapy alone.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HEIZER WD" publication="BULL JOHNS HOPKINS HOSP" d1="116" d2="261" d3="965"/>
<CITE num="002" author="GRAHAM DY" publication="N ENGL J MED" d1="296" d2="1314" d3="977"/>
<CITE num="003" author="DIMAGNO EP" publication="N ENGL J MED" d1="296" d2="1318" d3="977"/>
<CITE num="004" author="ROY CC" publication="PEDIATR CLIN GASTROENTEROL" d1="" d2="" d3="975"/>
<CITE num="005" author="HARO EN" publication="CLIN RES" d1="12" d2="207" d3="964"/>
<CITE num="006" author="VEEGER W" publication="N ENGL J MED" d1="267" d2="1341" d3="962"/>
<CITE num="007" author="REGAN PT" publication="N ENGL J MED" d1="297" d2="854" d3="977"/>
<CITE num="008" author="RICHARDSON CT" publication="GASTROENTEROLOGY" d1="74" d2="366" d3="978"/>
<CITE num="009" author="SAUNDERS JHB" publication="BR MED J" d1="1" d2="418" d3="977"/>
<CITE num="010" author="WIGGINS HS" publication="GUT" d1="8" d2="415" d3="967"/>
<CITE num="011" author="TIETZ NW" publication="CLIN CHIM ACTA" d1="13" d2="352" d3="966"/>
<CITE num="012" author="WORMSLEY KG" publication="GASTROENTEROLOGY" d1="54" d2="197" d3="968"/>
<CITE num="013" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="014" author="HILLER A" publication="J BIOL CHEM" d1="177" d2="1401" d3="948"/>
<CITE num="015" author="FREYE HB" publication="J PEDIATR" d1="64" d2="575" d3="964"/>
<CITE num="016" author="WALKENSTEIN SS" publication="GASTROENTEROLOGY" d1="74" d2="360" d3="978"/>
<CITE num="017" author="POUNDER RE" publication="GUT" d1="17" d2="161" d3="976"/>
<CITE num="018" author="ANTONOWICZ I" publication="J PEDIATR" d1="92" d2="214" d3="978"/>
<CITE num="019" author="MORIN CL" publication="J PEDIATR" d1="88" d2="213" d3="976"/>
<CITE num="020" author="REEMTSMA K" publication="PEDIATRICS" d1="22" d2="525" d3="958"/>
<CITE num="021" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="73" d2="1023" d3="977"/>
<CITE num="022" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="023" author="UFBERG MH" publication="GASTROENTEROLOGY" d1="73" d2="635" d3="977"/>
<CITE num="024" author="MCGREGOR CGA" publication="LANCET" d1="1" d2="122" d3="977"/>
<CITE num="025" author="AVELLA J" publication="LANCET" d1="1" d2="624" d3="978"/>
<CITE num="026" author="BRIMBLECOMBE RW" publication="IN: BURLAND WL" d1="" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79122</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RTIN DW             WE" publication="ST J MED                     1" d1="31" d2="17 9" d3="9"/>
<CITE num="2" author="GILLARD BK" publication="PEDIATR RES" d1="14" d2="1168" d3="980"/>
<CITE num="3" author="DURIE PR" publication="GUT" d1="21" d2="778" d3="980"/>
<CITE num="4" author="HUBBARD VS" publication="AM J CLIN NUTR" d1="33" d2="2281" d3="980"/>
<CITE num="5" author="LAVARENNE J" publication="THERAPIE" d1="35" d2="83" d3="980"/>
<CITE num="6" author="BOYLE BJ" publication="GASTROENTEROLOGY" d1="78" d2="950" d3="980"/>
<CITE num="7" author="BLAKER F" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="626" d3="980"/>
<CITE num="8" author="GOW R" publication="LANCET" d1="2" d2="1071" d3="981"/>
<CITE num="9" author="BRADBEAR RA" publication="BR J CLIN PHARMACOL" d1="12" d2="248" d3="981"/>
<CITE num="10" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="17" d2="89" d3="981"/>
<CITE num="11" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="17" d2="207" d3="981"/>
<CITE num="12" author="SCHONI M" publication="HELV PAEDIATR ACTA" d1="36" d2="359" d3="981"/>
<CITE num="13" author="DEBIEVILLE F" publication="ACTA PAEDIATR SCAND" d1="70" d2="33" d3="981"/>
<CITE num="14" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="15" author="HALL KW" publication="CAN MED ASSOC J" d1="124" d2="1579" d3="981"/>
<CITE num="16" author="STAUB JL" publication="N ENGL J MED" d1="304" d2="1364" d3="981"/>
<CITE num="17" author="CHASE HP" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="49" d3="982"/>
<CITE num="18" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="19" author="SALOM IL" publication="SCAND J GASTROENTEROL" d1="17" d2="129" d3="982"/>
<CITE num="20" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="18" d2="114" d3="982"/>
<CITE num="21" author="DIMAGNO EP" publication="DIG DIS SCI" d1="27" d2="481" d3="982"/>
<CITE num="22" author="GRAHAM DY" publication="DIG DIS SCI" d1="27" d2="485" d3="982"/>
<CITE num="23" author="HUBBARD VS" publication="J AM DIET ASSOC" d1="80" d2="127" d3="982"/>
<CITE num="24" author="BRADBEAR RA" publication="J PEDIATR" d1="100" d2="325" d3="982"/>
<CITE num="25" author="ISENBERG JN" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="447" d3="983"/>
<CITE num="26" author="SOMOGYI A" publication="CLIN PHARMACOKINET" d1="8" d2="463" d3="983"/>
<CITE num="27" author="GRENDELL JH" publication="CLIN GASTROENTEROL" d1="12" d2="551" d3="983"/>
<CITE num="28" author="SORKIN EM" publication="DRUG INTEL CLIN PHARM" d1="17" d2="110" d3="983"/>
<CITE num="29" author="LANKISCH PG" publication="CLIN GASTROENTEROL" d1="13" d2="985" d3="984"/>
<CITE num="30" author="SCHONI M" publication="PEDIATR RES" d1="18" d2="66" d3="984"/>
<CITE num="31" author="ZIEMNIAK JA" publication="EUR J CLIN PHARMACOL" d1="26" d2="183" d3="984"/>
<CITE num="32" author="ABRAMS CK" publication="J CLIN INVEST" d1="73" d2="374" d3="984"/>
<CITE num="33" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="34" author="GILLARD BK" publication="AM J DIS CHILD" d1="138" d2="577" d3="984"/>
<CITE num="35" author="HYMAN PE" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="316" d3="985"/>
<CITE num="36" author="PERRY RS" publication="CLIN PHARMACY" d1="4" d2="161" d3="985"/>
<CITE num="37" author="ZENTLERMUNRO PL" publication="GUT" d1="26" d2="892" d3="985"/>
<CITE num="38" author="SCHNEIDER MU" publication="HEPATOGASTROENTEROLOGY" d1="32" d2="97" d3="985"/>
<CITE num="39" author="CHALMERS DM" publication="ACTA PAEDIATR SCAND" d1="74" d2="114" d3="985"/>
<CITE num="40" author="SOMOGYI A" publication="EUR J PEDIATR" d1="144" d2="72" d3="985"/>
<CITE num="41" author="SINAASAPPEL M" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="22" d3="985"/>
<CITE num="42" author="RUBINSTEIN S" publication="PEDIATRICS" d1="78" d2="473" d3="986"/>
<CITE num="43" author="LAMERS CBHW" publication="BR MED J" d1="293" d2="994" d3="986"/>
<CITE num="44" author="BRAGGION C" publication="ARCH DIS CHILD" d1="62" d2="349" d3="987"/>
</CITATIONS>
<RECORDNUM>01102 </RECORDNUM>
<MEDLINENUM>79196324</MEDLINENUM>
<AUTHORS><AUTHOR>Church-J-A</AUTHOR><AUTHOR>Keens-T-G</AUTHOR><AUTHOR>Wang-C-I</AUTHOR><AUTHOR>ONeal-M</AUTHOR><AUTHOR>Richards-W</AUTHOR></AUTHORS>
<TITLE>Normal neutrophil and monocyte chemotaxis in patients with cystic
fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Aug. 95(2). P 2724.</SOURCE>
<MAJORSUBJ><TOPIC>CHEMOTAXIS-LEUKOCYTE</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MONOCYTES: im</TOPIC><TOPIC>NEUTROPHILS: im</TOPIC></MINORSUBJ>
<ABSTRACT>The prominent role of infection in the clinical course of cystic
fibrosis has led to considerable investigation of possible immune
deficiency in these patients.  Leukotaxis of circulating phagocytic
cells and the ability to generate chemotactic factors are important
in host defenses against bacterial invasion.  These properties were
investigated in patients with clinically stable cystic fibrosis to
determine if they possess dysfunctional inflammatory responses which
would predispose them to severe infection.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79123</PAPERNUM>
<REFERENCES>
<CITE num="001" author="TALAMO RC" publication="IN: MANGOS JA" d1="" d2="195" d3="976"/>
<CITE num="002" author="GALLIN JI" publication="IN: BELLANTI JA" d1="" d2="227" d3="975"/>
<CITE num="003" author="LETT-BROWN MA" publication="J IMMUNOL" d1="117" d2="246" d3="976"/>
<CITE num="004" author="KLEIN RB" publication="PEDIATRICS" d1="60" d2="467" d3="977"/>
<CITE num="005" author="ORR W" publication="J IMMUNOL METH" d1="20" d2="95" d3="978"/>
<CITE num="006" author="SORENSEN RU" publication="J PEDIATR" d1="93" d2="201" d3="978"/>
<CITE num="007" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="008" author="HILL HR" publication="J PEDIATR" d1="84" d2="55" d3="974"/>
</REFERENCES>
<RECORDNUM>01103 </RECORDNUM>
<MEDLINENUM>79196343</MEDLINENUM>
<TITLE>Hyperuricemia in cystic fibrosis [letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Aug. 95(2). P 330-1.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>URIC-ACID: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREATIC-EXTRACTS: ae, tu</TOPIC></MINORSUBJ>
<EXTRACT>Davidson et al report hyperuricemia in cystic fibrosis patients
ingesting large quantities of pancreatic extracts.  This article and
others emphasize the considerable purine content of these
preparations as causal to the increased serum and urine uric acid
levels in patients who consume them.  This may find clinical
application, since uric acid production from RNA might be decreased
by an inhibitor of ribonuclease.  While itself a purine chain,
polyadenylic acid added to pancreatic extracts may prevent the
hydrolysis of mixed-base ribonucleic acid to uric acid precursors,
while allowing the beneficial effects of the other pancreatic enzymes
to prevail. - A number of weaknesses to the proposal bears stressing
before we begin giving polyadenylic acid to our patients.  No one
knows whether nucleic acids are malabsorbed in cystic fibrosis.  If
polyadenylic acid produces only 70% inhibition of pancreatic
ribonucleases at a one-to-one ratio of substrate and inhibitor, a
relatively enormous amount of polyadenylic acid would have to be fed
with the pancreatic extracts.  If there were an intestinal enzyme
capable of cleaving polyadenylic acid, the treatment would add to,
not subtract from, the purine load.  Finally, Stapleton et al's
results suggest that more than 75% of the purine load in the
pancreatic extracts would probably be absorbed anyway.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79124</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DAVIDSON GP" publication="J PEDIATR" d1="93" d2="976" d3="978"/>
<CITE num="002" author="STAPLETON FB" publication="N ENGL J MED" d1="295" d2="246" d3="976"/>
<CITE num="003" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="90" d2="302" d3="977"/>
<CITE num="004" author="REDDI KK" publication="BIOCHEM BIOPHYS RES COMMUN" d1="67" d2="110" d3="975"/>
<CITE num="005" author="SCHMUKLER M" publication="J BIOL CHEM" d1="250" d2="2206" d3="975"/>
<CITE num="006" author="GAHL WA" publication="N ENGL J MED" d1="297" d2="1349" d3="977"/>
<CITE num="007" author="ZIMMERMAN SB" publication="ANAL BIOCHEM" d1="10" d2="444" d3="965"/>
<CITE num="008" author="ZAN-KOWALCZEWSKA M" publication="BIOCHIM BIOPHYS ACTA" d1="341" d2="138" d3="974"/>
</REFERENCES>
<RECORDNUM>01104 </RECORDNUM>
<MEDLINENUM>80051503</MEDLINENUM>
<AUTHORS><AUTHOR>Fellows-K-E</AUTHOR><AUTHOR>Khaw-K-T</AUTHOR><AUTHOR>Schuster-S</AUTHOR><AUTHOR>Shwachman-H</AUTHOR></AUTHORS>
<TITLE>Bronchial artery embolization in cystic fibrosis; technique and
long-term results.</TITLE>
<SOURCE>J-Pediatr. 1979 Dec. 95(6). P 959-63.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-ARTERIES</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>EMBOLIZATION-THERAPEUTIC</TOPIC><TOPIC>HEMOPTYSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANGIOGRAPHY</TOPIC><TOPIC>BRONCHIAL-DISEASES: ra, th</TOPIC><TOPIC>BRONCHOSCOPY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FOLLOW-UP-STUDIES</TOPIC><TOPIC>HEMOPTYSIS: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RECURRENCE</TOPIC></MINORSUBJ>
<ABSTRACT>Severe bronchial hemorrhage in 13 patients with cystic fibrosis was
treated by catheter embolization of bronchial arteries. Indications
were either excessive bleeding persisting for several days, or
bleeding serious enough to interfere with pulmonary drainage and
recurring over weeks or months. In follow-up ranging from one to 30
months, cessation of major bleeding was achieved in 12 of 13 patients
(93%), although 5 of 13 patients (40%) did have recurrence of minor
hemoptysis. No neurologic or other major complications were
encountered. However, there are potential risks and this approach at
present should be limited to patients with life-threatening bleeding
and carried out only by experienced angiographers.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="002" author="STERN RC" publication="AM REV RESPIR DIS" d1="117" d2="825" d3="978"/>
<CITE num="003" author="SCHUSTER SR" publication="J PEDIATR SURG" d1="12" d2="889" d3="977"/>
<CITE num="004" author="WHOLEY MH" publication="JAMA" d1="236" d2="2501" d3="976"/>
<CITE num="005" author="HARLEY JD" publication="AM J ROENTGENOL" d1="128" d2="302" d3="977"/>
<CITE num="006" author="BOOKSTEIN JJ" publication="CHEST" d1="72" d2="658" d3="977"/>
<CITE num="007" author="REMY J" publication="RADIOLOGY" d1="122" d2="33" d3="977"/>
<CITE num="008" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="009" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="010" author="FEIGELSON HH" publication="RADIOLOGY" d1="85" d2="663" d3="965"/>
<CITE num="011" author="KARDJIEV V" publication="RADIOLOGY" d1="112" d2="81" d3="974"/>
<CITE num="012" author="REUTER S" publication="RADIOLOGY" d1="84" d2="87" d3="965"/>
<CITE num="013" author="DICHIRO G" publication="RADIOLOGY" d1="112" d2="231" d3="974"/>
<CITE num="014" author="DICHIRO G" publication="J NEUROSURG" d1="39" d2="1" d3="973"/>
<CITE num="015" author="TVETEN L" publication="ACTA RADIOL" d1="17" d2="1" d3="976"/>
<CITE num="016" author="TVETEN L" publication="ACTA RADIOL" d1="17" d2="257" d3="976"/>
<CITE num="017" author="BOTENGA ASJ" publication="SELECTIVE BRONCHIAL AND INTER" d1="" d2="" d3="970"/>
<CITE num="018" author="HELENON CH" publication="NOUV PRESSE MED" d1="6" d2="4209" d3="977"/>
<CITE num="019" author="BARTH KH" publication="INVEST RADIOL" d1="12" d2="273" d3="977"/>
<CITE num="020" author="KERBER CW" publication="AM J ROENTGENOL" d1="130" d2="1193" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79125</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSCLAW DS           CL" publication="IN CHEST MED" d1="1" d2="07 9" d3="0"/>
<CITE num="2" author="ATHANASOULIS CA" publication="N ENGL J MED" d1="302" d2="1117" d3="980"/>
<CITE num="3" author="FELLOWS KE" publication="RADIOLOGY" d1="140" d2="249" d3="981"/>
<CITE num="4" author="TABACHNIK NF" publication="SURG GYNECOL OBSTET" d1="152" d2="837" d3="981"/>
<CITE num="5" author="SILVERMAN NA" publication="CHEST" d1="82" d2="195" d3="982"/>
<CITE num="6" author="HEASTON DK" publication="SEM RESPIR MED" d1="5" d2="58" d3="983"/>
<CITE num="7" author="MARMON L" publication="J PEDIATR SURG" d1="18" d2="811" d3="983"/>
<CITE num="8" author="PORTER DK" publication="J THORAC CARDIOVASC SURG" d1="86" d2="409" d3="983"/>
<CITE num="9" author="PORTER DK" publication="ARCH INTERN MED" d1="143" d2="287" d3="983"/>
<CITE num="10" author="UFLACKER R" publication="RADIOLOGY" d1="146" d2="627" d3="983"/>
<CITE num="11" author="WHITE RI" publication="ANN RADIOL (PARIS)" d1="27" d2="310" d3="984"/>
<CITE num="12" author="BARTH KH" publication="MED CLIN NORTH AM" d1="68" d2="1647" d3="984"/>
<CITE num="13" author="DAVIS PB" publication="CHEST" d1="85" d2="802" d3="984"/>
<CITE num="14" author="WHITE RI" publication="AM J ROENTGENOL" d1="142" d2="27" d3="984"/>
<CITE num="15" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="16" author="HOFFER FA" publication="PEDIATR CLIN NORTH AM" d1="32" d2="1461" d3="985"/>
<CITE num="17" author="TRENTO A" publication="ANN THORAC SURG" d1="39" d2="254" d3="985"/>
<CITE num="18" author="STANKIEWICZ JA" publication="EAR NOSE THROAT J" d1="64" d2="180" d3="985"/>
<CITE num="19" author="NOLAN MT" publication="IR J MED SCI" d1="154" d2="336" d3="985"/>
<CITE num="20" author="LOCK JE" publication="J AM COLL CARDIOL" d1="7" d2="1420" d3="986"/>
<CITE num="21" author="KAUFMAN SL" publication="AM J CARDIOL" d1="58" d2="1130" d3="986"/>
<CITE num="22" author="MOORE LB" publication="RADIOLOGY" d1="161" d2="173" d3="986"/>
<CITE num="23" author="FERNALD GW" publication="SEM ROENTGENOL" d1="22" d2="87" d3="987"/>
<CITE num="24" author="LOCK JE" publication="CIRCULATION" d1="75" d2="593" d3="987"/>
</CITATIONS>
<RECORDNUM>01105 </RECORDNUM>
<MEDLINENUM>80008528</MEDLINENUM>
<AUTHORS><AUTHOR>Schwachman-H</AUTHOR></AUTHORS>
<TITLE>Reliability of sweat test in cystic fibrosis [letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Oct. 95(4). P 661-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SODIUM: an</TOPIC></MINORSUBJ>
<EXTRACT>The report by Huff, Huang, and Arey again calls attention to the
heterogeneity of cystic fibrosis and to the fact that a properly
performed sweat test in the normal or borderline range does not rule
out cystic fibrosis.  This may occur in approximately 1% of patients
we classify as having cystic fibrosis and confirms our original
impression that the sweat test has a reliability of between 98% and
99%.  One must pay close attention to the clinical picture, the
family history, and especially the pulmonary or gastrointestinal
findings, and provide rational treatment until more acceptable
evidence of the disease can be documented.  In the same issue is a
report on a false positive sweat test in a Canadian patient with the
Mauriac syndrome.  The authors list a variety of conditions that have
been reported as yielding elevated sweat electrolytes.  The manner of
the collections can greatly influence the result. - In patients with
transient abnormal sweat electrolytes, sodium values were
consistently higher than chloride values.  Perhaps the finding of
sodium values in excess of chloride in the abnormal range suggests a
false positive test.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HUFF DS" publication="J PEDIATR" d1="94" d2="237" d3="979"/>
<CITE num="002" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="003" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="004" author="ROSENFELD R" publication="J PEDIATR" d1="94" d2="240" d3="979"/>
<CITE num="005" author="SHWACHMAN H" publication="CLIN CHEM" d1="25" d2="158" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79126</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DDY RM              CL" publication="IN PEDIATR" d1="26" d2="83 9" d3="7"/>
</CITATIONS>
<RECORDNUM>01106 </RECORDNUM>
<MEDLINENUM>79069499</MEDLINENUM>
<AUTHORS><AUTHOR>Hubbard-V-S</AUTHOR><AUTHOR>Farrell-P-M</AUTHOR><AUTHOR>di-SantAgnese-P-A</AUTHOR></AUTHORS>
<TITLE>25-Hydroxycholecalciferol levels in patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Jan. 94(1). P 84-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HYDROXYCHOLECALCIFEROLS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>VITAMIN-D: ad</TOPIC></MINORSUBJ>
<EXTRACT>Assessment of the status of circulating vitamin D in cystic fibrosis
patients was investigated by determining serum levels of
25-hydroxycholecalciferol.  The majority of the patients with CF and
pancreatic insufficiency had levels of 25-OH-D within the normal
range.  Clinical symptoms or pathologic signs resulting from
deficiencies of vitamins A and E in patients with CF have been
repeatedly documented.  In contrast, a paradoxical lack of vitamin D
deficiency signs has been observed in CF patients.  This is
especially puzzling since rickets had been commonly associated with
most other forms of steatorrhea.  We can only speculate why rickets
was formerly rarely reported in association with CF.  Perhaps because
of voracious appetites and the selective absorption of vitamin D via
the lymphatics without requiring esterification, these individuals
were spared clinical rickets.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="AM J MED" d1="21" d2="406" d3="956"/>
<CITE num="002" author="OPPENHEIMER EH" publication="BULL JOHNS HOPKINS HOSP" d1="98" d2="353" d3="956"/>
<CITE num="003" author="ANDERSEN DH" publication="J PEDIATR" d1="15" d2="763" d3="939"/>
<CITE num="004" author="PARSONS LG" publication="ARCH DIS CHILD" d1="2" d2="198" d3="927"/>
<CITE num="005" author="WEBER A" publication="PEDIATRICS" d1="50" d2="73" d3="972"/>
<CITE num="006" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="007" author="BELSEY RE" publication="J CLIN ENDOCRINOL METAB" d1="38" d2="1046" d3="974"/>
<CITE num="008" author="FARRELL PM" publication="PEDIATR RES" d1="11" d2="443" d3="977"/>
<CITE num="009" author="ARNAUD SB" publication="PEDIATRICS" d1="57" d2="221" d3="976"/>
<CITE num="010" author="HADDAD JG JR" publication="NATURE" d1="244" d2="515" d3="973"/>
<CITE num="011" author="THOMPSON GR" publication="J CLIN INVEST" d1="45" d2="94" d3="966"/>
<CITE num="012" author="BLOMSTRAND R" publication="ACTA CHEM SCAND" d1="21" d2="1662" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79127</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  NU" publication="TR REV" d1="37" d2="47 9" d3="9"/>
<CITE num="2" author="CHASE HP" publication="J PEDIATR" d1="95" d2="337" d3="979"/>
<CITE num="3" author="WEISMAN Y" publication="J PEDIATR" d1="95" d2="416" d3="979"/>
<CITE num="4" author="MEREDITH SC" publication="CLIN ENDOCRINOL METAB" d1="9" d2="131" d3="980"/>
<CITE num="5" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="6" author="CONGDEN PJ" publication="ARCH DIS CHILD" d1="56" d2="708" d3="981"/>
<CITE num="7" author="COPPENHAVER D" publication="HUM GENET" d1="57" d2="399" d3="981"/>
<CITE num="8" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="9" author="LOGVINOFF MM" publication="CLIN PEDIATR" d1="23" d2="389" d3="984"/>
<CITE num="10" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="11" author="HANLY JG" publication="Q J MED" d1="56" d2="377" d3="985"/>
<CITE num="12" author="REITER EO" publication="J PEDIATR" d1="106" d2="21" d3="985"/>
<CITE num="13" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="14" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
</CITATIONS>
<RECORDNUM>01107 </RECORDNUM>
<MEDLINENUM>79069484</MEDLINENUM>
<AUTHORS><AUTHOR>Hahn-T-J</AUTHOR><AUTHOR>Squires-A-E</AUTHOR><AUTHOR>Halstead-L-R</AUTHOR><AUTHOR>Strominger-D-B</AUTHOR></AUTHORS>
<TITLE>Reduced serum 25-hydroxyvitamin D concentration and disordered
mineral metabolism in patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Jan. 94(1). P 38-42.</SOURCE>
<MAJORSUBJ><TOPIC>CALCIUM: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HYDROXYCHOLECALCIFEROLS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BONE-AND-BONES: me</TOPIC><TOPIC>CALCIUM: ur</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KIDNEY: me</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PARATHYROID-HORMONES: bl</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Vitamin D and mineral metabolism were studied in 21 adolescents and
young adults with cystic fibrosis and the results were compared to
those in 21 matched controls. All CF patients had been maintained on
standard multivitamin supplements in combination with pancreatic
enzyme replacement. Despite this supplementation, relative to control
subjects the CF patients had a 36% reduction in serum 25-
hydroxyvitamin D concentration, a slight but significant reduction in
serum calcium concentration, evidence of calcium malabsorption with
secondary hyperparathyroidism, and a 14% decrease in bone mass
measured by the photon absorption technique. Currently accepted modes
of pancreatic enzyme replacement and vitamin D supplementation are
often inadequate to maintain normal mineral homeostasis in CF
patients; additional measurements may be required to reduce the risk
of clinically significant osteopenia concomitant with prolonged
survival in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BENNETT MJ" publication="AM J CLIN NUTR" d1="20" d2="415" d3="967"/>
<CITE num="002" author="TORSTENSON OL" publication="PEDIATRICS" d1="45" d2="857" d3="970"/>
<CITE num="003" author="GUGLER EC" publication="MOD PROBL PEDIATR" d1="10" d2="95" d3="967"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="IN: VAUGHAN VC III" d1="" d2="903" d3="975"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="006" author="HAHN TJ" publication="N ENGL J MED" d1="292" d2="550" d3="974"/>
<CITE num="007" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="008" author="HAHN TJ" publication="J CLIN ENDOCRINOL METAB" d1="39" d2="274" d3="974"/>
<CITE num="009" author="ANON" publication="MEDICAL LABORATORY TECHNOLOGY" d1="" d2="169" d3="969"/>
<CITE num="010" author="SLATOPOLSKY E" publication="J CLIN INVEST" d1="50" d2="492" d3="971"/>
<CITE num="011" author="HADDAD JG JR" publication="J LAB CLIN MED" d1="81" d2="22" d3="973"/>
<CITE num="012" author="KERMACK KA" publication="BIOMETRIKA" d1="37" d2="30" d3="950"/>
<CITE num="013" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="014" author="LAPEY A" publication="J PEDIATR" d1="84" d2="328" d3="974"/>
<CITE num="015" author="PARSONS JA" publication="CLIN ENDOCRINOL METAB" d1="1" d2="33" d3="972"/>
<CITE num="016" author="HAHN TJ" publication="DRUGS" d1="12" d2="201" d3="976"/>
<CITE num="017" author="REEMTSMA K" publication="PEDIATRICS" d1="22" d2="525" d3="958"/>
<CITE num="018" author="ARNAUD SB" publication="PROC SOC EXP BIOL MED" d1="149" d2="570" d3="975"/>
<CITE num="019" author="THOMPSON GR" publication="J CLIN INVEST" d1="45" d2="94" d3="966"/>
<CITE num="020" author="GERTNER JM" publication="BR MED J" d1="1" d2="1310" d3="977"/>
<CITE num="021" author="DELUCA HF" publication="J LAB CLIN MED" d1="87" d2="7" d3="976"/>
<CITE num="022" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="023" author="TYSON KRT" publication="J PEDIATR SURG" d1="3" d2="271" d3="968"/>
<CITE num="024" author="GARABEDIAN M" publication="PROC NAT ACAD SCI USA" d1="69" d2="1673" d3="972"/>
<CITE num="025" author="SCHNEIDER LE" publication="SCIENCE" d1="196" d2="1452" d3="977"/>
<CITE num="026" author="JUBIZ W" publication="J CLIN ENDOCRINOL METAB" d1="44" d2="617" d3="977"/>
<CITE num="027" author="LACHMAN E" publication="AM J ROENTG RAD THER NUCL MED" d1="74" d2="712" d3="955"/>
<CITE num="028" author="WILSON CR" publication="NORLAND CAMERON BONE MINERAL" d1="" d2="" d3="972"/>
<CITE num="029" author="LEVIN ME" publication="N ENGL J MED" d1="294" d2="241" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79128</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IOLI LV             CL" publication="IN ENDOCRINOL METAB" d1="8" d2="47 9" d3="9"/>
<CITE num="2" author="ANON" publication="NUTR REV" d1="37" d2="247" d3="979"/>
<CITE num="3" author="CHASE HP" publication="J PEDIATR" d1="95" d2="337" d3="979"/>
<CITE num="4" author="WEISMAN Y" publication="J PEDIATR" d1="95" d2="416" d3="979"/>
<CITE num="5" author="MEREDITH SC" publication="CLIN ENDOCRINOL METAB" d1="9" d2="131" d3="980"/>
<CITE num="6" author="LOVINGER RD" publication="PEDIATRICS" d1="66" d2="359" d3="980"/>
<CITE num="7" author="MITCHELL EA" publication="J PEDIATR" d1="97" d2="789" d3="980"/>
<CITE num="8" author="PITT MJ" publication="RADIOL CLIN NORTH AM" d1="19" d2="581" d3="981"/>
<CITE num="9" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="10" author="CONGDEN PJ" publication="ARCH DIS CHILD" d1="56" d2="708" d3="981"/>
<CITE num="11" author="COPPENHAVER D" publication="HUM GENET" d1="57" d2="399" d3="981"/>
<CITE num="12" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="13" author="LLOYDSTILL JD" publication="J PEDIATR" d1="99" d2="580" d3="981"/>
<CITE num="14" author="LEVI N" publication="RIV ITAL PEDIATR" d1="8" d2="695" d3="982"/>
<CITE num="15" author="AGUS ZS" publication="KIDNEY INT" d1="24" d2="113" d3="983"/>
<CITE num="16" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="17" author="GOTZ M" publication="ATEMWEGS LUNGENKRANKH" d1="10" d2="594" d3="984"/>
<CITE num="18" author="LOGVINOFF MM" publication="CLIN PEDIATR" d1="23" d2="389" d3="984"/>
<CITE num="19" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="20" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="21" author="LO CW" publication="AM J CLIN NUTR" d1="42" d2="644" d3="985"/>
<CITE num="22" author="HANLY JG" publication="Q J MED" d1="56" d2="377" d3="985"/>
<CITE num="23" author="FRIEDMAN HZ" publication="GASTROENTEROLOGY" d1="88" d2="808" d3="985"/>
<CITE num="24" author="REITER EO" publication="J PEDIATR" d1="106" d2="21" d3="985"/>
<CITE num="25" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="26" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
</CITATIONS>
<RECORDNUM>01108 </RECORDNUM>
<MEDLINENUM>79241418</MEDLINENUM>
<AUTHORS><AUTHOR>Weisman-Y</AUTHOR><AUTHOR>Reiter-E</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Root-A</AUTHOR></AUTHORS>
<TITLE>Serum concentrations of 25-hydroxyvitamin D and
24,25-dihydroxyvitamin D in patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Sep. 95(3). P 416-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>DIHYDROXYCHOLECALCIFEROLS: bl</TOPIC><TOPIC>HYDROXYCHOLECALCIFEROLS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>Steatorrhea is a prevalent gastrointestinal manifestation of cystic
fibrosis.  Although deficiencies of vitamins A, E, and K have been
described in patients with this disease, vitamin D deficiency and
rickets have rarely been reported.  The major form of vitamin D,
cholecalciferol (vitamin D3), is produced by ultraviolet irradiation
of 7-dehydrocholesterol in the skin.  Ergocalciferol (vitamin D2) is
a product of plant ergosterol.  We studied the vitamin D status of
patients with cystic fibrosis by measurement of the serum
concentrations of the major circulating metabolites of vitamin D:
25-hydroxyvitamin D and 24,25-dihydroxyvitamin D.  The mean serum
concentrations of total 25OHD, 25OHD3, and 24,25(OH)2D and
25OHD3/25OHD ratios in patients with cystic fibrosis were similar to
values recorded in control subjects.  The present study demonstrates
that the serum concentrations of the major metabolites of vitamin D
in patients with cystic fibrosis are similar to those in healthy
subjects.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="002" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="003" author="FARRELL PM" publication="J CLIN INVEST" d1="60" d2="233" d3="977"/>
<CITE num="004" author="TORSTENSON OL" publication="PEDIATRICS" d1="45" d2="857" d3="970"/>
<CITE num="005" author="KEATING JP" publication="PEDIATRICS" d1="46" d2="41" d3="970"/>
<CITE num="006" author="WEISMAN Y" publication="J PEDIATR" d1="91" d2="904" d3="977"/>
<CITE num="007" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="008" author="PREECE MA" publication="Q J MED" d1="44" d2="575" d3="975"/>
<CITE num="009" author="HADDAD JG JR" publication="NATURE" d1="244" d2="515" d3="973"/>
<CITE num="010" author="HAHN TJ" publication="J PEDIATR" d1="94" d2="38" d3="979"/>
<CITE num="011" author="HUBBARD VS" publication="J PEDIATR" d1="94" d2="84" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79129</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TT MJ               RA" publication="DIOL CLIN NORTH AM" d1="19" d2="81 9" d3="1"/>
<CITE num="2" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="3" author="SHANY S" publication="AM J CLIN NUTR" d1="40" d2="1290" d3="984"/>
<CITE num="4" author="HANLY JG" publication="Q J MED" d1="56" d2="377" d3="985"/>
<CITE num="5" author="REITER EO" publication="J PEDIATR" d1="106" d2="21" d3="985"/>
<CITE num="6" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="7" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
</CITATIONS>
<RECORDNUM>01109 </RECORDNUM>
<MEDLINENUM>79111345</MEDLINENUM>
<AUTHORS><AUTHOR>Huff-D-S</AUTHOR><AUTHOR>Huang-N-N</AUTHOR><AUTHOR>Arey-J-B</AUTHOR></AUTHORS>
<TITLE>Atypical cystic fibrosis of the pancreas with normal levels of sweat
chloride and minimal pancreatic lesions.</TITLE>
<SOURCE>J-Pediatr. 1979 Feb. 94(2). P 237-9.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREAS: pa</TOPIC></MINORSUBJ>
<EXTRACT>This paper presents additional evidence of the variability and
independence of the involvement of the sweat glands in cystic
fibrosis.  A case report of an infant girl, who died at age 9 years
of progressive pulmonary disease, is presented.  The case indicates
that fatal cystic fibrosis, or a variant thereof, can exist with
normal levels of sweat chloride and that the pulmonary disease
develops independently of the functional abnormality of the sweat
glands.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="BIRTH DEF ORIG ART SER" d1="8" d2="102" d3="972"/>
<CITE num="002" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="003" author="LANDING BH" publication="ANN NY ACAD SCI" d1="93" d2="518" d3="962"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2065" d3="960"/>
<CITE num="006" author="COGSWELL JJ" publication="ARCH DIS CHILD" d1="49" d2="520" d3="974"/>
<CITE num="007" author="SARSFIELD JK" publication="ARCH DIS CHILD" d1="50" d2="463" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79130</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WACHMAN H           J" publication="PEDIATR" d1="95" d2="61 9" d3="9"/>
<CITE num="2" author="DAVIS PB" publication="AM J MED" d1="69" d2="643" d3="980"/>
<CITE num="3" author="STERN RC" publication="LANCET" d1="1" d2="1401" d3="982"/>
<CITE num="4" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="5" author="BARBERO GJ" publication="J PEDIATR" d1="100" d2="914" d3="982"/>
<CITE num="6" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="7" author="YEUNG WH" publication="CLIN PEDIATR" d1="23" d2="603" d3="984"/>
<CITE num="8" author="MCCARTHY VP" publication="PEDIATR INFECT DIS" d1="5" d2="256" d3="986"/>
<CITE num="9" author="ROSENSTEIN BJ" publication="CLIN PEDIATR" d1="26" d2="78" d3="987"/>
</CITATIONS>
<RECORDNUM>01110 </RECORDNUM>
<MEDLINENUM>79241407</MEDLINENUM>
<AUTHORS><AUTHOR>Chipps-B-E</AUTHOR><AUTHOR>Alderson-P-O</AUTHOR><AUTHOR>Roland-J-M</AUTHOR><AUTHOR>Yang-S</AUTHOR><AUTHOR>van-Aswegen-A</AUTHOR><AUTHOR>Martinez-C-R</AUTHOR><AUTHOR>Rosenstein-B-J</AUTHOR></AUTHORS>
<TITLE>Noninvasive evaluation of ventricular function in cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Sep. 95(3). P 379-84.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HEART-VENTRICLE: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANGIOGRAPHY</TOPIC><TOPIC>CARBON-DIOXIDE: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>ECHOCARDIOGRAPHY</TOPIC><TOPIC>ELECTROCARDIOGRAPHY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEART-VENTRICLE: ra, ri</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OXYGEN: bl</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The cardiac function of 21 patients with cystic fibrosis was studied
using radionuclides and M-mode echocardiography. The patients (mean
age 13.2 years, range 4 to 27) had a wide range of clinical and
pulmonary function abnormalities (mean Shwachman-Kulczycki score
62.1). Decreased right ventricular ejection fraction was found in 13
of 18 patients (72%); an additional four patients had abnormal septal
motion on ECHO. Left ventricular ejection fraction was abnormal at
rest in four patients (19%); an additional four patients had
borderline low LVEF. The LV pre-ejection period to ejection time
ratio increased significantly (i.e., worsening LV performance) with
deterioration of S-K score, chest radiograph score, and forced
expiratory volume in 1 second. Three of eight patients with normal
LVEF at rest had an abnormal response to supine bicycle exercise:
LVEF fell in two patients and was unchanged in one. Thus evidence of
LV dysfunction was observed in seven of 21 (33%) of the patients;
four at rest and in three only during exercise.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LIEBMAN J" publication="IN: MANGOS JA" d1="" d2="41" d3="976"/>
<CITE num="002" author="SIASSI B" publication="J PEDIATR" d1="78" d2="794" d3="971"/>
<CITE num="003" author="ROSENTHAL A" publication="PEDIATR CLIN NORTH AM" d1="23" d2="327" d3="976"/>
<CITE num="004" author="GEWITZ M" publication="AM J DIS CHILD" d1="131" d2="275" d3="977"/>
<CITE num="005" author="FLEMING DG" publication="PEDIATR RES" d1="12" d2="560" d3="978"/>
<CITE num="006" author="MARSHALL RC" publication="CIRCULATION" d1="56" d2="820" d3="977"/>
<CITE num="007" author="KACHEL RG" publication="CHEST" d1="74" d2="286" d3="978"/>
<CITE num="008" author="WILLIAMS JF JR" publication="J CLIN INVEST" d1="47" d2="1143" d3="968"/>
<CITE num="009" author="FRANK MJ" publication="CIRCULATION" d1="47" d2="798" d3="973"/>
<CITE num="010" author="STEELE P" publication="AM J MED" d1="59" d2="21" d3="975"/>
<CITE num="011" author="BAUM GL" publication="N ENGL J MED" d1="285" d2="361" d3="971"/>
<CITE num="012" author="MICHELSON N" publication="DIS CHEST" d1="38" d2="435" d3="960"/>
<CITE num="013" author="BARNES GL" publication="AUST PAEDIATR J" d1="6" d2="81" d3="970"/>
<CITE num="014" author="OPPENHEIMER EH" publication="JOHNS HOPKINS MED J" d1="133" d2="252" d3="973"/>
<CITE num="015" author="STRAUSS HW" publication="AM J CARDIOL" d1="28" d2="575" d3="971"/>
<CITE num="016" author="BUROW RD" publication="CIRCULATION" d1="56" d2="1024" d3="977"/>
<CITE num="017" author="QURESHI S" publication="J NUCL MED" d1="19" d2="135" d3="978"/>
<CITE num="018" author="PITT B" publication="N ENGL J MED" d1="296" d2="1097" d3="977"/>
<CITE num="019" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="020" author="BRASFIELD D" publication="PEDIATRICS" d1="63" d2="24" d3="979"/>
<CITE num="021" author="GENTZLER R" publication="CIRCULATION" d1="50" d2="324" d3="974"/>
<CITE num="022" author="DOUGLASS KH" publication="J NUCL MED" d1="19" d2="670" d3="978"/>
<CITE num="023" author="CANTOR A" publication="CIRCULATION" d1="58" d2="1123" d3="978"/>
<CITE num="024" author="POLGAR G" publication="PULMONARY FUNCTION TESTING IN" d1="" d2="" d3="971"/>
<CITE num="025" author="HOOPER RG" publication="CIRCULATION" d1="50" d2="1205" d3="974"/>
<CITE num="026" author="BOWDEN DH" publication="AM J MED" d1="38" d2="226" d3="965"/>
<CITE num="027" author="ZINMAN R" publication="CF CENT DIRECTO 17TH MTG ABST" d1="" d2="" d3="977"/>
<CITE num="029" author="ROBOTHAM JL" publication="J APPL PHYSIOL" d1="44" d2="703" d3="978"/>
<CITE num="030" author="ROBOTHAM JL" publication="J APPL PHYSIOL" d1="46" d2="411" d3="979"/>
<CITE num="031" author="BERGER HJ" publication="AM J CARDIOL" d1="41" d2="897" d3="978"/>
<CITE num="032" author="WEISSLER AM" publication="MOD CONCEPTS CARDIOVASC DIS" d1="40" d2="5" d3="971"/>
<CITE num="033" author="BORER JS" publication="N ENGL J MED" d1="296" d2="839" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79131</PAPERNUM>
<CITATIONS>
<CITE num="1" author="STER LA             J" publication="PEDIATR" d1="97" d2="42 9" d3="0"/>
<CITE num="2" author="BOVE AA" publication="PROG CARDIOVASC DIS" d1="23" d2="365" d3="981"/>
<CITE num="3" author="BERGER HJ" publication="AM J CARDIOL" d1="47" d2="950" d3="981"/>
<CITE num="4" author="MATTHAY RA" publication="MED CLIN NORTH AM" d1="65" d2="489" d3="981"/>
<CITE num="5" author="JACOBSTEIN MD" publication="CHEST" d1="80" d2="399" d3="981"/>
<CITE num="6" author="NEWTH CJL" publication="AM REV RESPIR DIS" d1="124" d2="463" d3="981"/>
<CITE num="7" author="MOSS AJ" publication="PEDIATRICS" d1="70" d2="728" d3="982"/>
<CITE num="8" author="COATES AL" publication="CHEST" d1="82" d2="543" d3="982"/>
<CITE num="9" author="HIRSCHFELD SS" publication="CHEST" d1="82" d2="524" d3="982"/>
<CITE num="10" author="ROBOTHAM JL" publication="CLIN CHEST MED" d1="4" d2="161" d3="983"/>
<CITE num="11" author="DENNIS JB" publication="SEM NUCL MED" d1="13" d2="292" d3="983"/>
<CITE num="12" author="HESS OM" publication="AM HEART J" d1="106" d2="1377" d3="983"/>
<CITE num="13" author="BADKE FR" publication="AM J CARDIOL" d1="53" d2="1187" d3="984"/>
<CITE num="14" author="CHERON G" publication="ACTA PAEDIATR SCAND" d1="73" d2="697" d3="984"/>
<CITE num="15" author="PARRISH M" publication="J PEDIATR" d1="104" d2="165" d3="984"/>
<CITE num="16" author="GOODING CA" publication="J PEDIATR" d1="105" d2="384" d3="984"/>
<CITE num="17" author="BENSON LN" publication="AM REV RESPIR DIS" d1="130" d2="987" d3="984"/>
<CITE num="18" author="MICHAEL JR" publication="AM REV RESPIR DIS" d1="130" d2="516" d3="984"/>
<CITE num="19" author="MOSKOWITZ WB" publication="PEDIATR PHARMACOL" d1="5" d2="139" d3="985"/>
<CITE num="20" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="21" author="PANIDIS IP" publication="J AM COLL CARDIOL" d1="6" d2="701" d3="985"/>
<CITE num="22" author="PIEPSZ A" publication="PEDIATR PULMONOL" d1="3" d2="24" d3="987"/>
</CITATIONS>
<RECORDNUM>01111 </RECORDNUM>
<MEDLINENUM>79069472</MEDLINENUM>
<AUTHORS><AUTHOR>Finkelstein-E</AUTHOR><AUTHOR>Hall-K</AUTHOR></AUTHORS>
<TITLE>Aminoglycoside clearance in patients with cystic fibrosis [letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Jan. 94(1). P 163-4.</SOURCE>
<MAJORSUBJ><TOPIC>AMIKACIN: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>KANAMYCIN: aa</TOPIC><TOPIC>KIDNEY: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>We have been utilizing a patient's individual pharmacokinetic profile
to plan and monitor aminoglycoside therapy, and we have often noted
what appeared to be an extremely rapid elimination rate of gentamicin
in our patients with cystic fibrosis.  The patients with cystic
fibrosis had significantly greater renal and total clearances than
those without cystic fibrosis.  If this observation could be extended
to other drugs (such as the aminoglycosides), which are not normally
subject to renal secretion, it would prove intriguing evidence for a
possible primary renal defect in these patients.</EXTRACT>
<REFERENCES>
<CITE num="001" author="VOGELSTEIN B" publication="J PEDIATR" d1="91" d2="333" d3="977"/>
<CITE num="002" author="CLARKE JT" publication="CLIN PHARMACOL THER" d1="15" d2="610" d3="974"/>
<CITE num="003" author="HEWITT WL" publication="AM J MED US AMIKACIN SYMP" d1="62" d2="863" d3="977"/>
<CITE num="004" author="JUSKO WJ" publication="PEDIATRICS" d1="56" d2="1038" d3="975"/>
<CITE num="005" author="YAFFE SJ" publication="J INFECT DIS" d1="135" d2="828" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79132</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHALSEN H           AN" publication="TIMICROB AGENTS CHEMOTHER" d1="19" d2="29 9" d3="1"/>
<CITE num="2" author="LEVY J" publication="J ANTIMICROB CHEMOTHER" d1="10" d2="227" d3="982"/>
<CITE num="3" author="KRAEMER R" publication="EUR J PEDIATR" d1="138" d2="172" d3="982"/>
<CITE num="4" author="THIRUMOORTHI MC" publication="J PEDIATR" d1="102" d2="941" d3="983"/>
<CITE num="5" author="MACDONALD NE" publication="J PEDIATR" d1="103" d2="985" d3="983"/>
<CITE num="6" author="PADOAN R" publication="J PEDIATR" d1="103" d2="320" d3="983"/>
<CITE num="7" author="ISLES A" publication="AM REV RESPIR DIS" d1="127" d2="417" d3="983"/>
<CITE num="8" author="NAHATA MC" publication="DEVELOP PHARM THER" d1="7" d2="221" d3="984"/>
<CITE num="9" author="MARTINI N" publication="J CLIN HOSP PHARM" d1="9" d2="303" d3="984"/>
<CITE num="10" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="11" author="SCHOFIELD DH" publication="DRUG INTEL CLIN PHARM" d1="18" d2="153" d3="984"/>
<CITE num="12" author="LEEDER JS" publication="CLIN PHARMACOL THER" d1="36" d2="355" d3="984"/>
<CITE num="13" author="LEVY J" publication="J PEDIATR" d1="105" d2="117" d3="984"/>
<CITE num="14" author="SPINO M" publication="J PEDIATR" d1="105" d2="829" d3="984"/>
<CITE num="15" author="COURCOL RJ" publication="INT J CLIN PHARMACOL RES" d1="5" d2="87" d3="985"/>
<CITE num="16" author="FRASER GL" publication="DRUG INTEL CLIN PHARM" d1="19" d2="757" d3="985"/>
<CITE num="17" author="HORREVORTS  AM" publication="CHEST" d1="88" d2="260" d3="985"/>
<CITE num="18" author="SPINO M" publication="J PEDIATR" d1="107" d2="64" d3="985"/>
<CITE num="19" author="GOLDFARB J" publication="J CLIN PHARMACOL" d1="26" d2="222" d3="986"/>
<CITE num="20" author="AUTRET E" publication="EUR J CLIN PHARMACOL" d1="31" d2="79" d3="986"/>
<CITE num="21" author="RUBIO TT" publication="AM J MED" d1="81" d2="73" d3="986"/>
<CITE num="22" author="KEARNS GL" publication="J PEDIATR" d1="108" d2="847" d3="986"/>
<CITE num="23" author="PEDERSEN SS" publication="ANTIMICROB AGENTS CHEMOTHER" d1="31" d2="594" d3="987"/>
</CITATIONS>
<RECORDNUM>01112 </RECORDNUM>
<MEDLINENUM>80008520</MEDLINENUM>
<AUTHORS><AUTHOR>Loening-Baucke-V-A</AUTHOR><AUTHOR>Mischler-E</AUTHOR><AUTHOR>Myers-M-G</AUTHOR></AUTHORS>
<TITLE>A placebo-controlled trial of cephalexin therapy in the ambulatory
management of patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Oct. 95(4). P 630-7.</SOURCE>
<MAJORSUBJ><TOPIC>AMBULATORY-CARE</TOPIC><TOPIC>CEPHALEXIN: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADMINISTRATION-ORAL</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BACTERIAL-INFECTIONS: dt, et</TOPIC><TOPIC>CEPHALEXIN: ad, ae</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PLACEBOS</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MINORSUBJ>
<ABSTRACT>The effects of oral administration of cephalexin were evaluated in a
double-blind, placebo-controlled, crossover study in 17 patients
with mild to moderate pulmonary disease due to cystic fibrosis.  For
two years, four-month periods with cephalexin were alternated with
four-month placebo periods.  Thus, patients served as their own
control subjects.  Fungal vulvovaginitis occurred in two patients
during cephalexin therapy.  During the 2 years of study, the rate of
colonization with mucoid strains of Pseudomonas aeruginosa increased
and disease severity deteriorated in patients initially colonized
with P. aeruginosa.  Short-term courses of sputum culture-specific
antibiotics improved the course of some patients with mild to
moderate pulmonary disease due to cystic fibrosis.  Treatment with
cephalexin decreased the frequency of respiratory illnesses,
respiratory illnesses requiring antibiotics, and hospitalizations
for respiratory illnesses in patients initially colonized with
Staphylococcus aureus and/or Haemophilus influenzae, and also
reduced colonization with these organisms.  Improved weight gain in
16 of 17 patients was associated with periods of cephalexin therapy.
Pulmonary function tests remained stable or improved in 10 or 14
patients.  Disease severity improved in patients not colonized with
P. aeruginosa.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="N ENGL J MED" d1="241" d2="185" d3="949"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="AM J DIS CHILD" d1="72" d2="17" d3="946"/>
<CITE num="003" author="LAWSON D" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="225" d3="969"/>
<CITE num="004" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="005" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="006" author="MATTHEWS LW" publication="IN: MANGOS JA" d1="" d2="303" d3="973"/>
<CITE num="007" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="008" author="MONROE PW" publication="APPL MICROBIOL" d1="18" d2="214" d3="969"/>
<CITE num="009" author="HUANG NN" publication="J PEDIATR" d1="59" d2="512" d3="961"/>
<CITE num="010" author="LENNETTE EH" publication="MANUAL OF CLINICAL MICROBIOLO" d1="" d2="" d3="974"/>
<CITE num="011" author="CATLIN BW" publication="ANTIMICROB AGENTS CHEMOTHER" d1="7" d2="265" d3="975"/>
<CITE num="012" author="HUNTBERGER DV" publication="STATISTICAL INFERENCE IN BIOM" d1="" d2="" d3="970"/>
<CITE num="013" author="SNEDECOR GW" publication="STATISTICAL METHODS" d1="" d2="" d3="967"/>
<CITE num="014" author="LOURIA DB" publication="JAMA" d1="182" d2="1082" d3="962"/>
<CITE num="015" author="LORIAN V" publication="APPL MICROBIOL" d1="15" d2="564" d3="967"/>
<CITE num="016" author="BARTLETT JG" publication="AM REV RESPIR DIS" d1="117" d2="1019" d3="978"/>
<CITE num="017" author="STECHENBERG BW" publication="PEDIATRICS" d1="58" d2="532" d3="976"/>
<CITE num="018" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="019" author="MAY JR" publication="LANCET" d1="2" d2="534" d3="953"/>
<CITE num="020" author="MAY JR" publication="J CLIN MICROBIOL" d1="17" d2="254" d3="964"/>
<CITE num="021" author="REYNOLDS HY" publication="ANN INTERN MED" d1="82" d2="819" d3="975"/>
<CITE num="022" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="023" author="DOGGETT RG" publication="J PEDIATR" d1="68" d2="215" d3="966"/>
<CITE num="024" author="DOGGETT RG" publication="INFECT IMMUN" d1="6" d2="628" d3="972"/>
<CITE num="025" author="KULCZYCKI LL" publication="JAMA" d1="240" d2="30" d3="978"/>
<CITE num="026" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="027" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79133</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ENTZEN R            AM" publication="J DIS CHILD                 1" d1="34" d2="34 9" d3="0"/>
<CITE num="2" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="3" author="NOLAN G" publication="J PEDIATR" d1="101" d2="626" d3="982"/>
<CITE num="4" author="KRAEMER R" publication="EUR J PEDIATR" d1="138" d2="172" d3="982"/>
<CITE num="5" author="DAVIS PB" publication="J PEDIATR" d1="102" d2="177" d3="983"/>
<CITE num="6" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="7" author="DAVIS PB" publication="CHEST" d1="85" d2="802" d3="984"/>
<CITE num="8" author="HARRISON CJ" publication="PEDIATR PHARMACOL" d1="5" d2="7" d3="985"/>
<CITE num="9" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="10" author="MISCHLER EH" publication="SEM RESPIR MED" d1="6" d2="271" d3="985"/>
<CITE num="11" author="SMITH SR" publication="J CLIN HOSP PHARM" d1="10" d2="243" d3="985"/>
<CITE num="12" author="NELSON JD" publication="J PEDIATR" d1="106" d2="1030" d3="985"/>
<CITE num="13" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
<CITE num="14" author="FRIEND PA" publication="J INFECT" d1="13" d2="55" d3="986"/>
<CITE num="15" author="LITTLEWOOD JM" publication="J ROY SOC MED" d1="79" d2="55" d3="986"/>
<CITE num="16" author="FICK RB" publication="AM REV RESPIR DIS" d1="133" d2="418" d3="986"/>
</CITATIONS>
<RECORDNUM>01113 </RECORDNUM>
<MEDLINENUM>79111347</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenfeld-R</AUTHOR><AUTHOR>Spigelblatt-L</AUTHOR><AUTHOR>Chicoine-R</AUTHOR></AUTHORS>
<TITLE>False positive sweat test, malnutrition, and the Mauriac syndrome.</TITLE>
<SOURCE>J-Pediatr. 1979 Feb. 94(2). P 240-2.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>DWARFISM: co</TOPIC><TOPIC>HEPATOMEGALY: co</TOPIC><TOPIC>NUTRITION-DISORDERS: co</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DIABETES-MELLITUS-INSULIN-DEPENDENT: co</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<EXTRACT>Mauriac syndrome is characterised by hepatomegaly, glycogen
infiltration of the liver, retarded sexual maturation, and short
stature in diabetic children.  We report the first example of Mauriac
syndrome, in a patient clinically malnourished and edematous, who had
a transient false positive sweat test.  Malnourished children who
have a positive sweat test should have repeated sweat tests once the
malnourished state has been reversed.  This would eliminate error in
the diagnosis of cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="CONN JW" publication="ARCH INTERN MED" d1="83" d2="416" d3="949"/>
<CITE num="002" author="HARRIS RC" publication="PEDIATRICS" d1="31" d2="1044" d3="963"/>
<CITE num="003" author="LOBECK CC" publication="J PEDIATR" d1="62" d2="868" d3="963"/>
<CITE num="004" author="ROBINSON GC" publication="PEDIATRICS" d1="30" d2="797" d3="962"/>
<CITE num="005" author="MORSE WI" publication="N ENGL J MED" d1="264" d2="1021" d3="961"/>
<CITE num="006" author="MACE JW" publication="CLIN PEDIATR" d1="10" d2="285" d3="971"/>
<CITE num="007" author="DURAND P" publication="RECENT PROG MED" d1="44" d2="279" d3="968"/>
<CITE num="008" author="DURAND P" publication="J PEDIATR" d1="75" d2="665" d3="969"/>
<CITE num="009" author="MARDOFF L" publication="J PEDIATR" d1="73" d2="244" d3="968"/>
<CITE num="010" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="011" author="SCHALES O" publication="J BIOL CHEM" d1="140" d2="879" d3="941"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79134</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WACHMAN H           J" publication="PEDIATR" d1="95" d2="61 9" d3="9"/>
<CITE num="2" author="PARTINGTON MW" publication="AM J MED GENET" d1="10" d2="65" d3="981"/>
<CITE num="3" author="BEER SI" publication="ISR J MED SCI" d1="17" d2="1181" d3="981"/>
<CITE num="4" author="SCHWACHMAN H" publication="J PEDIATR" d1="98" d2="576" d3="981"/>
<CITE num="5" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="6" author="QUINTON PM" publication="ANNU REV MED" d1="34" d2="429" d3="983"/>
<CITE num="7" author="LUTHI M" publication="HELV PAEDIATR ACTA" d1="38" d2="149" d3="983"/>
<CITE num="8" author="DEMAY G" publication="ARCH FR PEDIATR" d1="41" d2="370" d3="984"/>
<CITE num="9" author="MOR A" publication="MINERAL ELECTROL METAB" d1="11" d2="155" d3="985"/>
<CITE num="10" author="CHRISTOFFEL KS" publication="J PEDIATR" d1="107" d2="231" d3="985"/>
<CITE num="11" author="BECK R" publication="ACTA PAEDIATR SCAND" d1="75" d2="639" d3="986"/>
<CITE num="12" author="RUDDY RM" publication="CLIN PEDIATR" d1="26" d2="83" d3="987"/>
</CITATIONS>
<RECORDNUM>01114 </RECORDNUM>
<MEDLINENUM>79111346</MEDLINENUM>
<AUTHORS><AUTHOR>Porter-R-C</AUTHOR><AUTHOR>Cloutier-M-M</AUTHOR><AUTHOR>Brasfield-D-M</AUTHOR><AUTHOR>Mangos-J-A</AUTHOR><AUTHOR>Miale-T</AUTHOR><AUTHOR>Tiller-R-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in two black children with sickle cell anemia.</TITLE>
<SOURCE>J-Pediatr. 1979 Feb. 94(2). P 239-40.</SOURCE>
<MAJORSUBJ><TOPIC>ANEMIA-SICKLE-CELL: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Sickle cell anemia and cystic fibrosis are the most frequent lethal
inherited diseases in the black and white population, respectively.
The occurrence of both diseases in the same individual has not been
reported in the literature.  This report presents two such patients
and poses questions concerning the possible clinical implications of
the simultaneous occurrence of both diseases.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79135</PAPERNUM>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="002" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="003" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="3" d2="692" d3="964"/>
<CITE num="004" author="KULCZYCKI LL" publication="AM J DIS CHILD" d1="127" d2="64" d3="974"/>
<CITE num="005" author="HEFFER ET" publication="NY STATE J MED" d1="74" d2="2355" d3="974"/>
<CITE num="006" author="SULTZ HA" publication="AM J PUBLIC HEALTH" d1="58" d2="491" d3="968"/>
<CITE num="007" author="WINTROBE MM" publication="CLINICAL HEMATOLOGY" d1="" d2="823" d3="974"/>
</REFERENCES>
<RECORDNUM>01115 </RECORDNUM>
<MEDLINENUM>79241401</MEDLINENUM>
<AUTHORS><AUTHOR>Chase-H-P</AUTHOR><AUTHOR>Long-M-A</AUTHOR><AUTHOR>Lavin-M-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis and malnutrition.</TITLE>
<SOURCE>J-Pediatr. 1979 Sep. 95(3). P 337-47. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>NUTRITION-DISORDERS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>DIETARY-PROTEINS: me</TOPIC><TOPIC>ENERGY-METABOLISM</TOPIC><TOPIC>FATTY-ACIDS-ESSENTIAL: df</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>IRON: df</TOPIC><TOPIC>LINOLEIC-ACIDS: bl</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SELENIUM: df</TOPIC><TOPIC>TRACE-ELEMENTS: df</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>VITAMIN-A-DEFICIENCY: et</TOPIC><TOPIC>VITAMIN-B-12-DEFICIENCY: et</TOPIC><TOPIC>VITAMIN-D-DEFICIENCY: et</TOPIC><TOPIC>VITAMIN-E-DEFICIENCY: et</TOPIC><TOPIC>VITAMIN-K-DEFICIENCY: et</TOPIC><TOPIC>ZINC: df</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis as a specific disease entity has been known to be
associated with malnutrition for almost half a century. The
importance of the malnutrition in the disease process remains
unknown, as does much information about specific nutritional
deficiencies in CF. Supplements for children with CF should include
extra energy as fat or carbohydrate, a form of linoleic acid that can
be absorbed, hydrolyzed protein, fat-soluble vitamins with vitamins A
and E in a water emulsion, vitamin B12, probably B vitamins and
vitamin C, and trace minerals. Routine measurements of nutritional
status, particularly in children with growth failure, should be made
at regular intervals and should include a three-day diet record and a
simultaneous 72-hour stool fat determination. If fat malabsorption is
not controlled by pancreatic enzymes, the use of antacids or
cimetidine should be considered. The true role of nutrition in
patients with CF will not be known until the appropriate studies are
completed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="REGAN PT" publication="N ENGL J MED" d1="297" d2="854" d3="977"/>
<CITE num="004" author="KATTWINKEL J" publication="PEDIATRICS" d1="50" d2="133" d3="972"/>
<CITE num="005" author="COX KL" publication="CYSTIC FIBROSIS" d1="17" d2="7" d3="978"/>
<CITE num="006" author="COX KL" publication="CYSTIC FIBROSIS" d1="17" d2="7" d3="978"/>
<CITE num="007" author="DIMAGNO EP" publication="N ENGL J MED" d1="296" d2="1318" d3="977"/>
<CITE num="009" author="KHAW K-T" publication="CF CLUB ABST" d1="" d2="58" d3="978"/>
<CITE num="010" author="GRACEY M" publication="ARCH DIS CHILD" d1="44" d2="401" d3="969"/>
<CITE num="011" author="YASSA JG" publication="ARCH DIS CHILD" d1="53" d2="777" d3="978"/>
<CITE num="012" author="CHASE HP" publication="LANCET" d1="2" d2="236" d3="978"/>
<CITE num="013" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="014" author="HANSEN AE" publication="PEDIATRICS" d1="31" d2="171" d3="963"/>
<CITE num="015" author="DUPONT J" publication="FED PROC" d1="37" d2="445" d3="978"/>
<CITE num="016" author="HOPKINS DT" publication="PROC SOC EXP BIOL MED" d1="114" d2="82" d3="963"/>
<CITE num="017" author="FRIEDMAN Z" publication="PEDIATRICS" d1="58" d2="650" d3="976"/>
<CITE num="018" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="019" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="020" author="FLEISHER DS" publication="J PEDIATR" d1="64" d2="341" d3="964"/>
<CITE num="021" author="DOLAN TF JR" publication="CLIN PEDIATR" d1="9" d2="295" d3="970"/>
<CITE num="022" author="STROBER W" publication="PEDIATRICS" d1="43" d2="416" d3="969"/>
<CITE num="023" author="WEST CD" publication="AM J DIS CHILD" d1="72" d2="251" d3="946"/>
<CITE num="024" author="ANFANGER H" publication="AM J DIS CHILD" d1="77" d2="425" d3="949"/>
<CITE num="025" author="FRISANCHO AR" publication="AM J CLIN NUTR" d1="27" d2="1052" d3="974"/>
<CITE num="026" author="VAUGHAN WJ" publication="SCIENCE" d1="199" d2="783" d3="978"/>
<CITE num="027" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
<CITE num="028" author="UNDERWOOD BA" publication="PEDIATR RES" d1="6" d2="26" d3="972"/>
<CITE num="029" author="ABERNATHY RS" publication="AM J DIS CHILD" d1="130" d2="1360" d3="976"/>
<CITE num="030" author="SMITH FR" publication="J LAB CLIN MED" d1="80" d2="423" d3="972"/>
<CITE num="031" author="COUSINS RJ" publication="J NUTR" d1="97" d2="409" d3="969"/>
<CITE num="032" author="OWEN GM" publication="J PEDIATR" d1="78" d2="1042" d3="971"/>
<CITE num="033" author="WARWICK WJ" publication="CLIN PEDIATR" d1="15" d2="807" d3="976"/>
<CITE num="034" author="SCOTT J" publication="AM J MED" d1="63" d2="488" d3="977"/>
<CITE num="035" author="HAHN TJ" publication="J PEDIATR" d1="94" d2="38" d3="979"/>
<CITE num="036" author="HUBBARD VS" publication="J PEDIATR" d1="94" d2="84" d3="979"/>
<CITE num="037" author="LUBIN AH" publication="CF CLUB ABST" d1="" d2="71" d3="978"/>
<CITE num="038" author="FARRELL PM" publication="J CLIN INVEST" d1="60" d2="233" d3="977"/>
<CITE num="039" author="OSKI FA" publication="J PEDIATR" d1="70" d2="211" d3="967"/>
<CITE num="040" author="DOLAN TF JR" publication="CLIN PEDIATR" d1="15" d2="597" d3="976"/>
<CITE num="041" author="GREEN J" publication="NUTR ABSTR REV" d1="39" d2="321" d3="969"/>
<CITE num="042" author="HOPE WC" publication="PROSTAGLANDINS" d1="10" d2="557" d3="975"/>
<CITE num="043" author="SCOTT ML" publication="IN: DELUCA HF" d1="" d2="357" d3="970"/>
<CITE num="044" author="KAPLAN E" publication="N ENGL J MED" d1="279" d2="65" d3="968"/>
<CITE num="045" author="OPPENHEIMER EH" publication="BULL JOHNS HOPKINS HOSP" d1="98" d2="353" d3="956"/>
<CITE num="046" author="DARBY CW" publication="ARCH DIS CHILD" d1="48" d2="72" d3="973"/>
<CITE num="047" author="NITOWSKY HM" publication="AM J CLIN NUTR" d1="10" d2="368" d3="962"/>
<CITE num="048" author="TENGERDY RP" publication="INT ARCH ALLERGY" d1="44" d2="221" d3="973"/>
<CITE num="049" author="HARRIES JT" publication="ARCH DIS CHILD" d1="46" d2="341" d3="971"/>
<CITE num="050" author="WALTERS TR" publication="AM J DIS CHILD" d1="124" d2="641" d3="972"/>
<CITE num="051" author="KOMP DM" publication="CHEST" d1="58" d2="501" d3="970"/>
<CITE num="052" author="ANSELL JE" publication="JAMA" d1="238" d2="40" d3="977"/>
<CITE num="053" author="FILER LJ JR" publication="PEDIATRICS" d1="48" d2="483" d3="971"/>
<CITE num="054" author="MOSS MH" publication="AM J DIS CHILD" d1="117" d2="540" d3="969"/>
<CITE num="055" author="SUTHERLAND JM" publication="AM J DIS CHILD" d1="113" d2="524" d3="967"/>
<CITE num="056" author="VEEGER W" publication="N ENGL J MED" d1="267" d2="1341" d3="962"/>
<CITE num="057" author="DEREN JJ" publication="N ENGL J MED" d1="288" d2="949" d3="973"/>
<CITE num="058" author="RUCKER RW" publication="N ENGL J MED" d1="289" d2="329" d3="973"/>
<CITE num="059" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="060" author="SHWACHMAN H" publication="PEDIATRICS" d1="25" d2="155" d3="960"/>
<CITE num="061" author="DAVIDSON M" publication="IN: RUDOLPH AM" d1="" d2="994" d3="977"/>
<CITE num="062" author="HALSTED JA" publication="LANCET" d1="1" d2="322" d3="970"/>
<CITE num="063" author="PALIN HD" publication="PEDIATR RES ABST 343" d1="10" d2="358" d3="976"/>
<CITE num="064" author="JACOB RA" publication="AM J CLIN NUTR" d1="31" d2="638" d3="978"/>
<CITE num="065" author="HAMBRIDGE KM" publication="PEDIATR CLIN NORTH AM" d1="24" d2="95" d3="977"/>
<CITE num="066" author="SMITH JC JR" publication="SCIENCE" d1="181" d2="954" d3="973"/>
<CITE num="067" author="SMITH JE" publication="J LAB CLIN MED" d1="84" d2="692" d3="974"/>
<CITE num="068" author="PEKAREK RS" publication="PROC SOC EXP BIOL MED" d1="138" d2="728" d3="971"/>
<CITE num="069" author="HEINRICH HC" publication="KLIN WOCHENSCHR" d1="55" d2="587" d3="977"/>
<CITE num="070" author="FISCHER WC" publication="J NUTR" d1="107" d2="1493" d3="977"/>
<CITE num="071" author="MISCHLER EH" publication="CF CLUB ABST" d1="" d2="80" d3="978"/>
<CITE num="072" author="HELLER RM" publication="J PEDIATR" d1="92" d2="947" d3="978"/>
<CITE num="073" author="CHASE HP" publication="JAMA" d1="230" d2="1535" d3="974"/>
<CITE num="074" author="HANSEN L" publication="AM J CLIN PATHOL" d1="46" d2="133" d3="966"/>
</REFERENCES>

</RECORD>
<RECORD>
<PAPERNUM>PN79136</PAPERNUM>
<CITATIONS>
<CITE num="1" author="U JY                NU" publication="TR REV" d1="37" d2="51 9" d3="9"/>
<CITE num="2" author="KARP RJ" publication="CLIN CHEST MED" d1="1" d2="375" d3="980"/>
<CITE num="3" author="LEE JA" publication="ANN CLIN LAB SCI" d1="10" d2="227" d3="980"/>
<CITE num="4" author="HUBBARD VS" publication="J PEDIATR" d1="96" d2="421" d3="980"/>
<CITE num="5" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="6" author="GOW R" publication="LANCET" d1="2" d2="1071" d3="981"/>
<CITE num="7" author="HAMILTON RM" publication="LIPIDS" d1="16" d2="374" d3="981"/>
<CITE num="8" author="PASSERO MA" publication="CLIN PEDIATR" d1="20" d2="264" d3="981"/>
<CITE num="9" author="SCHONI M" publication="HELV PAEDIATR ACTA" d1="36" d2="359" d3="981"/>
<CITE num="10" author="BELL L" publication="J CAN DIET ASSOC" d1="42" d2="62" d3="981"/>
<CITE num="11" author="CONGDEN PJ" publication="ARCH DIS CHILD" d1="56" d2="708" d3="981"/>
<CITE num="12" author="ANON" publication="J AM DIET ASSOC" d1="78" d2="443" d3="981"/>
<CITE num="13" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="14" author="CASTILLO R" publication="J PEDIATR" d1="99" d2="583" d3="981"/>
<CITE num="15" author="CORRIGAN JJ" publication="J PEDIATR" d1="99" d2="254" d3="981"/>
<CITE num="16" author="GORDON EF" publication="J PEDIATR" d1="99" d2="341" d3="981"/>
<CITE num="17" author="ROSENFELD RG" publication="J PEDIATR" d1="99" d2="252" d3="981"/>
<CITE num="18" author="REED MD" publication="AM J DIS CHILD" d1="135" d2="829" d3="981"/>
<CITE num="19" author="BRANCHINI BR" publication="LANCET" d1="1" d2="618" d3="982"/>
<CITE num="20" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="21" author="LEVI N" publication="RIV ITAL PEDIATR" d1="8" d2="695" d3="982"/>
<CITE num="22" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="23" author="MILLER M" publication="AM J CLIN NUTR" d1="36" d2="492" d3="982"/>
<CITE num="24" author="HUBBARD VS" publication="J AM DIET ASSOC" d1="80" d2="127" d3="982"/>
<CITE num="25" author="PENCHARZ PB" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="400" d3="983"/>
<CITE num="26" author="SHEPHERD RW" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="439" d3="983"/>
<CITE num="27" author="MERRITT RJ" publication="ADV NUTR RES" d1="5" d2="77" d3="983"/>
<CITE num="28" author="BRANCHINI BR" publication="PEDIATR RES" d1="17" d2="850" d3="983"/>
<CITE num="29" author="FARRELL PM" publication="J DENT CHILD" d1="50" d2="385" d3="983"/>
<CITE num="30" author="ATER JL" publication="PEDIATRICS" d1="71" d2="810" d3="983"/>
<CITE num="31" author="NEVE J" publication="ACTA PAEDIATR SCAND" d1="72" d2="437" d3="983"/>
<CITE num="32" author="SMITH AE" publication="J PEDIATR" d1="103" d2="820" d3="983"/>
<CITE num="33" author="HANSEN RC" publication="ARCH DERMATOL" d1="119" d2="51" d3="983"/>
<CITE num="34" author="HUBBARD VS" publication="EUR J PEDIATR" d1="141" d2="68" d3="983"/>
<CITE num="35" author="HOLT TL" publication="IRCS MED SCI BIOCHEM" d1="12" d2="370" d3="984"/>
<CITE num="36" author="SCHONI M" publication="PEDIATR RES" d1="18" d2="66" d3="984"/>
<CITE num="37" author="ZENTLERMUNRO PL" publication="GUT" d1="25" d2="500" d3="984"/>
<CITE num="38" author="ABRAMS CK" publication="J CLIN INVEST" d1="73" d2="374" d3="984"/>
<CITE num="39" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="40" author="PARSONS HG" publication="J PEDIATR" d1="105" d2="958" d3="984"/>
<CITE num="41" author="VICHINSKY EP" publication="J PEDIATR" d1="105" d2="15" d3="984"/>
<CITE num="42" author="KUHN RJ" publication="CLIN PHARMACY" d1="4" d2="555" d3="985"/>
<CITE num="43" author="MCKENNA MC" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="45" d3="985"/>
<CITE num="44" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="45" author="ZENTLERMUNRO PL" publication="GUT" d1="26" d2="892" d3="985"/>
<CITE num="46" author="MAAK B" publication="Z KLIN MED" d1="40" d2="1115" d3="985"/>
<CITE num="47" author="HOLT TL" publication="AM J CLIN NUTR" d1="41" d2="1061" d3="985"/>
<CITE num="48" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="49" author="FERNANDES J" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="5" d3="985"/>
<CITE num="50" author="HUGHES RL" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="42" d3="985"/>
<CITE num="51" author="NEIJENS HJ" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="38" d3="985"/>
<CITE num="52" author="ANON" publication="LANCET" d1="1" d2="249" d3="986"/>
<CITE num="53" author="ABMAN SH" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="393" d3="986"/>
<CITE num="54" author="GIBSON RA" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="408" d3="986"/>
<CITE num="55" author="LESTER LA" publication="J PARENT ENTERAL NUTR" d1="10" d2="289" d3="986"/>
<CITE num="56" author="KOHLER JA" publication="J CLIN HOSP PHARM" d1="11" d2="21" d3="986"/>
<CITE num="57" author="SOUTTER VL" publication="CLIN GASTROENTEROL" d1="15" d2="137" d3="986"/>
<CITE num="58" author="MISCHLER EH" publication="PEDIATR RES" d1="20" d2="36" d3="986"/>
<CITE num="59" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
<CITE num="60" author="CRAIGSCHMIDT MC" publication="AM J CLIN NUTR" d1="44" d2="816" d3="986"/>
<CITE num="61" author="MOORE MC" publication="AM J CLIN NUTR" d1="44" d2="33" d3="986"/>
<CITE num="62" author="GOODCHILD MC" publication="J ROY SOC MED" d1="79" d2="32" d3="986"/>
<CITE num="63" author="SHEPHERD RW" publication="J PEDIATR" d1="109" d2="788" d3="986"/>
<CITE num="64" author="DANIELS L" publication="J PEDIATR GASTROENTEROL NUTR" d1="6" d2="381" d3="987"/>
<CITE num="65" author="HUBBARD VS" publication="LIPIDS" d1="22" d2="424" d3="987"/>
<CITE num="66" author="ZAKRZEWSKI JT" publication="BR J CLIN PHARMACOL" d1="23" d2="19" d3="987"/>
<CITE num="67" author="YOUNGBERG  CA" publication="DIG DIS SCI" d1="32" d2="472" d3="987"/>
</CITATIONS>
<RECORDNUM>01116 </RECORDNUM>
<MEDLINENUM>79069483</MEDLINENUM>
<AUTHORS><AUTHOR>Moss-T-J</AUTHOR><AUTHOR>Austin-G-E</AUTHOR><AUTHOR>Moss-A-J</AUTHOR></AUTHORS>
<TITLE>Preatherosclerotic aortic lesions in cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Jan. 94(1). P 32-7.</SOURCE>
<MAJORSUBJ><TOPIC>AORTA: pa</TOPIC><TOPIC>ARTERIOSCLEROSIS: pa</TOPIC><TOPIC>ATHEROSCLEROSIS: pa</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ATHEROSCLEROSIS: co, et</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>ATHEROSCLEROSIS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Patients with cystic fibrosis have fat malabsorption, providing an
experimental model for evaluation of the hypothesis that a low-fat
intake may prevent atherosclerosis. We studied the frequency and
extent of aortic precursor lesions (fatty streaks, early
fibromusculoelastic lesions, late fibromusculoelastic lesions) found
at autopsy in this disease as well as in other patients with
debilitating disorders but with no apparent impairment of fat
absorption. Fatty streaks were less common in the cystic fibrosis
group, as were the late fibromusculoelastic lesions. There was no
significant difference in the frequency, length, or thickness of the
early fibromusculoelastic lesions. The findings suggest that fat may
be responsible for progression but not initiation of the
fibromusculoelastic precursor lesions, and support the concept that
early restriction of dietary fat may prevent, delay, or otherwise
modify atherosclerosis in the adult.</ABSTRACT>
<REFERENCES>
001$  ANON                  ARTERIOSCLEROSIS DHEW PUB NO?    2       971
002   STRONG JP             J ATHEROSCLER RES                9   251 969
003   HENNEKENS CH          PEDIATRICS                      58   211 976
004   GLAGOV S              IN: WISSLER RW                         9 972
005   MITCHELL S            PEDIATRICS                      49   165 972
006   SHOHL AT              J PEDIATR                       23   267 943
007   ANDERSEN DH           AM J DIS CHILD                  69   221 945
008   ROSS CAC              ARCH DIS CHILD                  30   316 955
009   BERRY HK              AM J DIS CHILD                 129   165 975
010   HOLMAN RL             PEDIATRICS                      24    34 959
011   ROSS R                N ENGL J MED                   295   369 976
012   WILENS SL             AM J PATHOL                     27   825 951
013   MCGILL HC JR          LAB INVEST                      18   560 968
014   SCHWARTZ CJ           ARCH PATHOL                     83   325 967
015   HARDIN NJ             AM J PATHOL                     73   301 973
016   GORE I                ARCH PATHOL                     84    49 967
017   STRONG JP             AM J PATHOL                     34   731 958
018   FRIEDMAN M            ARCH PATHOL                     79   345 965
</REFERENCES>

</RECORD>
<RECORD>
<PAPERNUM>PN79137</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SS TJ               J" publication="MENT DEFIC RES" d1="24" d2="37 9" d3="0"/>
<CITE num="2" author="MOSS AJ" publication="PEDIATRICS" d1="70" d2="728" d3="982"/>
</CITATIONS>
<RECORDNUM>01117 </RECORDNUM>
<MEDLINENUM>79069466</MEDLINENUM>
<AUTHORS><AUTHOR>Sacher-M</AUTHOR><AUTHOR>Shmerling-D-H</AUTHOR></AUTHORS>
<TITLE>PABA-test for diagnosis of exocrine pancreatic insufficiency
[letter].</TITLE>
<SOURCE>J-Pediatr. 1979 Jan. 94(1). P 159.</SOURCE>
<MAJORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: du</TOPIC><TOPIC>AMINOBENZOIC-ACIDS: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: ur</TOPIC><TOPIC>CYSTIC-FIBROSIS: ur</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>We have also found a significant difference between the 6-hour
urinary PABA recovery in healthy controls and CF patients, with no
overlap of the ranges, and a good correlation with fecal chymotrypsin
activity.  We can stress the usefulness of the test in this age
group.  In studying a group of healthy newborn infants, however, the
results were quite different: The PABA recovery was smaller and
showed greater variations and overlap with results in CF patients
occurred.  It is clear that the test is not applicable in newborn
infants when performed in the described manner.  One possible
explanation is the physiologically limited glomerular filtration rate
in the newborn infant, which could have delayed the PABA excretion.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79138</PAPERNUM>
<REFERENCES>
<CITE num="001" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="92" d2="734" d3="978"/>
<CITE num="002" author="SACHER M" publication="ARCH DIS CHILD" d1="53" d2="639" d3="978"/>
</REFERENCES>
<RECORDNUM>01118 </RECORDNUM>
<MEDLINENUM>79241408</MEDLINENUM>
<AUTHORS><AUTHOR>Fischer-E-G</AUTHOR><AUTHOR>Shwachman-H</AUTHOR><AUTHOR>Wepsic-J-G</AUTHOR></AUTHORS>
<TITLE>Brain abscess and cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1979 Sep. 95(3). P 385-8.</SOURCE>
<MAJORSUBJ><TOPIC>BRAIN-ABSCESS: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BRAIN-ABSCESS: mi</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROTEUS-INFECTIONS: et</TOPIC><TOPIC>PROTEUS-MIRABILIS</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: et</TOPIC><TOPIC>STAPHYLOCOCCAL-INFECTIONS: et</TOPIC></MINORSUBJ>
<ABSTRACT>Brain abscess has only recently been considered a complication of
cystic fibrosis. Three patients are reported here and a fourth cited
from the literature. All of our patients were young adults with
advanced pulmonary disease. The bacteria involved were mouth
organisms and were found in the sputum culture in only one of the
patients. Resistance was present to previously given antibiotics. As
patients with cystic fibrosis survive into adulthood, the risk of
developing a brain abscess appears to increase.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="CURR PROB PEDIATR NO 10" d1="8" d2="" d3="978"/>
<CITE num="002" author="DUFFNER PK" publication="ARCH NEUROL" d1="36" d2="27" d3="979"/>
<CITE num="003" author="EVERETT ED" publication="MEDICINE (BALTIMORE)" d1="56" d2="61" d3="977"/>
<CITE num="004" author="JAGELS AE" publication="J DENT RES" d1="55" d2="991" d3="976"/>
<CITE num="005" author="MOLINARI GF" publication="NEUROLOGY (MINN)" d1="23" d2="1205" d3="973"/>
<CITE num="006" author="PRUITT AA" publication="MEDICINE (BALTIMORE)" d1="57" d2="329" d3="978"/>
<CITE num="007" author="MATSON DD" publication="PEDIATRICS" d1="27" d2="772" d3="961"/>
<CITE num="008" author="FISCHBEIN CA" publication="AM J CARDIOL" d1="34" d2="97" d3="974"/>
<CITE num="009" author="NEWHOUSE M" publication="N ENGL J MED" d1="295" d2="1045" d3="976"/>
<CITE num="010" author="WOOD WG JR" publication="J EXP MED" d1="94" d2="521" d3="951"/>
<CITE num="011" author="GELLER A" publication="NEUROLOGY (MINN)" d1="27" d2="185" d3="977"/>
<CITE num="012" author="LEROUX BT" publication="BR HEART J" d1="32" d2="571" d3="970"/>
<CITE num="013" author="HARRIS P" publication="HUMAN PULMONARY CIRCULATI" d1="" d2="" d3="962"/>
<CITE num="014" author="WAGENVOORT CA" publication="PATHOLOGY OF PULMONARY HYPERT" d1="" d2="" d3="977"/>
<CITE num="015" author="COMROE JH JR" publication="LUNG CLINICAL PHYSIOLOGY AND" d1="" d2="" d3="962"/>
<CITE num="016" author="ROSENTHAL A" publication="AM J CARDIOL" d1="27" d2="162" d3="971"/>
<CITE num="017" author="ROSENTHAL A" publication="PEDIATRICS" d1="59" d2="588" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79139</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CARTHY MM           CL" publication="IN PEDIATR" d1="19" d2="46 9" d3="0"/>
<CITE num="2" author="SHERMAN JM" publication="J PEDIATR" d1="96" d2="952" d3="980"/>
<CITE num="3" author="FISCHER EG" publication="AM J DIS CHILD" d1="135" d2="746" d3="981"/>
<CITE num="4" author="SANGER RG" publication="ORAL SURG" d1="53" d2="131" d3="982"/>
<CITE num="5" author="AYRES J" publication="BR J DIS CHEST" d1="76" d2="99" d3="982"/>
<CITE num="6" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="7" author="SHWACHMAN H" publication="J PEDIATR SURG" d1="18" d2="570" d3="983"/>
<CITE num="8" author="RABKIN CS" publication="ANN NEUROL" d1="15" d2="608" d3="984"/>
<CITE num="9" author="KLINE MW" publication="PEDIATR INFECT DIS" d1="4" d2="72" d3="985"/>
<CITE num="10" author="CANNY GJ" publication="THORAX" d1="41" d2="221" d3="986"/>
<CITE num="11" author="KURLAND G" publication="PEDIATRICS" d1="78" d2="1097" d3="986"/>
</CITATIONS>
<RECORDNUM>01119 </RECORDNUM>
<MEDLINENUM>81009005</MEDLINENUM>
<AUTHORS><AUTHOR>Venugopal-S</AUTHOR><AUTHOR>Shandling-B</AUTHOR></AUTHORS>
<TITLE>Meconium ileus: laparotomy without resection, anastomosis, or
enterostomy.</TITLE>
<SOURCE>J-Pediatr-Surg. 1979 Dec. 14(6). P 715-8.</SOURCE>
<MAJORSUBJ><TOPIC>INFANT-NEWBORN-DISEASES: su</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: su</TOPIC><TOPIC>MECONIUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ILEOSTOMY</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: co, et</TOPIC><TOPIC>LAPAROTOMY</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC></MINORSUBJ>
<ABSTRACT>During the 14 yr from 1965 through 1978, 49 infants presented shortly
after birth with intestinal obstruction due to impacted meconium.
Three of these patients did not have fibrocystic disease. Eight
patients were cured by a Gastrografin enema. There were 18 patients
who had complications that included associated atresia, volvulus,
and/or peritonitis. Various operations were done including resection
with either primary anastomosis or enterostomy or varieties of the
foregoing. Twenty-three babies had the simple uncomplicated form of
meconium ileus. Eleven of these underwent resection and six patients
died. Twelve patients were treated by laparotomy, ileotomy through a
purse-string suture and prolonged irrigations using acetylcysteine.
Of this group only one succumbed. This latter course of management is
recommended for patients with simple uncomplicated meconium ileus as
it involves no resection, no enterostomy, nor any primary
anastomosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DONNISON AB" publication="PEDIATRICS" d1="37" d2="833" d3="966"/>
<CITE num="002" author="KALAYOGLU M" publication="J PEDIATR SURG" d1="6" d2="290" d3="971"/>
<CITE num="003" author="ONEILL JA JR" publication="AM J SURG" d1="119" d2="99" d3="970"/>
<CITE num="004" author="NOBLETT HR" publication="J PEDIATR SURG" d1="4" d2="190" d3="969"/>
<CITE num="005" author="MCPARTLIN JF" publication="ARCH DIS CHILD" d1="47" d2="207" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79140</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OSS K               J" publication="PEDIATR SURG" d1="20" d2="31 9" d3="5"/>
<CITE num="2" author="GHORY MJ" publication="SURG CLIN NORTH AM" d1="65" d2="1083" d3="985"/>
</CITATIONS>
<RECORDNUM>01120 </RECORDNUM>
<MEDLINENUM>80008799</MEDLINENUM>
<AUTHORS><AUTHOR>Morrissey-S-M</AUTHOR><AUTHOR>Tymvios-M-C</AUTHOR></AUTHORS>
<TITLE>The effect of histamine, metiamide and cystic fibrosis factor on the
electrophysiological properties of the frog's gastric mucosa
[proceedings].</TITLE>
<SOURCE>J-Physiol (Lond). 1979 Jun. 291. P 25P-26P.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GASTRIC-MUCOSA: de</TOPIC><TOPIC>HISTAMINE: pd</TOPIC><TOPIC>METIAMIDE: pd</TOPIC><TOPIC>THIOUREA: aa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>BIOLOGICAL-TRANSPORT-ACTIVE: de</TOPIC><TOPIC>CHLORIDES: me</TOPIC><TOPIC>ANURA</TOPIC><TOPIC>GASTRIC-MUCOSA: ph</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>MEMBRANE-POTENTIALS: de</TOPIC></MINORSUBJ>
<ABSTRACT>The total active transport of Cl ions across the frog's gastric
mucosa can be considered as: net Cl- flux (serosa to mucosa) = H+ +
SSC (short-circuit current), all terms expressed as micromole cm-2
hr-1.  The net chloride flux (Hogben, 1955; Durbin  Heinz, 1958)
may be divided into two fractions: an acidic one which is equivalent
to the acid secreted and an electromotive one which accounts for the
gastric electromotive force.  The changes in SCC can accordingly be
used as a partial index to the activity of the chloride pump.
Experiments were designed to investigate the effects of histamine,
metiamide (H2 receptor antagonist), cystic fibrosis (CF) and non-CF
plasma on the above parameters using the frog's isolated gastric
mucosa.  The SCC and the resistance of the mucosal preparation is
measured by means of an automatic SCC apparatus (de Jesus, 1977).
The H ion secretion is measured by pH meter.  Results obtained
(expressed as mean change (delta) plus or minus S.E. of mean) for
histamine (10-4 M) (n = 10) show an initial increase of the SCC by
36.94 plus or minus 2.95 microA cm-2 and a parallel small increase
in H+ output by 0.045 plus or minus 0.003 micromole cm-2 hr-1.  This
initial increase in SCC is followed by a drop to a steady-state
level of 23.62 plus or minus 2.23 microA cm-2 and also by a large
increase in H+ secretion 2.26 plus or minus 0.22 micromole cm-2
hr-1.  These results support the work of Rehm (1961) in that
histamine has an effect first on the Cl- pump and then on the H+
secretion.  Metiamide (10-4 M) (n = 12) caused a drop in the SCC by
20.16 plus or minus 2.32 microA cm-2 and also reduced the acid
secretion by 2.21 plus or minus 0.14 micromole cm-2 hr-1, thus
suggesting an effect on the Cl- pump as well as on the H+ secretion.
Significant differences are shown (P &lt; 0.001) between CF and non-CF
plasma results.  The CF plasma (n = 8) increased the SCC by 17.25
plus or minus 2.94 microA cm-2 and H+ secretion by 2.38 plus or
minus 0.43 micromole cm-2 hr-1.  Non-CF plasma caused a slight
increase in SCC by 5.17 plus or minus 1.1 microA cm-2 and had little
effect on the H+ secretion, 0.34 plus or minus 0.01 micromole cm-2
hr-1 (n = 8).  The effect of the CF plasma on the Cl- and H+
mechanism is of interest since in cystic fibrosis there is an
abnormal increase of Cl- and Na+ in the sweat of patients (di Sant
Agnese, Darling, Perera  She, 1953).</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79141</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DURBIN RP" publication="J GEN PHYSIOL" d1="41" d2="1035" d3="958"/>
<CITE num="002" author="HOGBEN CAM" publication="AM J PHYSIOL" d1="180" d2="641" d3="955"/>
<CITE num="003" author="DE JESUS HC" publication="J PHYSIOL (LOND)" d1="268" d2="353" d3="977"/>
<CITE num="004" author="REHM WS" publication="AM J PHYSIOL" d1="203" d2="63" d3="961"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="AM J DIS CHILD" d1="86" d2="618" d3="953"/>
</REFERENCES>
<RECORDNUM>01121 </RECORDNUM>
<MEDLINENUM>79218491</MEDLINENUM>
<AUTHORS><AUTHOR>Bond-C-E</AUTHOR><AUTHOR>Fraser-P-A</AUTHOR><AUTHOR>Smaje-L-H</AUTHOR></AUTHORS>
<TITLE>The chronically ligated submandibular salivary duct of the rabbit as
a possible model for cystic fibrosis [proceedings].</TITLE>
<SOURCE>J-Physiol (Lond). 1979 Apr. 289. P 25P.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>SUBMANDIBULAR-GLAND: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>BIOLOGICAL-TRANSPORT</TOPIC><TOPIC>EPITHELIUM: cy, pp</TOPIC><TOPIC>LIGATION</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>SODIUM: ph</TOPIC></MINORSUBJ>
<ABSTRACT>Schulz (1969) showed that the raised Na concentration in the sweat
of children suffering from cystic fibrosis  was due to a defect in
Na reabsorption in the duct epithelium, but somewhat surprisingly
the transepithelial potential difference (p.d.) is the same as that
in normal controls.  Na transport is also reduced in the chronically
ligated salivary duct of the rabbit submandibular gland (Fraser 
Smaje, 1978), and because p.d. is unaffected, the ligated gland may
be a useful model of this aspect of cystic fibrosis.  Here we would
like to report a further similarity to cystic fibrosis; duct
ligation leads to goblet cell hyperplasia which also occurs in the
salivary glands in cystic fibrosis (Lev  Spicer, 1965).  Sections
of the salivary duct 6 microm thick were taken at 60 microm
intervals from ducts which had been ligated for between 1 and 5
weeks and from their contralateral controls following fixation by
immersion.  Ligation resulted in an increase in luminal diameter by
distension of the previously convoluted epithelium, but there was no
significant change in epithelial surface area.  The number of cell
layers appeared to have increased however and there was a
proliferation of goblet cells.  The mucus in these cells was stained
by alcian blue at pH 1 indicating the presence of sulphomucin.  The
mean goblet cell density rose from 7.62 plus or minus 4.73 mm-2
(mean plus or minus S.E. of the mean, n = 6) in controls to 114 plus
or minus 49.6 in ligated ducts.  The transepithelial Na flux in the
same ducts was reduced from 10.1 plus or minus 0.79 n-mole cm-2
sec-1 to 1.6 plus or minus 0.84 while p.d. remained at -22 mV,
similar to those results previously reported.  There was no
significant correlation between the degree of diminution of Na
transport and the density of goblet cells but there was a positive
correlation (r = 0.90) between the number of goblet cells in the
control and contralateral ligated ducts.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79142</PAPERNUM>
<REFERENCES>
<CITE num="001" author="FRASER PA" publication="J PHYSIOL (LOND)" d1="285" d2="24P" d3="978"/>
<CITE num="002" author="LEV R" publication="AM J PATHOL" d1="46" d2="23" d3="965"/>
<CITE num="003" author="SCHULZ IJ" publication="J CLIN INVEST" d1="48" d2="1470" d3="969"/>
</REFERENCES>
<RECORDNUM>01122 </RECORDNUM>
<MEDLINENUM>79175557</MEDLINENUM>
<AUTHORS><AUTHOR>Hicks-J-M</AUTHOR></AUTHORS>
<TITLE>Sweat tests [letter].</TITLE>
<SOURCE>JAMA. 1979 May 25. 241(21). P 2264-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>I agree that sweat tests are frequently not performed reliably, but I
wonder why the clinical chemist has been singled out as being
responsible when most hospital laboratories are still directed by
pathologists and not by professional clinical chemists.  In addition
to our laboratory, I know of many other hospital clinical chemistry
laboratories in which the test is being performed properly.
Furthermore, the Pediatric Committee of the American Association for
Clinical Chemistry is working on a review article for the journal,
Clinical Chemistry, regarding the correct way the sweat test should
be run.  Clearly, clinical chemists do not "lack interest."</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="JAMA" d1="240" d2="2731" d3="978"/>
<CITE num="002" author="GIBSON LE" publication="PROC FOR QUANTITATIVE ION" d1="" d2="" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79143</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IEST JB             JA" publication="MA                           2" d1="42" d2="70 9" d3="9"/>
</CITATIONS>
<RECORDNUM>01123 </RECORDNUM>
<MEDLINENUM>80009690</MEDLINENUM>
<AUTHORS><AUTHOR>Priest-J-B</AUTHOR></AUTHORS>
<TITLE>The sweat test for cystic fibrosis [letter].</TITLE>
<SOURCE>JAMA. 1979 Nov 2. 242(18). P 1970.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>The major issue is not the "lack of interest of clinical chemists,"
but the actual performance of the test.  Neither the pathologist nor
the clinical chemist, in all likelihood, actually performs the test.
Rather, it is the medical technologist or technician who carries out
the actual procedure.  It is a major part of our roles as educators
and laboratory administrators to ensure that these people are
adequately trained for the task and that the test meets high enough
performance standards to provide a clinically relevant answer.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79144</PAPERNUM>
<REFERENCES>
<CITE num="000" author="HICKS J" publication="JAMA" d1="241" d2="2264" d3="979"/>
<CITE num="000" author="SHWACHMAN H" publication="JAMA" d1="240" d2="2731" d3="978"/>
<CITE num="001" author="ROSENSTEIN BJ" publication="JAMA" d1="240" d2="1987" d3="978"/>
</REFERENCES>
<RECORDNUM>01124 </RECORDNUM>
<MEDLINENUM>80098014</MEDLINENUM>
<AUTHORS><AUTHOR>Heinrich-H-C</AUTHOR><AUTHOR>Gabbe-E-E</AUTHOR><AUTHOR>Icagic-F</AUTHOR></AUTHORS>
<TITLE>Immunoreactive serum trypsin in diseases of the pancreas.</TITLE>
<SOURCE>Klin-Wochenschr. 1979 Nov 15. 57(22). P 1237-8.</SOURCE>
<MAJORSUBJ><TOPIC>PANCREATIC-DISEASES: en</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACUTE-DISEASE</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREATECTOMY</TOPIC><TOPIC>PANCREATITIS: en</TOPIC><TOPIC>RADIOIMMUNOASSAY</TOPIC></MINORSUBJ>
<ABSTRACT>Immunoreactive serum trypsin was measured with a double antibody
radioimmunoassay in normal subjects and patients with various
diseases of the pancreas. The normal range is 115-350 ng/ml with a
geometric mean of 212 ng/ml. No trypsin was found in serum after
total duodenopancreatectomy, in about 75% of patients with cystic
fibrosis and in a few patients with pancreas carcinoma or chronic
pancreatitis. Reduced serum trypsin levels between 10 and 100 ng/ml
were measured in the remaining 25% of cystic fibrosis and in one
third of the patients with chronic pancreatitis. Serum trypsin was
increased to 700-17,000 ng/ml in all patients with acute pancreatitis
or during the acute phase of chronic pancreatitis. Absent or reduced
serum trypsin is a reliable indicator of total or partial exocrine
pancreatic insufficiency whereas considerably increased serum trypsin
concentration do indicate acute pancreatitis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DANDONA P" publication="BR MED J" d1="2" d2="1125" d3="978"/>
<CITE num="002" author="ELIAS E" publication="LANCET" d1="2" d2="66" d3="977"/>
<CITE num="003" author="GEOKAS MC" publication="J LAB CLIN MED" d1="84" d2="574" d3="974"/>
<CITE num="004" author="GOBELET CH" publication="SCHWEIZ MED WOCHENSCHR" d1="108" d2="1902" d3="978"/>
<CITE num="006" author="TEMLER RS" publication="BIOCHIM BIOPHYS ACTA" d1="445" d2="720" d3="976"/>
<CITE num="007" author="TEMLER RS" publication="ENZYME" d1="22" d2="249" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79145</PAPERNUM>
<CITATIONS>
<CITE num="1" author="INRICH HC           KL" publication="IN WSCHR" d1="57" d2="95 9" d3="9"/>
<CITE num="2" author="FELBER JP" publication="RIC CLIN LAB" d1="10" d2="55" d3="980"/>
<CITE num="3" author="KOEHN HD" publication="CLIN CHEM" d1="27" d2="502" d3="981"/>
<CITE num="4" author="LANKISCH PG" publication="HEPATOGASTROENTEROLOGY" d1="28" d2="333" d3="981"/>
<CITE num="5" author="CARREL O" publication="HELV PAEDIATR ACTA" d1="36" d2="405" d3="981"/>
<CITE num="6" author="LANKISCH PG" publication="GUT" d1="23" d2="777" d3="982"/>
<CITE num="7" author="AMMANN RW" publication="KLIN WSCHR" d1="60" d2="243" d3="982"/>
<CITE num="8" author="MOLLERPETERSEN J" publication="CLIN CHIM ACTA" d1="124" d2="31" d3="982"/>
<CITE num="9" author="HEER M" publication="SCHWEIZ MED WOCHENSCHR" d1="113" d2="1950" d3="983"/>
<CITE num="10" author="KOOP H" publication="CLIN GASTROENTEROL" d1="13" d2="739" d3="984"/>
<CITE num="11" author="BORGSTROM A" publication="SCAND J GASTROENTEROL" d1="19" d2="220" d3="984"/>
<CITE num="12" author="VEZZADINI P" publication="AM J GASTROENTEROL" d1="79" d2="213" d3="984"/>
<CITE num="13" author="VEZZADINI P" publication="SURG GYNECOL OBSTET" d1="158" d2="319" d3="984"/>
<CITE num="14" author="DELFAVERO G" publication="RIC CLIN LAB" d1="15" d2="343" d3="985"/>
<CITE num="15" author="GERSMANN A" publication="MED WELT" d1="36" d2="23" d3="985"/>
<CITE num="16" author="DELFAVERO G" publication="KLIN WSCHR" d1="63" d2="603" d3="985"/>
<CITE num="17" author="NIEDERAU C" publication="GASTROENTEROLOGY" d1="88" d2="1973" d3="985"/>
<CITE num="18" author="NIEDERAU C" publication="GASTROENTEROLOGY" d1="89" d2="1451" d3="985"/>
</CITATIONS>
<RECORDNUM>01125 </RECORDNUM>
<MEDLINENUM>79155182</MEDLINENUM>
<AUTHORS><AUTHOR>Oppenheimer-E-H</AUTHOR><AUTHOR>Rosenstein-B-J</AUTHOR></AUTHORS>
<TITLE>Differential pathology of nasal polyps in cystic fibrosis and atopy.</TITLE>
<SOURCE>Lab-Invest. 1979 Apr. 40(4). P 445-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: co</TOPIC><TOPIC>NASAL-POLYPS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BASEMENT-MEMBRANE: pa</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>EXOCRINE-GLANDS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METAPLASIA</TOPIC><TOPIC>MUCOUS-MEMBRANE: pa</TOPIC><TOPIC>MUCUS</TOPIC><TOPIC>NASAL-POLYPS: co</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Nineteen nasal polyps from 13 patients were examined histologically.
Nine polyps from seven cystic fibrosis (CF) patients could be
positively identified by a triad of observations: delicate, barely
visible basement membrane of surface epithelium without submucosal
hyalinization, lack of extensive infiltration of eosinophils (Giemsa
stains), and a preponderance of acid mucin in glands and cysts of the
polyp and in its surface mucous blanket (Alcian Blue-periodic acid-
Schiff stains). Two polyps from two patients with CF and atopy showed
the characteristic findings of CF without modification. Eight polyps
from four atopic patients without CF were identified by the reverse
triad of changes: extensive thickening of the epithelial basement
membrane and its extension into the submucosa as an irregular hyaline
membrane, high stromal eosinophil count, and mainly neutral mucin in
mucous glands, cysts, and mucous blanket. Hyperplastic mucous glands,
mucous cysts of variable sizes, focal metaplasia of surface
epithelium, and acid mucin in goblet cells were considered
nonspecific lesions.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BLUMSTEIN GI" publication="ARCH OTOLARYNGOL" d1="83" d2="266" d3="966"/>
<CITE num="003" author="KULCZYCKI LL" publication="JAMA" d1="175" d2="358" d3="961"/>
<CITE num="004" author="LAMB D" publication="J PATHOL" d1="98" d2="213" d3="969"/>
<CITE num="005" author="LAMB D" publication="BR J DIS CHEST" d1="66" d2="239" d3="972"/>
<CITE num="006" author="NEELY JG" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="76" d2="313" d3="972"/>
<CITE num="007" author="RULON JT" publication="ARCH OTOLARYNGOL" d1="78" d2="192" d3="963"/>
<CITE num="008" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="389" d3="962"/>
<CITE num="009" author="TAYLOR BW" publication="ARCH DIS CHILD" d1="49" d2="133" d3="974"/>
<CITE num="010" author="VAN METRE TE JR" publication="J ALLERGY CLIN IMMUNOL" d1="31" d2="141" d3="960"/>
<CITE num="011" author="VAN METRE TE JR" publication="J ALLERGY CLIN IMMUNOL" d1="49" d2="131" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79146</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TSAKIS JG           HE" publication="AD NECK SURG" d1="2" d2="10 9" d3="0"/>
<CITE num="2" author="OPPENHEIMER EH" publication="HUM PATHOL" d1="12" d2="36" d3="981"/>
<CITE num="3" author="THAETE LG" publication="AM J ANAT" d1="162" d2="243" d3="981"/>
<CITE num="4" author="COLTEN HR" publication="N ENGL J MED" d1="304" d2="831" d3="981"/>
<CITE num="5" author="MILLS SE" publication="ARCH OTOLARYNGOL" d1="108" d2="530" d3="982"/>
<CITE num="6" author="STERN RC" publication="AM J DIS CHILD" d1="136" d2="1067" d3="982"/>
<CITE num="7" author="BUNNAG C" publication="ANN ALLERGY" d1="50" d2="126" d3="983"/>
<CITE num="8" author="KNOWLES MR" publication="SCIENCE" d1="221" d2="1067" d3="983"/>
<CITE num="9" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="10" author="STUTTS MJ" publication="PEDIATR RES" d1="20" d2="1316" d3="986"/>
<CITE num="11" author="DAVID TJ" publication="J ROY SOC MED" d1="79" d2="23" d3="986"/>
</CITATIONS>
<RECORDNUM>01126 </RECORDNUM>
<MEDLINENUM>80076794</MEDLINENUM>
<AUTHORS><AUTHOR>King-D-N</AUTHOR><AUTHOR>Heeley-A-F</AUTHOR><AUTHOR>Walsh-M-P</AUTHOR><AUTHOR>Kuzemko-J-A</AUTHOR></AUTHORS>
<TITLE>Sensitive trypsin assay for dried-blood specimens as a screening
procedure for early detection of cystic fibrosis.</TITLE>
<SOURCE>Lancet. 1979 Dec 8. 2(8154). P 1217-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BLOOD-SPECIMEN-COLLECTION</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>RADIOIMMUNOASSAY: mt</TOPIC><TOPIC>TRYPSIN: im</TOPIC><TOPIC>FEMALE</TOPIC></MINORSUBJ>
<ABSTRACT>An immunoreactive-trypsin assay uses small dried-blood spots
(diameter 1.25 mm) and is therefore suitable for incorporation in
established neonatal screening schemes. Blood specimens from neonates
with cystic fibrosis had trypsin levels greater than those in control
subjects, thus confirming earlier findings. Trypsin levels were below
normal in several older patients with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CROSSLEY JR" publication="LANCET" d1="1" d2="472" d3="979"/>
<CITE num="002" author="DANDONA P" publication="LANCET" d1="1" d2="1032" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79147</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MINICI R            RI" publication="C CLIN LAB" d1="10" d2="11 9" d3="0"/>
<CITE num="2" author="BONORA G" publication="SCAND J GASTROENTEROL" d1="15" d2="11" d3="980"/>
<CITE num="3" author="BURLINA A" publication="SCAND J GASTROENTEROL" d1="15" d2="35" d3="980"/>
<CITE num="4" author="TRAVERT G" publication="J GENET HUM" d1="28" d2="141" d3="980"/>
<CITE num="5" author="TRAVERT G" publication="NOUV PRESSE MED" d1="10" d2="2093" d3="981"/>
<CITE num="6" author="DURIE PR" publication="PEDIATR RES" d1="15" d2="1351" d3="981"/>
<CITE num="7" author="KIRBY LT" publication="CLIN CHEM" d1="27" d2="678" d3="981"/>
<CITE num="8" author="EVANS RT" publication="J CLIN PATHOL" d1="34" d2="911" d3="981"/>
<CITE num="9" author="BORGSTROM A" publication="ACTA PAEDIATR SCAND" d1="70" d2="619" d3="981"/>
<CITE num="10" author="CROSSLEY JR" publication="CLIN CHIM ACTA" d1="113" d2="111" d3="981"/>
<CITE num="11" author="TOBIN MJ" publication="IR J MED SCI" d1="150" d2="325" d3="981"/>
<CITE num="12" author="COX KL" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="345" d3="982"/>
<CITE num="13" author="DURIE PR" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="337" d3="982"/>
<CITE num="14" author="BURLINA A" publication="IRCS MED SCI BIOCHEM" d1="10" d2="951" d3="982"/>
<CITE num="15" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="16" author="ZUCCHELLI GC" publication="J NUCL MED ALLIED SCI" d1="26" d2="35" d3="982"/>
<CITE num="17" author="BROWN RC" publication="J CLIN PATHOL" d1="35" d2="547" d3="982"/>
<CITE num="18" author="HEELEY AF" publication="ARCH DIS CHILD" d1="57" d2="18" d3="982"/>
<CITE num="19" author="BORGSTROM A" publication="ACTA PAEDIATR SCAND" d1="71" d2="621" d3="982"/>
<CITE num="20" author="BORGSTROM A" publication="ACTA PAEDIATR SCAND" d1="71" d2="849" d3="982"/>
<CITE num="21" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="22" author="TRAVERT G" publication="ARCH FR PEDIATR" d1="40" d2="295" d3="983"/>
<CITE num="23" author="ANON" publication="PEDIATRICS" d1="72" d2="741" d3="983"/>
<CITE num="24" author="WILCKEN B" publication="J PEDIATR" d1="102" d2="383" d3="983"/>
<CITE num="25" author="MASOERO G" publication="AM J DIS CHILD" d1="137" d2="167" d3="983"/>
<CITE num="26" author="HALLINAN FM" publication="IR J MED SCI" d1="152" d2="409" d3="983"/>
<CITE num="27" author="HAMMOND KB" publication="LANCET" d1="1" d2="42" d3="984"/>
<CITE num="28" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="2" d2="249" d3="984"/>
<CITE num="29" author="KOOP H" publication="CLIN GASTROENTEROL" d1="13" d2="739" d3="984"/>
<CITE num="30" author="BLYTHE SA" publication="CLIN BIOCHEM" d1="17" d2="277" d3="984"/>
<CITE num="31" author="HJELM M" publication="CLIN BIOCHEM" d1="17" d2="284" d3="984"/>
<CITE num="32" author="CASSIO A" publication="ACTA PAEDIATR SCAND" d1="73" d2="554" d3="984"/>
<CITE num="33" author="REARDON MC" publication="J PEDIATR" d1="105" d2="271" d3="984"/>
<CITE num="34" author="NAYLOR EW" publication="SEM PERINATOL" d1="9" d2="232" d3="985"/>
<CITE num="35" author="PLUMBE RM" publication="ANN CLIN BIOCHEM" d1="22" d2="408" d3="985"/>
<CITE num="36" author="DURIE PR" publication="PEDIATR RES" d1="20" d2="209" d3="986"/>
<CITE num="37" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
<CITE num="38" author="BOURGUIGNON JP" publication="EUR J PEDIATR" d1="144" d2="547" d3="986"/>
<CITE num="39" author="BOWLING FG" publication="LANCET" d1="1" d2="826" d3="987"/>
</CITATIONS>
<RECORDNUM>01127 </RECORDNUM>
<MEDLINENUM>80076881</MEDLINENUM>
<AUTHORS><AUTHOR>Harris-A</AUTHOR><AUTHOR>Benson-P-F</AUTHOR><AUTHOR>Fensom-A-H</AUTHOR></AUTHORS>
<TITLE>Detection of cystic fibrosis with plasma hydrolases [letter].</TITLE>
<SOURCE>Lancet. 1979 Dec 22-29. 2(8156-8157). P 1371.</SOURCE>
<MAJORSUBJ><TOPIC>ACID-PHOSPHATASE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>MANNOSIDASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>HEAT</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>OILS: du</TOPIC><TOPIC>PARAFFIN: du</TOPIC></MINORSUBJ>
<EXTRACT>Dr Hosli and Mrs Hosli reported that differential thermolability of
plasma alpha-mannosidase and plasma acid phosphatase allowed
discrimination between normal people, cystic fibrosis carriers, and
patients.  We have repeated these experiments, paying special
attention to the technical details given in the Hoslis's paper.  In a
separate series of experiments we used larger volumes of plasma for
each assay, which was performed either with or without
non-fluorescent paraffin oil.  In both cases the blood samples were
processed exactly as outlined in Hosli and Vogt's paper.  There were
no significant differences in the heat stability of plasma
alpha-mannosidase and acid phosphatase between the three groups.</EXTRACT>
<REFERENCES>
<CITE num="000" author="PATRICK AD" publication="LANCET" d1="2" d2="1015" d3="979"/>
<CITE num="000" author="HOSLI P" publication="LANCET" d1="2" d2="543" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79148</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="3" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="4" author="KATZNELSON D" publication="ISR J MED SCI" d1="17" d2="687" d3="981"/>
<CITE num="5" author="HULTBERG B" publication="CLIN CHIM ACTA" d1="112" d2="167" d3="981"/>
<CITE num="6" author="SCANLIN TF" publication="CLIN CHIM ACTA" d1="114" d2="269" d3="981"/>
<CITE num="7" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="8" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="9" author="OGLESBEE LH" publication="CLIN CHIM ACTA" d1="143" d2="135" d3="984"/>
</CITATIONS>
<RECORDNUM>01128 </RECORDNUM>
<MEDLINENUM>80076806</MEDLINENUM>
<AUTHORS><AUTHOR>Applegarth-D-A</AUTHOR><AUTHOR>Davidson-A-G</AUTHOR><AUTHOR>Kirby-L-T</AUTHOR><AUTHOR>Bridges-M</AUTHOR><AUTHOR>Sorensen-P</AUTHOR><AUTHOR>Wong-L-T</AUTHOR><AUTHOR>Hardwick-D-F</AUTHOR></AUTHORS>
<TITLE>Dried blood spot screening for cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Dec 8. 2(8154). P 1236-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AGE-FACTORS</TOPIC><TOPIC>BLOOD-SPECIMEN-COLLECTION</TOPIC><TOPIC>ENZYME-TESTS: mt</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>We have measured immunoreactive trypsin IRT activity in dried blood
spot samples and have found abnormally high levels in infants with
cystic fibrosis (CF).  We agree with Crossley et al. that this test
deserves further investigation as a screen for CF in the newborn.
The low value for the 94 week infant is consistent with their finding
that, in children with low pancreatic enzyme output, the increased
IRT results are restricted to the first few months of life.  It
remains to be proved whether older CF patients with residual
pancreatic enzyme secretion do indeed continue to have increased IRT
levels.  If they do, the IRT test would also deserve further
investigation as a tool, to be used in conjunction with stool
pancreatic enzyme activity, in smaller centres who have had problems
with inaccurate sweat tests.</EXTRACT>
<REFERENCES>
<CITE num="001" author="CROSSLEY JR" publication="LANCET" d1="1" d2="472" d3="979"/>
<CITE num="002" author="STARKEY PM" publication="IN: BARRETT AJ" d1="" d2="663" d3="977"/>
<CITE num="003" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79149</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MINICI R            RI" publication="C CLIN LAB" d1="10" d2="11 9" d3="0"/>
<CITE num="2" author="BURLINA A" publication="SCAND J GASTROENTEROL" d1="15" d2="35" d3="980"/>
<CITE num="3" author="DURIE PR" publication="PEDIATR RES" d1="15" d2="1351" d3="981"/>
<CITE num="4" author="KIRBY LT" publication="CLIN CHEM" d1="27" d2="678" d3="981"/>
<CITE num="5" author="TOBIN MJ" publication="IR J MED SCI" d1="150" d2="325" d3="981"/>
<CITE num="6" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="7" author="ZUCCHELLI GC" publication="J NUCL MED ALLIED SCI" d1="26" d2="35" d3="982"/>
<CITE num="8" author="HEELEY AF" publication="ARCH DIS CHILD" d1="57" d2="18" d3="982"/>
<CITE num="9" author="MASOERO G" publication="AM J DIS CHILD" d1="137" d2="167" d3="983"/>
<CITE num="10" author="HALLINAN FM" publication="IR J MED SCI" d1="152" d2="409" d3="983"/>
<CITE num="11" author="NAYLOR EW" publication="SEM PERINATOL" d1="9" d2="232" d3="985"/>
</CITATIONS>
<RECORDNUM>01129 </RECORDNUM>
<MEDLINENUM>79243319</MEDLINENUM>
<AUTHORS><AUTHOR>Lieberman-J</AUTHOR></AUTHORS>
<TITLE>Age dependence of serum angiotensin-converting enzyme activity
[letter].</TITLE>
<SOURCE>Lancet. 1979 Jul 28. 2(8135). P 196.</SOURCE>
<MAJORSUBJ><TOPIC>KININASE-II: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GRANULOMATOUS-DISEASE-CHRONIC: en</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>We examined the age dependence of serum angiotensin-converting enzyme
(SACE) activity in healthy controls.  While we found no age
dependence in controls older than 20 years, those under 20 had much
increased SACE values.  We feel that it is inappropriate to evaluate
SACE activity in patients under 20 years old with diagnostic criteria
determined in adults. - Dr Romer and colleagues reported high
activities of SACE in 3 patients out of 10 with chronic granulomatous
disease (CGD) and concluded that "CGD is associated with increased
levels of SACE".  Unfortunately, Romer et al. did not study an
adequate paedeatric age control group, and their mean values are
compared primarily with that in 5 children with cystic fibrosis.  Our
most recent studies confirm our earlier observation that children
under the age 19 years definitely have higher mean SACE values than
do adults.  Cystic-fibrosis patients should not be used for
comparison since they tend to have lower SACE levels than comparable
aged controls.  In my opinion patients with CGD, according to the
data published by Romer et al., show no increase in SACE levels for
their age.</EXTRACT>
<REFERENCES>
<CITE num="000" author="ROMER FK" publication="LANCET" d1="1" d2="1237" d3="979"/>
<CITE num="001" author="LIEBERMAN J" publication="AM J MED" d1="59" d2="365" d3="975"/>
<CITE num="002" author="ROHRBACH MS" publication="AM REV RESPIR DIS" d1="119" d2="761" d3="979"/>
<CITE num="003" author="LIEBERMAN J" publication="AM J MED" d1="59" d2="365" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79150</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NTONASTASO CL       IT" publication="AL J GASTROENTEROL" d1="16" d2="9 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01130 </RECORDNUM>
<MEDLINENUM>79198307</MEDLINENUM>
<AUTHORS><AUTHOR>Brock-D-J</AUTHOR><AUTHOR>Hayward-C</AUTHOR></AUTHORS>
<TITLE>Methylumbelliferyl-guanidinobenzoate reactive proteases and prenatal
diagnosis of cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Jun 9. 1(8128). P 1245-6.</SOURCE>
<MAJORSUBJ><TOPIC>AMNIOTIC-FLUID: en</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>PEPTIDE-HYDROLASES: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYMECROMONE</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<EXTRACT>For several reasons the supernatant fraction of amniotic fluid is not
often used in the prenatal detection of inborn errors of metabolism.
In early pregnancy the bulk of the protein in amniotic fluid is
derived from the maternal circulation, and this can obscure the more
critical contribution from the fetus needed for prenatal diagnosis.
10 - 30% of amniotic fluids are significantly contaminated with
maternal blood, and if the enzyme in question is present in this
blood (as 4-methylumbelliferyl guanidinobenzoate [MUGB] protease is),
this can further distort diagnostic conclusions.  For this reason we
have examined the variation of MUGB protease in a heterogenous
collection of amniotic fluids.  No significant differences in titre
between individual weeks in the second trimester were observed.  A
further 104 second-trimester amniotic fluids from pregnancies with
abnormal outcome were also investigated.  The means of the four
groups were not significantly different from that of the normals and
the ranges were very similar.  We have not yet had the opportunity to
examine an amniotic fluid from a known case of cystic fibrosis.
Diagnosis of cystic fibrosis could probably be further refined by
coupling amniotic-fluid protease titration and isoelectric focusing
on polyacrylamide gel.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="874" d3="978"/>
<CITE num="002" author="RAO GJS" publication="ENZYME" d1="23" d2="314" d3="978"/>
<CITE num="003" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="004" author="SUTCLIFFE RG" publication="J OBSTET GYNAECOL BR COMMONW" d1="80" d2="721" d3="973"/>
<CITE num="005" author="DANN LG" publication="LANCET" d1="2" d2="405" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79151</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NN LG               LA" publication="NCET" d1="2" d2="07 9" d3="9"/>
<CITE num="2" author="BROCK DJH" publication="LANCET" d1="1" d2="619" d3="982"/>
<CITE num="3" author="CRISTOL P" publication="SEM HOP PARIS" d1="58" d2="449" d3="982"/>
<CITE num="4" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="5" author="BROCK DJH" publication="PRENAT DIAGN" d1="3" d2="1" d3="983"/>
<CITE num="6" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="7" author="SHAW LMA" publication="J OBSTET GYNAECOL BR COMMONW" d1="6" d2="1" d3="985"/>
</CITATIONS>
<RECORDNUM>01131 </RECORDNUM>
<MEDLINENUM>79198291</MEDLINENUM>
<AUTHORS><AUTHOR>Phillips-B</AUTHOR><AUTHOR>Davis-J-A</AUTHOR><AUTHOR>Goode-M</AUTHOR></AUTHORS>
<TITLE>Screening for cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Jun 9. 1(8128). P 1238-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>PEPTIDE-HYDROLASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>TRYPSIN-INHIBITORS: bl</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MINORSUBJ>
<EXTRACT>Our cystic-fibrosis  children usually either have severe lung disease
with mild steatorrhea or severe maldigestion with lesser pulmonary
problems.  We therefore measured serum-proteases in cystic-fibrosis
patients and controls to see if there was any support for the
following hypothesis: since lack of antitrypsin is associated with
lung damage, plasma-trypsin in excess of antitrypsin might be
responsible for the lung damage in cystic fibrosis.  General protease
and trypsin levels were measured spectrophotometrically using a
modification of the method of Erlanger, Kojowsky and Cohen.  Our
result showed no significant difference between protease and trypsin
levels in cystic-fibrosis patients and controls.  The difference
between our results and those of Crossley et al. may be explained by
the differing measuring technique used.  Our trypsin levels were
measured spectrophotometrically and theirs by radioimmunoassay.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79152</PAPERNUM>
<REFERENCES>
<CITE num="000" author="CROSSLEY JR" publication="LANCET" d1="1" d2="472" d3="979"/>
</REFERENCES>
<RECORDNUM>01132 </RECORDNUM>
<MEDLINENUM>79198289</MEDLINENUM>
<AUTHORS><AUTHOR>Romer-F-K</AUTHOR><AUTHOR>Faber-V</AUTHOR><AUTHOR>Koch-C</AUTHOR><AUTHOR>Pedersen-F-K</AUTHOR><AUTHOR>Friis-B</AUTHOR><AUTHOR>Johansen-K-S</AUTHOR><AUTHOR>Taudorff-E</AUTHOR></AUTHORS>
<TITLE>Serum-angiotensin-converting-enzyme in chronic granulomatous disease
[letter].</TITLE>
<SOURCE>Lancet. 1979 Jun 9. 1(8128). P 1237.</SOURCE>
<MAJORSUBJ><TOPIC>GRANULOMATOUS-DISEASE-CHRONIC: en</TOPIC><TOPIC>KININASE-II: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GRANULOMATOUS-DISEASE-CHRONIC: fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>KININASE-II: ge</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC></MINORSUBJ>
<EXTRACT>We have studied serum-angiotensin-converting-enzyme (SACE) in
sarcoidosis and other granulomatous disorders.  We have measured SACE
in 10 randomly chosen, consecutive patients with chronic
granulomatous disease (CGD) and in some of their family members and
in 5 children with cystic fibrosis and severe chronic pulmonary
involvement.  SACE levels in the patient with CGD differed
significantly from those of normal controls and those of family
members and patients with cystic fibrosis.  Our preliminary studies
show that CGD is associated with increased levels of SACE.</EXTRACT>
<REFERENCES>
<CITE num="001" author="CUSHMAN DW" publication="BIOCHEM PHARMACOL" d1="20" d2="1637" d3="971"/>
<CITE num="002" author="LIEBERMAN J" publication="AM J MED" d1="59" d2="365" d3="975"/>
<CITE num="004" author="STUDDY P" publication="LANCET" d1="2" d2="1331" d3="978"/>
<CITE num="005" author="LIEBERMAN J" publication="CLIN RES" d1="25" d2="145A" d3="977"/>
<CITE num="006" author="GEE JBL" publication="LUNG" d1="155" d2="243" d3="978"/>
<CITE num="007" author="SILVERSTEIN E" publication="AM J CLIN PATHOL" d1="69" d2="467" d3="978"/>
<CITE num="008" author="PERKS WH" publication="THORAX" d1="33" d2="101" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79153</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MER FK              LA" publication="NCET" d1="2" d2="60 9" d3="9"/>
<CITE num="2" author="ROMER FK" publication="ACTA MED SCAND" d1="" d2="1" d3="984"/>
<CITE num="3" author="FARGE D" publication="AM J NEPHROL" d1="6" d2="21" d3="986"/>
</CITATIONS>
<RECORDNUM>01133 </RECORDNUM>
<MEDLINENUM>79133794</MEDLINENUM>
<AUTHORS><AUTHOR>Crossley-J-R</AUTHOR><AUTHOR>Elliott-R-B</AUTHOR><AUTHOR>Smith-P-A</AUTHOR></AUTHORS>
<TITLE>Dried-blood spot screening for cystic fibrosis in the newborn.</TITLE>
<SOURCE>Lancet. 1979 Mar 3. 1(8114). P 472-4.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-STAINS</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANTIGENS</TOPIC><TOPIC>BLOOD-SPECIMEN-COLLECTION</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>RADIOIMMUNOASSAY</TOPIC><TOPIC>TRYPSIN: im</TOPIC></MINORSUBJ>
<ABSTRACT>Serum-immunoreactive-trypsin (I.R.T.) was measured in children with
cystic fibrosis (C.F.) and a variety of controls. In the first few
months of life all C.F. children had a raised serum-I.R.T. A dried
blood-spot assay for I.R.T. was established and has potential as a
screening test for C.F. in the newborn.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CROSSLEY JR" publication="LANCET" d1="2" d2="1093" d3="977"/>
<CITE num="002" author="FRIER BM" publication="GUT" d1="17" d2="685" d3="976"/>
<CITE num="003" author="ELIAS E" publication="LANCET" d1="2" d2="66" d3="977"/>
<CITE num="004" author="DANDONA P" publication="BR MED J" d1="2" d2="1125" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79154</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NG DN               LA" publication="NCET" d1="2" d2="17 9" d3="9"/>
<CITE num="2" author="STAGG BH" publication="ANN CLIN BIOCHEM" d1="16" d2="147" d3="979"/>
<CITE num="3" author="BURLINA A" publication="SCAND J GASTROENTEROL" d1="15" d2="35" d3="980"/>
<CITE num="4" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="5" author="ROMEO G" publication="J LAB CLIN MED" d1="95" d2="116" d3="980"/>
<CITE num="6" author="MASTELLA G" publication="RIV ITAL PEDIATR" d1="7" d2="581" d3="981"/>
<CITE num="7" author="BURLINA A" publication="IRCS MED SCI BIOCHEM" d1="10" d2="951" d3="982"/>
<CITE num="8" author="MASOERO G" publication="DIG DIS SCI" d1="27" d2="1089" d3="982"/>
<CITE num="9" author="SANDER J" publication="MONATSSCHR KINDERHEILKD" d1="130" d2="843" d3="982"/>
<CITE num="10" author="PITT D" publication="MED J AUST" d1="1" d2="333" d3="983"/>
<CITE num="11" author="HEELEY AF" publication="CLIN BIOCHEM" d1="16" d2="369" d3="983"/>
<CITE num="12" author="REY F" publication="CLIN BIOCHEM" d1="16" d2="23" d3="983"/>
<CITE num="13" author="BUCHANAN KD" publication="SCAND J GASTROENTEROL" d1="18" d2="155" d3="983"/>
<CITE num="14" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="15" author="KIRBY LT" publication="CLIN CHEM" d1="29" d2="1559" d3="983"/>
<CITE num="16" author="LUTHI M" publication="HELV PAEDIATR ACTA" d1="38" d2="149" d3="983"/>
<CITE num="17" author="TRAVERT G" publication="ARCH FR PEDIATR" d1="40" d2="295" d3="983"/>
<CITE num="18" author="WILCKEN B" publication="ARCH DIS CHILD" d1="58" d2="863" d3="983"/>
<CITE num="19" author="CARRERE J" publication="J IMMUNOL METH" d1="60" d2="235" d3="983"/>
<CITE num="20" author="ANON" publication="PEDIATRICS" d1="72" d2="741" d3="983"/>
<CITE num="21" author="LYON ICT" publication="NZ MED J" d1="96" d2="673" d3="983"/>
<CITE num="22" author="WILCKEN B" publication="J PEDIATR" d1="102" d2="383" d3="983"/>
<CITE num="23" author="MASOERO G" publication="AM J DIS CHILD" d1="137" d2="167" d3="983"/>
<CITE num="24" author="HALLINAN FM" publication="IR J MED SCI" d1="152" d2="409" d3="983"/>
<CITE num="25" author="JUNGLEE D" publication="BR MED J" d1="286" d2="1693" d3="983"/>
<CITE num="26" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="2" d2="249" d3="984"/>
<CITE num="27" author="RYLEY HC" publication="PRENAT DIAGN" d1="4" d2="303" d3="984"/>
<CITE num="28" author="ANDRIULLI A" publication="J CLIN GASTROENTEROL" d1="6" d2="239" d3="984"/>
<CITE num="29" author="KOOP H" publication="CLIN GASTROENTEROL" d1="13" d2="739" d3="984"/>
<CITE num="30" author="FIGARELLA C" publication="RIC CLIN LAB" d1="14" d2="349" d3="984"/>
<CITE num="31" author="BLYTHE SA" publication="CLIN BIOCHEM" d1="17" d2="277" d3="984"/>
<CITE num="32" author="HJELM M" publication="CLIN BIOCHEM" d1="17" d2="284" d3="984"/>
<CITE num="33" author="BORGSTROM A" publication="PEDIATR RES" d1="18" d2="957" d3="984"/>
<CITE num="34" author="PLESS IB" publication="PEDIATR CLIN NORTH AM" d1="31" d2="259" d3="984"/>
<CITE num="35" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="36" author="BROCK DJH" publication="BR J OBSTET GYNAECOL" d1="91" d2="449" d3="984"/>
<CITE num="37" author="SCHONI MH" publication="J PEDIATR" d1="104" d2="691" d3="984"/>
<CITE num="38" author="REARDON MC" publication="J PEDIATR" d1="105" d2="271" d3="984"/>
<CITE num="39" author="SANDER J" publication="KLIN PAEDIATR" d1="196" d2="224" d3="984"/>
<CITE num="40" author="SHEPS SB" publication="JAMA" d1="252" d2="2418" d3="984"/>
<CITE num="41" author="NAYLOR EW" publication="SEM PERINATOL" d1="9" d2="232" d3="985"/>
<CITE num="42" author="ROSALKI SB" publication="CLIN CHEM" d1="31" d2="779" d3="985"/>
<CITE num="43" author="SZIBOR R" publication="Z KLIN MED" d1="40" d2="313" d3="985"/>
<CITE num="44" author="REDDY S" publication="AUST J EXP BIOL MED SCI" d1="63" d2="667" d3="985"/>
<CITE num="45" author="DURIE PR" publication="J PEDIATR" d1="106" d2="233" d3="985"/>
<CITE num="46" author="CLEGHORN G" publication="J PEDIATR" d1="107" d2="377" d3="985"/>
<CITE num="47" author="STOLLINGER O" publication="WIEN MED WOCHENSCHR" d1="135" d2="307" d3="985"/>
<CITE num="48" author="MELLIS CM" publication="MED J AUST" d1="143" d2="227" d3="985"/>
<CITE num="49" author="BOLLBACH R" publication="EUR J PEDIATR" d1="144" d2="167" d3="985"/>
<CITE num="50" author="LAROCHE D" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="404" d3="986"/>
<CITE num="51" author="MOORE DJ" publication="CLIN BIOCHEM" d1="19" d2="303" d3="986"/>
<CITE num="52" author="DURIE PR" publication="PEDIATR RES" d1="20" d2="209" d3="986"/>
<CITE num="53" author="CARRERE J" publication="BIOL NEONATE" d1="49" d2="113" d3="986"/>
<CITE num="54" author="RAFFLES AKM" publication="ACTA PAEDIATR SCAND" d1="75" d2="502" d3="986"/>
<CITE num="55" author="DODGE JA" publication="J ROY SOC MED" d1="79" d2="27" d3="986"/>
<CITE num="56" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
<CITE num="57" author="GARCIAPUGES AM" publication="GASTROENTEROLOGY" d1="91" d2="17" d3="986"/>
<CITE num="58" author="BOURGUIGNON JP" publication="EUR J PEDIATR" d1="144" d2="547" d3="986"/>
<CITE num="59" author="ROBERTS DD" publication="ARCH BIOCHEM BIOPHYS" d1="245" d2="292" d3="986"/>
<CITE num="60" author="CARRERE J" publication="BIOCHIM BIOPHYS ACTA" d1="883" d2="46" d3="986"/>
<CITE num="61" author="BLANDIN C" publication="J BIOPHYS BIOMECAN" d1="11" d2="5" d3="987"/>
<CITE num="62" author="SARLES J" publication="ARCH FR PEDIATR" d1="44" d2="311" d3="987"/>
</CITATIONS>
<RECORDNUM>01134 </RECORDNUM>
<MEDLINENUM>79155633</MEDLINENUM>
<TITLE>Allergy and bronchial hyperreactivity in cystic fibrosis [editorial].</TITLE>
<SOURCE>Lancet. 1979 Mar 31. 1(8118). P 708.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: et</TOPIC><TOPIC>BRONCHI: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALLERGENS: im</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>A little-known feature of cystic fibrosis is the frequent occurrence
of positive skin-prick tests to environmental allergies.  In the
normal population only about half those with positive prick tests
actually have clinical allergic disease; so, are the positive
skin-tests of cystic fibrosis clinically important?  In particular,
do they mean a high prevalence of asthma, overt or hidden, amongst
these patients?  A general clinical impression is that asthma is no
more frequent amongst cystic fibrosis than in the normal population.
The often positive skin tests, although of considerable immunological
interest, do not necessarily imply additional clinical disease.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="002" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="003" author="GODFREY RC" publication="CLIN ALLERGY" d1="6" d2="79" d3="976"/>
<CITE num="004" author="COUNAHAN R" publication="ARCH DIS CHILD" d1="50" d2="477" d3="975"/>
<CITE num="005" author="MITCHELL I" publication="J PEDIATR" d1="93" d2="744" d3="978"/>
<CITE num="006" author="CHAN H" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="323" d3="975"/>
<CITE num="007" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="008" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="009" author="EMPEY DW" publication="AM REV RESPIR DIS" d1="113" d2="131" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79155</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NKAUER A            AM" publication="J PUBLIC HEALTH" d1="69" d2="62 9" d3="9"/>
<CITE num="2" author="ORMEROD LP" publication="THORAX" d1="35" d2="768" d3="980"/>
<CITE num="3" author="VANASPEREN P" publication="AM J DIS CHILD" d1="135" d2="815" d3="981"/>
<CITE num="4" author="CONNOLLY J" publication="BR J HOSP MED" d1="33" d2="24" d3="985"/>
</CITATIONS>
<RECORDNUM>01135 </RECORDNUM>
<MEDLINENUM>79177182</MEDLINENUM>
<AUTHORS><AUTHOR>Dandona-P</AUTHOR><AUTHOR>Hodson-M</AUTHOR><AUTHOR>Bell-J</AUTHOR><AUTHOR>Ramdial-L</AUTHOR><AUTHOR>Batten-J-C</AUTHOR></AUTHORS>
<TITLE>Serum-immunoreactive-trypsin concentrations in cystic fibrosis
[letter].</TITLE>
<SOURCE>Lancet. 1979 May 12. 1(8124). P 1032.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>TRYPSIN: im</TOPIC></MINORSUBJ>
<EXTRACT>We measured immunoreactive trypsin (IRT) concentrations in 32
patients with established cystic fibrosis and in 16 parents
(heterozygotes) of patients with CF.  29 patients (91%) and 6 parents
(38%) had abnormal trypsin concentrations.  We found that in only 3
out of the 29 patients with abnormal IRT was the concentration
supranormal.  Our data suggest that low IRT concentrations are an
excellent index of diminished pancreatic reserve in CF and that
serum-IRT concentration would be a useful diagnostic test.  The fact
that CF patients at birth invariably have very high IRT
concentrations which fall with age and the progress of the disease,
allied with the fact that heterozygotes have high concentrations,
supports the previous suggestion that an uncontrolled hypersecretion
of zymogen granules is the basic cellular defect in CF.</EXTRACT>
<REFERENCES>
<CITE num="000" author="CROSSLEY JR" publication="LANCET" d1="1" d2="472" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79156</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NG DN               LA" publication="NCET" d1="2" d2="17 9" d3="9"/>
<CITE num="2" author="DOMINICI R" publication="RIC CLIN LAB" d1="10" d2="511" d3="980"/>
<CITE num="3" author="FELBER JP" publication="RIC CLIN LAB" d1="10" d2="55" d3="980"/>
<CITE num="4" author="BURLINA A" publication="SCAND J GASTROENTEROL" d1="15" d2="35" d3="980"/>
<CITE num="5" author="VEZZADINI P" publication="SCAND J GASTROENTEROL" d1="15" d2="29" d3="980"/>
<CITE num="6" author="FOO Y" publication="J CLIN PATHOL" d1="33" d2="1102" d3="980"/>
<CITE num="7" author="DUFFY MJ" publication="CLIN CHIM ACTA" d1="103" d2="233" d3="980"/>
<CITE num="8" author="ODONNELL MD" publication="CLIN CHIM ACTA" d1="104" d2="265" d3="980"/>
<CITE num="9" author="DANDONA P" publication="LANCET" d1="1" d2="380" d3="981"/>
<CITE num="10" author="DURIE PR" publication="PEDIATR RES" d1="15" d2="1351" d3="981"/>
<CITE num="11" author="DURIE PR" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="337" d3="982"/>
<CITE num="12" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="13" author="MASOERO G" publication="AM J DIS CHILD" d1="137" d2="167" d3="983"/>
<CITE num="14" author="ANDRIULLI A" publication="J CLIN GASTROENTEROL" d1="6" d2="239" d3="984"/>
<CITE num="15" author="KOOP H" publication="CLIN GASTROENTEROL" d1="13" d2="739" d3="984"/>
<CITE num="16" author="HJELM M" publication="CLIN BIOCHEM" d1="17" d2="284" d3="984"/>
<CITE num="17" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="18" author="DURIE PR" publication="PEDIATR RES" d1="20" d2="209" d3="986"/>
</CITATIONS>
<RECORDNUM>01136 </RECORDNUM>
<MEDLINENUM>79133965</MEDLINENUM>
<AUTHORS><AUTHOR>Walsh-M-M</AUTHOR><AUTHOR>Nadler-H-L</AUTHOR></AUTHORS>
<TITLE>Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic
fluid: possible marker for cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Mar 17. 1(8116). P 622.</SOURCE>
<MAJORSUBJ><TOPIC>AMNIOCENTESIS</TOPIC><TOPIC>AMNIOTIC-FLUID: en</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HYMECROMONE: du</TOPIC><TOPIC>PEPTIDE-HYDROLASES: an</TOPIC><TOPIC>UMBELLIFERONES: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PREGNANCY-TRIMESTER-SECOND</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<EXTRACT>Previous studies in our laboratory have demonstrated significant
differences in the extent of protease reactivity with MUGB
(4-methylumbelliferyl guanidinobenzoate, a sensitive active site
titrant of many serine proteases) when plasma and cultivated skin
fibroblasts from patients with cystic fibrosis (CF), obligate
heterozygotes, and controls were compared.  Because of these
observations, and the potential value of amniotic fluid for the
prenatal detection of cystic fibrosis, these studies were extended to
human amniotic fluid obtained by amniocentesis done for the
intrauterine detection of genetic and other fetal abnormalities.  An
amniotic-fluid sample obtained from a woman who was subsequently
delivered of a baby with CF showed a much reduced level of MUGB
reactivity similar to the relative deficiency observed in plasma and
cultivated skin fibroblasts from patients with CF.  These
observations suggest that amniotic-fluid protease activity may be a
useful marker for the prenatal detection of CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="002" author="WALSH-PLATT M" publication="AM J HUM GENET" d1="29" d2="111A" d3="977"/>
<CITE num="003" author="RAO GJS" publication="ENZYME" d1="23" d2="314" d3="978"/>
<CITE num="004" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="129" d3="978"/>
<CITE num="005" author="WALSH-PLATT M" publication="PEDIATR RES" d1="12" d2="874" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79157</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NN LG               LA" publication="NCET" d1="2" d2="07 9" d3="9"/>
<CITE num="2" author="MAHONEY MJ" publication="CLIN PERINATOL" d1="6" d2="255" d3="979"/>
<CITE num="3" author="WALSH MMJ" publication="PEDIATR RES" d1="14" d2="353" d3="980"/>
<CITE num="4" author="FREZAL J" publication="ARCH FR PEDIATR" d1="38" d2="217" d3="981"/>
<CITE num="5" author="BRANCHINI BR" publication="PEDIATR RES" d1="17" d2="850" d3="983"/>
<CITE num="6" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="7" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
</CITATIONS>
<RECORDNUM>01137 </RECORDNUM>
<MEDLINENUM>80053578</MEDLINENUM>
<AUTHORS><AUTHOR>Patrick-A-D</AUTHOR><AUTHOR>Ellis-R-B</AUTHOR></AUTHORS>
<TITLE>Plasma hydrolases in cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Nov 10. 2(8150). P 1015-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HYDROLASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROLASES: ge</TOPIC></MINORSUBJ>
<EXTRACT>Dr Hosli and Esther Vogt reported that the alpha-mannosidase and acid
phosphatase activities of cystic fibrosis plasma assayed at pH 5.4
are abnormally thermolabile at 41 degrees and 36.5 degrees C,
respectively, and that the levels of residual activity after heat
inactivation clearly distinguish between CF patients, CF carriers,
and normal subjects.  We have repeated these experiments under
identical conditions and found no differences between the three
groups.</EXTRACT>
<REFERENCES>
<CITE num="000" author="HOSLI P" publication="LANCET" d1="2" d2="543" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79158</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="SACK J" publication="LANCET" d1="2" d2="268" d3="980"/>
<CITE num="3" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="4" author="KATZNELSON D" publication="ISR J MED SCI" d1="17" d2="687" d3="981"/>
<CITE num="5" author="HULTBERG B" publication="CLIN CHIM ACTA" d1="112" d2="167" d3="981"/>
<CITE num="6" author="SCANLIN TF" publication="CLIN CHIM ACTA" d1="114" d2="269" d3="981"/>
<CITE num="7" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="8" author="OGLESBEE LH" publication="CLIN CHIM ACTA" d1="143" d2="135" d3="984"/>
<CITE num="9" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
</CITATIONS>
<RECORDNUM>01138 </RECORDNUM>
<MEDLINENUM>80031544</MEDLINENUM>
<TITLE>Mechanical chest physiotherapy [editorial].</TITLE>
<SOURCE>Lancet. 1979 Oct 6. 2(8145). P 729.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>PERCUSSION: is</TOPIC><TOPIC>PHYSICAL-THERAPY: mt</TOPIC><TOPIC>SPUTUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DRAINAGE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Despite some critical debate lately about the usefulness of
physiotherapy in certain chest conditions, the fact remains that many
patients voluntarily undertake regular postural bronchial drainage to
help their sputum.  A substantial number also find rapid chest
percussion over affected lung segments useful in loosening the
sputum.  Chest percussion by a mechanical device controlled by the
patient himself seems worthy to trial.  Maxwell and Redmond have
compared a commercial device with manual percussion during postural
bronchial drainage.  The two techniques resulted in expectoration of
similar quantities of sputum, although all but one patient felt
subjectively that the machine delivered better-quality percussion.
Before parents and others are advised to buy percussing machines, we
need a formal study of postural drainage with and without chest
percussion.</EXTRACT>
<REFERENCES>
<CITE num="001" author="NEWTON DAG" publication="LANCET" d1="2" d2="228" d3="978"/>
<CITE num="002" author="GRAHAM WGB" publication="N ENGL J MED" d1="299" d2="624" d3="978"/>
<CITE num="003" author="FLOWER KA" publication="BR MED J" d1="2" d2="630" d3="979"/>
<CITE num="004" author="MAXWELL M" publication="ARCH DIS CHILD" d1="54" d2="542" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79159</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHIN GA             AM" publication="J MED GENET" d1="9" d2="41 9" d3="1"/>
<CITE num="2" author="TURKEL SB" publication="CLIN PERINATOL" d1="9" d2="613" d3="982"/>
<CITE num="3" author="CARSWELL F" publication="EUR J RESPIR DIS" d1="65" d2="53" d3="984"/>
</CITATIONS>
<RECORDNUM>01139 </RECORDNUM>
<MEDLINENUM>80031735</MEDLINENUM>
<AUTHORS><AUTHOR>Hirani-S</AUTHOR><AUTHOR>Winchester-B-G</AUTHOR></AUTHORS>
<TITLE>Detection of cystic fibrosis homozygotes and heterozygotes with
plasma [letter].</TITLE>
<SOURCE>Lancet. 1979 Oct 27. 2(8148). P 906-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>GENETIC-TECHNICS</TOPIC><TOPIC>MANNOSIDASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC></MINORSUBJ>
<EXTRACT>Dr Hosli and Esther Vogt base their diagnosis of heterozygotes and
homozygotes for cystic fibrosis on the thermal stability in plasma or
extracellular fluids of alpha-mannosidase and/or phosphatase activity
assayed at pH 5.4.  The activity of alpha-mannosidase in plasma and
this pH is a composite one: both acidic alpha-mannosidase, which has
a pH optimum of 4.25 and intermediate alpha-mannosidase, which has a
pH optimum of 5.6 - 6.0, will contribute to the activity measured at
pH 5.4.  These two forms of alpha-mannosidase are structurally and
genetically distinct and have different kinetics and
thermostabilities.  Therefore the total alpha-mannosidase activity at
pH 5.4 and the physicochemical properties of this activity will
depend upon the relative proportions of the two types of
alpha-mannosidase in the sample.  The proportions of the two forms
vary widely in normal plasma, especially in plasma from children.
Although the data of Hosli and Vogt suggest that the total
alpha-mannosidase at pH 5.4 does not differ significantly between
controls, CF heterozygotes and CF homozygotes, they do not show
whether the proportions of acidic and intermediate alpha-mannosidase
have changed.  An increase in the proportion of the thermolabile
intermediate alpha-mannosidase in CF would be manifested as a
decreased thermostability of alpha-mannosidase at pH 5.4.
Alternatively a mutation in the normally stable acidic
alpha-mannosidase leading to a less stable form would also be
reflected as a decreased stability in the activity at pH 5.4,
especially if the proportion of acidic alpha-mannosidase was
increased in CF.  These situations should also be considered as
possible explanations of the observations, in addition to the one
favoured by Hosli and Vogt.</EXTRACT>
<REFERENCES>
<CITE num="000" author="HOSLI P" publication="LANCET" d1="2" d2="543" d3="979"/>
<CITE num="001" author="HIRANI S" publication="CLIN CHIM ACTA" d1="81" d2="135" d3="977"/>
<CITE num="002" author="HIRANI S" publication="BIOCHEM J" d1="179" d2="583" d3="979"/>
<CITE num="003" author="HOSLI P" publication="FEBS LETTERS" d1="104" d2="271" d3="979"/>
<CITE num="004" author="HULTBERG B" publication="BIOCHIM BIOPHYS ACTA" d1="481" d2="573" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79160</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TTERWORTH J         CL" publication="IN CHIM ACTA                 1" d1="08" d2="47 9" d3="0"/>
<CITE num="2" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="3" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
</CITATIONS>
<RECORDNUM>01140 </RECORDNUM>
<MEDLINENUM>80031736</MEDLINENUM>
<AUTHORS><AUTHOR>Dann-L-G</AUTHOR><AUTHOR>Blau-K</AUTHOR></AUTHORS>
<TITLE>Arginine esterase in amniotic fluid: possible marker for cystic
fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1979 Oct 27. 2(8148). P 907.</SOURCE>
<MAJORSUBJ><TOPIC>AMNIOTIC-FLUID: en</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ESTERASES: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ARGININE</TOPIC><TOPIC>BENZOATES: du</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>COUMARINS: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: en, fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENETIC-MARKER</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<EXTRACT>Following Rao and Nadlers' report of decrease arginine activity in
the blood of patients with cystic fibrosis we have been trying to
apply their findings to the prenatal diagnosis of cystic fibrosis.
We were therefore most interested in the reports on the use of
4-methylumbelliferyl-rho-guanidinobenzoate (MUGB) for assaying
arginine esterase activity in amniotic fluid.  Our results with MUGB
are similar to those of Brock and Haywood but are substantially
higher than those of Walsh and Nedler.  A sample of amniotic fluid
that had been incubated with MUGB and then assayed with
pro-phe-arg-4-methylcoumarinyl-7-amide (PPA-MCA) showed less than 20%
of the activity of a similarly treated control sample that had not
been incubated with MUGB.  The activity of arginine esterase towards
PPA-MCA both in amniotic fluid and in cultures amniotic fluid cells
is much greater than towards CBZ-Arg-AMC.  These levels of activity
are high enough to warrant further investigation for use in an
antenatal diagnosis.</EXTRACT>
<REFERENCES>
<CITE num="005" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="006" author="WALSH-PLATT M" publication="LANCET" d1="1" d2="622" d3="979"/>
<CITE num="007" author="BROCK DJH" publication="LANCET" d1="1" d2="1245" d3="979"/>
<CITE num="008" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="009" author="DANN LG" publication="LANCET" d1="2" d2="405" d3="978"/>
<CITE num="010" author="BLAU K" publication="J INHER METAB DIS" d1="1" d2="85" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79161</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DLER HL             PE" publication="DIATRICS" d1="66" d2="90 9" d3="0"/>
<CITE num="2" author="WALSH MMJ" publication="AM J OBSTET GYNECOL" d1="137" d2="978" d3="980"/>
<CITE num="3" author="NADLER HL" publication="AM J OBSTET GYNECOL" d1="141" d2="885" d3="981"/>
<CITE num="4" author="DANN LG" publication="LANCET" d1="1" d2="619" d3="982"/>
<CITE num="5" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="6" author="SEYMOUR CA" publication="BIOESSAYS" d1="1" d2="38" d3="984"/>
</CITATIONS>
<RECORDNUM>01141 </RECORDNUM>
<MEDLINENUM>79243573</MEDLINENUM>
<AUTHORS><AUTHOR>Hosli-P</AUTHOR><AUTHOR>Vogt-E</AUTHOR></AUTHORS>
<TITLE>Detection of cystic fibrosis homozygotes and heterozygotes with
plasma.</TITLE>
<SOURCE>Lancet. 1979 Sep 15. 2(8142). P 543-5.</SOURCE>
<MAJORSUBJ><TOPIC>ACID-PHOSPHATASE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>MANNOSIDASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: en, fg</TOPIC><TOPIC>HEAT</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>Evidence is accumulating which indicates that the basic defect in
cystic fibrosis interferes with the formation of recognition markers
on hydrolytic enzymes. As a result these hydrolases leak into the
extracellular space and some of them display abnormal
thermolabilities. By heat inactivation of plasma alpha-mannosidase at
41 degrees C and plasma phosphatase at 36.5 degrees C, both enzymes
being assayed at pH 5.4, it is possible to differentiate normal
people from cystic fibrosis carriers and patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="004" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="005" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="006" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="43" d2="695" d3="968"/>
<CITE num="007" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="008" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="009" author="PAPP Z" publication="CLIN GENET" d1="11" d2="431" d3="977"/>
<CITE num="010" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="011" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="012" author="HOSLI P" publication="PROC INT CF CONG 7TH" d1="" d2="278" d3="976"/>
<CITE num="013" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="979"/>
<CITE num="014" author="NEUFELD EF" publication="J SUPRAMOL STRUCT" d1="6" d2="95" d3="977"/>
<CITE num="015" author="KAPLAN A" publication="PROC NAT ACAD SCI USA" d1="74" d2="2026" d3="977"/>
<CITE num="016" author="PAZUR JH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="40" d2="110" d3="970"/>
<CITE num="017" author="HIRANI S" publication="CLIN CHIM ACTA" d1="81" d2="135" d3="977"/>
<CITE num="018" author="KRESS BC" publication="BIOCHEM BIOPHYS RES COMMUN" d1="81" d2="756" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79162</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLBERG H            AC" publication="TA PAEDIATR SCAND SUPPL 301 19" d1="82" d2="15 9" d3="2"/>
<CITE num="2" author="CAREY WF" publication="MED J AUST" d1="2" d2="528" d3="983"/>
<CITE num="3" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="4" author="GUEANT JL" publication="CLIN CHIM ACTA" d1="143" d2="217" d3="984"/>
<CITE num="5" author="OGLESBEE LH" publication="CLIN CHIM ACTA" d1="143" d2="135" d3="984"/>
<CITE num="6" author="PERINI JM" publication="BULL EUR PHYSIOPATH RESP" d1="21" d2="569" d3="985"/>
<CITE num="7" author="MORSE ML" publication="LANCET" d1="1" d2="625" d3="986"/>
<CITE num="8" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
</CITATIONS>
<RECORDNUM>01142 </RECORDNUM>
<MEDLINENUM>80010695</MEDLINENUM>
<AUTHORS><AUTHOR>Lam-L-F</AUTHOR><AUTHOR>Shapiro-B-L</AUTHOR></AUTHORS>
<TITLE>Differential incorporation of 3H-thymidine into DNA in cultured skin
fibroblasts derived from patients with cystic fibrosis and controls.</TITLE>
<SOURCE>Life-Sci. 1979 Jun 25. 24(26). P 2483-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>DNA: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CELL-DIVISION</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>THYMIDINE: me</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>Tritiated thymidine (3H-TdR) incorporation into DNA of the
fibroblasts derived from subjects with cystic fibrosis (CF) and
their controls was studied with scintillation counting and
autoradiography.  3H-TdR incorporation at 24 hours postseeding was
significantly less (p &lt; 0.005) in CF strains in comparison with
cells from controls.  The percentage of labeled fibroblasts was not
significantly difference between the two strains (p &gt; 0.1).  The
cell cycle time and the duration of each phase were studied by a
mitotic selection and scintillation counting technique.  There was
no difference in cell cycle time between CF and control fibroblasts,
however, the duration of the synthetic phase was significantly (p &lt;
0.005) longer in CF subjects.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="004" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="005" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="007" author="BARRANCO SC" publication="CELL TISSUE KINET" d1="10" d2="335" d3="977"/>
<CITE num="008" author="BARRANCO SC" publication="J CELL PHYSIOL" d1="88" d2="33" d3="976"/>
<CITE num="009" author="BOLTON WE" publication="AM J HUM GENET" d1="27" d2="394" d3="975"/>
<CITE num="010" author="SHAPIRO BL" publication="GAP CONF REP TISS CULT APPR" d1="" d2="" d3="977"/>
<CITE num="011" author="SHAPIRO BL" publication="SCIENCE" d1="203" d2="1251" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79163</PAPERNUM>
<CITATIONS>
<CITE num="1" author="APIRO BL            AM" publication="J HUM GENET" d1="34" d2="46 9" d3="2"/>
<CITE num="2" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="3" author="AVIOLI LV" publication="AM J NEPHROL" d1="6" d2="151" d3="986"/>
</CITATIONS>
<RECORDNUM>01143 </RECORDNUM>
<MEDLINENUM>79220419</MEDLINENUM>
<AUTHORS><AUTHOR>Sordelli-D-O</AUTHOR><AUTHOR>Cassino-R-J</AUTHOR><AUTHOR>Pivetta-O-H</AUTHOR></AUTHORS>
<TITLE>Animal model for cystic fibrosis: pulmonary clearance of
Staphylococcus aureus in mice treated with reserpine.</TITLE>
<SOURCE>Life-Sci. 1979 May 21. 24(21). P 2003-10.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG: mi</TOPIC><TOPIC>RESERPINE: pd</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>DISEASE-MODELS-ANIMAL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>LUNG: de</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MICE</TOPIC><TOPIC>MICE-INBRED-BALB-C</TOPIC></MINORSUBJ>
<ABSTRACT>Since it has been demonstrated that chronic administration of
reserpine to rats produces CF-like alterations, we have studied the
lung resistance to bacterial infections in animals treated with
reserpine.  Mice of the BALB/c inbred strain were injected
subcutaneously with different doses of reserpine for 7 days; after,
they were submitted to an infective aerosol containing
Staphylococcus aureus in a nebulization chamber.  With each pair of
exposed animals, an individual value of the uncleared bacteria ratio
(UBR) at 4 hours was obtained.  Reserpinized animals showed a
significant increase in UBR values when compared to control mice (p
&lt; 0.05 and p &lt; 0.01 depending on the doses), suggesting an
impairment of the lung antibacterial defenses.  Although
pharmacological doses of reserpine produce catecholamine depletion,
we can not conclude that this action upon the nervous system is the
only cause of the CF-like response we detected.  In conclusion, the
observed UBR decrease lends support to the concept of a reserpine-
induced CF animal model.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="OPPENHEIMER EH" publication="COMPAR PATHOL BULL" d1="111" d2="3" d3="971"/>
<CITE num="004" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="005" author="PIVETTA OH" publication="PEDIATR RES" d1="11" d2="1133" d3="977"/>
<CITE num="006" author="THOMPSON FE" publication="PEDIATR RES" d1="10" d2="632" d3="976"/>
<CITE num="007" author="SNEDECOR GW" publication="STATISTICAL METHODS" d1="" d2="" d3="967"/>
<CITE num="008" author="FINNEY DJ" publication="PROBIT ANALYSIS" d1="" d2="" d3="971"/>
<CITE num="009" author="TAYLOR PW JR" publication="J PHARMACOL EXP THER" d1="156" d2="483" d3="967"/>
<CITE num="010" author="GREEN GM" publication="J CLIN INVEST" d1="43" d2="769" d3="964"/>
<CITE num="011" author="LEE JA" publication="FED PROC" d1="35" d2="262" d3="976"/>
<CITE num="012" author="STITZEL RE" publication="PHARMACOL REV" d1="28" d2="179" d3="977"/>
<CITE num="013" author="MARTINEZ JR" publication="PROC WORKSHOP ON MODEL SYS CF" d1="" d2="" d3="978"/>
<CITE num="014" author="MENOM AL" publication="J PHARM PHARMACOL" d1="28" d2="827" d3="976"/>
<CITE num="015" author="GREEN GM" publication="BR J EXP PATHOL" d1="46" d2="360" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79164</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ZLETT D             PE" publication="DIATR RES" d1="20" d2="36 9" d3="6"/>
</CITATIONS>
<RECORDNUM>01144 </RECORDNUM>
<MEDLINENUM>80032233</MEDLINENUM>
<AUTHORS><AUTHOR>Shier-W-T</AUTHOR></AUTHORS>
<TITLE>Increased resistance to influenza as a possible source of
heterozygote advantage in cystic fibrosis.</TITLE>
<SOURCE>Med-Hypotheses. 1979 Jun. 5(6). P 661-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>ORTHOMYXOVIRUS-INFECTIONS: im</TOPIC><TOPIC>PARAMYXOVIRUS-INFECTIONS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNITY-NATURAL</TOPIC><TOPIC>INFLUENZA: im</TOPIC><TOPIC>MEMBRANE-PROTEINS: an</TOPIC><TOPIC>SIALIC-ACIDS: an, me</TOPIC><TOPIC>SIALOGLYCOPROTEINS: an</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis is the most common lethal or semi-lethal genetic
disease in Caucasians of Central European origin, among whom it is
inherited as an autosomal recessive trait at a frequency
approximately 10 times that expected from recurrent mutation alone. A
decreased sialic acid content has been observed in cell surface
glycoproteins on cystic fibrosis fibroblasts and in numerous soluble
glycoprotein preparations from cystic fibrosis homozygotes. Sialic
acid residues on cell surface glycoconjugates play an essential role
in the binding and infectivity of myxoviruses and paramyxoviruses,
including those causing pandemic influenza. It is suggested that
increased resistance to these viruses conferred by similar but
quantitatively smaller alterations in sialoglycoconjugate structure
in cystic fibrosis heterozygotes may have provided a selective
advantage to maintain the high frequency of the cystic fibrosis gene
in Caucasian populations.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="003" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="004" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="005" author="HIRSCHHORN K" publication="IN: MANGOS JA" d1="" d2="275" d3="976"/>
<CITE num="006" author="ALLISON AC" publication="BR MED J" d1="1" d2="290" d3="954"/>
<CITE num="007" author="HALDANE JBS" publication="HEREDITAS SUPPL" d1="" d2="267" d3="949"/>
<CITE num="008" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="009" author="GAIRDNER D" publication="LANCET" d1="1" d2="279" d3="975"/>
<CITE num="010" author="CRAWFURD MDA" publication="HEREDITY" d1="29" d2="126" d3="972"/>
<CITE num="011" author="STUART AB" publication="LANCET" d1="2" d2="1521" d3="974"/>
<CITE num="012" author="DODGE JA" publication="LANCET" d1="1" d2="572" d3="975"/>
<CITE num="013" author="CRAWFURD MDA" publication="LANCET" d1="1" d2="167" d3="975"/>
<CITE num="014" author="ANDERSON CM" publication="MOD PROBL PEDIATR" d1="10" d2="381" d3="967"/>
<CITE num="015" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="016" author="ALHADEFF JA" publication="CLIN GENET" d1="14" d2="189" d3="978"/>
<CITE num="017" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="018" author="MANDEL ID" publication="AM J DIS CHILD" d1="113" d2="431" d3="967"/>
<CITE num="019" author="PEARSON RD" publication="PEDIATR RES" d1="11" d2="462" d3="977"/>
<CITE num="020" author="LAMB D" publication="J PATHOL" d1="98" d2="213" d3="969"/>
<CITE num="021" author="REID L" publication="IN: PORTER R" d1="32" d2="45" d3="968"/>
<CITE num="022" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="023" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="417" d3="978"/>
<CITE num="024" author="SCANLIN TF JR" publication="PEDIATR RES ABST 549" d1="11" d2="463" d3="977"/>
<CITE num="025" author="SPIRO RG" publication="ADV PROT CHEM" d1="27" d2="349" d3="973"/>
<CITE num="026" author="GRIMES WJ" publication="BIOCHEMISTRY" d1="12" d2="990" d3="973"/>
<CITE num="027" author="LURIA SE" publication="GENERAL VIROLOGY" d1="" d2="307" d3="967"/>
<CITE num="028" author="HIRST GK" publication="J EXP MED" d1="78" d2="99" d3="943"/>
<CITE num="029" author="GOTTSCHALK A" publication="YALE J BIOL MED" d1="26" d2="352" d3="954"/>
<CITE num="030" author="LEICHTENSTERN O" publication="INFLUENZE UND DENGUE" d1="" d2="" d3="896"/>
<CITE num="031" author="STUART-HARRIS CH" publication="INFLUENZA THE VIRUSES AND DIS" d1="" d2="" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79165</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RNET M              PE" publication="RSPECT BIOL MED" d1="24" d2="11 9" d3="1"/>
</CITATIONS>
<RECORDNUM>01145 </RECORDNUM>
<MEDLINENUM>79220977</MEDLINENUM>
<AUTHORS><AUTHOR>Danes-B-S</AUTHOR><AUTHOR>Sutanto-E</AUTHOR></AUTHORS>
<TITLE>Pathogenesis of cystic fibrosis: possible importance of alteration
in epithelial surface topography.</TITLE>
<SOURCE>Med-Hypotheses. 1979 Feb. 5(2). P 289-95.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: et</TOPIC><TOPIC>LUNG: ul</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-MEMBRANE: ul</TOPIC><TOPIC>EPITHELIUM: ul</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MICROSCOPY-ELECTRON-SCANNING</TOPIC><TOPIC>MUCOUS-MEMBRANE: ph</TOPIC><TOPIC>MUCUS: ph</TOPIC></MINORSUBJ>
<ABSTRACT>As the pathogenesis in cystic fibrosis (CF) has been considered to
lie in a disturbance in the behavior of secretions, particularly
mucins, from exocrine glands, it has been proposed that an alteration
in surface topography (form, number or distribution of microvilli or
blebs) of epithelial cells lining ducts could impair distribution
leading to retention of mucus leading to the clinical phenotype.
Scanning electronmicroscopy of human epithelial suspension cultures
now offers an opportunity to evaluate the role of plasmalemma
topography in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="ANDERSEN DH" publication="ANN NY ACAD SCI" d1="93" d2="500" d3="962"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="ANN NY ACAD SCI" d1="93" d2="555" d3="962"/>
<CITE num="004" author="DANES BS" publication="BIRTH DEF ORIG ART SER" d1="8" d2="114" d3="972"/>
<CITE num="006" author="FELIX JS" publication="AM J HUM GENET" d1="29" d2="41A" d3="977"/>
<CITE num="007" author="ANDREWS PM" publication="AM J ANAT" d1="139" d2="399" d3="974"/>
<CITE num="008" author="ANDREWS PM" publication="J CELL BIOL" d1="67" d2="11A" d3="975"/>
<CITE num="009" author="MISHIMA Y" publication="ACTA DERM VENEREOL SUPPL 73" d1="53" d2="83" d3="973"/>
<CITE num="010" author="DAWBER RPR" publication="BR J DERMATOL" d1="86" d2="272" d3="972"/>
<CITE num="011" author="ORFANOS CE" publication="ARCH DERMATOL" d1="107" d2="38" d3="973"/>
<CITE num="012" author="STEINRUD J" publication="DAN MED BULL" d1="21" d2="251" d3="974"/>
<CITE num="013" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="014" author="FARBER S" publication="J MICH MED SOC" d1="44" d2="587" d3="945"/>
<CITE num="015" author="JOHANSEN PG" publication="LANCET" d1="1" d2="455" d3="968"/>
<CITE num="016" author="GIBSON LE" publication="LANCET" d1="2" d2="189" d3="970"/>
<CITE num="017" author="TILLMAN B" publication="CELL TISSUE RES" d1="185" d2="279" d3="977"/>
<CITE num="018" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="113" d3="976"/>
<CITE num="019" author="PORTER KR" publication="J CELL BIOL" d1="57" d2="815" d3="973"/>
<CITE num="020" author="ANDREWS PM" publication="AM J ANAT" d1="140" d2="81" d3="974"/>
<CITE num="021" author="SYLVEN B" publication="ACTA HISTOCHEM SUPPL" d1="1" d2="79" d3="958"/>
<CITE num="022" author="DANES BS" publication="J EXP MED" d1="123" d2="1" d3="966"/>
<CITE num="023" author="DANES BS" publication="BIOCHEM BIOPHYS RES COMMUN" d1="36" d2="919" d3="969"/>
<CITE num="024" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="025" author="DANES BS" publication="J EXP MED" d1="136" d2="1313" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79166</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EOHARIDES TC        LI" publication="FE SCI" d1="27" d2="03 9" d3="0"/>
<CITE num="2" author="MICHALSEN H" publication="PATHOL RES PRACT" d1="178" d2="261" d3="984"/>
</CITATIONS>
<RECORDNUM>01146 </RECORDNUM>
<MEDLINENUM>80099211</MEDLINENUM>
<AUTHORS><AUTHOR>Hahnel-R</AUTHOR><AUTHOR>Hosli-P</AUTHOR></AUTHORS>
<TITLE>Alkaline phosphatase induction in cystic fibrosis fibroblasts
[letter].</TITLE>
<SOURCE>Med-J-Aust. 1979 Nov 3. 2(9). P 490.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: me</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Lysosomal acid hydrolases and alkaline phosphatase cooperate in the
intracellular digestion of natural polymers.  A stimulus for the
induction of these enzymes is the retention of any kind of polymer
inside the cell.  This stimulus is long-lasting and strong if
polymers are intracellularly retained because of a lack of digestive
enzymes.  In previous papers it has been demonstrated that the
alkaline phosphatase (AIP) induction with Tamm Horsfall glycoprotein
discriminates between fibroblasts of CF homozygotes on the one hand
and normals and CF carriers on the other hand, and a hypothesis has
been proposed to explain these observations.  As predicted, more
efficient inducing mixtures have since been developed; these have
been used in the present study.  The first writer familiarized
himself with ultramicrotechniques and then carried out double blind
studies on 20 fibroblast cultures from French patients.  These
findings demonstrate the reproducibility of the AIP induction and of
the methods used, and they particularly underline the importance of
employing the present ultramicrotechniques for a successful AIP
induction.  It is likely that amniotic fluid cells behave like skin
fibroblasts in this test; if this proves to be so, then the induction
of alkaline phosphatase should provide a useful technique for the
prenatal diagnosis of cystic fibrosis.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79167</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="002" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="003" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="979"/>
<CITE num="004" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
</REFERENCES>
<RECORDNUM>01147 </RECORDNUM>
<MEDLINENUM>79199129</MEDLINENUM>
<AUTHORS><AUTHOR>Phelan-P-D</AUTHOR><AUTHOR>Allan-J-L</AUTHOR><AUTHOR>Landau-L-I</AUTHOR><AUTHOR>Barnes-G-L</AUTHOR></AUTHORS>
<TITLE>Improved survival of patients with cystic fibrosis.</TITLE>
<SOURCE>Med-J-Aust. 1979 Apr 7. 1(7). P 261-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: mo</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt, th</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>The survival of 320 patients, who were born in and after 1958 with
cystic fibrosis and managed by the Departments of Thoracic Medicine
and Gastroenterology, Royal Children's Hospital, Melbourne, is
reviewed. Eighty per cent of patients survived to 11 years of age,
and 64% to 18 years. Of patients managed between 1973 and 1977, 91%
survived to 12 years of age, and 80% to 17 years of age. In the same
period, 79% of patients survived for 16 years after diagnosis. Forty-
four per cent of the 240 patients currently being managed have no
significant permanent lung disease, and only 9% have advanced
disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="MOD PROBL PEDIATR" d1="10" d2="344" d3="967"/>
<CITE num="002" author="WARWICK WJ" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="320" d3="969"/>
<CITE num="004" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="005" author="CROFTON J" publication="RESPIRATORY DISEASES" d1="" d2="638" d3="975"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="ARMITAGE P" publication="STATISTICAL METHODS IN MEDICA" d1="" d2="" d3="971"/>
<CITE num="008" author="REILLY BJ" publication="RADIOLOGY" d1="98" d2="281" d3="971"/>
<CITE num="009" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="010" author="WILLIAMS HE" publication="RESPIRATORY ILLNESS IN CHILDR" d1="" d2="" d3="975"/>
<CITE num="011" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="977"/>
<CITE num="012" author="ALLAN JL" publication="AUST PAEDIATR J" d1="10" d2="136" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79168</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LAN JL              ME" publication="D J AUST" d1="1" d2="00 9" d3="0"/>
<CITE num="2" author="ROBINSON MJ" publication="MED J AUST" d1="1" d2="580" d3="980"/>
<CITE num="3" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="4" author="SINCLAIR MI" publication="MED J AUST" d1="2" d2="283" d3="981"/>
<CITE num="5" author="FRYDMAN MI" publication="AUST PAEDIATR J" d1="17" d2="35" d3="981"/>
<CITE num="6" author="MILLER M" publication="AM J CLIN NUTR" d1="36" d2="492" d3="982"/>
<CITE num="7" author="WARWICK WJ" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="27" d3="982"/>
<CITE num="8" author="SHEPHERD RW" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="439" d3="983"/>
<CITE num="9" author="WILMOTT RW" publication="ARCH DIS CHILD" d1="58" d2="835" d3="983"/>
<CITE num="10" author="WESLEY AW" publication="NZ MED J" d1="96" d2="651" d3="983"/>
<CITE num="11" author="ANON" publication="LANCET" d1="1" d2="663" d3="984"/>
<CITE num="12" author="WELLS AL" publication="J FOOD NUTR" d1="41" d2="65" d3="984"/>
<CITE num="13" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="14" author="WESLEY AW" publication="NZ MED J" d1="97" d2="773" d3="984"/>
<CITE num="15" author="HOLT TL" publication="AM J CLIN NUTR" d1="41" d2="1061" d3="985"/>
<CITE num="16" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="17" author="HILL DJS" publication="MED J AUST" d1="143" d2="230" d3="985"/>
<CITE num="18" author="PEDERSEN SS" publication="ACTA PAEDIATR SCAND" d1="75" d2="840" d3="986"/>
<CITE num="19" author="LITTLEWOOD JM" publication="J ROY SOC MED" d1="79" d2="55" d3="986"/>
</CITATIONS>
<RECORDNUM>01148 </RECORDNUM>
<MEDLINENUM>80120196</MEDLINENUM>
<AUTHORS><AUTHOR>Carey-W-F</AUTHOR><AUTHOR>Pollard-A-C</AUTHOR></AUTHORS>
<TITLE>Alkaline phosphatase induction in cystic fibrosis fibroblasts
[letter].</TITLE>
<SOURCE>Med-J-Aust. 1979 Dec 1. 2(11). P 604-5.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: bi</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>ENZYME-INDUCTION</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Hosli has published a hypothesis relating to the primary cause of
cystic fibrosis (CF) based on his observations that the level of
alkaline phosphatase (ALP) in CF-derived skin fibroblasts, but not
fibroblasts derived from normal individuals, could be increased
several-fold by growing the cells in the presence of the urinary
glycoprotein, Tamm-Horsfall protein (THP).  However, we have not been
able to show, in Adelaide, any change or induction in the level of
ALP activity in CF-derived skin fibroblasts when grown in the
presence of locally prepared THP under what appear to be identical
cell culture conditions to those used by Hosli.  It thus appears that
under the conditions currently employed in our laboratory, there is
no diagnostic discrimination between fibroblasts of CF homozygotes
and normal individuals.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="978"/>
<CITE num="002" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="003" author="CAREY WF" publication="AUST J EXP BIOL MED SCI" d1="57" d2="225" d3="979"/>
<CITE num="004" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
<CITE num="005" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="006" author="CAREY WF" publication="PAEDIATR RES SOC AUST" d1="" d2="" d3="979"/>
<CITE num="007" author="CAREY WF" publication="HUMAN GENET SOC AUST" d1="" d2="" d3="979"/>
<CITE num="008" author="WIJCIK L" publication="BIOCHIM BIOPHYS ACTA" d1="585" d2="374" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79169</PAPERNUM>
<CITATIONS>
<CITE num="1" author="REY WF              ME" publication="D J AUST" d1="2" d2="14 9" d3="2"/>
<CITE num="2" author="CAREY WF" publication="MED J AUST" d1="2" d2="528" d3="983"/>
</CITATIONS>
<RECORDNUM>01149 </RECORDNUM>
<MEDLINENUM>79221582</MEDLINENUM>
<AUTHORS><AUTHOR>Weller-P-H</AUTHOR><AUTHOR>Bush-E</AUTHOR><AUTHOR>Preece-M-A</AUTHOR><AUTHOR>Norman-A-P</AUTHOR><AUTHOR>Matthew-D-J</AUTHOR></AUTHORS>
<TITLE>The short-term effects of chest physiotherapy on lung function tests
in children with cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 58-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>LUNG: pp</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>THORAX</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>Chest physiotherapy is an important part of the treatment program of
children with cystic fibrosis, but controlled studies of its effects
are few.  27 children with cystic fibrosis, 20 being chronic sputum
producers and 7 non-sputum producers, were studied in hospital with
serial lung function tests on 3 consecutive days.  On the 1st day
physiotherapy was performed twice; on the 2nd day no physiotherapy
was performed; on the 3rd day the two periods of physiotherapy were
preceded by an inhaled bronchodilator (Rimiterol).  Lung function
tests included peak flow, forced vital capacity (FVC), forced
expiratory volume in 1 sec (FEV1.0) and residual volume to total
lung capacity ratio, and were measured at the beginning of each day
and at similar intervals throughout the 3 days.  Sputum volume and
cough frequency were noted on day 1 and day 3.  Physiotherapy
resulted in significant improvement of peak flow in the sputum
producers.  However, the FVC and FEV1.0, while improving after
physiotherapy, also improved on the control day when no
physiotherapy was performed.  This suggests that physiotherapy may
be effective in removing sputum from central large airways with
resultant improvement in peak flow, but has little added effect on
the more peripheral airways, whose airflow improves through the day
with normal activity.  No significant effect was shown in the non-
sputum producers although there was a trend towards improvement in
peak flow.  A bronchodilator before physiotherapy may be beneficial
in those patients who demonstrate significant reduction in airflow
obstruction at formal testing of bronchodilator response, but may
lessen the beneficial effects of physiotherapy in those without a
positive response.  The study illustrates the importance of
examining difference methods of chest physiotherapy, to find ways of
improving sputum clearance.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79170</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TZ M                EU" publication="R J RESPIR DIS" d1="61" d2="22 9" d3="0"/>
</CITATIONS>
<RECORDNUM>01150 </RECORDNUM>
<MEDLINENUM>79221583</MEDLINENUM>
<AUTHORS><AUTHOR>Kerrebijn-K-F</AUTHOR><AUTHOR>Veentjer-M-A</AUTHOR><AUTHOR>Water-E-B</AUTHOR></AUTHORS>
<TITLE>Effect of four physiotherapy schedules on pulmonary function in
children with cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 60.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>LUNG: pp</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79171</PAPERNUM>
<ABSTRACT>In 17 children (group A) with cystic fibrosis (CF) the effect of the
following treatment schedules on pulmonary function has been studied in
random order on 4 consecutive days: (1) clapping and postural drainage (CP);
(2) CP after inhaling an aerosol of 5 ml 20% N-acetylcysteine by a Monaghan
ultrasonic device; (3) as in 2 but with the addition of 0.5 mg isoprenaline
to the aerosol; (4) as in 3 but with an IPPB device added to the nebulizer.
Treatment was started at 9.30 a.m. and lasted for about 1 h.  Pulmonary
function was measured prior to and 30 min after treatment (9.00 and 11.00
a.m., respectively).  In 8 children (group B) with CF (severity comparable
to the previous group) pulmonary function was measured at 9.00 and 11.00 a.m.
but without physiotherapy in between.  The following pulmonary function
measurements have been included in the evaluation of the results: VC, FVC,
FEV1, TLC (body box), TLC (helium dilution), TLCBb-TLCHe, RVBb, RVHe, maximal
expiratory flows at 60% TLBBb, 25% FVC, maximal midexpiratory flow, airway
conductance.  The technique of the determinations was carefully controlled
and initial values were reproducible in most children.  In group B, mean
values of pulmonary function were equal at 9.00 and 11.00 a.m.  In group A
none of the treatment schedules caused a significant improvement of mean
pulmonary function values.  In some of the children, however, pulmonary
function improved, but in others it deteriorated. The significance of these
findings was discussed.</ABSTRACT>
<RECORDNUM>01151 </RECORDNUM>
<MEDLINENUM>79221584</MEDLINENUM>
<AUTHORS><AUTHOR>Kraemer-R</AUTHOR><AUTHOR>Rudeberg-A</AUTHOR><AUTHOR>Rossi-E</AUTHOR></AUTHORS>
<TITLE>Relationship between clinical conditions, chest radiographic
findings and respiratory function tests in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 61-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp, ra</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG: pp</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>THORACIC-RADIOGRAPHY</TOPIC></MINORSUBJ>
<EXTRACT>We explored 44 children suffering from cystic fibrosis with
predominant pulmonary involvement and followed in particular the
course of illness of 30 of these patients during an average period of
4 years.  We were impressed by the enormous variability of the
pulmonary symptomatology in these children.  The question arose
whether this clinical impression is supported by the finding of the
thorax radiograph and the results of the lung functions tests and the
blood gas measures at rest and on exercise.  From the clinical point
of view, there is a possibility to make a classification of severity
in pulmonary aspects of this disease.  Because of the large ranges of
the score values a clear distinction of the severity could only be
possible if large groups of patients were to be compared.  For the
interindividual comparison the cumulative evaluation of a clinical
score, the chest radiograph and the lung function tests are
indispensable.  Only the continuous follow-up of these examinations
allows one to notice, in time, a progressive lung involvement with
its degenerative changes.</EXTRACT>
<REFERENCES>
<CITE num="001" author="KRAEMER R" publication="PROC EWGCF 7TH ANNU MTG" d1="" d2="31" d3="977"/>
<CITE num="002" author="KRAEMER R" publication="HELV PAEDIATR ACTA" d1="32" d2="107" d3="977"/>
<CITE num="003" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="004" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="005" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="006" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="007" author="KRAEMER R" publication="TAG SCHWEIZ GES PNEUMOLOGIE L" d1="" d2="" d3="978"/>
<CITE num="008" author="KRAEMER R" publication="PADIAT FORTBILDK PRAXIS" d1="48" d2="7" d3="979"/>
<CITE num="009" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="010" author="SCHERRER M" publication="SCHWEIZ MED WOCHENSCHR" d1="107" d2="1072" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79172</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AEMER R             HE" publication="LV PAEDIATR ACTA" d1="34" d2="17 9" d3="9"/>
<CITE num="2" author="KRAEMER R" publication="METH INF MED" d1="19" d2="50" d3="980"/>
</CITATIONS>
<RECORDNUM>01152 </RECORDNUM>
<MEDLINENUM>79221581</MEDLINENUM>
<AUTHORS><AUTHOR>Flower-K-A</AUTHOR><AUTHOR>Mann-N-M</AUTHOR><AUTHOR>Eden-R-I</AUTHOR></AUTHORS>
<TITLE>A new percussion aid for cystic fibrosis patients.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 54-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>PERCUSSION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC><TOPIC>SPUTUM</TOPIC><TOPIC>THORAX</TOPIC></MINORSUBJ>
<EXTRACT>This paper is a report on the first part of a comprehensive research
programme.  The aim is the development of a mechanical aid which will
enable patients with cystic fibrosis to give themselves satisfactory
physiotherapy.  The percussor, which can be used by patients, parents
or relatives, is portable and lightweight.  The domiciliary trial
showed that effective percussion could be self-administered to the
front of the chest and to a lesser extent to the sides of the chest.
The percussor was found to be very acceptable to adolescent patients
and especially girls with early breast development.  Further research
work has now been completed and as a result a system has been
developed which enables patients to treat themselves with
satisfactory chest percussion in the five preferred positions of
postural drainage.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79173</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HODSON ME" publication="BR MED J" d1="1" d2="971" d3="978"/>
<CITE num="002" author="FLOWER KA" publication="PROC EWGCF 8TH ANNU MTG" d1="" d2="" d3="978"/>
<CITE num="003" author="GASKELL DV" publication="BROMPTON HOSP GUIDE TO CHEST" d1="" d2="" d3="973"/>
</REFERENCES>
<RECORDNUM>01153 </RECORDNUM>
<MEDLINENUM>79221580</MEDLINENUM>
<AUTHORS><AUTHOR>Dab-I</AUTHOR><AUTHOR>Alexander-F</AUTHOR></AUTHORS>
<TITLE>The mechanism of autogenic drainage studied with flow volume curves.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 50-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: th</TOPIC><TOPIC>SPUTUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHI</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: et</TOPIC><TOPIC>POSTURE</TOPIC></MINORSUBJ>
<EXTRACT>In 1977, we demonstrated the efficiency of autogenic drainage with
two bronchorrheic children, who needed bronchography for diagnostic
purposes.  This demonstration was made possible thanks to a
radiocinematographic study after bronchography.  The examination also
showed the inefficacy of coughing.  The object of the present study
is to analyze the physiologic mechanism of autogenic drainage.  For
children older than five, this method is very simple and efficient
and as the effort or onset is not excessive and as expiration does
not need to be complete, autogenic drainage is not exhausting and can
be performed for a long time, which is indispensable since the
progression of secretions is slow.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DAB I" publication="IN: BARAN D" d1="" d2="185" d3="977"/>
<CITE num="002" author="DAB I" publication="PROC EWGCF 7TH ANNU MTG" d1="" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79174</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHLER I             DT" publication="SCH MED WSCHR                1" d1="11" d2="96 9" d3="6"/>
</CITATIONS>
<RECORDNUM>01154 </RECORDNUM>
<MEDLINENUM>79221579</MEDLINENUM>
<AUTHORS><AUTHOR>Bakken-A-F</AUTHOR><AUTHOR>Motzfeldt-C</AUTHOR></AUTHORS>
<TITLE>Intestinal lactase deficiency in newborns with cystic
fibrosis--dietary consequences.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 5-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINES: en</TOPIC><TOPIC>LACTOSE-INTOLERANCE: dh</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BETA-GALACTOSIDASES: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: dh, en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>LACTOSE-INTOLERANCE: et</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79175</PAPERNUM>
<EXTRACT>The problem of proper diet to children and infants with cystic
fibrosis is continuously discussed.  This paper deals with the diet
for CF infants younger than one year.  The basic view is that the
diet should be as close to the 'normal baby' diet as possible, partly
to ensure normal growth and development, and partly to avoid extra
work for the families with CF infants.  Infants suffering from CF
were given lactose-free diet until they reached the age of one year.
The weight increased more rapidly than in CF patients given the
traditional CF diet with low fat and high protein.  Furthermore, it
was not necessary to give increased amounts of calories to the
infants given lactose-free diet, nor did they receive additional
fat-soluble vitamins.</EXTRACT>
<RECORDNUM>01155 </RECORDNUM>
<MEDLINENUM>79221578</MEDLINENUM>
<AUTHORS><AUTHOR>Konradova-V</AUTHOR><AUTHOR>Vavrova-V</AUTHOR><AUTHOR>Tomanek-A</AUTHOR><AUTHOR>Houstek-J</AUTHOR></AUTHORS>
<TITLE>Ultrastructure of the bronchial epithelium in children with cystic
fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 46-9.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI: ul</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHI: pa</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>EPITHELIUM: pa, ul</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>The ultrastructure of the bronchial epithelium in 3 children with
cystic fibrosis was described.  In 2 of them a developed squamous
metaplasia with many signs of pathological alteration of the
epithelial cells was observed.  In the third patient severely injured
pseudostratified epithelium with remnants of ciliary border is
preserved.</EXTRACT>
<REFERENCES>
<CITE num="001" author="KONRADOVA V" publication="FOLIA MORPHOL (PRAGUE)" d1="24" d2="296" d3="976"/>
<CITE num="002" author="KONRADOVA V" publication="Z ERKR ATMUNGSORGANE" d1="" d2="270" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79176</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BERTSON B           EU" publication="R J RESPIR DIS" d1="63" d2="96 9" d3="2"/>
<CITE num="2" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
</CITATIONS>
<RECORDNUM>01156 </RECORDNUM>
<MEDLINENUM>79221585</MEDLINENUM>
<AUTHORS><AUTHOR>di-SantAgnese-P-A</AUTHOR><AUTHOR>Davis-P-B</AUTHOR></AUTHORS>
<TITLE>Recent research in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 66-76.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>RESEARCH</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>AUTONOMIC-NERVOUS-SYSTEM</TOPIC><TOPIC>BONE-MARROW</TOPIC><TOPIC>CYSTIC-FIBROSIS: et, fg, pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MICE</TOPIC><TOPIC>ANTHROPOIDEA</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>TISSUE-CULTURE</TOPIC></MINORSUBJ>
<EXTRACT>This review emphasizes some of the positive accomplishments of cystic
fibrosis research, some of the puzzles and some of the recent
developments that have promise.  One of the major unresolved
questions is the maintenance of this lethal gene at such a high
frequency, perhaps because of a heterozygote advantage in the past,
no longer operative at present.  Nothing is known of the chromosomal
localization of the trait; except that chromosomes are
morphologically normal, that it is autosomal, not sex linked and that
there is no correlation with blood groups or major HLA loci.  One of
the important achievements of the past many years is that we
understand relatively well the pathogenesis of most clinical
manifestations of CF.  The as yet unknown inherited basic defect or
metabolic error of CF gives rise to two main anomalies: the
electrolyte defect in exocrine sweat glands and the 'mucous
secretion' abnormality.  While the results of tissue culture studies
often have been conflicting and disparate, it does seem to be the
consensus that the fibroblasts are affected by the basic metabolic
error in some manner, and that they respond abnormally under
different experimental circumstances.  Virtually all investigators
have found some anomalies in biologic fluids of CF, although using
different approaches and methods.  An abnormality in the function of
the autonomic nervous system, which is so closely associated with the
exocrine glands, has always been an attractive explanation for the
generalized exocrinopathy of CF.  The search for a genetic animal
model for CF has led to interesting findings.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BARTMAN J" publication="J PEDIATR" d1="76" d2="430" d3="970"/>
<CITE num="002" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="003" author="DAVIS PB" publication="PEDIATR RES" d1="12" d2="703" d3="978"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="006" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="007" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="009" author="GUGLER EC" publication="J PEDIATR" d1="71" d2="585" d3="967"/>
<CITE num="010" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="979"/>
<CITE num="011" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="012" author="KAISER D" publication="LIFE SCI" d1="15" d2="803" d3="974"/>
<CITE num="013" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="014" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="015" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="016" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
<CITE num="018" author="ANON" publication="PROC WORKSHOP ON MODEL SYS CF" d1="" d2="" d3="978"/>
<CITE num="019" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="020" author="HOSLI P" publication="ACTA PAEDIATR SCAND" d1="67" d2="617" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79177</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              PE" publication="DIATR RES" d1="14" d2="83 9" d3="0"/>
<CITE num="2" author="HULTBERG B" publication="CLIN CHIM ACTA" d1="112" d2="167" d3="981"/>
<CITE num="3" author="MORIARTY CM" publication="J MED" d1="13" d2="257" d3="982"/>
<CITE num="4" author="KAMOUN P" publication="BIOCHEM MED" d1="31" d2="104" d3="984"/>
<CITE num="5" author="NEAL JL" publication="EVOLUTIONARY THEORY" d1="7" d2="153" d3="985"/>
<CITE num="6" author="RUPP GM" publication="MED HYPOTHESES" d1="20" d2="245" d3="986"/>
</CITATIONS>
<RECORDNUM>01157 </RECORDNUM>
<MEDLINENUM>79221586</MEDLINENUM>
<AUTHORS><AUTHOR>Roscher-A</AUTHOR><AUTHOR>Wiesmann-U-N</AUTHOR><AUTHOR>Hadorn-B</AUTHOR></AUTHORS>
<TITLE>Relevance of second messengers in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 77-83.</SOURCE>
<MAJORSUBJ><TOPIC>ADENOSINE-CYCLIC-MONOPHOSPHATE: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>ISOPROTERENOL: pd</TOPIC><TOPIC>RECEPTORS-ADRENERGIC</TOPIC><TOPIC>RECEPTORS-ADRENERGIC-BETA</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADRENERGIC-BETA-RECEPTOR-BLOCKADERS: pd</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>NEUROREGULATORS: ph</TOPIC><TOPIC>PROSTAGLANDINS-E: ph</TOPIC></MINORSUBJ>
<EXTRACT>Water, electrolyte and macromolecular secretion, which is affected in
cystic fibrosis, is regulated by neurotransmitters of the autonomic
nervous system stimulating the cells by binding to alpha-adrenergic,
beta-adrenergic and cholinergic receptors.  Therefore, a genetic
disturbance in cyclic 3'5'-adenosine monophosphate (c-AMP) response
could eventually explain some of the manifold expressions of labile
biochemical changes observed in CF, specially in tissue culture.  We
further characterized beta-receptors in cultured fibroblasts of CF
patients and normal controls and investigated isoproterenol and
prostaglandin E1-mediated c-AMP response using defined culture
conditions.  No significant difference was found between the two
phenotypes on basal c-AMP values.  With the exception of one cell
line, CF strains had 25 to 180% increased c-AMP content.  This
difference is highly significant (p &lt; 0.0025).  This statistically
significant difference in response can neither be attributed to
differences in dose- or time-response curves nor to differential
c-AMP escape into culture medium.  Since CF cells synthesize more
c-AMP than controls only in response to isoproterenol but not to
prostaglandin E1, the alteration which might be responsible for the
observed phenomenon is probably located proximal of the adenylate
cyclase at the cells border between intra- and extracellular space.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BERRIDGE MJ" publication="ADV CYCLIC NUCLEO RES" d1="6" d2="1" d3="975"/>
<CITE num="002" author="RAMWELL PW" publication="IN: RABIN BR" d1="" d2="207" d3="971"/>
<CITE num="003" author="BUTCHER FR" publication="BIOCHIM BIOPHYS ACTA" d1="392" d2="82" d3="975"/>
<CITE num="004" author="SCHRAMM M" publication="J CYCLIC NUCLEOTIDES RES" d1="1" d2="181" d3="975"/>
<CITE num="005" author="BUCHWALD M" publication="PROC NAT ACAD SCI USA" d1="73" d2="2899" d3="976"/>
<CITE num="006" author="SHAPIRO BL" publication="CF CONF REP" d1="2" d2="" d3="978"/>
<CITE num="007" author="RECHLER MM" publication="J CLIN ENDOCRINOL METAB" d1="39" d2="512" d3="974"/>
<CITE num="008" author="MANGANIELLO VC" publication="BIOCHIM BIOPHYS ACTA" d1="362" d2="509" d3="974"/>
<CITE num="009" author="GILMAN AG" publication="PROC NAT ACAD SCI USA" d1="67" d2="305" d3="970"/>
<CITE num="010" author="KELLY LA" publication="J BIOL CHEM" d1="249" d2="3098" d3="974"/>
<CITE num="011" author="DUNLOP D" publication="BR J PHARMAC CHEMOTHER" d1="32" d2="201" d3="968"/>
<CITE num="012" author="BARBERO GJ" publication="IN: DI SANTAGNESE PA" d1="" d2="208" d3="964"/>
<CITE num="013" author="LANDS AM" publication="NATURE" d1="214" d2="597" d3="967"/>
<CITE num="014" author="FRANKLIN TJ" publication="MOL PHARMACOL" d1="11" d2="485" d3="975"/>
<CITE num="015" author="HO RJ" publication="J BIOL CHEM" d1="246" d2="6822" d3="971"/>
<CITE num="016" author="NEWCOMBE DS" publication="PROC NAT ACAD SCI USA" d1="72" d2="3124" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79178</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKER M              EU" publication="R J PEDIATR                  1" d1="34" d2="17 9" d3="0"/>
</CITATIONS>
<RECORDNUM>01158 </RECORDNUM>
<MEDLINENUM>79221587</MEDLINENUM>
<AUTHORS><AUTHOR>Aggett-P-J</AUTHOR><AUTHOR>Thorn-J-M</AUTHOR><AUTHOR>Delves-H-T</AUTHOR><AUTHOR>Harries-J-T</AUTHOR><AUTHOR>Clayton-B-E</AUTHOR></AUTHORS>
<TITLE>Trace element malabsorption in exocrine pancreatic insufficiency.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 8-11.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>IRON: me</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: et</TOPIC><TOPIC>MANGANESE: me</TOPIC><TOPIC>PANCREATIC-DISEASES: me</TOPIC><TOPIC>ZINC: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>This paper presents preliminary results from metabolic balance
studies of iron, zinc and manganese absorption and retention in
children with cystic fibrosis and Shwachman's syndrome.
Malabsorption of zinc, iron and manganese in exocrine pancreatic
insufficiency has been demonstrated by these early studies.  A
possible relationship between this and the associated features of CF
has been briefly discussed, and indicates areas for further research.
If such relationships are established then some form of trace element
supplementation should be considered.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ALEXANDER FW" publication="Q J MED" d1="43" d2="89" d3="974"/>
<CITE num="002" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="56" d2="159" d3="974"/>
<CITE num="003" author="CAPLAN AH" publication="J PEDIATR" d1="73" d2="540" d3="968"/>
<CITE num="004" author="DAVIS AE" publication="LANCET" d1="2" d2="6" d3="962"/>
<CITE num="005" author="DODGE JA" publication="BR MED J" d1="1" d2="411" d3="978"/>
<CITE num="006" author="EVANS GW" publication="IN: KIRCHGESSNER M" d1="" d2="98" d3="978"/>
<CITE num="007" author="HALSTED JA" publication="LANCET" d1="1" d2="322" d3="970"/>
<CITE num="008" author="RAO GJS" publication="PEDIATR RES" d1="11" d2="981" d3="977"/>
<CITE num="009" author="RHEINHOLD JG" publication="CLIN CHEM" d1="21" d2="476" d3="975"/>
<CITE num="010" author="SINGER L" publication="CLIN BIOCHEM" d1="7" d2="146" d3="974"/>
<CITE num="011" author="UNDERWOOD EJ" publication="TRACE ELEMENTS IN HUMAN AND A" d1="" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79179</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AYTON BE            AD" publication="V CLIN CHEM" d1="21" d2="47 9" d3="0"/>
<CITE num="2" author="AGGETT PJ" publication="PROC NUTR SOC" d1="39" d2="241" d3="980"/>
<CITE num="3" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="4" author="HURRY VJ" publication="BIOL TRACE ELEMENT RES" d1="4" d2="157" d3="982"/>
<CITE num="5" author="DELVES HT" publication="ANN CLIN BIOCHEM" d1="19" d2="302" d3="982"/>
<CITE num="6" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="35" d2="1048" d3="982"/>
<CITE num="7" author="VANCAILLIEBERTRAND M" publication="ACTA PAEDIATR SCAND" d1="71" d2="203" d3="982"/>
<CITE num="8" author="SOLOMONS NW" publication="J AM DIET ASSOC" d1="80" d2="115" d3="982"/>
<CITE num="9" author="VANDERHOOF JA" publication="DIG DIS SCI" d1="28" d2="300" d3="983"/>
<CITE num="10" author="RUSSELL RM" publication="ANN INTERN MED" d1="99" d2="227" d3="983"/>
<CITE num="11" author="PATRICK J" publication="CRC CRIT REV CLIN LAB SCI" d1="20" d2="95" d3="984"/>
<CITE num="12" author="MCCLAIN CJ" publication="J AM COLL NUTR" d1="4" d2="49" d3="985"/>
<CITE num="13" author="DELVES HT" publication="CLIN ENDOCRINOL METAB" d1="14" d2="725" d3="985"/>
</CITATIONS>
<RECORDNUM>01159 </RECORDNUM>
<MEDLINENUM>79221588</MEDLINENUM>
<AUTHORS><AUTHOR>Hamdi-I</AUTHOR><AUTHOR>Bloom-A-L</AUTHOR><AUTHOR>Goodchild-M-C</AUTHOR><AUTHOR>Dodge-J-A</AUTHOR></AUTHORS>
<TITLE>Prostaglandins and cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 84-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>PROSTAGLANDINS-E: me</TOPIC><TOPIC>SWEAT: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADENOSINE-CYCLIC-MONOPHOSPHATE: bi</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PLATELET-AGGREGATION</TOPIC></MINORSUBJ>
<EXTRACT>We have investigated two aspects of prostaglandin function in cystic
fibrosis: the response of platelets to PGE1, and the concentrations
of PGE2 and PGE-alpha in the sweat.  Low concentrations of PGE1 have
less effect on platelet agglutination in CF patients and
heterozygotes than in normals, but no difference is observed when
high PG concentrations are used.  Sweat PGE2 and PGE-alpha
concentrations are similar in normals, CF patients and heterozygotes,
but sweat PGE2 concentrations are proportional to Na/Cl levels in CF,
but not in control children or heterozygotes.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BARNES GL" publication="LANCET" d1="2" d2="918" d3="975"/>
<CITE num="002" author="BUCHWALD M" publication="AM J HUM GENET" d1="27" d2="22A" d3="975"/>
<CITE num="003" author="CHASE HP" publication="PEDIATRICS" d1="57" d2="441" d3="976"/>
<CITE num="004" author="FORSTROM L" publication="PROSTAGLANDINS" d1="7" d2="459" d3="974"/>
<CITE num="005" author="FREWIN DB" publication="AUST J EXP BIOL MED SCI" d1="51" d2="701" d3="973"/>
<CITE num="006" author="GALABERT C" publication="PROC INT CF CONG 7TH" d1="" d2="100" d3="976"/>
<CITE num="007" author="ROBINSON PG" publication="PROC INT CF CONG 7TH" d1="" d2="107" d3="976"/>
<CITE num="008" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="009" author="SAMUELS CE" publication="LANCET" d1="2" d2="607" d3="975"/>
<CITE num="010" author="YASSA JG" publication="PROC INT CF CONG 7TH" d1="" d2="323" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79180</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DERSON CM           J" publication="PEDIATR GASTROENTEROL NUTR" d1="3" d2="15 9" d3="4"/>
<CITE num="2" author="DAVIS PB" publication="J LAB CLIN MED" d1="104" d2="203" d3="984"/>
<CITE num="3" author="KHULLAR AK" publication="CLIN SCI" d1="68" d2="433" d3="985"/>
<CITE num="4" author="STEAD RJ" publication="PROSTAGLANDINS LEUKOTR MED" d1="26" d2="91" d3="987"/>
</CITATIONS>
<RECORDNUM>01160 </RECORDNUM>
<MEDLINENUM>79221589</MEDLINENUM>
<AUTHORS><AUTHOR>Hosli-P</AUTHOR><AUTHOR>Kollberg-H</AUTHOR><AUTHOR>Vogt-E</AUTHOR></AUTHORS>
<TITLE>Operational definition of cystic fibrosis.  I.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 90-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: en, fg, me</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROLASES: me</TOPIC><TOPIC>LYSOSOMES: en</TOPIC></MINORSUBJ>
<EXTRACT>Recently, one of us suggested a new hypothesis concerning the 'basic
defect' of cystic fibrosis.  The purpose of the present paper is to
review this model and to critically discuss its eventual diagnostic
applications.  With extensive studies, we collected experimental data
which contribute five major arguments in favour of the proposition
that CF may be an enzyme recognition site mutant.  With fibroblast
cultures the three genotypes can be separated in the following way:
CF homozygote, leaky for alkaline phosphatase (A1P) and lysosomal
hydrolases/A1P is Tamm-Horsfall glycoprotein (THP) inducible; CF
heterozygote, leaky for A1P and lysosomal hydrolases/A1P is not THP
inducible; normal control, not leaky for A1P and lysosomal
enzymes/A1P is not THP inducible.  With the exception of a second
double-blind study, the THP induction as well as the leakage analysis
seem to be statistically unequivocal: they strongly support our
hypothesis concerning the basic defect in CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HOSLI P" publication="PROC INT CF CONG 7TH" d1="" d2="278" d3="976"/>
<CITE num="002" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="003" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="004" author="HOSLI P" publication="HUM HERED" d1="27" d2="185" d3="977"/>
<CITE num="005" author="WARD JB JR" publication="TEX REP BIOL MED" d1="34" d2="11" d3="976"/>
<CITE num="006" author="RENNERT OM" publication="GAP CONF REP TISS CULT APPR" d1="" d2="1" d3="977"/>
<CITE num="007" author="HOSLI P" publication="IN: MOTULSKY AG" d1="" d2="226" d3="974"/>
<CITE num="010" author="HOSLI P" publication="ADV EXP MED BIOL" d1="68" d2="1" d3="976"/>
<CITE num="011" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
<CITE num="012" author="BOAT TF" publication="IN: MANGOS JA" d1="" d2="165" d3="976"/>
<CITE num="013" author="HOSLI P" publication="HUM GENET" d1="41" d2="169" d3="978"/>
<CITE num="015" author="HICKMAN S" publication="BIOCHEM BIOPHYS RES COMMUN" d1="57" d2="55" d3="974"/>
<CITE num="016" author="WIESMANN UN" publication="N ENGL J MED" d1="284" d2="109" d3="971"/>
<CITE num="017" author="SCANLIN TF JR" publication="PROC INT CF CONG 7TH" d1="" d2="44" d3="976"/>
<CITE num="020" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="021" author="PALADE GE" publication="INT SYMP ON LYSOSOMES ABST" d1="" d2="36" d3="972"/>
<CITE num="022" author="PALADE GE" publication="CF Q ANNOTATED REFERENCES" d1="14" d2="29" d3="975"/>
<CITE num="023" author="HOSLI P" publication="TISSUE CULTIVATION ON PLASTIC" d1="" d2="" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79181</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SLI P               LA" publication="NCET" d1="2" d2="43 9" d3="9"/>
<CITE num="2" author="DISANTAGNESE PA" publication="MONOGR PAEDIATR" d1="10" d2="66" d3="979"/>
<CITE num="3" author="HOSLI P" publication="FEBS LETTERS" d1="104" d2="271" d3="979"/>
<CITE num="4" author="TEGNER H" publication="ACTA PAEDIATR SCAND" d1="70" d2="629" d3="981"/>
<CITE num="5" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="6" author="CAREY WF" publication="MED J AUST" d1="2" d2="528" d3="983"/>
<CITE num="7" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="8" author="CEDER O" publication="ACTA PAEDIATR SCAND" d1="72" d2="291" d3="983"/>
<CITE num="9" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="10" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
</CITATIONS>
<RECORDNUM>01161 </RECORDNUM>
<MEDLINENUM>79221590</MEDLINENUM>
<AUTHORS><AUTHOR>Casola-L</AUTHOR><AUTHOR>Di-Matteo-G</AUTHOR><AUTHOR>Mastella-G</AUTHOR><AUTHOR>Rutigliano-B</AUTHOR><AUTHOR>Romano-M</AUTHOR></AUTHORS>
<TITLE>Alpha-glucosidase in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 96-101.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLUCOSIDASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Studies are presented on the serum level of several acid glycosidases
in normal and cystic fibrosis subjects.  Levels of alpha-glucosidase
found in serum from CF patients were significantly higher than from
normals and heterozygotes.  The increase in alpha-glucosidase was
directly related to the clinical gravity of the disease.  Levels of
all other glycosidases studied in CF patients were in the normal
range.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="003" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
<CITE num="004" author="BARTMAN J" publication="J PEDIATR" d1="76" d2="430" d3="970"/>
<CITE num="005" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="006" author="DI MATTEO G" publication="MONOGR PAEDIATR" d1="10" d2="19" d3="979"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="534" d3="976"/>
<CITE num="008" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="009" author="MATALON R" publication="BIOCHEM BIOPHYS RES COMMUN" d1="33" d2="954" d3="968"/>
<CITE num="010" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="615" d3="958"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79182</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MATTEO G            MO" publication="NOGR PAEDIATR" d1="10" d2="19 9" d3="9"/>
<CITE num="2" author="HULTBERG B" publication="CLIN CHIM ACTA" d1="112" d2="167" d3="981"/>
</CITATIONS>
<RECORDNUM>01162 </RECORDNUM>
<MEDLINENUM>79221562</MEDLINENUM>
<AUTHORS><AUTHOR>Starkey-B-J</AUTHOR><AUTHOR>Goodchild-M-C</AUTHOR></AUTHORS>
<TITLE>Postprandial total serum bile acid concentrations in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 12-8.</SOURCE>
<MAJORSUBJ><TOPIC>BILE-ACIDS-AND-SALTS: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>EATING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<EXTRACT>In recent years, several workers have reported that a single 2-hour
postprandial total serum bile acid (TSBA) concentration, in a variety
of liver disease states, is a more sensitive index of deranged liver
function than are the 'conventional' serum liver function tests.
This observation seemed to us to provide a challenging situation for
the assessment of TSBA concentrations in cystic fibrosis.  The
distribution of results for the CF patients (mean TSBA concentration
27.0 micromol/l) and for the age-matched controls (mean concentration
19.9 micromol/l) shows a wider range for the CF group.  Statistical
analysis, however, of these two groups shows no significant
difference between them.  Many factors affect both the size and
distribution of the bile acid pool in CF, and a consideration of
these factors may go some way towards explaining the rather
unspectacular TSBA results.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BARNES S" publication="J CLIN PATHOL" d1="28" d2="506" d3="975"/>
<CITE num="002" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="004" author="FAUSA O" publication="SCAND J GASTROENTEROL" d1="11" d2="537" d3="976"/>
<CITE num="005" author="FEIGELSON J" publication="ACTA PAEDIATR SCAND" d1="59" d2="539" d3="970"/>
<CITE num="006" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="007" author="HARVEY IC" publication="CLIN RADIOL" d1="28" d2="635" d3="977"/>
<CITE num="008" author="HEATON KW" publication="BILE SALTS IN HEALTH AND DISE" d1="" d2="" d3="972"/>
<CITE num="009" author="KAPLOWITZ N" publication="JAMA" d1="225" d2="292" d3="973"/>
<CITE num="010" author="KATTWINKEL J" publication="J PEDIATR" d1="82" d2="234" d3="973"/>
<CITE num="011" author="MASHIGE F" publication="CLIN CHIM ACTA" d1="70" d2="79" d3="976"/>
<CITE num="012" author="MATHIS RK" publication="J PEDIATR" d1="90" d2="864" d3="977"/>
<CITE num="013" author="OPPENHEIMER EH" publication="J PEDIATR" d1="86" d2="683" d3="975"/>
<CITE num="014" author="ROLLER RJ" publication="GASTROENTEROLOGY" d1="72" d2="661" d3="977"/>
<CITE num="015" author="SANDBERG DH" publication="PEDIATR RES" d1="4" d2="262" d3="970"/>
<CITE num="016" author="SCHUSTER SR" publication="J PEDIATR SURG" d1="12" d2="201" d3="977"/>
<CITE num="017" author="SMALLEY CA" publication="ARCH DIS CHILD" d1="53" d2="477" d3="978"/>
<CITE num="018" author="TYSON KRT" publication="J PEDIATR SURG" d1="3" d2="271" d3="968"/>
<CITE num="019" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="67" d2="835" d3="974"/>
<CITE num="020" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="73" d2="1023" d3="977"/>
<CITE num="021" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="022" author="WEBER AM" publication="GASTROENTEROLOGY" d1="68" d2="1066" d3="975"/>
<CITE num="023" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="024" author="WEBSTER R" publication="ARCH DIS CHILD" d1="28" d2="343" d3="953"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79183</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LUND A              SC" publication="AND J CLIN LAB INVEST" d1="40" d2="95 9" d3="0"/>
<CITE num="2" author="STRANDVIK B" publication="SCAND J GASTROENTEROL" d1="20" d2="381" d3="985"/>
</CITATIONS>
<RECORDNUM>01163 </RECORDNUM>
<MEDLINENUM>79221568</MEDLINENUM>
<AUTHORS><AUTHOR>Carswell-F</AUTHOR><AUTHOR>Oliver-J</AUTHOR><AUTHOR>Silverman-M</AUTHOR></AUTHORS>
<TITLE>The cystic fibrosis gene, IgE and IgG4.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 144-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENES</TOPIC><TOPIC>IGE: an</TOPIC><TOPIC>IGG: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>We decided to survey a geographically defined population of cystic
fibrosis patients and parents living in Avon County, England.  By
examining the obligate heterozygotes (the parents), we would be able
to assess the influence of the CF gene without the presence of the
disease.  There is an increase in immediate hypersensitivity to A.
fumigatus in CF patients but not their parents.  This increased
sensitivity is probably IgE-mediated and a secondary effect of lung
damage.  There is no evidence that the CF gene produces a generalised
increase in skin reactivity (atopy), serum IgE or serum IgG4 in the
heterozygotes.  They are not therefore likely to develop asthma.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79184</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="002" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="003" author="MCFARLANE H" publication="LANCET" d1="1" d2="1241" d3="976"/>
<CITE num="004" author="MCFARLANE H" publication="CLIN ALLERGY" d1="7" d2="279" d3="977"/>
<CITE num="005" author="SHAKIB F" publication="CLIN ALLERGY" d1="6" d2="237" d3="976"/>
<CITE num="006" author="VIJAY HM" publication="INT ARCH ALLERGY APPL IMMUNOL" d1="53" d2="78" d3="977"/>
<CITE num="007" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="008" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="009" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="010" author="GODFREY RC" publication="CLIN ALLERGY" d1="6" d2="79" d3="976"/>
<CITE num="011" author="DAVIS JB" publication="CLIN ALLERGY" d1="6" d2="329" d3="976"/>
</REFERENCES>
<RECORDNUM>01164</RECORDNUM>
<MEDLINENUM>79221561</MEDLINENUM>
<AUTHORS><AUTHOR>Leupold-W</AUTHOR><AUTHOR>Dietzsch-H-J</AUTHOR></AUTHORS>
<TITLE>Bronchial reactivity in children with cystic fibrosis and other
recurrent or chronic bronchopulmonary diseases.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 119-22.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: et</TOPIC><TOPIC>BRONCHITIS: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>RESPIRATORY-HYPERSENSITIVITY: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RECURRENCE</TOPIC></MINORSUBJ>
<EXTRACT>In our efforts to standardize the evaluation of bronchial reactivity
we performed investigations into the threshold dosage of
acetylcholine-induced bronchospasm in patients with various recurrent
and chronic bronchopulmonary diseases.  A significantly decreased
threshold value of acetylcholine and thus an increased bronchial
reactivity could be proven in patients with cystic fibrosis in
comparison with healthy children.  The cause of bronchial
hyperreactivity in patients with CF may be due to proteases deriving
from leucocytes of the purulent sputum.  Furthermore, we investigated
the influence of terbutaline on the bronchial obstruction induced by
acetylcholine in patients with bronchial asthma and cystic fibrosis.
The groups were comparable, especially with regard to the degree of
the initial bronchial obstruction.</EXTRACT>
<REFERENCES>
<CITE num="001" author="EMPEY DW" publication="AM REV RESPIR DIS" d1="113" d2="131" d3="976"/>
<CITE num="002" author="HALUSZKA J" publication="RESPIRATION" d1="32" d2="217" d3="975"/>
<CITE num="003" author="MASTELLA G" publication="PROC EWGCF 4TH ANNU MTG" d1="" d2="51" d3="973"/>
<CITE num="004" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="005" author="MCCHESNEY-YOHE R" publication="ANN ALLERGY" d1="30" d2="627" d3="972"/>
<CITE num="006" author="MELLIS CM" publication="PEDIATRICS" d1="61" d2="446" d3="978"/>
<CITE num="007" author="OUELLETTE JJ" publication="J ALLERGY" d1="36" d2="558" d3="975"/>
<CITE num="008" author="ROTHSTEIN RJ" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="100" d3="974"/>
<CITE num="009" author="THAL W" publication="ASTHMA BRONCHIALE IM KINDESAL" d1="" d2="" d3="977"/>
<CITE num="010" author="ULMER WT" publication="DTSCH MED WSCHR" d1="96" d2="1759" d3="971"/>
<CITE num="011" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79185</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RGA LL              PE" publication="DIATR PULMONOL" d1="2" d2="82 9" d3="6"/>
</CITATIONS>
<RECORDNUM>01165 </RECORDNUM>
<MEDLINENUM>79221560</MEDLINENUM>
<AUTHORS><AUTHOR>Baran-D</AUTHOR><AUTHOR>Wolter-R</AUTHOR><AUTHOR>Bourdoux-P</AUTHOR><AUTHOR>Ermans-A-M</AUTHOR></AUTHORS>
<TITLE>Increased serum TSH response to TRH in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 114-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>THYROID-GLAND: pp</TOPIC><TOPIC>THYROTROPIN-RELEASING-HORMONE: du</TOPIC><TOPIC>THYROTROPIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INJECTIONS-INTRAVENOUS</TOPIC><TOPIC>THYROTROPIN-RELEASING-HORMONE: ad</TOPIC></MINORSUBJ>
<EXTRACT>The aim of the present study is to reassess the peripheral pattern of
thyroid function in subjects with cystic fibrosis with special
reference to their responsiveness to thyrotropin-releasing hormone
(TRH) stimulation.  In all the CF patients the basal levels of serum
T4, T3, and TBG were within the normal range.  Mean values in CF
patients and in control children were not significantly different.
In CF patients there is no correlation between the TSH response area
and the basal level of serum T4, or with grading according to
Shwachman and Kulczycki.  We found no relation with therapy.  In
basal conditions, our data show a completely normal pattern of the
serum concentration of T4, T3, TBG and TSH in subjects with CF in
absence of iodide therapy.  Thyroid status should be examined in
patients with CF specially when they receive iodide therapy or other
drugs which can enhance the impairment of thyroid function.</EXTRACT>
<REFERENCES>
<CITE num="001" author="AZIZI F" publication="TRANS ASSOC AM PHYSICIANS" d1="87" d2="111" d3="974"/>
<CITE num="002" author="DOLAN TF JR" publication="J PEDIATR" d1="79" d2="684" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79186</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GALLBLANK M         J" publication="PEDIATR" d1="98" d2="18 9" d3="1"/>
<CITE num="2" author="BECKER DJ" publication="ANNU REV NUTRITION" d1="3" d2="187" d3="983"/>
<CITE num="3" author="SACK J" publication="ISR J MED SCI" d1="19" d2="17" d3="983"/>
<CITE num="4" author="KNOPFLE G" publication="KLIN PAEDIATR" d1="197" d2="481" d3="985"/>
</CITATIONS>
<RECORDNUM>01166 </RECORDNUM>
<MEDLINENUM>79221559</MEDLINENUM>
<AUTHORS><AUTHOR>Super-M</AUTHOR></AUTHORS>
<TITLE>Factors influencing the frequency of cystic fibrosis in South West
Africa.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 106-13.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CONSANGUINITY</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENE-FREQUENCY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NAMIBIA</TOPIC><TOPIC>PEDIGREE</TOPIC></MINORSUBJ>
<EXTRACT>Drift, chance effect in a small community and consanguinity have
resulted in South West Africa's high cystic fibrosis incidence.
Isolated communities generations ago in Europe, e.g. Bad Gastein,
where this congress was held, surrounded by its Alpine peaks, could
have resulted in gene enrichment, which together with the increased
fertility of the heterozygote could still be responsible for most of
the CF seen wherever Europeans live today.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SUPER M" publication="S AFR MED J" d1="49" d2="818" d3="975"/>
<CITE num="002" author="SUPER M" publication="S AFR MED J" d1="54" d2="18" d3="978"/>
<CITE num="003" author="FALCONER DS" publication="INTRO TO QUANTITAT GENET" d1="" d2="100" d3="960"/>
<CITE num="004" author="GOLDBLATT I" publication="HIST SW AFRICA FROM BEGINNING" d1="" d2="" d3="971"/>
<CITE num="005" author="SUPER M" publication="LANCET" d1="2" d2="1288" d3="977"/>
<CITE num="006" author="KULCZYCKI LL" publication="AM J DIS CHILD" d1="127" d2="64" d3="974"/>
<CITE num="007" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79187</PAPERNUM>
<CITATIONS>
<CITE num="1" author="INGER KW            HU" publication="M GENET" d1="65" d2="94 9" d3="3"/>
<CITE num="2" author="KLINGER KW" publication="SEM RESPIR MED" d1="6" d2="243" d3="985"/>
</CITATIONS>
<RECORDNUM>01167 </RECORDNUM>
<MEDLINENUM>79221558</MEDLINENUM>
<AUTHORS><AUTHOR>Morrissey-S-M</AUTHOR><AUTHOR>Tymvios-M-C</AUTHOR></AUTHORS>
<TITLE>The effect of cystic fibrosis and non-cystic fibrosis plasma on
electrophysiological responses in isolated frog gastric mucosa.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 102-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GASTRIC-MUCOSA: ph</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>ELECTROPHYSIOLOGY</TOPIC><TOPIC>ANURA</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>An alternative method for assaying the cystic fibrosis factor could
be on the electrophysiological responses of isolated living tissues.
The ability of the frog's gastric mucosa to secrete hydrochloric acid
and maintain a negative potential difference is well known.  This
potential difference across the secretory (mucosa) to the nutrient
(serosa) side coupled with its property of transporting chloride and
hydrogen ions against an electrochemical gradient could therefore
serve as a useful model for investigating any induced changes in the
presence of CF and non-CF plasma.  From the results obtained the
short circuit current and H+ secretion responses in the presence of
CF (whole) plasma show significant increases compared to the control.
These findings show that in the presence of CF plasma, whole or
plasma fraction B, there is a marked increase in the actively
transported Cl- and H+.  The effect of CF plasma in increasing net
Cl- flux is important considering the elevation of this electrolyte
in the sweat of CF patients and deserved further investigation.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="002" author="DURBIN RP" publication="J GEN PHYSIOL" d1="41" d2="101" d3="957"/>
<CITE num="003" author="HENRIQUES DE JESUS C" publication="THESIS" d1="" d2="" d3="974"/>
<CITE num="004" author="HOGBEN CAM" publication="AM J PHYSIOL" d1="180" d2="641" d3="955"/>
<CITE num="005" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="006" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79188</PAPERNUM>
<CITATIONS>
<CITE num="1" author="X KL                J" publication="PEDIATR GASTROENTEROL NUTR" d1="1" d2="59 9" d3="2"/>
<CITE num="2" author="ALBAZZAZ FJ" publication="RESPIRATION" d1="46" d2="88" d3="984"/>
<CITE num="3" author="MINA M" publication="J PHYSIOL (LOND)" d1="348" d2="P  4" d3="984"/>
</CITATIONS>
<RECORDNUM>01168 </RECORDNUM>
<MEDLINENUM>79221557</MEDLINENUM>
<AUTHORS><AUTHOR>Berg-U</AUTHOR><AUTHOR>Kallner-A</AUTHOR><AUTHOR>Kusoffsky-E</AUTHOR><AUTHOR>Strandvik-B</AUTHOR></AUTHORS>
<TITLE>Fatty acid supplementation in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 1-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>FAT-EMULSIONS-INTRAVENOUS: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FAT-EMULSIONS-INTRAVENOUS: ae</TOPIC><TOPIC>FATTY-ACIDS: bl</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Elliott's works, together with the previous works of several authors
reporting low essential fatty acid concentrations in the serum lipids
of patients with cystic fibrosis, stimulated us to make a pilot study
treating older CF patients with Intralipid for 1 year.  We found no
side effects in treating older CF patients with Intralipid for 1
year.  On the other hand the objective benefit was very limited and
today confusing, i.e., only a slight but significant improvement in
the renal sodium excretion after an oral sodium load was found.  The
relevance of this is speculative.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="002" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="003" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="004" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="005" author="ROSENLUND ML" publication="NATURE" d1="251" d2="719" d3="974"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="BERG U" publication="ACTA PAEDIATR SCAND" d1="62" d2="505" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79189</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SOFFSKY E           J" publication="PEDIATR GASTROENTEROL NUTR" d1="2" d2="34 9" d3="3"/>
</CITATIONS>
<RECORDNUM>01169 </RECORDNUM>
<MEDLINENUM>79221563</MEDLINENUM>
<AUTHORS><AUTHOR>Price-J-F</AUTHOR><AUTHOR>Weller-P-H</AUTHOR><AUTHOR>Harper-S-A</AUTHOR><AUTHOR>Matthew-D-J</AUTHOR></AUTHORS>
<TITLE>Bronchial provocation tests in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 123-4.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: di</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>RESPIRATORY-HYPERSENSITIVITY: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ASTHMA: im</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PEAK-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>RESPIRATORY-HYPERSENSITIVITY: im</TOPIC><TOPIC>SKIN-TESTS</TOPIC></MINORSUBJ>
<EXTRACT>Patients with cystic fibrosis have a higher incidence of positive
skin prick tests than normal; this may be the result of defective
antigen handling at mucosal surfaces.  Our aim was to investigate
bronchial allergy in a group of children with CF and positive skin
tests.  We studied 15 children aged 7 to 16 years with mild to
moderate respiratory disease.  Only 1 child gave a history of
wheezing not associated with chest infections and this study supports
the hypothesis that clinical asthma is a product of bronchial allergy
and broncholability.  The responses to bronchial provocation with
Aspergillus suggest that allergy to this antigen may play a part in
the pathogenesis of lung disease in some patients with CF.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79190</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              SE" publication="M RESPIR MED" d1="6" d2="61 9" d3="5"/>
<CITE num="2" author="DARGA LL" publication="PEDIATR PULMONOL" d1="2" d2="82" d3="986"/>
</CITATIONS>
<RECORDNUM>01170 </RECORDNUM>
<MEDLINENUM>79221564</MEDLINENUM>
<AUTHORS><AUTHOR>Pryjma-J</AUTHOR><AUTHOR>Rudnik-J</AUTHOR><AUTHOR>Zebrak-J</AUTHOR><AUTHOR>Herman-T</AUTHOR><AUTHOR>Gawe-J</AUTHOR></AUTHORS>
<TITLE>The local immune status in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 125-30.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANTIBODIES: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNITY-CELLULAR</TOPIC><TOPIC>IMMUNOGLOBULINS: an</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LUNG-DISEASES: im</TOPIC><TOPIC>SPUTUM: im</TOPIC></MINORSUBJ>
<EXTRACT>We focused our study on concentration of immunoglobulins, lysozyme,
lactoferrin, some antiproteolytic fractions and acute phase proteins
in bronchial secretion of children with various pulmonary diseases,
especially with cystic fibrosis.  Secretory IgA is decreased in all
studied groups of patients having chronic or recurrent infections of
the respiratory tract (when compared to the group of healthy
children).  Groups which were characterized by the infection of the
lower part of the respiratory tract had increased lysozyme level.
The results obtained in the group of CF children are similar to those
obtained in groups with bronchiectasis and chronic bronchitis, which
suggests that the observed differences are characteristic for chronic
infection rather than for CF.  Although in CF as well as in
bronchiectasis massive bacterial infection results in increased
concentration of immunoglobulins, antiproteolytic fractions and acute
phase proteins, the results seen in both groups are somewhat
different.  These differences may indicate some difference in the
reactivity to infection of the respiratory tract in CF in comparison
to patients with bronchiectasis.  It seems conceivable that among
children with CF who have very low S-IgA, chronic respiratory tract
infections occur earlier and IgG response to permanent exposition to
variety of antigens is less vigorous.  The presented results raise
also a possibility that the bacterial infection in CF does not
stimulate defence mechanisms to the same extent as in bronchiectasis.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79191</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="003" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="004" author="WALDMAN RH" publication="IN: NETER E" d1="" d2="334" d3="975"/>
<CITE num="005" author="WALLWORK JC" publication="CLIN ALLERGY" d1="6" d2="349" d3="976"/>
</REFERENCES>
<RECORDNUM>01171 </RECORDNUM>
<MEDLINENUM>79221565</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Sorensen-H</AUTHOR><AUTHOR>Hoiby-N</AUTHOR></AUTHORS>
<TITLE>Complement activation and pulmonary inflammation in CF patients.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 131-4.</SOURCE>
<MAJORSUBJ><TOPIC>COMPLEMENT-3: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>LUNG: im</TOPIC><TOPIC>PNEUMONIA: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFLAMMATION</TOPIC><TOPIC>LUNG: pa</TOPIC></MINORSUBJ>
<EXTRACT>This study examined whether biologic activation of C3 with subsequent
pulmonary inflammation takes place in the lungs of patients with
cystic fibrosis.  Plasma complement C3 levels were all normal.
Eleven of the patients with the C3 split product C3c were from the
group of 14 patients suffering from chronic infection with mucoid
strains of Pseudomonas aeruginosa and 2 were from the group of 14 CF
patients without P. aeruginosa infection.  This difference was
significant (p &lt; 0.002).  A comparison of albumin ratios between the
13 patients with the C3 split product C3c and the remaining other 15
patients showed a significant higher ratio in the former group (p &lt;
0.01) on an average 4.1 versus 1.4 per cent.  The significantly
higher albumin ratio demonstrated in the patients with C3c in their
sputum sol phase supports the concept of complement-induced
inflammation with subsequent transudation of plasma proteins in these
patients.  This study thus shows that complement-mediated
inflammatory reactions may play an important role in the pathogenesis
of pulmonary tissue damage in patients with CF, even when the plasma
C3 levels are normal, and it supports the concept of chronic P.
aeruginosa lung infection as an immune complex disease in CF
patients.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="002" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="003" author="GEWURTZ H" publication="J EXP MED" d1="128" d2="1049" d3="968"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="GREENBLATT J" publication="INFECT IMMUN" d1="19" d2="296" d3="978"/>
<CITE num="006" author="GOTZ M" publication="EUR J PEDIATR" d1="127" d2="133" d3="978"/>
<CITE num="007" author="HANN S" publication="LANCET" d1="2" d2="520" d3="974"/>
<CITE num="008" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="009" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="010" author="LAURELL CB" publication="SCAND J CLIN LAB INVEST SUPPL" d1="124" d2="21" d3="972"/>
<CITE num="011" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="111" d2="100" d3="975"/>
<CITE num="012" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="013" author="NELSON RA JR" publication="IN: ZWEIFACH BW" d1="3" d2="37" d3="974"/>
<CITE num="014" author="SCANLIN TF JR" publication="LANCET" d1="1" d2="1382" d3="974"/>
<CITE num="015" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="016" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="86" d2="37" d3="978"/>
<CITE num="017" author="TEISBERG P" publication="CLIN CHIM ACTA" d1="62" d2="35" d3="975"/>
<CITE num="018" author="WEEKE B" publication="DAN MED BULL" d1="23" d2="155" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79192</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DSON ME             TH" publication="ORAX" d1="35" d2="01 9" d3="0"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
</CITATIONS>
<RECORDNUM>01172 </RECORDNUM>
<MEDLINENUM>79221566</MEDLINENUM>
<AUTHORS><AUTHOR>Hein-J</AUTHOR><AUTHOR>David-A</AUTHOR><AUTHOR>Grimm-J</AUTHOR><AUTHOR>Gottschalk-B</AUTHOR></AUTHORS>
<TITLE>Protein, IgA, secretory IgA, IgG and electrolytes as parameters of
parotid gland function in children with cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 135-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>ELECTROLYTES: me</TOPIC><TOPIC>IGA: an</TOPIC><TOPIC>IGA-SECRETORY: an</TOPIC><TOPIC>IGG: an</TOPIC><TOPIC>PAROTID-GLAND: pp</TOPIC><TOPIC>PROTEINS: an</TOPIC><TOPIC>SALIVA: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: im, me</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>To study the parotid gland function in children with cystic fibrosis
we investigated parotid saliva specimens of 18 such patients.  We
compared the results with a control group of 12 healthy children of
the same age and sex.  Furthermore, children with bronchial asthma
and chronic bronchitis were examined.  The flow rate of the parotid
and the protein output without stimulation were nearly the same for
the four groups.  In patients with CF the protein output after
stimulation was significantly lower.  An increased level of sodium
was observed in the stimulated secretion and the unstimulated saliva
as well.  In CF children we found a significant higher output of
sodium in both stimulated parotid saliva and unstimulated parotid
saliva.  The IgG output of the gland after stimulation was found to
be slightly reduced in patients with CF in comparison to healthy
children.  The output of the gland for IgA after stimulation was
observed to be strongly reduced for the group with CF and for the
group with bronchial asthma.  The decreased output of the gland for
secretory IgA after stimulation was demonstrated again in CF and in
bronchial asthma in comparison with healthy persons.  The increased
sodium concentration in parotid saliva may be caused in a similar way
as the electrolyte abnormality of sweat in CF patients, namely by a
decreased net reabsorption of sodium.  Due to the result of an
increased electrolyte output and decreased immunoglobulin output of
parotid gland we can suppose that the molecular magnitude plays its
role in this disturbance.</EXTRACT>
<REFERENCES>
<CITE num="002" author="LAKNER V" publication="ALLERGIE IMMUNOL" d1="23" d2="147" d3="977"/>
<CITE num="003" author="MANGOS JA" publication="MOD PROBL PEDIATR" d1="10" d2="107" d3="967"/>
<CITE num="004" author="MARTINEZ-TELLO FJ" publication="J IMMUNOL" d1="101" d2="989" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79193</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TZ S                CE" publication="LL CALC" d1="5" d2="21 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01173 </RECORDNUM>
<MEDLINENUM>79221567</MEDLINENUM>
<AUTHORS><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Hertz-J-B</AUTHOR></AUTHORS>
<TITLE>Precipitating antibodies against E. coli, B. fragilis, and P.
aeruginosa in CF patients and normal persons determined by means of
crossed immunoelectrophoresis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 138-43.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-BACTERIAL: an</TOPIC><TOPIC>BACTEROIDES-FRAGILIS: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>ESCHERICHIA-COLI: im</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>Wallwork and co-workers have proposed that increased absorption of
antigens takes place across the mucosal membranes of the gut and
respiratory tract possibly due to a transient defect in the
production of secretory IgA.  As a consequence of this hypothesis,
one would expect cystic fibrosis patients to produce a pronounced
antibody response against the intestinal bacterial flora.  The
present work was therefore carried out to investigate the antibody
response in CF patients and in normal persons against Escherichia
coli and Bacteroides fragilis which are present in the gut in large
numbers and against the respiratory pathogen P. aeruginosa.  A
significantly higher prevalence of precipitins against each of the 3
bacterial species was found in CF patients compared to normal
persons, and the prevalence of precipitins against each of these
bacteria increased significantly with age.  As regards P. aeruginosa
precipitins, the prevalence and number was significantly higher in CF
patients who have subsequently succumbed compared to CF patients who
are still alive.  Such a correlation between the antibody response
and the prognosis of the patients was not found as regards E. coli or
B. fragilis.  Considering the hypothesis of Wallwork and co-workers
concerning increased absorption of antigens from the gut, it seems
more attractive to suppose that increased absorption of antigens from
the gut flora occurs predominantly in CF patients with P. aeruginosa
lung infection with a pronounced antibody response against P.
aeruginosa.</EXTRACT>
<REFERENCES>
<CITE num="001" author="FINEGOLD SM" publication="ANAEROBIC BACTERIA HUMAN DIS" d1="" d2="" d3="977"/>
<CITE num="002" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="003" author="HOIBY N" publication="SCAND J IMMUNOL SUPPL 2" d1="4" d2="187" d3="975"/>
<CITE num="004" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="142" d3="977"/>
<CITE num="005" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="006" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="007" author="SASAKI M" publication="JAPAN J EXP MED" d1="45" d2="335" d3="975"/>
<CITE num="008" author="SCHWAB JH" publication="BACT REV" d1="39" d2="121" d3="975"/>
<CITE num="009" author="TOLO K" publication="IMMUNOLOGY" d1="33" d2="733" d3="977"/>
<CITE num="010" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="011" author="WALLWORK JC" publication="CLIN ALLERGY" d1="6" d2="349" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79194</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DSON ME             TH" publication="ORAX" d1="35" d2="01 9" d3="0"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
</CITATIONS>
<RECORDNUM>01174 </RECORDNUM>
<MEDLINENUM>79221577</MEDLINENUM>
<AUTHORS><AUTHOR>Prosser-R</AUTHOR></AUTHORS>
<TITLE>Screening for cystic fibrosis in the newborn.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 43-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ENGLAND</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>In an 8-year period, a programme of screening for cystic fibrosis has
been conducted over an extensive part of Wales.  The screening method
used is based on the detection of a high level of albumen (greater
than 20 mg%) in the meconium.  During the course of the
investigations several different tests have been used.  Because of
the high incidence of false-negative results (34%) the detection of
protein in meconium is not an ideal screening test, but is the most
satisfactory presently available, in the newborn period.  Because of
its relative simplicity, low cost, absence of direct involvement of
the parent or patient, and a high yield of positive cases, its use on
a wider scale may be justified.</EXTRACT>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="002" author="HARDY JD" publication="ARCH DIS CHILD" d1="48" d2="316" d3="973"/>
<CITE num="003" author="KOLLBERG H" publication="PROC INT CF CONG 7TH" d1="" d2="32" d3="976"/>
<CITE num="004" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="005" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="006" author="RYLEY HC" publication="ARCH DIS CHILD" d1="49" d2="901" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79195</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AVERT G             J" publication="GENET HUM" d1="28" d2="41 9" d3="0"/>
<CITE num="2" author="TRAVERT G" publication="NOUV PRESSE MED" d1="10" d2="2093" d3="981"/>
</CITATIONS>
<RECORDNUM>01175 </RECORDNUM>
<MEDLINENUM>79221569</MEDLINENUM>
<AUTHORS><AUTHOR>Michalsen-H</AUTHOR><AUTHOR>Rolla-G</AUTHOR><AUTHOR>Melsen-B</AUTHOR><AUTHOR>Sonju-T</AUTHOR></AUTHORS>
<TITLE>Sulphated glycoproteins in the pancreas.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 148-50.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>GLYCOPROTEINS: me</TOPIC><TOPIC>PANCREAS: me</TOPIC><TOPIC>SULFATES: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: et</TOPIC><TOPIC>ANTHROPOIDEA</TOPIC></MINORSUBJ>
<EXTRACT>Several reports have indicated the presence of abnormally high
amounts of sulphate in the mucous glands of patients with cystic
fibrosis.  Bearing these facts in mind, we suspected that abnormal,
over-sulphated, and strongly anionic, glycoproteins might be involved
in the pathogenesis of CF.  The present study was carried out to
determine whether sulphated blood-group substances occur in normal
pancreatic tissue.  The distribution of sulphate over the exocrine
part of pancreas does coincide with the distribution of blood-group
substance previously observed by fluorescent microscopy.  We
therefore find it very likely that the sulphate and blood-group
substance are associated with the same glycoprotein molecule.  Since
blood-group substance has been demonstrated in many secretions in
man, and since high amounts of sulphate have been found in the
mucous glands in CF, such a mechanism is possible in many locations
and may thus offer an explanation for the multiorgan involvement in
CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HAUG A" publication="ACTA CHEM SCAND" d1="24" d2="843" d3="970"/>
<CITE num="002" author="LAMB D" publication="BR J DIS CHEST" d1="66" d2="239" d3="972"/>
<CITE num="003" author="LUDWIG H" publication="SCAND J IMMUNOL" d1="6" d2="724" d3="977"/>
<CITE num="004" author="ROLLA G" publication="ACTA PATH MICROBIOL SCAND" d1="86" d2="83" d3="978"/>
<CITE num="005" author="SMIDSROD O" publication="CHEM SOC FARADAY DISC" d1="57" d2="263" d3="974"/>
<CITE num="006" author="SZULMAN AE" publication="J EXP MED" d1="111" d2="785" d3="960"/>
<CITE num="007" author="SONJU T" publication="ARCH ORAL BIOL" d1="19" d2="897" d3="974"/>
<CITE num="008" author="SONJU T" publication="ACTA PATH MICROBIOL SCAND" d1="83" d2="215" d3="975"/>
<CITE num="009" author="SONJU T" publication="ARCH ORAL BIOL" d1="19" d2="897" d3="974"/>
<CITE num="010" author="WATKINS WM" publication="IN: GOTTSCHALK A" d1="" d2="830" d3="972"/>
<CITE num="011" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="012" author="YOSIZAWA Z" publication="IN: GOTTSCHALK A" d1="5" d2="1000" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79196</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DO M                CA" publication="RBOHYD RES                   1" d1="51" d2="09 9" d3="6"/>
</CITATIONS>
<RECORDNUM>01176 </RECORDNUM>
<MEDLINENUM>79221570</MEDLINENUM>
<AUTHORS><AUTHOR>Ryley-H-C</AUTHOR></AUTHORS>
<TITLE>An evaluation of the meconium 'lactase test' for the detection of
cystic fibrosis in the newborn.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 151-4.</SOURCE>
<MAJORSUBJ><TOPIC>BETA-GALACTOSIDASES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>GALACTOSIDASES: an</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALBUMINS: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>Recently, Antonowicz et al. proposed a simple test for cystic
fibrosis that could be used to verify the Boehringer-Mannheim
meconium test result and thus reduce the false-positive incidence.
The test is based on the detection of lactase activity in meconium.
The 'lactase test' may be of some value as a confirmatory test when
used with the BM-mec test although its specificity in this study was
not as good as previously reported.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
<CITE num="002" author="ANTONOWICZ I" publication="LANCET" d1="1" d2="746" d3="976"/>
<CITE num="003" author="BRUNS WT" publication="AM J DIS CHILD" d1="131" d2="71" d3="977"/>
<CITE num="004" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="64" d2="117" d3="975"/>
<CITE num="006" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79197</PAPERNUM>
<CITATIONS>
<CITE num="1" author="STELLA G            RI" publication="V ITAL PEDIATR" d1="7" d2="81 9" d3="1"/>
<CITE num="2" author="PEDERZINI F" publication="RIV ITAL PEDIATR" d1="9" d2="445" d3="983"/>
</CITATIONS>
<RECORDNUM>01177 </RECORDNUM>
<MEDLINENUM>79221571</MEDLINENUM>
<AUTHORS><AUTHOR>Torriani-R</AUTHOR><AUTHOR>Chassot-J</AUTHOR><AUTHOR>Stocker-F</AUTHOR><AUTHOR>Weber-J-W</AUTHOR></AUTHORS>
<TITLE>Two children with cystic fibrosis and myocardial fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 155-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>MYOCARDIAL-DISEASES: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MYOCARDIAL-DISEASES: di</TOPIC></MINORSUBJ>
<EXTRACT>Usually cardiac affection in cystic fibrosis is secondary to
progressive affection of the lungs (cor pulmonale).  In rare cases,
babies and young children show a primary and severe cardiac affection
caused by myocardial fibrosis.  We could recently observe two of
these cases in our clinic.  The cases are presented and discussed.
In babies and young children cardiac insufficiency  caused by
cardiomyopathy might be the first presenting symptom in CF.
Therefore, in all children with cardiomyopathy of unknown origin, CF
has to be suspected and the sweat test has to be performed.  Rapidly
progressive cardiac insufficiency responding poorly to treatment and
rhythm disturbances are typical.  Correct early diagnosis is
important for early genetic counseling.</EXTRACT>
<REFERENCES>
<CITE num="001" author="COUSIN J" publication="J SCI MED LILLE" d1="5" d2="161" d3="975"/>
<CITE num="002" author="DESCHAMPS JP" publication="ARCH FR PEDIATR" d1="28" d2="417" d3="971"/>
<CITE num="003" author="MCGIVEN AR" publication="ARCH DIS CHILD" d1="37" d2="656" d3="962"/>
<CITE num="004" author="HIDE DW" publication="ARCH DIS CHILD" d1="52" d2="163" d3="977"/>
<CITE num="005" author="NEZELOF C" publication="ARCH FR PEDIATR" d1="16" d2="1035" d3="959"/>
<CITE num="006" author="OPPENHEIMER EH" publication="JOHNS HOPKINS MED J" d1="133" d2="252" d3="973"/>
<CITE num="007" author="NIZNIKOWSKA J" publication="HELV PAEDIATR ACTA" d1="26" d2="56" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79198</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HONI M              SC" publication="HWEIZ MED WOCHENSCHR         1" d1="11" d2="58 9" d3="1"/>
</CITATIONS>
<RECORDNUM>01178 </RECORDNUM>
<MEDLINENUM>79221572</MEDLINENUM>
<AUTHORS><AUTHOR>Di-Matteo-G</AUTHOR><AUTHOR>Romano-M</AUTHOR><AUTHOR>Mastella-G</AUTHOR><AUTHOR>Castellani-E</AUTHOR><AUTHOR>Rutigliano-B</AUTHOR><AUTHOR>Casola-L</AUTHOR></AUTHORS>
<TITLE>Chemical comparison of normal and cystic fibrosis meconium: a
quantitative and qualitative analysis of carbohydrate splitting
enzymes.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 19-26.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLYCOSIDE-HYDROLASES: me</TOPIC><TOPIC>MECONIUM: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ABO-BLOOD-GROUP-SYSTEM</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>Meconium specimens from more than 200 normal and premature and from 5
cystic fibrosis newborns were analyzed for their level of several
glycosidases.  Considerable scatter of activities were found in all
three groups studied and no evidence for any relation of such scatter
with the blood group-specific A, B, AB, H substances was found.
Alpha-glucosidase, an acid glycosidase found elevated in CF serum and
fibroblasts, was elevated in all CF meconium extracts including that
which had a very low albumin content.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="PEDIATR RES" d1="9" d2="301" d3="975"/>
<CITE num="002" author="CASOLA L" publication="MONOGR PAEDIATR" d1="10" d2="96" d3="979"/>
<CITE num="003" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79199</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SOLA L              MO" publication="NOGR PAEDIATR" d1="10" d2="96 9" d3="9"/>
<CITE num="2" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="117" d2="227" d3="981"/>
<CITE num="3" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="135" d2="49" d3="983"/>
<CITE num="4" author="SLOMIANY A" publication="J BIOL CHEM" d1="258" d2="8535" d3="983"/>
<CITE num="5" author="CABRINI G" publication="RIV ITAL PEDIATR" d1="10" d2="405" d3="984"/>
<CITE num="6" author="ALHADEFF JA" publication="PEDIATR RES" d1="19" d2="171" d3="985"/>
</CITATIONS>
<RECORDNUM>01179 </RECORDNUM>
<MEDLINENUM>79221573</MEDLINENUM>
<AUTHORS><AUTHOR>Kulczycki-L-L</AUTHOR><AUTHOR>Wientzen-R</AUTHOR></AUTHORS>
<TITLE>The use and abuse of antibiotics, including in management of
pulmonary manifestations in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 27-30.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>LUNG-DISEASES: dt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANTIBIOTICS: ad</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>SUBSTANCE-ABUSE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC></MINORSUBJ>
<EXTRACT>Individually and collectively opinion is expressed that antibiotics
are among the most frequently prescribed drugs in United States,
probably also in many other countries.  While it is adopted by many
that the increased longevity of cystic fibrosis patients is strongly
related to antibiotic usage, this has never been documented
adequately.  The principles which we try to follow while using
antibiotics in CF patients are outlined.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79200</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ROBERTS AW" publication="AM J HOSP PHARM" d1="29" d2="828" d3="972"/>
<CITE num="002" author="SCHECKLER WE" publication="JAMA" d1="213" d2="264" d3="970"/>
<CITE num="003" author="ACHONG MR" publication="CAN MED ASSOC J" d1="116" d2="256" d3="977"/>
<CITE num="004" author="CASTLE M" publication="JAMA" d1="237" d2="2819" d3="977"/>
<CITE num="005" author="KUNIN CM" publication="ANN INTERN MED" d1="79" d2="555" d3="973"/>
<CITE num="006" author="FINLAND M" publication="J INFECT DIS" d1="122" d2="419" d3="970"/>
<CITE num="007" author="MCGOWAN JE JR" publication="J INFECT DIS" d1="130" d2="165" d3="974"/>
<CITE num="008" author="OSOL A" publication="UNITED STATES DISPENSATORY" d1="" d2="" d3="973"/>
<CITE num="009" author="LARAYA-CUASAY LR" publication="J PEDIATR" d1="89" d2="23" d3="976"/>
<CITE num="010" author="DAVIS BD" publication="MICROBIOLOGY" d1="" d2="783" d3="973"/>
<CITE num="011" author="DI SANTAGNESE PA" publication="AM J DIS CHILD" d1="72" d2="17" d3="946"/>
<CITE num="012" author="HUANG NN" publication="J PEDIATR" d1="59" d2="512" d3="961"/>
<CITE num="013" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="014" author="DOERSHUK CF" publication="IN: MANGOS JA" d1="" d2="" d3="976"/>
<CITE num="015" author="KULCZYCKI LL" publication="JAMA" d1="240" d2="30" d3="978"/>
</REFERENCES>
<RECORDNUM>01180 </RECORDNUM>
<MEDLINENUM>79221574</MEDLINENUM>
<AUTHORS><AUTHOR>Paporisz-U</AUTHOR><AUTHOR>Posselt-H-G</AUTHOR><AUTHOR>Wonne-R</AUTHOR><AUTHOR>Ristow-W</AUTHOR><AUTHOR>Roser-D</AUTHOR><AUTHOR>Knothe-H</AUTHOR><AUTHOR>Bender-S-W</AUTHOR></AUTHORS>
<TITLE>Long-term tobramycin therapy in patients with cystic fibrosis and
advanced pulmonary disease.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 31-3.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: ad</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>LUNG-DISEASES: dt</TOPIC><TOPIC>TOBRAMYCIN: ad</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt, et</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC></MINORSUBJ>
<EXTRACT>The aim of our clinical study was to find if prolonged tobramycin
therapy can prevent further rapid deterioration in cystic fibrosis
patients.  Eleven courses of treatment were given to the nine
patients.  Eight of these markedly improved their physical activity
and gained weight.  However, only in four of these patients was
clinical improvement correlated with an improved radiogram.
Pseudomonas was eradicated from the sputum of only four patients
during therapy but reappeared in three of them before the end of
therapy.  Clinical improvement and negligible side effects suggest
treatment of exacerbating Pyocyaneus bronchopneumonia with prolonged
tobramycin therapy.  Dosage should be higher than 5 mg/kg/day with
strict control of tobramycin blood level and awareness of side
effects.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79201</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BOXERBAUM B" publication="J INFECT DIS SUPPL" d1="124" d2="293" d3="971"/>
<CITE num="002" author="DOGGETT RG" publication="SOUTH MED J" d1="61" d2="1347" d3="968"/>
<CITE num="003" author="DOGGETT RG" publication="J BACTERIOL" d1="87" d2="427" d3="964"/>
<CITE num="004" author="DOGGETT RG" publication="SOUTH MED J" d1="57" d2="1476" d3="964"/>
<CITE num="005" author="DOGGETT RG" publication="SOUTH MED J" d1="57" d2="1470" d3="964"/>
<CITE num="006" author="DOGGETT RG" publication="SOUTH MED J" d1="61" d2="1346" d3="968"/>
<CITE num="007" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="008" author="DOGGETT RG" publication="BACT PROC" d1="69" d2="87" d3="969"/>
<CITE num="009" author="DOGGETT RG" publication="INFECT IMMUN" d1="6" d2="628" d3="972"/>
<CITE num="010" author="HAWLEY HB" publication="CURR THER RES" d1="16" d2="414" d3="974"/>
<CITE num="011" author="HARRISON GM" publication="PAEDIATRICIAN" d1="1" d2="180" d3="972"/>
<CITE num="012" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="013" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="014" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="015" author="MAY JR" publication="CHEMOTHERAPY OF CHRONIC BRONC" d1="" d2="" d3="968"/>
<CITE num="016" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="017" author="WAITZ JA" publication="ANTIMICROB AGENTS CHEMOTHER" d1="2" d2="431" d3="972"/>
<CITE num="018" author="HUMPHREY JH" publication="ADV IMMUNOL" d1="11" d2="75" d3="969"/>
</REFERENCES>
<RECORDNUM>01181 </RECORDNUM>
<MEDLINENUM>79221575</MEDLINENUM>
<AUTHORS><AUTHOR>Guggenbichler-J-P</AUTHOR><AUTHOR>Kienel-G</AUTHOR></AUTHORS>
<TITLE>Bioavailability of oral antibiotics in cystic fibrosis.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 34-40.</SOURCE>
<MAJORSUBJ><TOPIC>AMPICILLIN: aa</TOPIC><TOPIC>CEPHALEXIN: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>EPICILLIN: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADMINISTRATION-ORAL</TOPIC><TOPIC>BIOLOGICAL-AVAILABILITY</TOPIC><TOPIC>CEPHALEXIN: ad, bl, tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, me</TOPIC><TOPIC>EPICILLIN: ad, bl, tu</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: dt</TOPIC></MINORSUBJ>
<EXTRACT>The present investigation was designed to assess the absorption and
disposition in cystic fibrosis patients of two commonly used
antibiotics: an aminopenicillin, epicillin, and a cephalexin,
Ospexin.  The pharmacokinetic parameters of epicillin in patients
with CF and their normal controls differ in a number of aspects.  The
difference found in the maximal plasma concentrations could be
accounted for by a manifold increase in the renal clearance of the
drug.  Our data support the idea that patients with CF exhibit an
unusually large and rapid renal clearance of certain penicillins.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="002" author="DEREN JJ" publication="N ENGL J MED" d1="288" d2="949" d3="973"/>
<CITE num="003" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="005" author="JUSKO WJ" publication="PEDIATRICS" d1="56" d2="1038" d3="975"/>
<CITE num="006" author="JUSKO WJ" publication="J PHARM SCI" d1="61" d2="1270" d3="972"/>
<CITE num="007" author="YAFFE SJ" publication="J INFECT DIS" d1="135" d2="828" d3="977"/>
<CITE num="008" author="PARSONS RL" publication="CLIN PHARMAKOKINET" d1="2" d2="45" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79202</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHALSEN H           AN" publication="TIMICROB AGENTS CHEMOTHER" d1="19" d2="29 9" d3="1"/>
<CITE num="2" author="LEFF RD" publication="PEDIATR CLIN NORTH AM" d1="30" d2="93" d3="983"/>
<CITE num="3" author="NAHATA MC" publication="DEVELOP PHARM THER" d1="7" d2="221" d3="984"/>
<CITE num="4" author="SPINO M" publication="J PEDIATR" d1="105" d2="829" d3="984"/>
<CITE num="5" author="HARRISON CJ" publication="PEDIATR PHARMACOL" d1="5" d2="7" d3="985"/>
<CITE num="6" author="SPINO M" publication="J PEDIATR" d1="107" d2="64" d3="985"/>
<CITE num="7" author="SORGEL F" publication="EUR J PEDIATR" d1="143" d2="249" d3="985"/>
<CITE num="8" author="SMITH MJ" publication="ANTIMICROB AGENTS CHEMOTHER" d1="30" d2="614" d3="986"/>
</CITATIONS>
<RECORDNUM>01182 </RECORDNUM>
<MEDLINENUM>79221576</MEDLINENUM>
<AUTHORS><AUTHOR>Stephan-U</AUTHOR></AUTHORS>
<TITLE>Progress in screening.</TITLE>
<SOURCE>Monogr-Paediatr. 1979. 10. P 41-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MASS-SCREENING</TOPIC></MINORSUBJ>
<EXTRACT>Since the Dresden Meeting in 1977 there have only been a few new
developments of interest in special field of screening for cystic
fibrosis.  There is no ideal screening test for CF available today.
The BM Test Meconium is the test most widely used now but many
technical, psychological and methodological problems remain to be
solved before the test can be endorsed without reservation.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79203</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="LANCET" d1="1" d2="746" d3="976"/>
<CITE num="002" author="CROSSLEY JR" publication="LANCET" d1="2" d2="1093" d3="977"/>
<CITE num="003" author="ROOMANS GM" publication="ACTA PAEDIATR SCAND" d1="67" d2="89" d3="978"/>
<CITE num="004" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="64" d2="117" d3="975"/>
<CITE num="005" author="HOLSCLAW DS" publication="PEDIATR ANN" d1="7" d2="15" d3="978"/>
</REFERENCES>
<RECORDNUM>01183 </RECORDNUM>
<MEDLINENUM>79156725</MEDLINENUM>
<AUTHORS><AUTHOR>Davidson-A-G</AUTHOR><AUTHOR>Applegarth-D-A</AUTHOR><AUTHOR>Wong-L-T</AUTHOR></AUTHORS>
<TITLE>Diagnosing cystic fibrosis in adults [letter].</TITLE>
<SOURCE>N-Engl-J-Med. 1979 May 17. 300(20). P 1164.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ELECTROLYTES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SWEAT: an</TOPIC></MINORSUBJ>
<EXTRACT>Gordeuk et al. state that cystic fibrosis may be first diagnosed in
adulthood, but we feel that a condition with such grave genetic and
prognostic implications must be diagnosed with special caution in
this age group.  In particular, the sweat test, which is the main
diagnostic tool for use with children, must be interpreted in adults
in the light of possible age-related increases in normal
sweat-electrolyte concentration and other factors that may affect the
assay.  Although it is generally accepted that "normal" sweat sodium
and chloride concentrations are higher in adults than in children,
there is no clear agreement about the upper limits of the normal
range in adults.  The volume of sweat produced during the test may
also have a substantial effect on electrolyte values.  For the
diagnosis of cystic fibrosis in adults, an attempt should thus be
made to base the diagnosis not only on "elevated" sweat-electrolyte
values and clinical impression but also on pancreatic-function data.</EXTRACT>
<REFERENCES>
<CITE num="001" author="GORDEUK V" publication="N ENGL J MED" d1="299" d2="1137" d3="978"/>
<CITE num="002" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="003" author="LOBECK CC" publication="PEDIATRICS" d1="30" d2="172" d3="962"/>
<CITE num="004" author="DOBSON RL" publication="MOD PROBL PEDIATR" d1="10" d2="23" d3="967"/>
<CITE num="005" author="GUP AM" publication="ARCH INTERN MED" d1="112" d2="699" d3="963"/>
<CITE num="006" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79204</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NG LTK              GU" publication="T" d1="23" d2="44 9" d3="2"/>
</CITATIONS>
<RECORDNUM>01184 </RECORDNUM>
<MEDLINENUM>79093917</MEDLINENUM>
<TITLE>Case records of the Massachusetts General Hospital.  Weekly
clinicopathological exercises.  Case 8-1979.</TITLE>
<SOURCE>N-Engl-J-Med. 1979 Feb 22. 300(8). P 420-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>ESOPHAGEAL-AND-GASTRIC-VARICES: pa</TOPIC><TOPIC>LIVER-CIRRHOSIS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRAIN-DISEASES: di, pa</TOPIC><TOPIC>BRAIN: pa</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>ESOPHAGEAL-AND-GASTRIC-VARICES: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEPATIC-ENCEPHALOPATHY: di, et, pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIVER-CIRRHOSIS: di</TOPIC><TOPIC>LIVER: pa</TOPIC></MINORSUBJ>
<EXTRACT>The case of a nine-year-old girl admitted to the hospital because of
coma is presented.  She was found shortly after birth to have
meconium ileus and a high concentration of sodium in her sweat
indicative of cystic fibrosis.  Clinical diagnoses were cystic
fibrosis of pancreas, cirrhosis of liver, and congestive heart
failure secondary to electrolyte imbalance.  Anatomical diagnoses
were cystic fibrosis of pancreas with cirrhosis of liver and
esophageal varices, brain necrosis, metabolic encephalopathy,
bronchiectasis, acute bronchopneumonia, and acute renal tubular
necrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="REYE RDK" publication="LANCET" d1="2" d2="249" d3="963"/>
<CITE num="003" author="WEBSTER R" publication="ARCH DIS CHILD" d1="28" d2="343" d3="953"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="005" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="006" author="COHN D" publication="MED J AUST" d1="1" d2="101" d3="977"/>
<CITE num="007" author="OPPENHEIMER EH" publication="J PEDIATR" d1="86" d2="683" d3="975"/>
<CITE num="008" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="009" author="BOVE KE" publication="IN: POLLACK JD" d1="" d2="93" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79205</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LMAN FD             N" publication="ENGL J MED                   3" d1="04" d2="11 9" d3="1"/>
</CITATIONS>
<RECORDNUM>01185 </RECORDNUM>
<MEDLINENUM>79135047</MEDLINENUM>
<AUTHORS><AUTHOR>Feigal-R-J</AUTHOR><AUTHOR>Shapiro-B-L</AUTHOR></AUTHORS>
<TITLE>Mitochondrial calcium uptake and oxygen consumption in cystic
fibrosis.</TITLE>
<SOURCE>Nature. 1979 Mar 15. 278(5701). P 276-7.</SOURCE>
<MAJORSUBJ><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MITOCHONDRIA: me</TOPIC><TOPIC>OXYGEN-CONSUMPTION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BIOLOGICAL-TRANSPORT-ACTIVE</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>ELECTRON-TRANSPORT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>SKIN: ul</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>Reports of exocrine gland secretory anomalies in cystic fibrosis and
increased calcium ion concentrations in some CF secretions and the
importance of cellular Ca to stimulus-secretion coupling led us to
study cellular Ca in CF.  We report data on Ca uptake studies with
mitochondrial and microsomal fractions isolated from skin fibroblasts
of subjects with CF and age-, sex- and passage number-matched
controls in which mitochondria from CF cells accumulated more Ca than
those from control cells.  We also describe subsequent studies which
show increased mitochondrial electron transport activity, measured as
oxygen uptake by whole cells, in cells from subjects with CF and
obligate heterozygotes.  One can hypothesise a mechanism to link the
altered mitochondrial Ca in CF fibroblasts and the major signs
associated with the disease.  Data suggest that the electron
transport system in CF and obligate heterozygote fibroblasts is more
active than that in respective controls, in the conditions of this
study.  The apparent central role of Ca in several pathogenetic
pathways in CF and the data reported here in which both mitochondrial
Ca capacity and oxygen consumption are increased in CF suggest that
this organelle is a suitable focus for CF investigations.</EXTRACT>
<REFERENCES>
<CITE num="001" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="002" author="BOTELHO SY" publication="J PEDIATR" d1="83" d2="601" d3="973"/>
<CITE num="003" author="WOTMAN S" publication="ARCH ORAL BIOL" d1="16" d2="663" d3="971"/>
<CITE num="004" author="ALLARS HM" publication="PEDIATR RES" d1="10" d2="578" d3="976"/>
<CITE num="005" author="BLOMFIELD J" publication="PEDIATR RES" d1="10" d2="574" d3="976"/>
<CITE num="006" author="DOUGLAS WW" publication="BR J PHARMACOL" d1="34" d2="451" d3="968"/>
<CITE num="008" author="PENNINGTON RJ" publication="BIOCHEM J" d1="80" d2="649" d3="961"/>
<CITE num="009" author="REED KC" publication="ANAL BIOCHEM" d1="67" d2="44" d3="975"/>
<CITE num="010" author="MOORE L" publication="J CELL PHYSIOL" d1="91" d2="289" d3="977"/>
<CITE num="011" author="KIMURA S" publication="J BIOL CHEM" d1="252" d2="1217" d3="977"/>
<CITE num="012" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="013" author="ASH GR" publication="FEBS LETTERS" d1="78" d2="166" d3="977"/>
<CITE num="014" author="ROSE B" publication="SCIENCE" d1="190" d2="1204" d3="975"/>
<CITE num="015" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="016" author="FORSTNER JF" publication="MOD PROBL PEDIATR" d1="19" d2="54" d3="977"/>
<CITE num="017" author="WALLACH D" publication="EUR J BIOCHEM" d1="21" d2="433" d3="971"/>
<CITE num="018" author="CARAFOLI E" publication="EXP BIOL SYMP" d1="30" d2="89" d3="976"/>
<CITE num="019" author="BYGRAVE FL" publication="BIOL REV" d1="53" d2="43" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79206</PAPERNUM>
<CITATIONS>
<CITE num="1" author="APIRO BL            PR" publication="OC NAT ACAD SCI USA" d1="76" d2="79 9" d3="9"/>
<CITE num="2" author="ANSAH TA" publication="CELL CALC" d1="1" d2="195" d3="980"/>
<CITE num="3" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="4" author="KATZ S" publication="CLIN CHIM ACTA" d1="100" d2="245" d3="980"/>
<CITE num="5" author="CROMWELL O" publication="LANCET" d1="2" d2="164" d3="981"/>
<CITE num="6" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="53" d3="981"/>
<CITE num="7" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="8" author="ROOMANS GM" publication="J SUBMICROSC CYTOL" d1="13" d2="445" d3="981"/>
<CITE num="9" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="10" author="SANGUINETTIBRICENO NR" publication="CLIN GENET" d1="22" d2="308" d3="982"/>
<CITE num="11" author="FEIGAL RJ" publication="LIFE SCI" d1="30" d2="93" d3="982"/>
<CITE num="12" author="SHAPIRO BL" publication="AM J HUM GENET" d1="34" d2="846" d3="982"/>
<CITE num="13" author="MATKOVICS B" publication="CLIN CHIM ACTA" d1="125" d2="59" d3="982"/>
<CITE num="14" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="15" author="FONDACARO JD" publication="LIFE SCI" d1="32" d2="1449" d3="983"/>
<CITE num="16" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="17" author="SEYMOUR CA" publication="BIOESSAYS" d1="1" d2="38" d3="984"/>
<CITE num="18" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="19" author="CABRINI G" publication="RIV ITAL PEDIATR" d1="10" d2="405" d3="984"/>
<CITE num="20" author="DEARBORN DG" publication="PEDIATR RES" d1="18" d2="890" d3="984"/>
<CITE num="21" author="VONRUECKER AA" publication="PEDIATR RES" d1="18" d2="594" d3="984"/>
<CITE num="22" author="WALLER RL" publication="LIFE SCI" d1="35" d2="775" d3="984"/>
<CITE num="23" author="RUSSI EW" publication="CHEST" d1="86" d2="475" d3="984"/>
<CITE num="24" author="GRINSTEIN S" publication="BIOCHIM BIOPHYS ACTA" d1="769" d2="270" d3="984"/>
<CITE num="25" author="CABRINI G" publication="LIFE SCI" d1="36" d2="1561" d3="985"/>
<CITE num="26" author="PINO JA" publication="ANAL CHEM" d1="57" d2="295" d3="985"/>
<CITE num="27" author="MUALLEM S" publication="BIOCHIM BIOPHYS ACTA" d1="819" d2="143" d3="985"/>
<CITE num="28" author="STUTTS MJ" publication="PEDIATR RES" d1="20" d2="1316" d3="986"/>
<CITE num="29" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
<CITE num="30" author="BATTINO M" publication="FEBS LETTERS" d1="199" d2="155" d3="986"/>
<CITE num="31" author="FEIGAL RJ" publication="ANN NY ACAD SCI" d1="488" d2="82" d3="986"/>
</CITATIONS>
<RECORDNUM>01186 </RECORDNUM>
<MEDLINENUM>79178685</MEDLINENUM>
<AUTHORS><AUTHOR>Columbo-J-L</AUTHOR><AUTHOR>Gibbs-G-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis and erroneous sweat tests.</TITLE>
<SOURCE>Nebr-Med-J. 1979 Jun. 64(6). P 164-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEATING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>Making the diagnosis of cystic fibrosis requires clinical suspicion
and sweat tests.  Physicians today are aware of the main clinical
features of pulmonary and pancreatic involvement and are suspecting
the diagnosis earlier than in past years.  The accuracy of the sweat
test is the most crucial factor in confirming the diagnosis.  The
present case illustrates this point.  The main purpose of this paper
is to serve as a reminder that the sweat test is often less than
accurate as frequently performed.  The principal pitfall of sweat
testing at present seems to be the use of a chloride electrode
applied to the skin without assurance that an adequate amount of
sweat is present.</EXTRACT>
<REFERENCES>
<CITE num="001" author="GIBSON LE" publication="CLIN PEDIATR" d1="12" d2="450" d3="973"/>
<CITE num="002" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="003" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="004" author="COLTMAN CA JR" publication="AM REV RESPIR DIS" d1="93" d2="63" d3="966"/>
<CITE num="005" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="006" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="007" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79207</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BSTER HL            CR" publication="C CRIT REV CLIN LAB SCI" d1="18" d2="13 9" d3="3"/>
</CITATIONS>
<RECORDNUM>01187 </RECORDNUM>
<MEDLINENUM>79201313</MEDLINENUM>
<AUTHORS><AUTHOR>Iveson-Iveson-J</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: a disease of unknown causes.</TITLE>
<SOURCE>Nurs-Mirror. 1979 May 24. 148(21). P 40.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: nu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>COMMUNITY-HEALTH-NURSING</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79208</PAPERNUM>
<EXTRACT>The author looks at the disease which affects two out of every 2000
newborn children - a disease which causes most of the childhood
chronic pulmonary disease in the Western world.  The author tells how
the Cystic Fibrosis Research Trust can help parents of affected
children.</EXTRACT>
<RECORDNUM>01188 </RECORDNUM>
<MEDLINENUM>80034503</MEDLINENUM>
<AUTHORS><AUTHOR>Clement-M</AUTHOR><AUTHOR>Jankowski-L-W</AUTHOR><AUTHOR>Beaudry-P-H</AUTHOR></AUTHORS>
<TITLE>Prone immersion physical exercise therapy in three children with
cystic fibrosis: a pilot study.</TITLE>
<SOURCE>Nurs-Res. 1979 Nov-Dec. 28(6). P 325-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>EXERCISE-THERAPY: mt</TOPIC><TOPIC>IMMERSION</TOPIC><TOPIC>PHYSICAL-THERAPY: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BRADYCARDIA</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>EVALUATION-STUDIES</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PILOT-PROJECTS</TOPIC><TOPIC>POSTURE</TOPIC></MINORSUBJ>
<ABSTRACT>Prone immersion physical exercise therapy has been used successfully
in the physical rehabilitation of middle-aged adults with moderate to
severe chronic obstructive pulmonary disease. The purpose of this
pilot project was to evaluate the effects of PIPE therapy in children
with cystic fibrosis. Three children with CF, two boys aged 6 and 14
years and one girl aged 15 years, voluntarily participated in the
experimental training program. The patients performed individualized
group exercise three times a week on alternate days for 28
consecutive weeks at an intensity of approximately 75 percent aerobic
capacity. Duration of exercise gradually increased from 15 (3 x 5
minutes) to 60 (3 x 20 minutes) minutes while the rest period after
each exercise was constant at two minutes. PIPE training resulted in
increased physical work capacity and maximal oxygen consumption in
all three subjects. Curiously, these changes were not accompanied by
training bradycardia.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79209</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANON" publication="GUIDELINES GRADED EXERCISE TE" d1="" d2="" d3="975"/>
<CITE num="002" author="ASTRAND PO" publication="J APPL PHYSIOL" d1="7" d2="218" d3="954"/>
<CITE num="003" author="BARACH AL" publication="BULL NY ACAD MED" d1="28" d2="175" d3="973"/>
<CITE num="004" author="BOYLE IR" publication="J PEDIATR" d1="88" d2="318" d3="976"/>
<CITE num="005" author="CHARD MA" publication="IN: SCIPIEN GM" d1="" d2="" d3="975"/>
<CITE num="006" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="007" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="009" author="DOUGLAS WW" publication="AM REV RESPIR DIS" d1="115" d2="559" d3="977"/>
<CITE num="010" author="GROSSMAN ML" publication="CLIN PEDIATR" d1="14" d2="830" d3="975"/>
<CITE num="011" author="HAAS A" publication="MED CLIN NORTH AM" d1="53" d2="593" d3="969"/>
<CITE num="012" author="JANKOWSKI LW" publication="MOREHOUSE C" d1="" d2="" d3="978"/>
<CITE num="013" author="JANKOWSKI LW" publication="CAN J APPL SPORTS SCI" d1="1" d2="277" d3="976"/>
<CITE num="014" author="JANKOWSKI LW" publication="SCAND J REHAB MED" d1="8" d2="135" d3="976"/>
<CITE num="015" author="KANEKO K" publication="J APPL PHYSIOL" d1="21" d2="767" d3="966"/>
<CITE num="016" author="KEENS TG" publication="AM REV RESPIR DIS" d1="116" d2="853" d3="977"/>
<CITE num="017" author="LEFCOE NM" publication="AM J MED" d1="54" d2="343" d3="973"/>
<CITE num="018" author="LORIN MI" publication="AM J PHYS MED" d1="50" d2="215" d3="971"/>
<CITE num="019" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="020" author="MILLER WF" publication="SOUTH MED J" d1="55" d2="1216" d3="962"/>
<CITE num="021" author="PAEZ PN" publication="AM REV RESPIR DIS" d1="95" d2="944" d3="967"/>
<CITE num="022" author="PARKS CR" publication="J PEDIATR" d1="76" d2="305" d3="970"/>
<CITE num="023" author="PATTON RG" publication="IN: WAECHTER EH" d1="" d2="" d3="976"/>
<CITE num="024" author="PIERCE AK" publication="ARCH INTERN MED" d1="113" d2="28" d3="964"/>
<CITE num="025" author="SCHOLANDER PF" publication="J BIOL CHEM" d1="167" d2="235" d3="947"/>
<CITE num="026" author="VYAS GN" publication="AM REV RESPIR DIS" d1="103" d2="390" d3="971"/>
<CITE num="027" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>
<RECORDNUM>01189 </RECORDNUM>
<MEDLINENUM>80121338</MEDLINENUM>
<AUTHORS><AUTHOR>Chu-J-Y</AUTHOR></AUTHORS>
<TITLE>Anemia, hypoproteinemia and edema in an infant with cystic fibrosis.</TITLE>
<SOURCE>Nutr-Rev. 1979 Nov. 37(11). P 351-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INFANT-NUTRITION-DISORDERS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANEMIA: co</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>EDEMA: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPOPROTEINEMIA: co</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>A patient with cystic fibrosis was encountered who presented with
anemia, hypoproteinemia, edema and failure to thrive.  A blood
transfusion resulted in some improvement, but the symptoms recurred
in a few weeks.  Only after the correct diagnosis was made and
appropriate therapy instituted did the patient show signs of
improvement.  The account of this case illustrates the importance of
considering the diagnosis of cystic fibrosis in any child with
malnutrition.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHAHIDI NT" publication="J PEDIATR" d1="59" d2="533" d3="961"/>
<CITE num="002" author="FLEISHER DS" publication="J PEDIATR" d1="64" d2="341" d3="964"/>
<CITE num="003" author="DOLAN TF JR" publication="CLIN PEDIATR" d1="9" d2="295" d3="970"/>
<CITE num="004" author="LEE PA" publication="JAMA" d1="228" d2="585" d3="974"/>
<CITE num="005" author="BASS HN" publication="PEDIATRICS" d1="59" d2="126" d3="977"/>
<CITE num="006" author="GOLDMAN AS" publication="J PEDIATR" d1="59" d2="301" d3="961"/>
<CITE num="007" author="CHASE HP" publication="J PEDIATR" d1="95" d2="337" d3="979"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79210</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ELSEN OH            J" publication="PEDIATR GASTROENTEROL NUTR" d1="1" d2="55 9" d3="2"/>
</CITATIONS>
<RECORDNUM>01190 </RECORDNUM>
<MEDLINENUM>80033423</MEDLINENUM>
<TITLE>Serum vitamin D and related mineral metabolism in cystic fibrosis.</TITLE>
<SOURCE>Nutr-Rev. 1979 Aug. 37(8). P 247-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MINERALS: me</TOPIC><TOPIC>VITAMIN-D: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>Two groups of investigators have independently explored the role of
vitamin D and related mineral metabolism in patients with cystic
fibrosis, and found relatively minor changes.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="IN: VAUGHAN VC III" d1="" d2="903" d3="975"/>
<CITE num="002" author="HAHN TJ" publication="J PEDIATR" d1="94" d2="38" d3="979"/>
<CITE num="003" author="HUBBARD VS" publication="J PEDIATR" d1="94" d2="84" d3="979"/>
<CITE num="004" author="ARNAUD SB" publication="PEDIATRICS" d1="57" d2="221" d3="976"/>
<CITE num="005" author="HUBBARD VS" publication="LANCET" d1="2" d2="1302" d3="977"/>
<CITE num="006" author="HAHN TJ" publication="J CLIN ENDOCRINOL METAB" d1="39" d2="274" d3="974"/>
<CITE num="007" author="ANON" publication="NUTR REV" d1="26" d2="200" d3="968"/>
<CITE num="008" author="REEMTSMA K" publication="PEDIATRICS" d1="22" d2="525" d3="958"/>
<CITE num="009" author="WILKINS L" publication="IN: THOMAS CC" d1="" d2="" d3="965"/>
<CITE num="010" author="ANON" publication="NUTR REV" d1="33" d2="61" d3="975"/>
<CITE num="011" author="HATHCOCK JN" publication="NUTR REV" d1="34" d2="65" d3="976"/>
<CITE num="012" author="ANDERSEN DH" publication="J PEDIATR" d1="15" d2="763" d3="939"/>
<CITE num="013" author="BLOMSTRAND R" publication="ACTA CHEM SCAND" d1="21" d2="1662" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79211</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CW                 AM" publication="J CLIN NUTR" d1="42" d2="44 9" d3="5"/>
</CITATIONS>
<RECORDNUM>01191 </RECORDNUM>
<MEDLINENUM>80121798</MEDLINENUM>
<AUTHORS><AUTHOR>Sherman-A-H</AUTHOR><AUTHOR>Amoore-J-E</AUTHOR><AUTHOR>Weigel-V</AUTHOR></AUTHORS>
<TITLE>The pyridine scale for clinical measurement of olfactory threshold:
a quantitative reevaluation.</TITLE>
<SOURCE>Otolaryngol-Head-Neck-Surg. 1979 Nov-Dec. 87(6). P 717-33.</SOURCE>
<MAJORSUBJ><TOPIC>PYRIDINES: du</TOPIC><TOPIC>SMELL: ph</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>EVALUATION-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INDICATOR-DILUTION-TECHNICS</TOPIC><TOPIC>PERCEPTUAL-DISORDERS: di, et</TOPIC><TOPIC>REFERENCE-VALUES</TOPIC><TOPIC>SENSORY-THRESHOLDS</TOPIC></MINORSUBJ>
<ABSTRACT>Serial dilutions of pyridine in water are employed for measuring the
olfactory detection thresholds of patients. Experimental precautions
are described that improve the precision and accuracy of the method.
Existing data on the sensitivities of hyposmic patients are
confirmed, but the sensitivities of normal subjects and of hyperosmic
patients are believed to have been substantially overestimated in
some earlier publications. Routine clinical applications of the
revised pyridine odor threshold test are discussed. In the author's
experience, the average cystic fibrosis patient is slightly hyposmic,
and some cases of pituitary tumor are accompanied by a 100,000-fold
hyperosmia.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SCHNEIDER RA" publication="N ENGL J MED" d1="277" d2="299" d3="967"/>
<CITE num="002" author="HENKIN RI" publication="IN: HAYASHI T" d1="" d2="" d3="967"/>
<CITE num="003" author="HENKIN RI" publication="IN: BOSMA JF" d1="" d2="" d3="970"/>
<CITE num="004" author="HENKIN RI" publication="LIFE SCI" d1="5" d2="331" d3="966"/>
<CITE num="005" author="AMOORE JE" publication="J CHEM ECOL" d1="1" d2="299" d3="975"/>
<CITE num="006" author="MITCHELL MJ" publication="Q J EXP PSYCHOL" d1="22" d2="301" d3="970"/>
<CITE num="007" author="AMOORE JE" publication="CHEM SENSES FLAVOR" d1="3" d2="57" d3="978"/>
<CITE num="008" author="AMOORE JE" publication="PERCEPT MOT SKILLS" d1="26" d2="143" d3="968"/>
<CITE num="009" author="VENSTROM D" publication="J FOOD SCI" d1="33" d2="264" d3="968"/>
<CITE num="010" author="CHEESMAN GH" publication="Q J EXP PSYCHOL" d1="5" d2="22" d3="953"/>
<CITE num="011" author="PATTERSON PM" publication="J HERED" d1="39" d2="295" d3="948"/>
<CITE num="012" author="HENKIN RI" publication="J CLIN INVEST" d1="45" d2="1631" d3="966"/>
<CITE num="013" author="HENKIN RI" publication="SCIENCE" d1="138" d2="1107" d3="962"/>
<CITE num="014" author="HERTZ J" publication="PHYSIOL BEHAV" d1="14" d2="89" d3="975"/>
<CITE num="015" author="LEMAGNEN J" publication="ARCH SCI PHYSIOL" d1="6" d2="125" d3="952"/>
<CITE num="016" author="AMOORE JE" publication="J CHEM ECOL" d1="1" d2="291" d3="975"/>
<CITE num="017" author="CURTIS RF" publication="NATURE" d1="235" d2="223" d3="972"/>
<CITE num="018" author="GUADAGNI DG" publication="J FOOD SCI" d1="43" d2="1347" d3="978"/>
<CITE num="019" author="HENKIN RI" publication="LANCET" d1="1" d2="823" d3="971"/>
<CITE num="020" author="HENKIN RI" publication="PERFUM FLAVORIST" d1="1" d2="19" d3="976"/>
<CITE num="021" author="STONE H" publication="PERCEPT PSYCHOPHYS" d1="2" d2="516" d3="967"/>
<CITE num="022" author="PARKER GH" publication="SMELL TASTE AND ALLIED SENSES" d1="" d2="" d3="922"/>
<CITE num="023" author="HENKIN RI" publication="LIFE SCI" d1="5" d2="1031" d3="966"/>
<CITE num="024" author="HENKIN RI" publication="JAMA" d1="217" d2="434" d3="971"/>
<CITE num="025" author="AMOORE JE" publication="CHEM SENSES FLAVOR" d1="2" d2="267" d3="977"/>
<CITE num="026" author="AMOORE JE" publication="IN: DENTON DA" d1="" d2="" d3="975"/>
<CITE num="027" author="ALTER M" publication="PATIENT CARE" d1="8" d2="76" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79212</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SOCKI CJ            PR" publication="OC NAT ACAD SCI USA" d1="81" d2="99 9" d3="4"/>
<CITE num="2" author="MOOREGILLON V" publication="J ROY SOC MED" d1="78" d2="435" d3="985"/>
<CITE num="3" author="DOTY RL" publication="CHEM SENSES" d1="11" d2="259" d3="986"/>
<CITE num="4" author="AMOORE JE" publication="J AM WATER WORKS ASSOC" d1="78" d2="70" d3="986"/>
</CITATIONS>
<RECORDNUM>01192 </RECORDNUM>
<MEDLINENUM>80211288</MEDLINENUM>
<AUTHORS><AUTHOR>Vawter-G-F</AUTHOR><AUTHOR>Shwachman-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in adults: an autopsy study.</TITLE>
<SOURCE>Pathol-Annu. 1979. 14 Pt 2. P 357-82.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ARTERIOVENOUS-ANASTOMOSIS: pa</TOPIC><TOPIC>AUTOPSY</TOPIC><TOPIC>BILIARY-TRACT: pa</TOPIC><TOPIC>BRONCHIAL-ARTERIES: pa</TOPIC><TOPIC>BRONCHIECTASIS: pa</TOPIC><TOPIC>ENDOCRINE-GLANDS: pa</TOPIC><TOPIC>EXOCRINE-GLANDS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HOARSENESS: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIVER-CIRRHOSIS-BILIARY: pa</TOPIC><TOPIC>LUNG: pa</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NASAL-POLYPS: pa</TOPIC><TOPIC>PANCREAS: pa</TOPIC><TOPIC>TRACHEITIS: pa</TOPIC><TOPIC>UROGENITAL-SYSTEM: pa</TOPIC></MINORSUBJ>
<ABSTRACT>An annotated catalog of clinical and pathologic observations in an
adult population with CF has been presented. The spectrum of disease
is broad, and the diagnosis usually requires the demonstration of
abnormalities in multiple systems. Tissues of each germ layer have
been found involved in CF. Correlation of clinical and pathologic
observations suggests that manifestations are essentially episodic
and focal. In this population, the most characteristic abnormalities
recognized by the pathologist are focal biliary cirrhosis,
distinctive obstructive lesions of the male genital tract, prolonged
staphylococcal or pseudomonas colonization of respiratory secretions,
and obstructive bronchopulmonary disease. Some form of pancreatic
atrophy is usually present.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="002" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="003" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="389" d3="962"/>
<CITE num="004" author="GELLER A" publication="NEUROLOGY (MINN)" d1="27" d2="185" d3="977"/>
<CITE num="006" author="MELLINS RB" publication="PEDIATRICS" d1="44" d2="315" d3="969"/>
<CITE num="007" author="WARING WW" publication="PEDIATRICS" d1="39" d2="166" d3="967"/>
<CITE num="008" author="FIELD WEH" publication="BR J DIS CHEST" d1="60" d2="66" d3="966"/>
<CITE num="009" author="LIEBOW AA" publication="AM J PATHOL" d1="25" d2="211" d3="949"/>
<CITE num="010" author="LACK EE" publication="HUM PATHOL" d1="8" d2="39" d3="977"/>
<CITE num="012" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="013" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="014" author="FARBER S" publication="ARCH PATHOL" d1="37" d2="238" d3="944"/>
<CITE num="015" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="016" author="ROBERTS WC" publication="AM J MED" d1="32" d2="324" d3="962"/>
<CITE num="017" author="BLANC WA" publication="PEDIATRICS" d1="22" d2="494" d3="958"/>
<CITE num="018" author="ESTERLY NB" publication="AM J DIS CHILD" d1="123" d2="200" d3="972"/>
<CITE num="019" author="KOPITO L" publication="PROC AM PEDIATR SOC ANNU MTG" d1="" d2="" d3="972"/>
<CITE num="020" author="DUNNILL MS" publication="J PATHOL BACTERIOL" d1="77" d2="299" d3="959"/>
<CITE num="021" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="022" author="DOLAN TF JR" publication="J PEDIATR" d1="79" d2="684" d3="971"/>
<CITE num="024" author="HOLSCLAW DS" publication="J UROL" d1="106" d2="568" d3="971"/>
<CITE num="025" author="GILLES FH" publication="J NEUROPATH EX NEUROL" d1="25" d2="138" d3="966"/>
<CITE num="026" author="SUNG JH" publication="J NEUROPATH EXP NEUROL" d1="23" d2="567" d3="964"/>
<CITE num="027" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="028" author="KOPITO LE" publication="PEDIATR RES" d1="10" d2="742" d3="976"/>
<CITE num="029" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79213</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSCLAW DS           CL" publication="IN CHEST MED" d1="1" d2="07 9" d3="0"/>
<CITE num="2" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="3" author="ABDULKARIM FW" publication="GASTROENTEROLOGY" d1="82" d2="758" d3="982"/>
<CITE num="4" author="IANNUCCI A" publication="HUM PATHOL" d1="15" d2="278" d3="984"/>
<CITE num="5" author="MCCARTHY VP" publication="GASTROENTEROLOGY" d1="86" d2="564" d3="984"/>
<CITE num="6" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="314" d3="985"/>
<CITE num="7" author="CASTILE R" publication="AM J DIS CHILD" d1="139" d2="728" d3="985"/>
<CITE num="8" author="STERN RC" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="35" d3="986"/>
<CITE num="9" author="DISIS ML" publication="PEDIATR RES" d1="20" d2="385" d3="986"/>
<CITE num="10" author="TRAVIS WD" publication="AM J CLIN PATHOL" d1="85" d2="419" d3="986"/>
<CITE num="11" author="ABDULKARIM FW" publication="ARCH PATHOL LAB MED" d1="110" d2="602" d3="986"/>
<CITE num="12" author="MCGLENNEN RC" publication="ARCH PATHOL LAB MED" d1="110" d2="879" d3="986"/>
<CITE num="13" author="HERNANZSCHULMAN M" publication="RADIOLOGY" d1="158" d2="629" d3="986"/>
<CITE num="14" author="GRISCOM NT" publication="AM J ROENTGENOL" d1="148" d2="691" d3="987"/>
</CITATIONS>
<RECORDNUM>01193 </RECORDNUM>
<MEDLINENUM>79157663</MEDLINENUM>
<AUTHORS><AUTHOR>Ghadially-F-N</AUTHOR></AUTHORS>
<TITLE>Invited review.  The technique and scope of electron-probe X-ray
analysis in pathology.</TITLE>
<SOURCE>Pathology. 1979 Jan. 11(1). P 95-110. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>ELECTRON-PROBE-MICROANALYSIS: mt</TOPIC><TOPIC>PATHOLOGY: is</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACID-PHOSPHATASE: an</TOPIC><TOPIC>ANTIGENS: me</TOPIC><TOPIC>BISMUTH: an</TOPIC><TOPIC>CALCIUM: an</TOPIC><TOPIC>CELL-NUCLEUS: an</TOPIC><TOPIC>COPPER: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ELECTRON-PROBE-MICROANALYSIS: is</TOPIC><TOPIC>FOREIGN-BODIES: pa</TOPIC><TOPIC>GOLD: an</TOPIC><TOPIC>HEMOSIDERIN: an</TOPIC><TOPIC>HEPATOLENTICULAR-DEGENERATION: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG: an</TOPIC><TOPIC>METALS: an</TOPIC><TOPIC>MINERALS: an</TOPIC><TOPIC>MITOCHONDRIA: an</TOPIC><TOPIC>NAILS: an</TOPIC><TOPIC>PROSTHESIS</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>STAINS-AND-STAINING</TOPIC></MINORSUBJ>
<EXTRACT>The purpose of this article is to review briefly both the techniques
and applications of electron-probe x-ray analysis, but only studies
of interest to pathologists will be dealt with.  The principles of
x-ray fluorescence spectrometry, the capabilities and limitations of
energy dispersive x-ray analysis, equipment, specimen preparation,
and the method of electron-probe x-ray analysis are discussed.
Applications of electron-probe x-ray analysis include mineral
deposits in lungs, intranuclear bismuth inclusions, gold deposits in
tissues, the nature of haemosiderin, copper in Wilson's disease,
calcium in mitochondria, surgical implants, foreign bodies in eyes
and wounds, the specificity of v. Kossa method for calcium,
cytochemical localization of acid phosphatase, chromaffin and
argentaffin reactions, the transfer of antigenic material from
macrophages to lymphocytes, and the diagnosis of cystic fibrosis by
electron-probe x-ray analysis of nails.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BEAVER DL" publication="ARCH PATHOL" d1="76" d2="89" d3="963"/>
<CITE num="002" author="BEEUWKES R 3RD" publication="KIDNEY INT" d1="12" d2="435" d3="977"/>
<CITE num="003" author="BERRY JP" publication="AM J PATHOL" d1="83" d2="427" d3="976"/>
<CITE num="004" author="BORLAND RM" publication="DEVELOP BIOL" d1="50" d2="201" d3="976"/>
<CITE num="005" author="BUJA LM" publication="J HISTOCHEM CYTOCHEM" d1="24" d2="508" d3="976"/>
<CITE num="006" author="BURR RE" publication="TOXICOL APPL PHARMACOL" d1="7" d2="588" d3="965"/>
<CITE num="007" author="CHANDLER JA" publication="X-RAY MICROANALYSIS ELECTRON" d1="" d2="" d3="977"/>
<CITE num="008" author="CHISHOLM IA" publication="CAN J OPHTHALMOL" d1="12" d2="316" d3="977"/>
<CITE num="009" author="CHONG AP" publication="AM J OBSTET GYNECOL" d1="128" d2="209" d3="977"/>
<CITE num="010" author="CLARKE JA" publication="NATURE" d1="227" d2="69" d3="971"/>
<CITE num="011" author="ECHLIN P" publication="NATURE" d1="270" d2="102" d3="977"/>
<CITE num="012" author="ELEY BM" publication="HISTOCHEM J" d1="8" d2="647" d3="976"/>
<CITE num="013" author="ESSNER E" publication="IN: HAYAT MA" d1="1" d2="" d3="973"/>
<CITE num="014" author="FOWLER BA" publication="J HISTOCHEM CYTOCHEM" d1="23" d2="722" d3="975"/>
<CITE num="015" author="GARDNER DL" publication="J PATHOL" d1="98" d2="105" d3="969"/>
<CITE num="016" author="GHADIALLY FN" publication="ULTRASTRUCTURAL PATHOL CELL" d1="" d2="" d3="975"/>
<CITE num="017" author="GHADIALLY FN" publication="J PATHOL" d1="120" d2="201" d3="976"/>
<CITE num="018" author="GHADIALLY FN" publication="J PATHOL" d1="124" d2="77" d3="978"/>
<CITE num="019" author="GHADIALLY FN" publication="VIRCHOWS ARCH CELL PATHOL" d1="22" d2="135" d3="976"/>
<CITE num="021" author="GHADIALLY FN" publication="VIRCHOWS ARCH CELL PATHOL" d1="16" d2="43" d3="974"/>
<CITE num="022" author="GHADIALLY FN" publication="ANN RHEUM DIS" d1="35" d2="67" d3="976"/>
<CITE num="023" author="GHADIALLY FN" publication="J PATHOL" d1="123" d2="181" d3="977"/>
<CITE num="024" author="GHADIALLY FN" publication="VIRCHOWS ARCH CELL PATHOL" d1="21" d2="45" d3="976"/>
<CITE num="025" author="GOLDFISCHER S" publication="AM J PATHOL" d1="53" d2="883" d3="968"/>
<CITE num="026" author="GOLDFISCHER S" publication="J HISTOCHEM CYTOCHEM" d1="12" d2="72" d3="964"/>
<CITE num="027" author="HARRISON JD" publication="J PATHOL" d1="121" d2="83" d3="977"/>
<CITE num="028" author="HESS H" publication="KLIN WOCHENSCHR" d1="50" d2="776" d3="972"/>
<CITE num="029" author="LALONDE JMA" publication="VIRCHOWS ARCH CELL PATHOL" d1="25" d2="221" d3="977"/>
<CITE num="031" author="LANGHANS" publication="Z CHIR" d1="22" d2="575" d3="885"/>
<CITE num="032" author="LECHENE CP" publication="AM J PHYSIOL" d1="232" d2="F391" d3="977"/>
<CITE num="033" author="LEVER JD" publication="J HISTOCHEM CYTOCHEM" d1="25" d2="275" d3="977"/>
<CITE num="034" author="MAUGH TH" publication="SCIENCE" d1="197" d2="356" d3="977"/>
<CITE num="035" author="NORTON WL" publication="ARTHRITIS RHEUM" d1="11" d2="436" d3="968"/>
<CITE num="036" author="ORYSCHAK AF" publication="VIRCHOWS ARCH CELL PATHOL" d1="17" d2="159" d3="974"/>
<CITE num="037" author="ORYSCHAK AF" publication="VIRCHOWS ARCH CELL PATHOL" d1="20" d2="29" d3="976"/>
<CITE num="038" author="ORYSCHAK AF" publication="J PATHOL" d1="119" d2="183" d3="976"/>
<CITE num="039" author="PAPPENHEIMER AM" publication="AM J PATHOL" d1="10" d2="577" d3="934"/>
<CITE num="040" author="REED GB" publication="ARCH PATHOL" d1="93" d2="249" d3="972"/>
<CITE num="041" author="RICHTER GW" publication="J EXP MED" d1="106" d2="203" d3="957"/>
<CITE num="042" author="ROOMANS GM" publication="ACTA PAEDIATR SCAND" d1="67" d2="89" d3="978"/>
<CITE num="043" author="RUSS JC" publication="PROC SCANNING ELECTRO 5TH ANN" d1="" d2="" d3="972"/>
<CITE num="044" author="RYDER TA" publication="J MICROSC" d1="101" d2="143" d3="974"/>
<CITE num="045" author="SALSBURY AJ" publication="PROC R SOC MED" d1="65" d2="826" d3="972"/>
<CITE num="046" author="SELZER S" publication="ORAL SURG" d1="35" d2="828" d3="973"/>
<CITE num="047" author="SHUMAN H" publication="PROC NAT ACAD SCI USA" d1="73" d2="1193" d3="976"/>
<CITE num="048" author="SIPPONEN P" publication="ARCH PATHOL LAB MED" d1="100" d2="664" d3="976"/>
<CITE num="049" author="STUMP IG" publication="CLIN BIOCHEM" d1="10" d2="127" d3="977"/>
<CITE num="050" author="STURGEON P" publication="IN: WOLMAN M" d1="" d2="" d3="969"/>
<CITE num="051" author="THOMAS I" publication="VIRCHOWS ARCH CELL PATHOL" d1="26" d2="105" d3="977"/>
<CITE num="052" author="WACHSTEIN M" publication="AM J CLIN PATHOL" d1="19" d2="608" d3="949"/>
<CITE num="053" author="WACHSTEIN M" publication="AM J PATHOL" d1="22" d2="603" d3="946"/>
<CITE num="054" author="WOOD JG" publication="ACTA HISTOCHEM" d1="52" d2="143" d3="975"/>
<CITE num="055" author="YAROM R" publication="VIRCHOWS ARCH CELL PATHOL" d1="15" d2="11" d3="973"/>
<CITE num="056" author="YAROM R" publication="J HISTOCHEM CYTOCHEM" d1="24" d2="453" d3="976"/>
<CITE num="057" author="ZS-NAGY I" publication="J ULTRASTRUCT RES" d1="58" d2="22" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79214</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AW CF               IN" publication="ORG PERSP BIOL MED" d1="2" d2="87 9" d3="9"/>
<CITE num="2" author="GHADIALLY FN" publication="CRC CRIT REV TOXICOL" d1="6" d2="303" d3="979"/>
<CITE num="3" author="GHADIALLY FN" publication="J SUBMICROSC CYTOL" d1="11" d2="503" d3="979"/>
<CITE num="4" author="HALL TA" publication="J MICROSC" d1="117" d2="145" d3="979"/>
<CITE num="5" author="BACHMANN S" publication="CELL TISSUE RES" d1="213" d2="109" d3="980"/>
<CITE num="6" author="DODSON RF" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="365" d3="981"/>
<CITE num="7" author="GHADIALLY FN" publication="J SUBMICROSC CYTOL" d1="13" d2="455" d3="981"/>
<CITE num="8" author="MORETON RB" publication="BIOL REV" d1="56" d2="409" d3="981"/>
<CITE num="9" author="DINSDALE D" publication="EXP MOL PATH" d1="36" d2="396" d3="982"/>
<CITE num="10" author="GHADIALLY FN" publication="VIRCHOWS ARCH CELL PATHOL" d1="39" d2="21" d3="982"/>
<CITE num="11" author="DAVID H" publication="BIOL ZENTRALBL" d1="101" d2="715" d3="982"/>
<CITE num="12" author="WEINER JM" publication="MED J AUST" d1="1" d2="272" d3="983"/>
<CITE num="13" author="WANG NS" publication="HUM PATHOL" d1="14" d2="888" d3="983"/>
<CITE num="14" author="BRAIN TJ" publication="PATHOLOGY" d1="15" d2="336" d3="983"/>
<CITE num="15" author="GOLIGORSKY MS" publication="NEPHRON" d1="35" d2="89" d3="983"/>
<CITE num="16" author="MUKHERJEE TM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="663" d3="983"/>
<CITE num="17" author="GHADIALLY FN" publication="J SUBMICROSC CYTOL" d1="16" d2="773" d3="984"/>
<CITE num="18" author="WOZNIEWICZ B" publication="FOLIA HISTOCHEM CYTOBIOL" d1="22" d2="162" d3="984"/>
<CITE num="19" author="FUNAHASHI A" publication="CHEST" d1="85" d2="506" d3="984"/>
<CITE num="20" author="HOOK GR" publication="J AM COLL NUTR" d1="4" d2="599" d3="985"/>
<CITE num="21" author="GOLIGORSKY MS" publication="MINERAL ELECTROL METAB" d1="11" d2="301" d3="985"/>
<CITE num="22" author="TERZAKIS JA" publication="ORAL SURG" d1="59" d2="399" d3="985"/>
<CITE num="23" author="WARLEY A" publication="J CELL SCI" d1="75" d2="401" d3="985"/>
<CITE num="24" author="BAKER D" publication="SCANN ELECTRON MICROSC" d1="1985" d2="659" d3="985"/>
<CITE num="25" author="HALL TA" publication="MICRON MICROSC ACTA" d1="17" d2="91" d3="986"/>
<CITE num="26" author="HARTMAN LC" publication="J ORAL MAXILLOFAC SURG" d1="44" d2="628" d3="986"/>
</CITATIONS>
<RECORDNUM>01194 </RECORDNUM>
<MEDLINENUM>80033905</MEDLINENUM>
<AUTHORS><AUTHOR>Cox-D-W</AUTHOR><AUTHOR>Talamo-R-C</AUTHOR></AUTHORS>
<TITLE>Genetic aspects of pediatric lung disease.</TITLE>
<SOURCE>Pediatr-Clin-North-Am. 1979 Aug. 26(3). P 467-80.</SOURCE>
<MAJORSUBJ><TOPIC>LUNG-DISEASES: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALPHA-1-ANTITRYPSIN: df</TOPIC><TOPIC>ASTHMA: fg</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CILIA: pa</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, pp</TOPIC><TOPIC>DEFICIENCY-DISEASES: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KARTAGENER-TRIAD: fg, pp</TOPIC><TOPIC>LUNG-DISEASES: im</TOPIC></MINORSUBJ>
<ABSTRACT>Several genetic diseases are described which affect the lung,
usually or at least in some cases, in the pediatric age group.
The four disorders discussed have been selected wither for their
high frequency or for their demonstration of the variety of ways in
which genetic factors can influence disease: cystic fibrosis, one of
the most common of the metabolic disorders inherited as an autosomal
recessive trait; immotile cilia syndrome, including Kartagener's
syndrome, single gene disorders involving structural abnormalities
of the cilia; asthma, a common disorder in children with a genetic
component; and alpha1-antitrypsin deficiency, an inherited protein
deficiency commonly causing obstructive lung disease in adults and
occasionally affecting children.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="AFZELIUS BA" publication="SCIENCE" d1="193" d2="317" d3="976"/>
<CITE num="002" author="BIAS WB" publication="IN: AUSTEN KF" d1="" d2="" d3="973"/>
<CITE num="003" author="BOIS E" publication="CLIN GENET" d1="14" d2="73" d3="978"/>
<CITE num="004" author="COX DW" publication="AM REV RESPIR DIS" d1="113" d2="601" d3="976"/>
<CITE num="006" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="008" author="ELIASSON R" publication="N ENGL J MED" d1="297" d2="1" d3="977"/>
<CITE num="009" author="FAGERHOL MK" publication="CLIN CHIM ACTA" d1="16" d2="199" d3="967"/>
<CITE num="010" author="FALLIERS CJ" publication="J ALLERGY" d1="47" d2="207" d3="971"/>
<CITE num="011" author="FISCHER TJ" publication="PEDIATRICS" d1="62" d2="443" d3="978"/>
<CITE num="012" author="GARROD AE" publication="Q J MED" d1="6" d2="242" d3="913"/>
<CITE num="013" author="GORDIS L" publication="EPIDEMIOL CHRONIC LUNG DIS IN" d1="" d2="" d3="973"/>
<CITE num="014" author="GRUNDBACHER FJ" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="104" d3="975"/>
<CITE num="015" author="HOLMES LB" publication="AM J MED SCI" d1="255" d2="13" d3="968"/>
<CITE num="016" author="HOUSTEK J" publication="CHEST" d1="64" d2="773" d3="973"/>
<CITE num="017" author="KARTAGENER M" publication="BEITR KLIN TUBERK" d1="83" d2="489" d3="933"/>
<CITE num="018" author="KARTAGENER M" publication="ARCH PEDIATR" d1="79" d2="193" d3="962"/>
<CITE num="019" author="KONIG P" publication="J ALLERGY CLIN IMMUNOL" d1="54" d2="280" d3="974"/>
<CITE num="020" author="KUEPPERS F" publication="IN: LENFANT C" d1="13" d2="" d3="978"/>
<CITE num="021" author="KUEPPERS F" publication="AM REV RESPIR DIS" d1="110" d2="176" d3="974"/>
<CITE num="022" author="LAURELL CB" publication="SCAND J CLIN LAB INVEST" d1="15" d2="132" d3="963"/>
<CITE num="023" author="LOGAN WD" publication="DIS CHEST" d1="48" d2="613" d3="965"/>
<CITE num="024" author="LUCK D" publication="PROC NAT ACAD SCI USA" d1="74" d2="3456" d3="977"/>
<CITE num="025" author="MARSH DG" publication="SCIENCE" d1="179" d2="691" d3="973"/>
<CITE num="026" author="MOROZ SP" publication="J PEDIATR" d1="88" d2="19" d3="976"/>
<CITE num="027" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="59" d2="55" d3="978"/>
<CITE num="028" author="MOSSBERG B" publication="MT SINAI J MED" d1="44" d2="837" d3="977"/>
<CITE num="029" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="030" author="PIERCE JA" publication="ANAL BIOCHEM" d1="74" d2="227" d3="976"/>
<CITE num="031" author="SCHAAP T" publication="IN: MANGOS JA" d1="" d2="291" d3="976"/>
<CITE num="032" author="SCHWARTZ M" publication="ACTA ALLERGOL SUPPL II" d1="5" d2="" d3="952"/>
<CITE num="033" author="SHARP HL" publication="J LAB CLIN MED" d1="73" d2="934" d3="969"/>
<CITE num="034" author="STURGESS JM" publication="N ENGL J MED" d1="300" d2="53" d3="979"/>
<CITE num="035" author="SVEGER T" publication="N ENGL J MED" d1="294" d2="1316" d3="976"/>
<CITE num="036" author="TALAMO RC" publication="J PEDIATR" d1="79" d2="20" d3="971"/>
<CITE num="037" author="TORGERSEN J" publication="ACTA RADIOL" d1="28" d2="17" d3="947"/>
<CITE num="038" author="TORGERSEN J" publication="AM J HUM GENET" d1="2" d2="361" d3="950"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79215</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ZELIUS BA           AM" publication="J HUM GENET" d1="33" d2="52 9" d3="1"/>
<CITE num="2" author="TURNER JAP" publication="PEDIATRICS" d1="67" d2="805" d3="981"/>
<CITE num="3" author="HURWITZ RC" publication="CLIN GENET" d1="22" d2="7" d3="982"/>
<CITE num="4" author="YARNAL JR" publication="POSTGRAD MED" d1="71" d2="195" d3="982"/>
<CITE num="5" author="RIMPELA A" publication="ACTA PAEDIATR SCAND SUPPL" d1="1982" d2="1" d3="982"/>
<CITE num="6" author="LEVISON H" publication="EUR J RESPIR DIS" d1="64" d2="102" d3="983"/>
<CITE num="7" author="CANET E" publication="PRESSE MED" d1="13" d2="1607" d3="984"/>
<CITE num="8" author="NADEL HR" publication="RADIOLOGY" d1="154" d2="651" d3="985"/>
<CITE num="9" author="STURGESS JM" publication="AM J MED GENET" d1="25" d2="149" d3="986"/>
</CITATIONS>
<RECORDNUM>01195 </RECORDNUM>
<MEDLINENUM>80033914</MEDLINENUM>
<AUTHORS><AUTHOR>Gurwitz-D</AUTHOR><AUTHOR>Corey-M</AUTHOR><AUTHOR>Francis-P-W</AUTHOR><AUTHOR>Crozier-D</AUTHOR><AUTHOR>Levison-H</AUTHOR></AUTHORS>
<TITLE>Perspectives in cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Clin-North-Am. 1979 Aug. 26(3). P 603-15.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, fg, ra</TOPIC><TOPIC>GROWTH</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG: pp</TOPIC><TOPIC>SEX-FACTORS</TOPIC><TOPIC>VENTILATION-PERFUSION-RATIO</TOPIC></MINORSUBJ>
<EXTRACT>It would seem that early diagnosis of cystic fibrosis and the
institution of an aggressive treatment program before widespread
irreversible lung damage has occurred may greatly prolong survival.
Individual prediction at the time of diagnosis is impossible, but
there are a number of factors which, when considered together, enable
the clinician to place patients in a number of broadly defined risk
groups.  It is the definition and characteristics of these groups
which would help the physician in assessment, counseling, and
follow-up of patients with cystic fibrosis which are addressed in
this article.  The heterogeneity of cystic fibrosis, sex differences,
presentation and age at diagnosis, pulmonary function, radiologic
assessment, and projections for the future are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BEDROSSIAN CWM" publication="HUM PATHOL" d1="7" d2="195" d3="976"/>
<CITE num="002" author="CHALON J" publication="JAMA" d1="218" d2="1928" d3="971"/>
<CITE num="003" author="COOPER DM" publication="AM REV RESPIR DIS" d1="109" d2="519" d3="974"/>
<CITE num="004" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="005" author="COREY M" publication="CF CLUB ABST" d1="" d2="" d3="978"/>
<CITE num="006" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="007" author="ANON" publication="CF FND 1976 REP SURVI STUD PA" d1="" d2="" d3="978"/>
<CITE num="008" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="009" author="DI SANTAGNESE PA" publication="AM J MED" d1="66" d2="121" d3="979"/>
<CITE num="010" author="FEATHERBY EA" publication="AM REV RESPIR DIS" d1="102" d2="737" d3="970"/>
<CITE num="011" author="FOX WW" publication="PEDIATRICS" d1="54" d2="293" d3="974"/>
<CITE num="013" author="GRACEY M" publication="AUSTRALAS ANN MED" d1="18" d2="91" d3="969"/>
<CITE num="014" author="HAYASHI M" publication="AM REV RESPIR DIS" d1="115" d2="595" d3="977"/>
<CITE num="015" author="HUTCHEON M" publication="AM REV RESPIR DIS" d1="110" d2="458" d3="974"/>
<CITE num="017" author="KEENS TG" publication="AM REV RESPIR DIS" d1="116" d2="853" d3="977"/>
<CITE num="018" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="64" d2="477" d3="975"/>
<CITE num="019" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="020" author="LAMARRE A" publication="PEDIATRICS" d1="50" d2="291" d3="972"/>
<CITE num="021" author="LAPIERRE JG" publication="CAN PAED SOC ANN MTG ABST" d1="" d2="61" d3="975"/>
<CITE num="022" author="LEVISON H" publication="IN: MANGOS JA" d1="" d2="3" d3="976"/>
<CITE num="023" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
<CITE num="024" author="MANSELL A" publication="AM REV RESPIR DIS" d1="109" d2="190" d3="974"/>
<CITE num="025" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="026" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="027" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="028" author="REID L" publication="MOD PROBL PEDIATR" d1="10" d2="195" d3="967"/>
<CITE num="029" author="REILLY BJ" publication="RADIOLOGY" d1="98" d2="281" d3="971"/>
<CITE num="030" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="031" author="SHWACHMAN H" publication="BIRTH DEF ORIG ART SER" d1="8" d2="102" d3="972"/>
<CITE num="032" author="SHWACHMAN H" publication="CURR PROB PEDIATR NO 10" d1="8" d2="" d3="978"/>
<CITE num="033" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="034" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="035" author="STERN RC" publication="JAMA" d1="239" d2="2676" d3="978"/>
<CITE num="036" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="037" author="WARWICK WJ" publication="J CHRON DIS" d1="28" d2="609" d3="975"/>
<CITE num="038" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="039" author="YEAGER H JR" publication="PROC SOC EXP BIOL MED" d1="155" d2="115" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79216</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSCLAW DS           CL" publication="IN CHEST MED" d1="1" d2="07 9" d3="0"/>
<CITE num="2" author="SVENONIUS E" publication="RESPIRATION" d1="40" d2="226" d3="980"/>
<CITE num="3" author="BELL L" publication="J CAN DIET ASSOC" d1="42" d2="62" d3="981"/>
<CITE num="4" author="CORKEY CWB" publication="AM REV RESPIR DIS" d1="124" d2="544" d3="981"/>
<CITE num="5" author="CORKEY CWB" publication="AM J OBSTET GYNECOL" d1="140" d2="737" d3="981"/>
<CITE num="6" author="GASKIN K" publication="J PEDIATR" d1="100" d2="857" d3="982"/>
<CITE num="7" author="MCLAUGHLIN FJ" publication="J PEDIATR" d1="100" d2="863" d3="982"/>
<CITE num="8" author="NOLAN G" publication="J PEDIATR" d1="101" d2="626" d3="982"/>
<CITE num="9" author="PARSONS HG" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="44" d3="983"/>
<CITE num="10" author="PENCHARZ PB" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="400" d3="983"/>
<CITE num="11" author="SINNEMA G" publication="ACTA PAEDIATR SCAND" d1="72" d2="427" d3="983"/>
<CITE num="12" author="BIBERSTEIN M" publication="AM J CLIN PATHOL" d1="80" d2="752" d3="983"/>
<CITE num="13" author="CHACE KV" publication="CLIN CHIM ACTA" d1="132" d2="143" d3="983"/>
<CITE num="14" author="BLYTHE SA" publication="CLIN BIOCHEM" d1="17" d2="277" d3="984"/>
<CITE num="15" author="WELLS AL" publication="J FOOD NUTR" d1="41" d2="65" d3="984"/>
<CITE num="16" author="COREY M" publication="J INFECT DIS" d1="149" d2="283" d3="984"/>
<CITE num="17" author="WANG EEL" publication="N ENGL J MED" d1="311" d2="1653" d3="984"/>
<CITE num="18" author="CANCIANI M" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="735" d3="985"/>
<CITE num="19" author="SCULLY BE" publication="REV INFECT DIS" d1="7" d2="S669" d3="985"/>
<CITE num="20" author="CHACE KV" publication="BIOCHEMISTRY" d1="24" d2="7334" d3="985"/>
<CITE num="21" author="LAMBERTY JM" publication="ANAESTHESIA" d1="40" d2="448" d3="985"/>
<CITE num="22" author="SIMMONS RJ" publication="PSYCHOSOM MED" d1="47" d2="111" d3="985"/>
<CITE num="23" author="LEVY LD" publication="J PEDIATR" d1="107" d2="225" d3="985"/>
<CITE num="24" author="TABLAN OC" publication="J PEDIATR" d1="107" d2="382" d3="985"/>
<CITE num="25" author="WIESEMANN HG" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="726" d3="985"/>
<CITE num="26" author="MELLIS CM" publication="MED J AUST" d1="143" d2="227" d3="985"/>
<CITE num="27" author="LEVY L" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="97" d3="986"/>
<CITE num="28" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="29" author="SOUTTER VL" publication="CLIN GASTROENTEROL" d1="15" d2="137" d3="986"/>
<CITE num="30" author="OLOUGHLIN E" publication="AM J CLIN NUTR" d1="43" d2="732" d3="986"/>
<CITE num="31" author="TSUI LC" publication="COLD SPRING HARBOR SYMP Q BIO" d1="51" d2="325" d3="986"/>
<CITE num="32" author="MARCOTTE JE" publication="CHEST" d1="90" d2="375" d3="986"/>
<CITE num="33" author="LEVY L" publication="J PEDIATR" d1="108" d2="1038" d3="986"/>
<CITE num="34" author="SHEPHERD RW" publication="J PEDIATR" d1="109" d2="788" d3="986"/>
<CITE num="35" author="WANG EEL" publication="PEDIATR INFECT DIS J" d1="6" d2="256" d3="987"/>
</CITATIONS>
<RECORDNUM>01196 </RECORDNUM>
<MEDLINENUM>80012551</MEDLINENUM>
<AUTHORS><AUTHOR>Pearson-R-D</AUTHOR><AUTHOR>Lubin-A-H</AUTHOR></AUTHORS>
<TITLE>Increased heparin binding in cystic fibrosis: a reflection of
altered glycoprotein biosynthesis?.</TITLE>
<SOURCE>Pediatr-Res. 1979 Jul. 13(7). P 834-40.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GLYCOPROTEINS: bi</TOPIC><TOPIC>HEPARIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CARBOHYDRATES: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GLYCOPROTEINS: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROTEIN-BINDING</TOPIC></MINORSUBJ>
<ABSTRACT>Some of the serum proteins which bind to heparin and contribute to
the pH 5.57 "heparin binding capacity" of human serum are
glycoproteins; those from cystic fibrosis serum were found to be 27%
higher in fucose (methylpentose) content, 27% lower in sialic acid
content, and 31% lower in hexose content when compared to heparin-
precipitated serum glycoproteins from normal control subjects.
Hexosamine content of the heparin-precipitated serum glycoproteins
was the same. Results of this preliminary investigation indicate that
altered carbohydrate composition in serum glycoproteins may affect
significantly their heparin binding capacity.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALTLAND K" publication="HUMANGENETIK" d1="28" d2="207" d3="975"/>
<CITE num="002" author="AYALA W" publication="J CLIN INVEST" d1="30" d2="781" d3="951"/>
<CITE num="003" author="BAIG MM" publication="J PEDIATR" d1="86" d2="72" d3="975"/>
<CITE num="004" author="BARTMAN J" publication="J PEDIATR" d1="76" d2="430" d3="970"/>
<CITE num="005" author="BENNETT G" publication="J CELL BIOL" d1="60" d2="258" d3="974"/>
<CITE num="006" author="BITTER T" publication="ANAL BIOCHEM" d1="4" d2="330" d3="962"/>
<CITE num="007" author="BOAT TF" publication="AM REV RESPIR DIS" d1="110" d2="428" d3="974"/>
<CITE num="008" author="BOWMAN BH" publication="TEX REP BIOL MED" d1="31" d2="611" d3="973"/>
<CITE num="009" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="010" author="CHANGUS JE" publication="ARCH PATHOL LAB MED" d1="100" d2="7" d3="976"/>
<CITE num="011" author="CHANGUS JE" publication="AM J PATHOL" d1="80" d2="317" d3="975"/>
<CITE num="012" author="COBURN AF" publication="TRANS ASSOC AM PHYSICIANS" d1="66" d2="308" d3="953"/>
<CITE num="013" author="COBURN AF" publication="J EXP MED" d1="99" d2="1" d3="954"/>
<CITE num="014" author="COBURN AF" publication="ARCH INTERN MED" d1="92" d2="185" d3="953"/>
<CITE num="015" author="CONOD EJ" publication="PEDIATR RES" d1="9" d2="724" d3="975"/>
<CITE num="016" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="017" author="CUNNINGHAM DG" publication="ILL MED J" d1="145" d2="493" d3="974"/>
<CITE num="018" author="CURRAN RC" publication="BIOCHEM SOC SYMP" d1="20" d2="24" d3="961"/>
<CITE num="019" author="DANES BS" publication="LANCET" d1="2" d2="765" d3="973"/>
<CITE num="020" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="021" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="022" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="19" d2="252" d3="957"/>
<CITE num="023" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="024" author="DISCHE Z" publication="J BIOL CHEM" d1="167" d2="189" d3="947"/>
<CITE num="025" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="026" author="DISCHE Z" publication="ANN NY ACAD SCI" d1="93" d2="526" d3="962"/>
<CITE num="027" author="DISCHE Z" publication="J BIOL CHEM" d1="175" d2="595" d3="948"/>
<CITE num="028" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="251" d3="973"/>
<CITE num="029" author="DOGGETT RG" publication="TEX REP BIOL MED" d1="31" d2="685" d3="973"/>
<CITE num="030" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="250" d3="973"/>
<CITE num="031" author="EHRLICH J" publication="J PHARM SCI" d1="62" d2="517" d3="973"/>
<CITE num="032" author="GUHA AK" publication="CLIN BIOCHEM" d1="10" d2="153" d3="977"/>
<CITE num="033" author="GOLDBERG AL" publication="ANNU REV BIOCHEM" d1="45" d2="835" d3="974"/>
<CITE num="034" author="GOLDBERG AL" publication="ANNU REV BIOCHEM" d1="45" d2="747" d3="976"/>
<CITE num="035" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="036" author="JOHANSEN PG" publication="LANCET" d1="1" d2="455" d3="968"/>
<CITE num="037" author="KRAUS I" publication="PEDIATRICS" d1="47" d2="1010" d3="971"/>
<CITE num="038" author="LOUISOT P" publication="CLIN CHIM ACTA" d1="48" d2="373" d3="973"/>
<CITE num="039" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="040" author="LUSTIG B" publication="BIOCHEM Z" d1="242" d2="320" d3="931"/>
<CITE num="041" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="042" author="MARTIN F" publication="DIGESTION" d1="1" d2="165" d3="968"/>
<CITE num="043" author="MATALON R" publication="LANCET" d1="2" d2="838" d3="969"/>
<CITE num="044" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="045" author="MCMANUS SP" publication="IR J MED SCI" d1="143" d2="227" d3="974"/>
<CITE num="046" author="MOLNAR J" publication="MOL CELL BIOCHEM" d1="6" d2="3" d3="975"/>
<CITE num="047" author="NOVAK RA" publication="TEX REP BIOL MED" d1="34" d2="199" d3="976"/>
<CITE num="048" author="PADDAY JF" publication="IN: BALAZS EA" d1="2" d2="" d3="970"/>
<CITE num="049" author="PEARSON RD" publication="HEALTH LAB SCI" d1="15" d2="32" d3="978"/>
<CITE num="050" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="051" author="RAO GJS" publication="PEDIATR RES" d1="11" d2="981" d3="977"/>
<CITE num="052" author="RIMINGTON C" publication="BIOCHEM J" d1="34" d2="931" d3="940"/>
<CITE num="053" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="054" author="SLACK J" publication="J LAB CLIN MED" d1="59" d2="302" d3="962"/>
<CITE num="055" author="SPIRO RG" publication="N ENGL J MED" d1="281" d2="991" d3="969"/>
<CITE num="056" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="057" author="STURGESS JM" publication="BIOCHIM BIOPHYS ACTA" d1="320" d2="123" d3="973"/>
<CITE num="058" author="WEIMER HR" publication="AM REV TUBERC" d1="68" d2="594" d3="952"/>
<CITE num="059" author="WIESMANN UN" publication="J PEDIATR" d1="77" d2="685" d3="970"/>
<CITE num="060" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="061" author="WILSON GB" publication="CLIN CHIM ACTA" d1="49" d2="79" d3="973"/>
<CITE num="062" author="WINZLER RJ" publication="METHODS BIOCHEM ANAL" d1="2" d2="279" d3="955"/>
<CITE num="063" author="WINZLER RJ" publication="IN: JEANLOZ RW" d1="2A" d2="" d3="965"/>
<CITE num="064" author="YOUNG MD" publication="BIOCHIM BIOPHYS ACTA" d1="141" d2="374" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79217</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="93" d2="50" d3="980"/>
<CITE num="3" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="4" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="938" d3="982"/>
<CITE num="5" author="MARGOLIES R" publication="PEDIATR RES" d1="16" d2="181" d3="982"/>
<CITE num="6" author="SCANLIN TF" publication="BIOCHEMISTRY" d1="21" d2="491" d3="982"/>
<CITE num="7" author="MARGOLIES R" publication="PEDIATR RES" d1="17" d2="931" d3="983"/>
<CITE num="8" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="9" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="134" d2="1" d3="983"/>
<CITE num="10" author="SLOMIANY A" publication="BIOCHIM BIOPHYS ACTA" d1="750" d2="253" d3="983"/>
<CITE num="11" author="GUEANT JL" publication="CLIN CHIM ACTA" d1="143" d2="217" d3="984"/>
<CITE num="12" author="SCANLIN TF" publication="PEDIATR RES" d1="19" d2="368" d3="985"/>
<CITE num="13" author="HUHLE D" publication="Z KLIN MED" d1="40" d2="1199" d3="985"/>
</CITATIONS>
<RECORDNUM>01197 </RECORDNUM>
<MEDLINENUM>80012535</MEDLINENUM>
<AUTHORS><AUTHOR>Mawhinney-T-P</AUTHOR><AUTHOR>Feather-M-S</AUTHOR><AUTHOR>Martinez-J-R</AUTHOR><AUTHOR>Barbero-G-J</AUTHOR></AUTHORS>
<TITLE>The chronically reserpinized rat as an animal model for cystic
fibrosis: I. Acute effect of isoproterenol and pilocarpine upon
pulmonary lavage fluid.</TITLE>
<SOURCE>Pediatr-Res. 1979 Jun. 13(6). P 760-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: ci</TOPIC><TOPIC>ISOPROTERENOL: pd</TOPIC><TOPIC>LUNG: de</TOPIC><TOPIC>PILOCARPINE: pd</TOPIC><TOPIC>RESERPINE: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CARBOHYDRATES: me</TOPIC><TOPIC>CHOLESTEROL: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>IRRIGATION</TOPIC><TOPIC>LIPIDS: me</TOPIC><TOPIC>LUNG: me</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHOSPHATIDYLCHOLINES: me</TOPIC><TOPIC>PHOSPHOLIPIDS: me</TOPIC><TOPIC>PROTEINS: me</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<ABSTRACT>Lung lavage samples from rats treated in a chronic fashion with
reserpine had mean increases of 133, 170, and 120% in the total
protein, lipid, and carbohydrate contents, respectively, when
compared with those of untreated control animals, when these values
were expressed in terms of body weight.  An acute single ip
injection of the beta-adrenergic agent isoproterenol (10 mg)
increased the glycoprotein content of pulmonary lavage fluid from
control rats approximately 15-19%, but only 9-10% in those from
reserpine treated rats.  By contrast, pilocarpine (10 mg),
administered in the same manner, caused a 15% increase in the total
protein, carbohydrate, and lipid content of lavage samples from
control rats and increased these same constituents in the lavage
samples of reserpine treated rats 98, 102, and 80%, respectively.
The increased  total carbohydrate content in the lavage samples of
the treated animals was not associated with changes in the percent
distribution of neutral sugars, amino sugars, or sialic acid.  The
ratio of these various sugar components did not change in the lavage
samples of control or reserpine treated rats upon stimulation with
either pilocarpine or isoproterenol.  The increased total lipid
content fround in the lavage samples from the treated rats probably
results from an increase in phospholipids.  A decrease in
phospholipid content occurred in the lavage samples of reserpine
treated rats upon stimulation, while the opposite was observed in
those of control animals.  Chronic treatment of rats with reserpine,
thus, appears to induce an enhanced production of glycoproteins in
the airways and to interfere with phospholipid metabolism in the
lung.  In addition, the drug treatment enhances the secretory
response to pilocarpine in comparison with the responses of control
animals.  The enhanced response or hypersecretion of glycoproteins
is a quantitative one and does not seem to involve alterations in
the ratios or distribution of the various sugar components.  This
disturbance in the secretory function of the respiratory tract, a
target organ which is prominently involved in cystic fibrosis (CF)
together with alterations in other exocrine glands which resemble
those of CF patients, makes the reserpine treated rat a useful model
for further study of possible pathogenetic mechanisms in CF.  The
experimental animal model for CF developed by the chronic
administration of reserpine to rats has been found to have changes
in the protein content of lung lavage samples, in addition to
morphologic and secretory alterations in the salivary glands and the
pancreas.  Further analysis of the organic composition of lung
lavage samples shows that the protein, carbohydrate, and lipid
contents are significantly increased after chronic reserpine
administration and that the response to stimulation with pilocarpine
is enhanced in the treated animals when compared to that of
untreated control rats.  It therefore appears that chronic reserpine
administration causes a hypersecretion of glycoproteins and changes
in lipid metabolism in the respiratory tract of the rat and that, in
conjunction with previous findings in other exocrine glands, these
effects on lung function make the reserpine treated rat a useful
tool for the study of the pathologic disturbance seen in the major
exocrine glands affected in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOAS NF" publication="J BIOL CHEM" d1="204" d2="553" d3="953"/>
<CITE num="002" author="BOAT TF" publication="ARCH BIOCHEM BIOPHYS" d1="177" d2="95" d3="976"/>
<CITE num="003" author="BOAT TF" publication="AM REV RESPIR DIS" d1="110" d2="428" d3="974"/>
<CITE num="004" author="BARBERO GJ" publication="IN: DI SANTAGNESE PA" d1="" d2="208" d3="964"/>
<CITE num="005" author="CHAKRIN LW" publication="AM REV RESPIR DIS" d1="108" d2="69" d3="973"/>
<CITE num="006" author="CHERNICK WS" publication="ANN NY ACAD SCI" d1="106" d2="698" d3="963"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="008" author="DUBOIS M" publication="ANAL CHEM" d1="28" d2="350" d3="956"/>
<CITE num="009" author="FLEMING WW" publication="ERGEBNISSE PHYSIOLOGIE" d1="68" d2="55" d3="973"/>
<CITE num="010" author="HUANG TC" publication="ANAL CHEM" d1="33" d2="1405" d3="961"/>
<CITE num="011" author="JANATUINEN M" publication="EXP PATHOL" d1="265" d2="112" d3="969"/>
<CITE num="012" author="LAMB D" publication="BR J DIS CHEST" d1="66" d2="239" d3="972"/>
<CITE num="013" author="LEV R" publication="AM J PATHOL" d1="46" d2="23" d3="965"/>
<CITE num="014" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="015" author="LOWRY RR" publication="LIPIDS" d1="9" d2="491" d3="974"/>
<CITE num="016" author="MARTINEZ JR" publication="J PHARMACOL EXP THER" d1="194" d2="384" d3="975"/>
<CITE num="017" author="MARTINEZ JR" publication="J PHARMACOL EXP THER" d1="201" d2="206" d3="977"/>
<CITE num="018" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="019" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="470" d3="975"/>
<CITE num="020" author="PERLMUTTER J" publication="PEDIATR RES" d1="12" d2="188" d3="978"/>
<CITE num="021" author="POORTHUIS JHM" publication="J LIPID RES" d1="17" d2="433" d3="976"/>
<CITE num="022" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="023" author="ROTH RH" publication="BIOCHEM PHARMACOL" d1="17" d2="1581" d3="968"/>
<CITE num="024" author="ROUSER G" publication="IN: MARINETTI GV" d1="1" d2="99" d3="967"/>
<CITE num="025" author="SAHU S" publication="AM REV RESPIR DIS" d1="115" d2="233" d3="977"/>
<CITE num="026" author="STURGESS JM" publication="BR J EXP PATHOL" d1="54" d2="388" d3="973"/>
<CITE num="027" author="SUN SC" publication="J PHARMACOL EXP THER" d1="161" d2="210" d3="968"/>
<CITE num="028" author="THOMPSON FE" publication="PEDIATR RES" d1="10" d2="632" d3="976"/>
<CITE num="029" author="TUCKLEY B" publication="LIPIDS" d1="9" d2="493" d3="974"/>
<CITE num="030" author="VAN GOLD LMG" publication="AM REV RESPIR DIS" d1="114" d2="977" d3="976"/>
<CITE num="031" author="VARMA R" publication="J CHROMATOGR" d1="77" d2="222" d3="973"/>
<CITE num="032" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79218</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="MAWHINNEY TP" publication="PEDIATR RES" d1="14" d2="872" d3="980"/>
<CITE num="3" author="MCCURDY RE" publication="PEDIATR RES" d1="15" d2="1308" d3="981"/>
<CITE num="4" author="FORSTNER J" publication="AM J PHYSIOL" d1="241" d2="G443" d3="981"/>
<CITE num="5" author="FORSTNER G" publication="ADV EXP MED BIOL" d1="144" d2="199" d3="982"/>
<CITE num="6" author="MARTINEZ JR" publication="PEDIATR RES" d1="17" d2="523" d3="983"/>
<CITE num="7" author="MODRZAKOWSKI MC" publication="CAN J MICROBIOL" d1="29" d2="1339" d3="983"/>
<CITE num="8" author="BOYD RL" publication="PEDIATR RES" d1="18" d2="1028" d3="984"/>
<CITE num="9" author="SPICER SS" publication="ENVIRON HEALTH PERSPECT" d1="55" d2="193" d3="984"/>
<CITE num="10" author="BRADY RC" publication="EXP CELL RES" d1="150" d2="141" d3="984"/>
<CITE num="11" author="MARTINEZ JR" publication="PEDIATR RES" d1="19" d2="711" d3="985"/>
<CITE num="12" author="BRADY RC" publication="AM J PHYSIOL" d1="248" d2="G 54" d3="985"/>
<CITE num="13" author="HAZLETT D" publication="PEDIATR RES" d1="20" d2="1236" d3="986"/>
</CITATIONS>
<RECORDNUM>01198 </RECORDNUM>
<MEDLINENUM>80055643</MEDLINENUM>
<AUTHORS><AUTHOR>Russell-D-H</AUTHOR><AUTHOR>Rosenblum-M-G</AUTHOR><AUTHOR>Beckerman-R-C</AUTHOR><AUTHOR>Durie-B-G</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR><AUTHOR>Barnett-D-R</AUTHOR></AUTHORS>
<TITLE>Altered polyamine metabolism in cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Res. 1979 Oct. 13(10). P 1137-40.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: ur</TOPIC><TOPIC>POLYAMINES: ur</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PUTRESCINE: ur</TOPIC><TOPIC>SPERMIDINE: ad, bl, ur</TOPIC><TOPIC>SPERMINE: ur</TOPIC></MINORSUBJ>
<ABSTRACT>Children with cystic fibrosis excreted elevated urinary levels of all
three polyamines--putrescine, spermidine, and spermine. Heterozygote
parents excreted intermediate concentrations of the polyamines, but
not levels significantly different from levels in normal controls.
Patients with cystic fibrosis who were administered a tracer amount
of [14C]spermidine excreted 11--13% of the radiolabel within 72 hr
whereas normal controls excreted 60--76% of the radiolabel within 72
hr. Spermine excretion was positively correlated with increased
pathology as assessed by the National Institutes of Health (NIH)
clinical score, whereas urinary putrescine and spermidine levels were
negatively correlated with increased pathology.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="002" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="003" author="COHEN LF" publication="BLOOD" d1="48" d2="469" d3="976"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="007" author="DURIE BGM" publication="CANCER RES" d1="37" d2="214" d3="977"/>
<CITE num="008" author="LUNDGREN DW" publication="CLIN CHIM ACTA" d1="62" d2="357" d3="975"/>
<CITE num="009" author="PROCTOR MS" publication="J INVEST DERMATOL" d1="65" d2="409" d3="975"/>
<CITE num="010" author="RENNERT OM" publication="IN: MANGOS JA" d1="" d2="41" d3="973"/>
<CITE num="011" author="ROSENBLUM MG" publication="SCIENCE" d1="200" d2="1496" d3="978"/>
<CITE num="012" author="ROSENBLUM MG" publication="CANCER RES" d1="38" d2="3161" d3="978"/>
<CITE num="013" author="RUSSELL DH" publication="IN: RUSSELL DH" d1="" d2="1" d3="973"/>
<CITE num="014" author="RUSSELL DH" publication="CLIN CHEM" d1="23" d2="22" d3="977"/>
<CITE num="015" author="RUSSELL DH" publication="POLYAMINES AS BIOCHEM MARKERS" d1="" d2="" d3="978"/>
<CITE num="016" author="RUSSELL DH" publication="LANCET" d1="2" d2="797" d3="975"/>
<CITE num="017" author="RUSSELL DH" publication="CLIN CHEM" d1="21" d2="860" d3="975"/>
<CITE num="018" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="019" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="020" author="TAUSSIG LM" publication="IN: KELLEY VC" d1="4" d2="1" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79219</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="THEOHARIDES TC" publication="LIFE SCI" d1="27" d2="703" d3="980"/>
<CITE num="3" author="KAMINSKA AM" publication="ANN NEUROL" d1="9" d2="605" d3="981"/>
<CITE num="4" author="PINEL JPJ" publication="PHYSIOL BEHAV" d1="27" d2="819" d3="981"/>
<CITE num="5" author="RUSSELL DH" publication="NEUROLOGY" d1="31" d2="80" d3="981"/>
<CITE num="6" author="RUSSELL DH" publication="CRC CRIT REV CLIN LAB SCI" d1="18" d2="261" d3="983"/>
<CITE num="7" author="NORDLANDER JE" publication="J ORGANIC CHEM" d1="49" d2="133" d3="984"/>
<CITE num="8" author="KAMOUN PP" publication="CLIN CHIM ACTA" d1="154" d2="219" d3="986"/>
</CITATIONS>
<RECORDNUM>01199 </RECORDNUM>
<MEDLINENUM>80055647</MEDLINENUM>
<AUTHORS><AUTHOR>Martinez-J-R</AUTHOR><AUTHOR>Martinez-A-M</AUTHOR><AUTHOR>Garrett-L</AUTHOR><AUTHOR>Korman-P</AUTHOR></AUTHORS>
<TITLE>Chronically reserpinized rat as a model for cystic fibrosis: Na+
transport inhibitory effect in submaxillary saliva.</TITLE>
<SOURCE>Pediatr-Res. 1979 Oct. 13(10). P 1156-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>RESERPINE: pd</TOPIC><TOPIC>SALIVA: me</TOPIC><TOPIC>SODIUM: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: ci, pp</TOPIC><TOPIC>FREEZING</TOPIC><TOPIC>HEAT</TOPIC><TOPIC>PAROTID-GLAND: se</TOPIC><TOPIC>RATS</TOPIC><TOPIC>SECRETORY-RATE</TOPIC><TOPIC>SUBMANDIBULAR-GLAND: se</TOPIC></MINORSUBJ>
<ABSTRACT>The retrograde perfusion assay in the rat parotid gland was used to
investigate the effects of salivary secretions from control and
reserpine-treated rats on Na+ reabsorption. Results demonstrated that
submaxillary saliva from the treated animals caused a 69% inhibition
of Na+ reabsorption, accompanied by a 28% reduction in the volume of
saliva secreted, and a 22% reduction in flow rate. By contrast,
submaxillary saliva from control rats caused a 6% inhibition of Na+
reabsorption, a 6% reduction in volume, and a 5% reduction in flow
rate. Parotid saliva from reserpine-treated rats also inhibited Na+
reabsorption to the extent of 39% and caused a 38% reduction in
volume and a 33% reduction in flow. Parotid saliva from control rats
only inhibited Na+ reabsorption to the extent of 2.7% and caused a 4--
6% reduction in salivary volumes and flow rates. The inhibition of
Na+ reabsorption and the reduction in salivary volume and flow rates
caused by submaxillary saliva of reserpine-treated rats were either
abolished or significantly reduced when the saliva was previously
heated to 100 degrees C, frozen, and then thawed or kept in glass
tubes at 4 degrees C for 24 hr. These results indicate that saliva
from reserpine-treated rats have comparable effects in this assay
system to those of saliva from cystic fibrosis (CF) patients and
further support its use as an animal model for this disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ADSHEAD PC" publication="ANN NY ACAD SCI" d1="253" d2="192" d3="975"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="003" author="MANGOS JA" publication="PFLUEGERS ARCH" d1="291" d2="99" d3="966"/>
<CITE num="004" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="005" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="006" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="470" d3="975"/>
<CITE num="007" author="PETERSEN OH" publication="ACTA PHYSIOL SCAND SUPPL 381" d1="" d2="1" d3="972"/>
<CITE num="008" author="PERLMUTTER J" publication="PEDIATR RES" d1="12" d2="188" d3="978"/>
<CITE num="009" author="TAYLOR A" publication="PEDIATR RES" d1="8" d2="861" d3="974"/>
<CITE num="010" author="THOMPSON FE" publication="PEDIATR RES" d1="10" d2="632" d3="976"/>
<CITE num="011" author="YOUNG JA" publication="PROC AUST PHYSIOL PHARMACO" d1="4" d2="101" d3="973"/>
<CITE num="012" author="WEISMAN UN" publication="LANCET" d1="1" d2="510" d3="972"/>
<CITE num="013" author="WOOD DL" publication="PEDIATR RES" d1="11" d2="827" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79220</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RTINEZ JR           PE" publication="DIATR RES" d1="15" d2="39 9" d3="1"/>
<CITE num="2" author="ROSCHER AA" publication="J PHARMACOL EXP THER" d1="216" d2="419" d3="981"/>
<CITE num="3" author="FORSTNER J" publication="AM J PHYSIOL" d1="241" d2="G443" d3="981"/>
<CITE num="4" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="3" d2="285" d3="982"/>
<CITE num="5" author="BAUM BJ" publication="J GERONTOL" d1="37" d2="392" d3="982"/>
<CITE num="6" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1982" d2="229" d3="982"/>
<CITE num="7" author="SHIFFMAN ML" publication="PEDIATR RES" d1="17" d2="486" d3="983"/>
<CITE num="8" author="VO CP" publication="ARCH ORAL BIOL" d1="28" d2="259" d3="983"/>
<CITE num="9" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="10" author="MULLER RM" publication="EXP MOL PATH" d1="40" d2="391" d3="984"/>
<CITE num="11" author="WATSON E" publication="J DENT RES" d1="63" d2="82" d3="984"/>
<CITE num="12" author="SATO K" publication="J CLIN INVEST" d1="73" d2="1763" d3="984"/>
<CITE num="13" author="MORTON AJ" publication="BR J PHARMACOL" d1="86" d2="287" d3="985"/>
<CITE num="14" author="BRADY RC" publication="AM J PHYSIOL" d1="248" d2="G 54" d3="985"/>
</CITATIONS>
<RECORDNUM>01200 </RECORDNUM>
<MEDLINENUM>80055641</MEDLINENUM>
<AUTHORS><AUTHOR>Will-P-C</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Hopfer-U</AUTHOR></AUTHORS>
<TITLE>Evidence against a specific effect of serum from patients with
cystic fibrosis on sodium-dependent glucose transport in the rat
jejunum.</TITLE>
<SOURCE>Pediatr-Res. 1979 Oct. 13(10). P 1129-33.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GLUCOSE: me</TOPIC><TOPIC>JEJUNUM: me</TOPIC><TOPIC>SODIUM: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MICROVILLI: me</TOPIC><TOPIC>PHLORHIZIN: pd</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<ABSTRACT>Sera from patients with cystic fibrosis of the pancreas (CF) and
normal human sera were assayed for the ability to inhibit sodium-
dependent glucose transport in rat brush-border membrane vesicles.
Fresh CF and age- and sex-matched control sera were both inhibitory
when compared to physiologic saline. The inhibition by CF serum was
44 +/- 13% (mean +/- SD) at a final serum concentration of 6.7%, 67
+/- 34% at 10% serum, and 68 +/- 28% at 20% serum. The ratio of the
inhibition of CF sera compared to that of control sera was 1.00,
0.78, and 0.93 at 6.7, 10, and 20% serum concentrations,
respectively. Although a slightly greater inhibition by CF serum was
observed at a concentration of 10%, this is probably not significant
because no difference could be detected at a concentration of 20%
serum. Glucose transport in the presence of serum was sensitive to
phlorizin indicating that the residual glucose transport was
proceeding by the sodium-dependent glucose transport system. These
findings suggest that CF serum does not specifically inhibit the
sodium-dependent glucose transport system. The intravesicular space
accessible to glucose was reduced in the presence of CF or control
serum. Fresh CF serum was 1.4 times more effective than fresh control
serum (P less than 0.01). The presence of substantial vesicle-
shrinking activity in control serum indicates that this activity
cannot be considered specific for CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="002" author="ARAKI H" publication="PROC INT CF CONG 7TH" d1="" d2="28" d3="976"/>
<CITE num="003" author="ARVANITAKIS S" publication="TEX REP BIOL MED" d1="34" d2="175" d3="976"/>
<CITE num="004" author="BARNETT DR" publication="TEX REP BIOL MED" d1="31" d2="709" d3="973"/>
<CITE num="005" author="BENKE PJ" publication="PROC SOC EXP BIOL MED" d1="137" d2="1283" d3="971"/>
<CITE num="006" author="BENSADOUN A" publication="ANAL BIOCHEM" d1="70" d2="241" d3="976"/>
<CITE num="007" author="BROWN GA" publication="LANCET" d1="2" d2="639" d3="971"/>
<CITE num="008" author="CONOD EJ" publication="PEDIATR RES" d1="11" d2="45" d3="977"/>
<CITE num="009" author="DESJEUX JF" publication="EUROPEAN SOC PEDIAT RES MTG" d1="" d2="" d3="970"/>
<CITE num="010" author="DESJEUX JF" publication="CF CLUB ABST" d1="15" d2="" d3="974"/>
<CITE num="011" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="012" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="013" author="DOGGETT RG" publication="TEX REP BIOL MED" d1="31" d2="685" d3="973"/>
<CITE num="014" author="FRIZZELL RA" publication="J MEMBR BIOL" d1="27" d2="297" d3="976"/>
<CITE num="015" author="FROMTER E" publication="NATURE NEW BIOL" d1="235" d2="9" d3="972"/>
<CITE num="016" author="GILMORE JP" publication="PROC SOC EXP BIOL MED" d1="157" d2="70" d3="978"/>
<CITE num="017" author="HOPFER U" publication="PROC NAT ACAD SCI USA" d1="72" d2="2027" d3="975"/>
<CITE num="018" author="HOPFER U" publication="J SUPRAMOL STRUCT" d1="7" d2="1" d3="977"/>
<CITE num="019" author="HOPFER U" publication="J BIOL CHEM" d1="248" d2="25" d3="973"/>
<CITE num="020" author="HOPFER U" publication="ANN NY ACAD SCI" d1="264" d2="414" d3="975"/>
<CITE num="021" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
<CITE num="022" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="023" author="MANGOS JA" publication="TEX REP BIOL MED" d1="31" d2="651" d3="973"/>
<CITE num="024" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="025" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="026" author="MENG K" publication="PFLUEGERS ARCH" d1="357" d2="91" d3="975"/>
<CITE num="027" author="MORIN CL" publication="BIOMEDICINE EXPRESS" d1="19" d2="133" d3="973"/>
<CITE num="028" author="MURER H" publication="PROC NAT ACAD SCI USA" d1="71" d2="484" d3="974"/>
<CITE num="029" author="SCHMITZ J" publication="BIOCHIM BIOPHYS ACTA" d1="323" d2="98" d3="973"/>
<CITE num="030" author="SCHNEYER LH" publication="AM J PHYSIOL" d1="219" d2="1050" d3="970"/>
<CITE num="031" author="SCHNEYER LH" publication="PHYSIOL REV" d1="52" d2="720" d3="972"/>
<CITE num="032" author="SCHULTZ SG" publication="PHYSIOL REV" d1="50" d2="637" d3="970"/>
<CITE num="033" author="SHAPIRO BL" publication="PEDIATR RES" d1="9" d2="885" d3="975"/>
<CITE num="034" author="SIGRIST-NELSON K" publication="J BIOL CHEM" d1="250" d2="5674" d3="975"/>
<CITE num="035" author="TANNENBAUM C" publication="FED PROC" d1="36" d2="360" d3="977"/>
<CITE num="036" author="TAUSSIG LM" publication="LANCET" d1="1" d2="1367" d3="972"/>
<CITE num="037" author="TAYLOR A" publication="PEDIATR RES" d1="8" d2="861" d3="974"/>
<CITE num="038" author="WILSON GB" publication="NATURE" d1="266" d2="463" d3="977"/>
<CITE num="039" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="317" d3="977"/>
<CITE num="040" author="ZAR JH" publication="BIOSTATISTICAL ANALYSIS" d1="" d2="" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79221</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LL PC               PE" publication="DIATR RES" d1="14" d2="45 9" d3="0"/>
<CITE num="2" author="BANCHINI G" publication="PEDIATR RES" d1="15" d2="1073" d3="981"/>
<CITE num="3" author="ALBAZZAZ FJ" publication="RESPIRATION" d1="46" d2="88" d3="984"/>
</CITATIONS>
<RECORDNUM>01201 </RECORDNUM>
<MEDLINENUM>80012536</MEDLINENUM>
<AUTHORS><AUTHOR>Feigal-R-J</AUTHOR><AUTHOR>Shapiro-B-L</AUTHOR></AUTHORS>
<TITLE>Altered intracellular calcium in fibroblasts from patients with
cystic fibrosis and heterozygotes.</TITLE>
<SOURCE>Pediatr-Res. 1979 Jun. 13(6). P 764-8.</SOURCE>
<MAJORSUBJ><TOPIC>BODY-FLUIDS: me</TOPIC><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>INTRACELLULAR-FLUID: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>The importance of intracellular calcium (Ca) in secretion and
transmembrane ion movement led us to study Ca in cells from patients
with cystic fibrosis (CF) which is a lethal genetic exocrinopathy.
Skin fibroblasts from patients with CF, obligate heterozygotes (HZ),
and age- and sex-matched controls (C) were used in matched pair
experiments measuring 45Ca exchange into and efflux from the cells
over time. CF cell lines and HZ cell lines exhibit increased 45Ca
exchange when compared with their respective controls (P less than
0.005). The magnitude of this difference (approximately 30%) is not
reduced when cells are washed with lanthanum chloride after the
exchange period. This difference is likely attributable to an altered
capacity of one or more of the intracellular Ca sequestering
organelles. Further evidence for this explanation was seen in 45Ca
efflux experiments in which CF cells retained a higher percent of
their initial 0-time 45Ca than did C cells late in the efflux period
(P less than 0.05). The finding of an altered Ca pool size in both CF
and particularly HZ cells suggests that altered Ca metabolism is
related to the basic gene defect in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="113" d3="976"/>
<CITE num="002" author="BLOMFIELD J" publication="ARCH DIS CHILD" d1="48" d2="267" d3="973"/>
<CITE num="003" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="004" author="BOLTON WE" publication="TEX REP BIOL MED" d1="34" d2="97" d3="976"/>
<CITE num="005" author="BORLE AB" publication="METHODS ENZYMOL" d1="39" d2="513" d3="975"/>
<CITE num="006" author="BORLE AB" publication="TISSUE RES SUPPL" d1="21" d2="21" d3="976"/>
<CITE num="007" author="BOTELHO SY" publication="J PEDIATR" d1="83" d2="601" d3="973"/>
<CITE num="008" author="CARAFOLI E" publication="SOC SYMP" d1="39" d2="89" d3="974"/>
<CITE num="009" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="010" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="011" author="DOUGLAS WW" publication="IN: CASE RM" d1="" d2="" d3="976"/>
<CITE num="012" author="DUNN OJ" publication="PRIMER FOR THE BIOMED SCI" d1="" d2="" d3="964"/>
<CITE num="013" author="FARRELL PM" publication="PROC SOC EXP BIOL MED" d1="149" d2="340" d3="975"/>
<CITE num="014" author="FLETCHER DS" publication="CLIN CHIM ACTA" d1="44" d2="5" d3="973"/>
<CITE num="015" author="FOSTER DO" publication="J BIOL CHEM" d1="244" d2="2675" d3="969"/>
<CITE num="016" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="017" author="LEHMANN H" publication="IN: STANBURY JB" d1="" d2="" d3="972"/>
<CITE num="018" author="LEHNINGER AL" publication="PROC NAT ACAD SCI USA" d1="71" d2="1520" d3="974"/>
<CITE num="019" author="LEHNINGER AL" publication="ADV IMMUNOL" d1="29" d2="259" d3="967"/>
<CITE num="020" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="021" author="MANGOS JA" publication="IN: ANDREOLI TE" d1="" d2="" d3="978"/>
<CITE num="022" author="MOORE L" publication="J CELL PHYSIOL" d1="91" d2="289" d3="977"/>
<CITE num="023" author="OYAMA VI" publication="PROC SOC EXP BIOL MED" d1="91" d2="305" d3="956"/>
<CITE num="024" author="RASMUSSEN H" publication="CRIT REV BIOCHEM" d1="1" d2="95" d3="972"/>
<CITE num="025" author="ROBBLEE LS" publication="BIOCHIM BIOPHYS ACTA" d1="463" d2="448" d3="976"/>
<CITE num="026" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="027" author="VANBREEMAN C" publication="CIRC RES" d1="33" d2="44" d3="972"/>
<CITE num="028" author="WOTMAN S" publication="ARCH ORAL BIOL" d1="16" d2="663" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79222</PAPERNUM>
<CITATIONS>
<CITE num="1" author="APIRO BL            PR" publication="OC NAT ACAD SCI USA" d1="76" d2="79 9" d3="9"/>
<CITE num="2" author="ANSAH TA" publication="CELL CALC" d1="1" d2="195" d3="980"/>
<CITE num="3" author="SCANLIN TF" publication="CLIN CHEST MED" d1="1" d2="424" d3="980"/>
<CITE num="4" author="KATZ S" publication="CLIN CHIM ACTA" d1="100" d2="245" d3="980"/>
<CITE num="5" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="53" d3="981"/>
<CITE num="6" author="ROOMANS GM" publication="J SUBMICROSC CYTOL" d1="13" d2="445" d3="981"/>
<CITE num="7" author="REZNIK VM" publication="PROC NAT ACAD SCI USA" d1="78" d2="7143" d3="981"/>
<CITE num="8" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="9" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="10" author="BOGART BI" publication="PEDIATR RES" d1="16" d2="223" d3="982"/>
<CITE num="11" author="FEIGAL RJ" publication="LIFE SCI" d1="30" d2="93" d3="982"/>
<CITE num="12" author="SHAPIRO BL" publication="AM J HUM GENET" d1="34" d2="846" d3="982"/>
<CITE num="13" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="14" author="FONDACARO JD" publication="LIFE SCI" d1="32" d2="1449" d3="983"/>
<CITE num="15" author="MINER C" publication="J PHYSIOL (LOND)" d1="338" d2="P 63" d3="983"/>
<CITE num="16" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="17" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="18" author="SEYMOUR CA" publication="BIOESSAYS" d1="1" d2="38" d3="984"/>
<CITE num="19" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="20" author="CABRINI G" publication="RIV ITAL PEDIATR" d1="10" d2="405" d3="984"/>
<CITE num="21" author="KAMOUN P" publication="BIOCHEM MED" d1="31" d2="104" d3="984"/>
<CITE num="22" author="RUSSI EW" publication="CHEST" d1="86" d2="475" d3="984"/>
<CITE num="23" author="GRINSTEIN S" publication="BIOCHIM BIOPHYS ACTA" d1="769" d2="270" d3="984"/>
<CITE num="24" author="WALLER RL" publication="CELL CALC" d1="6" d2="245" d3="985"/>
<CITE num="25" author="KIRKPATRICK C" publication="PEDIATR RES" d1="19" d2="1341" d3="985"/>
<CITE num="26" author="SUTER S" publication="PEDIATR RES" d1="19" d2="346" d3="985"/>
<CITE num="27" author="MUALLEM S" publication="BIOCHIM BIOPHYS ACTA" d1="819" d2="143" d3="985"/>
<CITE num="28" author="RUPP GM" publication="MED HYPOTHESES" d1="20" d2="245" d3="986"/>
<CITE num="29" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
<CITE num="30" author="FEIGAL RJ" publication="ANN NY ACAD SCI" d1="488" d2="82" d3="986"/>
<CITE num="31" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1986" d2="165" d3="986"/>
</CITATIONS>
<RECORDNUM>01202 </RECORDNUM>
<MEDLINENUM>80100643</MEDLINENUM>
<AUTHORS><AUTHOR>Van-Leuven-F</AUTHOR><AUTHOR>Cassiman-J-J</AUTHOR><AUTHOR>Van-Den-Berghe-H</AUTHOR></AUTHORS>
<TITLE>Anomalous alpha 2-macroglobulin-protease complexes in cystic
fibrosis: decreased uptake of the complexes by fibroblasts in
culture.</TITLE>
<SOURCE>Pediatr-Res. 1979 Dec. 13(12). P 1384-6.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-MACROGLOBULINS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, en</TOPIC><TOPIC>PEPTIDE-HYDROLASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MACROMOLECULAR-SYSTEMS</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Immunochemical and functional properties of control and Cystic
Fibrosis (CF) alpha 2-Macroglobulin (alpha 2M) are compared. Crossed
immunoelectrophoresis and Ouchterlony double diffusion revealed no
qualitative differences between the two alpha 2-M preparations.
Trypsin-esterase activity assayed with BAPNA as a substrate, in the
presence of an excess STI, gave similar ratios between total and
active alpha 2M. These alpha 2M-trypsin complexes were equally stable
under various experimental conditions and maintained a constant STI
non-inhibited esterase activity. Normal and CF-alpha 2M-trypsin
complexes were taken up by normal human fibroblasts to a similar
extent during a four hour period. The only significant difference was
observed when the uptake of alpha 2M from untreated sera was
examined. The uptake of alpha 2M from CF sera was always lower than
from pooled control sera despite large variation. Mixing of control
and CF serum did not affect the normal uptake and other serum
components were taken up to the normal extent. Intracellular
degradation of CF alpha 2M had a half life of 2.0 to 2.8 hours, which
compares well to the normal half life of 2.2 hours. More work needs
to be done on the nature of the interaction between alpha 2M and
proteases before a reasonable explanation for the molecular nature of
the abnormal behavior can be sought.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GANROT PO" publication="CLIN CHIM ACTA" d1="14" d2="493" d3="966"/>
<CITE num="002" author="ROMEO G" publication="NATURE" d1="274" d2="909" d3="978"/>
<CITE num="003" author="SHAPIRA E" publication="CLIN CHIM ACTA" d1="78" d2="359" d3="977"/>
<CITE num="004" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
<CITE num="005" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="006" author="STARKEY PM" publication="IN: BARRETT AJ" d1="" d2="663" d3="977"/>
<CITE num="007" author="VAN LEUVEN F" publication="EXP CELL RES" d1="117" d2="273" d3="978"/>
<CITE num="008" author="VAN LEUVEN F" publication="J BIOL CHEM" d1="254" d2="5160" d3="979"/>
<CITE num="009" author="VAN LEUVEN F" publication="EXP CELL RES" d1="109" d2="468" d3="977"/>
<CITE num="010" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79223</PAPERNUM>
<CITATIONS>
<CITE num="1" author="APIRA E             BI" publication="OCHEM BIOPHYS RES COMMUN" d1="93" d2="50 9" d3="0"/>
<CITE num="2" author="HUBBARD WJ" publication="J IMMUNOL" d1="126" d2="292" d3="981"/>
<CITE num="3" author="VANLEUVEN F" publication="J BIOL CHEM" d1="256" d2="9016" d3="981"/>
<CITE num="4" author="BLITZER MG" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="289" d3="982"/>
<CITE num="5" author="WILSON GB" publication="MED HYPOTHESES" d1="8" d2="527" d3="982"/>
<CITE num="6" author="BACK SA" publication="BIOCHEM MED" d1="30" d2="34" d3="983"/>
<CITE num="7" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="8" author="MARYNEN P" publication="ANN NY ACAD SCI" d1="421" d2="401" d3="983"/>
<CITE num="9" author="SHAPIRA E" publication="ANN NY ACAD SCI" d1="421" d2="352" d3="983"/>
<CITE num="10" author="VANLEUVEN F" publication="ANN NY ACAD SCI" d1="421" d2="434" d3="983"/>
<CITE num="11" author="MARYNEN P" publication="BIOCHIM BIOPHYS ACTA" d1="799" d2="187" d3="984"/>
<CITE num="12" author="VANLEUVEN F" publication="J IMMUNOL METH" d1="90" d2="125" d3="986"/>
<CITE num="13" author="VANLEUVEN F" publication="J BIOL CHEM" d1="261" d2="1369" d3="986"/>
</CITATIONS>
<RECORDNUM>01203 </RECORDNUM>
<MEDLINENUM>80055675</MEDLINENUM>
<AUTHORS><AUTHOR>Thomassen-M-J</AUTHOR><AUTHOR>Boxerbaum-B</AUTHOR><AUTHOR>Demko-C-A</AUTHOR><AUTHOR>Kuchenbrod-P-J</AUTHOR><AUTHOR>Dearborn-D-G</AUTHOR><AUTHOR>Wood-R-E</AUTHOR></AUTHORS>
<TITLE>Inhibitory effect of cystic fibrosis serum on pseudomonas
phagocytosis by rabbit and human alveolar macrophages.</TITLE>
<SOURCE>Pediatr-Res. 1979 Sep. 13(9). P 1085-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>MACROPHAGES: ph</TOPIC><TOPIC>PHAGOCYTOSIS</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: cy</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGGLUTINATION</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>ANTIBODIES-BACTERIAL: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LUNG: cy, mi</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>This report presents experimental observations indicating the
presence of an inhibitory activity in cystic fibrosis (CF) serum
which impairs phagocytosis of Pseudomonas aeruginosa by rabbit as
well as human alveolar macrophages. Of the 49 patient serum samples
studied, 40 consistently showed greater than or equal to 60%
inhibition, 3 showed no inhibition and 6 were in the range of 20-60%
inhibition of Pseudomonas phagocytosis. In parallel studies, the
phagocytosis of S. aureus and S. marcescens was found not to be
inhibited by CF serum. Mixing of CF serum with normal serum could not
overcome the inhibitory effect, indicating the presence of an
inhibitory factor rather than the lack of a necessary component. The
inhibitory activity is not lost upon exposure of serum to glass, upon
freezing the serum once, or upon heating at 56 degrees C for 30
minutes.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BIGGAR WD" publication="PROC NAT ACAD SCI USA" d1="68" d2="1716" d3="971"/>
<CITE num="002" author="BOXERBAUM B" publication="AM REV RESPIR DIS" d1="108" d2="777" d3="973"/>
<CITE num="003" author="BRAIN JD" publication="J APPL PHYSIOL" d1="34" d2="75" d3="973"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="534" d3="976"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="006" author="DOERSHUK CF" publication="IN: GREEN M" d1="" d2="707" d3="968"/>
<CITE num="007" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="008" author="GREEN GM" publication="J EXP MED" d1="119" d2="167" d3="964"/>
<CITE num="009" author="HENNEY CS" publication="SCIENCE" d1="169" d2="696" d3="970"/>
<CITE num="010" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S262" d2="1" d3="977"/>
<CITE num="011" author="KOSKI IR" publication="IN: BLOOM BR" d1="" d2="" d3="976"/>
<CITE num="012" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="013" author="MYRVIK QN" publication="J IMMUNOL" d1="86" d2="128" d3="961"/>
<CITE num="014" author="NETER E" publication="J INFECT DIS SUPPL" d1="130" d2="132" d3="974"/>
<CITE num="015" author="REYNOLDS HY" publication="J CLIN INVEST" d1="59" d2="165" d3="977"/>
<CITE num="016" author="REYNOLDS HY" publication="J CLIN INVEST" d1="56" d2="376" d3="975"/>
<CITE num="017" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="018" author="SORENSEN RU" publication="INFECT IMMUN" d1="18" d2="735" d3="977"/>
<CITE num="019" author="SORENSEN RU" publication="J PEDIATR" d1="93" d2="201" d3="978"/>
<CITE num="020" author="WALDMAN RH" publication="J EXP MED" d1="134" d2="482" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79224</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MKO CA              CU" publication="RRENT MICROBIOL" d1="4" d2="69 9" d3="0"/>
<CITE num="2" author="CASSINO RJJ" publication="PEDIATR RES" d1="14" d2="1212" d3="980"/>
<CITE num="3" author="SEALE TW" publication="PEDIATR RES" d1="14" d2="1398" d3="980"/>
<CITE num="4" author="THOMASSEN MJ" publication="PEDIATR RES" d1="14" d2="715" d3="980"/>
<CITE num="5" author="FICK RB" publication="J IMMUNOL METH" d1="38" d2="103" d3="980"/>
<CITE num="6" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="7" author="FICK RB" publication="CLIN CHEST MED" d1="2" d2="91" d3="981"/>
<CITE num="8" author="SORENSEN RU" publication="PEDIATR RES" d1="15" d2="14" d3="981"/>
<CITE num="9" author="THOMASSEN MJ" publication="INFECT IMMUN" d1="33" d2="512" d3="981"/>
<CITE num="10" author="FICK RB" publication="J CLIN INVEST" d1="68" d2="899" d3="981"/>
<CITE num="11" author="LEWISTON NJ" publication="CHEST" d1="80" d2="389" d3="981"/>
<CITE num="12" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="13" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="14" author="KONSTAN MW" publication="AM REV RESPIR DIS" d1="123" d2="120" d3="981"/>
<CITE num="15" author="SORENSEN RU" publication="AM REV RESPIR DIS" d1="123" d2="37" d3="981"/>
<CITE num="16" author="VANGEFFEL R" publication="ANN IMMUNOL (PARIS)" d1="D133" d2="293" d3="982"/>
<CITE num="17" author="SORDELLI DO" publication="CLIN IMMUNOL IMMUNOPATHOL" d1="22" d2="153" d3="982"/>
<CITE num="18" author="WOODS DE" publication="INFECT IMMUN" d1="36" d2="1223" d3="982"/>
<CITE num="19" author="HOOKE AM" publication="INFECT IMMUN" d1="38" d2="136" d3="982"/>
<CITE num="20" author="THOMASSEN MJ" publication="INFECT IMMUN" d1="38" d2="802" d3="982"/>
<CITE num="21" author="WINNIE GB" publication="INFECT IMMUN" d1="38" d2="1088" d3="982"/>
<CITE num="22" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="23" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="24" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="25" author="WINNIE GB" publication="CURRENT MICROBIOL" d1="9" d2="63" d3="983"/>
<CITE num="26" author="GOLD R" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="331" d3="983"/>
<CITE num="27" author="SCHILLER NL" publication="PEDIATR RES" d1="17" d2="747" d3="983"/>
<CITE num="28" author="FICK RB" publication="BULL EUR PHYSIOPATH RESP" d1="19" d2="151" d3="983"/>
<CITE num="29" author="THOMASSEN MJ" publication="J LEUKOCYTE BIOL" d1="35" d2="345" d3="984"/>
<CITE num="30" author="THOMASSEN MJ" publication="INFECT IMMUN" d1="45" d2="741" d3="984"/>
<CITE num="31" author="PIER GB" publication="J INFECT DIS" d1="150" d2="223" d3="984"/>
<CITE num="32" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="33" author="SHRYOCK TR" publication="CURRENT MICROBIOL" d1="12" d2="91" d3="985"/>
<CITE num="34" author="KLEIN TW" publication="MICROBIOL IMMUNOL" d1="29" d2="671" d3="985"/>
<CITE num="35" author="REYNOLDS HY" publication="DISEASE A MONTH" d1="31" d2="1" d3="985"/>
<CITE num="36" author="SHERMAN JM" publication="J PEDIATR" d1="106" d2="126" d3="985"/>
<CITE num="37" author="PIER GB" publication="J INFECT DIS" d1="151" d2="575" d3="985"/>
<CITE num="38" author="MOSS RB" publication="MONOGR ALLERGY" d1="19" d2="202" d3="986"/>
<CITE num="39" author="MOSS RB" publication="PEDIATR RES" d1="20" d2="453" d3="986"/>
<CITE num="40" author="SHRYOCK TR" publication="J CLIN MICROBIOL" d1="23" d2="513" d3="986"/>
<CITE num="41" author="FICK RB" publication="AM REV RESPIR DIS" d1="133" d2="418" d3="986"/>
<CITE num="42" author="SHRYOCK TR" publication="CURRENT MICROBIOL" d1="14" d2="251" d3="987"/>
</CITATIONS>
<RECORDNUM>01204 </RECORDNUM>
<MEDLINENUM>80055648</MEDLINENUM>
<AUTHORS><AUTHOR>Pivetta-O-H</AUTHOR><AUTHOR>Labal-M-L</AUTHOR><AUTHOR>Sordelli-D-O</AUTHOR></AUTHORS>
<TITLE>Serum ciliotoxic activity in mutant mice with some hereditary
alterations resembling cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Res. 1979 Oct. 13(10). P 1160-2.</SOURCE>
<MAJORSUBJ><TOPIC>CILIA: ph</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>SPERM-TAIL: ph</TOPIC><TOPIC>SPERMATOZOA: ph</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MICE</TOPIC><TOPIC>MICE-INBRED-BALB-C</TOPIC><TOPIC>MICE-INBRED-C57BL</TOPIC><TOPIC>MICE-INBRED-DBA</TOPIC></MINORSUBJ>
<ABSTRACT>Serum ciliotoxic activity (SCA), which had been described in cystic
fibrosis (CF), was studied in mutant mice with some hereditary
alterations resembling this inherited disease. A test was developed
to detect SCA in biologic fluids by means of a natural vibratile
system; it consisted in the incubation of mouse sperm with different
CF serum dilutions under controlled conditions, in order to determine
the sperm translation cessation time (STCT) and the sperm activity
cessation time (SACT). As the findings of this study were similar to
those obtained by other authors who have been employing alternative
systems, it was decided to apply this method on mice serum. Sera were
obtained from male and female 3- to 4-wk-old mice of DBA/2J-cri,
C57BL/6J-bgJ, and BALB/c inbred strains; SCA was investigated in
affected homozygotes and their +/? siblings were used as controls.
Male 8- to 16-wk-old BALB/c mice were employed as sperm donors.
Significant differences were found between cri/cri and +/? mice of
the DBA/2J-cri strain in both STCT and SACT determinations at 1/10
serum dilution. It is concluded that mouse sperm is a system
sensitive enough to detect SCA in biologic fluids from human beings.
Likewise, the test of the mouse sperm allowed us to detect SCA in
cri/cri mice, turning this mutation into a possible animal model for
CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="002" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="003" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="004" author="BOWMAN BH" publication="SCIENCE" d1="167" d2="871" d3="970"/>
<CITE num="005" author="COHEN FL" publication="J MED GENET" d1="11" d2="253" d3="974"/>
<CITE num="006" author="CONOVER JH" publication="LANCET" d1="1" d2="1194" d3="973"/>
<CITE num="007" author="DANES BS" publication="J EXP MED" d1="136" d2="1313" d3="972"/>
<CITE num="008" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="009" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="010" author="DIXON WJ" publication="BIOMETRICS" d1="9" d2="74" d3="953"/>
<CITE num="011" author="DOGGETT RG" publication="TEX REP BIOL MED" d1="31" d2="685" d3="973"/>
<CITE num="012" author="GREEN MC" publication="SCIENCE" d1="176" d2="800" d3="972"/>
<CITE num="013" author="KAISER D" publication="LIFE SCI" d1="15" d2="803" d3="974"/>
<CITE num="014" author="LANE PW" publication="GENETICS" d1="72" d2="451" d3="972"/>
<CITE num="015" author="PIVETTA OH" publication="MEDICINA" d1="37" d2="379" d3="977"/>
<CITE num="016" author="PIVETTA OH" publication="EFECTO DEL SUERO DE MUTACIONE" d1="" d2="" d3="975"/>
<CITE num="017" author="PIVETTA OH" publication="PEDIATR RES" d1="11" d2="1133" d3="977"/>
<CITE num="018" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="019" author="WILSON GB" publication="LIFE SCI" d1="15" d2="551" d3="974"/>
<CITE num="020" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="021" author="WOOD RE" publication="LANCET" d1="2" d2="1452" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79225</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VETTA OH            LI" publication="FE SCI" d1="26" d2="49 9" d3="0"/>
<CITE num="2" author="PIVETTA OH" publication="LIFE SCI" d1="28" d2="2207" d3="981"/>
<CITE num="3" author="CERQUETTI MC" publication="IMMUNOL COMMUN" d1="12" d2="375" d3="983"/>
<CITE num="4" author="CATANZARO OL" publication="LIFE SCI" d1="32" d2="825" d3="983"/>
</CITATIONS>
<RECORDNUM>01205 </RECORDNUM>
<MEDLINENUM>80055663</MEDLINENUM>
<AUTHORS><AUTHOR>Romeo-G</AUTHOR><AUTHOR>Parsons-M</AUTHOR><AUTHOR>Bossen-A</AUTHOR><AUTHOR>Blessing-Moore-J</AUTHOR><AUTHOR>Cavalli-Sforza-L-L</AUTHOR></AUTHORS>
<TITLE>Binding of 125I-labeled proteinases to plasma proteins in cystic
fibrosis.</TITLE>
<SOURCE>Pediatr-Res. 1979 Sep. 13(9). P 1030-6.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>PEPTIDE-PEPTIDOHYDROLASES: bl</TOPIC><TOPIC>TRYPSIN: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALPHA-MACROGLOBULINS: me</TOPIC><TOPIC>ARGININE</TOPIC><TOPIC>ELECTROPHORESIS-POLYACRYLAMIDE-GEL</TOPIC><TOPIC>ESTERASES: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGG: me</TOPIC><TOPIC>IMMUNOELECTROPHORESIS</TOPIC><TOPIC>IODINE-RADIOISOTOPES</TOPIC><TOPIC>PROTEIN-BINDING</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Samples of plasma or serum from 53 cystic fibrosis (CF) patients, 90
relatives of CF patients , and 159 controls have been incubated with
porcine or bovine 125I-trypsin, electrophoresed on polyacrylamide
gel, and autoradiographed. In these individuals, the main binding
protein for 125I-trypsin has been shown to be alpha 2-macroglobulin
(alpha 2M). Using this method of analysis, no difference in
electrophoretic migration of 125I-trypsin-alpha 2M complexes has been
observed between CF and control individuals. However, trypsin binding
to IgG has been observed in 80% of CF patients, 30% of their mothers,
3% of controls, and in two patients affected with pancreatitis. These
trypsin binding immunoglobulins are called TbIg, and specifically,
Tb1gG when referring to the G class. Experimental evidence indicates
that binding of trypsin to IgG occurs through the Fab portion of the
molecule. Tb1gG must be antibodies most probably induced by the
exogenous trypsin ingested daily by most CF patients (and by patients
affected with chronic pancreatitis). Antibodies against porcine
pancreatic elastase have been observed using the same analysis, but
not as frequently as Tb1g.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="AARON R" publication="IMMUNOCHEMISTRY" d1="3" d2="451" d3="966"/>
<CITE num="002" author="BORGSTROM A" publication="SCAND J CLIN LAB INVEST" d1="36" d2="809" d3="976"/>
<CITE num="003" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="004" author="DAIGER S" publication="PROC NAT ACAD SCI USA" d1="72" d2="2076" d3="975"/>
<CITE num="005" author="DANES BS" publication="J EXP MED" d1="137" d2="1538" d3="973"/>
<CITE num="006" author="DEBANNE MT" publication="BR J EXP PATHOL" d1="54" d2="571" d3="973"/>
<CITE num="007" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="008" author="DOLAN TF JR" publication="AM REV RESPIR DIS" d1="110" d2="812" d3="974"/>
<CITE num="009" author="ELIAS E" publication="LANCET" d1="2" d2="66" d3="977"/>
<CITE num="010" author="ERICKSON RP" publication="IMMUNOCHEMISTRY" d1="11" d2="41" d3="974"/>
<CITE num="012" author="GIBBONS RA" publication="BIOCHIM BIOPHYS ACTA" d1="444" d2="1" d3="976"/>
<CITE num="013" author="GOLDSMITH GH" publication="J LAB CLIN MED" d1="89" d2="131" d3="977"/>
<CITE num="014" author="HUNTER WM" publication="NATURE" d1="194" d2="495" d3="962"/>
<CITE num="015" author="KEIL B" publication="IN: BOYER PD" d1="3" d2="249" d3="971"/>
<CITE num="016" author="LAURELL CB" publication="ANAL BIOCHEM" d1="10" d2="358" d3="965"/>
<CITE num="017" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="109" d2="399" d3="974"/>
<CITE num="018" author="MURRAY MJ" publication="ANN INTERN MED" d1="53" d2="548" d3="960"/>
<CITE num="019" author="OHLSSON K" publication="ACTA PHYSIOL SCAND" d1="81" d2="269" d3="971"/>
<CITE num="020" author="OUCHTERLONY O" publication="IN: WEIR DM" d1="" d2="" d3="978"/>
<CITE num="021" author="OWEN JA" publication="NATURE" d1="182" d2="1373" d3="958"/>
<CITE num="022" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="023" author="ROMEO G" publication="AM J HUM GENET" d1="29" d2="92A" d3="977"/>
<CITE num="024" author="SCHROEDER DD" publication="J BIOL CHEM" d1="243" d2="294" d3="968"/>
<CITE num="025" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="026" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="027" author="STANWORTH DR" publication="IN: WEIR DM" d1="6" d2="1" d3="978"/>
<CITE num="028" author="STEIN AA" publication="J PEDIATR" d1="65" d2="495" d3="964"/>
<CITE num="029" author="TALAMO RC" publication="PEDIATR RES" d1="6" d2="430" d3="972"/>
<CITE num="030" author="TWAROG FJ" publication="J ALLERGY CLIN IMMUNOL" d1="59" d2="35" d3="977"/>
<CITE num="031" author="WALSH-PLATT M" publication="AM J HUM GENET" d1="29" d2="111A" d3="977"/>
<CITE num="032" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="033" author="YUNG BY" publication="BIOCHEM BIOPHYS RES COMMUN" d1="65" d2="927" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79226</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NARO M              PE" publication="DIATR RES" d1="14" d2="86 9" d3="0"/>
<CITE num="2" author="ROMEO G" publication="J LAB CLIN MED" d1="95" d2="116" d3="980"/>
<CITE num="3" author="PARSONS M" publication="CLIN CHIM ACTA" d1="100" d2="215" d3="980"/>
<CITE num="4" author="THOMAS JM" publication="CLIN CHIM ACTA" d1="111" d2="199" d3="981"/>
<CITE num="5" author="COX KL" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="345" d3="982"/>
<CITE num="6" author="ROBERTS RC" publication="PEDIATR RES" d1="16" d2="416" d3="982"/>
<CITE num="7" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="8" author="SHAPIRA E" publication="ANN NY ACAD SCI" d1="421" d2="352" d3="983"/>
</CITATIONS>
<RECORDNUM>01206 </RECORDNUM>
<MEDLINENUM>80055671</MEDLINENUM>
<AUTHORS><AUTHOR>Wolf-R-O</AUTHOR><AUTHOR>Taussig-L</AUTHOR></AUTHORS>
<TITLE>Serum salivary amylase in cystic fibrosis [letter].</TITLE>
<SOURCE>Pediatr-Res. 1979 Sep. 13(9). P 1076-7.</SOURCE>
<MAJORSUBJ><TOPIC>AMYLASES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>ISOENZYMES: an</TOPIC><TOPIC>SALIVA: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMYLASES: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOENZYMES: bl</TOPIC></MINORSUBJ>
<EXTRACT>We found that cystic fibrosis (CF) patients with pancreatic
insufficiency (PI) had a statistically lower total serum amylase
level than normal subjects, but all values were still within the
normal range.  Although we found that the absolute amount of salivary
amylase, in the serum of patients with CF and PI, was the same as
that for normal subjects, the percent of contribution was
considerably higher.  We found that the pancreas contributed
approximately 23% of the total serum amylase in CF patients with PI,
a value very similar to the 34% amount found by Kamaryt et al.  We
also found, as did Davidson et al., that CF patients without PI had
higher total serum amylase values than did normal subjects.  Thus,
we feel that Davidson et al. have misinterpreted the results of our
previous study and, in fact, we feel that Davidson et al. have
essentially confirmed our previous work by suggesting that CF
patients with pancreatic insufficiency have an increased salivary
amylase for reasons yet unknown.  Our experience has shown that,
indeed, the pancreatic portion is first increased and then decreases
as the patient with CF and apparent normal pancreatic function
progresses, with time, toward pancreatic insufficiency.  However, the
changes in serum amylase values in patients with CF are on the
average due to changes in the pancreatic contribution to the serum
and as expressed as a mean was highly significantly different for
both normal and abnormal pancreatic function.  The second important
point of our paper was that this mean variation occurred in serum
samples from patients with CF that had total amylase values within
the normal test range.  The serum salivary isoamylase in both normals
and patients with CF and PI had a higher serum salivary percent.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="10" d2="577" d3="975"/>
<CITE num="001" author="DAVIDSON GP" publication="PEDIATR RES" d1="12" d2="967" d3="978"/>
<CITE num="002" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
<CITE num="002" author="HUBBARD VS" publication="J PEDIATR" d1="92" d2="685" d3="978"/>
<CITE num="003" author="KAMARYT J" publication="CESK PEDIATR" d1="25" d2="78" d3="970"/>
<CITE num="004" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79227</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GEENEY KF           PE" publication="DIATR RES" d1="14" d2="67 9" d3="0"/>
</CITATIONS>
<RECORDNUM>01207 </RECORDNUM>
<MEDLINENUM>79157701</MEDLINENUM>
<AUTHORS><AUTHOR>Gabridge-M-G</AUTHOR><AUTHOR>Bright-M-J</AUTHOR><AUTHOR>Agee-C-C</AUTHOR><AUTHOR>Nickerson-J-M</AUTHOR><AUTHOR>Henderson-N-S</AUTHOR></AUTHORS>
<TITLE>Development of an improved tracheal explant bioassay for the
detection of the ciliary dyskinesia factor in cystic fibrosis serum.</TITLE>
<SOURCE>Pediatr-Res. 1979 Jan. 13(1). P 31-5.</SOURCE>
<MAJORSUBJ><TOPIC>CILIA: de</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>CYTOTOXINS: pd</TOPIC><TOPIC>TRACHEA: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CILIA: ph</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CULTURE-MEDIA</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GUINEA-PIGS</TOPIC><TOPIC>HAMSTERS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MOVEMENT</TOPIC><TOPIC>MUCUS: de</TOPIC><TOPIC>ORGAN-CULTURE: mt</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>RATS</TOPIC><TOPIC>TRACHEA: ul</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>A tracheal ring explant system, when used with 25% cystic fibrosis
(CF) serum, displayed obvious ciliostasis. Hamster, rabbit, and
guinea pig explants all had measurable decreases in ciliary activity
after 24 hr of incubation in the serum. The differential response to
CF serum (relative to normal serum) was greatly increased by using
explants which were maintained 24-72 hr in minimal essential medium
(MEM) with 10% horse serum and which were selected on the basis of
optimal ciliary activity and vigor. With such a bioassay system of
guinea pig tracheal explants, incubation with 25% normal serum would
produce essentially no change in relative ciliary activity (score of
242 of a possible 300), whereas CF serum resulted in an 86% decrease
(score of 33). Scanning electron microscopic observation indicated
that the explants displaying the CF-ciliostatic effect had
significant accumulations of mucous over the ciliated epithelial
surface. A biochemical viability assay (dehydrogenase activity)
showed no cytonecrosis when CF serum-treated tissues were compared to
standard explants (10% horse serum in MEM) or control explants (25%
normal human serum).</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARAD I" publication="ISR J MED SCI" d1="11" d2="10" d3="975"/>
<CITE num="002" author="BARGMAN GJ" publication="TEX REP BIOL MED" d1="34" d2="37" d3="976"/>
<CITE num="003" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="155" d3="976"/>
<CITE num="004" author="BERATIS NG" publication="PEDIATR RES" d1="7" d2="958" d3="973"/>
<CITE num="005" author="BOWMAN BH" publication="LIFE SCI" d1="19" d2="1289" d3="976"/>
<CITE num="006" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="007" author="CHANGUS JE" publication="ARCH PATHOL LAB MED" d1="100" d2="7" d3="976"/>
<CITE num="008" author="CHERRY JD" publication="ANN NY ACAD SCI" d1="225" d2="290" d3="973"/>
<CITE num="009" author="CHEUNG ATW" publication="PEDIATR RES" d1="10" d2="144" d3="976"/>
<CITE num="010" author="CHEUNG ATW" publication="PEDIATR RES" d1="10" d2="144" d3="976"/>
<CITE num="011" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="224" d3="973"/>
<CITE num="012" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="013" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="014" author="FORSTNER GG" publication="CAN MED ASSOC J" d1="113" d2="550" d3="975"/>
<CITE num="015" author="GABRIDGE MG" publication="IN: EVANS V" d1="1" d2="" d3="976"/>
<CITE num="016" author="GABRIDGE MG" publication="J CLIN MICROBIOL" d1="3" d2="560" d3="976"/>
<CITE num="017" author="GABRIDGE MG" publication="INFECT IMMUN" d1="10" d2="1127" d3="974"/>
<CITE num="018" author="GABRIDGE MG" publication="IN VITRO" d1="13" d2="510" d3="977"/>
<CITE num="019" author="GABRIDGE MG" publication="INFECT IMMUN" d1="13" d2="84" d3="976"/>
<CITE num="020" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="021" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="022" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="023" author="YEATES DB" publication="ARCH DIS CHILD" d1="51" d2="28" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79228</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNEDY JR            PE" publication="DIATR RES" d1="14" d2="73 9" d3="0"/>
<CITE num="2" author="GABRIDGE MG" publication="IN VITRO" d1="17" d2="847" d3="981"/>
<CITE num="3" author="TEGNER H" publication="ACTA PAEDIATR SCAND" d1="70" d2="629" d3="981"/>
<CITE num="4" author="GABRIDGE MG" publication="ENVIRON HEALTH PERSPECT" d1="44" d2="189" d3="982"/>
<CITE num="5" author="VONEULER AM" publication="ULTRASTRUCTURAL PATHOL" d1="5" d2="37" d3="983"/>
<CITE num="6" author="MA DI" publication="LIFE SCI" d1="32" d2="2849" d3="983"/>
<CITE num="7" author="RUTLAND J" publication="AM REV RESPIR DIS" d1="128" d2="1030" d3="983"/>
<CITE num="8" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="9" author="SANDERSON MJ" publication="CELL MOTIL" d1="4" d2="103" d3="984"/>
<CITE num="10" author="RUDICK VL" publication="J CELL PHYSIOL" d1="118" d2="67" d3="984"/>
<CITE num="11" author="WOOTEN MW" publication="J CELL PHYSIOL" d1="121" d2="490" d3="984"/>
<CITE num="12" author="WOOTEN MW" publication="IN VITRO CELL DEVEL BIOL" d1="21" d2="207" d3="985"/>
<CITE num="13" author="HINGLEY ST" publication="INFECT IMMUN" d1="51" d2="254" d3="986"/>
</CITATIONS>
<RECORDNUM>01208 </RECORDNUM>
<MEDLINENUM>79157717</MEDLINENUM>
<AUTHORS><AUTHOR>Verdugo-P</AUTHOR><AUTHOR>Hinds-T-R</AUTHOR><AUTHOR>Vincenzi-F-F</AUTHOR></AUTHORS>
<TITLE>Laser light-scattering spectroscopy: preliminary results on bioassay
of cystic fibrosis factor(s).</TITLE>
<SOURCE>Pediatr-Res. 1979 Feb. 13(2). P 131-5.</SOURCE>
<MAJORSUBJ><TOPIC>BIOLOGICAL-ASSAY: mt</TOPIC><TOPIC>CILIA: ph</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LASERS</TOPIC><TOPIC>SPECTRUM-ANALYSIS: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>EPITHELIUM</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MOVEMENT</TOPIC><TOPIC>SCATTERING-RADIATION</TOPIC><TOPIC>TRACHEA</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The effect of 7 cystic fibrosis sera and 4 normal sera was
investigated in 37 cultures of ciliated epithelium of the rabbit
trachea. Serum was introduced in the Rose culture chambers in a
concentration of 10% by volume. The frequency of ciliary beat was
monitored by laser light-scattering spectroscopy. The results show
that the response of cilia to sera can be well characterized by laser
light scattering. Our preliminary evidence suggests that an early
increase in the frequency of ciliary beat, followed by rapid arrest
of ciliary activity, is a sensitive and characteristic response
produced by cystic fibrosis serum, and not by normal serum.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERGE P" publication="C R ACAD SCI (D)(PARIS)" d1="256" d2="889" d3="967"/>
<CITE num="002" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="003" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="004" author="BOWMAN BH" publication="IN: MANGOS JA" d1="" d2="277" d3="976"/>
<CITE num="005" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="006" author="CHEUNG ATW" publication="PEDIATR RES" d1="10" d2="144" d3="976"/>
<CITE num="007" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="008" author="CONOVER JH" publication="LANCET" d1="2" d2="1362" d3="976"/>
<CITE num="009" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="250" d3="973"/>
<CITE num="010" author="DUBIN SB" publication="PROC NAT ACAD SCI USA" d1="57" d2="1164" d3="967"/>
<CITE num="011" author="ECKERT R" publication="J PHYSIOL (LOND)" d1="226" d2="699" d3="972"/>
<CITE num="012" author="LEE WI" publication="BIOPHYS J" d1="16" d2="1109" d3="976"/>
<CITE num="013" author="LEE WI" publication="ANN BIOMED ENG" d1="5" d2="248" d3="977"/>
<CITE num="014" author="LEE WI" publication="BIOPHYS J" d1="16" d2="120" d3="976"/>
<CITE num="015" author="NOSSAL R" publication="J PHYSIQUE COLL CL" d1="33" d2="171" d3="972"/>
<CITE num="016" author="RUMERY RE" publication="IN: DANIEL JC JR" d1="" d2="" d3="970"/>
<CITE num="017" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="018" author="VERDUGO P" publication="J CELL BIOL" d1="75" d2="293" d3="977"/>
<CITE num="019" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="143" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79229</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNEDY JR            PE" publication="DIATR RES" d1="14" d2="73 9" d3="0"/>
<CITE num="2" author="VERDUGO P" publication="FERTIL STERIL" d1="33" d2="193" d3="980"/>
<CITE num="3" author="VERDUGO P" publication="J APPL PHYSIOL" d1="48" d2="868" d3="980"/>
<CITE num="4" author="WILSON GB" publication="J CLIN INVEST" d1="66" d2="1010" d3="980"/>
<CITE num="5" author="SANDERSON MJ" publication="PEDIATR RES" d1="15" d2="219" d3="981"/>
<CITE num="6" author="BOGART BI" publication="PEDIATR RES" d1="16" d2="223" d3="982"/>
<CITE num="7" author="MCNEELY MC" publication="PEDIATR RES" d1="16" d2="21" d3="982"/>
<CITE num="8" author="DULFANO MJ" publication="THORAX" d1="37" d2="646" d3="982"/>
<CITE num="9" author="HARD R" publication="TISSUE CELL" d1="15" d2="217" d3="983"/>
<CITE num="10" author="RUTLAND J" publication="AM REV RESPIR DIS" d1="128" d2="1030" d3="983"/>
<CITE num="11" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="12" author="SANDERSON MJ" publication="CELL MOTIL" d1="5" d2="267" d3="985"/>
<CITE num="13" author="BRAGA PC" publication="J PHARMACOL METHODS" d1="16" d2="161" d3="986"/>
<CITE num="14" author="HINGLEY ST" publication="INFECT IMMUN" d1="51" d2="254" d3="986"/>
</CITATIONS>
<RECORDNUM>01209 </RECORDNUM>
<MEDLINENUM>80100639</MEDLINENUM>
<AUTHORS><AUTHOR>Tucker-R-D</AUTHOR><AUTHOR>Gibbs-G-E</AUTHOR><AUTHOR>Christensen-M-B</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis serum effect on the short circuit current of rat
jejunum.</TITLE>
<SOURCE>Pediatr-Res. 1979 Dec. 13(12). P 1371-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CELL-MEMBRANE: me</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENOTYPE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>JEJUNUM: bs</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MEMBRANE-POTENTIALS</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<ABSTRACT>Sera from 100 subjects were tested for the presence of the cystic
fibrosis (CF) "factor" utilizing the short circuit current rat
jejunum bioassay. Comparing the mean percent decrease in short
circuit current, the presumed normal group differs from the
homozygous CF group at P = 0.001 and from the heterozygous group at P
= 0.05. The two CF genotypes are statistically different at P =
0.004. There is, however, a large overlap among the three groups,
which limits the assay's utility as a guide for factor purification
as well as clinical use.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="002" author="ARAKI H" publication="PROC INT CF CONG 7TH" d1="" d2="28" d3="976"/>
<CITE num="003" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="004" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="005" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="006" author="CHERRY JD" publication="J PEDIATR" d1="79" d2="937" d3="971"/>
<CITE num="007" author="CONOVER JH" publication="LANCET" d1="1" d2="1194" d3="973"/>
<CITE num="008" author="GILMORE JP" publication="PROC SOC EXP BIOL MED" d1="157" d2="70" d3="978"/>
<CITE num="009" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="010" author="POSSELT HG" publication="Z KINDERHEILK" d1="110" d2="93" d3="971"/>
<CITE num="011" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="012" author="USSING HH" publication="ACTA PHYSIOL SCAND" d1="61" d2="484" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79230</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKER RD             CO" publication="MPUT BIOL MED" d1="11" d2="53 9" d3="1"/>
<CITE num="2" author="ALBAZZAZ FJ" publication="RESPIRATION" d1="46" d2="88" d3="984"/>
<CITE num="3" author="VONEULER AM" publication="EXP MOL PATH" d1="43" d2="142" d3="985"/>
</CITATIONS>
<RECORDNUM>01210 </RECORDNUM>
<MEDLINENUM>80055672</MEDLINENUM>
<AUTHORS><AUTHOR>Tully-G-W</AUTHOR><AUTHOR>Nevin-G-B</AUTHOR><AUTHOR>Young-I-R</AUTHOR><AUTHOR>Nevin-N-C</AUTHOR></AUTHORS>
<TITLE>Detection of cystic fibrosis protein by isoelectric focusing of
serum [letter].</TITLE>
<SOURCE>Pediatr-Res. 1979 Sep. 13(9). P 1078.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Several cystic fibrosis research groups have independently attempted
to reproduce the isoelectric focusing work of Wilson et al.  The
protocol that we employed with the LKB Mulitphor electrofocusing
apparatus was that of Wilson et al., although fixing and staining of
the polyacrylamide gels was performed in a boiling water bath for 30
min.  In 10 of 11 sera from patients with CF, the cystic fibrosis
protein band was directly identified by each of two independent
observers and in the sera from nine obligate heterozygote
individuals, the CFP band was noted in seven and eight instances by
each observer, respectively.  In sera from 26 normal control
individuals, the CFP band was observed in two instances.  Our results
would support the view that the CFP band is indeed directly
identifiable in both CT heterozygote and homozygote sera without
recourse to photographic image enhancement and that its frequency of
occurrence is similar to that reported previously.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ALTLAND K" publication="HUMANGENETIK" d1="28" d2="207" d3="975"/>
<CITE num="002" author="BEARN AG" publication="N ENGL J MED" d1="286" d2="764" d3="972"/>
<CITE num="003" author="DANES BS" publication="CLIN GENET" d1="11" d2="83" d3="977"/>
<CITE num="004" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="005" author="SCHOLEY J" publication="PEDIATR RES" d1="12" d2="800" d3="978"/>
<CITE num="006" author="SMITH QT" publication="PEDIATR RES" d1="10" d2="999" d3="976"/>
<CITE num="007" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="1148" d3="977"/>
<CITE num="009" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="986" d3="977"/>
<CITE num="010" author="WILSON GB" publication="PEDIATR RES" d1="12" d2="801" d3="978"/>
<CITE num="011" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79231</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RNOKY AL            J" publication="ROY SOC MED" d1="73" d2="73 9" d3="0"/>
<CITE num="2" author="NEVIN GB" publication="HUM GENET" d1="56" d2="387" d3="981"/>
<CITE num="3" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="4" author="JAMIESON A" publication="HUM GENET" d1="70" d2="168" d3="985"/>
<CITE num="5" author="GETLIFFE KA" publication="J INHERIT METAB DIS" d1="9" d2="348" d3="986"/>
</CITATIONS>
<RECORDNUM>01211 </RECORDNUM>
<MEDLINENUM>80055673</MEDLINENUM>
<AUTHORS><AUTHOR>Wilson-G-B</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis protein, a confirmed diagnostic marker for detecting
heterozygote carriers: significance in relation to future screening
and to a proposed primary defect in alpha 2-macroglobulin.</TITLE>
<SOURCE>Pediatr-Res. 1979 Sep. 13(9). P 1079-81.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-MACROGLOBULINS: me</TOPIC><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di, fg</TOPIC><TOPIC>GENETIC-SCREENING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>The fact that alpha2-macroglobulin and cystic fibrosis CDA are made
by fibroblasts and monocytes points to the fact that these markers
and the CF protein will be of value for the detection of the CF gene
antenatally.  Screening for CFP and CF-CDA by isoelectric focusing or
radioimmunoassay in conjunction with quantitation of the functional
capacity of A2M could distinguish a fetus homozygous from one
heterozygous for the CF gene.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ASHWELL G" publication="ADV ENZYM MOLEC BIOL" d1="41" d2="99" d3="974"/>
<CITE num="002" author="DANES BS" publication="TEX REP BIOL MED" d1="34" d2="135" d3="976"/>
<CITE num="003" author="DANN LG" publication="LANCET" d1="2" d2="405" d3="978"/>
<CITE num="004" author="HOVY M" publication="J EXP MED" d1="145" d2="1580" d3="977"/>
<CITE num="005" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="006" author="LOUISOT P" publication="CLIN CHIM ACTA" d1="48" d2="373" d3="973"/>
<CITE num="007" author="MOSHER DF" publication="J EXP MED" d1="143" d2="462" d3="976"/>
<CITE num="008" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="009" author="OHLSSON K" publication="CLIN SCI MOL MED" d1="51" d2="87" d3="976"/>
<CITE num="010" author="RAO GJS" publication="PEDIATR RES" d1="11" d2="981" d3="977"/>
<CITE num="011" author="SCHOLEY J" publication="PEDIATR RES" d1="12" d2="800" d3="978"/>
<CITE num="012" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="013" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="014" author="SMITH QT" publication="PEDIATR RES" d1="10" d2="999" d3="976"/>
<CITE num="015" author="THOMAS JM" publication="CF CLUB ABST" d1="17" d2="19" d3="976"/>
<CITE num="016" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="1148" d3="977"/>
<CITE num="017" author="TULLY GW" publication="PEDIATR RES" d1="13" d2="1078" d3="979"/>
<CITE num="019" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="986" d3="977"/>
<CITE num="021" author="WILSON GB" publication="TEX REP BIOL MED" d1="34" d2="51" d3="976"/>
<CITE num="022" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="023" author="WILSON GB" publication="NATURE" d1="266" d2="463" d3="977"/>
<CITE num="024" author="WILSON GB" publication="PEDIATR RES" d1="12" d2="801" d3="978"/>
<CITE num="025" author="WILSON GB" publication="J LAB CLIN MED" d1="92" d2="463" d3="978"/>
<CITE num="026" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
<CITE num="027" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="139" d3="977"/>
<CITE num="028" author="WOLFF J" publication="ENDOCRINOLOGY" d1="101" d2="1767" d3="977"/>
<CITE num="029" author="ANON" publication="GENETIC SCREENING PROG PRIN A" d1="" d2="" d3="975"/>
<CITE num="030" author="ANON" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79232</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSON JC             LA" publication="NCET" d1="1" d2="30 9" d3="0"/>
<CITE num="2" author="WILSON GB" publication="LANCET" d1="2" d2="313" d3="980"/>
<CITE num="3" author="WILSON GB" publication="J CLIN INVEST" d1="66" d2="1010" d3="980"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="5" author="FREZAL J" publication="ARCH FR PEDIATR" d1="38" d2="217" d3="981"/>
<CITE num="6" author="WILSON GB" publication="J CLIN INVEST" d1="68" d2="171" d3="981"/>
<CITE num="7" author="HALLINAN FM" publication="CLIN CHIM ACTA" d1="117" d2="103" d3="981"/>
<CITE num="8" author="HUBBARD WJ" publication="J IMMUNOL" d1="126" d2="292" d3="981"/>
<CITE num="9" author="WILSON GB" publication="MED HYPOTHESES" d1="8" d2="527" d3="982"/>
<CITE num="10" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="11" author="BULLOCK S" publication="CLIN GENET" d1="21" d2="336" d3="982"/>
<CITE num="12" author="BROCK DJH" publication="HUM GENET" d1="60" d2="30" d3="982"/>
<CITE num="13" author="BURY AF" publication="CLIN CHIM ACTA" d1="118" d2="45" d3="982"/>
<CITE num="14" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="15" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="16" author="GRATAROLI R" publication="PEDIATR RES" d1="18" d2="130" d3="984"/>
<CITE num="17" author="ANON" publication="LANCET" d1="2" d2="249" d3="985"/>
<CITE num="18" author="LAROCHE D" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="404" d3="986"/>
</CITATIONS>
<RECORDNUM>01212 </RECORDNUM>
<MEDLINENUM>80012528</MEDLINENUM>
<AUTHORS><AUTHOR>Nagy-E-C</AUTHOR><AUTHOR>Khan-S</AUTHOR><AUTHOR>Sturgess-J-M</AUTHOR></AUTHORS>
<TITLE>Serum factor in cystic fibrosis: correlation with clinical
parameters.</TITLE>
<SOURCE>Pediatr-Res. 1979 Jun. 13(6). P 729-32.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>PEPTIDES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>BIOLOGICAL-ASSAY</TOPIC><TOPIC>CARBON-DIOXIDE: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GALACTOSYLTRANSFERASES: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OXYGEN: bl</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>TRACHEA</TOPIC></MINORSUBJ>
<ABSTRACT>The relationship between the activity of the cystic fibrosis serum
ciliary dyskinesia factor, detected by the rabbit tracheal bioassay,
and clinical status of the patient has been investigated in children,
1-24 years old, with cystic fibrosis. No significant correlation was
found between the amount of serum factor activity and age, clinical
status assessed by the Schwachman score, pulmonary function (vital
capacity, functional residual capacity, total lung capacity, residual
volume, maximum breathing capacity, maximal midinspiratory flow, and
maximal midexpiratory flow) or blood gas levels (pCO2, pO2). The
activity showed no significant relationship to serum
galactosyltransferase activity in children with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ADSHEAD PC" publication="ANN NY ACAD SCI" d1="253" d2="192" d3="975"/>
<CITE num="002" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="003" author="BAKER AP" publication="IN: FALKNER F" d1="19" d2="" d3="977"/>
<CITE num="004" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="155" d3="976"/>
<CITE num="005" author="BERATIS NG" publication="PEDIATR RES" d1="7" d2="958" d3="973"/>
<CITE num="006" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="007" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="008" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="224" d3="973"/>
<CITE num="009" author="CZEGLEDY-NAGY E" publication="LAB INVEST" d1="35" d2="588" d3="976"/>
<CITE num="010" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="251" d3="973"/>
<CITE num="011" author="LOUISOT P" publication="CLIN CHIM ACTA" d1="48" d2="373" d3="973"/>
<CITE num="012" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="013" author="RAO GJS" publication="PEDIATR RES" d1="11" d2="981" d3="977"/>
<CITE num="014" author="SANCHIS J" publication="N ENGL J MED" d1="289" d2="749" d3="974"/>
<CITE num="015" author="SINGER L" publication="CLIN BIOCHEM" d1="7" d2="146" d3="974"/>
<CITE num="016" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="017" author="STURGESS JM" publication="IN: FALKNER F" d1="19" d2="" d3="977"/>
<CITE num="018" author="WARWICK WJ" publication="CF CLUB ABST" d1="18" d2="91" d3="977"/>
<CITE num="019" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="986" d3="977"/>
<CITE num="020" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="021" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="022" author="YEATES DB" publication="ARCH DIS CHILD" d1="51" d2="28" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79233</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RENSEN RU           PE" publication="DIATR RES" d1="15" d2="14 9" d3="1"/>
<CITE num="2" author="RUTLAND J" publication="AM REV RESPIR DIS" d1="128" d2="1030" d3="983"/>
<CITE num="3" author="WOOTEN MW" publication="J CELL PHYSIOL" d1="121" d2="490" d3="984"/>
<CITE num="4" author="WOOTEN MW" publication="IN VITRO CELL DEVEL BIOL" d1="21" d2="207" d3="985"/>
</CITATIONS>
<RECORDNUM>01213 </RECORDNUM>
<MEDLINENUM>79246210</MEDLINENUM>
<AUTHORS><AUTHOR>Chase-H-P</AUTHOR><AUTHOR>Cotton-E-K</AUTHOR><AUTHOR>Elliott-R-B</AUTHOR></AUTHORS>
<TITLE>Intravenous linoleic acid supplementation in children with cystic
fibrosis.</TITLE>
<SOURCE>Pediatrics. 1979 Aug. 64(2). P 207-13.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC><TOPIC>LINOLEIC-ACIDS: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ARACHIDONIC-ACIDS: bl</TOPIC><TOPIC>BODY-HEIGHT</TOPIC><TOPIC>BODY-WEIGHT</TOPIC><TOPIC>CALORIC-INTAKE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa, pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>FAT-EMULSIONS-INTRAVENOUS: tu</TOPIC><TOPIC>LINOLEIC-ACIDS: bl</TOPIC><TOPIC>PLACEBOS</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SKINFOLD-THICKNESS</TOPIC><TOPIC>SODIUM: me</TOPIC><TOPIC>SWEAT: me</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Ten children with CF in matched pairs were infused with either
Intralipid or with 10% glucose on a double blind basis every other
week for one year. Although statistically there was significantly
greater gain in height and weight in the study year compared to the
previous year only for the test group, both groups improved more than
expected. Cumulative data analysis showed greater improvement for the
Intralipid group (23 of a possible 45 points) compared to the glucose
group (-2 points; P less than .02). This study indicates the need to
better define the role of nutrition in the pathophysiology of CF.
Meanwhile, it is recommended that all children with CF have plasma
linoleic acid levels measured at least once yearly, and if levels are
low, appropriate supplements should be given.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="002" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="003" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="004" author="RIVERS JPW" publication="LANCET" d1="2" d2="642" d3="975"/>
<CITE num="005" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="006" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="007" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
<CITE num="008" author="JELLIFFE DB" publication="ASSESSMENT NUTRITIONAL STATUS" d1="" d2="" d3="966"/>
<CITE num="009" author="FRISANCHO AR" publication="AM J CLIN NUTR" d1="27" d2="1052" d3="974"/>
<CITE num="010" author="CHASE HP" publication="LANCET" d1="2" d2="236" d3="978"/>
<CITE num="011" author="OBRIEN D" publication="LAB MANUAL PEDIAT MICROBIOC" d1="" d2="" d3="968"/>
<CITE num="012" author="MOORE RB" publication="J ALLERGY CLIN IMMUNOL" d1="49" d2="137" d3="972"/>
<CITE num="013" author="HOLLANDER M" publication="NONPARAMET STAT METHODS" d1="" d2="" d3="973"/>
<CITE num="014" author="VERGROESEN AJ" publication="NUTR REV" d1="35" d2="1" d3="977"/>
<CITE num="015" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="016" author="HANSEN AE" publication="PEDIATRICS" d1="31" d2="171" d3="963"/>
<CITE num="017" author="HOPKINS DT" publication="PROC SOC EXP BIOL MED" d1="114" d2="82" d3="963"/>
<CITE num="018" author="DAVIDSON M" publication="IN: RUDOLPH AM" d1="" d2="994" d3="977"/>
<CITE num="019" author="WEIHOFEN DM" publication="J AM DIET ASSOC" d1="54" d2="206" d3="969"/>
<CITE num="020" author="KHAW K-T" publication="CF CLUB ABST" d1="" d2="58" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79234</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RP RJ               CL" publication="IN CHEST MED" d1="1" d2="75 9" d3="0"/>
<CITE num="2" author="PARSONS HG" publication="PEDIATRICS" d1="66" d2="812" d3="980"/>
<CITE num="3" author="HUBBARD VS" publication="J PEDIATR" d1="96" d2="421" d3="980"/>
<CITE num="4" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="5" author="HUBBARD VS" publication="CLIN CHIM ACTA" d1="102" d2="115" d3="980"/>
<CITE num="6" author="LLOYDSTILL JD" publication="AM J CLIN NUTR" d1="34" d2="1" d3="981"/>
<CITE num="7" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="8" author="KUSOFFSKY E" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="434" d3="983"/>
<CITE num="9" author="ROGIERS V" publication="EUR J PEDIATR" d1="141" d2="39" d3="983"/>
<CITE num="10" author="BERTRAND JM" publication="J PEDIATR" d1="104" d2="41" d3="984"/>
<CITE num="11" author="DAVIS PB" publication="J LAB CLIN MED" d1="104" d2="203" d3="984"/>
<CITE num="12" author="MCKENNA MC" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="45" d3="985"/>
<CITE num="13" author="GIBSON RA" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="408" d3="986"/>
<CITE num="14" author="LESTER LA" publication="J PARENT ENTERAL NUTR" d1="10" d2="289" d3="986"/>
<CITE num="15" author="MISCHLER EH" publication="PEDIATR RES" d1="20" d2="36" d3="986"/>
<CITE num="16" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
<CITE num="17" author="CARLSTEDTDUKE J" publication="PROC NAT ACAD SCI USA" d1="83" d2="9202" d3="986"/>
</CITATIONS>
<RECORDNUM>01214 </RECORDNUM>
<MEDLINENUM>79179506</MEDLINENUM>
<AUTHORS><AUTHOR>Brasfield-D</AUTHOR><AUTHOR>Hicks-G</AUTHOR><AUTHOR>Soong-S</AUTHOR><AUTHOR>Tiller-R-E</AUTHOR></AUTHORS>
<TITLE>The chest roentgenogram in cystic fibrosis: a new scoring system.</TITLE>
<SOURCE>Pediatrics. 1979 Jan. 63(1). P 24-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: ra</TOPIC><TOPIC>LUNG: ra</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>EVALUATION-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>A roentgenogram scoring system is presented that is useful in the
evaluation and follow-up of patients with cystic fibrosis. The system
has been shown to be reproducible by and between observers and to
correlate significantly with results of pulmonary function tests,
Shwachman-Kulczycki scores, and, in a short-term evaluation,
morbidity.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HODSON CJ" publication="CLIN RADIOL" d1="13" d2="54" d3="962"/>
<CITE num="002" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="003" author="REILLY BJ" publication="RADIOLOGY" d1="98" d2="281" d3="971"/>
<CITE num="004" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="005" author="MATTHEW DJ" publication="PEDIATR RADIOL" d1="5" d2="198" d3="977"/>
<CITE num="006" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="007" author="COOPERMAN EM" publication="CAN MED ASSOC J" d1="105" d2="580" d3="971"/>
<CITE num="008" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="009" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="010" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="011" author="KNUDSON RJ" publication="AM REV RESPIR DIS" d1="113" d2="587" d3="976"/>
<CITE num="012" author="ZAPLETAL A" publication="J APPL PHYSIOL" d1="26" d2="308" d3="969"/>
<CITE num="013" author="DRAPER NR" publication="APPLIED REGRESSION ANALYSIS" d1="" d2="" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79235</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IPPS BE             J" publication="PEDIATR" d1="95" d2="79 9" d3="9"/>
<CITE num="2" author="LESTER LA" publication="J PEDIATR" d1="97" d2="742" d3="980"/>
<CITE num="3" author="BRASFIELD D" publication="AM J ROENTGENOL" d1="134" d2="1195" d3="980"/>
<CITE num="4" author="FEIGELSON J" publication="ARCH FR PEDIATR" d1="38" d2="617" d3="981"/>
<CITE num="5" author="HEN J" publication="J PEDIATR" d1="99" d2="585" d3="981"/>
<CITE num="6" author="HYATT AC" publication="J PEDIATR" d1="99" d2="307" d3="981"/>
<CITE num="7" author="NOLAN G" publication="J PEDIATR" d1="101" d2="626" d3="982"/>
<CITE num="8" author="DANTZKER DR" publication="AM REV RESPIR DIS" d1="125" d2="400" d3="982"/>
<CITE num="9" author="TUMMLER B" publication="MONATSSCHR KINDERHEILKD" d1="130" d2="157" d3="982"/>
<CITE num="10" author="KATZ SM" publication="JAMA" d1="248" d2="2284" d3="982"/>
<CITE num="11" author="PALMER J" publication="ANN INTERN MED" d1="99" d2="596" d3="983"/>
<CITE num="12" author="HARMS HK" publication="KLIN PAEDIATR" d1="195" d2="24" d3="983"/>
<CITE num="13" author="MCCARTHY VP" publication="GASTROENTEROLOGY" d1="86" d2="564" d3="984"/>
<CITE num="14" author="BERTRAND JM" publication="J PEDIATR" d1="104" d2="41" d3="984"/>
<CITE num="15" author="WHEELER WB" publication="J PEDIATR" d1="104" d2="695" d3="984"/>
<CITE num="16" author="MCCARTHY VP" publication="ARCH INTERN MED" d1="144" d2="408" d3="984"/>
<CITE num="17" author="WANG EEL" publication="N ENGL J MED" d1="311" d2="1653" d3="984"/>
<CITE num="18" author="AUERBACH HS" publication="LANCET" d1="2" d2="686" d3="985"/>
<CITE num="19" author="PANIDIS IP" publication="J AM COLL CARDIOL" d1="6" d2="701" d3="985"/>
<CITE num="20" author="TEMEERMAN GJ" publication="PEDIATR RADIOL" d1="15" d2="98" d3="985"/>
<CITE num="21" author="FARRELL PM" publication="PEDIATR RES" d1="19" d2="104" d3="985"/>
<CITE num="22" author="BOSSO JA" publication="ANTIMICROB AGENTS CHEMOTHER" d1="28" d2="829" d3="985"/>
<CITE num="23" author="JEWETT CV" publication="J PEDIATR" d1="106" d2="669" d3="985"/>
<CITE num="24" author="ZACH MS" publication="AM REV RESPIR DIS" d1="131" d2="537" d3="985"/>
<CITE num="25" author="SMITH TF" publication="AM J DIS CHILD" d1="139" d2="1039" d3="985"/>
<CITE num="26" author="BOLAND MP" publication="LANCET" d1="1" d2="232" d3="986"/>
<CITE num="27" author="OBERWALDNER B" publication="PEDIATR PULMONOL" d1="2" d2="358" d3="986"/>
<CITE num="28" author="RUBIO TT" publication="J ANTIMICROB CHEMOTHER" d1="18" d2="147" d3="986"/>
<CITE num="29" author="JACOBSEN LE" publication="J CAN ASSOC RADIOL" d1="37" d2="17" d3="986"/>
<CITE num="30" author="KATZ JN" publication="J PEDIATR" d1="108" d2="352" d3="986"/>
<CITE num="31" author="HARDY KA" publication="J PEDIATR" d1="109" d2="51" d3="986"/>
<CITE num="32" author="WATTS WJ" publication="AM REV RESPIR DIS" d1="134" d2="699" d3="986"/>
<CITE num="33" author="ANDREASSON B" publication="ACTA PAEDIATR SCAND" d1="76" d2="70" d3="987"/>
<CITE num="34" author="FIEL SB" publication="CHEST" d1="91" d2="181" d3="987"/>
</CITATIONS>
<RECORDNUM>01215 </RECORDNUM>
<MEDLINENUM>79200786</MEDLINENUM>
<AUTHORS><AUTHOR>Lloyd-Still-J-D</AUTHOR><AUTHOR>Simon-S-H</AUTHOR><AUTHOR>Wessel-H-U</AUTHOR><AUTHOR>Gibson-L-E</AUTHOR></AUTHORS>
<TITLE>Negative effects of oral fatty acid supplementation on sweat
chloride in cystic fibrosis.</TITLE>
<SOURCE>Pediatrics. 1979 Jul. 64(1). P 50-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>OILS: pd</TOPIC><TOPIC>SAFFLOWER-OIL: pd</TOPIC><TOPIC>SODIUM-CHLORIDE: an</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, dt</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROSTAGLANDINS-E: bl</TOPIC><TOPIC>PROSTAGLANDINS-F: bl</TOPIC><TOPIC>SWEAT: de</TOPIC></MINORSUBJ>
<ABSTRACT>Essential fatty acid supplementation with oral safflower oil (1
gm/kg/day) to 11 cystic fibrosis patients (aged 6 months to 14 years)
for one year produced no significant change in sweat chloride
concentration (mEq/liter) or sweat rate (gm/min/m2), Addition of
vitamin E (10 mg/kg/day) to the safflower oil had no effect on sweat
chloride concentration or rate compared to placebo. No clinical
improvement could be detected compared to a control group. These
results do not support previous reports of the effects of fatty acid
supplementation on sweat electrolyte concentrations in cystic
fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="002" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="003" author="BEVERIDGE J" publication="PEDIATRICS" d1="58" d2="465" d3="976"/>
<CITE num="004" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="005" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="SCHWARTZ IL" publication="J CLIN INVEST" d1="35" d2="114" d3="956"/>
<CITE num="008" author="SHWACHMAN H" publication="MOD PROBL PEDIATR" d1="10" d2="158" d3="967"/>
<CITE num="009" author="HOLMAN RT" publication="PROC WEST HEM NUTR CONG 5TH" d1="" d2="" d3="977"/>
<CITE num="010" author="HUBBARD VS" publication="LANCET" d1="2" d2="1302" d3="977"/>
<CITE num="011" author="DUBOIS RS" publication="GASTROENTEROLOGY" d1="72" d2="1052" d3="977"/>
<CITE num="012" author="LEMEN RJ" publication="AM REV RESPIR DIS" d1="117" d2="639" d3="978"/>
<CITE num="013" author="CHASE HP" publication="PEDIATR RES" d1="12" d2="431" d3="978"/>
<CITE num="014" author="HYMAN AL" publication="AM REV RESPIR DIS" d1="117" d2="111" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79236</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GIERS V             PE" publication="DIATR RES" d1="14" d2="88 9" d3="0"/>
<CITE num="2" author="LLOYDSTILL JD" publication="AM J CLIN NUTR" d1="34" d2="1" d3="981"/>
<CITE num="3" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="4" author="ROGIERS V" publication="EUR J PEDIATR" d1="141" d2="39" d3="983"/>
<CITE num="5" author="ANON" publication="J AM COLL TOXICOL" d1="4" d2="171" d3="985"/>
<CITE num="6" author="GIBSON RA" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="408" d3="986"/>
<CITE num="7" author="MISCHLER EH" publication="PEDIATR RES" d1="20" d2="36" d3="986"/>
</CITATIONS>
<RECORDNUM>01216 </RECORDNUM>
<MEDLINENUM>79179608</MEDLINENUM>
<AUTHORS><AUTHOR>Beckerman-R-C</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR></AUTHORS>
<TITLE>Hypoelectrolytemia and metabolic alkalosis in infants with cystic
fibrosis.</TITLE>
<SOURCE>Pediatrics. 1979 Apr. 63(4). P 580-3.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALOSIS: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>WATER-ELECTROLYTE-IMBALANCE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHLORIDES: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPOKALEMIA: et</TOPIC><TOPIC>HYPONATREMIA: et</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>The records of all children in the Tucson area diagnosed as having
cystic fibrosis (CF) before the age of 12 months were reviewed to
ascertain the prevalence of metabolic alkalosis as a major presenting
manifestation of CF. Five of eleven infants (46%) in whom CF had been
diagnosed between 1 and 12 months of age initially were seen with
hypokalemia, hypochloremia, and metabolic alkalosis unassociated with
marked dehydration, hyperpyrexia, or major pulmonary and/or
gastrointestinal symptoms. Two infants had repeated episodes of
metabolic alkalosis; for one of these infants, both episodes of
metabolic alkalosis occurred before the diagnosis of CF. It is
postulated that chronic loss of sweat electrolytes together with mild
gastrointestinal or respiratory illness may predispose the infant
with cystic fibrosis to a severe electrolyte and acid-base
disturbance. The lack of shock and hyperpyrexia together with the
apparent chronicity of electrolyte losses differentiates metabolic
alkalosis from the heat prostration syndrome, a more acute
complication of cystic fibrosis. Quantitative sweat testing should be
part of the evaluation of any infant with unexplained metabolic
alkalosis. Serum electrolytes should be assessed regularly in infants
with cystic fibrosis during hot weather months.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GOTTLIEB RP" publication="J PEDIATR" d1="79" d2="930" d3="971"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2014" d3="960"/>
<CITE num="003" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="82" d2="535" d3="973"/>
<CITE num="004" author="HOCHMAN HI" publication="ARCH DIS CHILD" d1="51" d2="390" d3="976"/>
<CITE num="005" author="SHETH KJ" publication="WIS MED J" d1="76/4" d2="S47" d3="977"/>
<CITE num="006" author="RENDLE-SHORT J" publication="ARCH DIS CHILD" d1="31" d2="28" d3="956"/>
<CITE num="007" author="KESSLER WR" publication="PEDIATRICS" d1="8" d2="648" d3="951"/>
<CITE num="008" author="SIMOPOULOS AP" publication="PEDIATR RES" d1="5" d2="626" d3="971"/>
<CITE num="009" author="MONTALVO JM" publication="J CLIN ENDOCRINOL METAB" d1="28" d2="582" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79237</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKERMAN RC          PE" publication="DIATRICS" d1="64" d2="89 9" d3="9"/>
<CITE num="2" author="NUSSBAUM E" publication="AM J DIS CHILD" d1="133" d2="965" d3="979"/>
<CITE num="3" author="SIMOPOULOS AP" publication="NUTR REV" d1="38" d2="201" d3="980"/>
<CITE num="4" author="GROSSMAN H" publication="PEDIATRICS" d1="66" d2="366" d3="980"/>
<CITE num="5" author="LEBOWITZ MD" publication="ENVIRON RES" d1="25" d2="225" d3="981"/>
<CITE num="6" author="GONZALEZ J" publication="PEDIATRICS" d1="67" d2="820" d3="981"/>
<CITE num="7" author="LAUGHLIN JJ" publication="PEDIATRICS" d1="68" d2="203" d3="981"/>
<CITE num="8" author="RAPAPORT R" publication="J PEDIATR" d1="98" d2="768" d3="981"/>
<CITE num="9" author="TABACHNIK NF" publication="SURG GYNECOL OBSTET" d1="152" d2="837" d3="981"/>
<CITE num="10" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="11" author="RUDDY R" publication="CLIN PEDIATR" d1="21" d2="367" d3="982"/>
<CITE num="12" author="FORSYTH JS" publication="SCOTT MED J" d1="27" d2="333" d3="982"/>
<CITE num="13" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="14" author="ZAMMARCHI E" publication="RIV ITAL PEDIATR" d1="9" d2="505" d3="983"/>
<CITE num="15" author="ORENSTEIN DM" publication="PEDIATR RES" d1="17" d2="267" d3="983"/>
<CITE num="16" author="HILL ID" publication="ARCH DIS CHILD" d1="58" d2="224" d3="983"/>
<CITE num="17" author="CARLILE JR" publication="AM J DIS CHILD" d1="137" d2="702" d3="983"/>
<CITE num="18" author="ORENSTEIN DM" publication="J APPL PHYSIOL" d1="57" d2="408" d3="984"/>
<CITE num="19" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="319" d3="985"/>
<CITE num="20" author="ORENSTEIN DM" publication="SEM RESPIR MED" d1="6" d2="252" d3="985"/>
</CITATIONS>
<RECORDNUM>01217 </RECORDNUM>
<MEDLINENUM>79179561</MEDLINENUM>
<AUTHORS><AUTHOR>Nezelof-C</AUTHOR><AUTHOR>LeSec-G</AUTHOR></AUTHORS>
<TITLE>Multifocal myocardial necrosis and fibrosis in pancreatic diseases
of children.</TITLE>
<SOURCE>Pediatrics. 1979 Mar. 63(3). P 361-8.</SOURCE>
<MAJORSUBJ><TOPIC>ENDOMYOCARDIAL-FIBROSIS: pa</TOPIC><TOPIC>MYOCARDIUM: pa</TOPIC><TOPIC>PANCREATIC-DISEASES: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACUTE-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEART-FAILURE-CONGESTIVE: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINE-SMALL: su</TOPIC><TOPIC>LIPOMATOSIS: pa</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MYOCARDITIS: pa</TOPIC><TOPIC>NECROSIS</TOPIC><TOPIC>PANCREAS: pa</TOPIC><TOPIC>PANCREATIC-NEOPLASMS: pa</TOPIC><TOPIC>PANCREATITIS: pa</TOPIC><TOPIC>POSTOPERATIVE-COMPLICATIONS: pa</TOPIC></MINORSUBJ>
<ABSTRACT>From a review of 2,000 autopsies of children, 16 cases of extensive
necrosis and scarring fibrosis of the myocardium were found. These
lesions involved mainly the left ventricle and spared the
endocardium, the pericardium, and the coronary vessels. These
necrotic of fibrotic heart lesions were found to be closely
associated with various pancreatic diseases: cystic fibrosis (11
cases), pancreatic lipomatosis (2 cases), extensive small bowel
resection (3 cases, 2 of which were associated with acute
interstitial pancreatitis). To explain these unexpected associations,
two hypotheses can be put forth: (1) The lack of absorption of some
presently undetermined substances indispensable for the correct
trophicity of the myocardium, and (2) the release in the blood of
proteolytic enzymes with consecutive activation of phlogistic
substances such as kinins.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WISSLER H" publication="HELV PAEDIATR ACTA SUPPL 1" d1="1" d2="3" d3="945"/>
<CITE num="002" author="ESTAGER EM" publication="LES LESIONS DE NECROSE MYOCAR" d1="" d2="" d3="958"/>
<CITE num="003" author="HERMIER M" publication="PEDIATRIE" d1="22" d2="931" d3="967"/>
<CITE num="004" author="KINTZEN W" publication="INT Z VITAMINFORSCH" d1="22" d2="273" d3="950"/>
<CITE num="005" author="LINHARTOVA A" publication="ZENTRALBL ALLG PATHOL" d1="103" d2="405" d3="962"/>
<CITE num="006" author="MOUY A" publication="ARCH FR PEDIATR" d1="25" d2="687" d3="968"/>
<CITE num="007" author="FARBER S" publication="ARCH PATHOL" d1="37" d2="238" d3="944"/>
<CITE num="008" author="NEZELOF C" publication="ARCH FR PEDIATR" d1="16" d2="1035" d3="959"/>
<CITE num="009" author="OPPENHEIMER EH" publication="JOHNS HOPKINS MED J" d1="133" d2="252" d3="973"/>
<CITE num="010" author="SHWACHMAN H" publication="N ENGL J MED" d1="281" d2="500" d3="969"/>
<CITE num="012" author="RICOUR C" publication="ARCH FR PEDIATR" d1="30" d2="469" d3="973"/>
<CITE num="013" author="RICOUR C" publication="ARCH FR PEDIATR" d1="34" d2="154" d3="977"/>
<CITE num="014" author="GALLOIS B" publication="THESIS" d1="" d2="" d3="973"/>
<CITE num="015" author="MCGIVEN AR" publication="ARCH DIS CHILD" d1="37" d2="656" d3="962"/>
<CITE num="016" author="OPPERMANN A" publication="ARCH FR PEDIATR" d1="17" d2="1339" d3="960"/>
<CITE num="017" author="CLAVER M" publication="PATHOL EUR" d1="7" d2="69" d3="974"/>
<CITE num="018" author="BURDZINSKA J" publication="KARDIOL POL" d1="7" d2="233" d3="964"/>
<CITE num="019" author="KUTOR J" publication="GYOGYSZERESZET" d1="17" d2="286" d3="966"/>
<CITE num="020" author="DEGARCIA DADONI CR" publication="ARCH ARGENT PEDIATR" d1="63" d2="188" d3="965"/>
<CITE num="021" author="POWELL LW JR" publication="VA MED" d1="84" d2="178" d3="957"/>
<CITE num="022" author="GIRON B" publication="MED INFANT" d1="7" d2="747" d3="976"/>
<CITE num="023" author="OPPENHEIMER EH" publication="CYSTIC FIBROSIS" d1="15" d2="21" d3="975"/>
<CITE num="024" author="PICANDET B" publication="MED INFANT" d1="7" d2="757" d3="976"/>
<CITE num="025" author="NEZELOF C" publication="ARCH FR PEDIATR" d1="18" d2="1135" d3="961"/>
<CITE num="026" author="BODIAN M" publication="ACTA PAEDIATR SCAND" d1="53" d2="282" d3="964"/>
<CITE num="027" author="SACREZ R" publication="ANN PEDIATR (PARIS)" d1="16" d2="43" d3="969"/>
<CITE num="028" author="SHWACHMAN H" publication="J PEDIATR" d1="65" d2="645" d3="964"/>
<CITE num="029" author="ARGOSTI B" publication="MED INFANT" d1="8" d2="822" d3="976"/>
<CITE num="030" author="MOZZICONACCI P" publication="IN: FLAMMARION M" d1="" d2="" d3="966"/>
<CITE num="031" author="GODEAU P" publication="SEM HOP PARIS" d1="51" d2="2383" d3="975"/>
<CITE num="032" author="LEVY A" publication="PRESSE MED" d1="73" d2="1345" d3="966"/>
<CITE num="033" author="BLUMENSTOCK DA" publication="PEDIATRICS" d1="19" d2="1002" d3="957"/>
<CITE num="034" author="HENDREN WH" publication="ARCH DIS CHILD" d1="40" d2="132" d3="965"/>
<CITE num="035" author="RIEMENSCHNEIDER TA" publication="PEDIATRICS" d1="41" d2="428" d3="968"/>
<CITE num="036" author="STRICKLER GB" publication="AM J DIS CHILD" d1="95" d2="206" d3="958"/>
<CITE num="037" author="COHEN MI" publication="PEDIATR RES" d1="7" d2="106" d3="973"/>
<CITE num="038" author="GUPTA MC" publication="GUT" d1="14" d2="438" d3="973"/>
<CITE num="039" author="DESCHAMPS JP" publication="MED INFANT" d1="1" d2="27" d3="973"/>
<CITE num="040" author="CLAIREAUX AE" publication="ARCH DIS CHILD" d1="31" d2="22" d3="956"/>
<CITE num="041" author="BLANC WA" publication="PEDIATRICS" d1="22" d2="494" d3="958"/>
<CITE num="042" author="DESJEUX JF" publication="ANN MED INTERNE PARIS" d1="127" d2="353" d3="976"/>
<CITE num="043" author="FEER W" publication="SCHWEIZ MED WOCHENSCHR" d1="82" d2="101" d3="952"/>
<CITE num="044" author="HARIDAS G" publication="ARCH DIS CHILD" d1="27" d2="23" d3="947"/>
<CITE num="045" author="HEGGTVEIT HA" publication="AM J PATHOL" d1="45" d2="757" d3="964"/>
<CITE num="046" author="WARTER J" publication="PRESSE MED" d1="70" d2="255" d3="962"/>
<CITE num="047" author="WERLE E" publication="MUNCH MED WOCHENSCHR" d1="115" d2="225" d3="973"/>
<CITE num="048" author="DOS REIS L" publication="ARCH SURG" d1="87" d2="604" d3="963"/>
<CITE num="049" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="050" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="051" author="LESEC G" publication="NOUV PRESSE MED" d1="5" d2="2470" d3="976"/>
<CITE num="052" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79238</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHMAN DS            PE" publication="DIATRICS" d1="64" d2="88 9" d3="9"/>
<CITE num="2" author="ZIMMERMANN A" publication="HELV PAEDIATR ACTA" d1="37" d2="183" d3="982"/>
<CITE num="3" author="GUESNU M" publication="ARCH FR PEDIATR" d1="39" d2="127" d3="982"/>
<CITE num="4" author="MOSS AJ" publication="PEDIATRICS" d1="70" d2="728" d3="982"/>
<CITE num="5" author="ROSSI E" publication="MONATSSCHR KINDERHEILKD" d1="130" d2="314" d3="982"/>
<CITE num="6" author="CHERON G" publication="ACTA PAEDIATR SCAND" d1="73" d2="697" d3="984"/>
<CITE num="7" author="SAVILAHTI E" publication="ACTA PAEDIATR SCAND" d1="73" d2="642" d3="984"/>
<CITE num="8" author="MICHAEL JR" publication="AM REV RESPIR DIS" d1="130" d2="516" d3="984"/>
<CITE num="9" author="SULLIVAN MM" publication="CHEST" d1="90" d2="239" d3="986"/>
</CITATIONS>
<RECORDNUM>01218 </RECORDNUM>
<MEDLINENUM>79200748</MEDLINENUM>
<AUTHORS><AUTHOR>Phelps-D-L</AUTHOR></AUTHORS>
<TITLE>Vitamin E: where do we stand?.</TITLE>
<SOURCE>Pediatrics. 1979 Jun. 63(6). P 933-5.</SOURCE>
<MAJORSUBJ><TOPIC>CHILD-NUTRITION</TOPIC><TOPIC>INFANT-NUTRITION-DISORDERS: dt</TOPIC><TOPIC>VITAMIN-E-DEFICIENCY: dt</TOPIC><TOPIC>VITAMIN-E: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADMINISTRATION-ORAL</TOPIC><TOPIC>ANEMIA-HEMOLYTIC: dt</TOPIC><TOPIC>BILIARY-TRACT: ab</TOPIC><TOPIC>BRONCHI: ab</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-PREMATURE-DISEASES: dt</TOPIC><TOPIC>LUNG: ab</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: dt</TOPIC><TOPIC>RETROLENTAL-FIBROPLASIA: dt</TOPIC><TOPIC>VITAMIN-E-DEFICIENCY: et</TOPIC><TOPIC>VITAMIN-E: ad, ae, ph</TOPIC></MINORSUBJ>
<EXTRACT>I propose that clinicians should have a general understanding of what
little physiology is known about tocopherol, be able to recognize the
circumstances that cause low tocopherol levels, understand when to
provide physiologic replacement therapy, and accept the
responsibility for protecting their patients from uncontrolled
experimental use of tocopherols.  Tocopherol physiology, tocopherol
pharmacology, tocopherol deficiency, therapy in deficiency states,
and pharmacological doses of tocopherol are discussed.  Patients with
prolonged fat malabsorption and some premature infants receiving iron
must be given vitamin E.  Use of tocopherol therapy in
bronchopulmonary dysplasia and retrolental fibroplasia, while
promising, is unproven and should be used only in a controlled study.
Research on the role of vitamin E in human physiology is entering a
rapid-growth phase.</EXTRACT>
<REFERENCES>
<CITE num="001" author="MELHORN DK" publication="OHIO STATE MED J" d1="69" d2="899" d3="973"/>
<CITE num="002" author="OSKI FA" publication="HOSP PRACT" d1="12" d2="79" d3="977"/>
<CITE num="003" author="BIERI JG" publication="VITAM HORM" d1="34" d2="31" d3="976"/>
<CITE num="005" author="DORMANDY TL" publication="LANCET" d1="1" d2="647" d3="978"/>
<CITE num="007" author="HORWITT MK" publication="AM J CLIN NUTR" d1="4" d2="408" d3="956"/>
<CITE num="008" author="OSKI FA" publication="J PEDIATR" d1="70" d2="211" d3="967"/>
<CITE num="009" author="RITCHIE JH" publication="N ENGL J MED" d1="279" d2="1185" d3="968"/>
<CITE num="010" author="ROSENBLUM JL" publication="PEDIATR RES" d1="12" d2="555" d3="978"/>
<CITE num="011" author="HILLMAN RW" publication="AM J CLIN NUTR" d1="5" d2="597" d3="957"/>
<CITE num="012" author="CORRIGAN JJ JR" publication="JAMA" d1="230" d2="1300" d3="974"/>
<CITE num="014" author="EHRLICH HP" publication="ANN SURG" d1="175" d2="235" d3="972"/>
<CITE num="015" author="LEVY L" publication="INFLAMMATION" d1="1" d2="333" d3="976"/>
<CITE num="016" author="EHRENKRANZ RA" publication="N ENGL J MED" d1="299" d2="564" d3="978"/>
<CITE num="017" author="NORTHWAY WH JR" publication="N ENGL J MED" d1="299" d2="599" d3="978"/>
<CITE num="018" author="PHELPS DL" publication="PEDIATRICS" d1="59" d2="998" d3="977"/>
<CITE num="019" author="JOHNSON L" publication="AM J CLIN NUTR" d1="27" d2="1158" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79239</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GASHI A             PE" publication="DIATR PHARMACOL" d1="1" d2="29 9" d3="0"/>
<CITE num="2" author="LEBOULANGER J" publication="REV PRAT" d1="31" d2="69" d3="981"/>
<CITE num="3" author="BELL EF" publication="AM J CLIN NUTR" d1="34" d2="414" d3="981"/>
<CITE num="4" author="HAGA P" publication="EUR J PEDIATR" d1="136" d2="143" d3="981"/>
<CITE num="5" author="LLOYD BW" publication="NEUROPEDIATRICS" d1="13" d2="155" d3="982"/>
<CITE num="6" author="ANDERSON SA" publication="AM J CLIN NUTR" d1="35" d2="381" d3="982"/>
<CITE num="7" author="GUGGENHEIM MA" publication="J PEDIATR" d1="100" d2="51" d3="982"/>
<CITE num="8" author="WILLE L" publication="KLIN PAEDIATR" d1="194" d2="1" d3="982"/>
<CITE num="9" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="S282" d3="983"/>
<CITE num="10" author="GREGORY JG" publication="SCIENTOMETRICS" d1="6" d2="307" d3="984"/>
<CITE num="11" author="VAISMAN N" publication="NUTR RES" d1="5" d2="931" d3="985"/>
<CITE num="12" author="BOHLES H" publication="KLIN PAEDIATR" d1="197" d2="386" d3="985"/>
<CITE num="13" author="CONWAY SP" publication="BR J NUTR" d1="56" d2="105" d3="986"/>
</CITATIONS>
<RECORDNUM>01219 </RECORDNUM>
<MEDLINENUM>80012602</MEDLINENUM>
<AUTHORS><AUTHOR>Beckerman-R-C</AUTHOR></AUTHORS>
<TITLE>Metabolic alkalosis in infants with cystic fibrosis [letter].</TITLE>
<SOURCE>Pediatrics. 1979 Sep. 64(3). P 389.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALOSIS: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBON-DIOXIDE: bl</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ELECTROLYTES: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SWEAT: ah</TOPIC></MINORSUBJ>
<EXTRACT>I have diagnosed six cystic fibrosis infants under 1 year of age,
four of whom had documented episodes of hypoelectrolytemia and severe
metabolic alkalosis.  These additional data support our previous
hypothesis that chronic sweat electrolyte depletion, more frequently
than previously recognized, can cause severe metabolic derangements
in infants with cystic fibrosis, especially those living in both
humid and dry, hot climates.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BECKERMAN RC" publication="PEDIATRICS" d1="63" d2="580" d3="979"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2014" d3="960"/>
<CITE num="003" author="GOTTLIEB RP" publication="J PEDIATR" d1="79" d2="930" d3="971"/>
<CITE num="004" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="82" d2="535" d3="973"/>
<CITE num="005" author="SHETH KJ" publication="WIS MED J" d1="76/4" d2="S47" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79240</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PAPORT R            J" publication="PEDIATR" d1="98" d2="68 9" d3="1"/>
<CITE num="2" author="FORSYTH JS" publication="SCOTT MED J" d1="27" d2="333" d3="982"/>
</CITATIONS>
<RECORDNUM>01220 </RECORDNUM>
<MEDLINENUM>80146088</MEDLINENUM>
<AUTHORS><AUTHOR>Pryor-J-A</AUTHOR><AUTHOR>Webber-B-A</AUTHOR></AUTHORS>
<TITLE>An evaluation of the forced expiration technique as an adjunct to
postural drainage.</TITLE>
<SOURCE>Physiotherapy. 1979 Oct. 65(10). P 304-7.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-SPASM: th</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>RESPIRATORY-THERAPY: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>A criticism often levelled at the forced expiration technique (FET)
is that it increases and may even produce bronchospasm.  It was our
impression that the use of forced expiration when combined with
periods of relaxed diaphragmatic breathing did not aggravate
bronchospasm and shortened the postural drainage session.  Two groups
of patients were studied: 24 with cystic fibrosis to evaluate the use
of the FET as an independent means of postural drainage; and 20
asthmatic patients to assess the effect of the FET on bronchospasm.
The studies indicate that the forced expiration technique increases
the efficiency of postural drainage, but does not increase airway
obstruction.  This technique can be applied to both medical and
surgical conditions when postural drainage, or a modified form of
postural drainage, is indicated.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="THORAX" d1="14" d2="286" d3="959"/>
<CITE num="002" author="COCHRANE GM" publication="BR MED J" d1="2" d2="1181" d3="977"/>
<CITE num="003" author="COTES JE" publication="LUNG FUNCTION" d1="" d2="" d3="975"/>
<CITE num="004" author="GASKELL DV" publication="BROMPTON HOSP GUIDE TO CHEST" d1="" d2="" d3="977"/>
<CITE num="006" author="MEAD J" publication="J APPL PHYSIOL" d1="22" d2="95" d3="967"/>
<CITE num="007" author="PRYOR JA" publication="BR MED J" d1="2" d2="417" d3="979"/>
<CITE num="009" author="THOMPSON BJ" publication="NZ J PHYSIOTHERAPY" d1="4" d2="4" d3="973"/>
<CITE num="010" author="THOMPSON BJ" publication="ASTHMA AND YOUR CHILD" d1="" d2="" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79241</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NDERMEER JWM        RE" publication="V INFECT DIS" d1="6" d2="07 9" d3="4"/>
<CITE num="2" author="BATTISTINI A" publication="RIV ITAL PEDIATR" d1="10" d2="220" d3="984"/>
<CITE num="3" author="RIVINGTONLAW BA" publication="CHEST" d1="85" d2="378" d3="984"/>
<CITE num="4" author="OBERWALDNER B" publication="PEDIATR PULMONOL" d1="2" d2="358" d3="986"/>
<CITE num="5" author="HOFMEYR JL" publication="THORAX" d1="41" d2="951" d3="986"/>
<CITE num="6" author="VERBOON JML" publication="EUR J RESPIR DIS" d1="69" d2="169" d3="986"/>
<CITE num="7" author="WEBBER BA" publication="BR J DIS CHEST" d1="80" d2="353" d3="986"/>
</CITATIONS>
<RECORDNUM>01221 </RECORDNUM>
<MEDLINENUM>79180081</MEDLINENUM>
<AUTHORS><AUTHOR>Martodam-R-R</AUTHOR><AUTHOR>Baugh-R-J</AUTHOR><AUTHOR>Twumasi-D-Y</AUTHOR><AUTHOR>Liener-I-E</AUTHOR></AUTHORS>
<TITLE>A rapid procedure for the large scale purification of elastase and
cathepsin G from human sputum.</TITLE>
<SOURCE>Prep-Biochem. 1979. 9(1). P 15-31.</SOURCE>
<MAJORSUBJ><TOPIC>CATHEPSINS: ip</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>PANCREATOPEPTIDASE: ip</TOPIC><TOPIC>SPUTUM: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMINO-ACID-SEQUENCE</TOPIC><TOPIC>BINDING-SITES</TOPIC><TOPIC>CHROMATOGRAPHY-AFFINITY: mt</TOPIC><TOPIC>CHROMATOGRAPHY-GEL: mt</TOPIC><TOPIC>DEOXYRIBONUCLEASES</TOPIC><TOPIC>ELECTROPHORESIS-DISC</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LEUKOCYTES: en</TOPIC><TOPIC>SUPPURATION</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>A procedure is described which permits the rapid isolation of large
amounts of elastase and cathepsin G from purulent sputum. This
procedure involves: (1) digestion of sputum with DNase, (2)
extraction of the insoluble residue that remains with 1 M NaCl, pH 8,
(3) affinity chromatography on Sepharose-bound Trasylol, and (4)
separation of the two enzymes by chromatogrphy on CM-Sephadex.
Starting with 500 g of sputum it was possible to isolate 175 mg of
each of these two enzymes within 7 to 10 days. Active site titration
indicated both enzymes to be at least 97% pure. Disc gel
electrophoresis in the presence and absence of SDS and amino acid
sequence of the N-terminal region support the conclusion that the
elastase and cathepsin G isolated from sputum are identical to the
same enzymes isolated directly from the leukocytes of human blood.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="JANOFF A" publication="AM J PATHOL" d1="68" d2="579" d3="972"/>
<CITE num="002" author="LAZARUS GS" publication="AM J PATHOL" d1="68" d2="565" d3="972"/>
<CITE num="003" author="STARKEY PM" publication="IN: BARRETT AJ" d1="" d2="57" d3="977"/>
<CITE num="004" author="TWUMASI DY" publication="J BIOL CHEM" d1="252" d2="1917" d3="977"/>
<CITE num="005" author="BAUGH RJ" publication="BIOCHEMISTRY" d1="15" d2="836" d3="976"/>
<CITE num="006" author="BIETH J" publication="BIOCHEM MED" d1="11" d2="350" d3="974"/>
<CITE num="007" author="VISSER L" publication="BIOCHIM BIOPHYS ACTA" d1="268" d2="257" d3="972"/>
<CITE num="008" author="POWERS JC" publication="BIOCHEM BIOPHYS RES COMMUN" d1="67" d2="639" d3="975"/>
<CITE num="010" author="CHASE T JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="29" d2="508" d3="967"/>
<CITE num="011" author="BREWER JM" publication="J CHEM EDUC" d1="46" d2="41" d3="969"/>
<CITE num="012" author="WEBER K" publication="J BIOL CHEM" d1="244" d2="4406" d3="969"/>
<CITE num="013" author="ANON" publication="BECKMAN INSTRUCTION MANUAL" d1="" d2="" d3="974"/>
<CITE num="014" author="SMITHIES O" publication="BIOCHEMISTRY" d1="10" d2="4912" d3="971"/>
<CITE num="015" author="WARBURG O" publication="BIOCHEM Z" d1="310" d2="384" d3="942"/>
<CITE num="016" author="JANOFF A" publication="LAB INVEST" d1="29" d2="458" d3="973"/>
<CITE num="017" author="SCHMIDT W" publication="PHYSIOL CHEM" d1="355" d2="1077" d3="974"/>
<CITE num="018" author="OHLSSON K" publication="EUR J BIOCHEM" d1="42" d2="519" d3="974"/>
<CITE num="019" author="TAYLOR JC" publication="ARCH BIOCHEM BIOPHYS" d1="169" d2="91" d3="975"/>
<CITE num="020" author="DRUZE D" publication="BIOCHIM BIOPHYS ACTA" d1="438" d2="505" d3="976"/>
<CITE num="021" author="FEINSTEIN G" publication="BIOCHIM BIOPHYS ACTA" d1="403" d2="477" d3="975"/>
<CITE num="022" author="RINDLER-LUDWIG R" publication="BIOCHIM BIOPHYS ACTA" d1="379" d2="606" d3="975"/>
<CITE num="023" author="STARKEY PM" publication="BIOCHEM J" d1="155" d2="255" d3="976"/>
<CITE num="024" author="STARKEY PM" publication="BIOCHEM J" d1="155" d2="265" d3="976"/>
<CITE num="025" author="STARKEY PM" publication="BIOCHEM J" d1="155" d2="273" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79242</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NIOR RM             J" publication="CLIN INVEST" d1="66" d2="59 9" d3="0"/>
<CITE num="2" author="MCDONALD JA" publication="J BIOL CHEM" d1="255" d2="8848" d3="980"/>
<CITE num="3" author="BOUDIER C" publication="ARCH BIOCHEM BIOPHYS" d1="210" d2="790" d3="981"/>
<CITE num="4" author="BOUDIER C" publication="J BIOL CHEM" d1="256" d2="256" d3="981"/>
<CITE num="5" author="MARTODAM RR" publication="BIOCHIM BIOPHYS ACTA" d1="667" d2="328" d3="981"/>
<CITE num="6" author="BAICI A" publication="SCAND J IMMUNOL" d1="16" d2="487" d3="982"/>
<CITE num="7" author="BAICI A" publication="MOL IMMUNOL" d1="19" d2="719" d3="982"/>
<CITE num="8" author="BOUDIER C" publication="BIOCHEM MED" d1="28" d2="41" d3="982"/>
<CITE num="9" author="CAMPBELL EJ" publication="J CLIN INVEST" d1="70" d2="845" d3="982"/>
<CITE num="10" author="CAMPBELL EJ" publication="PROC NAT ACAD SCI USA" d1="79" d2="6941" d3="982"/>
<CITE num="11" author="LAINE A" publication="BIOCHEM BIOPHYS RES COMMUN" d1="105" d2="186" d3="982"/>
<CITE num="12" author="LAINE A" publication="BIOCHEM BIOPHYS RES COMMUN" d1="107" d2="337" d3="982"/>
<CITE num="13" author="BROWER MS" publication="J BIOL CHEM" d1="257" d2="9849" d3="982"/>
<CITE num="14" author="VISCARELLO BR" publication="PREPAR BIOCHEM" d1="13" d2="57" d3="983"/>
<CITE num="15" author="STERRENBERG L" publication="THROMB RES" d1="31" d2="719" d3="983"/>
<CITE num="16" author="ANDREWS JL" publication="CHEMBIOL INTERACT" d1="47" d2="157" d3="983"/>
<CITE num="17" author="STONE PJ" publication="CHEST" d1="83" d2="S 65" d3="983"/>
<CITE num="18" author="CAMPBELL EJ" publication="J LAB CLIN MED" d1="101" d2="527" d3="983"/>
<CITE num="19" author="CAMPBELL EJ" publication="AM REV RESPIR DIS" d1="127" d2="631" d3="983"/>
<CITE num="20" author="MCGOWAN SE" publication="AM REV RESPIR DIS" d1="128" d2="688" d3="983"/>
<CITE num="21" author="STONE PJ" publication="ANN NY ACAD SCI" d1="421" d2="398" d3="983"/>
<CITE num="22" author="SNIDER GL" publication="AM REV RESPIR DIS" d1="129" d2="155" d3="984"/>
<CITE num="23" author="MCGOWAN SE" publication="AM REV RESPIR DIS" d1="130" d2="734" d3="984"/>
<CITE num="24" author="SENIOR RM" publication="J IMMUNOL" d1="132" d2="2547" d3="984"/>
<CITE num="25" author="BOUDIER C" publication="ADV EXP MED BIOL" d1="167" d2="313" d3="984"/>
<CITE num="26" author="MIKUNITAKAGAKI Y" publication="J BIOL CHEM" d1="259" d2="6739" d3="984"/>
<CITE num="27" author="BREUER R" publication="EXP LUNG RES" d1="9" d2="167" d3="985"/>
<CITE num="28" author="LENTINI A" publication="BIOCHEM INT" d1="10" d2="221" d3="985"/>
<CITE num="29" author="STERRENBERG L" publication="HAEMOSTASIS" d1="15" d2="126" d3="985"/>
<CITE num="30" author="STEIN RL" publication="ANNU REP MED CHEM" d1="20" d2="237" d3="985"/>
<CITE num="31" author="BINDER R" publication="RESPIRATION" d1="47" d2="267" d3="985"/>
<CITE num="32" author="JACQUOT J" publication="INFECT IMMUN" d1="47" d2="555" d3="985"/>
<CITE num="33" author="DORING G" publication="INFECT IMMUN" d1="49" d2="557" d3="985"/>
<CITE num="34" author="BREUER R" publication="J LAB CLIN MED" d1="105" d2="635" d3="985"/>
<CITE num="35" author="LAURENT P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="126" d2="275" d3="985"/>
<CITE num="36" author="BRUCE MC" publication="AM REV RESPIR DIS" d1="132" d2="529" d3="985"/>
<CITE num="37" author="LUCEY EC" publication="AM REV RESPIR DIS" d1="132" d2="362" d3="985"/>
<CITE num="38" author="SNIDER GL" publication="AM REV RESPIR DIS" d1="132" d2="1155" d3="985"/>
<CITE num="39" author="TOURNIER JM" publication="AM REV RESPIR DIS" d1="132" d2="524" d3="985"/>
<CITE num="40" author="SMITH CE" publication="BIOCHEM J" d1="225" d2="463" d3="985"/>
<CITE num="41" author="BALDUYCK M" publication="BIOL CHEM HOPPE SEYLER" d1="366" d2="9" d3="985"/>
<CITE num="42" author="BALDUYCK M" publication="BIOL CHEM HOPPE SEYLER" d1="366" d2="9" d3="985"/>
<CITE num="43" author="VERCAIGNEMARKO D" publication="BIOL CHEM HOPPE SEYLER" d1="366" d2="655" d3="985"/>
<CITE num="44" author="DORING G" publication="CLIN EXP IMMUNOL" d1="64" d2="597" d3="986"/>
<CITE num="45" author="WELGUS HG" publication="J CLIN INVEST" d1="77" d2="1675" d3="986"/>
<CITE num="46" author="NILES RM" publication="J LAB CLIN MED" d1="108" d2="489" d3="986"/>
<CITE num="47" author="GOLDSTEIN W" publication="AM REV RESPIR DIS" d1="134" d2="49" d3="986"/>
<CITE num="48" author="LUCEY EC" publication="AM REV RESPIR DIS" d1="134" d2="471" d3="986"/>
<CITE num="49" author="HECK LW" publication="ANAL BIOCHEM" d1="158" d2="217" d3="986"/>
<CITE num="50" author="SKINNER M" publication="PROC SOC EXP BIOL MED" d1="181" d2="211" d3="986"/>
<CITE num="51" author="BRUCH M" publication="BIOCHEM J" d1="238" d2="269" d3="986"/>
<CITE num="52" author="BERMAN G" publication="J BIOL CHEM" d1="261" d2="4095" d3="986"/>
<CITE num="53" author="JOHNSON DA" publication="J BIOL CHEM" d1="261" d2="4748" d3="986"/>
<CITE num="54" author="LAURENT P" publication="BIOCHEM PHARMACOL" d1="36" d2="765" d3="987"/>
<CITE num="55" author="PETERSON MW" publication="J APPL PHYSIOL" d1="62" d2="1521" d3="987"/>
<CITE num="56" author="BROWER MS" publication="BLOOD" d1="69" d2="813" d3="987"/>
<CITE num="57" author="MORRISON HM" publication="CLIN SCI" d1="72" d2="151" d3="987"/>
<CITE num="58" author="BOUDIER C" publication="ARCH BIOCHEM BIOPHYS" d1="253" d2="439" d3="987"/>
<CITE num="59" author="SMITH CE" publication="ARCH BIOCHEM BIOPHYS" d1="253" d2="146" d3="987"/>
<CITE num="60" author="SELLOUM L" publication="BIOL CHEM HOPPE SEYLER" d1="368" d2="47" d3="987"/>
</CITATIONS>
<RECORDNUM>01222 </RECORDNUM>
<MEDLINENUM>79223914</MEDLINENUM>
<AUTHORS><AUTHOR>Shapiro-B-L</AUTHOR><AUTHOR>Feigal-R-J</AUTHOR><AUTHOR>Lam-L-F</AUTHOR></AUTHORS>
<TITLE>Mitrochondrial NADH dehydrogenase in cystic fibrosis.</TITLE>
<SOURCE>Proc-Natl-Acad-Sci-USA. 1979 Jun. 76(6). P 2979-83.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>MITOCHONDRIA: en</TOPIC><TOPIC>NADH-NADPH-OXIDOREDUCTASES: me</TOPIC><TOPIC>SKIN: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>OXYGEN-CONSUMPTION</TOPIC></MINORSUBJ>
<ABSTRACT>We have shown that skin fibroblast from patients with cystic fibrosis
(CF) and from carriers for CF [heterozygotes (HZ)] consume more O2
than do their controls. When the mitochondrial electron transport
inhibitor rotenone was added to the cells, the relative inhibition of
O2 consumption was CF greater than HZ greater than controls (P less
than 0.005 in both comparisons). Because rotenone specifically
inhibits NADH dehydrogenase, [NADH: (acceptor) oxidoreductase, EC
1.6.99.3], which is the enzyme of energy-conserving site 1 of the
mitochondrial electron transport system, activity and kinetics of
this enzyme system were studied in fibroblast homogenates. NADH
dehydrogenase activity was equal in cells from the three genotypes.
At pH 8.0, affinity of the enzyme for its substrate was CF greater
than HZ = controls; at pH 8.6, affinity was CF greater than HZ =
controls (P less than 0.005 for the differences). pH optima for the
genotypes were without exception 8.6 (CF), 8.3 (HZ), and 8.0
(control). HZ and control lines were distinguished unequivocally in a
blind test on the basis of differences in pH optima. Purified
mitochondrial preparations revealed pH optima identical to those
found in whole cell homogenates. These data suggest that the mutant
gene responsible for CF is expressed in the complex mitochondrial
NADH dehydrogenase system.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="534" d3="976"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="005" author="PALADE GE" publication="SCIENCE" d1="189" d2="347" d3="975"/>
<CITE num="006" author="SHAPIRO BL" publication="GAP CONF REP TISS CULT APPR" d1="" d2="" d3="977"/>
<CITE num="007" author="SHAPIRO BL" publication="SCIENCE" d1="203" d2="1251" d3="979"/>
<CITE num="008" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="009" author="FEIGAL RJ" publication="PEDIATR RES" d1="13" d2="764" d3="979"/>
<CITE num="010" author="FEIGAL RJ" publication="NATURE" d1="278" d2="276" d3="979"/>
<CITE num="011" author="MITCHELL P" publication="BIOL REV" d1="41" d2="445" d3="966"/>
<CITE num="012" author="BYGRAVE FL" publication="BIOL REV" d1="53" d2="43" d3="978"/>
<CITE num="013" author="FEIGAL RJ" publication="DISSERTATION" d1="" d2="" d3="979"/>
<CITE num="014" author="SLATER EC" publication="METHODS ENZYMOL" d1="10" d2="48" d3="967"/>
<CITE num="015" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="016" author="KING TE" publication="METHODS ENZYMOL" d1="10" d2="275" d3="967"/>
<CITE num="017" author="STANBURY JB" publication="METABOLIC BASIS OF INHERITED" d1="" d2="" d3="978"/>
<CITE num="018" author="SINGER TP" publication="METHODS ENZYMOL" d1="53" d2="397" d3="978"/>
<CITE num="019" author="HATEFI Y" publication="IN: BOYER PD" d1="13" d2="175" d3="976"/>
<CITE num="020" author="RAGAN CI" publication="BIOCHIM BIOPHYS ACTA" d1="456" d2="249" d3="976"/>
<CITE num="021" author="HATEFI Y" publication="METHODS ENZYMOL" d1="53" d2="11" d3="976"/>
<CITE num="022" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="023" author="CARAFOLI E" publication="ANN NY ACAD SCI" d1="307" d2="269" d3="978"/>
<CITE num="024" author="LEHNINGER AL" publication="ANN NY ACAD SCI" d1="307" d2="160" d3="978"/>
<CITE num="025" author="WALLACH D" publication="EUR J BIOCHEM" d1="21" d2="433" d3="971"/>
<CITE num="026" author="ARGENT BE" publication="J PHYSIOL (LOND)" d1="230" d2="575" d3="973"/>
<CITE num="027" author="MANGOS JA" publication="IN: ANDREOLI TE" d1="" d2="" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79243</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              PE" publication="DIATR RES" d1="14" d2="83 9" d3="0"/>
<CITE num="2" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="3" author="SANGUINETTIBRICENO NR" publication="CLIN GENET" d1="22" d2="308" d3="982"/>
<CITE num="4" author="FEIGAL RJ" publication="LIFE SCI" d1="30" d2="93" d3="982"/>
<CITE num="5" author="SHAPIRO BL" publication="AM J HUM GENET" d1="34" d2="846" d3="982"/>
<CITE num="6" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="695" d3="982"/>
<CITE num="7" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="8" author="SEYMOUR CA" publication="BIOESSAYS" d1="1" d2="38" d3="984"/>
<CITE num="9" author="REGELMANN WE" publication="PEDIATR RES" d1="20" d2="619" d3="986"/>
<CITE num="10" author="STUTTS MJ" publication="PEDIATR RES" d1="20" d2="1316" d3="986"/>
<CITE num="11" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
<CITE num="12" author="BATTINO M" publication="FEBS LETTERS" d1="199" d2="155" d3="986"/>
<CITE num="13" author="FEIGAL RJ" publication="ANN NY ACAD SCI" d1="488" d2="82" d3="986"/>
</CITATIONS>
<RECORDNUM>01223 </RECORDNUM>
<MEDLINENUM>80122681</MEDLINENUM>
<AUTHORS><AUTHOR>Mangos-J-A</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: potential management through manipulation of the
secretory process in affected exocrine glands.</TITLE>
<SOURCE>Prog-Clin-Biol-Res. 1979. 34. P 111-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>EXOCRINE-GLANDS: se</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CATS</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>EXOCRINE-GLANDS: de</TOPIC><TOPIC>FERRETS</TOPIC><TOPIC>ISOPROTERENOL: pd</TOPIC><TOPIC>MACROMOLECULAR-SYSTEMS</TOPIC><TOPIC>MUCUS: se</TOPIC><TOPIC>PAROTID-GLAND: de</TOPIC><TOPIC>RATS</TOPIC><TOPIC>SALIVA: se</TOPIC><TOPIC>SODIUM: se</TOPIC><TOPIC>TRACHEA: de</TOPIC><TOPIC>WATER-ELECTROLYTE-BALANCE</TOPIC></MINORSUBJ>
<EXTRACT>Ten years ago, we demonstrated that chronic administration of
isoproterenol to rats results is structural and functional changes of
their salivary glands similar to those seen in exocrine glands of
patients with cystic fibrosis.  Recently, we began to study the
cellular pathophysiology of these glands and managed to achieve
pharmacological control of this abnormality.  We demonstrated that
administration of a beta-adrenergic antagonist in these animals
resulted in the correction of the electrolyte abnormality which is
very similar to that seen in the sweat glands of patients with cystic
fibrosis.  These two examples of manipulation of the secretory
processes in exocrine glands of experimental animals demonstrate the
feasibility of this approach in the therapy of patients with cystic
fibrosis.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79244</PAPERNUM>
<REFERENCES>
<CITE num="001" author="MANGOS JA" publication="IN: ANDREOLI TE" d1="" d2="" d3="978"/>
<CITE num="002" author="MANGOS JA" publication="J DENT RES" d1="57" d2="989" d3="978"/>
<CITE num="004" author="MANGOS JA" publication="CF PROJECTIONS INTO THE FUTUR" d1="" d2="" d3="976"/>
<CITE num="007" author="MANGOS JA" publication="AM J PHYSIOL" d1="225" d2="683" d3="973"/>
<CITE num="008" author="MANGOS JA" publication="AM J PHYSIOL" d1="229" d2="553" d3="975"/>
<CITE num="009" author="MANGOS JA" publication="AM J PHYSIOL" d1="229" d2="560" d3="975"/>
<CITE num="010" author="MANGOS JA" publication="AM J PHYSIOL" d1="229" d2="566" d3="975"/>
<CITE num="011" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="012" author="NADEL JA" publication="CIBA FOUND SYMP 54" d1="" d2="" d3="978"/>
<CITE num="013" author="STURGESS JM" publication="BR J EXP PATHOL" d1="54" d2="388" d3="973"/>
</REFERENCES>
<RECORDNUM>01224 </RECORDNUM>
<MEDLINENUM>80122682</MEDLINENUM>
<AUTHORS><AUTHOR>Gluckson-M-M</AUTHOR><AUTHOR>Denning-C-R</AUTHOR></AUTHORS>
<TITLE>Changing patterns of genetic counseling in a cystic fibrosis center.</TITLE>
<SOURCE>Prog-Clin-Biol-Res. 1979. 34. P 119-32.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ABORTION-LEGAL: px</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ATTITUDE-TO-HEALTH</TOPIC><TOPIC>CYSTIC-FIBROSIS: px</TOPIC><TOPIC>FAMILY-PLANNING</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PRENATAL-DIAGNOSIS</TOPIC><TOPIC>RELIGION</TOPIC><TOPIC>RISK</TOPIC></MINORSUBJ>
<EXTRACT>The change of life expectancy of cystic fibrosis patients has
stimulated our interest in assessing the understanding and
utilization of genetic information by adult CF patients and how this
may affect their coping mechanism(s).  The present study was designed
to obtain information in these areas with the expectation that more
effective genetic counseling might be developed for this enlarging
group of patients.  Knowledge of genetics, attitudes concerning
reproduction, attitudes toward prenatal diagnosis, and attitudes
toward a carrier identification study are reported for 25 males and
15 females with proven cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BOYLE IR" publication="J PEDIATR" d1="88" d2="318" d3="976"/>
<CITE num="002" author="CARTER CO" publication="LANCET" d1="1" d2="281" d3="971"/>
<CITE num="003" author="ANON" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="" d3="975"/>
<CITE num="004" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="005" author="DENNING CR" publication="IN: MANGOS JA" d1="" d2="127" d3="976"/>
<CITE num="006" author="DENNING CR" publication="PEDIATRICS" d1="41" d2="7" d3="968"/>
<CITE num="007" author="DODGE JA" publication="PATIENT COUNS HEALTH EDUC" d1="1" d2="8" d3="978"/>
<CITE num="008" author="EMERY AEH" publication="BR MED J" d1="1" d2="724" d3="973"/>
<CITE num="009" author="GLUCKSON MM" publication="CF CLUB ABST" d1="18" d2="" d3="977"/>
<CITE num="010" author="KABACK MM" publication="PROG MED GENET" d1="10" d2="103" d3="974"/>
<CITE num="011" author="LEONARD CO" publication="N ENGL J MED" d1="287" d2="433" d3="972"/>
<CITE num="012" author="MERRITT AD" publication="J LAB CLIN MED" d1="60" d2="998" d3="962"/>
<CITE num="013" author="MOHR I" publication="CF CLUB ABST" d1="16" d2="" d3="975"/>
<CITE num="014" author="SHAW MW" publication="IN: LUBS HA" d1="" d2="" d3="977"/>
<CITE num="015" author="SIBINGA MS" publication="PEDIATR RES" d1="6" d2="331" d3="972"/>
<CITE num="016" author="STEINHAUER PD" publication="PEDIATR CLIN NORTH AM" d1="21" d2="825" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79245</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SSARGE E            EU" publication="R J PEDIATR                  1" d1="43" d2="54 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01225 </RECORDNUM>
<MEDLINENUM>80080576</MEDLINENUM>
<TITLE>New test to detect carriers of gene for cystic fibrosis [news].</TITLE>
<SOURCE>Public-Health-Rep. 1979 Nov-Dec. 94(6). P 577.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HETEROZYGOTE-DETECTION: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN79246</PAPERNUM>
<EXTRACT>Development of a new test to detect carriers of the gene for cystic
fibrosis was announced.  The test involves the interaction between
red blood cells from a mouse and a small amount of a person's blood
serum.  The gene for cystic fibrosis is associated with a lectin, a
factor in the person's blood serum that acts to agglutinate (or
cluster) the red blood cells of the mouse.</EXTRACT>
<RECORDNUM>01226 </RECORDNUM>
<MEDLINENUM>81015715</MEDLINENUM>
<AUTHORS><AUTHOR>Swan-H-A</AUTHOR><AUTHOR>Chappell-J-S</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis--its surgical presentation.</TITLE>
<SOURCE>S-Afr-J-Surg. 1979 Jun. 17(2). P 51-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>BILIARY-TRACT-DISEASES: su</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>GASTROINTESTINAL-DISEASES: su</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIVER-DISEASES: su</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREATIC-DISEASES: su</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: su</TOPIC></MINORSUBJ>
<ABSTRACT>In a series of 62 cases of cystic fibrosis presenting at the
Transvaal Memorial Hospital for Children, Johannesburg, during the
10-year period 1968-1978, 15 patients required surgical treatment
for 17 complications of the disease.  Meconium ileus, rectal
prolapse, intussusception and ethmoiditis were the commonest
surgical presentations, and portal hypertension, bronchial
obstruction and nasal polyposis were also experienced.  As the basic
defect is unknown, treatment today is still directed towards these
usually unpredictable secondary consequences.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN79247</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="003" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="004" author="MCPARTLIN JF" publication="ARCH DIS CHILD" d1="47" d2="207" d3="972"/>
<CITE num="005" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="006" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="007" author="BERNSTEIN JG" publication="AM J DIS CHILD" d1="99" d2="804" d3="960"/>
<CITE num="008" author="GRACEY M" publication="IN: ANDERSON CM" d1="329" d2="359" d3="975"/>
<CITE num="009" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
<CITE num="010" author="LLOYD-STILL JD" publication="BR MED J" d1="1" d2="110" d3="971"/>
<CITE num="011" author="ALTERMAN K" publication="AM J DIS CHILD" d1="101" d2="210" d3="961"/>
<CITE num="012" author="BOAT TF" publication="JAMA" d1="209" d2="1498" d3="969"/>
<CITE num="013" author="TAYLOR BW" publication="ARCH DIS CHILD" d1="49" d2="133" d3="974"/>
<CITE num="014" author="WANG CI" publication="AM J DIS CHILD" d1="119" d2="236" d3="970"/>
<CITE num="015" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="016" author="KISSANE JM" publication="PATHOLOGY OF INFANCY AND CHIL" d1="" d2="" d3="967"/>
<CITE num="017" author="GRAND RJ" publication="CLIN PEDIATR" d1="9" d2="588" d3="970"/>
<CITE num="018" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="019" author="KOMP DM" publication="CHEST" d1="58" d2="501" d3="970"/>
<CITE num="020" author="ESTERLY JR" publication="J PEDIATR" d1="69" d2="3" d3="966"/>
<CITE num="021" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="022" author="TAYLOR WF" publication="AM J DIS CHILD" d1="123" d2="161" d3="972"/>
<CITE num="023" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="024" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="279" d2="103" d3="968"/>
</REFERENCES>
<RECORDNUM>01227 </RECORDNUM>
<MEDLINENUM>80103180</MEDLINENUM>
<AUTHORS><AUTHOR>Friis-B</AUTHOR></AUTHORS>
<TITLE>Chemotherapy of chronic infections with mucoid Pseudomonas
aeruginosa in lower airways of patients with cystic fibrosis.</TITLE>
<SOURCE>Scand-J-Infect-Dis. 1979. 11(3). P 211-7.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PNEUMONIA: dt</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CARBENICILLIN: tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>COLISTIN: tu</TOPIC><TOPIC>DRUG-EVALUATION</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENTAMICINS: tu</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PNEUMONIA: co</TOPIC><TOPIC>PRECIPITINS: an</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC></MINORSUBJ>
<ABSTRACT>The bacteriological effect of chemotherapy against Pseudomonas
aeruginosa (Ps.ae.) in lungs of patients with cystic fibrosis is
reviewed. During a 5-year period 49 children and adults were treated
with 190 courses of different antibiotics. The mucoid strains of
Ps.ae. disappeared in 72.0% of the courses in which a combination of
tobramycin and carbenicillin was employed. Tobramycin given alone had
only bacteriological effect in 26.6% of the courses. Colimycin alone
or in combination with carbenicillin had no effect. In 18 patients
who received subsequent courses of tobramycin and combination of
tobramycin and carbenicillin a significant difference in favour of
the combination therapy was found, also in cases with many
precipitins against Ps.ae. in serum. In 74.5% of the initially
successful courses the patients were recolonized with Ps.ae. within 1
month. No nephrotoxic or ototoxic side effects were demonstrated in
spite of the high doses of tobramycin (10 mg/kg/24 h) emmployed and
the repeated courses.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON EL" publication="ANTIMICROB AGENTS CHEMOTHER" d1="8" d2="300" d3="975"/>
<CITE num="002" author="DAVIES J" publication="J INFECT DIS SUPPL" d1="124" d2="7" d3="971"/>
<CITE num="003" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="004" author="HAWLEY HB" publication="CURR THER RES" d1="16" d2="414" d3="974"/>
<CITE num="005" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="006" author="HUANG NN" publication="J PEDIATR" d1="78" d2="338" d3="971"/>
<CITE num="007" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="008" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="009" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="010" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="011" author="KLASTERSKY J" publication="AM J MED SCI" d1="266" d2="13" d3="973"/>
<CITE num="012" author="KLUGE RM" publication="ANN INTERN MED" d1="81" d2="584" d3="974"/>
<CITE num="013" author="KLUGE RM" publication="ANTIMICROB AGENTS CHEMOTHER" d1="6" d2="442" d3="974"/>
<CITE num="014" author="MARKS MI" publication="J PEDIATR" d1="79" d2="822" d3="971"/>
<CITE num="015" author="MCCRAE WM" publication="SCOTT MED J" d1="21" d2="68" d3="976"/>
<CITE num="016" author="MEYER RD" publication="APPL MICROBIOL" d1="22" d2="1147" d3="971"/>
<CITE num="017" author="MEYERS BR" publication="J CLIN PHARMACOL" d1="12" d2="321" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79248</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            AC" publication="TA PATH MICROBIOL SCAND (C) S2" d1="76" d2="1 9" d3="1"/>
<CITE num="2" author="FEIGELSON J" publication="NOUV PRESSE MED" d1="10" d2="955" d3="981"/>
<CITE num="3" author="MALMBORG AS" publication="SCAND J INFECT DIS" d1="1981" d2="64" d3="981"/>
<CITE num="4" author="MOLLER NE" publication="SCAND J INFECT DIS" d1="1981" d2="87" d3="981"/>
<CITE num="5" author="DAVIDSON S" publication="ISR J MED SCI" d1="18" d2="859" d3="982"/>
<CITE num="6" author="KELLY HW" publication="J PEDIATR" d1="101" d2="793" d3="982"/>
<CITE num="7" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="8" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="9" author="PERMIN H" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="313" d3="983"/>
<CITE num="10" author="HEILESEN AM" publication="SCAND J INFECT DIS" d1="15" d2="271" d3="983"/>
<CITE num="11" author="DORING G" publication="INFECT IMMUN" d1="42" d2="197" d3="983"/>
<CITE num="12" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND" d1="72" d2="283" d3="983"/>
<CITE num="13" author="SZAFF M" publication="ACTA PAEDIATR SCAND" d1="72" d2="651" d3="983"/>
<CITE num="14" author="DRUSANO GL" publication="REV INFECT DIS" d1="6" d2="13" d3="984"/>
<CITE num="15" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="16" author="FRASER GL" publication="DRUG INTEL CLIN PHARM" d1="19" d2="757" d3="985"/>
<CITE num="17" author="STACK BHR" publication="THORAX" d1="40" d2="358" d3="985"/>
<CITE num="18" author="STOUT SA" publication="DRUG INTEL CLIN PHARM" d1="21" d2="322" d3="987"/>
</CITATIONS>
<RECORDNUM>01228 </RECORDNUM>
<MEDLINENUM>79181690</MEDLINENUM>
<AUTHORS><AUTHOR>Gawel-J</AUTHOR><AUTHOR>Rudnik-J</AUTHOR><AUTHOR>Pryjma-J</AUTHOR><AUTHOR>Zebrak-J</AUTHOR><AUTHOR>Hauszka-J</AUTHOR><AUTHOR>Rudnik-I</AUTHOR><AUTHOR>Majewska-Zalewska-H</AUTHOR></AUTHORS>
<TITLE>Proteins in bronchial secretion of children with chronic pulmonary
diseases.  I. Relation to clinical diagnosis.</TITLE>
<SOURCE>Scand-J-Respir-Dis. 1979 Apr. 60(2). P 63-8.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI: se</TOPIC><TOPIC>IGA: se</TOPIC><TOPIC>IGA-SECRETORY</TOPIC><TOPIC>IGG: se</TOPIC><TOPIC>LACTOFERRIN: se</TOPIC><TOPIC>LACTOGLOBULINS: se</TOPIC><TOPIC>MURAMIDASE: se</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BRONCHI: im</TOPIC><TOPIC>BRONCHIECTASIS: di, im</TOPIC><TOPIC>BRONCHITIS: di, im</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, im</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGA: an</TOPIC><TOPIC>IGA-SECRETORY: an</TOPIC><TOPIC>IGG: an</TOPIC><TOPIC>LACTOFERRIN: an</TOPIC><TOPIC>MURAMIDASE: an</TOPIC><TOPIC>RECURRENCE</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: im</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: di, im</TOPIC></MINORSUBJ>
<ABSTRACT>Bronchial secretions from 207 children suffering from various
pulmonary diseases and from 15 healthy controls were tested
concentration of IgA, IgG, lactoferrin and lysozyme. The results
obtained suggest that in many cases of chronic lung diseases in
children the levels of lactoferrin and immunoglobulins, especially
secretory IgA, are very low. In severe infections (cystic fibrosis,
bronchiectases) significant increase of IgG concentration was
observed.</ABSTRACT>
<REFERENCES>001$  ADINOLFI M            IMMUNOLOGY                      10   517 966
002   ALFORD RH             J IMMUNOL                      101   984 968
003   BISERTE G             EXP ANNU BIOCHIM MED            24    85 963
004   BRUZDZINSKI H         MED DOSW MIKROBIOL              28   377 976
005   BULLEN GJ             BR J HAEMATOL                   23   289 972
006   DEUSCHL H             CLIN EXP IMMUNOL                16   401 973
007   FALK GA               AM REV RESPIR DIS              105    14 972
008   FLEMMING A            PROC R SOC LOND BIOL            93   306 922
009   HEISE ER              J RETICULOENDOTHEL SOC           4   510 967
010   HILL IR               IMMUNOLOGY                      26  1239 974
011   KALTREIDER HB         J IMMUNOL                      116   423 976
012   KOBAYASHI K           IMMUNOCHEMISTRY                  8   785 971
013   LICHT W               PNEUMONOLOGY                   144   139 971
014   LOWRY OH              J BIOL CHEM                    193   265 951
015   MANCINI G             IMMUNOCHEMISTRY                  2   235 965
016   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
017   MASSON PL             IN: DULFANO MJ                           973
018   MCINTOSH K            J ALLERGY CLIN IMMUNOL          57   595 976
019   MEDICI TC             AM REV RESPIR DIS              103   784 971
020   MESTECKY J            SCIENCE                        171  1163 971
021   NEWHOUSE M            N ENGL J MED                   295  1045 976
022   SIEGLER DIM           THORAX                          29   313 974
023   SOOTHILL JF           IN: BRENT L                      5       974
024   SOUTAR CA             THORAX                          30   239 975
025   SZOTOWA W             CZYNNE PORADNICTWO W OPIECE Z            976
026   THACORE H             AM REV RESPIR DIS               93   786 966
027   TISCHENDORF FW        IN: ENGELHARDT A                 1       974
028   WALDMAN RH            IN: NETER E                          334 975
029   ZEBRAK J              SCAND J RESPIR DIS              60    69 979</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79249</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BRAK J              SC" publication="AND J RESPIR DIS" d1="60" d2="69 9" d3="9"/>
<CITE num="2" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="3" author="GOLDSTEIN E" publication="REV INFECT DIS" d1="5" d2="1078" d3="983"/>
<CITE num="4" author="JACQUOT J" publication="BULL EUR PHYSIOPATH RESP" d1="19" d2="453" d3="983"/>
<CITE num="5" author="MOSS RB" publication="MONOGR ALLERGY" d1="19" d2="202" d3="986"/>
<CITE num="6" author="DVORETSKY LI" publication="TER ARKH" d1="58" d2="72" d3="986"/>
<CITE num="7" author="DVORETSKY LI" publication="KLIN MED" d1="65" d2="79" d3="987"/>
<CITE num="8" author="MOSS RB" publication="CHEST" d1="91" d2="522" d3="987"/>
</CITATIONS>
<RECORDNUM>01229 </RECORDNUM>
<MEDLINENUM>79181691</MEDLINENUM>
<AUTHORS><AUTHOR>Zebrak-J</AUTHOR><AUTHOR>Herman-T</AUTHOR><AUTHOR>Werys-R</AUTHOR><AUTHOR>Pryjma-J</AUTHOR><AUTHOR>Gawel-J</AUTHOR></AUTHORS>
<TITLE>Proteins in bronchial secretion of children with chronic pulmonary
diseases.  II.  Relation to bronchoscopic and bronchographic
examination.</TITLE>
<SOURCE>Scand-J-Respir-Dis. 1979 Apr. 60(2). P 69-75.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI: se</TOPIC><TOPIC>IGA: se</TOPIC><TOPIC>IGA-SECRETORY</TOPIC><TOPIC>IGG: se</TOPIC><TOPIC>LACTOFERRIN: se</TOPIC><TOPIC>LACTOGLOBULINS: se</TOPIC><TOPIC>MURAMIDASE: se</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BRONCHI: im</TOPIC><TOPIC>BRONCHIECTASIS: di, im</TOPIC><TOPIC>BRONCHITIS: di, im</TOPIC><TOPIC>BRONCHOGRAPHY</TOPIC><TOPIC>BRONCHOSCOPY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, im</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGA: an</TOPIC><TOPIC>IGA-SECRETORY: an</TOPIC><TOPIC>IGG: an</TOPIC><TOPIC>LACTOFERRIN: an</TOPIC><TOPIC>MURAMIDASE: an</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: im</TOPIC></MINORSUBJ>
<ABSTRACT>The concentration of immunoglobulins, lactoferrin and lysozyme we
compared in bronchial secretions obtained from children with various
chronic lung diseases. The IgG, lactoferrin and lysozyme, but not
secretory IgA, concentrations were shown to be increased during
chronic inflammatory response.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALFORD RH" publication="J IMMUNOL" d1="101" d2="984" d3="968"/>
<CITE num="002" author="DEUSCHL H" publication="CLIN EXP IMMUNOL" d1="16" d2="401" d3="973"/>
<CITE num="003" author="FALK GA" publication="AM REV RESPIR DIS" d1="105" d2="14" d3="972"/>
<CITE num="004" author="GAWEL J" publication="SCAND J RESPIR DIS" d1="60" d2="63" d3="979"/>
<CITE num="005" author="HAND WL" publication="J CLIN INVEST" d1="53" d2="354" d3="974"/>
<CITE num="006" author="KALTREIDER HB" publication="J CLIN INVEST" d1="54" d2="263" d3="974"/>
<CITE num="007" author="MARTINEZ-TELLO FJ" publication="J IMMUNOL" d1="101" d2="989" d3="968"/>
<CITE num="008" author="MASSON PL" publication="IN: DULFANO MJ" d1="" d2="" d3="973"/>
<CITE num="009" author="MASSON PL" publication="PROTIDES BIOL FLUIDS" d1="16" d2="633" d3="968"/>
<CITE num="010" author="MASSON PL" publication="J EXP MED" d1="130" d2="643" d3="969"/>
<CITE num="011" author="MEDICI TC" publication="AM REV RESPIR DIS" d1="103" d2="784" d3="971"/>
<CITE num="012" author="NEWHOUSE M" publication="N ENGL J MED" d1="295" d2="1045" d3="976"/>
<CITE num="013" author="SIEGLER DIM" publication="THORAX" d1="29" d2="313" d3="974"/>
<CITE num="014" author="SOUTAR CA" publication="THORAX" d1="30" d2="239" d3="975"/>
<CITE num="015" author="TOURVILLE DR" publication="J EXP MED" d1="129" d2="411" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79250</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WEL J               SC" publication="AND J RESPIR DIS" d1="60" d2="63 9" d3="9"/>
<CITE num="2" author="AMBRUSO DR" publication="J CLIN INVEST" d1="67" d2="352" d3="981"/>
<CITE num="3" author="LEE GR" publication="SEM HEMATOL" d1="20" d2="61" d3="983"/>
<CITE num="4" author="KIJLSTRA A" publication="BR J OPHTHALMOL" d1="67" d2="199" d3="983"/>
<CITE num="5" author="STELANDER M" publication="EUR J RESPIR DIS" d1="65" d2="5" d3="984"/>
<CITE num="6" author="FICK RB" publication="J CLIN INVEST" d1="74" d2="236" d3="984"/>
<CITE num="7" author="PRYJMA J" publication="ANN ALLERGY" d1="54" d2="60" d3="985"/>
</CITATIONS>
<RECORDNUM>01230 </RECORDNUM>
<MEDLINENUM>80081508</MEDLINENUM>
<AUTHORS><AUTHOR>Kurz-J-B</AUTHOR><AUTHOR>Perkins-J-P</AUTHOR><AUTHOR>Buchwald-M</AUTHOR></AUTHORS>
<TITLE>Killing of fibroblasts by dexamethasone or dibutyryl adenosine
3',5'-monophosphate is not a valid test for cystic fibrosis.</TITLE>
<SOURCE>Science. 1979 Dec 14. 206(4424). P 1317-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DEXAMETHASONE: pd</TOPIC><TOPIC>DIBUTYRYL-CYCLIC-AMP: pd</TOPIC><TOPIC>FIBROBLASTS: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CELL-DIVISION: de</TOPIC><TOPIC>CELL-SURVIVAL: de</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>DOSE-RESPONSE-RELATIONSHIP-DRUG</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>OUABAIN: pd</TOPIC><TOPIC>SKIN: cy</TOPIC></MINORSUBJ>
<ABSTRACT>Assays based on the counting of total cells and of colony-forming
cells were used to demonstrate that neither dexamethasone nor
dibutyryl adenosine 3',5'-monophosphate (cyclic AMP) kills human
fibroblasts under a variety of conditions. These results contradict
those of previous studies showing that dexamethasone and dibutyryl
cyclic AMP kill a higher percentage of fibroblasts from normal humans
than from individuals with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="002" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="003" author="BRESLOW JL" publication="CELL" d1="13" d2="663" d3="978"/>
<CITE num="004" author="EPSTEIN J" publication="SOMATIC CELL GENET" d1="4" d2="451" d3="978"/>
<CITE num="005" author="BUCHWALD M" publication="PROC NAT ACAD SCI USA" d1="73" d2="2899" d3="976"/>
<CITE num="006" author="ELMORE E" publication="IN VITRO" d1="13" d2="837" d3="977"/>
<CITE num="009" author="SIBLEY CH" publication="CELL" d1="2" d2="213" d3="974"/>
<CITE num="010" author="SIBLEY CH" publication="CELL" d1="2" d2="221" d3="974"/>
<CITE num="011" author="MANKOVITZ R" publication="CELL" d1="3" d2="221" d3="974"/>
<CITE num="012" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="016" author="HAM RG" publication="IN VITRO" d1="14" d2="11" d3="978"/>
<CITE num="018" author="PRATT WB" publication="J INVEST DERMATOL" d1="71" d2="23" d3="978"/>
<CITE num="019" author="CASTOR CW" publication="J LAB CLIN MED" d1="65" d2="490" d3="965"/>
<CITE num="020" author="THRASH CR" publication="NATURE" d1="242" d2="399" d3="973"/>
<CITE num="021" author="KAMELY D" publication="EXP CELL RES" d1="97" d2="120" d3="976"/>
<CITE num="022" author="GOSPODAROWICZ D" publication="J CELL BIOL" d1="66" d2="541" d3="975"/>
<CITE num="023" author="HARVEY W" publication="ANN RHEUM DIS" d1="33" d2="427" d3="974"/>
<CITE num="024" author="MILO GF" publication="IN VITRO" d1="12" d2="23" d3="976"/>
<CITE num="025" author="HAYASHI I" publication="IN VITRO" d1="14" d2="23" d3="978"/>
<CITE num="026" author="MACIEIRA-COELHO A" publication="EXPERIENTIA" d1="22" d2="390" d3="966"/>
<CITE num="027" author="MACIEIRA-COELHO A" publication="NATURE" d1="251" d2="67" d3="974"/>
<CITE num="028" author="CRISTOFALO VJ" publication="IN VITRO" d1="6" d2="396" d3="971"/>
<CITE num="029" author="GROVE GL" publication="CELL BIOL INT REP" d1="1" d2="147" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79251</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ANLIN TF            CL" publication="IN CHEST MED" d1="1" d2="24 9" d3="0"/>
<CITE num="2" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="3" author="EPSTEIN J" publication="PEDIATR RES" d1="14" d2="964" d3="980"/>
<CITE num="4" author="WEICHSELBAUM RR" publication="J CELL PHYSIOL" d1="103" d2="429" d3="980"/>
<CITE num="5" author="BRESLOW JL" publication="SCIENCE" d1="207" d2="1007" d3="980"/>
<CITE num="6" author="LITTLEFIELD JW" publication="N ENGL J MED" d1="304" d2="44" d3="981"/>
<CITE num="7" author="SHAPIRO BL" publication="N ENGL J MED" d1="304" d2="975" d3="981"/>
<CITE num="8" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="9" author="UNSICKER K" publication="CELL TISSUE RES" d1="223" d2="73" d3="982"/>
<CITE num="10" author="GRANAT M" publication="FERTIL STERIL" d1="39" d2="180" d3="983"/>
<CITE num="11" author="LANGHOFF E" publication="PEDIATR RES" d1="18" d2="488" d3="984"/>
<CITE num="12" author="JANSEN RPS" publication="AM J OBSTET GYNECOL" d1="153" d2="363" d3="985"/>
<CITE num="13" author="PINSKY L" publication="ADV HUM GENET" d1="16" d2="299" d3="987"/>
</CITATIONS>
<RECORDNUM>01231 </RECORDNUM>
<MEDLINENUM>79138718</MEDLINENUM>
<AUTHORS><AUTHOR>Shapiro-B-L</AUTHOR><AUTHOR>Lam-L-F</AUTHOR><AUTHOR>Fast-L-H</AUTHOR></AUTHORS>
<TITLE>Premature senescence in cultured skin fibroblasts from subjects with
cystic fibrosis.</TITLE>
<SOURCE>Science. 1979 Mar 23. 203(4386). P 1251-3.</SOURCE>
<MAJORSUBJ><TOPIC>CELL-SURVIVAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGING</TOPIC><TOPIC>CELL-DIVISION</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DNA: bi</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SKIN: pa</TOPIC></MINORSUBJ>
<ABSTRACT>Cultured skin fibroblasts from subjects with cystic fibrosis
exhibited normal population doubling times in early passages. After
about 13 cumulative population doublings, cystic fibrosis lines
doubled more slowly than controls and ceased doubling after about 19
weekly passages. Control lines continued doubling for 27 passages.
The premature senescence noted in cells from subjects with cystic
fibrosis reconciles controversial observations of cell doubling
reported in the literature. Data presented here demonstrate that
experiments with cystic fibrosis cells in late passage may generate
misleading results since differences from control lines may be
ascribed to generalized senile changes rather than to specific
results of the cystic fibrosis genotype.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="GAP CONF REP TISS CULT APPR" d1="" d2="" d3="977"/>
<CITE num="002" author="RAFF EC" publication="J CELL PHYSIOL" d1="74" d2="235" d3="969"/>
<CITE num="003" author="HOUCK JC" publication="PROC SOC EXP BIOL MED" d1="135" d2="369" d3="970"/>
<CITE num="004" author="HOUCK JC" publication="PROC SOC EXP BIOL MED" d1="147" d2="167" d3="974"/>
<CITE num="005" author="FLETCHER DS" publication="CLIN CHIM ACTA" d1="44" d2="5" d3="973"/>
<CITE num="006" author="WELCH DW" publication="PEDIATR RES" d1="9" d2="698" d3="975"/>
<CITE num="007" author="FARRELL PM" publication="PROC SOC EXP BIOL MED" d1="149" d2="340" d3="975"/>
<CITE num="008" author="BOLTON WE" publication="AM J HUM GENET" d1="27" d2="394" d3="975"/>
<CITE num="009" author="BARRANCO SC" publication="J CELL PHYSIOL" d1="88" d2="33" d3="976"/>
<CITE num="010" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="011" author="HAYFLICK L" publication="EXP CELL RES" d1="25" d2="585" d3="961"/>
<CITE num="012" author="HAYFLICK L" publication="EXP CELL RES" d1="37" d2="614" d3="965"/>
<CITE num="013" author="SCHNEIDER EL" publication="PROC SOC EXP BIOL MED" d1="141" d2="1092" d3="972"/>
<CITE num="014" author="GOLDSTEIN S" publication="SCIENCE" d1="199" d2="781" d3="978"/>
<CITE num="015" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="016" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="017" author="DOERING KM" publication="EUR J PEDIATR" d1="126" d2="185" d3="977"/>
<CITE num="018" author="KELLER PJ" publication="BIOCHEMISTRY" d1="10" d2="4867" d3="971"/>
<CITE num="019" author="ROBINSON AB" publication="PROC NAT ACAD SCI USA" d1="66" d2="753" d3="970"/>
<CITE num="019" author="MARTIN GM" publication="IN: BERGSMA D" d1="" d2="" d3="978"/>
<CITE num="020" author="ARGLEBE C" publication="CLIN OTOLARYNGOLOGY" d1="1" d2="249" d3="976"/>
<CITE num="021" author="CHILLA R" publication="ARCH OTO RHINO LARYNGOL" d1="214" d2="267" d3="977"/>
<CITE num="022" author="SWENEY LR" publication="PEDIATRICS" d1="40" d2="421" d3="967"/>
<CITE num="023" author="SWENEY LR" publication="ARCH PATHOL" d1="86" d2="413" d3="968"/>
<CITE num="024" author="STREHLER BL" publication="TIME CELLS AND AGING" d1="" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79252</PAPERNUM>
<CITATIONS>
<CITE num="1" author="M LFH               LI" publication="FE SCI" d1="24" d2="83 9" d3="9"/>
<CITE num="2" author="SHAPIRO BL" publication="PROC NAT ACAD SCI USA" d1="76" d2="2979" d3="979"/>
<CITE num="3" author="HOEHN H" publication="AM J MED GENET" d1="7" d2="141" d3="980"/>
<CITE num="4" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="5" author="CHASE HP" publication="METABOLISM" d1="29" d2="365" d3="980"/>
<CITE num="6" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="7" author="VRACKO R" publication="EXP CELL RES" d1="129" d2="345" d3="980"/>
<CITE num="8" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="53" d3="981"/>
<CITE num="9" author="KURZ JB" publication="PEDIATR RES" d1="15" d2="1328" d3="981"/>
<CITE num="10" author="SHAPIRO BL" publication="AM J HUM GENET" d1="34" d2="846" d3="982"/>
<CITE num="11" author="ANDERSON PJ" publication="BIOCHEM BIOPHYS RES COMMUN" d1="108" d2="182" d3="982"/>
<CITE num="12" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="13" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="14" author="CARMAGNOL F" publication="PEDIATR RES" d1="17" d2="181" d3="983"/>
<CITE num="15" author="VRACKO R" publication="IN VITRO" d1="19" d2="504" d3="983"/>
<CITE num="16" author="THOMPSON KVA" publication="GERONTOLOGY" d1="29" d2="97" d3="983"/>
<CITE num="17" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="18" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="19" author="MATTHEWS LW" publication="PEDIATR CLIN NORTH AM" d1="31" d2="133" d3="984"/>
<CITE num="20" author="GRINSTEIN S" publication="BIOCHIM BIOPHYS ACTA" d1="769" d2="270" d3="984"/>
<CITE num="21" author="RAVIA Y" publication="HUM GENET" d1="71" d2="294" d3="985"/>
<CITE num="22" author="AVIOLI LV" publication="AM J NEPHROL" d1="6" d2="151" d3="986"/>
<CITE num="23" author="MATTES PM" publication="PROC NAT ACAD SCI USA" d1="84" d2="3009" d3="987"/>
</CITATIONS>
<RECORDNUM>01232 </RECORDNUM>
<MEDLINENUM>80036401</MEDLINENUM>
<AUTHORS><AUTHOR>Howie-A-D</AUTHOR><AUTHOR>Stack-B-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in adolescents and young adults.</TITLE>
<SOURCE>Scott-Med-J. 1979 Jul. 24(3). P 193-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, th</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GASTROINTESTINAL-DISEASES: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>JOINT-DISEASES: co</TOPIC><TOPIC>LUNG-DISEASES: co</TOPIC><TOPIC>LUNG: ra</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SINUSITIS: co</TOPIC></MINORSUBJ>
<ABSTRACT>With the early diagnosis of cystic fibrosis and the better management
of these patients in childhood increasing numbers are surviving to
adult life. The main problem requiring continuous medical care in the
older cystic fibrosis patient is persisting and often progressive
chest disease. For this reason the cystic fibrosis clinic for
adolescents and young adults was started in the Western Infirmary in
1975. This paper presents our observations on 13 patients who had
attended between 1975 and 1977. Eleven patients are alive and well
and have shown no evidence of deterioration over this period. Ten are
at school or in regular employment. With optimum medical supervision
it is possible to give young adults with cystic fibrosis a worthwhile
existence.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOAT TF" publication="AM REV RESPIR DIS" d1="116" d2="1" d3="977"/>
<CITE num="002" author="BOAT TF" publication="CLIN PEDIATR" d1="13" d2="505" d3="974"/>
<CITE num="003" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="004" author="COOPERMAN EM" publication="CAN MED ASSOC J" d1="105" d2="580" d3="971"/>
<CITE num="005" author="GAYTON WF" publication="AM J DIS CHILD" d1="126" d2="856" d3="973"/>
<CITE num="006" author="GRACEY M" publication="AUSTRALAS ANN MED" d1="18" d2="91" d3="969"/>
<CITE num="007" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
<CITE num="008" author="LAWSON D" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="225" d3="969"/>
<CITE num="009" author="MCCRAE WM" publication="SCOTT MED J" d1="21" d2="68" d3="976"/>
<CITE num="010" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="011" author="MATHIEU J-P" publication="BR J DIS CHEST" d1="72" d2="57" d3="978"/>
<CITE num="012" author="MILNER AD" publication="ARCH DIS CHILD" d1="44" d2="351" d3="969"/>
<CITE num="013" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="014" author="ROSAN RC" publication="AM J DIS CHILD" d1="104" d2="625" d3="962"/>
<CITE num="015" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="016" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="017" author="STRUNK RC" publication="ARCH DIS CHILD" d1="52" d2="687" d3="977"/>
<CITE num="018" author="WARWICK WJ" publication="JAMA" d1="238" d2="2159" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79253</PAPERNUM>
<CITATIONS>
<CITE num="1" author="COBS WH             AM" publication="J GASTROENTEROL" d1="76" d2="42 9" d3="1"/>
<CITE num="2" author="MACPHERSON AIS" publication="SCOTT MED J" d1="29" d2="6" d3="984"/>
<CITE num="3" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
</CITATIONS>
<RECORDNUM>01233 </RECORDNUM>
<MEDLINENUM>79181843</MEDLINENUM>
<AUTHORS><AUTHOR>Frydman-M-I</AUTHOR></AUTHORS>
<TITLE>Implications of cystic fibrosis for health services and the
afflicted.</TITLE>
<SOURCE>Soc-Sci-Med. 1979 Mar. 13A(2). P 147-50. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: px</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADAPTATION-PSYCHOLOGICAL</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, th</TOPIC><TOPIC>FAMILY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MENTAL-DISORDERS: co</TOPIC><TOPIC>PARENT-CHILD-RELATIONS</TOPIC><TOPIC>REVIEW</TOPIC></MINORSUBJ>
<ABSTRACT>"Psychosocial" literature on cystic fibrosis (CF) is critically
reviewed.  Major methodological shortcomings include the anecdotal
nature of findings, overemphasis on negative consequences of the
disease, and the lack of a suitable theoretical framework.  Avenues
for future research are suggested.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KRAMM ER" publication="PEDIATRICS" d1="28" d2="135" d3="961"/>
<CITE num="002" author="POGUE RE" publication="MINN MED" d1="52" d2="1551" d3="969"/>
<CITE num="003" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="004" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="005" author="ANON" publication="GAP CONF REP CHRON BRONC CF" d1="" d2="" d3="977"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="007" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="008" author="LAPEY A" publication="IN: GELLIS SS" d1="" d2="221" d3="976"/>
<CITE num="009" author="LIFSCHITZ M" publication="ARCH FOUND THANATOLOGY" d1="1" d2="23" d3="969"/>
<CITE num="010" author="TOWNES BD" publication="J PSYCHOSOM RES" d1="18" d2="9" d3="974"/>
<CITE num="011" author="TURK J" publication="PEDIATRICS" d1="34" d2="67" d3="964"/>
<CITE num="012" author="TROPAUER A" publication="AM J DIS CHILD" d1="119" d2="424" d3="970"/>
<CITE num="013" author="TEICHER JD" publication="CALIF MED" d1="110" d2="371" d3="969"/>
<CITE num="014" author="BLOM G" publication="PEDIATRICS" d1="22" d2="593" d3="958"/>
<CITE num="015" author="MATTSSON A" publication="PEDIATRICS" d1="50" d2="801" d3="972"/>
<CITE num="016" author="FRIEDMAN SB" publication="PEDIATRICS" d1="32" d2="610" d3="963"/>
<CITE num="017" author="LAWLER RH" publication="CAN MED ASSOC J" d1="94" d2="1043" d3="966"/>
<CITE num="018" author="GAYTON WF" publication="AM J DIS CHILD" d1="126" d2="856" d3="973"/>
<CITE num="019" author="GOLDBERG DP" publication="DETECTION OF PSYCHIATRIC ILLN" d1="" d2="" d3="972"/>
<CITE num="020" author="KULCZYCKI LL" publication="CLIN PROC CHILD HOSP DC" d1="25" d2="320" d3="969"/>
<CITE num="021" author="ELLIS CE" publication="J PEDIATR" d1="87" d2="565" d3="975"/>
<CITE num="022" author="BURTON L" publication="FAMILY LIFE OF SICK CHILDREN" d1="" d2="" d3="975"/>
<CITE num="023" author="SPOCK A" publication="NC MED J" d1="27" d2="426" d3="966"/>
<CITE num="024" author="GREEN MN" publication="PEDIATRICS" d1="34" d2="58" d3="964"/>
<CITE num="025" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
<CITE num="026" author="GORDON NB" publication="J HLTH HUM BEHAV" d1="6" d2="190" d3="965"/>
<CITE num="027" author="BLUMENTHAL MD" publication="ARCH GEN PSYCHIAT" d1="21" d2="160" d3="969"/>
<CITE num="028" author="ORBACH CE" publication="CANCER" d1="8" d2="20" d3="955"/>
<CITE num="029" author="LINDEMANN E" publication="AM J PSYCHIATRY" d1="101" d2="141" d3="944"/>
<CITE num="030" author="GLASER BG" publication="AWARENESS OF DYING" d1="" d2="" d3="965"/>
<CITE num="031" author="NAJMAN JM" publication="HOSP HLTH ADMIN" d1="5" d2="8" d3="973"/>
<CITE num="032" author="PINKERTON P" publication="ARIZ MED" d1="26" d2="348" d3="969"/>
<CITE num="033" author="ROSENLUND ML" publication="ANN INTERN MED" d1="78" d2="959" d3="973"/>
<CITE num="034" author="MCCRAE WM" publication="LANCET" d1="2" d2="141" d3="973"/>
<CITE num="035" author="BURTON L" publication="PRACTITIONER" d1="210" d2="247" d3="973"/>
<CITE num="036" author="MEYEROWITZ JH" publication="SOC SCI MED" d1="1" d2="249" d3="967"/>
<CITE num="037" author="PLESS IB" publication="CHRONIC CHILDHOOD DISORDER" d1="" d2="" d3="975"/>
<CITE num="038" author="ALLAN JL" publication="AUST PAEDIATR J" d1="10" d2="136" d3="974"/>
<CITE num="039" author="HALLORAN KH" publication="J PEDIATR" d1="88" d2="1054" d3="976"/>
<CITE num="040" author="KUPST MJ" publication="PEDIATRICS" d1="59" d2="266" d3="977"/>
<CITE num="041" author="FRASER FC" publication="AM J HUM GENET" d1="26" d2="636" d3="974"/>
<CITE num="042" author="TAVORMINA JB" publication="J ABNORM CHILD PSYCHOL" d1="4" d2="99" d3="976"/>
<CITE num="043" author="GAYTON WF" publication="PEDIATRICS" d1="59" d2="888" d3="977"/>
<CITE num="044" author="BEDELL JR" publication="J PSYCHOSOM RES" d1="21" d2="237" d3="977"/>
<CITE num="045" author="CHODOFF P" publication="AM J PSYCHIATRY" d1="120" d2="743" d3="964"/>
<CITE num="046" author="GOFFMAN E" publication="ASYLUMS" d1="" d2="" d3="961"/>
<CITE num="047" author="SZASZ TS" publication="IDEOLOGY AND INSANITY" d1="" d2="" d3="973"/>
<CITE num="048" author="DENZIN NK" publication="IN: SPITZER SP" d1="" d2="" d3="968"/>
<CITE num="049" author="BOZEMAN MF" publication="CANCER" d1="8" d2="1" d3="955"/>
<CITE num="050" author="PARSONS T" publication="J SOC ISSUES" d1="8" d2="31" d3="952"/>
<CITE num="051" author="GORDON NB" publication="J HLTH HUM BEHAV" d1="6" d2="190" d3="965"/>
<CITE num="052" author="PRATT L" publication="FAMILY STRUCTURE EFFECTIVE HE" d1="" d2="" d3="976"/>
<CITE num="053" author="FREIDSON E" publication="PROF DOMINANCE THE SOCIAL STR" d1="" d2="" d3="970"/>
<CITE num="054" author="STRAUSS AL" publication="CHRONIC ILLNESS AND THE QUALI" d1="" d2="" d3="975"/>
<CITE num="055" author="ANDERSEN DH" publication="CHILDREN" d1="7" d2="11" d3="960"/>
<CITE num="056" author="KULCZYCKI LL" publication="PUBL HEALTH REP" d1="76" d2="88" d3="961"/>
<CITE num="057" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="058" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="059" author="ANON" publication="GAP CONF REP PSYCHOSOCIAL ASP" d1="" d2="" d3="974"/>
<CITE num="060" author="GOLODETZ A" publication="MED CARE" d1="7" d2="385" d3="969"/>
<CITE num="061" author="PATTERSON PR" publication="PSYCHOSOCIAL ASPECTS OF CF" d1="" d2="" d3="973"/>
<CITE num="062" author="MCCRAE WM" publication="PHYSIOTHERAPY" d1="61" d2="252" d3="975"/>
<CITE num="063" author="HAMBURG DA" publication="PSYCHOTHER PSYCHOSOM" d1="23" d2="13" d3="974"/>
<CITE num="064" author="HAGGERTY RJ" publication="CHILD HEALTH AND THE COMMUNIT" d1="" d2="" d3="975"/>
<CITE num="065" author="PLESS IB" publication="PEDIATR CLIN NORTH AM" d1="21" d2="223" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79254</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ESS IB              PE" publication="DIATR CLIN NORTH AM" d1="31" d2="33 9" d3="4"/>
</CITATIONS>
<RECORDNUM>01234 </RECORDNUM>
<MEDLINENUM>79138906</MEDLINENUM>
<AUTHORS><AUTHOR>Wood-R-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: diagnosis, treatment, and prognosis.</TITLE>
<SOURCE>South-Med-J. 1979 Feb. 72(2). P 189-202. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AEROSOLS</TOPIC><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>COUGH: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di, fg, mo, pp, px</TOPIC><TOPIC>DIET</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: di</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>INFERTILITY: et</TOPIC><TOPIC>SWEAT: an</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>UNITED-STATES</TOPIC></MINORSUBJ>
<EXTRACT>This review is intended to present a brief summary of the important
areas and concepts of cystic fibrosis relevant to clinical practice,
indicating those that remain controversial and offering opinions
based on both relevant literature and the clinical experience of the
Cleveland Cystic Fibrosis Center.  The sweat test, tests of
pancreatic function, tests of pulmonary function, genetics and family
history in diagnosis, infertility as a diagnostic factor, the role of
circulating factors in diagnosis, heterozygote detection and prenatal
diagnosis, miscellaneous factors leading to diagnosis, neonatal
screening, and general observations on the diagnosis of CF are
examined.  A philosophy of treatment, physical measures,
antimicrobial therapy, aerosol therapy, the role of hospitalization
in a therapeutic program, other drug therapy, the treatment of cor
pulmonale, respiratory failure, and specific pulmonary complications
are discussed.  Enzyme replacement and obstructive phenomena, glucose
intolerance, the treatment of the sweat defect, psychosocial therapy,
and prognosis are also considered.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="GIBSON LE" publication="PROC FOR QUANTITATIVE ION" d1="" d2="" d3="975"/>
<CITE num="006" author="HADORN B" publication="J PEDIATR" d1="73" d2="39" d3="968"/>
<CITE num="007" author="LOBER CW" publication="CHEST" d1="66" d2="332" d3="974"/>
<CITE num="008" author="BARBERO GJ" publication="AM J DIS CHILD" d1="112" d2="536" d3="966"/>
<CITE num="009" author="LAPEY A" publication="J PEDIATR" d1="84" d2="328" d3="974"/>
<CITE num="010" author="TAUSSIG LM" publication="PEDIATRICS" d1="54" d2="229" d3="974"/>
<CITE num="011" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
<CITE num="012" author="ANON" publication="CF FND 1975 REP SURVI STUD PA" d1="" d2="" d3="977"/>
<CITE num="013" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="014" author="KAPLAN E" publication="N ENGL J MED" d1="279" d2="65" d3="968"/>
<CITE num="015" author="COHEN LF" publication="GAP CONF REP PROB REPRO PHYSI" d1="" d2="6" d3="975"/>
<CITE num="016" author="HERROD HG" publication="J PEDIATR" d1="91" d2="276" d3="977"/>
<CITE num="017" author="OPPENHEIMER EH" publication="J PEDIATR" d1="75" d2="806" d3="969"/>
<CITE num="018" author="OPPENHEIMER EH" publication="J PEDIATR" d1="77" d2="991" d3="970"/>
<CITE num="019" author="KOPITO LE" publication="FERTIL STERIL" d1="24" d2="512" d3="973"/>
<CITE num="020" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="021" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="022" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="023" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
<CITE num="024" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="025" author="ANON" publication="GAP CONF REP CILIARY INHIBITO" d1="" d2="" d3="973"/>
<CITE num="026" author="WOOD RE" publication="HOSP PRACT" d1="11" d2="91" d3="976"/>
<CITE num="027" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="028" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="029" author="HOLSCLAW DS" publication="CF CLUB ABST" d1="" d2="" d3="977"/>
<CITE num="031" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="032" author="COMROE JH JR" publication="PHYSIOLOGY OF RESPIRATION" d1="" d2="" d3="965"/>
<CITE num="033" author="MELLINS RB" publication="AM REV RESPIR DIS SUPPL" d1="110" d2="137" d3="974"/>
<CITE num="034" author="WOOD RE" publication="IN: BARAN D" d1="" d2="" d3="977"/>
<CITE num="035" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="120" d2="432" d3="970"/>
<CITE num="036" author="PENNINGTON JE" publication="J INFECT DIS" d1="128" d2="63" d3="973"/>
<CITE num="037" author="MARKS MI" publication="J PEDIATR" d1="79" d2="822" d3="971"/>
<CITE num="038" author="STERN RC" publication="CLIN PEDIATR" d1="11" d2="521" d3="972"/>
<CITE num="039" author="RUCKER RW" publication="PEDIATRICS" d1="54" d2="358" d3="974"/>
<CITE num="040" author="PENNINGTON JE" publication="AM J MED" d1="58" d2="629" d3="975"/>
<CITE num="041" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="042" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="043" author="DOERSHUK CF" publication="PEDIATRICS" d1="41" d2="723" d3="968"/>
<CITE num="044" author="MOTOYAMA EK" publication="PEDIATRICS" d1="50" d2="299" d3="972"/>
<CITE num="045" author="CHANG N" publication="AM REV RESPIR DIS" d1="107" d2="672" d3="973"/>
<CITE num="046" author="WOLFSDORF J" publication="PEDIATRICS" d1="43" d2="799" d3="969"/>
<CITE num="047" author="BAU SK" publication="PEDIATRICS" d1="48" d2="605" d3="971"/>
<CITE num="048" author="WOOD RE" publication="PROC INT CF CONG 7TH" d1="" d2="" d3="976"/>
<CITE num="049" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="050" author="HUANG NN" publication="GUIDE TO DRUG THERAPY IN PATI" d1="" d2="" d3="972"/>
<CITE num="051" author="YEATES DB" publication="AM REV RESPIR DIS" d1="107" d2="602" d3="973"/>
<CITE num="052" author="STREIDER DJ" publication="PROC INT CF CONG 7TH" d1="" d2="" d3="976"/>
<CITE num="053" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="054" author="BOWDEN DH" publication="AM J MED" d1="38" d2="226" d3="965"/>
<CITE num="055" author="BLOCK AJ" publication="AM REV RESPIR DIS SUPPL" d1="110" d2="71" d3="974"/>
<CITE num="056" author="KELMINSON LL" publication="PEDIATRICS" d1="39" d2="24" d3="967"/>
<CITE num="057" author="DAVIS PB" publication="JAMA" d1="239" d2="1851" d3="978"/>
<CITE num="058" author="STOWE SM" publication="AM REV RESPIR DIS" d1="111" d2="611" d3="975"/>
<CITE num="059" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="060" author="STERN RC" publication="AM REV RESPIR DIS" d1="117" d2="825" d3="978"/>
<CITE num="061" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="062" author="BROWN CH 3RD" publication="N ENGL J MED" d1="291" d2="265" d3="974"/>
<CITE num="063" author="KYLSTRA JA" publication="AM REV RESPIR DIS" d1="103" d2="651" d3="971"/>
<CITE num="064" author="REGAN PT" publication="N ENGL J MED" d1="297" d2="854" d3="977"/>
<CITE num="065" author="FARRELL PM" publication="J CLIN INVEST" d1="60" d2="233" d3="977"/>
<CITE num="066" author="GRAHAM DY" publication="N ENGL J MED" d1="296" d2="1314" d3="977"/>
<CITE num="067" author="DIMAGNO EP" publication="N ENGL J MED" d1="296" d2="1318" d3="977"/>
<CITE num="068" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="069" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="070" author="STAPLETON FB" publication="N ENGL J MED" d1="295" d2="246" d3="976"/>
<CITE num="071" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="072" author="HUANG NN" publication="IN: SENIOR JR" d1="" d2="207" d3="968"/>
<CITE num="073" author="ALLAN JD" publication="AM J DIS CHILD" d1="126" d2="22" d3="973"/>
<CITE num="074" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
<CITE num="075" author="RAEBURN JA" publication="PROC NUTR SOC" d1="36" d2="77" d3="977"/>
<CITE num="076" author="WAGGET J" publication="J PEDIATR" d1="77" d2="407" d3="970"/>
<CITE num="077" author="DONNISON AB" publication="PEDIATRICS" d1="37" d2="833" d3="966"/>
<CITE num="078" author="STERN RC" publication="GASTROENTEROLOGY" d1="70" d2="645" d3="976"/>
<CITE num="079" author="HANDWERGER S" publication="N ENGL J MED" d1="281" d2="451" d3="969"/>
<CITE num="080" author="LIPPE BM" publication="J PEDIATR" d1="90" d2="751" d3="977"/>
<CITE num="081" author="WILMSHURST EG" publication="PEDIATRICS" d1="55" d2="75" d3="975"/>
<CITE num="082" author="CHAZAN BI" publication="J PEDIATR" d1="77" d2="86" d3="970"/>
<CITE num="083" author="ANON" publication="CF FND 1976 REP SURVI STUD PA" d1="" d2="" d3="978"/>
<CITE num="084" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="085" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79255</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSCLAW DS           CL" publication="IN CHEST MED" d1="1" d2="07 9" d3="0"/>
<CITE num="2" author="REED MD" publication="PEDIATR RES" d1="15" d2="1234" d3="981"/>
<CITE num="3" author="CONGDEN PJ" publication="ARCH DIS CHILD" d1="56" d2="708" d3="981"/>
<CITE num="4" author="KANG SB" publication="ANESTH ANALG CLEVE" d1="61" d2="793" d3="982"/>
<CITE num="5" author="IANNUCCI A" publication="HUM PATHOL" d1="15" d2="278" d3="984"/>
<CITE num="6" author="LEEDER JS" publication="CLIN PHARMACOL THER" d1="36" d2="355" d3="984"/>
<CITE num="7" author="NAYLOR EW" publication="SEM PERINATOL" d1="9" d2="232" d3="985"/>
<CITE num="8" author="GILLIGAN PH" publication="J CLIN MICROBIOL" d1="22" d2="5" d3="985"/>
<CITE num="9" author="REED MD" publication="ANTIMICROB AGENTS CHEMOTHER" d1="27" d2="583" d3="985"/>
<CITE num="10" author="KATZ JN" publication="J PEDIATR" d1="108" d2="352" d3="986"/>
</CITATIONS>
<RECORDNUM>01235 </RECORDNUM>
<MEDLINENUM>80014930</MEDLINENUM>
<AUTHORS><AUTHOR>van-Vroonhoven-T-J</AUTHOR><AUTHOR>Molenaar-J-C</AUTHOR></AUTHORS>
<TITLE>Distal splenorenal shunt for decompression of portal hypertension in
children with cystic fibrosis.</TITLE>
<SOURCE>Surg-Gynecol-Obstet. 1979 Oct. 149(4). P 559-60.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HYPERTENSION-PORTAL: su</TOPIC><TOPIC>RENAL-VEINS: su</TOPIC><TOPIC>SPLENIC-VEIN: su</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERTENSION-PORTAL: co</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC></MINORSUBJ>
<ABSTRACT>Apart from the sound physiologic basis for the distal splenorenal
shunt as compared with the portacaval shunt and the conventional
central splenorenal shunt, there are two important reasons why we
think the use of this type of shunt is especially advantageous in
children with portal hypertension secondary to cystic fibrosis.
Firstly, the thick, fibrotic retroperitoneal area in the porta
hepatis, where a portacaval shunt has to be constructed, can be
avoided, which makes the distal splenorenal shunt the easier
operation. Secondly, notwithstanding the relatively small-sized
vessels, a wide anastomosis can be constructed with a high flow rate
and, therefore, a minimal chance of shunt thrombosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GALAMBOS JT" publication="N ENGL J MED" d1="295" d2="1089" d3="976"/>
<CITE num="002" author="MAILLARD JN" publication="ETUDE HEMODYNAMIQUE DE LANAST" d1="" d2="" d3="978"/>
<CITE num="003" author="MAKSOUD JG" publication="J PEDIATR SURG" d1="13" d2="335" d3="978"/>
<CITE num="004" author="SCHUSTER SR" publication="J PEDIATR SURG" d1="12" d2="201" d3="977"/>
<CITE num="005" author="STERN RC" publication="GASTROENTEROLOGY" d1="70" d2="645" d3="976"/>
<CITE num="006" author="WARREN WD" publication="ANN SURG" d1="166" d2="437" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79256</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BACHNIK NF          SU" publication="RG GYNECOL OBSTET            1" d1="52" d2="37 9" d3="1"/>
<CITE num="2" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="3" author="HENDERSON JM" publication="SEM LIVER DIS" d1="3" d2="251" d3="983"/>
<CITE num="4" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="299" d3="985"/>
<CITE num="5" author="BERNARD O" publication="CLIN GASTROENTEROL" d1="14" d2="33" d3="985"/>
<CITE num="6" author="SCHRODER R" publication="SCHWEIZ MED WOCHENSCHR" d1="115" d2="828" d3="985"/>
</CITATIONS>
<RECORDNUM>01236 </RECORDNUM>
<MEDLINENUM>80124640</MEDLINENUM>
<AUTHORS><AUTHOR>Bowman-B-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: review of investigations of the mucociliary
inhibitor.</TITLE>
<SOURCE>Tex-Rep-Biol-Med. 1979. 38. P 47-53. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: ph</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BIOLOGICAL-ASSAY</TOPIC><TOPIC>BODY-FLUIDS</TOPIC><TOPIC>CILIA: de</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, me</TOPIC><TOPIC>GENES-RECESSIVE</TOPIC><TOPIC>GILLS</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>OYSTERS</TOPIC><TOPIC>PROTEINS: an</TOPIC><TOPIC>REVIEW</TOPIC></MINORSUBJ>
<EXTRACT>Recently, we found the cystic fibrosis mucociliary inhibitor in urine
from homozygotes and heterozygotes, but not from normals.  In recent
studies we have attempted to compare the relative concentrations of
CFMI in material from homozygotes and heterozygotes.  The unites of
inhibition which reflect the concentration of the CFMI in serum and
tissue culture medium fractions from heterozygotes is close to
one-half of that in fractions from homozygous sources.  With
purification of the CFMI and the generation of a monospecific
antibody preparation, answers will become available to the questions
of whether or not there is a normal counterpart to the CFMI and
whether or not quantitation of the CFMI will be useful in
heterozygote detection and prenatal diagnosis of cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="002" author="BARNETT DR" publication="TEX REP BIOL MED" d1="31" d2="703" d3="973"/>
<CITE num="003" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="155" d3="976"/>
<CITE num="004" author="BERATIS NG" publication="PEDIATR RES" d1="7" d2="958" d3="973"/>
<CITE num="005" author="BOWMAN BH" publication="PROC NAT ACAD SCI USA" d1="70" d2="548" d3="973"/>
<CITE num="006" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="007" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="008" author="BOWMAN BH" publication="CLIN GENET" d1="4" d2="461" d3="973"/>
<CITE num="009" author="BOWMAN BH" publication="CLIN GENET" d1="12" d2="333" d3="977"/>
<CITE num="011" author="CARSON SD" publication="DISSERTATION" d1="" d2="" d3="978"/>
<CITE num="012" author="COHEN FL" publication="J MED GENET" d1="11" d2="253" d3="974"/>
<CITE num="013" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="014" author="DANES BS" publication="J EXP MED" d1="136" d2="1313" d3="972"/>
<CITE num="015" author="FANCONI G" publication="WIEN MED WOCHENSCHR" d1="86" d2="753" d3="936"/>
<CITE num="016" author="HIRSCHHORN K" publication="IN: MANGOS JA" d1="" d2="305" d3="976"/>
<CITE num="017" author="LITT M" publication="BIOCHEM BIOPHYS RES COMMUN" d1="43" d2="919" d3="971"/>
<CITE num="018" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="019" author="MAYO BJ" publication="TEX REP BIOL MED" d1="34" d2="107" d3="976"/>
<CITE num="020" author="MCNEELY MC" publication="DISSERTATION" d1="" d2="" d3="978"/>
<CITE num="021" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="022" author="WILSON GB" publication="CLIN RES" d1="24" d2="295" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79257</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLINAN F            ME" publication="D HYPOTHESES" d1="7" d2="93 9" d3="1"/>
<CITE num="2" author="THOMAS JM" publication="CLIN CHIM ACTA" d1="111" d2="199" d3="981"/>
<CITE num="3" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="4" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="5" author="CEDER O" publication="ULTRASTRUCTURAL PATHOL" d1="4" d2="305" d3="983"/>
<CITE num="6" author="VONEULER AM" publication="ULTRASTRUCTURAL PATHOL" d1="5" d2="37" d3="983"/>
</CITATIONS>
<RECORDNUM>01237 </RECORDNUM>
<MEDLINENUM>80015007</MEDLINENUM>
<AUTHORS><AUTHOR>Landau-L-I</AUTHOR><AUTHOR>Mellis-C-M</AUTHOR><AUTHOR>Phelan-P-D</AUTHOR><AUTHOR>Bristowe-B</AUTHOR><AUTHOR>McLennan-L</AUTHOR></AUTHORS>
<TITLE>"Small airways disease" in children: no test is best.</TITLE>
<SOURCE>Thorax. 1979 Apr. 34(2). P 217-23.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: di</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ASTHMA: pp</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HELIUM: du</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG: ph</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NITROGEN: du</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>Tests claimed to detect small airway disease were evaluated in
children.  Fifty-two subjects who were normal, 30 with cystic
fibrosis (CF), and 35 with asthma were selected on the basis of
normal spirometry, informed consent being obtained from them and
their parents.  Tests undertaken were measurement of maximum
expiratory flow volume curves breathing air and a helium-oxygen
mixture, single breath nitrogen washout curves, lung volumes, and,
except in the normal subjects, measurement of arterial oxygen
tension.  Closing volumes were normal in most children with CF and
asthma, whereas the slope of the alveolar plateau was abnormal in
83%.  Maximum expiratory flow rate at 50% of total lung capacity was
reduced in 65% and maximum mid-expiratory flow rate in 57%; residual
volume increased in 51%, and results of other tests were abnormal in
less than 50% of the children.  There was evidence suggesting that
lung disease was more patchy in children with mild CF than in those
with interval phase asthma.  These tests do not detect specific
pathological processes in small airways but reflect the consequences
of small airway abnormalities, which may vary in the same disease as
well as in different diseases.  No one test alone appears most
useful.  Together they contribute to understanding the functional
abnormalities present in each individual.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANTHONISEN NR" publication="CLIN SCI" d1="35" d2="495" d3="968"/>
<CITE num="002" author="ANTHONISEN NR" publication="RESPIR PHYSIOL" d1="8" d2="58" d3="969"/>
<CITE num="003" author="ALDERSON PO" publication="RADIOLOGY" d1="111" d2="151" d3="974"/>
<CITE num="004" author="BODE FR" publication="AM J MED" d1="59" d2="43" d3="975"/>
<CITE num="005" author="BUIST AS" publication="AM REV RESPIR DIS" d1="108" d2="1078" d3="973"/>
<CITE num="006" author="BURROWS B" publication="AM REV RESPIR DIS" d1="115" d2="751" d3="977"/>
<CITE num="007" author="COLLEY JRT" publication="BR MED J" d1="3" d2="195" d3="973"/>
<CITE num="008" author="COOPER DM" publication="AM REV RESPIR DIS" d1="109" d2="519" d3="974"/>
<CITE num="009" author="DEMUTH GR" publication="AM J DIS CHILD" d1="103" d2="129" d3="962"/>
<CITE num="010" author="DESPAS PJ" publication="J CLIN INVEST" d1="51" d2="3235" d3="972"/>
<CITE num="011" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="012" author="FOX WW" publication="PEDIATRICS" d1="54" d2="293" d3="974"/>
<CITE num="013" author="GELB AF" publication="AM REV RESPIR DIS" d1="112" d2="401" d3="975"/>
<CITE num="014" author="HILL DJ" publication="AM REV RESPIR DIS" d1="106" d2="873" d3="972"/>
<CITE num="015" author="KNUDSON RJ" publication="AM REV RESPIR DIS" d1="115" d2="423" d3="977"/>
<CITE num="016" author="LAMARRE A" publication="PEDIATRICS" d1="50" d2="291" d3="972"/>
<CITE num="017" author="LANDAU LI" publication="AM REV RESPIR DIS" d1="108" d2="593" d3="973"/>
<CITE num="018" author="MCCARTHY DS" publication="AM J MED" d1="52" d2="747" d3="972"/>
<CITE num="019" author="MANSELL A" publication="J APPL PHYSIOL" d1="33" d2="711" d3="972"/>
<CITE num="020" author="MATSUBA K" publication="AM REV RESPIR DIS" d1="107" d2="552" d3="973"/>
<CITE num="021" author="MELLINS RB" publication="PEDIATRICS" d1="44" d2="315" d3="969"/>
<CITE num="022" author="MELLIS CM" publication="AUST PAEDIATR J" d1="12" d2="77" d3="976"/>
<CITE num="023" author="STANESCU D" publication="J APPL PHYSIOL" d1="42" d2="859" d3="977"/>
<CITE num="024" author="WEST JB" publication="VENTILATION BLOOD FLOW AND GA" d1="" d2="107" d3="965"/>
<CITE num="025" author="WOOLCOCK AJ" publication="J CLIN INVEST" d1="48" d2="1097" d3="969"/>
<CITE num="026" author="ZAPLETAL A" publication="J APPL PHYSIOL" d1="26" d2="308" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79258</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSMANN HC           CL" publication="IN CHEST MED" d1="1" d2="39 9" d3="0"/>
<CITE num="2" author="THOMPSON JE" publication="MED J AUST" d1="1" d2="668" d3="980"/>
<CITE num="3" author="MARTIN AJ" publication="AM REV RESPIR DIS" d1="122" d2="609" d3="980"/>
<CITE num="4" author="KERREBIJN KF" publication="EUR J RESPIR DIS" d1="63" d2="5" d3="982"/>
<CITE num="5" author="WOOLCOCK AJ" publication="EUR J RESPIR DIS" d1="65" d2="1" d3="984"/>
<CITE num="6" author="FELDMAN M" publication="AVIAT SPACE ENVIRON MED" d1="57" d2="706" d3="986"/>
</CITATIONS>
<RECORDNUM>01238 </RECORDNUM>
<MEDLINENUM>80237415</MEDLINENUM>
<AUTHORS><AUTHOR>Lieberman-J</AUTHOR><AUTHOR>Costea-N-V</AUTHOR><AUTHOR>Jakulis-V-J</AUTHOR><AUTHOR>Kaneshiro-W</AUTHOR></AUTHORS>
<TITLE>Detection of a lectin in the blood of cystic fibrosis homozygotes
and heterozygotes.</TITLE>
<SOURCE>Trans-Assoc-Am-Physicians. 1979. 92. P 121-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LECTINS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>DEXTRANS: pd</TOPIC><TOPIC>DOGS</TOPIC><TOPIC>GUINEA-PIGS</TOPIC><TOPIC>HAMSTERS</TOPIC><TOPIC>HEMAGGLUTINATION-INHIBITION-TESTS: mt</TOPIC><TOPIC>HEMAGGLUTINATION-TESTS: mt</TOPIC><TOPIC>HEMAGGLUTINATION: de</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGM: im</TOPIC><TOPIC>LYMPHOCYTES: de, en</TOPIC><TOPIC>MICE</TOPIC><TOPIC>PEDIGREE</TOPIC><TOPIC>PHYTOHEMAGGLUTININS: pd</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>RATS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>We theorize that cystic fibrosis may be a disease in which a plasma
factor with lectin-like activity stimulates mucus secretion, causes
precipitation of mucus glycoproteins, and incidentally affects
lymphocytes in culture.  To confirm our theory, we planned to search
for additional lectin-like activities in CF serum.  Our experiments
suggest that the lectin-like substance in CF blood requires IgM for
its red-blood-cell-agglutination activity.  Thus, no difference in
agglutination titer is observed between CF homozygotes and
heterozygotes, because IgM is the limiting factor, and IgM
concentrations do not differ appreciably in such subjects.  We
suspect that CF homozygotes have a larger pool of free lectin in
their blood than do heterozygotes, so that quantitation of this free
lectin pool may distinguish between the two phenotypes.  Excess free
lectin may account for the signs and symptoms of CF, whereas lesser
amounts may theoretically be advantageous to the heterozygote.</EXTRACT>
<REFERENCES>
<CITE num="001" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="002" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="116" d2="1047" d3="977"/>
<CITE num="003" author="LIEBERMAN J" publication="CHEST" d1="75S" d2="220S" d3="979"/>
<CITE num="004" author="FREED DLJ" publication="LANCET" d1="1" d2="585" d3="978"/>
<CITE num="005" author="SHARON N" publication="SCIENCE" d1="177" d2="949" d3="972"/>
<CITE num="006" author="BROOKS DE" publication="IN: MOHN JF" d1="" d2="27" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN79259</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EBERMAN J           J" publication="LAB CLIN MED" d1="97" d2="46 9" d3="1"/>
<CITE num="2" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="3" author="LIEBERMAN J" publication="AM J MED" d1="77" d2="678" d3="984"/>
<CITE num="4" author="QURESHI AR" publication="J PEDIATR" d1="106" d2="913" d3="985"/>
</CITATIONS>
<RECORDNUM>01239 </RECORDNUM>
<MEDLINENUM>80105142</MEDLINENUM>
<AUTHORS><AUTHOR>Bohles-H</AUTHOR><AUTHOR>Heid-H</AUTHOR><AUTHOR>Stehr-K</AUTHOR><AUTHOR>Fekl-W</AUTHOR></AUTHORS>
<TITLE>Deficiencies of essential fatty acids and vitamin E in cystic
fibrosis.</TITLE>
<SOURCE>Z-Ernahrungswiss. 1979 Jul. 18(2). P 81-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FATTY-ACIDS-ESSENTIAL: df</TOPIC><TOPIC>VITAMIN-E-DEFICIENCY: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BODY-HEIGHT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHOLESTEROL-ESTERS: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FATTY-ACIDS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHOSPHOLIPIDS: bl</TOPIC><TOPIC>TRIGLYCERIDES: bl</TOPIC><TOPIC>VITAMIN-E-DEFICIENCY: co</TOPIC><TOPIC>VITAMIN-E: bl</TOPIC></MINORSUBJ>
<ABSTRACT>In 25 children (13 male; 12 female) with cystic fibrosis aged 6
months to 16 years and 24 matched controls total serum vitamin E
levels and fatty acid patterns of serum cholesterol esters,
phospholipids and triglycerides are demonstrated. Compared to
controls (1.02 +/- 0.24 mg/dl) the total serum vitamin E levels are
significantly decreased in patients with cystic fibrosis (0.30 +/-
0.26 mg/dl) (p less than 0.01). There is no significant difference
comparing the fatty acid patterns of the serum ester fractions of
both groups. Differences can be seen best in the cholesterol ester
fraction. In this fraction linoleic acid shows a trend to be
decreased in the cystic fibrosis patients compared to the control
group. A possible influence of height velocity on the levels of
essential fatty acids is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="NUTR REV" d1="17" d2="13" d3="959"/>
<CITE num="002" author="BLANC WA" publication="PEDIATRICS" d1="22" d2="494" d3="958"/>
<CITE num="003" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="004" author="FOLCH J" publication="J BIOL CHEM" d1="226" d2="497" d3="957"/>
<CITE num="005" author="GORDON HH" publication="TRANS AM CLIN CLIMAT ASSOC" d1="68" d2="155" d3="956"/>
<CITE num="006" author="GORDON HH" publication="AM J CLIN NUTR" d1="4" d2="391" d3="956"/>
<CITE num="007" author="HARRIS R" publication="ARCH DIS CHILD" d1="30" d2="424" d3="955"/>
<CITE num="008" author="HARRIES JT" publication="ARCH DIS CHILD" d1="46" d2="341" d3="971"/>
<CITE num="009" author="HOLMAN RT" publication="J NUTR" d1="70" d2="405" d3="960"/>
<CITE num="010" author="JENSEN SB" publication="ACTA PAEDIATR SCAND" d1="45" d2="70" d3="956"/>
<CITE num="011" author="MCWHIRTER WR" publication="ACTA PAEDIATR SCAND" d1="64" d2="446" d3="975"/>
<CITE num="012" author="MULLER DPR" publication="GUT" d1="15" d2="966" d3="974"/>
<CITE num="013" author="NITOWSKY HM" publication="AM J DIS CHILD" d1="92" d2="164" d3="956"/>
<CITE num="014" author="NITOWSKY HM" publication="AM J CLIN NUTR" d1="4" d2="397" d3="956"/>
<CITE num="015" author="NITOWSKY HM" publication="BULL JOHNS HOPKINS HOSP" d1="98" d2="361" d3="956"/>
<CITE num="016" author="PAULSRUD JR" publication="AM J CLIN NUTR" d1="25" d2="897" d3="972"/>
<CITE num="017" author="QUAIFE ML" publication="J BIOL CHEM" d1="180" d2="1229" d3="949"/>
<CITE num="018" author="ROBINSON GR" publication="LANCET" d1="2" d2="919" d3="975"/>
<CITE num="019" author="ROSS CAC" publication="ARCH DIS CHILD" d1="30" d2="316" d3="955"/>
<CITE num="020" author="RIVERS JPW" publication="LANCET" d1="2" d2="642" d3="975"/>
<CITE num="021" author="SHMERLING DH" publication="PEDIATRICS" d1="46" d2="690" d3="970"/>
<CITE num="022" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="023" author="UNDERWOOD BA" publication="PEDIATR RES" d1="6" d2="26" d3="972"/>
<CITE num="024" author="WATTS R" publication="LANCET" d1="2" d2="983" d3="975"/>
<CITE num="025" author="WITTING LA" publication="AM J CLIN NUTR" d1="27" d2="952" d3="974"/>
<CITE num="026" author="ZOLLNER N" publication="Z GESAMTE EXP MED" d1="146" d2="89" d3="968"/>
</REFERENCES>
</RECORD>
</FILE>
